Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),-0.628094167187293,-2.2525696740426557,0.0,0.0,0.0,63/91,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;EIF4A1;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPL28;RPS24;RPS27;RPL14;RWDD1;RPL26;EIF4A2;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;RPL36A;DRG2;FTSJ1;RPS26;RPL35A;RPS29;RPL8;RPL36;TMA7;RPS3;RPL13A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6133105448435813,-2.200276805409264,0.0,0.0011192625077585242,0.002,60/87,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;SEC61B;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6018789276246405,-2.178137744996066,0.0,0.0011192625077585242,0.002,68/91,31.89%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A;TRAM1;RPS2;RPL21;RPL29;SRP14;SEC63;RPL19;RPL23A;RPS21
prerank,muscle contraction (GO:0006936),0.6666964860373987,2.1296844761040155,0.0,0.026822585389999286,0.027,20/126,3.93%,SNTB1;ITGA1;GJC1;EDNRA;CALD1;CASQ2;UTRN;DMD;DYSF;KCNJ12;UTS2;MYLK;CACNA1H;VCL;MYH11;ROCK1;TACR2;MYL9;ITGB5;TMOD1
prerank,transition metal ion transport (GO:0000041),0.8010587659032333,2.112919037710452,0.0,0.021011025222166108,0.042,7/35,3.70%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1;ATP7A
prerank,response to ATP (GO:0033198),0.893281802005957,2.083591503887114,0.0,0.03248513119455469,0.092,2/18,0.02%,ABCC9;TRPC3
prerank,bone development (GO:0060348),-0.6821023479552526,-2.0754977708938025,0.0,0.005316496911852989,0.015,16/39,11.93%,RANBP3L;SULF1;AKAP13;CYP26B1;TGM2;FGFR2;GJA1;LRP6;SKI;SULF2;SFRP4;RPL13;GNAS;NOTUM;MYOC;DYM
prerank,protein targeting to ER (GO:0045047),-0.5654181479056469,-2.07013772642047,0.0,0.005372460037240915,0.02,73/99,32.06%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;CHMP4B;CHMP4A;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;SPCS1;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A;EDEM1;RPS2;RPL21;RPL29;SRP14;SEC63;RPL19;RPL23A;GET3;RPS21;SPCS2
prerank,embryonic skeletal system development (GO:0048706),-0.6859769441745259,-2.0528156947309424,0.0,0.00634248754396497,0.03,13/35,6.25%,SULF1;COL1A1;PDGFRA;PCSK5;OSR1;KIAA1217;HOXB3;RBP4;WNT9A;HOXA3;SULF2;SIX1;WNT5A
prerank,positive regulation of calcium ion transport (GO:0051928),0.7887670136644195,2.0463890132491307,0.0,0.06795054965466485,0.211,5/36,1.47%,TRPC3;TRPC6;PDGFRB;CACNB2;MYLK
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6400310296433848,2.0454715988484464,0.0,0.05614861208306518,0.215,16/142,4.04%,TRPC3;TRPC4;TRPC6;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;ATP1A2;TRPC1;GPER1;CCRL2;ADCY8;ACKR3;ATP2B3;TACR1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7451333806799905,2.0437681401937127,0.0017699115044247787,0.048578682428554266,0.223,11/46,5.56%,GRM3;GRM7;MEF2C;CDH2;ATP1A2;NRXN1;CACNG7;GRIK1;GRM5;ATAD1;GRM1
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5489437747318683,-2.0414684129488214,0.0,0.006075996470689131,0.034,66/110,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;CTIF;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;SMG6;RPL18;RPS9;UPF3A;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;SMG5;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;PNRC2;UPF2;RPL36A;RPS26;RPL35A;DHX34;HELZ2;RPS29;RPL8;RPL36;RPS3;RPL13A
prerank,sprouting angiogenesis (GO:0002040),-0.6216315628873232,-2.0340561330144955,0.0,0.0057362203522624364,0.037,26/51,14.62%,ROBO1;EFNB2;NRP1;TEK;CCBE1;RECK;SLIT2;RSPO3;RNF213;THBS1;BMP4;EPHB4;ANGPT1;RAMP2;VEGFD;VEGFC;BMPER;ACVRL1;PTK2B;SEMA3E;AKT1;CDH13;KDR;FLT4;PARVA;ESM1
prerank,response to purine-containing compound (GO:0014074),0.8813201968552693,2.0314440911344027,0.00211864406779661,0.05581652293061756,0.281,2/17,0.02%,ABCC9;TRPC3
prerank,response to organophosphorus (GO:0046683),0.8905527325268346,2.030199416821382,0.0,0.05029234760624866,0.287,2/16,0.02%,ABCC9;TRPC3
prerank,regulation of heart contraction (GO:0008016),0.6622092299630055,2.022764700793663,0.0,0.053049113326887484,0.324,15/90,3.94%,ABCC9;ACE2;PDE4D;TBX2;CASQ2;ATP2A3;KCNJ12;ATP1A2;TRPC1;CACNA1H;ITPR2;ATP1A4;FXYD2;ATP2B3;ITPR1
prerank,manganese ion transport (GO:0006828),0.927621329898041,2.018277776729599,0.0,0.05328753630813192,0.344,6/14,2.39%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6539073993669303,2.0175482180153486,0.0,0.04966242325239262,0.353,25/107,6.61%,GRM3;GRM7;PTEN;MEF2C;SLC12A2;CEL;CLSTN1;CDH2;ATP1A2;BEGAIN;LRRC4C;EIF4EBP2;IL1B;GRIK1;NMU;GRM5;RIMS1;CLSTN3;NRG3;RIMS2;ITGB1;GRM1;GRID1;SYN1;CHRNA7
prerank,regulation of cardiac conduction (GO:1903779),0.7228469016239353,2.0106092915765266,0.0,0.053868692324915236,0.394,15/54,7.48%,ABCC9;ACE2;CASQ2;ATP2A3;ATP1A2;TRPC1;ITPR2;ATP1A4;FXYD2;ATP2B3;ITPR1;ATP1B2;RYR2;ATP2A2;STIM1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8134490581985907,2.0069847208940788,0.00398406374501992,0.05350761906004986,0.421,7/21,6.40%,PDE4D;CACNA1C;CASQ2;DMD;ATP1A2;AKAP6;RYR2
prerank,cellular calcium ion homeostasis (GO:0006874),0.616653640026035,1.9646397053916584,0.0,0.11750846932761594,0.706,21/133,7.48%,TRPC3;ATP13A5;TRPC4;TRPC6;PTH1R;ATP2A3;TRPC1;GPER1;ATP2C1;STIM2;ADCY8;ATP2B3;ATP13A4;SLC24A4;SLC24A2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1
prerank,potassium ion import across plasma membrane (GO:1990573),0.7329389891786485,1.9527716148209957,0.0018315018315018315,0.1344705614218631,0.777,9/41,4.90%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;ATP1A4;FXYD2;SLC12A6;ATP1B2
prerank,inorganic ion transmembrane transport (GO:0098660),0.9023605131183752,1.951642609109952,0.0,0.1288601706444549,0.779,3/12,1.67%,ABCC9;KCNJ8;CACNA1H
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.730058561426578,1.9412819643545478,0.0037313432835820895,0.14499974102005497,0.839,12/35,7.26%,GUCY1B1;PDE4D;CAP2;PDE3A;RAPGEF2;IRAG1;PDE7B;PDE9A;AKAP6;RIMS2;HTR2C;CAP1
prerank,metal ion transport (GO:0030001),0.6479106455527199,1.9397797009803313,0.0,0.14017284438995922,0.849,10/86,3.94%,TRPC3;TRPC4;CACNA1C;ATP2A3;TRPC1;ATP2C1;NDFIP2;CACNG7;CACNA2D1;ITPR1
prerank,chordate embryonic development (GO:0043009),-0.5769982764793984,-1.9389939163745855,0.0,0.03718438775775542,0.225,22/55,11.87%,SULF1;ALDH1A2;COL1A1;CHD7;BMP7;PCSK5;KIAA1217;RBP4;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;SULF2;WNT5A;HINFP;TBX1;FUT8;FLCN;TGFB1;PTCH1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.823669457249061,1.935785063197604,0.0063025210084033615,0.14310084591401373,0.862,4/16,1.22%,CACNA1C;CASQ2;DMD;ATP1A2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8229012155118612,1.9338700126281043,0.0,0.14023741728071293,0.868,6/17,6.40%,GJD3;GJC1;CACNA1C;ATP1A2;ATP1B2;RYR2
prerank,eye morphogenesis (GO:0048592),-0.7294246395042017,-1.932392251101812,0.0020920502092050207,0.036935662756031294,0.247,11/19,7.32%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;MFAP5;NKD1;SKI;RARG;FBN2;STAT3
prerank,androgen receptor signaling pathway (GO:0030521),-0.8345842356326303,-1.9272924875954691,0.0,0.03724091616723817,0.264,6/11,12.24%,ZMIZ1;DDX5;AR;TMF1;KDM3A;PLPP1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.8529613240538858,1.9199083959997316,0.0,0.16893971242463043,0.91,4/15,5.56%,GRM3;GRM7;GRM5;GRM1
prerank,amino acid import (GO:0043090),-0.7189582406081264,-1.9195152924909356,0.0,0.04001363465236724,0.306,15/21,22.09%,SLC6A13;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SFXN2;SLC22A4;SLC7A5;SLC6A1;SLC25A38;SLC7A1;SLC22A2;SH3BP4;SLC36A1;SLC1A1
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.8400715375485329,-1.9191781422637826,0.0,0.0369356627560313,0.306,7/11,11.59%,TGFBR3;TGFBR2;TGFBR1;SMAD7;ACVR1;USP15;TGFB1
prerank,skin development (GO:0043588),-0.5626483885465059,-1.9187205131898575,0.0,0.03469713774051425,0.31,21/65,14.82%,COL1A2;COL3A1;COL5A2;COL1A1;ERRFI1;CLIC4;COL5A1;ITGA6;ANXA1;ADAM9;ITGA3;LSR;WNT5A;TXNIP;ITGB4;GATA6;WNT16;MET;UGCG;CLDN1;PKD1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7796942099945061,1.907294742192215,0.008247422680412371,0.19564231222341902,0.936,6/20,6.59%,CACNA1C;CASQ2;DMD;ATP1A2;RYR2;ATP2A2
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.7796368314722902,1.893913054138535,0.0058823529411764705,0.22834183562442872,0.961,11/24,10.18%,PDE4D;PDE3A;RAPGEF2;GPR61;PRKAR1B;PEX5L;PRKAR2B;PRKAR2A;GPR62;CGAS;PRKAR1A
prerank,proteoglycan metabolic process (GO:0006029),-0.6672026413407268,-1.8931799408039272,0.0,0.05066528285120253,0.436,8/26,8.95%,SULF1;IGF1;CHST11;ADAMTS12;BMPR2;CSGALNACT1;SULF2;FOXL1
prerank,cGMP metabolic process (GO:0046068),0.8665830912497857,1.8836118494522318,0.011160714285714286,0.2526538529374655,0.974,4/12,3.73%,GUCY1B1;GUCY1A1;PDE9A;GUCY2D
prerank,cation transport (GO:0006812),0.5652025301971243,1.883146288349486,0.0,0.2448365594399135,0.975,19/167,5.52%,ABCC9;ANO1;TRPC6;KCNJ8;SLC12A2;NEDD4L;KCNJ12;ATP1A2;KCNG1;KCNMB1;ATP1A4;SLC5A1;KCNQ4;NDFIP2;FGF13;SCN2A;KCNH4;KCNAB3;SCN5A
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6340339392593497,-1.878291851077166,0.0041841004184100415,0.06044017541896031,0.526,12/30,12.55%,TGFBR3;SMAD3;FSTL1;DKK3;SMURF2;SMAD7;ITGA3;LTBP4;SFRP4;FKBP1A;TGFB1;TWSG1
prerank,platelet degranulation (GO:0002576),-0.5041627448585477,-1.8712768611175323,0.0,0.06412715779745898,0.566,42/118,18.44%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;SERPING1;VWF;PECAM1;ACTN2;APP;SPARC;PCDH7;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;IGF2;GAS6;SRGN;TMSB4X;ECM1;PSAP;LGALS3BP;ITGB3;TGFB1;ACTN1;F5;APOOL;SCG3;SERPINE1;APLP2;SYTL4;CD109;CALM1;QSOX1;CYRIB;BRPF3;MAGED2
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7968579427487411,1.8708826127063585,0.008264462809917356,0.28125887936513355,0.981,4/17,1.63%,PTEN;MEF2C;PRKG1;GPER1
prerank,skeletal system morphogenesis (GO:0048705),-0.5957174810471355,-1.8590899057671035,0.0,0.07169498174697658,0.624,12/42,6.60%,PDGFRA;WWOX;CYP26B1;HOXB3;FGFR2;TGFBR1;LRP6;SKI;HOXA3;SFRP4;SIX1;FBN2
prerank,bone morphogenesis (GO:0060349),-0.7661825017030166,-1.8572022000092532,0.0,0.06957100114014828,0.634,6/14,5.90%,CYP26B1;FGFR2;BMPR2;LRP6;SKI;SFRP4
prerank,cGMP-mediated signaling (GO:0019934),0.8232553700109488,1.8518668916107903,0.014285714285714285,0.35068046824702775,0.992,4/13,2.42%,GUCY1B1;PDE3A;IRAG1;PDE9A
prerank,regulation of adenylate cyclase activity (GO:0045761),0.7822160081290233,1.8509424647467734,0.003937007874015748,0.34233921186450283,0.992,4/22,2.17%,GRM3;CACNA1C;CAP2;NF1
prerank,chemical synaptic transmission (GO:0007268),0.5336876081208787,1.8465818727880832,0.0,0.3491252378808643,0.993,66/284,12.33%,GRM3;GRM7;LIN7A;PTEN;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;SLC1A4;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;SNAP25;GRM5;RIMS1;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;GABRG2;GRM1;GRID1;ASIC2;HTR1B;GRIA2;CDH8;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;SLC32A1;OPRK1;CHRNA7;CHRFAM7A;ERC2;RIMBP2;PRKAR2A;KCNQ3;SYT1;SLC5A7;GRM4;PLP1;GRIN2B;CACNA1A;SLC12A5;STXBP2;PRKAR1A;APBA2;DLG2;GAD1;BRSK1;NTSR1;SCN2B;GABRA5;KCNC4;GABRA4;DLGAP2;GRIK5;GRIK2
prerank,inorganic cation import across plasma membrane (GO:0098659),0.6339264571064316,1.844147512085163,0.001697792869269949,0.3484849899614019,0.994,13/75,4.90%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;TRPV2;ATP1A4;SLC5A1;FXYD2;CACNA2D1;SLC24A2;SLC12A6;ATP1B2
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.751507304424651,-1.8431843517499953,0.00375234521575985,0.08489606121348406,0.705,8/15,10.61%,NTRK3;F3;VEGFD;VEGFC;IL16;CXCL12;CDH13;KDR
prerank,calcium ion transport (GO:0006816),0.5888059871382756,1.8385762455315324,0.004531722054380665,0.3593649612466571,0.997,21/113,7.48%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;ATP2A3;TRPC1;CACNA1H;TRPV2;ATP2C1;CACNG7;CACNA2D1;STIM2;ITPR1;SLC24A4;SLC24A2;RYR2;ATP2A2;CHRNA7;CACNA1D;STIM1
prerank,inorganic cation transmembrane transport (GO:0098662),0.5299257404809131,1.8381725437144834,0.0,0.35003473933949064,0.997,42/268,9.02%,ABCC9;TRPC3;TRPC4;TRPC6;CACNA1C;KCNJ8;SLC30A10;SLC12A2;ATP2A3;KCNJ12;ATP1A2;TRPC1;KCNG1;CACNA1H;TRPV2;ATP2C1;KCNV2;ATP1A4;KCNQ4;KCND2;SLC24A4;SLC24A2;SCN2A;KCNH8;KCNH4;KCNAB3;SCN5A;ASIC2;KCNQ5;ATP6V0E2;HCN2;SCN8A;ATP2A2;CACNA1D;KCNA4;KCNQ3;SLC9A7;RYR3;HCN3;SLC6A15;SCN9A;PKD2
prerank,ATP transport (GO:0015867),-0.8373805750832719,-1.82976210383883,0.0,0.100360538195681,0.77,5/10,10.65%,CD47;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,respiratory tube development (GO:0030323),-0.6407007378885403,-1.828534943364821,0.004291845493562232,0.09773196715473295,0.775,10/28,8.16%,GLI2;PDPN;PCSK5;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6
prerank,mesenchymal cell development (GO:0014031),0.8007347077433564,1.8281166000542728,0.006198347107438017,0.382777258979707,0.997,6/18,2.80%,HEY2;CDH2;HEYL;NOTCH1;TBX20;NRG1
prerank,renal system development (GO:0072001),-0.5606783573139271,-1.81629952870191,0.0,0.11105030620456315,0.832,15/52,9.11%,SULF1;WNT4;GLI2;PCSK5;GREB1L;RBP4;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STAT1;STRA6;ARL3
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5554427194663213,1.8161460500731637,0.001451378809869376,0.426163547872871,1.0,16/140,6.40%,TRPC3;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;GPER1;CCRL2;CACNA2D1;ADCY8;ACKR3;TACR1;GRM1;CXCR2;HTR2C;RYR2
prerank,digestive tract development (GO:0048565),-0.6181073110678257,-1.815990909648375,0.0,0.10684293355311579,0.834,15/33,16.39%,CLMP;GLI2;PCSK5;RARB;FGFR2;SMO;STRA6;BBS7;KIT;GLI3;ZIC3;GATA6;PKD1;PKDCC;EPHB3
prerank,regulation of bone mineralization (GO:0030500),-0.5498721804305703,-1.813136457079838,0.0,0.10713580724264593,0.847,25/55,12.78%,BMP6;WNT4;BMP7;OSR1;ENPP1;SGMS2;ANKH;BMPR2;BMP4;ADGRV1;ACVR1;SRGN;BMP2K;FBN2;ANO6;PTK2B;KL;ATRAID;ECM1;NOTUM;P2RX7;TGFB1;TMEM119;S1PR1;CCN1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.699867768990204,1.8127204094556737,0.005928853754940711,0.4303364509332648,1.0,7/32,6.29%,TRPC3;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,respiratory system development (GO:0060541),-0.6156567243566883,-1.8091487325490616,0.004310344827586207,0.10934333729640967,0.864,13/32,13.41%,GLI2;PDPN;CHD7;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6;DISP1;ZIC3;SPEF2
prerank,positive regulation of behavior (GO:0048520),0.8554969727127323,1.8087400704709928,0.011389521640091117,0.4370591274937106,1.0,2/10,0.63%,SGIP1;MEF2C
prerank,collagen fibril organization (GO:0030199),-0.505290979025116,-1.8082922561175123,0.0,0.1065372090718299,0.867,39/88,12.53%,COL1A2;COL3A1;COL5A2;COL1A1;ADAMTS2;COL22A1;COL12A1;COL5A1;LOXL1;COL6A3;COL25A1;COL6A1;COL8A2;ITGA6;TLL1;COL4A5;COL6A2;TGFBR1;PLEC;COL11A1;COL23A1;COL4A6;PLOD2;COL13A1;SERPINH1;P4HB;COL18A1;CYP1B1;ITGB4;COL14A1;DPT;COL15A1;COL16A1;LUM;ADAMTS14;LAMA3;ADAMTS3;COL20A1;COL9A2
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.45707772034302174,-1.8069419547182437,0.0,0.10477096545839613,0.872,88/168,24.60%,SAMD4A;RPLP1;RPS14;DDX5;CNOT7;RPL9;TUT4;RPS12;THRAP3;TUT7;RPL41;RPS20;CTIF;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RC3H2;SMG6;RPL18;RPS9;UPF3A;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;ZC3H12A;MTPAP;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;ATM;RPS24;RPS27;RPL14;RPL26;CNOT8;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;XRN1;NBDY;RPL31;CNOT3;SMG5;RPS25;RPL15;RPSA;PNLDC1;RPS7;RPL38;RPLP0;RPL27;AGO1;CNOT11;PNRC2;UPF2;TENT4B;RPL36A;PAN3;RPS26;RPL35A;DHX34;CSDE1;HELZ2;EXOSC7;SAMD4B;RPS29;RPL8;RPL36;POLR2G
prerank,cGMP biosynthetic process (GO:0006182),0.86131989966974,1.8048442709649635,0.011286681715575621,0.44387754146747466,1.0,3/10,3.73%,GUCY1B1;GUCY1A1;GUCY2D
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7937602137634692,1.8047088640929538,0.010893246187363835,0.43273771095865515,1.0,6/18,2.51%,IL34;DAAM2;TNFRSF21;NOTCH1;NF1;PTN
prerank,positive regulation of phosphatase activity (GO:0010922),0.7436855654950455,1.8032203347215359,0.013972055888223553,0.42851945821356124,1.0,3/21,0.63%,ITGA1;PDGFRB;MEF2C
prerank,extracellular matrix organization (GO:0030198),-0.43244332435091387,-1.8014450552742027,0.0,0.10964913050144715,0.889,110/276,12.53%,FLRT2;ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;GSN;COL12A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL25A1;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;TLL1;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;PLEC;COL11A1;CAPN2;TIMP2;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HTRA1;HSPG2;ADAM10;PLOD2;COL13A1;GAS6;BGN;ST7;SERPINH1;ADAMTS1;ITGA11;SPOCK2;NDNF;P4HB;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CYP1B1;CD47;GFOD2;KLK2;CAPNS1;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;CAPN1;DPT;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;TGFB1;CTSS;ADAMTS3;F11R;COL20A1;SMOC2;COL9A2
prerank,neurotransmitter secretion (GO:0007269),0.6615400038262456,1.8009501190634127,0.005681818181818182,0.42797670205193034,1.0,14/44,10.73%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;RIMS2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;GAD1;BRSK1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.833801066895002,1.795319687987244,0.015730337078651686,0.44135146805544356,1.0,2/10,0.99%,PDE4D;PDE3A
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.7779729029189192,1.793267721053324,0.016,0.440231004654909,1.0,4/17,1.62%,NOTCH3;HEYL;NOTCH1;MAML2
prerank,central nervous system neuron development (GO:0021954),0.7868157891493663,1.7930886956988548,0.02240325865580448,0.43082478238820565,1.0,7/15,9.18%,PTEN;RAPGEF2;MAP2;ATP7A;NTRK2;B4GALT6;ARHGAP35
prerank,prostaglandin metabolic process (GO:0006693),-0.6367062538021266,-1.792267758539769,0.0,0.12013417583274827,0.907,9/26,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;ACOX1;TBXAS1;GSTM1;PTGS2
prerank,regulation of multicellular organism growth (GO:0040014),-0.722383211243947,-1.7920745003692438,0.006134969325153374,0.11661993226000107,0.907,5/15,13.15%,IGF1;APP;GHR;PTCH1;MFSD2A
prerank,mesonephros development (GO:0001823),-0.7901837372830867,-1.7880679581313632,0.0,0.119446295749855,0.919,5/11,5.35%,ZBTB16;BMP7;OSR1;BMP4;FGF1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5327991552267066,-1.7875696818358557,0.0,0.11664072012671409,0.924,19/58,14.57%,ST3GAL4;PLPP3;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.7698508539757634,-1.7871120024478029,0.005628517823639775,0.11376974196510177,0.925,8/11,17.18%,NUPR1;ARHGEF2;BIRC3;SLC25A4;CASP8;YBX3;PELI1;RIPK1
prerank,secondary palate development (GO:0062009),-0.7440394563287459,-1.7855075273955292,0.0,0.11278968185326614,0.928,5/14,6.25%,TGFBR3;CHD7;TGFBR2;LEF1;WNT5A
prerank,anterograde trans-synaptic signaling (GO:0098916),0.5276938296261202,1.780636740268054,0.0,0.47417047733002526,1.0,66/224,16.41%,GRM3;GRM7;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;SNAP25;GRM5;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;GABRG2;GRM1;ASIC2;HTR1B;GRIA2;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;OPRK1;CHRNA7;CHRFAM7A;PRKAR2A;KCNQ3;SYT1;GRM4;PLP1;GRIN2B;CACNA1A;SLC12A5;PRKAR1A;APBA2;DLG2;GAD1;NTSR1;SCN2B;GABRA5;KCNC4;GABRA4;GRIK2;SLC12A4;NLGN3;DLGAP1;CHRNB2;CAMKK2;PCDHB16;GABRB3;CDK5;GRIN2A;HTR4;GRIA1;GRIA4;MAPK1;APBA1
prerank,diacylglycerol metabolic process (GO:0046339),0.7469234047215861,1.7806151146263398,0.0078125,0.46371282993866175,1.0,4/23,1.88%,DGKB;PLCE1;DGKH;DGKG
prerank,visual perception (GO:0007601),-0.5058082773521695,-1.7796808766678451,0.0,0.11898382269977424,0.937,17/84,12.34%,COL1A1;EFEMP1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.6545460665874423,-1.7768743530925784,0.004149377593360996,0.11991234002039974,0.943,7/23,4.34%,TGFBR3;SMAD3;DKK3;SMURF2;SMAD7;ITGA3;LTBP4
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.7740452949261573,1.7711768564973298,0.02028397565922921,0.48371964630985953,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.7740452949261573,1.7711768564973298,0.02028397565922921,0.48371964630985953,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5853350430922544,-1.770819858674747,0.0,0.1261232120584737,0.954,17/38,16.54%,SMAD3;ROCK2;PTGIS;CAV1;KLF4;KLF2;CD34;DDAH1;P2RX4;CD47;NOS1AP;AKT1;ZC3H12A;PTGS2;HSP90AB1;SIRPA;TLR4
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8052923109169869,1.7707203218440006,0.012096774193548387,0.4759705031046193,1.0,2/12,0.33%,GJD3;PDE4D
prerank,cellular response to BMP stimulus (GO:0071773),-0.5250553235053341,-1.7704615856176902,0.0,0.12337716720138193,0.954,19/66,9.07%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;BMP7;BMPR2;BMP4;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,negative regulation of nuclear division (GO:0051784),-0.7746865869873024,-1.7704161785497978,0.003738317757009346,0.1203487011467353,0.954,4/11,6.19%,BMP7;TOM1L2;BMP4;TOM1L1
prerank,signal release from synapse (GO:0099643),0.6538346456329807,1.7696605693024374,0.011406844106463879,0.4705995236690283,1.0,13/43,10.73%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;GAD1;BRSK1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.6031793295676274,-1.7684113327012265,0.0,0.12082575266681043,0.957,11/30,16.35%,ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;F11R;LPAR6;PRAG1;LPAR4;NET1
prerank,chloride transmembrane transport (GO:1902476),0.654473526322773,1.76771526752856,0.005660377358490566,0.4696813519024809,1.0,7/48,5.87%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;GABRG2;GABRA2
prerank,positive regulation of blood coagulation (GO:0030194),-0.687426844843753,-1.766954347060475,0.005535055350553505,0.12018747404740342,0.957,7/17,15.72%,ST3GAL4;F3;THBS1;THBD;ANO6;USF1;SERPINE1
prerank,calcium ion import (GO:0070509),0.7102518581509819,1.7653543795346314,0.00998003992015968,0.47007895728590904,1.0,4/28,1.67%,TRPC4;CACNA1C;CACNB2;CACNA1H
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6839526757191768,1.7649098575671733,0.023465703971119134,0.46284434366243005,1.0,3/32,0.19%,DLC1;ITGA1;PDGFRB
prerank,skeletal system development (GO:0001501),-0.45769162408023617,-1.7631778216766718,0.0,0.12395181539409517,0.967,40/148,8.79%,BMP6;SULF1;IGF1;FBN1;COL1A2;EXT1;ZBTB16;COL1A1;WWOX;GLI2;AKAP13;CHD7;BMP7;PCSK5;KIAA1217;ITGB8;RBP4;TLL1;SUFU;ANKH;TGM2;NPR3;FGFR2;GJA1;TGFBR1;CREB3L2;TNFRSF11B;COL13A1;PAPSS2;IGF2;TEAD4;SULF2;WNT5A;PRELP;ALPL;EVC;RPL13;GNAS;MMP14;CMKLR1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.6717865900928118,-1.7605061579333354,0.0036968576709796672,0.125815280985765,0.974,7/18,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,peptide cross-linking (GO:0018149),-0.6343784174774341,-1.7603199593853271,0.0040650406504065045,0.12329298335464454,0.974,6/25,6.06%,FN1;COL3A1;TGM2;THBS1;ANXA1;NDNF
prerank,prostanoid biosynthetic process (GO:0046457),-0.7102266016301446,-1.753956046057081,0.0,0.13075905905857194,0.978,7/15,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6308390961033659,-1.7525586955825683,0.0,0.12990589318771806,0.978,15/24,19.57%,SEC23A;SEC24D;B2M;SEC31A;TAPBP;ACE;SEC24A;ERAP1;IDE;CALR;PDIA3;HFE;BCAP31;SAR1B;CANX
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.55576110754915,-1.7523768947022116,0.0044943820224719105,0.12743270010209032,0.978,15/43,13.06%,NFIB;SMAD3;FOXO3;NR3C1;BMP4;KLF4;DDX5;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;PPARA;ATOH8
prerank,negative regulation of cell aging (GO:0090344),0.7780019515247096,1.7509611393130788,0.029288702928870293,0.513340423533131,1.0,4/16,2.56%,SLC30A10;CDK6;AKT3;FOXM1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6694932372366715,1.750426121692353,0.008802816901408451,0.5061686777516471,1.0,6/37,5.80%,GRM3;GRM7;GRIK1;GRM5;GRM1;GRIA2
prerank,arachidonic acid metabolic process (GO:0019369),-0.5742260552838782,-1.7479582968393221,0.004098360655737705,0.13173034453557977,0.982,11/35,12.26%,PTGDS;PLA2G4A;PTGIS;PTGS1;CYP1B1;DAGLB;GPX4;TBXAS1;MGLL;PTGS2;EPHX2
prerank,cAMP-mediated signaling (GO:0019933),0.7081611231035001,1.7436224237366393,0.030425963488843813,0.5262428692394284,1.0,8/24,7.26%,PDE4D;CAP2;PDE3A;RAPGEF2;PDE7B;AKAP6;RIMS2;CAP1
prerank,BMP signaling pathway (GO:0030509),-0.516478870187034,-1.7426182231436098,0.0,0.13728873920166057,0.987,18/62,9.07%,BMP6;TGFBR3;SMAD3;SMAD6;BMP7;BMPR2;BMP4;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,negative regulation of wound healing (GO:0061045),0.6871951779461137,1.7415014625054837,0.019455252918287938,0.5265049990511944,1.0,7/28,5.26%,PTEN;SLC12A2;VTN;AJAP1;PHLDB2;FGF2;CLASP2
prerank,kidney development (GO:0001822),-0.5130094421400576,-1.741283567324611,0.0,0.1367475428596738,0.988,17/65,9.11%,SULF1;ZBTB16;WNT4;GLI2;CTSH;BMP7;PCSK5;OSR1;GREB1L;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STRA6;ARL3
prerank,calcium ion transmembrane transport (GO:0070588),0.584761339010636,1.7406389228379824,0.011363636363636364,0.5207346139047931,1.0,12/86,4.63%,TRPC3;TRPC4;TRPC6;CACNA1C;ATP2A3;TRPC1;TRPV2;ATP2C1;CACNA2D1;ATP2B3;SLC24A4;SLC24A2
prerank,tight junction assembly (GO:0120192),-0.5394002823729692,-1.7401389069475752,0.0,0.13596887041366534,0.99,15/49,12.07%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;LSR;PDCD6IP;PARD6G;CLDN11;ACTG1;PARD3;PATJ;F11R
prerank,positive regulation of transporter activity (GO:0032411),0.8080108896439757,1.7388730201244935,0.027253668763102725,0.5194949009442391,1.0,4/13,7.40%,TRPC6;NR1H3;STK39;PDZK1
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.7418187686077502,-1.7384031105377553,0.007532956685499058,0.13616989905711255,0.99,3/12,1.10%,NFIB;EPHA4;GLI2
prerank,lung development (GO:0030324),-0.59399653928718,-1.7358402608807788,0.004424778761061947,0.13777292387168352,0.99,11/33,8.16%,ERRFI1;GLI2;PDPN;RBP4;FGFR2;BMP4;ITGA3;RCN3;FGF1;ABCA3;STRA6
prerank,aorta morphogenesis (GO:0035909),0.7554550632322935,1.735326793991943,0.024793388429752067,0.5261772937353419,1.0,4/17,1.47%,PDGFRB;TBX2;HEY2;MYLK
prerank,positive regulation of embryonic development (GO:0040019),-0.6558429230781454,-1.7326021707739634,0.003795066413662239,0.14094567506791889,0.991,5/19,7.38%,PLCB1;WNT4;OSR1;NIBAN2;NR2C2
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.6745359530286154,1.732254881867591,0.02119460500963391,0.5313405151395582,1.0,5/32,1.69%,DLC1;PTEN;ARHGAP6;AJAP1;PHLDB2
prerank,sensory perception of light stimulus (GO:0050953),-0.4903048126552291,-1.7301682886708338,0.0,0.1431256931796213,0.993,17/87,12.34%,COL1A1;EFEMP1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,sodium ion homeostasis (GO:0055078),0.719428692018197,1.7278044114474242,0.014861995753715499,0.5425051109508435,1.0,6/21,5.65%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,negative regulation of cell junction assembly (GO:1901889),0.7153467421618627,1.7260210558777942,0.027559055118110236,0.5411240291259857,1.0,7/25,2.62%,DLC1;PTEN;ARHGAP6;PHLDB2;SLIT1;ROCK1;IL1B
prerank,in utero embryonic development (GO:0001701),-0.6055506870854417,-1.725319617990258,0.01037344398340249,0.1485280983979908,0.994,12/25,14.82%,CHD7;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;HINFP;FUT8;FLCN;ZNF568;PKD1
prerank,mesonephric tubule development (GO:0072164),-0.6858779985983594,-1.724425002715968,0.007561436672967864,0.14753037710023995,0.994,7/15,6.83%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6934521675736389,1.7224410154878482,0.017964071856287425,0.5472517011765939,1.0,4/24,4.10%,PDE4D;CASQ2;DMD;AKAP6
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7720286565468801,1.7188968457737523,0.03346456692913386,0.5544032818761051,1.0,3/14,3.07%,ACE2;ENPEP;ECE1
prerank,potassium ion transmembrane transport (GO:0071805),0.5300043510581958,1.7176528545292629,0.005873715124816446,0.5510321901145495,1.0,30/135,10.26%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;KCNG1;KCNV2;ATP1A4;KCNQ4;FXYD2;KCNE4;KCND2;SLC24A4;SLC24A2;SLC12A6;ATP1B2;KCNH8;KCNH4;KCNAB3;KCNQ5;HCN2;KCNE5;KCNA4;KCNQ3;SLC9A7;HCN3;PKD2;KCNJ3;SLC12A5;KCNJ6
prerank,positive regulation of protein secretion (GO:0050714),-0.49870070734208316,-1.7171271001911517,0.005089058524173028,0.1584610123272365,0.994,22/69,17.59%,BMP6;IGF1;UNC13B;CD2AP;MCU;MYRIP;RBP4;MYO18A;EZR;TCF7L2;ADAM9;NNAT;GOLPH3;C1QTNF3;MYH10;NLGN2;TGFB1;PPID;PPIA;SYTL4;TLR4;ACSL4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.569106071069755,-1.7168115147689573,0.002188183807439825,0.15656617046028823,0.994,12/35,12.07%,NOTCH2;PDGFRA;NRP1;NTRK3;BAIAP2L1;TEK;BAIAP2;PTK2B;SEMA3E;IQGAP2;ARHGDIA;F11R
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.8086755865456653,1.7120066098100055,0.02608695652173913,0.5669725587513335,1.0,2/12,3.74%,ANO1;ADCY8
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7993716447404481,1.7113219428390343,0.025423728813559324,0.5615661882497264,1.0,2/11,0.68%,DLC1;FAP
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5732438463225129,1.7113125031167051,0.01155115511551155,0.5533210102781078,1.0,10/75,4.08%,RGS5;RGS4;RGS6;PLCE1;METAP2;GPER1;ROCK1;RGS3;GUCY2D;RGS11
prerank,cardiac muscle cell action potential (GO:0086001),0.6672722238444847,1.7108051991925246,0.030534351145038167,0.5469734176244685,1.0,8/30,7.38%,CACNA1C;DMD;ATP1A2;FGF12;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.7005390680461854,-1.7104421687030527,0.007407407407407408,0.1658710339366731,0.997,6/15,7.99%,PDGFRA;TGFBR2;FGFR2;TGFBR1;SIX1;TBX1
prerank,embryonic appendage morphogenesis (GO:0035113),-0.7418962371851626,-1.7088479023689265,0.0,0.16631879812869813,0.997,5/12,11.87%,CYP26B1;MBNL1;LRP6;SKI;PTCH1
prerank,retinoic acid metabolic process (GO:0042573),-0.7111446494424836,-1.7068416938611537,0.005964214711729622,0.16726756365946838,0.997,4/14,13.43%,ALDH1A2;CYP26B1;SCPEP1;ADH1A
prerank,cellular sodium ion homeostasis (GO:0006883),0.7472999763996364,1.705288891202887,0.024336283185840708,0.5625334789268327,1.0,5/15,4.90%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2
prerank,regulation of BMP signaling pathway (GO:0030510),-0.4958282598768789,-1.7052856421632776,0.0,0.167609560536839,0.997,21/73,7.15%,SULF1;ZNF423;FSTL1;SMAD6;CDH5;SKIL;HTRA3;BMPR2;SMURF2;BMP4;FOXD1;SMAD9;SMAD7;ITGA3;SKI;BMPER;SFRP4;ACVRL1;SMURF1;NBL1;VWC2
prerank,substrate-dependent cell migration (GO:0006929),-0.7158793191512371,-1.7033716624676873,0.0020242914979757085,0.16880200559318173,0.998,10/14,19.65%,NRP1;CD2AP;ANKS1A;SDCBP;VEGFC;ITGA11;EPHA8;OPHN1;NTN1;ITGA2
prerank,cellular metal ion homeostasis (GO:0006875),0.5396291102269497,1.7028802998961352,0.007692307692307693,0.5642187504220273,1.0,22/102,8.66%,ATP13A5;PTH1R;SLC12A2;ATP2A3;NEDD4L;ATP1A2;ATP2C1;ATP1A4;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;ATP1B2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1;STC2;LETM1
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6643598378672657,-1.7003224004463857,0.005917159763313609,0.17177287789524381,1.0,5/17,3.70%,NRP1;NTRK3;BAIAP2L1;TEK;BAIAP2
prerank,inositol lipid-mediated signaling (GO:0048017),0.6217888546691592,1.6985057883046506,0.015789473684210527,0.5745745490718829,1.0,11/50,7.20%,ADAP2;PDGFRB;PLCL1;PLCE1;PIK3CD;PIK3R1;PIK3CA;PITPNM2;OGT;PIK3C2A;IRS1
prerank,integrin-mediated signaling pathway (GO:0007229),-0.49391304708301653,-1.6938321469403166,0.0025380710659898475,0.18158781282589787,1.0,27/73,11.50%,ITGBL1;DAB2;FN1;COL3A1;NRP1;FBLN1;PLPP3;NEDD9;ITGB8;FYB1;ITGA5;SEMA7A;ADAM9;ADAM10;ADAMTS1;ITGA11;ITGA10;PTK2B;PTPRA;CD47;ZYX;ITGB4;ADAM15;LAMA5;COL16A1;ITGB3;LAMA3
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.7051318806184077,-1.6935205008553469,0.005847953216374269,0.1793947363538258,1.0,4/14,4.28%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.779948556813725,1.6929243772879188,0.026748971193415638,0.5902560994065004,1.0,3/13,0.73%,GJC1;CACNA1C;CACNB2
prerank,T cell migration (GO:0072678),0.7771715001433595,1.6927329528200854,0.04086021505376344,0.5830166826166782,1.0,3/13,5.80%,SLC12A2;PIK3CD;CXCL10
prerank,heart morphogenesis (GO:0003007),0.6122955932820664,1.692041765515466,0.015734265734265736,0.5784618370952558,1.0,8/50,1.88%,DLC1;TBX2;HEY2;HEYL;NOTCH1;TBX20;PTK2;TBX3
prerank,cellular response to interferon-gamma (GO:0071346),-0.47070371333997724,-1.6906847703730774,0.0027397260273972603,0.1827155490926379,1.0,28/88,16.88%,DAPK1;SP100;B2M;VCAM1;LGALS9;IRF1;WNT5A;CCL15;ICAM1;IRF2;STAT1;CCL14;CD47;GBP4;PRKCD;IRF9;OAS2;PML;GBP6;CAMK2A;GBP5;CCL25;GBP7;GBP2;CCL13;SIRPA;TLR4;TRIM8
prerank,lipid phosphorylation (GO:0046834),0.8099374870974831,1.689742666477726,0.034934497816593885,0.5798031232219802,1.0,3/10,1.88%,DGKB;DGKH;DGKG
prerank,response to interferon-gamma (GO:0034341),-0.49508637868994415,-1.6886942465660364,0.0,0.1840067562755014,1.0,21/67,16.54%,DAPK1;SP100;IFITM3;LGALS9;WNT5A;CCL15;STAT1;CCL14;CD47;GBP4;GBP6;GBP5;GCH1;CCL25;GBP7;IFITM2;GBP2;CXCL16;CCL13;SIRPA;TLR4
prerank,response to cholesterol (GO:0070723),-0.6679644292527205,-1.6872218223540127,0.005649717514124294,0.1844891426520846,1.0,8/17,11.87%,TGFBR2;TGFBR1;LRP6;SMO;GRAMD1C;GRAMD1A;TGFB1;PTCH1
prerank,negative regulation of cellular senescence (GO:2000773),0.7727056908128593,1.6872121759084773,0.04184100418410042,0.5834899300575127,1.0,3/13,2.36%,SLC30A10;CDK6;AKT3
prerank,regulation of DNA binding (GO:0051101),-0.5404964214141788,-1.6871930922174418,0.0066815144766146995,0.18202006532423,1.0,18/44,21.26%,IGF1;SP100;LEF1;SKI;SMO;FOXC1;MDFI;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;NFKBIA;E2F1;PLAUR;RSF1;HJURP
prerank,eye development (GO:0001654),-0.5160106136566864,-1.68683948784328,0.0,0.18015526665976245,1.0,15/54,8.16%,PBX1;FBN1;SMOC1;COL5A2;EFEMP1;LAMA1;COL5A1;SHROOM2;PBX3;RBP4;SKI;RAB3GAP1;FBN2;FOXC1;STRA6
prerank,regulation of epithelial cell migration (GO:0010632),-0.5209608652797276,-1.6863053500923908,0.0044742729306487695,0.1787946230299124,1.0,23/51,15.88%,MCC;DOCK5;GLUL;CTSH;PLCG1;MACF1;SASH1;BMPR2;ARSB;RAB11A;PTPRG;BMPER;PRKCE;RREB1;HIF1A;DAB2IP;RHOJ;PFN1;EVL;PLCG2;CORO1C;DUSP10;CEACAM1
prerank,positive regulation of ossification (GO:0045778),-0.5373286055695478,-1.6858424090539617,0.004395604395604396,0.1775001102303985,1.0,20/39,15.76%,BMP6;ZBTB16;WNT4;BMP7;OSR1;BMPR2;BMP4;ADGRV1;ACVR1;WNT5A;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6246820864549283,-1.6835823289397622,0.007920792079207921,0.17995090239870273,1.0,7/20,11.77%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7446143425209365,1.683318244719946,0.04365904365904366,0.5922174675958604,1.0,7/17,7.38%,CACNA1C;CACNB2;ATP1A2;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.48820795881669715,-1.683187853604351,0.0024390243902439024,0.17832613565170877,1.0,28/75,11.34%,SULF1;DCN;ROCK2;WNT4;TEK;SEMA6A;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;HSPG2;HOXA5;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;HGS;STAB1;EMILIN1;DAB2IP;PML;ECSCR
prerank,placenta development (GO:0001890),0.7843590081896674,1.6827591840287293,0.031936127744510975,0.5869619181778621,1.0,3/12,2.53%,PTK2;NODAL;ADAM19
prerank,response to laminar fluid shear stress (GO:0034616),-0.7604338008817896,-1.6817459447927123,0.01289134438305709,0.17888110797074055,1.0,6/10,7.47%,ABCA1;SMAD6;KLF4;SMAD7;KLF2;MAP2K5
prerank,response to muscle stretch (GO:0035994),0.742368450299539,1.6809496558071573,0.04693877551020408,0.5869005204876762,1.0,5/15,6.40%,DMD;CDH2;PTK2;PIK3CA;RYR2
prerank,cardiac ventricle development (GO:0003231),0.7218635520428884,1.679950979069038,0.030612244897959183,0.5834629798888775,1.0,4/20,5.52%,HEY2;HEYL;NOTCH1;SCN5A
prerank,negative regulation of cyclase activity (GO:0031280),0.776003872069767,1.67977312801395,0.03578528827037773,0.5770999185048302,1.0,1/14,0.04%,GRM3
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5767596719390997,-1.6774880581950906,0.004016064257028112,0.18520252533442316,1.0,10/31,10.27%,PDGFRA;OSR1;HOXB3;TGFBR2;FGFR2;TGFBR1;HOXA3;SIX1;TBX1;HOXB9
prerank,mesenchyme morphogenesis (GO:0072132),0.7331727821140634,1.6774121322135283,0.033264033264033266,0.579281667442812,1.0,4/17,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,neuron cell-cell adhesion (GO:0007158),0.7553502543517924,1.6754452300269014,0.03941908713692946,0.5802938622529251,1.0,7/14,7.52%,CEL;NRXN1;ASTN1;ASTN2;CNTN4;NINJ2;NRXN3
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.6003183853285792,-1.6743252678366434,0.004081632653061225,0.18932325318735435,1.0,11/26,10.87%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;ST3GAL3;PRELP;LUM;OMD
prerank,negative regulation of lyase activity (GO:0051350),0.7582504126538757,1.6739569565693233,0.032,0.5792205831708631,1.0,1/16,0.04%,GRM3
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7415478900576582,-1.6738717735007353,0.007561436672967864,0.18792555685822135,1.0,4/10,6.89%,PODXL;DPP4;PIEZO1;WNK1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7055357143566539,1.6735990433411467,0.03505154639175258,0.5738993638367211,1.0,4/21,1.44%,PDE4D;PTEN;DMD;NCK2
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6666758596274679,1.6733911860176933,0.04590818363273453,0.568094137078073,1.0,9/27,7.08%,PDE4D;CACNA1C;CTNNA3;FGF13;SCN5A;PDE4B;RYR2;ATP2A2;STC1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.7076210549780443,-1.6730470071791426,0.0166358595194085,0.18733997462177737,1.0,4/13,2.27%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,negative regulation of chemokine production (GO:0032682),-0.6854718170765897,-1.6729621516572988,0.011741682974559686,0.1851772621269886,1.0,7/14,21.75%,APOD;KLF4;LGALS9;MAP2K5;C1QTNF3;SIRPA;SIGIRR
prerank,actin filament depolymerization (GO:0030042),-0.7308748526040323,-1.6721867019341223,0.009416195856873822,0.1843185508312341,1.0,5/11,13.17%,MICAL3;GSN;MICAL2;DSTN;TWF1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6621688693732838,1.6700432096635272,0.0299625468164794,0.5741049280482196,1.0,10/30,7.70%,GJC1;CACNA1C;NEDD4L;FGF12;KCNE4;CACNA2D1;SCN5A;RYR2;CACNA1D;KCNE5
prerank,cellular response to type I interferon (GO:0071357),-0.5442601438318742,-1.669873290011092,0.00663716814159292,0.1846652990998337,1.0,19/41,17.63%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;IFIT1;SAMHD1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,type I interferon signaling pathway (GO:0060337),-0.5442601438318742,-1.669873290011092,0.00663716814159292,0.1846652990998337,1.0,19/41,17.63%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;IFIT1;SAMHD1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,diol metabolic process (GO:0034311),-0.6501921381003796,-1.668334023367857,0.005747126436781609,0.1851543219731113,1.0,10/19,16.17%,PLPP3;NOS3;NAAA;AKT1;DEGS2;GCH1;PLPP1;SPHK1;PTS;CALM1
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7231763288329276,1.668302719631642,0.03711340206185567,0.5743951179190971,1.0,4/16,3.00%,SOX5;TCF15;PTN;RBM24
prerank,inorganic anion transmembrane transport (GO:0098661),0.5846450105834506,1.6681054282068872,0.02058319039451115,0.5687182845950663,1.0,8/63,5.87%,ANO1;ANO4;SLC12A2;SLC5A1;XPR1;SLC12A6;GABRG2;GABRA2
prerank,carbohydrate biosynthetic process (GO:0016051),-0.6141587370315447,-1.668042426165547,0.00808080808080808,0.18373711576226864,1.0,7/21,11.77%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.617971462384446,-1.6672181777337152,0.004106776180698152,0.1833201075909664,1.0,7/23,12.56%,TGFBR3;ADAMTS9;FGFR2;SMAD7;FKBP1A;TGFB1;ID2
prerank,ureteric bud development (GO:0001657),-0.6456628174028706,-1.666410543381249,0.015533980582524271,0.18289993001782906,1.0,7/17,6.83%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,dendrite morphogenesis (GO:0048813),0.6392015730427305,1.6657833510064772,0.033210332103321034,0.5711835170870361,1.0,9/35,4.29%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;PTN;WASL;MINK1
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.4791637434810577,-1.665068979714668,0.0,0.18331305951245105,1.0,36/92,13.39%,DOCK5;ANXA3;NRP2;ROCK2;FOXP1;NRP1;CTSH;TEK;SPARC;PLCG1;SASH1;BMPR2;THBS1;BMP4;ANGPT1;RAB11A;FOXC2;ADAM9;FGF1;PRKCE;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;RREB1;HIF1A;ZC3H12A;KDR;ITGB3;PFN1;SMOC2;FLT4;CALR;ATOH8;PLCG2
prerank,cellular response to zinc ion (GO:0071294),-0.6732813112634624,-1.6650059157345702,0.017408123791102514,0.18141785343146863,1.0,13/15,31.15%,P2RX4;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;ATP13A2;HVCN1;MT2A
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6205972720510765,-1.66481240472593,0.012170385395537525,0.17991242181163633,1.0,12/20,17.67%,ENTPD1;APP;TXNIP;ANO6;P2RX4;IL18;NT5E;P2RX7;ENTPD5;TXN;HSP90AB1;SUGT1
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.575572963418009,1.664290683483789,0.013445378151260505,0.5710781106059885,1.0,14/69,7.20%,PDGFRB;PLCL1;PTEN;PLCE1;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;PITPNM2;OGT;NYAP2;PIK3C2A;IRS1
prerank,bicellular tight junction assembly (GO:0070830),-0.5228540875815859,-1.6635310491053414,0.0,0.18017744965321264,1.0,13/46,12.07%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;CLDN11;PARD3;PATJ;F11R
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.511456464896721,1.6632500617850405,0.002844950213371266,0.5687349485668737,1.0,28/172,9.40%,INPP4B;PIP5K1B;DGKB;PTEN;PIK3CD;PLD1;DGKH;PIK3R1;DGKG;CDS2;PLD6;PIP4K2A;PIK3CA;SLC44A2;FGF2;PITPNM2;CPNE7;INPP5J;PIP4K2C;LIPH;PIK3C2A;ABHD3;PIKFYVE;ACHE;MTMR12;MTMR14;STARD7;MTMR7
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7083994951062751,1.6622540664350278,0.031683168316831684,0.566536756590258,1.0,6/21,3.95%,GUCY1B1;GUCY1A1;GUCY2D;ADCY8;ADCY3;ADCY6
prerank,peptidyl-arginine modification (GO:0018195),0.7411305716277342,1.6622526202715828,0.04811715481171548,0.560582623217515,1.0,1/15,0.14%,ART3
prerank,negative regulation of neurogenesis (GO:0050768),0.6531754699150835,1.6607526541855817,0.03505535055350553,0.560657228434919,1.0,7/34,2.62%,PTEN;RAPGEF2;NOTCH1;LINGO1;NF1;PTN;IL1B
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5586318513626102,1.6606956668324537,0.015025041736227046,0.5550984742068478,1.0,10/76,6.60%,ANO1;PLCE1;PTH1R;GRM5;TACR1;GRM1;CXCR2;HTR2C;TRHR;OPRK1
prerank,leukotriene biosynthetic process (GO:0019370),0.75856823445154,1.6602960550312866,0.037527593818984545,0.5507935799881077,1.0,3/14,1.42%,GGT5;GGT1;GGTA1
prerank,extracellular structure organization (GO:0043062),-0.41584419638788445,-1.6593610607699414,0.0,0.18635131668649033,1.0,88/204,12.53%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;COL11A1;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HSPG2;COL13A1;BGN;ST7;ADAMTS1;ITGA11;SPOCK2;NDNF;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CD47;GFOD2;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;ADAMTS3;F11R;SMOC2;COL9A2
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5341149387596892,-1.6581711638466186,0.0043859649122807015,0.18680024895111536,1.0,9/38,14.60%,BMP6;SASH1;DDX60;USP15;IFI35;PUM1;GBP5;CYBA;CD180
prerank,macrophage differentiation (GO:0030225),-0.6996517464551235,-1.6571372717326942,0.013108614232209739,0.1866514466546586,1.0,5/13,10.08%,IL31RA;IL15;BMP4;CSF1;CASP8
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.46946796545215136,-1.656402832525186,0.002506265664160401,0.18600315511587068,1.0,36/84,13.46%,ANXA3;NRP2;ROCK2;FOXP1;NRP1;PLPP3;TEK;SPARC;PLCG1;SASH1;NOS3;BMPR2;THBS1;BMP4;ANGPT1;FOXC2;FGF1;WNT5A;MAPK14;PTK2B;RHOB;P2RX4;TMSB4X;PIK3CB;AKT1;HIF1A;ZC3H12A;KDR;GATA2;ITGB3;TGFB1;SMOC2;FLT4;CALR;ATOH8;MET
prerank,protein O-linked mannosylation (GO:0035269),-0.6435367848265459,-1.6558200498529188,0.016822429906542057,0.18518706946550129,1.0,5/18,7.52%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,phospholipid translocation (GO:0045332),-0.5919657274895205,-1.655126513197761,0.01160541586073501,0.18454400227922546,1.0,14/28,17.15%,ABCA1;ATP10A;PLSCR2;ANO6;ABCA4;PLSCR4;P2RX7;ATP9A;ATP8A1;MFSD2A;TMEM30A;PLSCR3;ATP11A;ATP11B
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7787460753488932,1.6540341334513928,0.034623217922606926,0.5690361819033923,1.0,1/13,0.04%,GRM3
prerank,keratan sulfate metabolic process (GO:0042339),-0.5694873404587,-1.6533002828681598,0.0041928721174004195,0.1862186849542004,1.0,13/31,10.87%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;HEXA;ST3GAL3;PRELP;HEXB;LUM;OMD
prerank,odontogenesis (GO:0042476),-0.5506883458744776,-1.652357686706694,0.004329004329004329,0.1862803954089089,1.0,9/35,7.99%,COL1A2;GLI2;OSR1;WNT6;FGFR2;BMP4;LRP6;FOXC1;TBX1
prerank,striated muscle contraction (GO:0006941),0.5896153669621786,1.6522560839910223,0.02631578947368421,0.5701319341880282,1.0,10/53,8.91%,CASQ2;DMD;ATP1A2;RCSD1;PIK3CA;SCN5A;RYR2;MYL3;KCNE5;STAC
prerank,glycolipid metabolic process (GO:0006664),-0.5134622398542218,-1.6517776087324,0.002136752136752137,0.18541724436780288,1.0,16/47,15.35%,ST3GAL4;ST3GAL6;ESYT2;ST3GAL2;ST6GALNAC3;SMPD3;HEXA;HEXB;FUCA1;B3GALNT1;PSAP;NAGA;ST6GALNAC6;ESYT3;UGCG;SUMF2
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5263150381854287,-1.6506877356827074,0.011061946902654867,0.1856684306139429,1.0,18/47,13.90%,ZBTB16;MEDAG;BMP7;TMEM64;SOX13;SIX1;SYAP1;NOCT;WDFY2;AKT1;CMKLR1;RREB1;CARM1;ZC3H12A;METRNL;PTGS2;ID2;SFRP1
prerank,vascular transport (GO:0010232),0.5595420540149418,1.6500186157846755,0.018302828618968387,0.5731800598736184,1.0,15/81,5.04%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,regulation of interleukin-1 production (GO:0032652),-0.6737377708858256,-1.649394717630755,0.005836575875486381,0.18616000414757017,1.0,6/15,16.54%,FOXP1;ANXA1;GAS6;CEACAM1;SIRPA;TLR4
prerank,transport across blood-brain barrier (GO:0150104),0.5553584116852488,1.6481487302144142,0.02181208053691275,0.574809758017841,1.0,15/83,5.04%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7367772173045344,-1.6480921770761745,0.009940357852882704,0.1869379569561973,1.0,7/11,16.27%,DAB2;RSPO3;NKD1;MLLT3;WNT5B;SFRP1;PLEKHA4
prerank,Notch signaling pathway (GO:0007219),0.5887921255127562,1.6475906795255104,0.02072538860103627,0.5714425950838328,1.0,6/59,1.62%,NOTCH3;HEY2;HEYL;NOTCH1;DTX3;MAML2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7034901890814089,-1.6474813466667817,0.016574585635359115,0.1862682941650097,1.0,6/13,16.85%,NOS3;AKT1;GCH1;PTS;CALM1;FPGS
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7162514027602657,-1.6470778100015404,0.01727447216890595,0.1852897627427283,1.0,5/11,17.18%,EGFR;BMP4;DDX5;TGFB1;RIPK1
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.6739787748303986,-1.64622395692583,0.005639097744360902,0.1852328108023488,1.0,11/15,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SPHK1;SIRT3;ORMDL3;ORMDL2;RACK1;SPHK2
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.724114253787129,1.645664695828838,0.029585798816568046,0.5734531204661899,1.0,2/17,0.19%,ITGA1;PDGFRB
prerank,monocyte chemotaxis (GO:0002548),-0.5584139473647936,-1.6437555735203462,0.014522821576763486,0.18889081085481133,1.0,9/32,15.69%,FLT1;IL6R;ANXA1;CCL15;CCL14;RPS19;CCL25;TNFRSF11A;CCL13
prerank,external encapsulating structure organization (GO:0045229),-0.4125057548528766,-1.6435503505747286,0.0,0.18759242967873502,1.0,87/205,12.53%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;COL11A1;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HSPG2;COL13A1;BGN;ST7;ADAMTS1;ITGA11;SPOCK2;NDNF;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CD47;GFOD2;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;ADAMTS3;F11R;SMOC2;COL9A2
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7648446164874124,1.6434747928641127,0.04772234273318872,0.5763960722649022,1.0,3/11,1.01%,MEF2C;PIK3CD;RAPGEF2
prerank,primary alcohol metabolic process (GO:0034308),-0.5929603897023796,-1.6423007526343658,0.014227642276422764,0.18828593668462815,1.0,8/25,13.43%,IGF1;DHRS3;RBP4;GPD2;NAAA;CYP1B1;ALDH3A2;ADH1A
prerank,regulation of vasoconstriction (GO:0019229),0.6606522582732222,1.6412398266981552,0.028462998102466792,0.5790220186375098,1.0,5/27,3.07%,ACE2;TBXA2R;SMTNL2;PER2;ECE1
prerank,positive regulation of DNA binding (GO:0043388),-0.5671461114754746,-1.640515959182912,0.010309278350515464,0.18962089777459457,1.0,16/31,26.37%,IGF1;SKI;NIBAN2;FOXC1;PINX1;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;PARK7;PLAUR;TRIM6;PRKN;TWIST1
prerank,potassium ion transport (GO:0006813),0.5168963923963409,1.640298559317503,0.011940298507462687,0.577111739110807,1.0,23/120,9.41%,ABCC9;KCNJ8;KCNJ12;ATP1A2;KCNG1;KCNMB1;KCNV2;ATP1A4;KCNQ4;KCND2;SLC24A4;SLC24A2;KCNH8;KCNH4;KCNAB3;KCNQ5;HCN2;KCNA4;KCNQ3;SLC9A7;HCN3;PKD2;KCNJ3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6398731428903754,-1.638240566455288,0.014084507042253521,0.1925818779796794,1.0,6/18,11.59%,EGFR;ESR1;BMP4;DDX5;ZC3H12A;TGFB1
prerank,icosanoid secretion (GO:0032309),-0.7084967635797266,-1.637895890396375,0.017045454545454544,0.19158854317588303,1.0,4/12,6.53%,ABCC4;ANXA1;ACE;BDKRB2
prerank,cation transmembrane transport (GO:0098655),0.6102556814403336,1.6369451429295327,0.020754716981132074,0.5836561466560894,1.0,4/44,1.67%,ABCC9;KCNJ8;ATP1A2;CACNA1H
prerank,cyclooxygenase pathway (GO:0019371),-0.7224172618433843,-1.628963836987552,0.016423357664233577,0.20833720747863838,1.0,5/10,11.61%,PTGDS;PTGIS;PTGS1;TBXAS1;PTGS2
prerank,pinocytosis (GO:0006907),0.758404346668871,1.6289363903508183,0.05219206680584551,0.6087086358429533,1.0,2/10,7.39%,CARMIL1;PPT1
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.6379165805214073,-1.6287793603320568,0.022556390977443608,0.20697746681934556,1.0,7/17,10.61%,ROBO1;EFNB2;NRP1;SLIT2;EPHB4;AKT1;KDR
prerank,pore complex assembly (GO:0046931),-0.62418304454649,-1.6287212128428352,0.023255813953488372,0.20536569962271023,1.0,8/19,17.48%,AFDN;ADAM10;ANO6;PLEKHA7;GSDMD;P2RX7;NUP98;TPR
prerank,ganglion development (GO:0061548),-0.7136727904247469,-1.6279243426334875,0.02018348623853211,0.20521066717878556,1.0,2/11,1.02%,NRP2;NRP1
prerank,myelin maintenance (GO:0043217),0.7688412331337795,1.6277379662088476,0.04782608695652174,0.6076453518699869,1.0,2/10,3.42%,PTEN;ABCD2
prerank,cardiac muscle contraction (GO:0060048),0.6236568877417259,1.627520431901582,0.04927007299270073,0.6029443331436627,1.0,8/34,7.70%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;MYL3;KCNE5
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6512788852979652,1.6272508538349617,0.051923076923076926,0.5985507827252252,1.0,3/28,2.83%,NOTCH3;CHAC1;TSPAN15
prerank,regulation of endothelial cell migration (GO:0010594),-0.466710863463827,-1.6271702260860583,0.005319148936170213,0.20503956423379696,1.0,38/85,13.06%,ANXA3;NRP2;DCN;ROCK2;FOXP1;GLUL;NRP1;TEK;SP100;APOE;ADAMTS9;SPARC;SLIT2;SASH1;PTPRM;BMPR2;THBS1;BMP4;ANGPT1;FOXC2;FGF1;BMPER;ACVRL1;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;PRCP;DAB2IP;ZC3H12A;KDR;ITGB3;RHOJ;SMOC2;FLT4;CALR;ATOH8
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5819229748778019,1.6268469300724395,0.039927404718693285,0.5947255548198515,1.0,9/48,6.29%,PDE4D;CASQ2;DMD;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,B cell homeostasis (GO:0001782),0.7796088311782372,1.6257499000783364,0.06763285024154589,0.5932340230700427,1.0,2/10,0.75%,MEF2C;DOCK10
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7347452087992933,1.6246448768620183,0.05725971370143149,0.5921804881117292,1.0,6/14,10.18%,RAPGEF2;PRKAR1B;PKIA;PRKAR2B;PRKAR2A;PRKAR1A
prerank,neuron projection extension (GO:1990138),-0.5521449267924299,-1.6242292509420118,0.006342494714587738,0.20953334153509165,1.0,5/32,1.93%,AUTS2;ALCAM;NRP2;NRP1;IQGAP1
prerank,blood vessel diameter maintenance (GO:0097746),0.6264770592702391,1.623169699133891,0.034990791896869246,0.5928099676769039,1.0,7/34,3.95%,ACE2;EDNRA;PER2;GPER1;ROCK1;ECE1;ADCY6
prerank,negative regulation of cartilage development (GO:0061037),-0.69239519229093,-1.6227588084017428,0.017241379310344827,0.21096263414678085,1.0,4/13,4.28%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.4417282888290658,-1.6214393566969807,0.0030120481927710845,0.2117772060411718,1.0,26/108,11.01%,NXN;SULF1;TRABD2B;WWOX;VGLL4;APP;MDFIC;MACF1;RSPO3;ESR1;FGFR2;NKD1;LRRK2;NFATC1;ITGA3;RNF43;SKI;SULF2;SFRP4;RSPO2;TIAM1;FOXL1;TLE1;FZD7;NOTUM;MDFI
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6076838771933546,-1.621428447316291,0.01006036217303823,0.21010543058947714,1.0,10/23,14.97%,UACA;BMP7;HDAC7;CCN3;TMSB4X;C1QTNF3;IFI35;ZC3H12A;RELA;PPM1B
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4813288648610526,-1.621383074376504,0.0,0.20849621994525788,1.0,15/63,5.29%,IGF1;WWOX;SP100;SH3RF1;CAV1;ITGA6;THBS1;BMP4;TGFBR1;DEPTOR;TCF7L2;ACVR1;CFLAR;AR;TNFSF10
prerank,regulation of necroptotic process (GO:0060544),-0.5841376626931325,-1.620244171103464,0.01593625498007968,0.2090178318060165,1.0,11/23,17.18%,ARHGEF2;CFLAR;SDCBP;PDCD6IP;BIRC3;SLC25A4;FLOT2;CASP8;YBX3;PELI1;RIPK1
prerank,heart looping (GO:0001947),0.6096110353453545,1.6198349553176727,0.035842293906810034,0.5995879472564456,1.0,6/40,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,nucleotide catabolic process (GO:0009166),-0.6516769435528282,-1.6195890369694892,0.02012072434607646,0.20879092969533225,1.0,12/16,25.02%,XDH;SAMHD1;NT5E;DERA;NUDT3;GDA;GPX1;NT5C1A;PNP;VCP;NT5C2;NT5C
prerank,smooth muscle contraction (GO:0006939),0.7284709593672504,1.619373389453975,0.03870967741935484,0.59629486582547,1.0,6/14,7.15%,EDNRA;MYLK;MYH11;ROCK1;SMTN;PIK3C2A
prerank,regulation of biosynthetic process (GO:0009889),0.7767093197682402,1.6193079352067816,0.03624733475479744,0.5916145710866453,1.0,4/11,7.50%,SLC25A33;CCN6;SNCA;PIKFYVE
prerank,inositol phosphate metabolic process (GO:0043647),0.6069006944653998,1.6191631076391768,0.02422145328719723,0.5872656056777067,1.0,8/46,5.65%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;FGF2;ITPKB;INPP5J
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.5847833464365103,1.6189906047270486,0.025906735751295335,0.583003302278497,1.0,6/55,2.56%,PDGFRB;ACE2;PID1;SLC25A33;CCN6;FOXM1
prerank,regulation of blood circulation (GO:1903522),0.6248829958538368,1.6180857239014765,0.04419889502762431,0.5815590884216922,1.0,6/34,3.07%,ACE2;TBX2;KCNJ12;PER2;CACNA1H;ECE1
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6151238640593816,-1.6180312066233846,0.016822429906542057,0.2103164205985002,1.0,9/18,16.20%,FN1;SMAD3;ITGB8;CD34;LGALS9;HIF1A;PTGS2;LTBP1;CD200
prerank,membrane depolarization during action potential (GO:0086010),0.6506643121658309,1.6176199242893776,0.04609218436873747,0.578531910190963,1.0,10/26,11.06%,CACNA1C;ATP1A2;CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;CACNA1D;SCN9A;SCN2B
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6579722894719204,-1.6166421346548634,0.01509433962264151,0.21174884885152545,1.0,7/15,14.52%,EGFR;IGF1R;DDR1;PTK2B;BMX;KDR;MAPK3
prerank,carnitine shuttle (GO:0006853),-0.7155480165425434,-1.6145004695831175,0.011214953271028037,0.21439903821694437,1.0,7/11,18.86%,PRKAG2;CPT1A;SLC25A20;CPT2;ACACA;PRKAA2;ACACB
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6209148405130211,-1.6138043725517466,0.019267822736030827,0.21409526656040537,1.0,10/19,12.41%,ROBO1;DCN;SEMA6A;CCBE1;JCAD;XDH;PIK3CB;DAB2IP;ADAMTS3;SMOC2
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.4990873797108205,-1.6137555011054703,0.009029345372460496,0.21262595942842993,1.0,15/51,7.15%,FBN1;FSTL1;SMAD6;SKIL;HTRA3;BMPR2;SMURF2;SMAD9;SMAD7;SKI;BMPER;GREM2;SMURF1;NBL1;VWC2
prerank,muscle cell differentiation (GO:0042692),0.6294074508008646,1.6129889734083152,0.044859813084112146,0.591099120345901,1.0,6/32,1.29%,MEF2C;DMD;GLMN;HEY2;SYNE1;RORA
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7186673856564936,1.6124984508476208,0.060291060291060294,0.588115583605843,1.0,2/16,0.30%,GUCY1B1;GUCY1A1
prerank,vasoconstriction (GO:0042310),0.7647870904187322,1.6119021583105269,0.046153846153846156,0.5858322294214157,1.0,2/11,7.15%,EDNRA;PIK3C2A
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.7340184810098167,1.6115903641927698,0.049783549783549784,0.5823457850066538,1.0,2/13,0.50%,PDE4D;CASQ2
prerank,actin filament network formation (GO:0051639),0.7171927114832004,1.6104089224604228,0.056133056133056136,0.581903416949133,1.0,3/11,7.02%,CARMIL1;SPIRE1;PLS3
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5036185762745288,-1.6097718173594067,0.009216589861751152,0.21930812746005368,1.0,21/48,13.38%,PLCG1;JCAD;HDAC7;NOS3;THBS1;ANGPT1;FOXC2;ANXA1;HDAC9;MAPK14;P2RX4;TMSB4X;AKT1;HIF1A;FGFBP1;KDR;GATA2;TGFB1;PTGS2;RHOJ;SRPX2
prerank,negative regulation of heart contraction (GO:0045822),0.7463595097851694,1.6060039542762052,0.054466230936819175,0.5929524096344235,1.0,2/11,1.22%,PDE4D;ATP1A2
prerank,cellular protein metabolic process (GO:0044267),-0.3685821490597834,-1.6055442423373418,0.0,0.22638337125208416,1.0,138/396,18.98%,IGF1;FBN1;FN1;FSTL1;IGFBP2;ST3GAL6;CTSH;IGFBP5;PCSK5;APOE;PAPPA;APP;CP;ST3GAL1;CPE;RPLP1;BMP4;RPS14;IGFBP6;YES1;ITIH2;CSF1;IGFBP4;PHKA2;ADAM10;IGFBP3;PLOD2;DENND3;IGF2;GAS6;WWP2;RPL9;VWA1;RPS12;P4HB;SERPIND1;RPL41;RPS20;TNC;CALU;RPL18A;RPS13;RPS19;ABCA3;RPS23;SRBD1;RPS4X;SEPHS1;DUSP12;CST3;MSLN;RPS11;RPL13;RPL18;RPS9;EEF1A1;GOLM1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;SFTPA2;SFTPA1;NOTUM;IDE;DAB2IP;PRSS23;ST8SIA2;MXRA8;RPL11;RPS18;CKAP4;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;GATA6;CCN1;RPS24;LMCD1;RPS27;RPL14;SPG7;RPL26;SPP1;MRPS7;MRPS6;F5;UBE2G2;LTBP1;SARS1;MSRB3;RPL10;MRPS18A;RPL7;NEDD8;SCG3;MRPL52;RCN1;RPL10A;MRPL24;HARS1;RPL22;UBA3;RPS15;RPS6;MMP2;FBXL2;DNAJC3;RPL23;RPL17;APLP2;AFG3L2;PDIA6;RPL31;MANBA;RIPK1;RPS25;UBA7;PSEN2;RPL15;RPSA;SPCS1;RPN2;QSOX1;RPS7;RPL38;UBE2M;RPLP0;HSP90B1;RPL27;CSF2RA
prerank,focal adhesion assembly (GO:0048041),0.6867420077912451,1.6053380413937166,0.04816955684007707,0.5906745958037689,1.0,4/21,2.10%,DLC1;PTPRK;PEAK1;FERMT2
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.7016721192464965,-1.6031764766213048,0.030360531309297913,0.2296643757586584,1.0,5/11,7.77%,SLIT2;RIN3;CCN3;NBL1;DUSP1
prerank,regulation of focal adhesion assembly (GO:0051893),0.56964779623681,1.6031233161210732,0.03547297297297297,0.5940144775656993,1.0,10/54,2.15%,DLC1;PTEN;LIMS1;ARHGAP6;PTK2;VCL;PHLDB2;PEAK1;FERMT2;ROCK1
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7002162724813085,1.6030460391522843,0.06172839506172839,0.5897853030931308,1.0,4/16,4.10%,TRPC3;ROCK1;PDE9A;AKAP6
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6868556548137847,1.6018630365445496,0.042884990253411304,0.5894582455945082,1.0,5/18,4.24%,ITGA4;MEF2C;COL4A3;AKT3;FGF2
prerank,ERBB signaling pathway (GO:0038127),0.5523929657655229,1.6018536357217499,0.038525963149078725,0.5850793203179745,1.0,10/64,3.06%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;ERBB4;NRG1;PIK3CA
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.6340598086254076,1.5998405988223234,0.04638218923933209,0.5879378260276041,1.0,11/37,16.99%,DYNLL1;IFT43;IFT81;IFT20;KIF3A;IFT57;KIF3C;TRIP11;IFT80;TNPO1;TRAF3IP1
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.559249261276237,-1.5996508263991391,0.020179372197309416,0.2349710577868649,1.0,14/30,21.76%,FLT1;BMP4;MLLT3;ACE;KIT;KDR;TGFB1;FLT4;SFRP1;LMBR1L;CSF1R;PLEK;FSTL3;SP7
prerank,positive regulation of glucose import (GO:0046326),-0.5964670132173913,-1.5993690039580304,0.023391812865497075,0.2338523359275912,1.0,5/21,1.64%,IGF1;SORBS1;OSBPL8;OCLN;RHOQ
prerank,lipid catabolic process (GO:0016042),0.6991297701213709,1.59932347311683,0.03490759753593429,0.5852254237334182,1.0,5/18,7.39%,CEL;PLA1A;LIPH;LIPC;PPT1
prerank,cellular response to increased oxygen levels (GO:0036295),-0.716297606604167,-1.5987597254888368,0.025089605734767026,0.2334960024337692,1.0,10/11,27.55%,FOXO1;CAV1;ATP6V1G1;ATP6V0A2;CCDC115;ATG7;TMEM199;FAS;ATP6AP1;ATP6V0D1
prerank,regulation of Ras protein signal transduction (GO:0046578),0.5369593242885283,1.5984678446756313,0.02996845425867508,0.5838578538517996,1.0,20/86,9.11%,DLC1;STARD8;EPS8;PLCE1;NOTCH1;SPRY4;FOXM1;CADM4;STARD13;SH3BP1;RALGPS1;PDCD10;EPS8L1;SPRY2;OGT;LZTR1;FGF10;ARHGDIB;LRRD1;LYN
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.480561600724148,-1.5982683182548665,0.004987531172069825,0.2330642735580052,1.0,13/56,6.10%,BMP6;DAB2;LDLRAD4;SMAD6;BMP7;BMPR2;BMP4;TGFBR1;SMAD7;ACVR1;SDCBP;BMPER;ACVRL1
prerank,heart contraction (GO:0060047),0.5999917011549416,1.5975428764251767,0.0423572744014733,0.5827303859257743,1.0,9/41,7.70%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;SGCZ;MYL3;KCNE5
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5147417269474392,-1.5975058918508165,0.010940919037199124,0.23307042777631612,1.0,19/40,15.76%,BMP6;WNT4;BMP7;OSR1;WNT6;BMPR2;BMP4;ADGRV1;ACVR1;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,protein localization to cell surface (GO:0034394),0.6544263377513471,1.5969966279839656,0.0546875,0.580274795152999,1.0,7/26,7.63%,PTPRK;PIGU;JAM3;VCL;GGA3;EMP2;FGF10
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6481687843312443,1.596500801465031,0.052123552123552123,0.5777393303110203,1.0,5/24,2.30%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.5110773240636168,1.596401416750285,0.00911854103343465,0.5740033273459848,1.0,24/119,11.03%,INPP4B;PIP5K1B;PTEN;PIK3CD;PIGU;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;ITPKB;SOCS5;PIGO;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;PIGZ;SOCS6;FIG4;DPM3
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7618307704680679,1.5963770521514107,0.05672268907563025,0.5700743852606891,1.0,2/11,3.42%,SLC30A10;ABCD2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6675592737838382,-1.596207954774223,0.01876172607879925,0.2345926588070047,1.0,7/13,16.12%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NNMT;PARP16
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4988808703065106,1.5956748860173378,0.00872093023255814,0.5683386974244604,1.0,18/140,3.88%,DLC1;STARD8;CHN1;PLCE1;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;ARHGAP6;ARHGAP32;ARHGEF6;ARHGAP1;FOXM1;STARD13;ARAP2;SH3BP1;RAC3
prerank,negative regulation of biosynthetic process (GO:0009890),0.7052166149572167,1.5949666669149976,0.056,0.566707832477177,1.0,3/16,3.42%,SLC30A10;GPER1;ABCD2
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.43951369709343807,-1.5944326374761832,0.006042296072507553,0.23657425991453765,1.0,29/95,13.00%,TGFBR3;DAB2;LDLRAD4;SMAD3;SMAD6;DKK3;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;THBS1;TGFBR1;SNX6;SMAD7;ITGA3;LTBP4;SKI;SDCBP;SMURF1;PRDM16;FKBP1A;FLCN;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB
prerank,sensory perception of smell (GO:0007608),0.7602351107809016,1.592146591684938,0.054466230936819175,0.5718945171842882,1.0,3/11,6.84%,ADCY3;SLC24A4;UBR3
prerank,response to interleukin-1 (GO:0070555),-0.4652270558194153,-1.5911776570657385,0.005128205128205128,0.242003339002698,1.0,22/73,16.31%,ADAMTS12;HDAC4;PTGIS;APP;IL1R1;ANXA1;IRAK2;LGALS9;CCL15;CCL14;CD47;HIF1A;IRAK3;DAB2IP;ZC3H12A;CCL25;RELA;TNFRSF11A;SFRP1;GBP2;CCL13;SIRPA
prerank,calcium ion homeostasis (GO:0055074),0.5135776321584677,1.591161640459441,0.0265625,0.5710822375672108,1.0,18/95,8.35%,ATP13A5;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;TFAP2B;SNCA;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1;STC2
prerank,determination of heart left/right asymmetry (GO:0061371),0.5967426413113632,1.5896443034069339,0.040780141843971635,0.5723003060513816,1.0,6/43,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,regulation of melanin biosynthetic process (GO:0048021),0.7415148259623933,1.5895100058094624,0.06756756756756757,0.568826085075888,1.0,5/10,12.24%,RAPGEF2;ZEB2;ATP7A;APPL1;OPN3
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4184332317010421,-1.5891740792133948,0.002967359050445104,0.2450174446671664,1.0,36/128,9.07%,BMP6;TGFBR3;ZMIZ1;COL1A2;COL3A1;SMAD3;SMAD6;CDH5;BMP7;CLDN5;TGFBR2;BMPR2;SMURF2;BMP4;TGFBR1;DDX5;SMAD9;ADAM9;SMAD7;ACVR1;PXN;ID1;PDCD4;RGMB;SKI;APPL2;ACVRL1;SMURF1;PRKCZ;RHOA;HIVEP1;FKBP1A;ZYX;USP15;PARD3;TMEM100
prerank,protein mannosylation (GO:0035268),-0.5908749450325614,-1.5887065877337971,0.01532567049808429,0.24432342686601938,1.0,5/22,7.52%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,polyol metabolic process (GO:0019751),0.5973290891645378,1.587513677651397,0.02982456140350877,0.5714470809531124,1.0,7/46,5.65%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;ITPKB;INPP5J
prerank,response to nitric oxide (GO:0071731),0.7289531180983853,1.5870590974129504,0.06097560975609756,0.5692110254229715,1.0,1/13,0.12%,GUCY1B1
prerank,regulation of transmembrane transport (GO:0034762),0.6278035613804495,1.5864178551160768,0.037243947858473,0.5675138011677421,1.0,4/31,1.12%,ACE2;KCNJ8;NEDD4L;KCNJ12
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7609436209324388,1.5835486558466547,0.06073752711496746,0.5693166795283857,1.0,4/11,5.65%,PTEN;IMPA2;INPP5A;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7609436209324388,1.5835486558466547,0.06073752711496746,0.5693166795283857,1.0,4/11,5.65%,PTEN;IMPA2;INPP5A;INPP5J
prerank,lymphocyte chemotaxis (GO:0048247),0.6252192970044016,1.5823841871026463,0.05156537753222836,0.5694341986226233,1.0,3/34,0.77%,CYP7B1;SLC12A2;PIK3CD
prerank,vesicle transport along actin filament (GO:0030050),0.6761831197545264,1.5823002376814777,0.07602339181286549,0.5659796249207183,1.0,4/19,8.18%,MYO1B;WASL;ACTN4;MYO6
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46016893235645795,-1.5822782239850992,0.004807692307692308,0.2572080575192209,1.0,21/74,10.08%,EYA2;IGF1;EYA1;SH3RF1;ITGA6;EYA4;NOS3;THBS1;BMP4;TGFBR1;TCF7L2;ARHGEF2;ACVR1;CFLAR;AR;TNFSF10;ICAM1;MAP2K5;AKT1;MCL1;CASP8
prerank,positive regulation of exosomal secretion (GO:1903543),-0.645001032395227,-1.5809674847217683,0.0210727969348659,0.25858009541487914,1.0,7/15,15.65%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;SDC1
prerank,myotube cell development (GO:0014904),-0.7032717078457881,-1.5807037174564083,0.03495145631067961,0.2574228141999487,1.0,4/10,14.30%,IGF1;SKI;SIX1;CAV2
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.6232276315069945,-1.5801946371075062,0.013307984790874524,0.2570322498521706,1.0,5/17,5.90%,SULF1;FSTL1;SLIT2;ITGA3;SFRP4
prerank,detection of calcium ion (GO:0005513),0.713711499132184,1.5791080784287495,0.0767590618336887,0.5724501391748972,1.0,5/13,8.40%,CASQ2;KCNMB1;RYR2;STIM1;SYT1
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4735127728087386,-1.5790965671968786,0.007042253521126761,0.2578183877871502,1.0,12/62,8.36%,AUTS2;NOTCH2;IGF1;ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;ALS2;RAPGEF1;PIK3CB
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.636971666454406,-1.5781246641409712,0.022448979591836733,0.25819384723677263,1.0,6/16,9.43%,BMPR2;ACE;DDAH1;PLCB3;KLK2;PRCP
prerank,vasculogenesis (GO:0001570),0.6171300795534573,1.577748876004072,0.06095238095238095,0.573188968596352,1.0,6/32,2.21%,PDGFRB;GLMN;HEY2;NOTCH1;TBX20;SPRED1
prerank,neuron projection regeneration (GO:0031102),0.7532163157610046,1.577224541004323,0.0782608695652174,0.5712757986206726,1.0,4/10,8.93%,RTN4RL1;PTN;DHFR;GAP43
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5149067131665314,1.5771393370034832,0.014106583072100314,0.5679527818785551,1.0,20/109,10.75%,INPP4B;PDGFRB;PIP5K1B;PTEN;PIK3CD;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;INPP5B;FIG4;PLA2G4E
prerank,dendritic spine morphogenesis (GO:0060997),0.6986870386803777,1.5737810667782695,0.058091286307053944,0.575461805426566,1.0,3/15,3.93%,PTEN;DOCK10;WASL
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5378132844311524,-1.572625864155869,0.032520325203252036,0.26966862867850444,1.0,14/33,12.45%,CDH5;TEK;NUPR1;CAST;ANGPT1;TCF7L2;RAMP2;GAS6;YAP1;NDNF;ICAM1;KDR;GATA2;PPARA
prerank,regulation of angiogenesis (GO:0045765),-0.3937146592608921,-1.5717478479454015,0.0034965034965034965,0.2699251504004838,1.0,60/192,11.79%,SULF1;ANXA3;FLT1;CDH5;DCN;ROCK2;GLUL;PTGIS;CTSH;TEK;SEMA6A;SP100;SPARC;F3;PLCG1;CLDN5;ITGB8;SASH1;THBS2;PTPRM;NOS3;THBS1;KLF4;RAMP2;HSPG2;CD34;HOXA5;VEGFD;VEGFC;NIBAN2;FGF1;NPR1;GTF2I;BMPER;ADAMTS1;WNT5A;PRKCB;FOXC1;CYP1B1;STAT1;RHOB;SERPINF1;SEMA3E;HK2;PIK3R6;PLXND1;TIE1;HGS;PPP1R16B;HIF1A;STAB1;ECM1;EMILIN1;DAB2IP;ZC3H12A;KDR;PML;GATA2;ECSCR;RHOJ
prerank,leukotriene metabolic process (GO:0006691),0.6693917489345339,1.5693182944660575,0.06832298136645963,0.5865871738250197,1.0,2/19,0.87%,GGT5;GGT1
prerank,positive regulation of cell communication (GO:0010647),0.6217975070963426,1.5685896598329443,0.04892367906066536,0.5853504951570626,1.0,10/28,12.33%,CLSTN1;NMU;RIMS1;CLSTN3;RIMS2;ANK3;SYT1;KCTD13;WLS;GRIK2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5042404253480407,1.5677298295970297,0.023289665211062592,0.5843319425380846,1.0,17/116,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.4038713115661668,-1.5674845068237209,0.0,0.2785582736029932,1.0,39/151,15.58%,ST3GAL4;LARGE1;PLA2G4A;PLPP3;PAM;PCSK5;APOE;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;LPCAT3;HACD3;ACER3;CSNK1G2;GSTA4;GOLPH3;GSTM1;SPNS2;MGST1;DEGS2;ALAS1;GCH1;PLPP1;GSTT1;ALDH3A2;MFSD2A;SPHK1;ASL;LPIN3;SPTLC2;GSTM2;VAPA;GCNT1;AKR1A1;TYW5
prerank,negative regulation of stem cell differentiation (GO:2000737),0.7334114697854982,1.5660141325175094,0.08369098712446352,0.5864496611763442,1.0,6/12,13.28%,NOTCH1;TCF15;N4BP2L2;JAG1;YTHDF2;HNRNPU
prerank,lipid oxidation (GO:0034440),-0.6888547665791898,-1.5659930801538844,0.022222222222222223,0.2803138792817945,1.0,5/12,20.34%,ADIPOR2;ACOX1;ALOX12;PPARGC1A;ADIPOR1
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.7251171790751461,1.5655952197271388,0.07956989247311828,0.5842338407230188,1.0,3/11,3.38%,NR1H3;SCARB1;LDLR
prerank,positive regulation of organelle organization (GO:0010638),-0.5342242821424117,-1.564586303451401,0.018633540372670808,0.2819967538778272,1.0,17/32,20.13%,ANXA2;ANXA1;SORBS3;RAB3GAP1;IRGM;C2CD5;P2RX7;LMAN1;UVRAG;SURF4;PFDN2;SYNJ1;RAB3GAP2;STX18;ADRB2;PPARGC1A;TMED9
prerank,base conversion or substitution editing (GO:0016553),0.737851396681277,1.5634249975258503,0.06711409395973154,0.5877970303949381,1.0,2/11,6.19%,APOBEC1;ADARB2
prerank,presynapse assembly (GO:0099054),0.7020813849182943,1.5630126640396964,0.07269155206286837,0.5856532167289464,1.0,3/16,2.44%,PTEN;CEL;LRRTM3
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.4639378643160457,-1.5625329851541956,0.010554089709762533,0.2854832300840134,1.0,15/66,3.56%,NFIB;TGFBR3;MCC;SULF1;ROBO1;MTSS1;APOE;SPARC;CAV1;NUPR1;XDH;FGFR2;PTPRM;THBS1;B2M
prerank,dendritic cell migration (GO:0036336),0.677142772552662,1.5621888336229204,0.07505070993914807,0.5846046349048892,1.0,2/16,5.78%,EPS8;CXCR2
prerank,sulfur compound transport (GO:0072348),-0.5529168634181922,-1.5611182970585888,0.018867924528301886,0.28709791717998395,1.0,9/27,13.53%,SLC13A4;SLC6A13;SLC6A6;SLC26A7;ABCG2;SLC5A6;MGST1;SLC35F3;SLC25A19
prerank,ethanol metabolic process (GO:0006067),-0.6718309027520719,-1.5608285779531457,0.01818181818181818,0.2860384449072948,1.0,3/12,13.43%,ALDH1A1;SULT1A1;ADH1A
prerank,positive regulation of bone mineralization (GO:0030501),-0.5153531659921502,-1.5607151534631256,0.012958963282937365,0.2844885479095228,1.0,18/35,15.76%,BMP6;WNT4;BMP7;OSR1;BMPR2;BMP4;ADGRV1;ACVR1;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5719561462515265,1.5601211727421052,0.0600375234521576,0.5879436651177102,1.0,8/45,3.06%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;PIK3CA
prerank,cell cycle checkpoint signaling (GO:0000075),-0.6674065622972305,-1.5595133992290666,0.02666666666666667,0.2856761132380189,1.0,6/12,17.44%,WEE1;PLK2;CHFR;NABP1;ZW10;PRCC
prerank,regulation of calcium ion transport (GO:0051924),0.5601168356566599,1.559361613473141,0.038917089678511,0.5868781683331844,1.0,13/54,12.17%,TRPC6;CACNB2;MYLK;EPB41;CACNA2D1;STIM2;STC1;CACNA1D;STIM1;PKD2;CASQ1;PACSIN3;SLC8B1
prerank,regulation of aerobic respiration (GO:1903715),0.709404131756226,1.5592809777916026,0.10245901639344263,0.5837075609685655,1.0,3/15,3.70%,CBFA2T3;SLC25A33;ATP7A
prerank,cellular component disassembly (GO:0022411),-0.47532877796120415,-1.5580590697965184,0.017456359102244388,0.28718065060179515,1.0,18/53,15.44%,GSN;ADAMTS5;TLL1;BSG;CAPN2;TIMP2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;MMP14;ADAM15;CAPN1;MMP19;CTSS;WASHC1;MMP2
prerank,positive regulation of calcium ion import (GO:0090280),0.733737103212287,1.557315627186319,0.1031390134529148,0.5867284608798449,1.0,3/12,9.15%,PDGFRB;STC1;PDGFB
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4884898300274568,-1.5567107159759852,0.016129032258064516,0.2887147938724841,1.0,12/49,10.31%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,extracellular matrix disassembly (GO:0022617),-0.47587616769264485,-1.5559040694855617,0.017543859649122806,0.2888175004014206,1.0,18/53,15.44%,GSN;ADAMTS5;TLL1;BSG;CAPN2;TIMP2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;MMP14;ADAM15;CAPN1;MMP19;CTSS;WASHC1;MMP2
prerank,amyloid fibril formation (GO:1990000),-0.48355715113234277,-1.555399694938131,0.011682242990654205,0.28838307268083724,1.0,13/51,8.56%,TSPAN5;SNCAIP;GSN;APP;B2M;HSPG2;ADAM10;IAPP;GGA2;FKBP1A;H3-3A;CST3;TGFBI
prerank,sphingolipid metabolic process (GO:0006665),-0.41515767174368845,-1.555351832184647,0.0,0.2867874187048257,1.0,43/108,24.73%,PLPP3;SGMS1;ESYT2;CERT1;SGMS2;ELOVL7;ST6GALNAC3;ACER2;SMPD3;HACD4;HACD3;HEXA;HEXB;ACER3;CSNK1G2;NSMAF;B3GALNT1;PSAP;SPNS2;DEGS2;ST6GALNAC6;PLPP1;ALDH3A2;ESYT3;PLA2G15;SPHK1;UGCG;SPTLC2;VAPA;SUMF2;SERINC1;ELOVL1;CLN8;NEU3;ORMDL3;GLB1;ENPP2;SUMF1;SGPL1;PPM1L;SPTSSA;ORMDL2;PDXDC1
prerank,regulation of keratinocyte migration (GO:0051547),0.713229176635838,1.5537116767813464,0.08723404255319149,0.5948412202732443,1.0,6/12,12.35%,PTEN;MAPRE2;FGF10;MTOR;MAP4K4;IQSEC1
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.4951070711594509,-1.553532951607467,0.02576112412177986,0.28931260282881566,1.0,16/45,13.44%,SMAD3;BMP7;PTPN3;TOM1L2;BMP4;GAS1;WEE1;TOM1L1;FOXC1;PLK2;CHFR;BTG3;NABP1;TGFB1;TRIM35;ZW10
prerank,regulation of platelet activation (GO:0010543),-0.5853505352131625,-1.5535219685442976,0.027196652719665274,0.2876171531097812,1.0,5/21,3.29%,PDGFRA;PLA2G4A;APOE;NOS3;THBD
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6988542885296204,1.5532261078464495,0.05664488017429194,0.5928973209243424,1.0,3/15,2.70%,GGT5;GGT1;CHAC1
prerank,response to calcium ion (GO:0051592),0.5084246187150486,1.5524858619114872,0.02037617554858934,0.5918288512365957,1.0,22/102,11.38%,TRPC3;CASQ2;MEF2C;TRPC1;RASGRP2;KCNMB1;ADCY8;PPP3CA;ITPKB;CPNE7;SLC25A13;SCN5A;RYR2;STIM1;SYT1;RYR3;PKD2;HPCA;CPNE4;BRAF;CHP2;SYT2
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6035413328881379,-1.5520811839381061,0.02835538752362949,0.2893525382483427,1.0,4/18,10.31%,IGF1;IGFBP2;IGF2;IL18
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6645990181388323,-1.5518197576383999,0.03536345776031434,0.2883088542043869,1.0,7/12,20.50%,PTPN14;BMP4;IFI27;TGFB1;SIRT7;TPR;NUP214
prerank,activin receptor signaling pathway (GO:0032924),-0.6229387007906015,-1.5513271683114727,0.03195488721804511,0.2877944631791494,1.0,3/15,4.09%,SMAD3;TGFBR1;ACVR1
prerank,cell-matrix adhesion (GO:0007160),0.5045987689060872,1.550617712774572,0.028846153846153848,0.5944657087760826,1.0,12/95,3.62%,DLC1;PTPRK;ITGA1;ITGA4;ITGA7;ECM2;VTN;VCL;PEAK1;FERMT2;CD96;ITGB5
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6206759898206271,-1.5502103357893768,0.02099236641221374,0.28863958019847147,1.0,6/16,4.69%,IGF1;IGFBP2;IGFBP5;IGFBP6;IGFBP4;IGFBP3
prerank,actin filament bundle organization (GO:0061572),0.5991574501861382,1.5496702460693585,0.04980842911877394,0.5940975353839164,1.0,4/33,1.13%,MYO1B;EPS8;CALD1;AIF1L
prerank,inositol phosphate catabolic process (GO:0071545),0.7336976126309357,1.5480644703495778,0.09503239740820735,0.5958230484947034,1.0,4/12,5.65%,PTEN;IMPA2;INPP5A;INPP5J
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.36990371647643827,-1.547610609600663,0.0,0.29344733852256294,1.0,123/306,27.15%,EXT1;ST3GAL4;LARGE1;APOE;RPLP1;ST3GAL2;RPS14;REV1;THRB;RPL9;RPS12;RPL41;RPS20;PTMS;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;EEF1D;GOLPH3;RPS11;POLR2A;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;NR4A2;MMS19;RPL37;RPL11;RPS18;EEF1B2;ALAS1;PWP1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;POLR2F;MEF2A;RPL28;ATM;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;RPA1;DTX1;MRPL52;GCNT1;RAD50;DBF4;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;EEFSEC;RPS25;POLR2E;RPL15;RPSA;RPS7;RPL38;GAL3ST2;TYMS;RPLP0;RPL27;RFC3;E2F1;RRBP1;RPL36A;THAP1;TOP3A;POLE2;RPS26;MCM8;RPL35A;RMI2;CDC45;FARSB;RPS29;BRCA1;RPL8;RPL36;RPA3;POLR2G;MRPL35;GTPBP2;ING4;PPP5C;RPS3;RRAGC;RPL13A;EPC1;POLA1;ABCF1;B4GALT5;HUS1;ASMT;MRPL34;EXT2;POLD1
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4334253809728642,-1.5471845200066738,0.005194805194805195,0.29288655461644325,1.0,27/87,9.05%,TGFBR3;ZMIZ1;COL1A2;COL3A1;SMAD3;SMAD6;CDH5;FMOD;CLDN5;TGFBR2;TGFBR1;SMAD9;ADAM9;SMAD7;ACVR1;PXN;ID1;SKI;APPL2;ACVRL1;SMURF1;PRKCZ;RHOA;FKBP1A;ZYX;USP15;PARD3
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.5595741496765615,-1.5470954430526884,0.032454361054766734,0.2913856033769749,1.0,12/25,17.92%,EPHA4;TAF1;PML;PRKCG;RPL11;TRIM39;HSP90AB1;OPHN1;HIPK2;RPL23;HFE;RPS7
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4314431021009819,-1.5469674441940773,0.007594936708860759,0.29001617843079397,1.0,30/88,13.06%,SULF1;NRP2;NRP1;TEK;APOE;SPARC;F3;CAV1;XDH;PTPRM;BMPR2;THBS1;BMP4;TGFBR1;ANGPT1;VEGFD;VEGFC;ACVRL1;WNT5A;STAT1;AKT1;TIE1;PPP1R16B;HIF1A;ECM1;CDH13;KDR;ITGB3;FLT4;ATOH8
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.6160179754811734,1.5465816262070748,0.06415094339622641,0.5972795373864683,1.0,5/27,2.30%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,regulation of interleukin-12 production (GO:0032655),-0.4909654947174127,-1.5464575154510394,0.0069605568445475635,0.2895538431088295,1.0,15/47,22.30%,PLCB1;FOXP1;THBS1;IL16;LGALS9;MAPK14;CD47;CMKLR1;IRAK3;MAST2;PLCG2;TLR4;SYK;MDK;CCL19
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6381351469240607,1.545919591949751,0.07692307692307693,0.5959481759113582,1.0,5/22,7.81%,DYNLL1;ROCK1;TESK1;ANKLE2;CDKN1A
prerank,cellular response to inorganic substance (GO:0071241),0.6525973493214206,1.545639991410548,0.08829568788501027,0.5934558763820468,1.0,1/21,0.12%,GUCY1B1
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.46707943150808473,-1.5455954165815613,0.007407407407407408,0.29023482904837195,1.0,23/63,16.89%,TIMP3;LEPR;PTPN3;NUPR1;TIMP2;DAP;RASIP1;STAT3;CST3;ATRAID;AKT1;MCL1;FOXK1;DAPL1;DAB2IP;ZKSCAN3;EIF4G3;MFSD2A;MET;RGP1;WASHC1;TIMP4;SIRT2
prerank,central nervous system myelination (GO:0022010),0.717526736895492,1.5454973029377284,0.0975609756097561,0.5907060361969001,1.0,4/11,9.76%,PTEN;B4GALT6;TENM4;PLP1
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.575615996591737,-1.5454009873988037,0.040776699029126215,0.28903234725491633,1.0,9/20,17.18%,NUPR1;CFLAR;SDCBP;PDCD6IP;BIRC3;FLOT2;CASP8;PELI1;RIPK1
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6729742607387541,-1.5447834160309089,0.05027932960893855,0.28895627075299235,1.0,7/11,19.47%,TGFBR2;FGFR2;WNT5A;STAT1;TBX1;CHRD;CTNNBIP1
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6567528237389282,-1.544063010423231,0.027124773960216998,0.28927061243334806,1.0,7/13,19.03%,SP100;MDFIC;APOD;SUFU;TPR;PARK7;CHP1
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6367033414368354,1.5436614892533123,0.06483300589390963,0.5928621943050735,1.0,6/26,7.50%,SLC30A10;SLC25A33;CCN6;ABCD2;SNCA;PIKFYVE
prerank,embryonic digit morphogenesis (GO:0042733),0.6712574971455533,1.5435858724996305,0.08536585365853659,0.5898587795430079,1.0,4/18,3.07%,TBX2;MAP3K20;TBX3;ECE1
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4967929802571052,1.5424594520023773,0.023088023088023088,0.5904158498657032,1.0,17/117,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5567723754388534,1.5420266646450744,0.04159132007233273,0.5886115418621509,1.0,3/47,0.80%,PDGFRB;ACE2;PID1
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6140279754626968,1.5418780543693986,0.07465618860510806,0.5859850383954213,1.0,7/25,6.29%,CACNB2;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6793286287045779,1.5417625110233173,0.0794979079497908,0.5832628262385962,1.0,6/17,7.70%,KCNJ8;NEDD4L;KCNE4;SCN5A;RYR2;KCNE5
prerank,axon development (GO:0061564),0.516639808570915,1.5414190390569873,0.05345911949685535,0.5812080535450975,1.0,21/78,12.82%,GRM7;RTN4RL1;SEMA5A;SVBP;DHFR;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;MARK2;GAP43;ARHGAP35;PLP1;CTNNA2;BRSK1;PAK3;ZDHHC17;SLITRK2
prerank,artery development (GO:0060840),-0.5510125821399315,-1.5411996471445288,0.03125,0.2949010716183765,1.0,8/23,8.16%,ROBO1;NRP1;BMPR2;TGFBR1;SMAD7;ACVRL1;TBX1;STRA6
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.6466467156010927,-1.5407509368859542,0.04933586337760911,0.2943476909747909,1.0,4/13,8.75%,IGF1;SORBS1;IGF2;AKT1
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5134728091596169,-1.5400855752987657,0.03655913978494624,0.2943417077468449,1.0,13/35,12.24%,ZMIZ1;RBFOX2;NR3C1;ESR1;DDX5;NR3C2;AR;YAP1;TMF1;EGLN2;PGR;KDM3A;PLPP1
prerank,apical junction assembly (GO:0043297),-0.4766189789128757,-1.5398604325498344,0.014218009478672985,0.29327097730317137,1.0,14/53,10.00%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;RHOA;CLDN11;PARD3;CTNNA1;PATJ
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5594057266588308,-1.5385769428802987,0.03556485355648536,0.2948293901485424,1.0,6/24,10.76%,IGF1;SORBS1;ENPP1;IGF2;AKT1;PPP1R3B
prerank,translation (GO:0006412),-0.37916653105172066,-1.537423749411283,0.0,0.2961556624807047,1.0,93/208,26.69%,RPLP1;RPS14;LARS2;RPL9;RPS12;RPL41;RPS20;RPL18A;RARS2;RPS13;RPS19;RPS23;SRBD1;RPS4X;EEF1D;RPS11;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;KARS1;RPL11;RPS18;EEF1B2;CARS1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RWDD1;RPL26;MRPS7;MRPS6;QARS1;SARS1;RPL10;MRPS18A;RPL7;MRPS24;MRPL52;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;EEFSEC;RPS25;MARS2;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;RRBP1;RPL36A;DRG2;FARSA;FTSJ1;RPS26;PPA1;RPL35A;APEH;FARSB;RPS29;TRMT112;RPL8;RPL36;MRPL35;GTPBP2;TMA7;RPS3;RPL13A;ABCF1;ASMT;MRPL34
prerank,stabilization of membrane potential (GO:0030322),-0.6295507513897616,-1.5374020752117803,0.03231939163498099,0.29462204107152173,1.0,2/16,2.80%,KCNK2;KCNK5
prerank,artery morphogenesis (GO:0048844),0.6045796824000229,1.537174432775303,0.06201550387596899,0.591099196244558,1.0,5/30,2.17%,PDGFRB;TBX2;HEY2;NOTCH1;NF1
prerank,mesenchyme development (GO:0060485),-0.6254518450545715,-1.536451427627935,0.04142011834319527,0.2955445222867561,1.0,5/15,3.45%,BMP7;FGFR2;BMPR2;BMP4;TGFBR1
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.6091634475073975,1.535756756815807,0.07,0.5924514615557557,1.0,3/27,0.73%,PDE4D;DMD;CACNB2
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.5978019751481368,1.53572803114079,0.05961538461538462,0.5894495974394964,1.0,4/33,1.63%,PTEN;MEF2C;PRKG1;GPER1
prerank,positive regulation of interleukin-2 production (GO:0032743),0.6460253584357555,1.5345000902349457,0.053061224489795916,0.5903099768404231,1.0,5/25,6.03%,PDE4D;GLMN;IL1B;SPTBN1;PDE4B
prerank,regulation of tissue remodeling (GO:0034103),-0.6044187863021536,-1.5341065151935573,0.04093567251461988,0.2999564612239805,1.0,7/18,15.88%,LEPR;IL15;CST3;IL18;TGFB1;FLT4;CEACAM1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.6585114739625921,-1.533858044815042,0.05103969754253308,0.2990247499785444,1.0,4/12,8.75%,IGF1;SORBS1;IGF2;AKT1
prerank,defense response to tumor cell (GO:0002357),0.720044047590826,1.5332299453568532,0.08453608247422681,0.5909633126097643,1.0,2/10,1.51%,DLEC1;RBMS3
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.44511095468549966,-1.5322719747647247,0.005194805194805195,0.30145470208962916,1.0,24/65,13.92%,FBN1;LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;TGFBR1;SNX6;SMAD7;SKI;SMURF1;FBN2;PRDM16;FKBP1A;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB;LTBP1
prerank,regulation of glucose import (GO:0046324),-0.5281922022732022,-1.5321181760556042,0.031315240083507306,0.3002871121851626,1.0,7/30,2.24%,PRKAG2;IGF1;SORBS1;OSBPL8;OCLN;RHOQ;ENPP1
prerank,actin filament bundle assembly (GO:0051017),0.5955054499597184,1.5320358804985303,0.06262230919765166,0.5916649681873996,1.0,4/33,1.13%,MYO1B;EPS8;CALD1;AIF1L
prerank,response to metal ion (GO:0010038),0.5328813097395921,1.5314109647775427,0.051696284329563816,0.5906077849683652,1.0,6/67,6.29%,TRPC3;NEDD4L;TRPC1;PPP3CA;SLC25A13;SNCA
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5710943322566278,-1.53108180425469,0.04085603112840467,0.301341237333688,1.0,8/21,19.09%,IGF1;CTSH;LGALS9;KARS1;KDR;MAPK3;ZFP36L2;MT3
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5726106970242594,1.5293033987190428,0.0740072202166065,0.5934826059405494,1.0,8/42,4.29%,LIMS1;ECM2;GCNT2;NOTCH1;PTK2;NF1;CORO2B;MINK1
prerank,response to iron ion (GO:0010039),-0.6651598252686572,-1.5271727059352185,0.05384615384615385,0.3084457879073209,1.0,4/12,9.23%,BMP6;B2M;ACO1;HIF1A
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5841244494530753,1.5267778931576665,0.07167832167832168,0.5980533424616643,1.0,14/41,14.03%,ACE2;GNG2;KCNJ12;KCNMB1;AKAP6;ANK3;PDZK1;KCNE5;STAC;KCNJ3;KCNJ6;PIRT;KCNMA1;ANK2
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.49500391969932556,-1.5262560191770183,0.015283842794759825,0.3094475307802381,1.0,16/43,12.78%,BMP6;IGF1;WNT4;BMP7;IL6R;BMPR2;BMP4;IL6ST;ACVR1;ZHX3;YAP1;FBN2;ATRAID;CCN4;TMEM119;CCN1
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5955470476159159,1.5252933804487703,0.06666666666666667,0.5997476178459338,1.0,5/35,7.39%,SGIP1;VTN;LDLRAP1;IL4;PPT1
prerank,regulation of T cell migration (GO:2000404),-0.5902561648031851,-1.5246957321076762,0.04790419161676647,0.3117117676429628,1.0,5/18,6.58%,APP;APOD;LRCH1;CXCL12;RHOA
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5654904386614268,1.5246849638271276,0.0584070796460177,0.598599638148614,1.0,6/44,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,chloride transport (GO:0006821),0.5341470692677807,1.5246296892082871,0.023423423423423424,0.5958261472337686,1.0,9/74,6.37%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;SLC26A1;GABRG2;GABRA2;TTYH1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7131600604934012,1.524052449081366,0.09381663113006397,0.5946912422160932,1.0,5/11,7.70%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6404165322017628,1.5238666995465635,0.075,0.5923342962118594,1.0,6/20,5.65%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,clathrin coat assembly (GO:0048268),0.6781443130443411,1.521384270160819,0.08024691358024691,0.5970523431247439,1.0,4/15,10.21%,SGIP1;PIK3C2A;AP2S1;HIP1
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6611576874378658,-1.5210305911328057,0.051233396584440226,0.31982643517152415,1.0,6/11,14.15%,SEMA6A;ADAMTS9;THBS1;KLF2;PIK3CB;CREB3L1
prerank,regulation of autophagosome maturation (GO:1901096),-0.6208452145977021,-1.5208194656100833,0.04127579737335835,0.31862422645487637,1.0,6/13,18.05%,CLEC16A;IRGM;PHF23;UVRAG;TBC1D25;ADRB2
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6925327484978937,1.52046377938773,0.08620689655172414,0.5969835228614166,1.0,6/13,4.24%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.5208081890682006,-1.5202796141498178,0.03879310344827586,0.3184749539576105,1.0,14/33,25.64%,IGF1;IAPP;TFRC;AKT1;FLCN;BNIP3;ADCK1;GPX1;VAT1;PRELID1;TMEM14A;PSMD10;BCL2L1;PRKN
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5811558408803796,1.5200284243172544,0.07024029574861368,0.5952140028801153,1.0,15/39,11.62%,UTRN;DMD;NEDD4L;HECW2;FGF12;FXYD2;STK39;FGF13;ANK3;HECW1;NETO1;SCN2B;RANGRF;FGF11;FGF14
prerank,regulation of ion transmembrane transport (GO:0034765),0.5928397701617987,1.519874552835211,0.058287795992714025,0.5928827992847427,1.0,5/33,4.10%,KCNJ8;CASQ2;NEDD4L;KCNJ12;AKAP6
prerank,neural crest cell differentiation (GO:0014033),0.6609014574869052,1.5197586449655567,0.09375,0.5903977729673722,1.0,3/18,2.80%,MEF2C;CDH2;NRG1
prerank,endocardial cushion morphogenesis (GO:0003203),0.6631196790097067,1.5185598847003097,0.06471816283924843,0.5911706375804453,1.0,4/18,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,action potential (GO:0001508),0.5577271115298759,1.518094184537202,0.0603290676416819,0.5897690469807731,1.0,12/44,8.85%,DMD;GPER1;CACNA1H;KCNE4;KCND2;AKAP6;SCN2A;SCN5A;ANK3;SCN8A;KCNE5;SCN9A
prerank,anion transport (GO:0006820),-0.5148810930298751,-1.5177935763781663,0.031185031185031187,0.32350584403352844,1.0,6/33,4.69%,SLC13A4;SLC13A3;SLCO2B1;SLC26A7;ABCG2;SLC22A6
prerank,cellular response to heat (GO:0034605),0.5907915725791462,1.5176667510267612,0.0673076923076923,0.5881646354618422,1.0,1/35,0.04%,ANO1
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5805661670126215,1.5170610163970983,0.08687943262411348,0.5872627940859466,1.0,9/35,10.51%,DLC1;TNFAIP1;SPRY4;CUL3;SPRY2;LZTR1;KCTD13;ARHGAP35;ABL2
prerank,positive regulation of signal transduction (GO:0009967),-0.3670057714520951,-1.5164751916646777,0.0,0.32543388548604657,1.0,55/238,11.84%,TSPAN5;BMP6;SULF1;IGF1;SORBS1;ROBO1;ZMIZ1;NRP1;NTRK3;PTGIS;VWF;TEK;CCBE1;F3;LIMS2;MACF1;RSPO3;JCAD;SASH1;SHANK3;FGFR2;NOS3;IL6ST;ITGA5;TGFBR1;KAT2B;LRRK2;KLF2;SKI;SMO;IGF2;SLC39A14;GAS6;MN1;FGF1;CCN3;SULF2;YAP1;BMP2K;PRKCZ;RSPO2;PRKCB;PTK2B;STAT3;EVC;TTC23;HIF1A;TRIM16;NLGN2;DAB2IP;VPS35;ITGB3;POGLUT1;ERN1;ADAMTS3
prerank,hemopoiesis (GO:0030097),-0.4269020319794459,-1.516138548377591,0.010899182561307902,0.3246412633340981,1.0,23/87,13.90%,TGFBR3;NOTCH2;ZBTB16;FLT1;MECOM;TEK;MFAP5;TGFBR2;FGFR2;BMP4;ETV6;CD34;WNT5A;KIT;FLCN;KDR;CD164;MKNK2;TGFB1;FLT4;FLT3LG;TAL1;SFRP1
prerank,heterochromatin organization (GO:0070828),-0.6323610428427426,-1.5159229231504538,0.04,0.3235381902941785,1.0,7/14,20.12%,MECOM;SETD7;PRDM16;EZH1;SNAI1;SETDB1;HP1BP3
prerank,endocardial cushion development (GO:0003197),0.6364743470995113,1.5157108089509184,0.06986027944111776,0.5886109325349045,1.0,4/21,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,regulation of muscle contraction (GO:0006937),0.6198665800883778,1.5154808004700984,0.0694980694980695,0.5864703981876915,1.0,4/26,3.41%,PLCE1;ATP1A2;MYL9;CHRNA3
prerank,amino acid import across plasma membrane (GO:0089718),-0.5570361972229076,-1.5132971627275695,0.031683168316831684,0.32862093209501375,1.0,9/24,6.93%,SLC6A13;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SLC7A2;SLC6A9;SLC22A4;SLC7A5
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6339696297839177,1.51187816802352,0.07331975560081466,0.5944342361864601,1.0,2/26,3.74%,ANO1;ADCY8
prerank,fatty acid transmembrane transport (GO:1902001),-0.5878792939011618,-1.5108976051104237,0.03598484848484849,0.33347502755430675,1.0,6/19,9.91%,PRKAG2;SLC2A1;CPT1A;SLC25A20;CPT2;ACACA
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5629354582142401,-1.5085128046420586,0.037815126050420166,0.3385039132160128,1.0,9/23,16.17%,PRKAG2;CEMIP;BMP7;APP;CALM2;IRGM;TGFB1;SPHK1;CALM1
prerank,cellular response to leucine (GO:0071233),0.7313253399752041,1.5078655291101246,0.10065645514223195,0.601077245717365,1.0,4/10,12.03%,UBR1;SESN3;MTOR;UBR2
prerank,response to leucine (GO:0043201),0.7313253399752041,1.5078655291101246,0.10065645514223195,0.601077245717365,1.0,4/10,12.03%,UBR1;SESN3;MTOR;UBR2
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.39444323708068607,-1.5076370197226852,0.003003003003003003,0.33928720980380034,1.0,34/136,12.56%,HDAC4;PTGIS;BMP7;SP100;ANXA4;NUPR1;SUFU;ESR1;KLF4;TCF7L2;SMAD7;TAF1;ID1;IRAK2;GAS6;ARRB1;WWP2;DAP;GLIS2;SFRP4;BHLHE40;ID3;CYP1B1;MAP2K5;TMSB4X;CMKLR1;NLRC5;IRAK3;DAB2IP;ZC3H12A;MDFI;CEBPG;PTCH1;ID2
prerank,blood circulation (GO:0008015),0.5461790743478447,1.5066335782179479,0.05008944543828265,0.6020891170632195,1.0,7/49,3.95%,GUCY1B1;ACE2;GUCY1A1;COL4A3;ADORA2A;ROCK1;ADCY6
prerank,regulation of autophagy (GO:0010506),-0.37023105378926285,-1.5062718028113617,0.0,0.3413643542203426,1.0,68/216,19.58%,PRKAG2;DAPK1;LEPR;DCN;FOXO1;FOXO3;NUPR1;SNX6;LRRK2;WDR41;ACER2;TPCN1;DAP;RASIP1;SNX32;PLK2;EXOC4;STAT3;CAPNS1;ATP6V1G1;PIK3CB;AKT1;MCL1;EEF1A1;IRGM;CAPN1;FOXK1;DAPL1;FLCN;ATF6;PSAP;GFAP;ATP6V0B;ZC3H12A;ZKSCAN3;PIP4K2B;TRIM27;OPTN;VPS35;ERN1;SH3GLB1;EIF4G3;RAB8A;ATP6V0A1;PRKAG3;ATM;PRKAB1;MET;TICAM1;BNIP3;WASHC1;ATP6V0A2;FBXL2;SREBF1;PRKAA2;GPR137;MTMR3;TRIM8;SIRT2;RRAGB;TRIM14;LAMTOR5;SH3BP4;TMEM59;MT3;PIM2;ATG101;ORMDL3
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6547817682002849,1.5062649298960222,0.08102766798418973,0.6004993059123616,1.0,5/18,7.70%,NEDD4L;ATP1A2;STK39;BIN1;KCNE5
prerank,ruffle organization (GO:0031529),0.6533205200366505,1.5060983828580128,0.0874751491053678,0.5982168067025933,1.0,2/16,1.13%,CARMIL1;AIF1L
prerank,regulation of cell morphogenesis (GO:0022604),-0.5117291008034618,-1.5054685922209785,0.0273109243697479,0.3420892609427291,1.0,8/30,6.66%,FMNL2;PDPN;SPARC;CAPZB;MACF1;MOV10;EFNA5;MYO9A
prerank,positive regulation of axonogenesis (GO:0050772),-0.4954907427279325,-1.505169883237146,0.03167420814479638,0.3412848873183314,1.0,10/43,8.74%,PLXNA2;ROBO1;TIAM2;PLXNA4;SLIT2;MACF1;SEMA7A;RHOA;TIAM1;PLXND1
prerank,sensory organ development (GO:0007423),-0.46711905180040325,-1.5051122707855182,0.014150943396226415,0.3398228800678546,1.0,13/51,16.97%,PBX1;SMOC1;CHD7;SHROOM2;PBX3;RBP4;FOXC1;STRA6;ATF6;MEIS2;HIPK2;MEIS1;RAB18
prerank,epithelial cell differentiation (GO:0030855),-0.42695807824759746,-1.5046320561519797,0.018229166666666668,0.33956742964255204,1.0,21/88,16.16%,DAB2;MAF;FSTL1;ANXA4;FGFR2;BMP4;ANXA1;CPT1A;CNN3;SIX1;TBX1;AKT1;CTSB;FZD7;KDR;ANXA7;HDAC1;GATA6;BDH2;CASP6;KDM6B
prerank,tube closure (GO:0060606),0.5998622538265707,1.5045569518523176,0.07706093189964158,0.6001907474409267,1.0,3/31,2.42%,DLC1;VASP;GRHL3
prerank,regulation of peptide hormone secretion (GO:0090276),0.5203854712780674,1.504210492863526,0.05492730210016155,0.5984618199996582,1.0,18/67,12.83%,CACNA1C;RAPGEF4;PER2;ITPR2;IL1B;FFAR2;GIPR;SNAP25;ITPR1;TFAP2B;HTR2C;RAP1A;CACNA1D;GCK;CACNA1A;SLC8B1;KCNG2;RASL10B
prerank,embryonic organ morphogenesis (GO:0048562),-0.48067582964293576,-1.503108174848935,0.034858387799564274,0.3422694288328298,1.0,17/42,14.67%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;MFAP5;FGFR2;ACVR1;HOXA3;RARG;SIX1;FBN2;TBX1;HOXB9;ID2;SOX17;HOXC4
prerank,nitric oxide metabolic process (GO:0046209),-0.6243483041277771,-1.5024508580951619,0.05263157894736842,0.3422080044070074,1.0,6/14,18.74%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7166027656741862,1.5013596347643114,0.10067114093959731,0.6043020235780063,1.0,4/10,3.66%,NEDD4L;ATP1A2;HECW2;STK39
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5854663609542663,1.5012224241084102,0.0726950354609929,0.6019994008467965,1.0,8/33,4.24%,MEF2C;TBXA2R;NOTCH1;RGCC;STARD13;MECP2;PDCD10;FGF2
prerank,B cell receptor signaling pathway (GO:0050853),0.6022100799213229,1.5011270521056945,0.09786476868327403,0.5996258503970537,1.0,4/32,2.48%,MEF2C;PIK3CD;BCAR1;RFTN1
prerank,xenobiotic transport (GO:0042908),-0.5972501644936902,-1.5010901114339799,0.037109375,0.3442405841570465,1.0,8/17,16.74%,SLC47A1;GJA1;ABCG2;SLC22A4;SLC7A5;ABCA3;SLC22A18;SLC22A2
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6644451188200848,-1.500791470630971,0.05871886120996441,0.3433763268617891,1.0,3/10,2.43%,ERRFI1;ENPP1;CAV1
prerank,negative regulation of angiogenesis (GO:0016525),-0.4260274859882074,-1.5005795586721302,0.010309278350515464,0.34235570311856034,1.0,30/84,11.34%,SULF1;DCN;ROCK2;TEK;SEMA6A;ADAMTS9;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;KLF2;HSPG2;HOXA5;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;PIK3CB;HGS;STAB1;EMILIN1;DAB2IP;PML;ECSCR
prerank,second-messenger-mediated signaling (GO:0019932),0.5034986010207714,1.5005465887393603,0.04133545310015898,0.5986263024886626,1.0,12/82,8.64%,GUCY1B1;GUCY1A1;PLCE1;INPP5A;CCRL2;ACKR3;CXCR2;RYR2;MAFA;ACKR2;CCR9;GPR62
prerank,primary neural tube formation (GO:0014020),0.602981228411252,1.50051424526043,0.08648648648648649,0.5960403853866669,1.0,3/30,2.42%,DLC1;VASP;GRHL3
prerank,lung epithelium development (GO:0060428),-0.6666139021652508,-1.5004118649477607,0.05474452554744526,0.34123707359827005,1.0,5/10,14.82%,ERRFI1;BMP4;RCN3;STRA6;PKD1
prerank,blood vessel endothelial cell migration (GO:0043534),-0.5648972601808182,-1.5002934496138431,0.03807615230460922,0.3399403738336776,1.0,9/22,10.61%,ROBO1;EFNB2;CDH5;NRP1;SLIT2;EPHB4;ID1;AKT1;KDR
prerank,carboxylic acid metabolic process (GO:0019752),-0.5089672018272381,-1.4999203902741844,0.04251012145748988,0.3393036695465615,1.0,12/33,19.67%,PLA2G4A;PTGIS;DDO;ST3GAL1;SLC2A1;CSGALNACT1;CARNMT1;TBXAS1;PON3;AGXT;CYB5R3;GNE
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5361128389412902,-1.4989942792066868,0.030120481927710843,0.34019530168249634,1.0,5/26,1.64%,IGF1;SORBS1;OSBPL8;OCLN;RHOQ
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6321323641811483,-1.4988367257646902,0.06560636182902585,0.33910642516452544,1.0,4/12,6.58%,JAM2;APP;CXCL12;RHOA
prerank,glutathione biosynthetic process (GO:0006750),0.7085297368280572,1.498738010030425,0.11538461538461539,0.598751475941933,1.0,2/11,2.70%,GGT1;CHAC1
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6291679932764382,-1.497743006004494,0.06227106227106227,0.34041569700255686,1.0,5/12,18.05%,IGF1R;IRGM;UVRAG;BNIP3;ADRB2
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.6348505168345578,-1.4969470624520849,0.0625,0.3410517223641085,1.0,6/13,19.01%,ENTPD1;ENPP1;ENPP3;ENTPD5;SMPDL3A;ENTPD2
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5818724393691307,1.4956193695870095,0.083984375,0.6052885350213945,1.0,9/33,7.20%,PTEN;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;NYAP2;PIK3C2A;IRS1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6364789648859793,1.4951448137589278,0.10153256704980843,0.6041145949446709,1.0,4/20,1.63%,ITGA4;PLA2R1;RGCC;GPER1
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6366999842644219,-1.4950736335968215,0.05927342256214149,0.3444654179851168,1.0,6/13,18.74%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,regulation of feeding behavior (GO:0060259),0.7072650056118185,1.4939611777664714,0.10655737704918032,0.6048860703224356,1.0,1/11,0.11%,SGIP1
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7102830484466502,1.4938763295699373,0.10352422907488987,0.6025871083571378,1.0,2/12,1.87%,PTEN;BTRC
prerank,negative regulation of proteolysis (GO:0045861),-0.515258652224243,-1.4928204094297157,0.0392156862745098,0.3486724591900618,1.0,9/34,9.38%,TIMP3;EPHA4;PTPN3;GAS1;TIMP2;LRRK2;CST3;AKT1;ECM1
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5948655583522245,1.4926946752631207,0.06547619047619048,0.6034851475965376,1.0,17/32,18.46%,NEDD4L;RAPGEF2;SDC2;HECW2;CHRNA3;CAPRIN2;IL1RAPL1;ADGRB3;HECW1;SARM1;CUX2;LZTS1;CHRNB2;NSMF;GORASP1;GSK3B;KNDC1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.47511147528214087,1.4924017549712718,0.03680981595092025,0.601777312132296,1.0,16/107,7.48%,ATP13A5;SLC30A10;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1
prerank,positive regulation of inflammatory response (GO:0050729),-0.42123541521441143,-1.492097650564198,0.016713091922005572,0.34905772199197305,1.0,28/86,22.24%,APP;IL15;NUPR1;LBP;IL6ST;PDCD4;IL16;WNT5A;RPS19;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;KARS1;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGT;AGTR1;CD81;MDK;VAMP8;LPL
prerank,cellular response to purine-containing compound (GO:0071415),0.6869531809343172,1.4915239056927858,0.11235955056179775,0.6016971711834038,1.0,3/10,8.62%,CASQ2;RYR2;RYR3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6296448941301129,1.490943946979491,0.092,0.6008941057496874,1.0,7/22,11.85%,PTEN;HEXIM1;CDKN1A;INCA1;NR2F2;LATS2;APC
prerank,atrioventricular valve development (GO:0003171),0.6687223602878775,1.4905023662979702,0.09414225941422594,0.5997960159973806,1.0,4/14,1.81%,HEYL;NOTCH1;TBX20;SLIT3
prerank,regulation of exosomal secretion (GO:1903541),-0.5684824707665854,-1.4898884518706208,0.03488372093023256,0.35338880829023833,1.0,8/19,15.65%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;ATP9A;SDC1
prerank,purine-containing compound catabolic process (GO:0072523),-0.6284503492109808,-1.4892731673479465,0.05870841487279843,0.3536626206580467,1.0,9/13,25.02%,XDH;DPYD;NT5E;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,actin filament-based transport (GO:0099515),0.637432725086763,1.4892097776211681,0.10179640718562874,0.6009461260038382,1.0,4/21,8.18%,MYO1B;WASL;ACTN4;MYO6
prerank,urogenital system development (GO:0001655),-0.6428551211279975,-1.48842689742724,0.05178571428571429,0.35459786739307286,1.0,4/11,16.39%,OSR1;ANXA1;EPHB2;EPHB3
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.5776992099763457,1.4880192991551637,0.07407407407407407,0.6016825894520662,1.0,9/39,7.70%,TRPC6;UTRN;NEDD4L;FGF12;FXYD2;STK39;CACNA1D;PDZK1;KCNE5
prerank,negative regulation of cellular component movement (GO:0051271),-0.601471602910534,-1.4868213470099616,0.055970149253731345,0.3573052579724647,1.0,7/15,15.08%,TGFBR3;FBLN1;SP100;CD9;CCDC125;ACTN1;FRMD5
prerank,sphingolipid biosynthetic process (GO:0030148),-0.4342399726302097,-1.4864233894986376,0.026737967914438502,0.3568285733962176,1.0,22/71,16.93%,LARGE1;PLPP3;SGMS1;CERT1;SGMS2;ELOVL7;A4GALT;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA;ST3GAL5;ELOVL1;CLN8
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6467168022061157,1.4863219615751144,0.1111111111111111,0.604175010550652,1.0,3/18,2.79%,DLC1;TNFAIP1;CUL3
prerank,positive regulation of biosynthetic process (GO:0009891),-0.491266081398653,-1.4855005089566773,0.04008438818565401,0.3578243971919121,1.0,12/40,14.15%,SORBS1;WNT4;APOE;VIM;BMP4;RAB27A;AKT1;TGFB1;PPARA;CYBA;PLCG2;CREB3L1
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.44803214229235966,-1.4854432596933944,0.026785714285714284,0.35647320167313507,1.0,13/57,10.31%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;CNOT7;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6294201275018559,-1.4853457442491869,0.0421455938697318,0.35527573609618135,1.0,5/12,11.78%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6408816394259421,-1.4852518858974435,0.04428044280442804,0.3540411494478198,1.0,6/12,18.65%,CYP26B1;DHRS3;KLF2;TRIM16;CALR;EZH2
prerank,cellular response to growth factor stimulus (GO:0071363),-0.38035474467128344,-1.485198657593711,0.009708737864077669,0.35267585396779416,1.0,41/151,9.07%,BMP6;SMAD3;ADAMTS12;EGFR;FLT1;NRP1;WNT4;NTRK3;WWOX;BMP7;SEMA6A;IQGAP1;NR3C1;PLCG1;TGFBR2;BMPR2;BMP4;GAS1;TGFBR1;CLEC3B;MAGI2;KLF4;SMAD9;ANXA1;SMAD7;ACVR1;RAMP2;APPL2;NDNF;ACVRL1;WNT5A;MAPK14;FOXC1;SYAP1;MAP2K5;TBX1;RAPGEF1;EHD1;AKT1;EEF1A1;TMEM100
prerank,neuronal action potential (GO:0019228),0.6151353394100976,1.4848412857242852,0.08523908523908524,0.6060828426803311,1.0,7/22,8.85%,GPER1;CACNA1H;SCN2A;SCN5A;ANK3;SCN8A;SCN9A
prerank,epithelial structure maintenance (GO:0010669),-0.6617529973663816,-1.4844936940197582,0.04924242424242424,0.35303131750991046,1.0,3/11,12.19%,CXADR;RBP4;STRAP
prerank,glycerolipid metabolic process (GO:0046486),0.7056058155965855,1.484367209316442,0.09183673469387756,0.605004472526079,1.0,2/11,1.88%,DGKB;DGKG
prerank,aggrephagy (GO:0035973),0.6037902451280434,1.4839488204870366,0.0946969696969697,0.6037178951936713,1.0,1/27,0.06%,DYNLL1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5037102706838797,-1.4835425222468694,0.05506607929515418,0.35428389245583153,1.0,11/33,13.06%,SMAD3;FOXO3;NR3C1;KLF4;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;ATOH8
prerank,regulation of cell killing (GO:0031341),-0.5975706854150511,-1.4835341726696956,0.045368620037807186,0.35282312329632814,1.0,6/16,13.32%,CD55;CFH;WNT5A;ICAM1;FZD7;CYBA
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6695631232872645,-1.4832606180772834,0.05714285714285714,0.352091309620385,1.0,5/10,13.24%,TGFBR2;FGFR2;STAT1;TBX1;CHRD
prerank,positive regulation of cell differentiation (GO:0045597),-0.3644439478836763,-1.4827835538534229,0.0,0.35197351355092754,1.0,64/237,12.78%,BMP6;RANBP3L;IGF1;DAB2;PLCB1;SMAD3;ZBTB16;COL1A1;WNT4;BOC;PDPN;MEDAG;PRKCH;BMP7;CCN2;TMEM64;SLC6A6;CDON;IL6R;TGFBR2;BMPR2;BMP4;IL6ST;GJA1;TGFBR1;TCF4;CSF1;ARHGEF2;LEF1;ACVR1;CD34;HOXA5;ZHX3;IGFBP3;SDCBP;AR;YAP1;ACVRL1;NBL1;RHOA;FBN2;MAPK14;FOXC1;SYAP1;VWC2;NOCT;WDFY2;ATRAID;TIAM1;AKT1;CMKLR1;TMEM100;CTNNA1;CCN4;CARM1;IL18;ZC3H12A;KDR;TGFB1;BCL9L;TMEM119;ID2;MEF2A;CCN1
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5700005495043299,1.482305557841199,0.10018214936247723,0.606003551145283,1.0,11/38,11.06%,CACNA1C;CACNB2;KCNE4;CACNA2D1;CTNNA3;SCN5A;BIN1;CACNA1D;KCNE5;KCNJ3;SCN2B
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.637391548779968,1.4817955544532535,0.08651911468812877,0.6049131638430316,1.0,4/20,3.66%,CASQ2;NEDD4L;HECW2;STK39
prerank,regulation of macrophage migration (GO:1905521),-0.6660487823445729,-1.481622225995908,0.06469500924214418,0.353443833956156,1.0,7/10,25.68%,CSF1;PTK2B;EMILIN1;CD200;CD81;P2RY12;CD200R1
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6206233074386711,-1.4807882247521649,0.05162523900573614,0.35415749954679215,1.0,6/13,8.48%,GLUL;NOS3;DDAH1;ALDH4A1;PRODH;GLS
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5511009138458443,1.4807499233818973,0.07180385288966724,0.6053653990709582,1.0,9/48,7.33%,GUCY1B1;GUCY1A1;GUCY2D;ADCY8;ADCY3;ADCY6;SLC26A1;ADCY9;ADSL
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.607133346322741,-1.480569663276259,0.0509433962264151,0.35325926677799735,1.0,6/15,28.09%,MOXD1;DDC;SAT1;ASMT;SRM;SMOX
prerank,Golgi localization (GO:0051645),0.6780159481005248,1.4804857703642886,0.11016949152542373,0.6037217384191149,1.0,4/11,8.16%,ARHGAP21;PDCD10;YWHAZ;HOOK3
prerank,activation of protein kinase B activity (GO:0032148),-0.5201914765569263,-1.4792786833660478,0.0367965367965368,0.35538623763553756,1.0,13/29,19.09%,IGF1;NTRK3;OSBPL8;GAS6;FGF1;WNT5A;AKT1;IL18;TXN;PPIA;PDPK1;PARK7;MT3
prerank,acidic amino acid transport (GO:0015800),-0.5970170509585468,-1.478841138787529,0.0419047619047619,0.35514470160494366,1.0,7/17,16.02%,SLC6A13;SLC1A3;SLC6A6;GJA1;SLC6A1;SLC25A22;ARL6IP5
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6781126843255032,-1.4778509152699733,0.06043956043956044,0.35491814121022797,1.0,8/10,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6781126843255032,-1.4778509152699733,0.06043956043956044,0.35491814121022797,1.0,8/10,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6588477696488659,1.4772987337124615,0.10062893081761007,0.6104697858432755,1.0,4/15,6.68%,NR1H3;SCARB1;LDLR;SIK1
prerank,regulated exocytosis (GO:0045055),-0.37325454716047796,-1.4761881591259332,0.006329113924050633,0.35788753126567185,1.0,42/173,16.17%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;SERPING1;VWF;PECAM1;ACTN2;APP;SPARC;PCDH7;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;IGF2;GAS6;ARHGAP17;SRGN;TMSB4X;ECM1;PSAP;STX1A;LGALS3BP;ITGB3;TGFB1;ACTN1;RAB11FIP1;F5;APOOL;SCG3;RAB11FIP5;SERPINE1;APLP2;SYTL4;CD109;CALM1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6853769853156334,1.474945372481264,0.14345991561181434,0.6149912540162447,1.0,2/12,1.34%,IL34;PTK2
prerank,histone H4 deacetylation (GO:0070933),-0.65874711496996,-1.474620651310007,0.062264150943396226,0.3606823431251845,1.0,6/10,19.29%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT2;SMARCAD1
prerank,lipid modification (GO:0030258),0.5796094573622076,1.474080698179035,0.07861060329067641,0.6151706314025557,1.0,5/37,3.81%,DGKB;MBOAT2;DGKH;DGKG;PLPPR5
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6237573455628012,-1.4739108763762145,0.07809523809523809,0.36104842602050863,1.0,5/13,6.60%,FBN1;FSTL1;GREM2;NBL1;FBN2
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6338001453713595,-1.4729986409140725,0.048598130841121495,0.36207701471457643,1.0,6/12,10.23%,ADAMTS12;DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,visual system development (GO:0150063),-0.4876853240678817,-1.4728339959987709,0.02536997885835095,0.36103458162027313,1.0,10/37,16.97%,PBX1;SMOC1;PBX3;RBP4;FOXC1;ATF6;MEIS2;HIPK2;MEIS1;RAB18
prerank,purine nucleotide catabolic process (GO:0006195),-0.6234389535583311,-1.4722937815226147,0.05813953488372093,0.3610102520630043,1.0,9/13,25.02%,XDH;NT5E;HINT1;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,rRNA metabolic process (GO:0016072),-0.37333476746583816,-1.4719946838523874,0.003205128205128205,0.36049398474596045,1.0,64/160,24.45%,RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;XRN1;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;ESF1;RPL36A;RRP12;RRP7A;DEDD2;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36
prerank,positive regulation of coagulation (GO:0050820),-0.6618861097827686,-1.4714527866979326,0.06,0.3592011569300715,1.0,2/10,3.21%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.6618861097827686,-1.4714527866979326,0.06,0.3592011569300715,1.0,2/10,3.21%,ST3GAL4;THBS1
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5800693567627501,1.4706894368854215,0.07706093189964158,0.6227506156676501,1.0,2/35,0.19%,ITGA1;PDGFRB
prerank,positive regulation of binding (GO:0051099),-0.4166105803791522,-1.4703789930684341,0.01728395061728395,0.36075983052956767,1.0,30/84,16.89%,IGF1;APOE;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;SKI;PARP9;FOXC1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;CEBPG;RPL11;ADD1;NME1;RAN;MET;TXN;PKD1;HIPK2;HFE;HMGB2;SIRT2
prerank,UV protection (GO:0009650),-0.6559693673325312,-1.4701028371491232,0.07428571428571429,0.36012378396182987,1.0,5/10,23.71%,SCARA3;ERCC5;MFAP4;GPX1;ERCC2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.4157300386024439,-1.4696745892689496,0.021164021164021163,0.35982580826714783,1.0,20/86,6.78%,BMP6;IGF1;EGFR;EPHA7;NRP1;PECAM1;APP;IL15;IL6R;ITGA5;PTPRJ;ANGPT1;GHR;ARHGEF2;ACVR1;CNOT7;IGF2;EFNA5;PRKCZ;PTK2B
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7109335758951978,1.4696200693246073,0.06638115631691649,0.6233519173181409,1.0,2/10,1.47%,CARMIL1;SEMA5A
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.39069522833667836,-1.469610855503057,0.006557377049180328,0.35865341384543586,1.0,37/132,13.83%,IGF1;DAPK1;DCN;VGLL4;FOXO1;APOE;FOXO3;APP;EZR;SNX9;LRRK2;ADAM9;CNOT7;TPCN1;MOV10;TNFRSF1B;PLK2;PRKCD;DAGLB;PIK3CB;DTX3L;IRGM;HIF1A;FLCN;ATF6;ZC3H12A;TRIM27;P2RX7;OPTN;VPS35;SH3GLB1;PPARA;GRSF1;ENTPD5;TICAM1;BNIP3;CNOT8
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.5955798338820846,-1.4695003691895805,0.05672268907563025,0.3576467675359606,1.0,8/16,14.25%,BMP7;SOX13;SIX1;RREB1;FLCN;METRNL;PTGS2;FTO
prerank,regulation of protein localization to nucleus (GO:1900180),-0.47286434770221053,-1.4685300498135656,0.035555555555555556,0.3588904672047446,1.0,21/43,21.83%,GLUL;BMP4;LIMK2;PARP9;YAP1;MFHAS1;TFRC;AKT1;DTX3L;CTNNA1;CARD10;FLCN;TGFB1;BYSL;TPR;PARK7;LAMTOR5;ORMDL3;CDK5RAP3;SIN3A;EIF2AK3
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4243181925538277,-1.4684108990452043,0.0160857908847185,0.35784842094858527,1.0,23/76,13.40%,EGFR;NFAT5;UACA;BMP7;APP;DLG1;HDAC7;SASH1;EZR;RASSF2;NR3C2;NOD1;PDCD4;CCN3;LGALS9;RHOA;TMSB4X;C1QTNF3;IFI35;ZC3H12A;TRIP6;RELA;SPHK1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.5634816179678733,-1.4678914201994941,0.05263157894736842,0.3579250588012961,1.0,7/19,10.93%,ELF1;KLF4;PARP9;IRAK2;WNT5A;MAP2K5;MAVS
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5503176768132344,1.4678581802907666,0.08823529411764706,0.6260829638271994,1.0,5/46,2.73%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,positive regulation of endocytosis (GO:0045807),0.5559847157960759,1.4678414009483514,0.08743169398907104,0.6236603105607773,1.0,10/45,7.39%,SGIP1;NEDD4L;VTN;LDLRAP1;AXL;GPC3;IL4;CBLL1;SNCA;PPT1
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5181165472216016,-1.4672426365261049,0.05702647657841141,0.35819741330385485,1.0,7/26,10.23%,EGFR;IQGAP1;PLCG1;FOXC1;SYAP1;EEF1A1;DAB2IP
prerank,homotypic cell-cell adhesion (GO:0034109),-0.47854578459292507,-1.4667085134719933,0.03282275711159737,0.35822225406305724,1.0,14/39,14.13%,FN1;PDGFRA;TJP2;PLPP3;MEGF11;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;MEGF10;ACTB;PPIA
prerank,ceramide metabolic process (GO:0006672),-0.4545559699662171,-1.4660622411588415,0.02696078431372549,0.3586780341529576,1.0,18/49,24.03%,PLPP3;SGMS1;SGMS2;ST6GALNAC3;ACER2;ACER3;NSMAF;DEGS2;ST6GALNAC6;PLPP1;PLA2G15;SPTLC2;CLN8;ORMDL3;CLN6;SGPL1;SPTSSA;ORMDL2
prerank,regulation of nervous system development (GO:0051960),0.5639613265869614,1.4659463946107287,0.07879924953095685,0.6266702626588186,1.0,6/37,2.62%,HEY2;HEYL;PER2;PTN;GBX2;IL1B
prerank,inorganic anion transport (GO:0015698),0.5311511886410497,1.4646223514944374,0.09289617486338798,0.6278755121950392,1.0,2/53,0.25%,ANO1;ANO4
prerank,positive regulation of angiogenesis (GO:0045766),-0.3959637012735115,-1.464197466994539,0.00819672131147541,0.36199675380080865,1.0,33/108,11.02%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;ITGB8;SASH1;NOS3;THBS1;ITGA5;KLF4;FOXC2;RAMP2;CD34;VEGFD;VEGFC;FGF1;BMPER;WNT5A;PRKCB;CYP1B1;RHOB;HK2;PIK3R6;TIE1;HIF1A;ECM1;ZC3H12A;KDR;GATA2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5676503884862497,-1.4638354233782436,0.060362173038229376,0.36165758288378286,1.0,5/19,7.47%,APP;KLF4;SLCO1C1;KLF2;MAP2K5
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7040225961083996,1.4633766932830612,0.13043478260869565,0.6290505087501298,1.0,3/10,1.22%,BMP5;NOTCH1;TBX20
prerank,synapse assembly (GO:0007416),0.506350381345641,1.4621626625647242,0.06996587030716724,0.6303723420686886,1.0,13/67,5.87%,PTEN;ADGRL3;CDH2;FARP1;PCDHB11;LRRTM3;PLXNB1;NRXN1;FGF13;DNER;RYK;GABRG2;GABRA2
prerank,exit from mitosis (GO:0010458),0.6600374913486162,1.4618472773880269,0.1044776119402985,0.6288222019911828,1.0,2/12,5.26%,EPS8;CLASP2
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5186419953532536,-1.4617119184081895,0.040339702760084924,0.3657077497877669,1.0,10/26,16.54%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;NOS1AP;AKT1;PTGS2;HSP90AB1;TLR4
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.5426617973399264,-1.461642236913446,0.05148514851485148,0.3645119365595772,1.0,5/22,3.94%,SP100;MDFIC;APOD;SUFU;LRRK2
prerank,endocrine system development (GO:0035270),-0.555368128373472,-1.4613617186702603,0.05108055009823183,0.3640167278869341,1.0,7/21,8.16%,WNT4;GLI2;DKK3;TGFBR1;SIX1;TBX1;STRA6
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.4009529162346866,-1.4605067974604902,0.016901408450704224,0.3651066742699835,1.0,33/113,12.65%,BMP6;NOTCH2;IGF1;EGFR;NRP2;NRP1;TEK;TGFA;OSR1;F3;FGFR2;BMPR2;BMP4;TGFBR1;TCF7L2;VEGFD;VEGFC;FGF1;YAP1;WNT5A;STXBP4;TBX1;AKT1;PPP1R16B;RREB1;HIF1A;ECM1;CDH13;FZD7;KDR;ITGB3;NME1;FLT4
prerank,neural tube closure (GO:0001843),0.5766834962389299,1.4604056061494577,0.09156193895870736,0.6306849523438512,1.0,3/34,2.42%,DLC1;VASP;GRHL3
prerank,cell-substrate junction assembly (GO:0007044),0.5829554076749495,1.4586151344846305,0.09433962264150944,0.6336536056852003,1.0,5/33,2.10%,DLC1;PTPRK;LAMC1;PEAK1;FERMT2
prerank,cellular response to fatty acid (GO:0071398),0.680303203147243,1.4582042956704273,0.11304347826086956,0.6323509819259094,1.0,3/12,7.20%,PID1;FFAR2;IRS1
prerank,positive regulation of glial cell differentiation (GO:0045687),0.6423805456021913,1.4576665089064587,0.08823529411764706,0.6314424151469262,1.0,5/17,8.39%,IL34;NOTCH1;PTN;BIN1;TENM4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4862258817859806,-1.4574716005531894,0.05197505197505198,0.3717971855194687,1.0,25/36,35.05%,CSF1;PARP9;GAS6;PARP14;CASP4;WNT5A;IRGM;HIF1A;NLRC5;MAVS;RIPK1;AGPAT2;TRIM6;ZBP1;PRKN;HSPA1B;IL7;LAPTM5;CXCR4;AGPAT1;EDN1;ADAM17;FADD;C1QTNF4;CD74
prerank,glutathione metabolic process (GO:0006749),0.5657441644150375,1.4560204405992208,0.09230769230769231,0.6336124593471688,1.0,4/38,4.12%,GGT5;GGT1;CHAC1;GSTT2
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5303529635785103,-1.455479889196769,0.0694980694980695,0.3759755756277771,1.0,11/24,4.79%,ROBO1;SMAD6;NRP2;NRP1;SEMA3C;TGFBR2;FGFR2;BMPR2;BMP4;ACVR1;ZFPM2
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5554640356691194,-1.4553915073388113,0.06346153846153846,0.3748606711468532,1.0,9/18,22.55%,ESR1;KAT2B;RPS13;ZC3H12A;TGFB1;TMBIM6;PTBP3;RPS26;NUDT16
prerank,osteoclast differentiation (GO:0030316),-0.5452782813604338,-1.4551883461317212,0.058712121212121215,0.37410549848608843,1.0,10/22,21.19%,FOXP1;ANXA2;CSF1;SBNO2;MAPK14;TNFRSF11A;SNX10;GLO1;CSF1R;TYROBP
prerank,aorta development (GO:0035904),0.6635346024818354,1.4548688981929316,0.12258064516129032,0.634629118147607,1.0,7/14,9.82%,PDGFRB;TBX2;TFAP2B;ROBO2;PKD2;JAG1;EFEMP2
prerank,protein ADP-ribosylation (GO:0006471),0.5891297469241958,1.454790495288535,0.087890625,0.6325390823042352,1.0,2/28,0.90%,ART3;PARP8
prerank,lipoprotein biosynthetic process (GO:0042158),-0.6273327242089703,-1.4534004054707013,0.07468123861566485,0.37743443669104,1.0,4/11,13.66%,APOE;WIPI2;ATG10;UGCG
prerank,axon extension (GO:0048675),-0.5266783173691425,-1.453269627860367,0.04356435643564356,0.37648101125331496,1.0,6/23,5.79%,AUTS2;ALCAM;NRP2;NRP1;SLIT2;MAP1B
prerank,activation of adenylate cyclase activity (GO:0007190),0.5733572541314431,1.4530270063683064,0.08872458410351201,0.635340318181018,1.0,8/35,7.26%,EDNRA;CAP2;GIPR;ADCY8;ADCY3;ADCY6;ADCY9;CAP1
prerank,negative regulation of bone mineralization (GO:0030502),-0.6114351808312283,-1.4522100692239885,0.06990291262135923,0.3779943283269017,1.0,4/13,9.38%,ENPP1;SRGN;PTK2B;ECM1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.655321535411611,1.452116333838995,0.12101910828025478,0.6356352231786772,1.0,10/17,21.13%,KCNG1;KCNE4;AKAP6;ANK3;KCNE5;RNF207;SUMO1;VAMP2;KCNS2;KCNAB1
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6530807876607025,1.4517501540016238,0.13655462184873948,0.6342727128325841,1.0,4/14,5.93%,DMD;FXYD2;ACTN4;ANK3
prerank,amino sugar metabolic process (GO:0006040),-0.6662771624276463,-1.4517014262397137,0.06015037593984962,0.3779402674965738,1.0,6/10,19.67%,ST3GAL1;CSGALNACT1;EXTL2;GFPT2;GFPT1;GNE
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6599568517451221,1.450987011727405,0.1315240083507307,0.6341786386678449,1.0,4/13,16.10%,PIGU;PTPRT;JAK2;MGAT5
prerank,NAD biosynthetic process (GO:0009435),-0.5546477305097295,-1.4509514180018794,0.053061224489795916,0.3785345801239328,1.0,11/20,24.30%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NMNAT1;NNMT;PARP16;QPRT;NAPRT;KYNU
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.42662598459509027,-1.450852731257692,0.03902439024390244,0.37749280502055765,1.0,15/66,16.54%,IGF1;FOXP1;APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;ZC3H12A;P2RX7;GBP5;GIT1;SIRPA;TLR4
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6515316386960625,1.450652901699433,0.1165644171779141,0.6327853696453226,1.0,3/14,1.63%,ITGA4;RGCC;GPER1
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.6214728125413015,1.45011973443116,0.12015503875968993,0.6320893452904305,1.0,6/20,11.85%,PTEN;HEXIM1;INCA1;NR2F2;LATS2;APC
prerank,regulation of adaptive immune response (GO:0002819),-0.5692990361742187,-1.4498297056679919,0.07434944237918216,0.37899710463062336,1.0,5/18,12.08%,IL6ST;ADCY7;IRF1;TRIM27;AHR
prerank,regulation of actin filament-based movement (GO:1903115),0.6921508468485332,1.4496669639317994,0.12882096069868995,0.6309530144457036,1.0,4/10,7.08%,PDE4D;SCN5A;PDE4B;STC1
prerank,positive regulation of insulin secretion (GO:0032024),0.5617034924752158,1.449333798731188,0.10845588235294118,0.6296552973978629,1.0,3/36,3.74%,ANO1;GPER1;ADCY8
prerank,positive regulation of neurogenesis (GO:0050769),-0.4313118998705886,-1.4488737216387138,0.025,0.3800207120092345,1.0,13/68,8.74%,PLXNA2;ROBO1;CUX1;TIAM2;PLXNA4;SLIT2;SHANK3;TGM2;RHOA;SERPINF1;OBSL1;TIAM1;PLXND1
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6591398940289169,1.4487086058033107,0.12863070539419086,0.6292253410246681,1.0,3/13,4.24%,ITGA4;AKT3;FGF2
prerank,regulation of response to stress (GO:0080134),0.6850212968831446,1.4484120541148382,0.12236286919831224,0.6277651180624616,1.0,4/10,14.18%,ADCY8;CORO2B;DYRK3;MLC1
prerank,positive regulation of vasoconstriction (GO:0045907),0.6648409875384858,1.4481879535350033,0.14347826086956522,0.6262573387633973,1.0,2/13,1.02%,TBXA2R;SMTNL2
prerank,embryonic heart tube development (GO:0035050),0.6692970466761962,1.4476220126562749,0.12337662337662338,0.6256673575264343,1.0,4/14,10.34%,TBX2;TBX20;RYR2;CITED2
prerank,organic hydroxy compound transport (GO:0015850),-0.477846177442767,-1.4471636800543612,0.03773584905660377,0.38310535386668937,1.0,7/36,8.16%,ABCC4;SLCO2B1;RBP4;SLCO1C1;SLC16A1;NPC2;STRA6
prerank,organic acid transport (GO:0015849),-0.40312776168374703,-1.447099505934091,0.02247191011235955,0.3820042938979843,1.0,20/94,11.28%,SLC7A11;ABCC4;SLC6A13;SLC13A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLC6A12;SLCO1C1;ABCG2;SLC7A2;SLC16A1;SLC22A6;SLC7A7;SLC25A17;SLC7A14;SLC5A6;SLC38A5;SLC3A2
prerank,peptide catabolic process (GO:0043171),0.6140295929551745,1.4465371842582362,0.10344827586206896,0.6264371555599834,1.0,6/23,3.20%,ENPEP;GGT5;GGT1;CHAC1;ECE1;ANPEP
prerank,receptor clustering (GO:0043113),0.5631624284317747,1.4463551546489957,0.100990099009901,0.6246660820838096,1.0,4/27,3.96%,ITGA4;PTN;NRXN1;AGRN
prerank,endothelial cell differentiation (GO:0045446),-0.6198324283989858,-1.4459805926768348,0.06493506493506493,0.3837416508559036,1.0,7/12,16.16%,FSTL1;BMPR2;ACVRL1;TIE1;KDR;SOX18;KDM6B
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5191682920844274,-1.4458558311689471,0.057692307692307696,0.3827226151101554,1.0,10/25,16.54%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;NOS1AP;AKT1;PTGS2;HSP90AB1;TLR4
prerank,cellular glucan metabolic process (GO:0006073),-0.6388903482542168,-1.4452321399234038,0.060263653483992465,0.3829520380214481,1.0,2/11,1.80%,PRKAG2;PHKB
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.32771059857714363,-1.4447368773752611,0.0,0.38292102319005317,1.0,103/476,13.90%,NFIB;IGF1;ZMIZ1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;COL1A1;WNT4;HDAC4;GLI2;TBL1XR1;CREB5;IL31RA;BMP7;SP100;ELF2;FOXO1;APOE;FOXO3;MDFIC;ZIC2;KAT6B;HIVEP3;ESR1;ELF1;BMP4;ELF4;TGFBR1;KLF4;TCF4;FOXC2;LRP6;NFATC1;CDH1;LEF1;ACVR1;FZD2;KLF2;MLLT3;RGMB;CREB3L2;PARP9;QRICH1;NIBAN2;ARNT2;AR;BRD7;YAP1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;PRDM16;FOXC1;STAT1;STAT3;HINFP;SFR1;TBX1;FZD4;AKT1;DTX3L;RREB1;HIF1A;TRIM16;FOXK1;MMS19;FZD7;CD38;KARS1;ZKSCAN3;ESRRG;PML;BRCA2;KDM3A;GLI3;TGFB1;NSD1;AHR;HDAC1;ATXN7L3;ZIC3;RELA;PPARA;ID2;GATA6;FBXW11;PRDM11;ATOH8;CLOCK;SPP1;RET;TAL1;SOX17;SFRP1
prerank,neuropeptide signaling pathway (GO:0007218),0.5024009603537757,1.4444838416144596,0.07768595041322314,0.6278521334124555,1.0,9/58,11.05%,CYSLTR2;RAPGEF2;SORCS1;NMU;SORT1;OPRK1;GPR37;NXPH4;NTSR1
prerank,iron ion homeostasis (GO:0055072),-0.4376841527295075,-1.4441988274125448,0.0397196261682243,0.38290539506948484,1.0,17/58,18.23%,BMP6;CP;SCARA5;B2M;NEO1;ABCG2;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;BDH2;ATP6V0A2;HFE;CYB561A3;FRRS1;FTH1
prerank,response to zinc ion (GO:0010043),-0.5127580802695013,-1.4440816748602423,0.05578512396694215,0.3818764862197335,1.0,16/25,31.15%,PAM;P2RX4;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B;CRIP1;ATP13A2;HVCN1;KHK;MT2A
prerank,response to alcohol (GO:0097305),-0.5082577249457012,-1.4438331765141992,0.05410821643286573,0.38123136211232345,1.0,4/27,3.45%,TGFBR3;SLIT2;TGFBR2;TGFBR1
prerank,negative regulation of programmed cell death (GO:0043069),-0.33674113096905417,-1.4434845790114583,0.0,0.380879773109988,1.0,75/355,14.18%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;MECOM;SMAD6;FHL2;CTSH;IL31RA;PDPN;TEK;FOXO1;SH3RF1;OSR1;ANXA4;NUPR1;ANXA5;MYO18A;USP47;THBS1;BMP4;IL6ST;IGF1R;ANGPT1;TXNDC5;ANXA1;LEF1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;ZFAND6;RNF144B;WNT5A;CCND2;PTK2B;PLK2;CARD14;HSPA5;SH3RF2;TFRC;BIRC3;GOLPH3;ERC1;GPX4;TPT1;ERCC5;SON;AKT1;BAG3;MCL1;PRDX2;IFIT3;CD38;GCLC;KDR;ARHGDIA;RAB7A;BNIP3L;HDAC1;RELA;FLT4;GATA6;CBX4;UBB;SPHK1;MET;PIM3;BNIP3;SFRP1;RPL10;HYPK
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.47848727686710424,-1.4432626499851524,0.056433408577878104,0.38017491735102243,1.0,8/37,12.75%,ALCAM;HMCN1;CXADR;VCAM1;ADGRL1;ICAM1;CD164;FAT4
prerank,negative regulation of T cell activation (GO:0050868),0.5850782008819251,1.4432044119776364,0.08795411089866156,0.6291735174608047,1.0,4/35,3.86%,GLMN;TNFRSF21;PTPN22;PAG1
prerank,ribosome biogenesis (GO:0042254),-0.3620885330232468,-1.4431731442518994,0.007042253521126761,0.37912405837801905,1.0,74/187,25.80%,GLUL;RPLP1;RPS14;SDAD1;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;NAF1;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;CUL4A;PAK1IP1;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RAN;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RBIS;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;ESF1;RPL36A;RRP12;RIOK2;RRP7A;URB2;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;RRS1;RPL13A;FBL
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.40569838646896694,-1.4427961281360224,0.016304347826086956,0.3788424702755688,1.0,17/85,6.10%,BMP6;TGFBR3;MCC;IGF1;EGFR;MTSS1;TGFA;OSR1;NUPR1;FGFR2;BMP4;ANGPT1;B2M;TCF7L2;FGF1;YAP1;ACVRL1
prerank,bile acid biosynthetic process (GO:0006699),0.6001524189471581,1.442348851990165,0.09896907216494845,0.6292281556872319,1.0,5/24,6.00%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.6277294878772713,-1.4418366367034459,0.06985294117647059,0.38017863591347484,1.0,3/12,6.46%,SORBS1;IGF2;PRKCZ
prerank,sulfur compound catabolic process (GO:0044273),0.5601558985219574,1.4416981653942766,0.09981515711645102,0.6288542551922239,1.0,8/38,6.34%,CSPG4;GGT5;GGT1;CHAC1;CTH;ACAN;TXN2;GNS
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.5224618011978877,-1.440381043160012,0.06365503080082136,0.3825144264138967,1.0,5/23,15.88%,IGF1;GAS6;ZC3H12A;GIT1;CEACAM1
prerank,phosphatidic acid metabolic process (GO:0046473),0.5337712264298284,1.4402513341310839,0.09671532846715329,0.6307762311825715,1.0,5/48,2.73%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6598723653534055,-1.4395185529093606,0.08286252354048965,0.38359040668858424,1.0,3/10,5.50%,CD55;TGFBR2;LGALS9
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.41333333730636096,-1.4394946484791162,0.02481389578163772,0.382380439494854,1.0,15/76,10.42%,PTGIS;BMP7;ANXA4;KLF4;IRAK2;ARRB1;DAP;CYP1B1;MAP2K5;TMSB4X;CMKLR1;NLRC5;IRAK3;DAB2IP;ZC3H12A
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5126617418514626,-1.4389184751646382,0.06048387096774194,0.3826707305937804,1.0,10/26,18.74%,NOS3;ACER2;ACER3;CYP1B1;AKT1;GCH1;SPHK1;SPTLC2;NOS1;CYB5R3
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.368090784606744,-1.4386764860085741,0.020618556701030927,0.3821242409224314,1.0,38/152,16.27%,RNF220;SULF1;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;MACF1;RSPO3;FGFR2;SMURF2;USP47;RNF146;LRRK2;SKI;TNKS2;SULF2;LYPD6;SFRP4;RSPO2;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;WNT5B;PSMB4;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;GSKIP;PSME3;HHEX;PLEKHA4
prerank,sphingosine metabolic process (GO:0006670),-0.555855098650097,-1.4378156315683284,0.08023483365949119,0.38325655967776867,1.0,7/17,14.16%,PLPP3;ACER2;NAAA;ACER3;PLPP1;SPHK1;SPTLC2
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5831944325892356,1.4377978839881143,0.10606060606060606,0.6353576467940181,1.0,5/25,5.53%,ITGA4;ITGA7;JAM3;CTNNA3;ITGB1
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5528388374474912,-1.4376210343806548,0.06374501992031872,0.38250524536990343,1.0,7/18,20.26%,DDX60;BIRC3;USP15;PUM1;RNF125;NPLOC4;SEC14L1
prerank,regulation of response to biotic stimulus (GO:0002831),-0.5020938287340542,-1.4373391418397732,0.065439672801636,0.38201151494642144,1.0,11/28,13.27%,FOXP1;CD55;APPL2;IRF1;ERAP1;BIRC3;RNF135;CASP8;SAMHD1;GATA6;LRP8
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4066019192196285,-1.436654137391888,0.013157894736842105,0.3826366232311456,1.0,21/79,10.23%,SULF1;ADAMTS12;SMAD6;SKIL;SLIT2;HTRA3;BMPR2;SMURF2;THBS1;SMAD9;SMAD7;SKI;NIBAN2;SULF2;BMPER;SMURF1;NBL1;VWC2;HGS;EMILIN1;DAB2IP
prerank,axoneme assembly (GO:0035082),0.5668004838756907,1.4363484090834995,0.12126865671641791,0.6372529151709738,1.0,8/31,8.56%,RSPH6A;SPEF1;TTLL3;JHY;GAS8;RSPH1;LRGUK;CFAP46
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6520815560090725,-1.4360328251718257,0.0789980732177264,0.38175076127242497,1.0,3/10,7.47%,KLF4;WNK1;MAP2K5
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6520815560090725,-1.4360328251718257,0.0789980732177264,0.38175076127242497,1.0,3/10,7.47%,KLF4;WNK1;MAP2K5
prerank,small GTPase mediated signal transduction (GO:0007264),0.46792889856496395,1.4356544558035838,0.057902973395931145,0.6370270896147783,1.0,15/103,5.13%,RAPGEF5;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP32;RASGRP2;ARHGAP1;RASGRP3;NF1;RRAD;FGF2;RIN2;RIT2;SIAH2
prerank,regulation of cellular senescence (GO:2000772),0.5685162284868983,1.4355509320912858,0.12962962962962962,0.6350919976009936,1.0,7/28,11.35%,SLC30A10;CDK6;AKT3;NEK6;CGAS;NUAK1;RBL1
prerank,regulation of dendrite development (GO:0050773),0.5591790745487547,1.4355075684056593,0.08900523560209424,0.6329883507576475,1.0,13/37,10.80%,NEDD4L;BMP5;SDC2;HECW2;MARK1;PTN;CHRNA3;CSMD3;BCL11A;ADGRB3;HECW1;SARM1;VLDLR
prerank,membrane assembly (GO:0071709),0.5577238932218376,1.4346230002293563,0.0972972972972973,0.6333878554580015,1.0,10/34,11.13%,PTEN;CEL;RFTN1;NRXN1;SPTBN1;ANK3;EMP2;IL1RAPL1;UBXN2B;STX4
prerank,glycoprotein catabolic process (GO:0006516),-0.5652106970472794,-1.4332479270743805,0.07086614173228346,0.38768544225742874,1.0,11/17,33.53%,ADAMTS12;ADAMTS9;STT3B;EDEM2;MANBA;NGLY1;FBXO17;EDEM1;FBXO44;NEU2;FBXO2
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5836207931794688,1.4331514034361632,0.1264591439688716,0.6355054335267525,1.0,7/25,8.91%,TRPC6;DMD;STK39;ATP1B2;ANK3;PDZK1;STAC
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5023572255719408,-1.4329910521800044,0.08382066276803118,0.3871866569696218,1.0,7/26,9.12%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1;PPP2R1B
prerank,positive regulation of lipid transport (GO:0032370),-0.6277374898736477,-1.4325234000550422,0.05415860735009671,0.3870806452464638,1.0,5/12,21.92%,APOE;ABCA3;SPP1;PRELID1;DBI
prerank,endoderm formation (GO:0001706),0.5523281148384486,1.4323061626753801,0.1018867924528302,0.6356128835489523,1.0,8/35,5.23%,ITGA4;ITGA7;VTN;TBX20;NODAL;MMP15;ITGB5;LAMB1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.3839630813489939,-1.4322608357908473,0.019886363636363636,0.38660103793221406,1.0,33/112,22.82%,IGF1;FOXP1;APP;LBP;THBS1;PTPRJ;ARHGEF2;CD34;GAS6;LGALS9;WNT5A;STAT3;CD47;IL33;OAS2;IRAK3;ZC3H12A;TRIM27;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;SIRPA;TLR4;RIPK1;SYK;DICER1;TYROBP;LPL;CCL19;RARA;PTPN6
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5492348042231051,-1.4314697710383342,0.07142857142857142,0.38727186707129063,1.0,6/18,9.91%,MDFIC;APOD;SUFU;MFHAS1;CTNNA1;FLCN
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5756817846175828,1.4314531542289504,0.12452830188679245,0.6358473292157155,1.0,10/26,12.17%,ITPR2;ITPR1;FGF2;HTR2C;RYR2;RYR3;LETM1;PKD2;CHERP;SLC8B1
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.47335503240674426,-1.4312635473313577,0.04310344827586207,0.38656660436456236,1.0,12/35,11.70%,PLXNA2;NRP2;NRP1;SEMA3D;SEMA6A;SEMA3C;PLXNA4;SEMA7A;SEMA3E;PLXND1;ARHGDIA;SEMA3B
prerank,positive regulation of response to wounding (GO:1903036),0.6004481539461908,1.4309456605451965,0.11650485436893204,0.635143668032138,1.0,8/24,7.15%,VTN;PTK2;MYLK;SCARF1;PTN;ITGB1;ARFGEF1;HRAS
prerank,substantia nigra development (GO:0021762),0.5563463955855057,1.4305295644604024,0.10674157303370786,0.6342031164025935,1.0,2/37,0.70%,DYNLL1;GNB4
prerank,protein localization to cell-cell junction (GO:0150105),-0.5688094770011415,-1.429255450305688,0.10058027079303675,0.39061212212171464,1.0,7/15,13.84%,CDH5;TJP2;LSR;ACTG1;F11R;ARHGEF18;ACTB
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5439371433229818,1.4282650135357888,0.0933572710951526,0.6383113036760819,1.0,10/37,9.82%,PTEN;MEF2C;PRKG1;GPER1;LDLRAP1;FGF2;HTR1B;CDKN1A;PDGFB;EFEMP2
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5390457210272962,-1.4266651499512815,0.05394190871369295,0.39613524456836746,1.0,7/22,6.31%,TIMP3;PTPN3;APOE;SNX9;TIMP2;ADAM9;TNFRSF1B
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5678421395710396,-1.4266364135312681,0.0741444866920152,0.3949571504473985,1.0,7/16,16.31%,APOD;PDCD4;APPL2;ADCY7;ZC3H12A;PPARA;SIRPA
prerank,negative regulation of cytokine production (GO:0001818),-0.36352719961077,-1.426043374508926,0.0033222591362126247,0.39526599527087175,1.0,44/163,17.49%,FN1;LGR4;ANXA4;APOD;HDAC7;THBS1;EZR;KLF4;ANXA1;LEF1;PDCD4;HDAC9;CD34;GAS6;ARRB1;SRGN;LGALS9;APPL2;ADCY7;IKBKE;MAP2K5;TMSB4X;C1QTNF3;CMKLR1;PCBP2;NLRC5;RNF135;IRAK3;ZC3H12A;TRIM27;MAVS;RNF125;PPARA;TWSG1;SSC5D;SARS1;ZFPM1;CEACAM1;CD200;SIRPA;ASB1;TLR4;HOMER3;UBA7
prerank,regulation of stress fiber assembly (GO:0051492),0.48115521262120925,1.4256748806322734,0.06359300476947535,0.6434390201514382,1.0,11/74,3.09%,DLC1;CARMIL1;ARHGAP6;PIK3R1;RGCC;PHLDB2;PPM1E;FERMT2;ROCK1;WAS;LIMK1
prerank,regulation of postsynapse organization (GO:0099175),-0.5040942543920344,-1.4255847734585232,0.07707910750507099,0.3953172996152676,1.0,10/28,15.95%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2;WNT5A;VPS35;ABHD17C;TANC2;HOMER1
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5547068154468431,-1.4254065758683752,0.07269155206286837,0.39459341419678823,1.0,3/17,2.78%,BMP6;CD55;SASH1
prerank,positive regulation of autophagy (GO:0010508),-0.4076900112819908,-1.4251542320813606,0.02680965147453083,0.3940250358984878,1.0,29/81,19.69%,DAPK1;DCN;FOXO1;FOXO3;LRRK2;TPCN1;PLK2;PIK3CB;IRGM;FLCN;ATF6;ZC3H12A;KDR;TRIM27;OPTN;BNIP3L;SH3GLB1;LARP1;TICAM1;BNIP3;PRKAA2;TRIM8;PARK7;TRIM14;SH3BP4;TMEM59;PIM2;ORMDL3;IKBKG
prerank,keratan sulfate catabolic process (GO:0042340),-0.6316213656908118,-1.4251186930543047,0.06343283582089553,0.39292617382461015,1.0,8/11,13.97%,OGN;FMOD;HEXA;PRELP;HEXB;LUM;OMD;GALNS
prerank,regulation of DNA repair (GO:0006282),-0.45670669546727166,-1.4250667988825854,0.0515695067264574,0.39185448644339815,1.0,17/44,25.15%,EYA2;EYA1;EGFR;EYA4;PML;CEBPG;POLH;CDK9;SIRT7;NPAS2;BABAM2;RAD52;BABAM1;WRAP53;RNF8;BRCA1;RPS3
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5699515020920863,-1.4246009832708546,0.06720977596741344,0.3918337320854211,1.0,3/17,2.43%,PRKAG2;ADIPOR2;CAV1
prerank,regulation of cartilage development (GO:0061035),0.6134987739858253,1.4245006725232559,0.1310483870967742,0.6445643694248937,1.0,3/18,1.50%,SOX5;MBOAT2;TRPS1
prerank,peripheral nervous system development (GO:0007422),0.5920129309904593,1.4243286174863972,0.11728395061728394,0.6428896872020341,1.0,4/23,6.51%,SERPINI1;NF1;ASIC2;SCN8A
prerank,regulation of catabolic process (GO:0009894),0.5919625762813693,1.423639979428913,0.12650602409638553,0.6426935031094104,1.0,4/18,9.18%,FAP;NEDD4L;ITGB1;ZDHHC2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6241916609053898,1.4233600327945517,0.13043478260869565,0.6412788715405039,1.0,7/16,4.24%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;AKAP6;FGF2
prerank,mitochondrial membrane organization (GO:0007006),-0.47647217096130323,-1.4226211891298857,0.06359649122807018,0.39571695547031077,1.0,15/32,29.59%,MICOS10;MTX2;SLC25A4;SPG7;BNIP3;APOOL;CHCHD6;MICOS13;MAIP1;RCC1L;HSPA9;BCL2L1;TIMM50;DNAJC11;MTX3
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5349764493388964,-1.4225691074640232,0.0888030888030888,0.3935252809281469,1.0,6/21,8.98%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5349764493388964,-1.4225691074640232,0.0888030888030888,0.3935252809281469,1.0,6/21,8.98%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,negative regulation of blood pressure (GO:0045776),-0.5984040920547298,-1.4223353186031713,0.06963249516441006,0.3929485300887126,1.0,5/13,15.92%,NOS3;BMPR2;PRCP;SCPEP1;NOS1
prerank,sulfate transport (GO:0008272),-0.5777662873482469,-1.4214132681504579,0.08932038834951456,0.39410439288904564,1.0,3/14,2.95%,SLC13A4;SLC26A7;SLC26A2
prerank,primary miRNA processing (GO:0031053),-0.6376218752748506,-1.4210996269065854,0.0928030303030303,0.39379664321480135,1.0,1/10,0.62%,SMAD3
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4779822988522989,-1.420894489902422,0.04308390022675737,0.3931409558501816,1.0,10/39,7.32%,TSPAN5;ROBO1;ZMIZ1;NOS3;IL6ST;KAT2B;CCN3;YAP1;BMP2K;STAT3
prerank,glucan biosynthetic process (GO:0009250),0.6586718109294597,1.4200582001073272,0.13747228381374724,0.6463184292724434,1.0,2/12,3.23%,PER2;UGP2
prerank,glycogen biosynthetic process (GO:0005978),0.6586718109294597,1.4200582001073272,0.13747228381374724,0.6463184292724434,1.0,2/12,3.23%,PER2;UGP2
prerank,rRNA processing (GO:0006364),-0.36028650734243123,-1.419877734134919,0.006600660066006601,0.3945483371192103,1.0,70/172,25.91%,NSA2;RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;NAT10;TFB1M;ESF1;RPL36A;RRP12;RIOK2;MRPL1;RRP7A;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;RPL13A;FBL;NHP2
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.660835231001744,1.4189226951824605,0.14853556485355648,0.6472216568854396,1.0,3/12,8.17%,IL1B;CARD9;IL12RB1
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.4899872418902783,-1.4187690696141395,0.06369426751592357,0.3962421077392818,1.0,9/29,14.82%,IL31RA;IL15;GHR;SOCS2;STAT2;STAT1;STAT3;FER;PKD1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5530105041989848,1.4185815950762595,0.10097087378640776,0.6460444673651375,1.0,10/29,13.89%,PTEN;BMP5;IL17RD;SPRED1;SPRY2;HPN;VASN;FUZ;SPRED2;SFRP2
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4588234694653518,1.4182242429547687,0.05873261205564142,0.6450642484660697,1.0,15/100,4.24%,PDGFRB;PIP5K1B;PTEN;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PIP4K2A;PLXNB1;PIK3CA;NCF1;FGF2
prerank,Notch signaling involved in heart development (GO:0061314),0.666473258645598,1.4178781819394972,0.13537117903930132,0.6439365421328325,1.0,3/11,1.19%,HEY2;HEYL;NOTCH1
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6599249893925481,1.4176747112786505,0.155902004454343,0.6424052603146561,1.0,2/12,2.70%,GGT1;CHAC1
prerank,regulation of protein import into nucleus (GO:0042306),-0.47292202572135633,-1.416577710130433,0.06458333333333334,0.4007521059859053,1.0,12/36,13.00%,SMAD3;MDFIC;APOD;SUFU;BMP4;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,regulation of calcium ion import (GO:0090279),0.6097929895535072,1.4153637534496435,0.12058212058212059,0.6467531008811829,1.0,4/21,9.15%,PDGFRB;STC1;PKD2;PDGFB
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5653798255495573,1.4145192177603665,0.1180952380952381,0.6468440396746462,1.0,9/31,17.60%,PTEN;BTRC;MAGEC2;CDC14B;SKP1;BMI1;RAB1A;DCUN1D2;GORASP1
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6273286963607887,-1.4142833136340744,0.09398496240601503,0.4054297997956598,1.0,4/11,6.25%,MECOM;ETV6;CD34;WNT5A
prerank,ribosomal small subunit assembly (GO:0000028),-0.5665787977778146,-1.413510597536337,0.0803921568627451,0.4062890080216001,1.0,9/16,22.26%,RPS14;RPS19;RPS5;RPS27;MRPS7;RPS15;RPSA;RRP7A;RPS27L
prerank,positive regulation of ATPase activity (GO:0032781),0.5338584188029494,1.4134181587723722,0.10594795539033457,0.6477998250984699,1.0,7/41,9.11%,DYNLL1;FXYD2;ATP1B2;RYR2;MYL3;FGF10;MSH3
prerank,epithelial cell-cell adhesion (GO:0090136),0.6878352859197974,1.4127041279228718,0.14505494505494507,0.6477354438621361,1.0,3/11,3.62%,SERPINB8;VCL;ITGB5
prerank,positive regulation of phosphorylation (GO:0042327),-0.34323160894530297,-1.4125027364693032,0.0,0.4077453679579957,1.0,72/240,14.80%,IGF1;DAB2;EPHA4;EPHA3;EGFR;FLT1;LEPR;ROCK2;EPHA7;PDGFRA;NRP1;NTRK3;LMO4;TEK;PECAM1;APP;ITGA6;FGFR2;THBS1;BMP4;EPHB4;IGF1R;ANGPT1;LRRK2;NIBAN1;VEGFD;SDCBP;VEGFC;LIMK2;IGF2;GAS6;ARRB1;AR;FGF1;EFNA5;DDR1;CCND2;CARD14;FNIP1;CCND3;TFRC;TBX1;WDFY2;AKT1;TIE1;KIT;IRGM;HIF1A;EPHA8;FZD7;FLCN;KDR;P2RX7;MAVS;ITGB3;TGFB1;FGFR4;TMEM119;EPHB2;FLT4;CCN1;ENTPD5;KCTD20;CDK2AP1;MET;CCND1;RET;LIMCH1;PPIA;FXR2;MAPK3;RAD50
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5218818282711284,-1.4124772273587223,0.07459677419354839,0.40663165854027106,1.0,7/22,13.00%,MAN1C1;RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,protein export from nucleus (GO:0006611),-0.5075428281043273,-1.4122753830918326,0.0861344537815126,0.40595390862795216,1.0,12/27,20.50%,RANBP3L;SMURF1;CCHCR1;DUSP16;TGFB1;RAN;CALR;PKD1;STYX;TPR;CHP1;NUP214
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3840550989068627,-1.4114173045776155,0.0160857908847185,0.40702548836490493,1.0,31/95,11.09%,UST;EXT1;CHST11;ST3GAL4;DCN;B4GALT1;ST3GAL6;CEMIP;OGN;FMOD;ST3GAL1;HS3ST3A1;ST3GAL2;ANGPT1;NDST1;CSGALNACT1;HSPG2;CHSY1;BGN;HEXA;SDC4;ST3GAL3;HS6ST1;PRELP;GLCE;HS3ST3B1;LUM;PXYLP1;OMD;CHST15;DSEL
prerank,cell junction assembly (GO:0034329),0.45769141550935294,1.410815231603453,0.08384146341463415,0.6509887032684275,1.0,20/100,7.13%,GJC1;PTEN;LIMS1;ADGRL3;CDH2;FARP1;VASP;FERMT2;PCDHB11;NRXN1;SH3BP1;DNER;GJA4;RYK;CDH8;CDH22;FBLIM1;CDH20;CDH19;CDH7
prerank,arachidonate transport (GO:1903963),-0.6324173455950362,-1.4102857603815229,0.08743169398907104,0.40768249821503,1.0,3/10,6.53%,ANXA1;ACE;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.6324173455950362,-1.4102857603815229,0.08743169398907104,0.40768249821503,1.0,3/10,6.53%,ANXA1;ACE;BDKRB2
prerank,regulation of plasminogen activation (GO:0010755),-0.5955170881739409,-1.4101846535749112,0.09205776173285199,0.40676186596615105,1.0,6/12,19.73%,THBS1;CLEC3B;ENO1;SERPINE1;PLGRKT;SERPINE2
prerank,regulation of interleukin-4 production (GO:0032673),-0.5347076639025805,-1.4100630681622297,0.08299595141700405,0.4059395141677671,1.0,8/21,22.35%,LEF1;LGALS9;PRKCZ;SLC7A5;ZFPM1;CEBPB;SYK;RARA
prerank,positive regulation of signaling (GO:0023056),0.5387024826163881,1.4099370543883294,0.11969111969111969,0.6513261708586154,1.0,11/37,12.33%,CLSTN1;ECE1;NMU;RIMS1;CLSTN3;RIMS2;SNCA;SYT1;KCTD13;WLS;GRIK2
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6348453451504172,-1.4098122240848316,0.06769825918762089,0.40544165081044775,1.0,5/10,14.34%,TUT4;TUT7;CHFR;UBB;NEDD8
prerank,female gamete generation (GO:0007292),0.5624753432807749,1.4095410073457253,0.11650485436893204,0.6504703308006389,1.0,6/29,7.87%,DIAPH2;PTN;BCL2L10;FMN2;MEI4;NANOS1
prerank,regulation of cholesterol transport (GO:0032374),0.6072785318094736,1.4090151313950943,0.12883435582822086,0.6497891180325548,1.0,4/20,6.00%,NR1H3;ARV1;ABCA5;OSBPL6
prerank,Golgi to plasma membrane transport (GO:0006893),-0.4497845401423676,-1.4088634376586697,0.05569007263922518,0.40671639833210466,1.0,12/47,10.97%,VAMP5;STXBP6;MACF1;KIF13A;VPS35L;GGA2;EXOC4;GOLPH3;EXOC6;ARL3;EXOC5;OPTN
prerank,carboxylic acid transmembrane transport (GO:1905039),0.545063404805422,1.4086525831969596,0.10526315789473684,0.6486707697151893,1.0,2/40,3.11%,SLC38A11;SLC19A1
prerank,metanephric mesenchyme development (GO:0072075),-0.6351878275408421,-1.4078960705634307,0.09441233140655106,0.4080983729993183,1.0,4/10,7.09%,WNT4;OSR1;SIX1;STAT1
prerank,filopodium assembly (GO:0046847),-0.5625139454614698,-1.4076988935175019,0.07258064516129033,0.40746228426921366,1.0,6/16,10.58%,FGD5;FGD6;EZR;SRGAP2;DNM3;FGD4
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43656185896706245,-1.4072193341079438,0.05191873589164785,0.407541184922459,1.0,23/50,27.31%,SH3RF1;USP47;THBS1;KLF4;GAS6;FNIP1;MAP2K5;AKT1;DNAJB6;GPX1;PARK7;LAMTOR5;MT3;PLAUR;RFFL;VEGFA;PIH1D1;RPS6KA3;YWHAE;CD44;CDKN2D;PAK2;SFN
prerank,cellular potassium ion homeostasis (GO:0030007),0.6306545613868587,1.4072083883625695,0.15021459227467812,0.6506985443378281,1.0,4/13,4.90%,SLC12A2;ATP1A2;ATP1A4;ATP1B2
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5226393761659084,-1.4067692209821898,0.0775347912524851,0.4076543224384617,1.0,6/21,6.61%,FOXP1;PRKCH;ELF2;ELF1;SLC39A10;PRKCB
prerank,embryonic digestive tract development (GO:0048566),-0.5489300269534243,-1.4064004116339384,0.08221797323135756,0.4074901527193106,1.0,9/18,14.89%,PDGFRA;GLI2;PCSK5;RARB;FGFR2;STRA6;GLI3;ID2;PKDCC
prerank,positive regulation of lyase activity (GO:0051349),0.647862776142335,1.406320734940199,0.1352549889135255,0.6510987022070526,1.0,4/14,7.48%,CACNA1C;NF1;CACNA1D;STIM1
prerank,embryonic limb morphogenesis (GO:0030326),0.5408648599800018,1.4060624798300911,0.10575139146567718,0.6498307483903607,1.0,5/34,3.07%,CACNA1C;TBX2;MAP3K20;TBX3;ECE1
prerank,endothelial cell proliferation (GO:0001935),-0.5558907867737187,-1.4054055127601413,0.0851063829787234,0.4090324455874394,1.0,7/17,6.10%,TEK;DLG1;BMPR2;BMP4;CD34;BMPER;ACVRL1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4791329991482649,1.404316206576554,0.09895833333333333,0.6525329712383201,1.0,11/70,5.23%,ITGA4;LAMC3;MEF2C;PIK3R1;LAMC1;PEAK1;FERMT2;RILPL2;ABI2;NTNG2;LAMB1
prerank,regulation of peptidase activity (GO:0052547),-0.5298319970416585,-1.4041941851408126,0.068359375,0.41099131698997854,1.0,6/19,12.11%,CTSH;CAV1;RCN3;CST3;ECM1;HDAC1
prerank,ncRNA processing (GO:0034470),-0.34515994963999286,-1.4036161435324683,0.014652014652014652,0.411293117788335,1.0,74/200,25.83%,SMAD3;RPLP1;RPS14;RPL9;TUT4;TUT7;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;KARS1;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;SARS1;RPL10;BYSL;INTS11;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;AGO1;ESF1;RPL36A;DICER1;RRP12;RRP7A;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;INTS5;RPL13A;FBL;POP1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.5351182153926562,-1.403454644453189,0.06930693069306931,0.4106605231591241,1.0,5/21,5.90%,ERRFI1;ROCK2;BMP4;MAFG;SFRP4
prerank,negative regulation of synaptic transmission (GO:0050805),0.577693093213577,1.4031012784068067,0.1188118811881188,0.6538399638597473,1.0,5/23,8.09%,PTEN;IL1B;SLC24A2;ATAD1;ACHE
prerank,cellular response to glucagon stimulus (GO:0071377),0.6173228249461804,1.4023024108499964,0.13883299798792756,0.6540350785271328,1.0,9/17,10.18%,CYSLTR2;PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6356280271643053,-1.4019904658178546,0.10740740740740741,0.41328690587729505,1.0,5/10,25.05%,BMP4;IRF1;GLI3;MDK;LAG3
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4919253955566357,-1.401885188388686,0.065439672801636,0.41242040714059125,1.0,5/30,10.31%,IGF1;IGFBP2;IGF2;LGALS9;IL18
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5504020740615544,-1.4015698167246764,0.0847457627118644,0.4120088541989457,1.0,8/17,13.90%,NPR3;FGFR2;MN1;RHOA;ATRAID;TMEM119;CCN1;SFRP1
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6272636493929272,-1.4015124156539573,0.09611829944547134,0.4110614555623154,1.0,2/10,1.96%,ABCA1;APOE
prerank,negative regulation of nervous system development (GO:0051961),0.61267342516985,1.4013619444172425,0.15461847389558234,0.6545618676511488,1.0,5/17,8.16%,NOTCH1;SLIT1;IL1B;ROBO2;HOOK3
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5850750181237399,-1.400792709202142,0.08901515151515152,0.41169541507982516,1.0,9/14,28.63%,LRRK2;CREB3L1;CREB3;TMBIM6;PARK7;XBP1;BCL2L1;PRKN;SYVN1
prerank,positive regulation of heart rate (GO:0010460),0.6159093917288665,1.4007363298532698,0.12831858407079647,0.6542736166296759,1.0,3/17,6.59%,PDE4D;RYR2;ATP2A2
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.3475179682324835,-1.400460221444843,0.014492753623188406,0.41146658584401485,1.0,45/186,14.35%,NXN;MCC;DAB2;TRABD2B;IGFBP2;BICC1;WWOX;TMEM64;VGLL4;DKK3;APOE;CAV1;RNF213;IGFBP6;NKD1;TCF7L2;TLE4;LRP6;NFATC1;MLLT3;RNF43;IGFBP4;SFRP4;SOX13;PFDN5;WNT5A;SCYL2;AMFR;FZD4;TLE2;TLE1;NOTUM;DAB2IP;ZNRF3;MDFI;PSME2;GLI3;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8
prerank,bile acid metabolic process (GO:0008206),0.5699050455573752,1.400318203774429,0.10778443113772455,0.6533801343242793,1.0,5/27,6.00%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.41344553701351233,-1.3994126394176798,0.050666666666666665,0.4130963084493396,1.0,27/69,28.70%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;IL33;OAS2;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;TLR4;RIPK1;SYK;TYROBP;LPL;CCL19;SETD4;TWIST1;FZD5;CLU;SPHK2;CCR2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.4186749471354194,-1.399226785710504,0.054245283018867926,0.412475607376869,1.0,16/63,8.93%,AUTS2;PHACTR1;NRP1;GSN;NEDD9;MCU;SIPA1L1;CXADR;NRK;EZR;PARVB;ANXA1;RHOA;DTNBP1;KIT;EFS
prerank,regulation of cell migration (GO:0030334),-0.3246499846947771,-1.3991066472613471,0.0,0.41172784157353476,1.0,89/382,9.91%,PLXNA2;AFDN;SULF1;IGF1;ROBO1;DAB2;PHACTR1;PDGFD;LDLRAD4;EPHA4;DPYSL3;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NTRK3;CTSH;LMO4;CLIC4;PDPN;SEMA3D;IGFBP5;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;FOXO3;PODXL;RECK;PLXNA4;SLIT2;F3;CAV1;ITGA6;MACF1;CLDN5;PODN;SASH1;THBS1;PTPRJ;IGF1R;TGFBR1;MAGI2;SEMA7A;NKD1;ARSB;SRGAP3;SRGAP2;ANXA1;CSF1;ADAM9;SMAD7;CDH1;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;APPL2;SCAI;ACE;ACVRL1;SYNE2;RHOA;PTK2B;CYP1B1;RHOB;STAT3;HSPA5;SH3RF2;SEMA3E;TMSB4X;ACTG1;TBCCD1;TIAM1;MMP14;PLXND1;AKT1;KIT;ADAM15;ZMYND8;TWIST2;CDH13;FLCN
prerank,regulation of cation channel activity (GO:2001257),0.4549318143913384,1.3988982748118404,0.08517350157728706,0.6553270074806635,1.0,24/89,12.89%,PDE4D;MEF2C;DMD;CACNB2;KCNG1;FGF12;CACNG7;FGF13;MINK1;ITGB1;GRIA2;ANK3;KCNE5;STAC;NETO1;GRIN2B;HPCA;DLG2;GSG1L;FGF11;FGF14;PIRT;DLG3;JPH4
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.4722047805878871,-1.3980873423657965,0.05251141552511415,0.4131681921545473,1.0,15/33,17.84%,GLUL;SEMA6A;ADAMTS9;THBS1;ITGA5;KLF4;KLF2;FGF1;BMPER;PIK3CB;PPP1R16B;RHOJ;CREB3L1;CEACAM1;PDPK1
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.32327003362752604,-1.3979188654176904,0.0,0.4125372320712234,1.0,87/390,10.61%,FLRT2;SULF1;IGF1;SORBS1;PDGFD;EPHA4;PLCB1;EPHA3;EGFR;FLT1;EFNB2;COL1A1;NRP2;MTSS1;ROCK2;EPHA7;PDGFRA;NRP1;NTRK3;IL31RA;RHOQ;TEK;RBFOX2;NEDD9;FOXO1;ELMO1;SIPA1L1;FGFR2;VAV2;ANKS1A;CYFIP2;PTPRJ;EPHB4;IGF1R;MPZL1;SHB;ANGPT1;BAIAP2;YES1;FOXC2;GHR;CSF1;AP3S1;PXN;SOCS2;ATP6V0A4;COL4A6;ARHGEF28;VEGFD;SDCBP;VEGFC;IGF2;SLC39A14;AP2A2;FGF1;SULF2;PTPRG;EFNA5;DDR1;BDKRB2;RHOA;MAPK14;PTK2B;KL;FOXC1;STAT3;NAMPT;EFNB1;ACTG1;RAPGEF1;ARPC2;POLR2A;ATP6V1G1;PIK3CB;TIAM1;AKT1;TIE1;KIT;EFS;FRS2;EPHA8;GRB14;IDE;ATP6V0B;FGFBP1;ARPC1B;KDR
prerank,regulation of stem cell proliferation (GO:0072091),-0.5511600243094199,-1.397893864365345,0.08670520231213873,0.41147941011036504,1.0,4/17,5.88%,FBLN1;GJA1;YAP1;ACE
prerank,positive regulation of ion transport (GO:0043270),0.5117780374459999,1.3971162523787497,0.10990990990990991,0.658330057300562,1.0,9/48,7.38%,TRPC6;CACNB2;MYLK;STIM2;SCN5A;ANK3;RAB3B;PRSS8;CACNA1D
prerank,B cell proliferation (GO:0042100),0.6112414702352873,1.3971097051505958,0.13473684210526315,0.6563405364371038,1.0,1/17,0.63%,MEF2C
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5157349514611893,-1.3970223639546362,0.07692307692307693,0.4115683860414199,1.0,6/20,15.76%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,positive regulation of glycolytic process (GO:0045821),-0.5157349514611893,-1.3970223639546362,0.07692307692307693,0.4115683860414199,1.0,6/20,15.76%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,cardiac atrium morphogenesis (GO:0003209),0.6132600690844963,1.3965465238146364,0.15040650406504066,0.6559459205374266,1.0,3/16,1.22%,HEY2;NOTCH1;TBX20
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5431204887849616,-1.3964768510149708,0.07421875,0.41173638315408173,1.0,11/18,13.38%,JCAD;HDAC7;FOXC2;ANXA1;HDAC9;FGFBP1;KDR;GATA2;PTGS2;RHOJ;SRPX2
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5001783603917123,-1.396437954069286,0.08074534161490683,0.4107425494894799,1.0,10/24,17.31%,EPHA4;APOE;CTSC;TMF1;PTK2B;PSME2;UBB;PKD1;PSME3;GPX1
prerank,dendritic spine organization (GO:0097061),0.5580162831031767,1.3960782355628412,0.126232741617357,0.6552278251319053,1.0,4/26,6.61%,PTEN;DOCK10;WASL;CHRNA7
prerank,regulation of neurogenesis (GO:0050767),0.4987243208292253,1.3958590203056065,0.10696095076400679,0.6539153002151087,1.0,6/55,2.62%,HEY2;HEYL;NOTCH1;PER2;GPER1;IL1B
prerank,regulation of cholesterol esterification (GO:0010872),-0.6097881702061583,-1.395417590802908,0.09021113243761997,0.4123012752386341,1.0,4/10,19.00%,APOE;STARD4;AGT;AGTR1
prerank,positive regulation of vasculature development (GO:1904018),-0.3882588942670626,-1.3940379379138068,0.03225806451612903,0.4147696674584412,1.0,32/94,13.40%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;ITGB8;SASH1;NOS3;THBS1;RAMP2;CD34;VEGFD;VEGFC;FGF1;WNT5A;PRKCB;CYP1B1;RHOB;HK2;PIK3R6;TIE1;HIF1A;ECM1;ZC3H12A;KDR;GATA2;SMOC2;GATA6;SPHK1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6130956559574683,1.3937740390058444,0.15555555555555556,0.6577877684758836,1.0,3/16,3.38%,NR1H3;SCARB1;LDLR
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5692428121601976,-1.3936622660368185,0.09351145038167939,0.4146970953218344,1.0,8/15,28.30%,IGF1;AKT1;GPX1;PRELID1;PSMD10;BCL2L1;PRKN;CLU
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5373219589165299,1.3932685014909476,0.12840466926070038,0.6571987135924581,1.0,5/32,3.65%,CARMIL1;PLCE1;PIK3R1;PIK3CA;ABI2
prerank,sulfation (GO:0051923),-0.6239824645630403,-1.3931197476240083,0.08765652951699464,0.4150313741598168,1.0,1/11,0.04%,UST
prerank,negative regulation of immune response (GO:0050777),0.43357499627552265,1.3930363517405007,0.055162659123055166,0.6558893809378943,1.0,19/154,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;CD300A;NPSR1;PRKAR2B;CACTIN;GPR45;ADCY9
prerank,heart development (GO:0007507),0.4330517619050087,1.3929499471519218,0.0621301775147929,0.6541686329982319,1.0,15/150,3.07%,DLC1;ADAP2;CACNA1C;PTEN;PLCE1;TBX2;MEF2C;BMP5;NOTCH1;PTK2;NF1;FGF12;ERBB4;UTY;ECE1
prerank,negative regulation of potassium ion transport (GO:0043267),0.6489635061140507,1.3922673379439179,0.16527196652719664,0.6539526193407914,1.0,5/13,7.70%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6054252444623993,-1.391872538015925,0.11211573236889692,0.4171793949193708,1.0,4/12,5.72%,IQGAP1;PODXL;MAGI2;PROM1
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5871540904663344,-1.390974048861608,0.09981515711645102,0.4184254475012345,1.0,8/13,12.24%,BMP7;NR3C1;ESR1;BMP4;NR3C2;AR;PGR;PLPP1
prerank,negative regulation of blood coagulation (GO:0030195),-0.4638225882667334,-1.390687834055804,0.06724511930585683,0.41803139604393175,1.0,7/38,4.57%,PDGFRA;SERPING1;APOE;F3;NOS3;THBD;CD34
prerank,purine ribonucleotide transport (GO:0015868),-0.5560746567872172,-1.3901427460572606,0.09541284403669725,0.418350594989774,1.0,5/16,10.65%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,regulation of protein export from nucleus (GO:0046825),-0.5029844045849539,-1.3893063308997735,0.09941520467836257,0.41943563005030865,1.0,13/23,25.85%,PTPN14;SP100;TCF7L2;GAS6;IFI27;ANP32B;BAG3;SIRT7;TPR;PARK7;YWHAE;XPO4;TP53
prerank,regulation of cell adhesion (GO:0030155),-0.36320844782473094,-1.389283354723749,0.022922636103151862,0.41842729962973657,1.0,32/129,13.68%,PLXNA2;PKP4;EPHA4;ROCK2;EPHA7;FBLN1;PODXL;PLXNA4;TGM2;PTPRJ;ANGPT1;ADAM10;CXCL12;P4HB;ACVRL1;EFNA5;PTK2B;STX3;DUSP1;TGFBI;PLXND1;PPP1CB;CDH13;EPHA8;FLCN;IL18;ARHGDIA;CD164;EPHB2;ATM;CHRD;RET
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5523894540491118,-1.3887595672022865,0.10318949343339587,0.4186070700528709,1.0,2/17,3.14%,PLA2G4A;LPGAT1
prerank,muscle organ development (GO:0007517),0.49658401238664773,1.3885946909123916,0.10338680926916222,0.6621433451580189,1.0,6/54,1.67%,LAMA2;UTRN;MEF2C;DMD;ITGA7;CACNA1H
prerank,cardiac muscle cell development (GO:0055013),0.6049944328723696,1.388571909492623,0.1663286004056795,0.6602721250228786,1.0,3/20,2.04%,PDGFRB;HEY2;MYH11
prerank,smooth muscle cell differentiation (GO:0051145),0.6404093850019836,1.388433744864375,0.16989247311827957,0.6586635873320734,1.0,2/12,0.68%,MEF2C;HEY2
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5351145551634908,-1.3876027024275712,0.09505703422053231,0.42044173000849777,1.0,5/18,9.65%,PRKAG2;OCLN;SLC2A1;PRKCB;C2CD5
prerank,response to cytokine (GO:0034097),-0.3594582051174832,-1.3874940439464767,0.00980392156862745,0.4196313674010963,1.0,27/141,7.32%,TIMP3;DPYSL3;ALDH1A2;AFF3;COL3A1;SMAD3;NFAT5;PTPN14;PTPN13;HDAC4;SP100;APP;IL1R1;IL6R;IL6ST;TIMP2;ANXA1;ADAM9;LEF1;ADAM10;IRAK2;IFITM3;LGALS9;IKBKE;RHOA;STAT1;STAT3
prerank,positive regulation of cyclase activity (GO:0031281),0.6204003739758168,1.3870870336658432,0.15821501014198783,0.6605205438076452,1.0,4/14,7.48%,CACNA1C;NF1;CACNA1D;STIM1
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5240703712400718,-1.386154311091717,0.08213552361396304,0.4219705751365618,1.0,8/19,16.20%,IGF1;NUPR1;TNFRSF1B;IL33;IL18;PTGS2;SPHK1;CD200
prerank,intestinal lipid absorption (GO:0098856),0.648834362555318,1.3860403326909072,0.16452991452991453,0.6614804063647395,1.0,2/11,3.38%,CEL;LDLR
prerank,nucleoside catabolic process (GO:0009164),-0.6035799242039781,-1.385613104401344,0.12301587301587301,0.4223312361756052,1.0,6/11,18.32%,DPYD;UPP2;UPB1;NT5E;DERA;NT5C1A
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5861402370872748,-1.385455240868073,0.11553784860557768,0.42165359718303014,1.0,6/13,11.61%,BMP7;SOX13;SIX1;RREB1;METRNL;PTGS2
prerank,prostanoid metabolic process (GO:0006692),-0.5788323948629712,-1.3850588514213091,0.11411992263056092,0.4216515338388423,1.0,6/13,24.76%,PTGS1;ACOX1;GSTM1;PTGR2;PTGES;PTGR1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5892650226942231,-1.3845525553280997,0.0962962962962963,0.4218881054625227,1.0,3/13,6.46%,SORBS1;IGF2;PRKCZ
prerank,positive regulation of ruffle assembly (GO:1900029),0.634979526070713,1.382812117357242,0.13598326359832635,0.6680903032295094,1.0,3/13,7.15%,EPS8;EPS8L1;HRAS
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6412618145364306,1.382552496227008,0.14660831509846828,0.6668820363114133,1.0,4/11,9.27%,HEY2;TBX20;SOX4;JAG1
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.43946150184060406,-1.3822785475803716,0.07127429805615551,0.42665720080561137,1.0,16/46,10.31%,IGF1;FOXP1;ELN;IGFBP5;OGN;IL6R;APOD;THBS1;BMP4;TCF7L2;IGFBP3;STAT1;AKT1;CCN4;CDH13;IL18
prerank,glycosphingolipid metabolic process (GO:0006687),-0.4372102730640248,-1.3821336584762454,0.056133056133056136,0.4259387390320753,1.0,19/42,22.78%,LARGE1;ESYT2;ST6GALNAC3;A4GALT;SMPD3;HEXA;HEXB;B3GALNT1;PSAP;ST6GALNAC6;ESYT3;UGCG;SUMF2;ST3GAL5;NEU3;GLB1;ST8SIA5;CLN6;SUMF1
prerank,phospholipid homeostasis (GO:0055091),-0.608411052219157,-1.3819984518000388,0.10516252390057361,0.4251816071979113,1.0,3/11,8.29%,ABCA1;RCN3;TLCD2
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5815111847695488,-1.3818705031144212,0.1001788908765653,0.42442546782897483,1.0,5/13,13.39%,SEMA7A;WNT5A;IRAK3;TGFB1;PLCG2
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5839719941243714,1.381309434883911,0.16733870967741934,0.6682751539546509,1.0,5/18,6.61%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7
prerank,negative regulation of reproductive process (GO:2000242),-0.549350902681921,-1.3806821285053619,0.096,0.4264810929938834,1.0,6/17,14.40%,SULF1;IGF1;GJA1;DUSP1;CALR;PAEP
prerank,regulation of membrane repolarization (GO:0060306),0.6383397152034468,1.3803372285406028,0.16375545851528384,0.6689130231039697,1.0,5/13,7.70%,CASQ2;NEDD4L;CACNA2D1;AKAP6;KCNE5
prerank,regulation of protein autophosphorylation (GO:0031952),-0.4548193411308831,-1.3799427687111636,0.07889125799573561,0.42716093977350195,1.0,14/36,19.03%,PDGFD;ERRFI1;EPHA7;ENPP1;RASSF2;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC;PPP2R5C;CHP1
prerank,dicarboxylic acid transport (GO:0006835),-0.49525288996687333,-1.379879883809154,0.07659574468085106,0.4262910830048476,1.0,6/28,4.69%,SLC13A3;SLC1A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,response to glucagon (GO:0033762),0.5967027025684956,1.3795561216492938,0.15353535353535352,0.6691335830198836,1.0,9/19,10.18%,CYSLTR2;PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5053830468049729,-1.3790762661066895,0.09533073929961089,0.42732718645096035,1.0,13/21,34.04%,FOXP1;PRKCH;SLC39A10;PRKCB;RELA;RAB29;IKBKG;CD81;RPS3;BCL10;KCNN4;NFAM1;CARD11
prerank,fatty acid metabolic process (GO:0006631),0.4410614789804209,1.3788376026980014,0.076103500761035,0.6691197504940165,1.0,15/115,7.27%,GGT5;CEL;GGT1;PER2;ACSF2;ABCD2;SLC27A2;PPARD;BAAT;ACOT12;SLC27A4;PON2;LIPH;LIPC;AOAH
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5908523905070355,-1.3783244188291028,0.12,0.42834981596552096,1.0,5/12,22.24%,FOXP1;KLF4;MAP2K5;TLR4;LPL
prerank,lipid translocation (GO:0034204),-0.5169801665119732,-1.3782440385477728,0.09694793536804308,0.42749455757346305,1.0,8/21,17.15%,ABCA1;ATP10A;ABCA4;ATP9A;ATP8A1;TMEM30A;ATP11A;ATP11B
prerank,response to interferon-beta (GO:0035456),-0.5130978884986173,-1.3778675442005652,0.09306930693069307,0.4273537707401164,1.0,11/22,25.16%,IFITM3;IRF1;IKBKE;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6;PLSCR1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5954756857615265,1.3776672706924558,0.16632443531827515,0.6704522353445385,1.0,2/20,1.01%,PDE4D;RAPGEF2
prerank,supramolecular fiber organization (GO:0097435),-0.3244631195765976,-1.3775574404651747,0.0,0.427144757332811,1.0,84/334,13.07%,TSPAN5;COL1A2;COL3A1;SNCAIP;COL5A2;COL1A1;ADAMTS2;COL22A1;GSN;COL12A1;RHOBTB1;COL5A1;FIGN;LOXL1;SHROOM2;CD2AP;ELMO1;COL6A3;APP;DLG1;COL25A1;COL6A1;COL8A2;ITGA6;VIM;TLL1;COL4A5;SHROOM3;COL6A2;TGFBR1;PLEC;COL11A1;B2M;CLIP4;ARHGEF2;FBLN5;COL23A1;COL4A6;HSPG2;ADAM10;PLOD2;COL13A1;HDGFL3;ARHGAP17;IAPP;SERPINH1;PGM5;P4HB;SHROOM4;RHOA;COL18A1;CYP1B1;GGA2;FKBP1A;RHOB;H3-3A;FAT1;CST3;ITGB4;TGFBI;TRIOBP;COL14A1;DPT;GFAP;EMILIN1;COL15A1;SPAST;COL16A1;LUM;MAP7D3;MFAP4;ADAMTS14;AVIL;LAMA3;ADAMTS3;COL20A1;MDM2;EVL;ACTN1;COL9A2;TRPV4;CCDC88C;UBB;DNAJB6
prerank,cardiac muscle cell contraction (GO:0086003),0.5996532606182874,1.3772682092425392,0.16260162601626016,0.6696578122999498,1.0,6/19,7.38%,CACNA1C;FGF12;PIK3CA;CACNA2D1;SCN5A;CACNA1D
prerank,regulation of dendrite extension (GO:1903859),0.5848247637185912,1.3772205800480346,0.1646090534979424,0.6678874562460939,1.0,5/18,11.38%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4187908606123437,-1.3770180997653043,0.04878048780487805,0.42752527759497716,1.0,23/57,22.77%,GLUL;SDAD1;RPS19;NAF1;RPL11;CUL4A;PAK1IP1;RPS16;RPS24;RPL14;RPL26;BYSL;RPL7;RPS15;RPS6;EBNA1BP2;RBIS;RPS25;RPS7;RPL38;RIOK2;URB2;RPL35A
prerank,negative regulation of cell population proliferation (GO:0008285),0.38814825322560154,1.3769985918743253,0.029304029304029304,0.6665754400390049,1.0,36/351,5.65%,DLC1;PTPRK;ITGA1;PTEN;GLMN;FAP;RERG;CBFA2T3;IGFBP7;RAPGEF2;CDK6;BMP5;NOTCH1;COL4A3;PER2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;NODAL;TNS2;NF1;ERBB4;IL1B;PLXNB1;ETS1;SH2B3;MYO16;RPS6KA2;GAS8;CD300A;FABP3;TNFRSF8;TFAP2B
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.5335609071106919,-1.37673356836737,0.1073558648111332,0.4272098800753118,1.0,3/18,2.68%,EPHA4;ROCK2;SLC2A13
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.6173695398036932,-1.3765098158864335,0.10091743119266056,0.42677561518326984,1.0,4/10,10.90%,DCN;LRRK2;KDR;MYOC
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4480815051861064,-1.3762592014326411,0.07991360691144708,0.42627522094266723,1.0,13/39,14.82%,NRP1;GLI2;SLIT2;TGFBR2;BMP4;LRP6;RASIP1;SIX1;SEMA3E;TIE1;KDR;MET;PKD1
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4021801629687412,-1.3752463793305139,0.03825136612021858,0.4279477050649958,1.0,28/73,28.70%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;IL33;OAS2;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;TLR4;RIPK1;SYK;TYROBP;LPL;CCL19;SETD4;TWIST1;BCL10;FZD5;CLU;SPHK2;CCR2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.39178710889182494,-1.3749947273922627,0.04096385542168675,0.4275365447111784,1.0,25/82,9.60%,BMP6;RANBP3L;IGF1;SMOC1;SMAD6;WNT4;BMP7;TMEM64;IL6R;HDAC7;SUFU;FGFR2;BMPR2;BMP4;IL6ST;DDX5;ACVR1;ZHX3;SKI;YAP1;FBN2;NOCT;ATRAID;TWIST2;CCN4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.3181782470029944,-1.3743497646621399,0.005,0.42816533559508285,1.0,79/348,12.79%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;CDH5;ROCK2;NTRK3;GSN;CTSH;OCLN;BMP7;OSR1;APP;F3;WNT6;CLDN5;ITGB8;ANXA2;NOS3;BMP4;GJA1;EZR;TGFBR1;FOXD1;ANGPT1;MAGI2;KLF4;CSF1;LEF1;KLF2;RAMP2;CD34;HOXA5;SMO;MED26;GAS6;ARRB1;AR;FGF1;RAB27A;LGALS9;YAP1;MOV10;SFRP4;WNT5A;MAPK14;STAT3;HINFP;SCYL2;MAP2K5;TFRC;ACTG1;DTNBP1;PIK3CB;NOS1AP;AKT1;DTX3L;HGS;IL33;HIF1A;TLE1;EMILIN1;SEC16B;ZC3H12A;P2RX7;GATA2;VPS35;RPL11;TGFB1;FGFR4;EPHX2;TMEM119;EPHB2;ID2;ATM;PRKAB1
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5074431769445775,1.373515314963313,0.13768115942028986,0.6743026221677976,1.0,5/41,1.22%,MEF2C;HEY2;HEYL;NOTCH1;TBX20
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.6081379240012847,-1.37335756056593,0.10634328358208955,0.4297913959140185,1.0,5/10,14.09%,EPHA4;ANXA2;ATRAID;DAB2IP;RGP1
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.58852989506783,-1.3731041256933978,0.08112874779541446,0.42943000851889945,1.0,3/13,13.81%,BCL2L11;BNIP3L;BNIP3
prerank,protein O-linked glycosylation (GO:0006493),-0.38486419901113766,-1.3728749149597614,0.0335195530726257,0.42892237914508696,1.0,17/96,11.40%,TMTC1;GXYLT2;ST3GAL4;LARGE1;TMTC4;ST3GAL1;ST3GAL2;EOGT;PLOD2;TMTC2;ST3GAL3;TET3;RXYLT1;ST6GALNAC2;GALNT12;POGLUT1;POGLUT2
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6099811480584099,-1.3727073541879353,0.10800744878957169,0.42832860971370035,1.0,3/11,10.01%,DAB2;EZR;RAB21
prerank,response to thyroid hormone (GO:0097066),-0.5737770460429998,-1.3721754460710656,0.09765625,0.4286079212724676,1.0,5/13,11.78%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,lymphocyte migration (GO:0072676),-0.4697633382049245,-1.3716775292396228,0.08541666666666667,0.4288805570600342,1.0,26/32,52.41%,CCL15;CCL14;CCL25;S1PR1;RET;CCL13;CCL19;CKLF;CCL2;CX3CL1;MYO1G;CCL5;CCL11;ZAP70;ADAM8;CCL4;GATA3;CRTAM;CCL7;CCL8;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,retinol metabolic process (GO:0042572),-0.5789392254602941,-1.3714430890831102,0.1005586592178771,0.42841104939823893,1.0,4/14,13.43%,DHRS3;RBP4;CYP1B1;ADH1A
prerank,carnitine metabolic process (GO:0009437),-0.592292118081819,-1.3712670718098587,0.10076045627376426,0.4278613561725079,1.0,5/12,17.19%,CPT1A;CPT2;TMLHE;ACADL;CPT1C
prerank,regulation of receptor internalization (GO:0002090),-0.45872792416712005,-1.3712375899769833,0.0767590618336887,0.4269217305659788,1.0,16/35,28.11%,RIN3;ANGPT1;MAGI2;SDCBP;ARRB1;SFRP4;SCYL2;ATXN2;ANKRD13D;VEGFA;NTF3;CD63;ANKRD13A;TBC1D5;PICK1;MKLN1
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5878600979148686,1.370548106127744,0.15513626834381553,0.6803063962794205,1.0,6/19,4.24%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,muscle tissue morphogenesis (GO:0060415),0.6213826471007194,1.3699993161677129,0.15876288659793814,0.6799249133781216,1.0,4/16,1.47%,HEY2;NOTCH1;TBX20;MYLK
prerank,cellular iron ion homeostasis (GO:0006879),-0.4201319680387242,-1.3692799676145524,0.07906976744186046,0.43082874713536273,1.0,23/55,28.78%,BMP6;CP;SCARA5;ABCG2;SLC39A14;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;ATP6V0A2;HFE;CYB561A3;FRRS1;FTH1;NUBP1;CCDC115;TMEM199;SMAD4;ATP6AP1;ALAS2;ATP6V0D1;ATP13A2
prerank,inhibitory synapse assembly (GO:1904862),0.623439534270949,1.3691061212119093,0.18807339449541285,0.6804972560064468,1.0,4/11,5.87%,PLXNB1;FGF13;GABRG2;GABRA2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.49430233396745993,1.368850964220618,0.1024793388429752,0.6791983105128525,1.0,11/57,9.86%,GRM7;ADCY8;ADCY3;ADCY6;HTR1B;OPRK1;ADCY9;GPR37;AKAP12;GRM4;NPY1R
prerank,ketone body metabolic process (GO:1902224),-0.6230387401753962,-1.3686855311357473,0.09498207885304659,0.4312433969751499,1.0,4/10,14.74%,ACSS3;HMGCS2;BDH1;BDH2
prerank,positive regulation of macroautophagy (GO:0016239),-0.43880774663613337,-1.3685183564852965,0.06407322654462243,0.4306895794266384,1.0,20/48,19.69%,DCN;HSPB8;RAB3GAP1;VPS13D;SLC25A4;BAG3;IRGM;KDR;PIP4K2B;OPTN;BNIP3L;SH3GLB1;UVRAG;LARP1;BNIP3;SPTLC2;PRKAA2;RAB3GAP2;ADRB2;IKBKG
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.4497588572693236,-1.368428638037666,0.07205240174672489,0.4299229170646545,1.0,14/37,16.54%,APOD;PDCD4;APPL2;ADCY7;MAPK14;STAT3;HIF1A;IL17RA;ZC3H12A;GBP5;PPARA;TICAM1;SIRPA;TLR4
prerank,cellular response to drug (GO:0035690),0.5657578899578308,1.3680121017564608,0.15576923076923077,0.6795976447044415,1.0,5/25,6.03%,MEF2C;PPM1E;IL1B;HTR1B;PDE4B
prerank,cellular component assembly (GO:0022607),0.39996344141681023,1.3679973976771962,0.0398936170212766,0.6777471270599709,1.0,34/253,7.90%,MYO1B;LIN7A;EPS8;CALD1;LIMS1;AIF1L;LAMC1;VASP;FERMT2;WASF3;WAS;RSPH6A;LRRTM3;SPEF1;WIPF1;SH3BP1;TTLL3;SPTBN1;JHY;RAC3;WASL;RIMS1;PDCD10;GAS8;YTHDF3;ANK3;FBLIM1;YWHAZ;PLS3;RSPH1;LRGUK;DARS1;REC8;TEX12
prerank,import into cell (GO:0098657),-0.451613367260393,-1.3679444756251715,0.08478260869565217,0.43014280450391995,1.0,11/41,9.26%,SLC6A13;GLUL;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SLC12A7;SLC39A14;SLC22A4;SLC7A5;SLC5A6
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5857721991200368,1.3669206755152956,0.16767676767676767,0.678802115729404,1.0,4/19,1.81%,HEY2;HEYL;NOTCH1;SLIT3
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.585862092299995,1.3662741290738791,0.1543340380549683,0.678720083825284,1.0,7/19,9.04%,RAPSN;CHRNA3;CHRNA7;CHRFAM7A;ACHE;SLC5A7;COLQ
prerank,adenine nucleotide transport (GO:0051503),-0.5381416936002521,-1.3654362455106939,0.11517367458866545,0.4355735573709522,1.0,5/17,10.65%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,negative regulation of axonogenesis (GO:0050771),0.5504076845107871,1.365106629977703,0.15213358070500926,0.6801212583783749,1.0,4/27,4.23%,PTEN;MAP2;LINGO1;FGF13
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6462013103117223,1.3642224579786728,0.19230769230769232,0.6805371344462641,1.0,2/11,1.63%,MEF2C;GPER1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6115238702812033,1.3635025718011686,0.16594827586206898,0.6805024638757563,1.0,2/13,2.21%,PLA2R1;SPRED1
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4816011572276218,-1.3629394567305395,0.08333333333333333,0.4412007573415402,1.0,9/28,16.31%,PRKAG2;ADIPOR2;TNFRSF1B;CD47;NOS1AP;AVIL;FGFR4;PRKAA2;SIRPA
prerank,positive regulation of dendrite extension (GO:1903861),0.59014316990585,1.362884001101235,0.17124735729386892,0.6802530112214519,1.0,5/17,11.38%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,cellular response to amino acid stimulus (GO:0071230),0.5522394243276957,1.362689414239612,0.13686131386861314,0.6789524786644026,1.0,4/33,2.38%,SPAAR;UBR1;CPEB1;SESN3
prerank,regulation of fat cell differentiation (GO:0045598),-0.39938231026395654,-1.362024661338462,0.05995203836930456,0.4425485867595268,1.0,28/74,19.25%,SMAD3;ZBTB16;MEDAG;TMEM64;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;SYAP1;NOCT;TRIO;WDFY2;AKT1;CMKLR1;CARM1;ANKRD26;ZC3H12A;GATA2;TGFB1;ID2;SFRP1;FTO;ZFPM1;SIRT2;CEBPB;ZFP36L2;E2F1
prerank,pyroptosis (GO:0070269),-0.5541065111611572,-1.3618436360930573,0.1065891472868217,0.44199962090028794,1.0,4/15,10.41%,GSDME;CASP4;CASP8;GSDMD
prerank,cell part morphogenesis (GO:0032990),0.5943938172041452,1.3616945300095296,0.16056910569105692,0.6796852856153859,1.0,3/13,12.39%,PID1;SUPV3L1;MFF
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.5277135748076017,1.3616691150631623,0.15122873345935728,0.6779038950161346,1.0,3/35,1.42%,GGT5;GGT1;GGTA1
prerank,protein depolymerization (GO:0051261),-0.48869324155188454,-1.3615009769444733,0.09240246406570841,0.44186255644832756,1.0,3/27,1.88%,MICAL3;GSN;MICAL2
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.4382399093867785,1.361304490855847,0.09863429438543247,0.6770769651667432,1.0,33/118,13.34%,CHN1;MEF2C;PID1;NEDD4L;CDH2;SDC2;HECW2;PHLDB2;FERMT2;NF1;LRRC4C;CDX1;ETS1;CHRNA3;ABI2;FGF2;TSPAN12;CLASP2;EMP2;ADGRB3;MARK2;HECW1;ARHGAP35;ZMYM3;EPHA2;SARM1;BRSK1;PAK3;PAK1;PPFIA2;PHLDB1;RNH1;LZTS1
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5342617281636688,1.3612521471302654,0.15145985401459855,0.6753893262100701,1.0,9/31,12.56%,LIN7A;MTCL1;SH3BP1;CRB1;MARK2;CAMSAP3;DLG2;PARD3B;DLG3
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.642649107545392,1.3612214444850863,0.17880794701986755,0.6736795156339821,1.0,2/13,1.37%,HEY2;PER2
prerank,mitochondrion morphogenesis (GO:0070584),0.6286449813693584,1.3600451415344346,0.145610278372591,0.6749319940511955,1.0,3/11,12.39%,PID1;SUPV3L1;MFF
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5148667787308354,1.3598508624355674,0.13440860215053763,0.6736389524693708,1.0,12/41,10.52%,ITPR2;TRPV2;CACNA2D1;ITPR1;FGF2;SLC24A2;HTR2C;RYR2;RYR3;PKD2;GRIN2B;CHERP
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.5724561193192903,-1.3591138930899518,0.1087378640776699,0.4472061170433695,1.0,9/14,28.90%,SEMA7A;WNT5A;KIT;MAVS;PLCG2;TICAM1;NR4A3;BCL10;LAPTM5
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.5100581533848157,-1.3588780578638737,0.10476190476190476,0.44677142469832076,1.0,10/21,19.67%,MCU;TGM2;SLC8A3;RAP1GDS1;MCUB;AFG3L2;MICU2;BCAP31;MICU1;MAIP1
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5645689367992103,-1.3583030957030866,0.1111111111111111,0.4472315679277141,1.0,8/14,25.02%,DPYD;UPP2;UPB1;NT5E;NT5C1A;ERH;CAD;NT5C
prerank,cytosolic calcium ion transport (GO:0060401),0.5421504593253178,1.3582546619880962,0.13580246913580246,0.6760912794552283,1.0,6/28,6.59%,CACNA1C;ATP2A3;CACNA2D1;ATP2B3;RYR2;ATP2A2
prerank,regulation of chemokine production (GO:0032642),-0.45301498902076676,-1.3578993244502167,0.0945054945054945,0.4472172510931479,1.0,19/36,33.25%,FOXP1;APP;IL6R;LGALS9;WNT5A;IL33;HIF1A;IL18;TLR4;CSF1R;SIGIRR;LPL;EGR1;IL7;AIF1;HMOX1;TREM2;TLR7;ADAM17
prerank,plasma membrane tubulation (GO:0097320),-0.5630032481156382,-1.3578227344163587,0.10076045627376426,0.4464115761779679,1.0,6/13,17.70%,SNX9;CAVIN2;FNBP1L;CHMP4A;EHD2;MICALL1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.39163355589717563,-1.3575359402094969,0.054187192118226604,0.44616665600370503,1.0,30/77,25.64%,IGF1;SH3RF1;ITGA6;THBS1;BMP4;TGFBR1;TCF7L2;ACVR1;CFLAR;AR;AKT1;MCL1;NR4A2;RELA;QARS1;MAZ;TMBIM6;PSME3;RIPK1;GPX1;PRELID1;PARK7;PLAUR;ZMYND11;NDUFA13;PIH1D1;TMEM14A;PSMD10;BCL2L1;PRKN
prerank,glucose transmembrane transport (GO:1904659),0.597180719140971,1.3572671604274889,0.17494600431965443,0.6768279937852002,1.0,7/18,12.50%,SLC5A1;SORT1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.4829821138297695,-1.3568822028231022,0.088659793814433,0.4468508961783547,1.0,15/27,22.34%,SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC25A22;SLC7A1;ARL6IP5;SLC22A2;SLC25A29;SLC1A1;SLC38A1
prerank,positive regulation of dephosphorylation (GO:0035306),0.529568524346688,1.3562948743397043,0.17439703153988867,0.6776438051645841,1.0,1/27,0.07%,DLC1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.45883096580361815,1.355884097757817,0.11736334405144695,0.676870544154721,1.0,19/75,12.82%,MEF2C;FARP1;BTBD3;SDC2;MAP2;MINK1;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;CTNNA2;BRSK1;PAK3;RB1;ZDHHC17;SLITRK2
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.56292772696784,1.3557877521567707,0.16666666666666666,0.6753558986837631,1.0,3/23,3.57%,CASQ2;ATP1A2;CACNA2D1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5634606254856742,-1.3554489632090614,0.13740458015267176,0.4495136295648104,1.0,4/13,12.45%,NFIB;BMP4;RELA;PPARA
prerank,regulation of establishment of cell polarity (GO:2000114),-0.5492083472496337,-1.3543269526822914,0.1233644859813084,0.4513876559350596,1.0,5/16,6.78%,CDH5;ROCK2;GSN;RAP1B;PTK2B
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6423483340283382,1.3543237386369424,0.18599562363238512,0.6774820383505609,1.0,2/11,4.97%,LIMD1;AJUBA
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6405730827786187,1.3542884575738936,0.17225950782997762,0.6757860041719199,1.0,6/12,17.51%,PTEN;B4GALT6;ARHGAP35;EPHB1;CHRNB2;SPTBN4
prerank,protein import into peroxisome matrix (GO:0016558),0.6151340242907594,1.3542718677205892,0.16455696202531644,0.6740567200381044,1.0,7/12,24.44%,PEX7;PEX5L;PEX1;PEX12;PEX2;PEX5;PEX6
prerank,regulation of monocyte differentiation (GO:0045655),0.6238488539856542,1.354235593417382,0.1767337807606264,0.6723948268253311,1.0,2/14,1.10%,IL34;CDK6
prerank,limb morphogenesis (GO:0035108),-0.5126936104808048,-1.3538478863091699,0.11464968152866242,0.45172624487336566,1.0,7/20,11.87%,PCSK5;CYP26B1;MBNL1;LRP6;SKI;GLI3;PTCH1
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6425117733047587,1.3532285010844625,0.1857451403887689,0.6732655200843918,1.0,3/10,6.03%,CACNB2;CACNA2D1;PDE4B
prerank,negative regulation of secretion by cell (GO:1903531),0.5281555809272668,1.3525332612383614,0.15065913370998116,0.6734071321107925,1.0,5/38,6.29%,GRM7;NOTCH1;RHBDF1;HTR1B;SNCA
prerank,purine nucleotide metabolic process (GO:0006163),-0.48560717586941715,-1.3520819713019274,0.10816326530612246,0.4553175040873294,1.0,12/24,25.02%,FHIT;XDH;PRPS2;NT5E;GDA;GPX1;PRPS1;PRPS1L1;NT5C1A;PNP;NT5C2;NT5C
prerank,regulation of amyloid-beta formation (GO:1902003),-0.45666974561085333,-1.3520369069188387,0.08459869848156182,0.45440545298093704,1.0,5/34,2.68%,IGF1;EPHA4;ROCK2;APOE;SLC2A13
prerank,thyroid hormone generation (GO:0006590),-0.6055712977644874,-1.3515055480704081,0.12014134275618374,0.45479282725366477,1.0,2/10,12.80%,CPQ;SLC5A5
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.42888837202564145,-1.3513826941291904,0.07809110629067245,0.4541144121725022,1.0,19/44,27.31%,SH3RF1;USP47;THBS1;CAST;KLF4;GAS6;FNIP1;MAP2K5;AKT1;DNAJB6;GPX1;LAMTOR5;MT3;VEGFA;RPS6KA3;YWHAE;CD44;CDKN2D;SFN
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6429227360358756,1.3511217288768715,0.1772428884026258,0.6754056713186436,1.0,4/10,8.96%,NEDD4L;HECW2;STK39;HECW1
prerank,negative regulation of leukocyte activation (GO:0002695),0.596896255642243,1.3511186247621783,0.15086206896551724,0.6736719885268598,1.0,5/15,6.03%,GPER1;NR1H3;LRFN5;CD300A;IL4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5606039171078011,1.3510880943351458,0.13636363636363635,0.6720048508899091,1.0,5/23,9.56%,PTEN;INPP5J;MTMR12;MTMR7;INPP5B
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4603311002361121,-1.3510225070779573,0.09051724137931035,0.4540074275598486,1.0,9/32,15.88%,PRKAG2;SORBS1;APOE;ADIPOR2;AKT1;AVIL;PPARA;PRKAA2;CEACAM1
prerank,protein deacylation (GO:0035601),-0.49457597567988326,-1.3509166250965952,0.10766045548654245,0.45329631893457834,1.0,12/23,21.43%,HDAC4;HDAC7;LYPLA1;NOTUM;HDAC1;ABHD17C;HDAC5;LYPLAL1;SIRT7;SIRT2;SIRT3;SIN3A
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5594038131952499,1.3506274417207802,0.15308151093439365,0.6715414641236539,1.0,5/27,6.77%,MAP3K20;MAP3K5;BTRC;TNIP2;KAT7
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6120084607955459,1.350518340578936,0.16985138004246284,0.6701107140741513,1.0,2/12,2.62%,GCNT2;IL1B
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.5075682776863485,-1.3504129523946955,0.11485148514851486,0.45366277012689044,1.0,4/22,12.33%,ALDH1A2;RBP1;CUBN;VKORC1L1
prerank,amino acid transport (GO:0006865),0.5022673120853957,1.3501649548837593,0.12780656303972365,0.6694030087160419,1.0,3/49,2.19%,SLC38A11;SLC1A5;SLC1A4
prerank,regulation of synapse assembly (GO:0051963),0.500159630232145,1.3501608187062173,0.13419117647058823,0.6677021904757943,1.0,17/46,15.09%,MEF2C;CLSTN1;SLIT1;LRFN5;NRXN1;CLSTN3;SNCA;ROBO2;IL1RAPL1;SLITRK1;CUX2;IL1RAPL2;EPHB1;SLITRK2;NLGN3;CHRNB2;SYNDIG1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.614469127492469,1.3499908194259265,0.17473684210526316,0.6664240829764625,1.0,4/12,7.30%,CACNA1C;CTNNA3;RYR2;BIN1
prerank,cellular response to interferon-beta (GO:0035458),-0.5623343599177696,-1.349738305140058,0.14007782101167315,0.45439321839977115,1.0,8/14,23.98%,IRF1;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6
prerank,cellular amino acid catabolic process (GO:0009063),-0.3802922008492209,-1.3495000698565573,0.056451612903225805,0.4540408726872401,1.0,43/87,36.38%,GLUL;DDO;NOS3;ALDH7A1;IVD;ASPA;DDAH1;CARNMT1;ALDH4A1;PRODH;GLS;BCKDHB;AUH;PIPOX;CARNS1;NOS1;CBS;HOGA1;BCKDK;HNMT;BCKDHA;GCDH;ABAT;AMT;KYNU;HMGCL;AASS;ALDH6A1;MTRR;BLMH;FAH;HYKK;BCAT1;ALDH5A1;ACADSB;GLDC;SHMT1;HGD;IL4I1;HMGCLL1;HAAO;HSD17B10;NOS2
prerank,negative regulation of gene expression (GO:0010629),-0.32075413855076557,-1.349333220069796,0.004310344827586207,0.45348951022315287,1.0,87/302,19.17%,NOTCH2;IGF1;ROBO1;SLC24A3;DAPK1;LGR4;SAMD4A;ROCK2;FOXP1;WNT4;IGFBP5;OCLN;APOE;APP;CLDN5;ITGB8;XDH;ESR1;BMP4;DNMT3A;KLF4;KAT2B;TAF1;HDAC9;RBBP7;CD34;ADAM10;SMO;PARP9;CNOT7;WWP2;SRGN;LGALS9;PARP14;YAP1;MOV10;RNF139;ACVRL1;DDX6;SLC7A5;HINFP;RPS13;PGR;H3-3A;NOCT;IGF2BP2;HIF1A;FLOT2;FLCN;EMILIN1;JARID2;ZC3H12A;KDR;ANXA7;TRIM27;GATA2;ERN1;TGFB1;HDAC1;CPEB3;TWSG1;ID2;NUDT12;CALR;ATOH8;LARP1;CNOT8;SFRP1;CREB3L1;FXR2;TMBIM6;BMPR1A;PRKAA2;ASB1;PPHLN1;PNPT1;TNRC6A;PAIP2B;LSM5;PARK7;EIF4E2;TYMS;EZH2;PTBP3;ZFP36L2;PTRH2;AGO1
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5759250492183241,1.3490398992080048,0.17221135029354206,0.6673377551878351,1.0,3/19,1.44%,IL34;PTK2;JAM3
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5869471697165827,1.3489746850515298,0.16059957173447537,0.6658339002803536,1.0,4/21,2.15%,ASPN;HEY2;NOTCH1;ROCK1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.5897516083589056,-1.3487292708252956,0.12849162011173185,0.4540079581967695,1.0,7/11,16.20%,THBS1;CD34;LGALS9;PTGS2;GATA6;BMPR1A;CD200
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5561434539757913,1.3485456615028448,0.15576923076923077,0.6652001176719824,1.0,8/24,10.52%,ITPR2;ITPR1;FGF2;HTR2C;RYR2;RYR3;PKD2;CHERP
prerank,positive regulation of neuron differentiation (GO:0045666),0.49638108633571176,1.3477808710550647,0.13978494623655913,0.6655897320525423,1.0,6/40,8.37%,MEF2C;HEYL;ZEB1;BRINP1;BEND6;BRINP3
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4881848172509655,-1.3473141014176424,0.11368421052631579,0.45665417249363754,1.0,12/24,22.24%,COL5A1;PDPN;ITGA5;ACVRL1;DDR1;RHOA;CCN1;CEACAM1;CD151;RHOC;TMEFF2;LCP1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.3987070183538134,-1.3472289522424865,0.06684491978609626,0.45590636838004023,1.0,28/68,30.22%,APP;IL6R;LBP;ARHGEF2;IL16;LGALS9;WNT5A;STAT3;IL33;IL17RA;MAVS;CYBA;PLCG2;TLR4;POU2F2;SYK;TYROBP;XBP1;LPL;RAB7B;IL17D;MYD88;SETD4;TWIST1;BCL10;SPHK2;F2R;AIF1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5413217042287477,-1.3469589305807839,0.12716763005780346,0.4556674758559725,1.0,6/15,12.11%,GLI2;WNT6;LRP6;FOXC1;TBX1;HDAC1
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.4800267992520595,-1.346937418328071,0.099601593625498,0.4547071289451638,1.0,7/25,6.10%,SULF1;ZNF423;CDH5;BMPR2;BMP4;FOXD1;ACVRL1
prerank,regulation of monooxygenase activity (GO:0032768),-0.4997885431523075,-1.3462743402415358,0.11623246492985972,0.45541031901380846,1.0,8/23,9.96%,EGFR;POR;CAV1;NOS3;DDAH1;NOS1AP;AKT1;LYPLA1
prerank,microtubule bundle formation (GO:0001578),0.5112365082463526,1.346020813743555,0.13736263736263737,0.6685473247265132,1.0,13/42,11.53%,MTCL1;RSPH6A;SPEF1;TTLL3;NCKAP5;JHY;GAS8;TPPP;RSPH1;LRGUK;CFAP46;CCDC66;KIF20A
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6136159501253601,-1.3456303566151138,0.13358778625954199,0.4560592369848491,1.0,5/10,21.92%,APOE;ABCA3;TMEM30A;PRELID1;DBI
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5646163729777075,-1.345346561852556,0.12475247524752475,0.4557515272624476,1.0,2/13,0.60%,IGF1;PLCB1
prerank,positive regulation of cell motility (GO:2000147),-0.33417549000852537,-1.3451437866664686,0.021739130434782608,0.45533589694697807,1.0,75/205,17.55%,IGF1;DAB2;PDGFD;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NTRK3;CTSH;PDPN;SEMA3D;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;ITGA6;THBS1;IGF1R;TGFBR1;SEMA7A;CSF1;ADAM9;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;SPOCK2;SYNE2;CAVIN1;PTK2B;STAT3;HSPA5;SH3RF2;SEMA3E;ACTG1;TIAM1;MMP14;KIT;TWIST2;CDH13;KDR;MYOC;TGFB1;SEMA3B;TRIP6;WNT5B;EPHB2;ATM;CCN1;SPHK1;FER;RET;MAZ;WASHC1;CLDN1;SNAI1;CXCL16;LAMC2;NTN1;RUFY3;SEMA3G;SEMA6B;CD151;WNT11;PDGFC;ROR2
prerank,gland development (GO:0048732),-0.41274768894062774,-1.3450153061860504,0.06220095693779904,0.4546701107003918,1.0,14/59,8.16%,TGFBR3;WNT4;GLI2;DKK3;CAV1;FGFR2;EZR;TGFBR1;IGSF3;ANXA1;LSR;SIX1;TBX1;STRA6
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6183850711538484,1.3449189988563268,0.2053941908713693,0.669614528132993,1.0,2/13,2.38%,SPAAR;SESN3
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.3389441673639524,-1.3445627980415513,0.013157894736842105,0.4548943912201998,1.0,51/182,14.30%,NOTCH2;IGF1;ROBO1;SLC24A3;ROCK2;FOXP1;WNT4;OCLN;APOE;APP;CLDN5;ITGB8;XDH;RIN3;ESR1;BMP4;KLF4;TAF1;CD34;ADAM10;SMO;SDCBP;PARP9;CNOT7;WWP2;LGALS9;PARP14;YAP1;MOV10;ACVRL1;SLC7A5;HINFP;PGR;NOCT;HIF1A;ATXN2;FLOT2;FLCN;EMILIN1;ZC3H12A;KDR;ANXA7;OPTN;GATA2;TGFB1;HDAC1;ID2;ATOH8;SFRP1;CREB3L1;HSP90AB1
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.585883124036366,-1.3443756317073658,0.13197026022304834,0.4544181659462803,1.0,5/11,21.23%,LPCAT3;ATL2;BNIP1;STX18;MOSPD3
prerank,endodermal cell differentiation (GO:0035987),0.5339270764760645,1.344016406586134,0.13018867924528302,0.6703232314814722,1.0,7/31,5.23%,ITGA4;ITGA7;VTN;NODAL;MMP15;ITGB5;LAMB1
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.43625161513362304,-1.3439623896711992,0.07865168539325842,0.45445909040829224,1.0,21/42,32.01%,REV1;POLH;UBB;RPA1;RFC3;VCP;UBE2L6;POLI;USP43;RFC1;USP10;RPA3;POLA1;CDKN2D;POLD1;ISG15;DTL;WRN;PCNA;PARP10;RFC5
prerank,dopamine metabolic process (GO:0042417),-0.5167861965833497,-1.3437923550301771,0.13592233009708737,0.45393300242233214,1.0,5/18,11.82%,SNCAIP;MOXD1;MAOA;MAOB;GCH1
prerank,response to UV-A (GO:0070141),-0.5461039314730707,-1.3435991729515082,0.116600790513834,0.4534403246902751,1.0,5/14,15.44%,EGFR;AKT1;PPID;CCND1;MMP2
prerank,negative regulation of secretion (GO:0051048),0.6539938461908814,1.3433817999760547,0.20518867924528303,0.6702435663961867,1.0,2/10,2.80%,NR1H3;NRG1
prerank,ERBB2 signaling pathway (GO:0038128),0.5297350474719529,1.343165761507809,0.15594541910331383,0.6691790235809963,1.0,5/31,3.06%,GAB1;PIK3R1;ERBB4;NRG1;PIK3CA
prerank,regulation of macroautophagy (GO:0016241),-0.3679375711715073,-1.3426396119860782,0.05325443786982249,0.45505674017360137,1.0,33/105,21.25%,PRKAG2;DCN;SNX6;LRRK2;SNX32;EXOC4;CLEC16A;NRBP2;CAPNS1;ATP6V1G1;AKT1;CAPN1;ATP6V0B;KDR;VPS35;BNIP3L;ERN1;SH3GLB1;ATP6V0A1;PRKAG3;PRKAB1;LARP1;BNIP3;ATP6V0A2;PRKAA2;TBC1D25;QSOX1;RRAGB;LAMTOR5;ATG101;IKBKG;USP36;PRKAG1
prerank,secretory granule organization (GO:0033363),-0.5944074432131748,-1.3422516480002191,0.122568093385214,0.4551031134958435,1.0,3/10,8.10%,ABCA1;SRGN;DTNBP1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45065416086958265,1.3418869059125536,0.11290322580645161,0.6709595413008027,1.0,12/72,4.24%,PDGFRB;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PLXNB1;PIK3CA;NCF1;FGF2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.50384279162539,-1.3417363726271088,0.11380597014925373,0.4554636355508081,1.0,6/20,14.51%,ZMIZ1;TGFBR1;HIF1A;DNAJB2;HSP90AB1;WASHC1
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5157828872756453,-1.3407975715041676,0.12350597609561753,0.45689911487096324,1.0,6/18,13.00%,RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,positive regulation of T cell migration (GO:2000406),-0.49713536786668333,-1.3406063675182007,0.12072434607645875,0.45643145655373035,1.0,6/20,6.89%,APP;ADAM10;CXCL12;WNT5A;RHOA;WNK1
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.30062077773266843,-1.3405817142294296,0.0,0.4555209102136135,1.0,143/572,16.89%,NFIB;BMP6;FOXP2;PRDM6;DAB2;AEBP1;SMAD3;SMARCA2;ZBTB16;FOXP1;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;LCOR;SP100;GLIS3;OSR1;SKIL;FOXO3;NR3C1;DLG1;HDAC8;CAV1;RARB;SUFU;ESR1;FGFR2;SMURF2;BMP4;EZR;RPS14;DNMT3A;KLF4;DDX5;TCF7L2;FOXC2;SMAD7;KLF2;ETV6;TAF1;ID1;HDAC9;THRB;MXI1;SKI;SDCBP;ZFPM2;PARP9;IGF2;GATAD2A;GTF2IRD1;WWP2;AR;RARG;CREM;YAP1;FOXP4;GLIS2;SOX13;BHLHE40;KMT5A;ATXN1;ATN1;PRDM16;ID3;FOXC1;IRF2;GLIS1;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;NR2C2;MAP2K5;IFI27;KLF10;ZNF219;RTF1;ZBTB18;BAG3;RREB1;IL33;NR4A2;FLCN;BHLHE41;DAB2IP;PRDM5;ZKSCAN3;TGIF1;KLF12;TRIM27;MDFI;GLI3;NSD1;PTCH1;ZMYM5;HDAC1;LRRFIP1;MDM2;RELA;CPEB3;PPARA;ID2;MEF2A;GATA6;CBX4;UBB;CALR;ZGPAT;PPID;MEIS2;EZH1;CCND1;KCNIP3;HDAC5;ZNF568;SARS1;RPL10;ENO1;MAZ;ZBTB4;BEND3;NKX6-1;SNAI1;ZFPM1;YEATS2;RPL23;HHEX;SOX18;PHF21A;HCFC2;MNT;ZFP69;ZNF436;SIRT7;SIRT2
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.614858995744717,1.3386379035832565,0.18008474576271186,0.6776000307033492,1.0,2/14,0.65%,MEF2C;PRKG1
prerank,retinoid metabolic process (GO:0001523),-0.3930273720590864,-1.3385276353745394,0.06310679611650485,0.4596815841990874,1.0,14/71,9.47%,ALDH1A1;ALDH1A2;RBP1;APOE;CYP26B1;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;CYP1B1;ABCA4;STRA6;SCPEP1
prerank,regulation of cellular component size (GO:0032535),0.5338169605893498,1.338148974823696,0.16173570019723865,0.6771632115179417,1.0,2/30,0.42%,EPS8;PTEN
prerank,oogenesis (GO:0048477),0.6027656990993285,1.3381366083390371,0.17782426778242677,0.675523950209611,1.0,6/15,18.70%,PTN;FMN2;MEI4;NANOS1;TRIP13;KMT2D
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3622307050515522,-1.3380541192415023,0.04,0.45992734968813276,1.0,30/104,13.24%,LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;BMPR2;SMURF2;TGFBR1;SNX6;MAGI2;SMAD9;SMAD7;ACVR1;SKI;CCN3;BMPER;SMURF1;NBL1;PRDM16;VWC2;FKBP1A;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB;CHRD
prerank,cellular response to alkaloid (GO:0071312),0.5809225769046215,1.337967944894963,0.17842323651452283,0.6743057373641647,1.0,4/17,8.62%,CASQ2;HTR1B;RYR2;RYR3
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.509451361848663,-1.3379564077394632,0.11515151515151516,0.45924093138715616,1.0,11/21,28.63%,LRRK2;BCL2L11;CREB3L1;CREB3;TMBIM6;PARK7;XBP1;EIF2AK3;BCL2L1;PRKN;SYVN1
prerank,neuron projection development (GO:0031175),0.41066977915758657,1.3373246791785538,0.07923497267759563,0.6743228646473555,1.0,30/168,11.67%,GRM7;FRY;PTEN;DOCK10;RAPGEF2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;SVBP;MINK1;CNTNAP2;RYK;LAMB1;CNTN4;NYAP2;TAOK3;MARK2;BLOC1S1;MAP4K4;LYN;TMEM108;PLP1;NCKAP1;PRMT1;PAK3;PAK1;RB1
prerank,endoderm development (GO:0007492),0.6290079516519551,1.337087690824316,0.19047619047619047,0.6733212183014726,1.0,2/13,1.71%,TBX20;LAMC1
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5357031629891764,-1.3369338190981002,0.15294117647058825,0.46081468786409496,1.0,5/16,6.98%,RBFOX2;ESR1;DDX5;AR;EGLN2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.5078230816278215,-1.3364245435391706,0.1272365805168986,0.4611783011570552,1.0,3/19,12.68%,IGF1;ZC3H12A;GIT1
prerank,acylglycerol homeostasis (GO:0055090),0.5714046528675112,1.3360169006143339,0.1814516129032258,0.6744680841685267,1.0,4/20,6.95%,RORA;NR1H3;SCARB1;LIPC
prerank,postreplication repair (GO:0006301),-0.4153683267868947,-1.3359946313280147,0.10089686098654709,0.46131607639713285,1.0,21/45,32.01%,REV1;POLH;UBB;RPA1;RFC3;VCP;UBE2L6;POLI;USP43;RFC1;BRCA1;USP10;RPA3;POLD1;WDR33;ISG15;DTL;UBE2V1;PCNA;PARP10;RFC5
prerank,regulation of ossification (GO:0030278),-0.4459041441599089,-1.3359869030094857,0.10217391304347827,0.460366660222428,1.0,14/36,10.11%,ZBTB16;SMAD6;ENPP1;SGMS2;ANKH;BMPR2;BMP4;LRP6;ACVR1;CHSY1;BMP2K;WNT5A;ECM1;NOTUM
prerank,positive regulation of vascular permeability (GO:0043117),-0.5701483954789407,-1.335799131308254,0.13786764705882354,0.45988192764207986,1.0,4/12,3.53%,BMP6;TJP2;OCLN;ANGPT1
prerank,positive regulation of cell migration (GO:0030335),-0.3254934808444117,-1.335570904517931,0.01195219123505976,0.45951763459089434,1.0,74/253,13.68%,IGF1;DAB2;DOCK5;PDGFD;FN1;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NRP1;NTRK3;CTSH;PDPN;SEMA3D;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;PLCG1;ITGA6;BMPR2;SMURF2;THBS1;IGF1R;TGFBR1;SEMA7A;RAB11A;CSF1;ARHGEF2;ADAM9;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;PRKCE;SYNE2;PTK2B;STAT3;HSPA5;SH3RF2;SEMA3E;ACTG1;TIAM1;MMP14;KIT;RREB1;HIF1A;TWIST2;CCN4;CDH13;DAB2IP;KDR;MYOC;TGFB1;SEMA3B;TRIP6;PFN1;WNT5B;EPHB2;ATM;CCN1;PLCG2;SPHK1;FER;RET
prerank,Ras protein signal transduction (GO:0007265),0.4159702378913752,1.3353086155548854,0.08017492711370262,0.674591285646729,1.0,25/137,8.64%,EPS8;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP6;RASGRP2;ARHGAP1;RASGRP3;ROCK1;NF1;WAS;LIMK1;CDC42EP1;ABI2;FGF2;RTKN;EPS8L1;RIT2;HACE1;RAP1A;HRAS;CDKN1A;ARHGDIB;GNA12
prerank,acute inflammatory response (GO:0002526),-0.4876744037682209,-1.3351988030130733,0.11967545638945233,0.4595070816790084,1.0,4/23,6.62%,F3;IL6R;LBP;ANO6
prerank,regulation of mitochondrial fusion (GO:0010635),0.6262501744169958,1.3347106810089286,0.19873150105708245,0.6744838571783268,1.0,2/11,2.73%,PID1;PLD6
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4263523214947646,-1.333963689135437,0.09953703703703703,0.46174203496724076,1.0,12/45,11.25%,SP100;B2M;VCAM1;IRF1;ICAM1;IRF2;STAT1;PRKCD;IRF9;OAS2;PML;CAMK2A
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.43147629458216724,1.3336735029708089,0.10879284649776454,0.6755178288881838,1.0,12/110,3.95%,S1PR3;PTH1R;ADGRL3;TBXA2R;GNG2;RAPGEF2;UCN2;ADORA2A;GPER1;ADCY8;ADCY3;ADCY6
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5844049737752276,-1.332556038420382,0.14519056261343014,0.4645631734522262,1.0,5/11,8.75%,IGF1;PLCB1;IGF1R;GHR;AKT1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5829944245707314,-1.3325502609670803,0.13333333333333333,0.4636211002044779,1.0,6/11,25.85%,HSPA5;ATF6;CREB3L1;CEBPB;ATF3;TP53
prerank,regulation of wound healing (GO:0061041),0.501678484311609,1.332170169213269,0.1412639405204461,0.677944085174912,1.0,9/42,7.15%,VTN;AJAP1;PTK2;MYLK;CADM4;FGF2;ITGB1;ARFGEF1;HRAS
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5709771598531335,-1.3313805059645725,0.12643678160919541,0.46576488972757085,1.0,3/12,13.15%,LPCAT3;P4HB;MFSD2A
prerank,neurotransmitter transport (GO:0006836),0.45121873819443764,1.3313443018885445,0.11993243243243243,0.6784562918008712,1.0,19/73,13.14%,LIN7A;ATP1A2;NRXN1;SNAP25;RIMS1;SYN2;GABRA2;SYN1;SLC32A1;SYT1;SLC5A7;SLC6A15;GRM4;STXBP2;GAD1;BRSK1;GLS2;PPFIA2;SLC29A2
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4353402582301996,-1.3309978008033065,0.09594882729211088,0.4657576981824411,1.0,16/37,27.06%,CAV1;NUPR1;GSDME;BCL2L11;BECN1;EIF5A;UBB;BID;BCAP31;RPS7;BBC3;BCL2L1;RPS3;RACK1;TP53;MSX1
prerank,regulation of interleukin-2 production (GO:0032663),0.502745227710095,1.3306919328237194,0.12614259597806216,0.6785533807351286,1.0,6/43,6.03%,PDE4D;GLMN;IL1B;SPTBN1;NAV3;PDE4B
prerank,negative regulation of B cell proliferation (GO:0030889),0.6257301401727232,1.3303626654065308,0.18995633187772926,0.6777666382931483,1.0,3/11,9.11%,TNFRSF21;CD300A;LYN
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4748157841509772,-1.3302595329643798,0.128099173553719,0.46662717723764224,1.0,8/28,13.00%,NOD1;IRAK2;LACC1;MAP2K6;IRGM;CASP8;RELA;UBB
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.4414989246934979,1.3301742882688627,0.11764705882352941,0.6766435651868544,1.0,12/87,5.83%,DLC1;PDGFRB;EPS8;ROCK1;RND3;GRHL3;PIK3CA;SH3BP1;RAC3;CORO2B;ESAM;TESK1
prerank,establishment of skin barrier (GO:0061436),-0.5326342737683071,-1.3295336609714647,0.11605415860735009,0.4665706171853029,1.0,9/15,36.35%,LSR;MET;UGCG;CLDN1;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,regulation of water loss via skin (GO:0033561),-0.5326342737683071,-1.3295336609714647,0.11605415860735009,0.4665706171853029,1.0,9/15,36.35%,LSR;MET;UGCG;CLDN1;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,erythrocyte differentiation (GO:0030218),-0.4235700217722123,-1.329153085622282,0.11060948081264109,0.46662781924067676,1.0,22/44,27.92%,TGFBR3;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;CEBPG;ALAS1;ID2;TAL1;HIPK2;ZFPM1;PTPN2;CDK5RAP3;VEGFA;LYAR;HSPA9;ACIN1;NCKAP1L;ALAS2;HCLS1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5593177432247418,-1.3290035072195439,0.13706563706563707,0.46609223849962933,1.0,2/13,3.24%,GLI2;BMP4
prerank,protein N-linked glycosylation (GO:0006487),-0.391796022015278,-1.328632741842966,0.078125,0.46616150591353306,1.0,20/66,19.40%,B4GALT1;MAN1C1;ST3GAL1;STT3A;STT3B;FUT8;MGAT1;SLC39A8;LMAN1;MGAT2;GFPT2;ENTPD5;ALG6;MCFD2;OST4;ASGR1;RPN2;OSTC;GFPT1;DOLPP1
prerank,intracellular lipid transport (GO:0032365),-0.5055873475196878,-1.3279162500512696,0.15083798882681565,0.46716886505651145,1.0,7/21,9.91%,PRKAG2;CERT1;CPT1A;SLC25A20;NPC2;CPT2;ACACA
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6166626203753012,1.3274761485007955,0.17916666666666667,0.682155747227188,1.0,5/12,11.72%,GGT1;CTH;SEPHS2;PSAT1;SRR
prerank,eye photoreceptor cell development (GO:0042462),0.582503228371635,1.3274043413613075,0.18907563025210083,0.6807487020917089,1.0,1/15,0.82%,RORB
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5572182054283245,-1.3268769634680753,0.1475095785440613,0.46901837888119047,1.0,3/13,6.17%,GLUL;DDO;ASPA
prerank,nervous system development (GO:0007399),0.3687627997039363,1.3261381206342013,0.0475609756097561,0.682315178294152,1.0,94/429,13.51%,RAPGEF5;SERPINI1;PTEN;MEF2C;ADGRL3;CDH2;KALRN;DPF3;FARP1;BTBD3;SEMA5A;ST8SIA4;ADORA2A;DPYSL2;TBX3;MERTK;NF1;PCDHB11;LSAMP;GFRA2;ZEB2;PTN;FGF12;ERBB4;GBX2;CHAC1;NRG1;NAB1;LIMK1;NRXN1;TBX6;CHRNA3;GRIK1;AXL;FGF13;FGF2;DNER;ACAN;ROGDI;NAV3;SCN2A;RYK;SREBF2;MYLIP;FEZ2;CNTN4;MOG;RBFOX3;ASIC2;NINJ2;PCDH1;SCN8A;ANKLE2;LIG4;CNTN6;PPT1;IGSF8;NES;ACHE;ROBO2;ITM2B;ADAM23;SLITRK1;PKD2;JAG1;ACTL6B;MARCKS;NCKAP1;GDF11;BTBD6;APBA2;CHERP;TRAK1;SPOCK1;VLDLR;SOX6;AHI1;IL1RAPL2;FGF11;EP300;TRAK2;APC;MYT1L;EPHB1;GFRA1;ARHGAP26;PPP2R5D;ZC4H2;APC2;RPS6KA6;FEZ1;RITA1;NLGN3;DSCAM
prerank,COPII vesicle coating (GO:0048208),-0.40232616956950656,-1.3259053701631145,0.08695652173913043,0.46861435199584445,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.40232616956950656,-1.3259053701631145,0.08695652173913043,0.46861435199584445,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,vesicle coating (GO:0006901),-0.40232616956950656,-1.3259053701631145,0.08695652173913043,0.46861435199584445,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,negative regulation of inflammatory response (GO:0050728),0.4010659485094616,1.3255956330740333,0.08423913043478261,0.6821030075804668,1.0,24/182,7.27%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;RORA;ADORA2A;GPER1;NR1H3;MYH9;PRKAR1B;ADCYAP1R1;GIPR;LRFN5;ADCY8;ADCY3;ADCY6;PPARD;NPSR1;IL4;PRKAR2B;GPR45;ADCY9;AOAH
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.4041671046548013,-1.3245527367576588,0.08665105386416862,0.47111549771568695,1.0,26/55,27.22%,WWOX;CAV1;NUPR1;TGFBR1;GSDME;TNFSF10;BCL2L11;BECN1;DAB2IP;PML;TRIM39;BID;BCAP31;RIPK1;AGT;BBC3;TPD52L1;DEDD2;BCL2L1;RPS3;RACK1;TP53;FAS;CRADD;BCL10;PAK2
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6277872927905955,1.3244093387392357,0.17873303167420815,0.6835616463782804,1.0,4/10,11.93%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5162235386042935,1.3239930379196936,0.16353383458646617,0.6829869500434166,1.0,13/34,18.54%,MEF2C;MPP2;CHRNA3;GABRG2;GABRA2;GRIN2B;GABRA5;GABRA4;NLGN3;INSYN2A;GRIN2A;GSK3B;GRID2
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.4569590270122715,-1.3236760932795706,0.11066398390342053,0.472447183289888,1.0,10/33,6.10%,MCC;DCN;SP100;APOE;ADAMTS9;SLIT2;PTPRM;THBS1;PTPRG;ACVRL1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.5094826807714828,-1.32292339009735,0.137546468401487,0.47343243353573156,1.0,6/17,7.97%,ANXA4;KLF4;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,positive regulation of cell junction assembly (GO:1901890),0.4860920542181684,1.3227861133834622,0.12824956672443674,0.6845712836540304,1.0,8/56,4.34%,ACE2;LIMS1;CLSTN1;FERMT2;ROCK1;NRXN1;CLSTN3;CNTNAP2
prerank,histone H3 acetylation (GO:0043966),-0.4303704602473036,-1.321807900820395,0.11879049676025918,0.47537726661530827,1.0,23/40,32.81%,KAT6B;KAT2B;LEF1;KAT14;TADA1;MEAF6;TRIM16;TADA2A;BRCA2;YEATS2;BRPF3;PHF14;BRPF1;BRD1;TAF5;SGF29;JADE1;ING4;TAF6L;JADE3;POLE3;NAA60;MAP3K7
prerank,stem cell development (GO:0048864),0.5985085471775079,1.3214751992911093,0.20734341252699784,0.6865469499099857,1.0,4/16,11.05%,CDH2;NRG1;KLHL12;SNAI2
prerank,cellular defense response (GO:0006968),0.48859138232205174,1.32144500533342,0.16117216117216118,0.6850333361586392,1.0,8/40,8.21%,NCF2;IL1RL2;ADORA2A;NCF1;ITGB1;CXCR2;KLRG1;CCR9
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.5089463580375959,-1.3184429279179626,0.12544802867383512,0.4832504707605187,1.0,4/19,2.62%,ROCK2;PRKCH;OCLN;CLDN5
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.44284214895690244,-1.318127806922371,0.1282608695652174,0.4831335401064197,1.0,12/36,11.82%,EGFR;APOE;CAV1;NPR3;NOS3;DDAH1;PIK3CB;NOS1AP;AKT1;HIF1A;LYPLA1;GCH1
prerank,modulation by symbiont of host process (GO:0044003),-0.5870787115789908,-1.3180411206451936,0.15101289134438306,0.48241983669384897,1.0,4/10,14.26%,B2M;HGS;UBB;ENO1
prerank,lamellipodium organization (GO:0097581),0.523119917177356,1.3168618932565697,0.16061185468451242,0.6953128566436988,1.0,5/29,5.53%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,axonogenesis (GO:0007409),0.38399576482849546,1.3163052109729236,0.07942708333333333,0.6951322055796101,1.0,34/237,7.59%,NOTCH3;PTEN;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PIK3CA;NRXN1;SPTBN1;NTNG2;RYK;SEMA6C;GRB10;SPTB;FEZ2;CNTN4;SLITRK5;ANK3;B4GALT6;DOK4;SPTA1;CNTN6;NRXN3;CCK
prerank,regulation of actin filament-based process (GO:0032970),0.4528053431084809,1.3144892564606443,0.12935323383084577,0.6982792270494628,1.0,8/70,3.97%,DLC1;PDGFRB;ROCK1;RND3;GRHL3;SH3BP1;RAC3;CORO2B
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5314417090213159,1.3135539184454084,0.169921875,0.6992085836335947,1.0,7/27,9.15%,PDGFRB;RGCC;FGF2;TNKS;CDKN1A;PRKD2;PDGFB
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.596771136620463,-1.3135005966116884,0.15441176470588236,0.49333426695520644,1.0,5/10,23.39%,FN1;GATA6;HSP90AB1;TYROBP;CDH3
prerank,positive regulation of nuclear division (GO:0051785),0.5300782963636543,1.313454798087433,0.17611336032388664,0.6978611686009623,1.0,3/25,2.62%,PDGFRB;RGCC;IL1B
prerank,positive regulation of protein transport (GO:0051222),-0.3836570370457695,-1.3134162176243327,0.08958837772397095,0.49256363431987343,1.0,19/67,19.90%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;GOLPH3;MYH10;TGFB1;PPID;PPIA;SYTL4;RUFY3;TPR;OAZ1;RAB29;CHP1;VPS28
prerank,cytoskeleton organization (GO:0007010),0.420513773468108,1.3133925878371204,0.10638297872340426,0.696418798850689,1.0,14/114,4.97%,MAST4;PLCE1;LIMD1;ARHGAP10;SH3KBP1;DPYSL2;MARK1;WASF3;SIPA1;RND3;ABI2;RAC3;FMNL3;AJUBA
prerank,defense response to symbiont (GO:0140546),0.4358608291076906,1.3131960907012619,0.1281645569620253,0.695314753096791,1.0,1/92,0.01%,ABCC9
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5828070088742496,-1.312905606809235,0.17248062015503876,0.4928251355134238,1.0,6/10,25.02%,DPYD;UPP2;UPB1;NT5E;NT5C1A;NT5C
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.522560662339915,-1.3097364506405837,0.13034623217922606,0.5002642536883292,1.0,7/16,22.85%,CLEC16A;FLCN;GPR137;SIK3;RRAGB;LAMTOR5;PIH1D1
prerank,synapse organization (GO:0050808),0.4157391509860892,1.3097325841535075,0.1261682242990654,0.7028298412980442,1.0,22/125,8.63%,PTEN;CACNB2;ADGRL3;CDH2;APBB2;FARP1;PCDHB11;LRRC4C;DOK7;LRFN5;NRXN1;RAB39B;GRM5;AGRN;DNER;RYK;ANK3;SNCA;CHRNA7;PPFIBP2;ACHE;SLITRK1
prerank,COPII-coated vesicle budding (GO:0090114),-0.3877478148524238,-1.3095507329239084,0.10220994475138122,0.4998284666985752,1.0,35/68,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;VAPA;SEC23IP;NAPA;SAR1A;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;SEC31B;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5314484991480366,1.3094785863304745,0.16184971098265896,0.7018986641658223,1.0,2/26,1.22%,CASQ2;ATP1A2
prerank,positive regulation of peptidase activity (GO:0010952),-0.4945477707632788,-1.3094527109025536,0.13111545988258316,0.49911893849398137,1.0,11/20,34.23%,CTSH;RCN3;PSME2;PSME3;PRELID1;VCP;NDUFA13;NCSTN;VSIR;APH1A;PINK1
prerank,positive regulation of leukocyte activation (GO:0002696),-0.516486450490488,-1.308884298515301,0.1510204081632653,0.49963616530549226,1.0,6/18,16.54%,LBP;THBS1;WNT5A;IL33;KARS1;TLR4
prerank,maintenance of blood-brain barrier (GO:0035633),0.5193256224088446,1.3086711294746165,0.16727941176470587,0.7023916475895572,1.0,8/30,5.53%,LAMA2;SLC12A2;DMD;JAM3;VCL;LAMC1;ESAM;ITGB1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6247013769377675,1.3082327178872897,0.2100456621004566,0.7019372614515726,1.0,3/10,7.20%,PTH1R;SNCA;IRS1
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5374123852787148,1.3082247397828783,0.18480492813141683,0.700360718596276,1.0,10/22,18.34%,DMD;CACNB2;PDE4B;STAC;HPCA;CBARP;GPR35;FMR1;CACNB4;GNB5
prerank,regulation of mitochondrial fission (GO:0090140),-0.4855379214921848,-1.3080315520204946,0.14677103718199608,0.5009135232922803,1.0,13/24,25.64%,DCN;MCU;LRRK2;STAT2;KDR;VPS35;BNIP3;MYO19;CYRIB;DDHD1;INF2;RALBP1;PRKN
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6132111408020087,1.3078472068913871,0.2236024844720497,0.699703716150936,1.0,3/11,7.30%,CACNB2;CACNA2D1;BIN1
prerank,positive regulation of synapse assembly (GO:0051965),0.532101049496294,1.3070596006516506,0.19056603773584907,0.7001708489941363,1.0,10/27,15.09%,CLSTN1;NRXN1;AGRN;CLSTN3;IL1RAPL1;CUX2;EPHB1;SLITRK2;NLGN3;SYNDIG1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.542505329735664,-1.3068722924919884,0.15294117647058825,0.5032139035124592,1.0,5/13,11.15%,NUPR1;LRRK2;CHMP4B;CHMP4A;PHF23
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5182532714509245,-1.3068054563792535,0.13793103448275862,0.5023861824795427,1.0,6/17,22.35%,LGALS9;PRKCZ;SLC7A5;CEBPB;SYK;RARA
prerank,ion transport (GO:0006811),0.42041353659186964,1.306794437144644,0.1305732484076433,0.6992664193728103,1.0,12/111,7.10%,ANO1;TRPC6;SLC12A2;ATP1A4;CHRNA3;SLC24A4;SLC24A2;SLC12A6;SLC26A1;SLC32A1;CHRNA7;SLC15A2
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.4804058694427834,-1.3066011672556097,0.16194331983805668,0.5019513486680235,1.0,3/22,2.68%,EPHA4;ROCK2;SLC2A13
prerank,fluid transport (GO:0042044),-0.5526996582312353,-1.3060386756763622,0.15667311411992263,0.5024840438306183,1.0,2/12,15.56%,PDPN;AQP11
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6082897001448089,1.3059713885369908,0.21135029354207435,0.6998212335320311,1.0,3/13,4.38%,NOTCH1;TBX3;SOSTDC1
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5726986335319306,-1.3058482218999035,0.15700934579439252,0.5020312879453075,1.0,4/11,15.88%,SMAD7;AHR;HFE;CEACAM1
prerank,axon guidance (GO:0007411),0.38798722950802633,1.305613145194878,0.0855614973262032,0.6992116392363282,1.0,26/201,5.42%,NOTCH3;CHN1;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PLXNB1;PIK3CA;NRXN1;SPTBN1;RYK;SEMA6C;GRB10;SPTB;FEZ2;CNTN4
prerank,negative regulation of transport (GO:0051051),0.4673290809239159,1.3048803812272969,0.18024263431542462,0.6994245311201657,1.0,7/51,6.29%,PTEN;DYSF;NR1H3;NRG1;NDFIP2;SCAMP5;SNCA
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.4653841245474446,-1.3039700117603084,0.119140625,0.5059798360554372,1.0,6/26,10.09%,LGR4;APPL2;IRF1;BIRC3;FLOT2;IRAK3
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5376186020678537,1.3037739518998401,0.1975806451612903,0.7007991813009515,1.0,3/21,2.02%,CSPG4;CHST3;CHST7
prerank,alcohol catabolic process (GO:0046164),0.6318630500619615,1.3037616873178626,0.18599562363238512,0.6992794025246898,1.0,2/10,2.20%,CEL;SCARF1
prerank,sodium ion export across plasma membrane (GO:0036376),0.5852019728418251,1.3036312020669496,0.20625,0.6981136651609606,1.0,4/13,4.90%,ATP1A2;ATP1A4;FXYD2;ATP1B2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4191473233818633,1.3030342126614385,0.13161875945537066,0.6980383697630348,1.0,23/108,11.50%,DLC1;PDGFRB;PTK2;PHLDB2;ROCK1;RND3;GRHL3;SPEF1;PLXNB1;SH3BP1;RAC3;CORO2B;SYDE1;TESK1;TPPP;MTOR;CORO1A;MARK2;ARHGAP35;BICD2;CAMSAP3;PAK3;PAK1
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5630260598484258,1.3030245295375624,0.19144602851323828,0.6965209499747934,1.0,2/21,3.42%,SLC30A10;ABCD2
prerank,peptidyl-amino acid modification (GO:0018193),0.6221552049479298,1.302754349903281,0.19246861924686193,0.6957021353224279,1.0,2/10,3.70%,METAP2;ATP7A
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5743447249646744,1.3027306287227758,0.20404040404040405,0.6942223133093031,1.0,1/15,0.40%,KCNJ8
prerank,inner mitochondrial membrane organization (GO:0007007),-0.40788555215406996,-1.301980089235058,0.12389380530973451,0.5102247295924472,1.0,23/47,29.59%,MICOS10;MTX2;ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;TIMM13;AFG3L2;TIMM8B;MAIP1;TIMM9;HSPA9;ATP5MC2;NDUFA13;ATP5F1E;DNAJC11;TIMM10;MTX3
prerank,regulation of filopodium assembly (GO:0051489),-0.42924867415984647,-1.3013458522949473,0.14157303370786517,0.5109090278949768,1.0,10/38,9.00%,DPYSL3;NRP1;PALM;RHOQ;CAPZB;FNBP1L;ARAP1;DOCK11;PRKCD;PPP1R16B
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5340740463144565,1.300166622234763,0.19721115537848605,0.6991971032012492,1.0,7/26,7.38%,CASQ2;NEDD4L;KCNG1;STK39;ATP1B2;ITGB1;CACNA1D
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.46783106266801583,-1.299719212922458,0.1463917525773196,0.5143321534935553,1.0,8/24,15.72%,SLIT2;CXCL12;CCN3;NBL1;ANO6;DUSP1;CREB3;SERPINE1
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.43955044666430787,-1.299714787835503,0.12162162162162163,0.5133634195652214,1.0,9/36,11.16%,AFDN;VAMP5;MACF1;KIF13A;RILPL1;GGA2;GOLPH3;OPTN;RAB7A
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.4001886466822251,1.2987779902804588,0.10393258426966293,0.7012117033137979,1.0,25/163,12.13%,PDE4D;MEF2C;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;WAS;RFTN1;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;CSK;PRKD2;BLNK;EIF2B3;PAK3;PAK1;TEC;PSME4
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.5051824306324677,-1.298057009907747,0.16700201207243462,0.5168690302971279,1.0,9/18,22.82%,ADAMTS9;STT3B;FUCA1;SAMHD1;DERA;NAGA;MANBA;NGLY1;FBXO17
prerank,protein autoubiquitination (GO:0051865),-0.38585779525602004,-1.2976739597041427,0.11352657004830918,0.5168907467864148,1.0,16/61,16.96%,RNF220;SH3RF1;RNF213;RNF146;WWP2;SH3RF3;SH3RF2;AMFR;RNF185;DTX3L;MDM2;RNF181;TRIM17;RNF115;RNF187;UBE3D
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.4639499284376514,-1.2976411545657707,0.13535353535353536,0.5160331120210705,1.0,6/26,14.70%,ST3GAL4;LARGE1;ST3GAL2;GOLPH3;ALG6;GCNT1
prerank,protein prenylation (GO:0018342),0.6079476653347049,1.2974375719927627,0.22532188841201717,0.7030032603630303,1.0,2/10,3.16%,PTAR1;CHML
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3635640205269929,-1.2971230176468114,0.08136482939632546,0.5164230574860007,1.0,14/86,6.10%,BMP6;SULF1;DAB2;ZNF423;CDH5;BMP7;BMPR2;THBS1;BMP4;TGFBR1;FOXD1;ACVR1;SDCBP;ACVRL1
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.4841268244101286,-1.2971137154614671,0.14763779527559054,0.5154701063141659,1.0,9/24,11.02%,CDH5;TEK;ANGPT1;RAMP2;GAS6;NDNF;ICAM1;KDR;GATA2
prerank,regulation of cell division (GO:0051302),-0.37324790875994995,-1.2967448976660834,0.09043927648578812,0.5155301992575239,1.0,32/72,28.47%,FGFR2;RAB11A;KIF13A;MLLT3;FGF1;TXNIP;PLK2;CALM2;BECN1;FLCN;EFHC1;SH3GLB1;GIT1;UVRAG;TAL1;MYO19;CALM1;SIRT2;SMYD5;PLK4;CETN2;CCP110;BCL2L1;RACK1;PLK5;KLHL21;DLL1;FSD1;SFN;KIF18B;TLE6;KLHL9
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.465341832606811,-1.2965251732896799,0.1134453781512605,0.5151368804776149,1.0,6/23,15.76%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,regulation of Notch signaling pathway (GO:0008593),0.4411096070850831,1.2962122893334407,0.16097560975609757,0.7044791274028197,1.0,8/76,5.07%,NOTCH3;NOTCH1;MAML2;CHAC1;TSPAN15;CD46;PDCD10;SREBF2
prerank,positive regulation of kinase activity (GO:0033674),-0.3489668337997699,-1.2961645113403384,0.0440251572327044,0.5151531924572265,1.0,31/107,13.68%,PRKAG2;EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;LMO4;TEK;IQGAP1;FGFR2;EPHB4;IGF1R;SNX9;RASSF2;CSF1;GAS6;DDR1;PTK2B;ALS2;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;CCN1;MET;RET
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5250210734861656,-1.2956243473045506,0.150390625,0.515637727542412,1.0,6/15,22.48%,ATL2;REEP1;RAB18;ZFYVE27;REEP2;TMEM33
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.48047247662674664,-1.2955671610288504,0.14455445544554454,0.5138858445434716,1.0,13/23,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.48047247662674664,-1.2955671610288504,0.14455445544554454,0.5138858445434716,1.0,13/23,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5911927086217541,1.295280131617781,0.2190082644628099,0.705416387932874,1.0,2/14,1.34%,IL34;PTK2
prerank,protein localization to organelle (GO:0033365),-0.34096070778579,-1.295012877458302,0.06752411575562701,0.5144452064811526,1.0,46/133,24.43%,ZNF423;COL1A1;LAMP2;BMP7;APP;BMP4;TRAM2;RAB11A;LRRK2;SIX1;EHD1;OBSL1;ARL3;TULP3;TOR1AIP1;STX1A;OPTN;VPS35;RPL11;GBP5;MDM2;ALDH3A2;CALR;SNX10;RPA1;SCG3;VAPA;TTC21B;TMEM30A;GBP2;HHEX;LAMP5;MICALL1;RAB6A;GET1;WDR35;FAM83H;CEP68;TULP1;GAK;SEC61B;CNTLN;RIPOR1;WDR83OS;CCDC47;YWHAE
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5753238354780398,-1.2948062145224237,0.17857142857142858,0.5140812299601657,1.0,7/10,37.03%,INO80;SSBP1;DBF4;STOML2;WIZ;ATRX;E2F8
prerank,positive regulation of filopodium assembly (GO:0051491),-0.48164566823864313,-1.2944021481376682,0.16176470588235295,0.5142075037037981,1.0,7/24,7.63%,DPYSL3;NRP1;PALM;RHOQ;FNBP1L;ARAP1;DOCK11
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.40925739633155844,-1.2930675898372601,0.09382151029748284,0.5169871446782806,1.0,9/45,6.10%,BMP6;DAB2;BMP7;BMPR2;BMP4;TGFBR1;ACVR1;SDCBP;ACVRL1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5271473743604731,1.293052037772811,0.20576923076923076,0.7096877376467053,1.0,8/27,13.61%,PTEN;MARK1;NTNG2;IL1RAPL1;CTNNA2;BRSK1;PSEN1;ULK4
prerank,regulation of cytokine production (GO:0001817),0.4168653231839085,1.2925473116784663,0.13529411764705881,0.7094388785138322,1.0,12/126,7.25%,ACE2;PLA2R1;GLMN;PIK3CD;AFAP1L2;RGCC;RPS6KA4;CARD9;MOG;SCAMP5;NLRP4;TRAF3
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4758235008294054,1.2922874710412222,0.17747440273037543,0.7085088747487913,1.0,15/54,11.54%,NEDD4L;GNG2;KCNJ12;KCNMB1;STK39;AKAP6;DPP10;KCNAB3;BIN1;CACNA1D;KCNE5;KCNJ3;KCNJ6;KCNIP1;KCNIP4
prerank,regulation of developmental growth (GO:0048638),-0.45166851094002214,-1.292129538822419,0.14189189189189189,0.5186102829699122,1.0,6/29,6.22%,IGF1;PLCB1;APOE;APP;GHR;SIX1
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5093190235159782,1.2921256135747452,0.19092627599243855,0.7074005974623653,1.0,16/32,18.25%,MEF2C;GPER1;CHRNA3;RIMS1;RIMS2;SYN1;VPS18;BAIAP3;MCTP2;PNKD;RAB5A;PREPL;SYT11;FMR1;GSK3B;CPLX1
prerank,negative regulation of apoptotic process (GO:0043066),-0.29425551622282115,-1.2915933012898535,0.005917159763313609,0.5190398852984447,1.0,120/444,19.21%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;SMAD6;FHL2;CTSH;IL31RA;PDPN;PRKCH;TEK;FOXO1;SH3RF1;APOE;OSR1;CAV1;ANXA4;NUPR1;RNF213;ANXA5;MYO18A;USP47;THBS1;BMP4;IL6ST;ITGA5;IGF1R;SNX6;ANGPT1;TXNDC5;KLF4;ANXA1;LEF1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;ZFAND6;YAP1;RNF144B;NDNF;SIX1;WNT5A;CCND2;PTK2B;PLK2;CARD14;FNIP1;MAEA;HSPA5;SH3RF2;MAP2K5;NRBP2;TFRC;BIRC3;TBX1;GOLPH3;PRKCD;ERC1;TPT1;ERCC5;SON;AKT1;BAG3;MCL1;TLE1;PRDX2;IFIT3;NR4A2;CD38;GCLC;ZC3H12A;KDR;TRIM27;ARHGDIA;PRKCG;BNIP3L;FOXQ1;HDAC1;RELA;FLT4;GATA6;CBX4;UBB;DNAJB6;SPHK1;PIM3;BNIP3;SFRP1;QARS1;RPL10;HYPK;MAZ;MAPK3;DNAJC3;TMBIM6;RETREG1;PRKAA2;BNIP1;BID;TCIM;RIPK1;WNT11;GPX1;PSEN2;PRELID1;NFKBIA;ALOX12;PARK7;LAMTOR5;HSP90B1;HMGN5;BABAM2;MT3;PIM2;PTRH2;PPARGC1A
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5008339880775201,1.2907949314496887,0.1937269372693727,0.7091264555639162,1.0,3/40,1.34%,PTEN;GLMN;PTK2
prerank,regulation of cell-cell adhesion (GO:0022407),-0.4216447049909241,-1.2904297512747769,0.13656387665198239,0.5212252684193118,1.0,15/39,16.39%,AFDN;EPHA7;PODXL;DPP4;SMAD7;CDH1;PTPRG;EFNA5;CD47;FLOT2;MDGA1;TGFB1;MEGF10;CEACAM1;EPHB3
prerank,positive regulation of cellular component organization (GO:0051130),-0.3466286087971698,-1.290312855293163,0.04594594594594595,0.5205910478075376,1.0,35/107,20.13%,DAB2;TRABD2B;ATP10A;CDH5;BMP7;APOE;FRMPD4;SHANK3;IGF1R;TGFBR1;ASAP1;ADGRL1;AR;FNIP1;TFRC;BCL2L11;DAB2IP;LMAN1;TGFB1;SH3GLB1;ADD1;TAL1;BNIP3;SURF4;TMEM30A;BID;CD151;GPX1;PARK7;VCP;LRP4;RHOC;NOX1;SYK;TMED9
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5830169988086429,-1.2899457242055545,0.15492957746478872,0.5206422382137768,1.0,6/10,25.85%,MLLT3;ACE;SFRP1;LMBR1L;SP7;TP53
prerank,negative regulation of cell differentiation (GO:0045596),-0.3290811644748638,-1.2893691787773403,0.035830618892508145,0.5211635363878403,1.0,49/181,13.47%,RANBP3L;LDLRAD4;ABCA1;SMAD3;ADAMTS12;EGFR;ZBTB16;COL5A2;SMAD6;EFEMP1;COL5A1;BMP7;TMEM64;FOXO1;OSR1;ENPP1;CAV1;HDAC7;XDH;SUFU;BMP4;TGFBR1;SMAD7;ADGRV1;WNT9A;PDCD4;SKI;ZFPM2;IGF2;YAP1;WNT5A;PTK2B;NOCT;TRIO;TBX1;ANP32B;TWIST2;DAB2IP;ANKRD26;GATA2;ITGB3;TGFB1;PTCH1;PPARA;ID2;CALR;CHRD;PTHLH;MEIS2
prerank,response to growth factor (GO:0070848),-0.41718360890718725,-1.289311257075734,0.11612903225806452,0.5203484197470705,1.0,13/41,15.92%,TGFBR2;BMPR2;TGFBR1;KLF4;ACVR1;ACVRL1;MAP2K5;AKT1;GATA6;SPHK1;SFRP1;BMPR1A;NOS1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.31120419241631914,-1.2889651698155773,0.020491803278688523,0.5203731725742254,1.0,62/248,16.27%,RNF220;MCC;DAB2;LRRK1;LGR4;EGFR;COL1A1;IGFBP2;BICC1;TBL1XR1;TMEM64;DKK3;APOE;CAV1;FGFR2;SMURF2;USP47;IGFBP6;NKD1;RNF146;TCF7L2;TLE4;LRRK2;LRP6;MLLT3;IGFBP4;TNKS2;LYPD6;SFRP4;SOX13;PFDN5;WNT5A;WNK1;USP8;CSNK1G2;SCYL2;AMFR;FZD4;TLE2;TLE1;USP34;FZD7;NOTUM;DAB2IP;ZNRF3;PSME2;GLI3;TGFB1;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;SOX7;GSKIP;PSME3;HHEX;PLEKHA4
prerank,regulation of vasculogenesis (GO:2001212),0.6012569304333052,1.2882389102674552,0.21987315010570824,0.7144212032735441,1.0,5/14,6.90%,HEY2;RAPGEF2;RIN2;EMP2;RAP1A
prerank,receptor signaling pathway via STAT (GO:0097696),-0.465740533390167,-1.2877756772490174,0.13347457627118645,0.5225730441333303,1.0,6/25,7.32%,IL31RA;GHR;SOCS2;STAT2;STAT1;STAT3
prerank,T cell receptor signaling pathway (GO:0050852),0.40433433135148056,1.2876942438145356,0.11866859623733719,0.7142553891417095,1.0,23/138,12.13%,PDE4D;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;WAS;RFTN1;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;CSK;PRKD2;EIF2B3;PAK3;PAK1;TEC;PSME4
prerank,regulation of T cell cytokine production (GO:0002724),-0.532059795585981,-1.2873000320579195,0.16666666666666666,0.5228770380507181,1.0,4/15,6.31%,CD55;B2M;SMAD7;TNFRSF1B
prerank,response to ketone (GO:1901654),-0.46915938023815645,-1.28680628316384,0.14770459081836326,0.5231738214674548,1.0,5/24,5.52%,TGFBR3;SLIT2;CAV1;THBS1;YAP1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.34563269057050616,-1.2866768745710464,0.0728862973760933,0.5225940246524723,1.0,24/121,7.32%,BMP6;IGF1;EPHA4;NRP1;IL31RA;NEDD9;PECAM1;IL15;IL6R;IL6ST;ITGA5;PTPRJ;ANGPT1;GHR;ARHGEF2;ACVR1;PARP9;IGF2;GAS6;PARP14;ACE;EFNA5;PTK2B;STAT3
prerank,secretion (GO:0046903),-0.5338533677842011,-1.2865493066258011,0.17115384615384616,0.5219940244064111,1.0,6/14,16.74%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;SLC22A2
prerank,mesenchymal cell differentiation (GO:0048762),0.4654861535067155,1.2860356413173728,0.16842105263157894,0.7168840671546477,1.0,7/51,2.15%,LIMS1;MEF2C;HEY2;HEYL;NOTCH1;TBX20;ROCK1
prerank,aminoglycan catabolic process (GO:0006026),0.5023133747945825,1.285576628066555,0.21022727272727273,0.7165889679642384,1.0,7/28,6.34%,SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,cell-cell junction assembly (GO:0007043),0.44520284641377067,1.2855244786759896,0.15333333333333332,0.7152134223217291,1.0,11/63,7.13%,GJD3;GJC1;CDH2;JAM3;VCL;GJA4;CDH8;CDH22;CDH20;CDH19;CDH7
prerank,lamellipodium assembly (GO:0030032),0.5185199927871916,1.2854558911105147,0.18518518518518517,0.7138437550794012,1.0,5/26,5.53%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,regulation of metal ion transport (GO:0010959),0.577944559395865,1.2849773799702149,0.1961206896551724,0.7135665578944181,1.0,4/16,7.48%,SLC30A10;EPB41;CACNA2D1;STIM1
prerank,regulation of cell communication (GO:0010646),0.49069560324304445,1.2833809518420576,0.17153284671532848,0.7163114101725852,1.0,10/35,14.03%,CASQ2;IGFBP7;GRK3;RYR2;GRK5;NCLN;TBX18;PTPN1;GRK4;ANK2
prerank,embryonic organ development (GO:0048568),-0.3887571264456729,-1.2831728459285798,0.09950248756218906,0.5302025434582694,1.0,25/61,16.15%,PBX1;GLI2;PBX3;PCSK5;RBP4;RARB;TGFBR2;FGFR2;COL13A1;TEAD4;TEAD1;STRA6;KIT;KDR;GLI3;TGFB1;FLT3LG;MFSD2A;TAL1;SOX17;RPL10;PKDCC;ZFPM1;BMPR1A;SOX18
prerank,protein polymerization (GO:0051258),0.4552745105579518,1.2830331440228357,0.17314487632508835,0.7156903601492082,1.0,9/56,6.38%,CASQ2;ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL;FGF13;TPPP
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5861768795947749,-1.2824665308179188,0.1856060606060606,0.5312153203564757,1.0,5/10,10.23%,DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5099440885908485,1.2824175551121888,0.20075757575757575,0.715784179836851,1.0,10/33,13.46%,CEL;LRRC4C;EIF4EBP2;GRIK1;NRG3;GRID1;CACNA1A;GRIK5;GRIK2;NLGN3
prerank,regulation of interleukin-6 production (GO:0032675),-0.3534194486549856,-1.2810776911277069,0.07865168539325842,0.5341161020807741,1.0,36/96,26.93%,APP;IL6R;LBP;ARHGEF2;IL16;GAS6;ARRB1;LGALS9;WNT5A;STAT3;CD47;C1QTNF3;IL33;IL17RA;IRAK3;ZC3H12A;MAVS;CYBA;PLCG2;CD200;SIRPA;TLR4;POU2F2;SYK;TYROBP;XBP1;LPL;PTPN6;RAB7B;IL17D;MYD88;CD200R1;NCKAP1L;SETD4;TWIST1;BCL10
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5244701023708072,-1.2806510421065402,0.16374269005847952,0.5343391421032224,1.0,4/15,8.90%,PIEZO2;COL11A1;ADGRV1;KIT
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.476214994286923,-1.280439619053009,0.1717171717171717,0.5339786413585345,1.0,10/22,19.61%,GSN;SLIT2;KANK3;TMSB4X;PRKCD;PFN1;TWF1;CYRIB;TMSB10;SSH3
prerank,negative regulation of T cell proliferation (GO:0042130),0.5380656541042397,1.2802709676558108,0.21414913957934992,0.7198055332284516,1.0,2/28,1.05%,GLMN;TNFRSF21
prerank,replicative senescence (GO:0090399),0.5948314228669858,1.2802654233031654,0.22437137330754353,0.7183039324739969,1.0,1/12,0.58%,PLA2R1
prerank,"phagocytosis, engulfment (GO:0006911)",-0.4269710893289362,-1.279991771157898,0.14655172413793102,0.5342452569290975,1.0,5/36,3.21%,GULP1;GSN;RHOBTB1;ELMO1;THBS1
prerank,acylglycerol metabolic process (GO:0006639),0.4968433204769348,1.279344948544602,0.1824953445065177,0.7191370428895564,1.0,3/37,1.88%,DGKB;DGKH;DGKG
prerank,ear morphogenesis (GO:0042471),-0.4845044444441655,-1.2793276386040382,0.14052953156822812,0.535123609702224,1.0,6/20,12.29%,CHD7;OSR1;FGFR2;SIX1;TBX1;EPHB2
prerank,microtubule anchoring (GO:0034453),0.6015176564577425,1.2791468687704721,0.2012847965738758,0.7180939555278912,1.0,5/12,18.98%,CLASP2;BICD2;CAMSAP3;GCC2;BCCIP
prerank,cellular response to cadmium ion (GO:0071276),-0.45685707295832506,-1.2788928749324393,0.15430861723446893,0.5353852298049431,1.0,12/24,20.00%,EGFR;AKT1;MAPK3;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,response to retinoic acid (GO:0032526),-0.3906004104836509,-1.2787615160773265,0.11848341232227488,0.5347680642684124,1.0,17/59,13.68%,EPHA3;CTSH;WNT6;RBP4;WNT9A;ACER2;RARG;WNT5A;PTK2B;TBX1;FZD4;TRIM16;FZD7;WNT5B;ATM;GATA6;RET
prerank,regulation of smooth muscle contraction (GO:0006940),0.5451922472216086,1.2784773694485263,0.2099009900990099,0.7183017140450556,1.0,3/20,3.63%,PLCE1;CHRNA3;NMU
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4386492803240772,1.2782739095372129,0.16422764227642275,0.7173432984890681,1.0,9/72,4.91%,DLC1;STARD8;EPS8;TNFAIP1;CUL3;STARD13;PDCD10;EPS8L1;RIT2
prerank,receptor catabolic process (GO:0032801),-0.4597677552352755,-1.2780107214967324,0.18295218295218296,0.5358638539369307,1.0,10/24,13.03%,RNF43;AP2A2;SMURF1;CLTA;BECN1;ZNRF3;TGFB1;SH3GLB1;AP2A1;UVRAG
prerank,negative regulation of autophagy (GO:0010507),-0.39363513632501607,-1.2778935432915162,0.09501187648456057,0.5351943537986799,1.0,20/54,20.95%,LEPR;NUPR1;LRRK2;DAP;RASIP1;STAT3;NRBP2;AKT1;MCL1;FOXK1;DAPL1;ZKSCAN3;EIF4G3;MET;WASHC1;SIRT2;QSOX1;MT3;USP36;TBC1D14
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4510469826867749,-1.2777396312907416,0.14867617107942974,0.5346562207939056,1.0,14/29,27.00%,TCF7L2;TLE4;LEF1;TRRAP;TLE2;TLE1;BCL9L;HDAC1;PYGO2;SMARCA4;PYGO1;TCF7;CTNNB1;BCL9
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5102260644006331,-1.2775845502202938,0.18470149253731344,0.5341358406494352,1.0,5/18,6.78%,CDH5;ROCK2;TEK;RAP1B;PTK2B
prerank,negative regulation of cell cycle (GO:0045786),0.4418960204945348,1.277473035797469,0.1791044776119403,0.717960535113438,1.0,17/73,11.85%,PTPRK;PTEN;CDK6;GPER1;SIPA1;RPS6KA2;HEXIM1;BRINP1;NUPR2;BRINP3;INCA1;HTRA2;NR2F2;TAF6;LATS2;RB1;APC
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2827637988368987,-1.2769768195200195,0.0,0.5347919316885291,1.0,185/807,14.50%,BMP6;FOXP2;PRDM6;DAB2;FOXN3;ZNF423;AEBP1;PLCB1;SMAD3;SMARCA2;ZBTB16;MECOM;FOXP1;WNT4;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;BMP7;LCOR;SP100;GLIS3;VGLL4;RBFOX2;DKK3;FOXO1;OSR1;SKIL;FOXO3;MDFIC;ZIC2;NR3C1;DLG1;HDAC8;KAT6B;CAV1;RARB;SUFU;ESR1;FGFR2;SMURF2;USP47;BMP4;EZR;RPS14;SNX6;FOXD1;DNMT3A;KLF4;DDX5;TCF7L2;FOXC2;TFDP2;SMAD7;LEF1;KLF2;ETV6;TAF1;ID1;PDCD4;HDAC9;SBNO2;THRB;MXI1;ZHX3;SKI;SDCBP;ZFPM2;PARP9;CNOT7;IGF2;GATAD2A;GAS6;GTF2IRD1;NIBAN2;WWP2;AR;BRD7;DAP;RARG;SCMH1;CREM;YAP1;FOXP4;GLIS2;SOX13;BHLHE40;PFDN5;KMT5A;ATXN1;IRF1;MIDEAS;WNT5A;ATN1;PRDM16;ID3;FOXC1;IRF2;GLIS1;SFMBT1;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;IFI27;KLF10;ZNF219;RTF1;ZBTB18;RREB1;TLE2;IL33;CBFA2T2;ZMYND15;RCOR3;TLE1;TWIST2;FOXK1;NR4A2;FLCN;BHLHE41;EHMT1;CD38;PHF10;IKZF1;GCLC;DAB2IP;JARID2;PRDM5;ZKSCAN3;TGIF1;PML;KLF12;TRIM27;MDFI;PATZ1;GLI3;TGFB1;NSD1;ELK3;PTCH1;ZMYM5;AHR;HDAC1;LRRFIP1;MDM2;RELA;CPEB3;PPARA;ID2;MEF2A;GATA6;CBX4;FBXW11;PRDM11;UBB;CALR;ATOH8;ZGPAT;PPID;CLOCK;MEIS2;EZH1;CCND1;KCNIP3;HDAC5;ZNF568;SFRP1;QARS1;SARS1;RPL10;CREB3L1;ENO1;POU2F1;MAZ;ZBTB4
prerank,sphingoid metabolic process (GO:0046519),-0.5521017376444078,-1.2768026644932167,0.18415841584158416,0.5342691997352029,1.0,5/12,13.40%,PLPP3;NAAA;DEGS2;PLPP1;SPHK1
prerank,cellular response to organic substance (GO:0071310),-0.33869793118172614,-1.2767832337575427,0.06609195402298851,0.5333857303918751,1.0,23/116,7.47%,DPYSL3;SMAD3;NFAT5;PTPN14;PTPN13;IGFBP5;SLIT2;TGFBR2;BMPR2;TGFBR1;CLEC3B;KLF4;LRRK2;GHR;LEF1;ACVR1;SOCS2;RAMP2;ACVRL1;RHOA;CYP1B1;STAT3;MAP2K5
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46802598295452535,1.276383180339895,0.16824196597353497,0.719247627232831,1.0,8/46,5.23%,ITGA4;LAMC3;PIK3R1;LAMC1;PEAK1;FERMT2;NTNG2;LAMB1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5019555139986496,-1.2749604849103306,0.17054263565891473,0.5373502584040761,1.0,5/16,16.10%,IGF1R;CLEC16A;IRAK3;BNIP3;TBC1D25
prerank,potassium ion homeostasis (GO:0055075),0.5244840310732773,1.274447073634409,0.1991869918699187,0.7226539840489392,1.0,6/23,5.65%,SLC12A2;ATP1A2;ATP1A4;SLC12A6;ATP1B2;TFAP2B
prerank,neurotrophin signaling pathway (GO:0038179),0.538830728699361,1.2743525187488516,0.2231237322515213,0.7214051202526863,1.0,6/21,10.31%,RAPGEF2;BCAR1;SORT1;NTRK2;RAP1A;DDIT4
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5562925362419121,1.2740707120123869,0.2135523613963039,0.720666780793165,1.0,2/21,1.87%,PTEN;BTRC
prerank,positive regulation of translational initiation (GO:0045948),0.5665660510108187,1.2738754628963522,0.2219959266802444,0.7196728723538212,1.0,10/18,19.10%,DAZL;RPS6KB2;BOLL;YTHDF3;DDX3X;MTOR;YTHDF2;RPS6KB1;HABP4;POLR2D
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5448185534909503,1.273569075008609,0.226215644820296,0.7189264014249815,1.0,4/20,1.88%,HEY2;HEYL;NOTCH1;TBX3
prerank,endoplasmic reticulum organization (GO:0007029),-0.37141259630690365,-1.2735271750946846,0.12894736842105264,0.5403583389430341,1.0,33/72,28.13%,APP;TRAM2;LRRK2;SEC31A;LPCAT3;STX1A;SEC16B;LMAN1;ATL2;ALDH3A2;DOP1B;CAV2;VAPA;REEP1;REEP5;BNIP1;RAB18;STX18;GET1;SEC61A1;MOSPD3;GAK;EIF2AK3;SEC61B;REEP2;TMEM33;WDR83OS;CCDC47;SEC31B;ATL3;TRAM1;SEC16A;TLE6
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.3267679488169664,-1.2733099142388007,0.05379746835443038,0.5400176975699245,1.0,40/138,14.22%,EPHA4;EPHA3;EGFR;FLT1;MTSS1;EPHA7;PDGFRA;NTRK3;IL31RA;TEK;NEDD9;FGFR2;BMPR2;IL6ST;EPHB4;IGF1R;MPZL1;YES1;CSF1;NPR1;PTPRG;DDR1;BDKRB2;PTK2B;TRIO;RAPGEF1;PIK3CB;TIE1;KIT;EFS;FRS2;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;FER;RET;STYK1
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4714189311698971,1.2726556334347972,0.18620689655172415,0.7198902286784226,1.0,9/42,9.82%,UTRN;LIMS1;CDK6;FERMT2;ROCK1;RIN2;EMP2;MAP4K4;EFEMP2
prerank,positive regulation of immune effector process (GO:0002699),-0.4489981297334026,-1.2726231954108542,0.15833333333333333,0.5409051311533022,1.0,7/27,7.41%,LBP;MYO18A;PTPRJ;DDX60;LGALS9;APPL2;RPS19
prerank,regulation of tube diameter (GO:0035296),0.5759927994987596,1.2723812812947748,0.23684210526315788,0.7176269128178041,1.0,3/13,3.95%,ACE2;ROCK1;ADCY6
prerank,vascular process in circulatory system (GO:0003018),0.5759927994987596,1.2723812812947748,0.23684210526315788,0.7176269128178041,1.0,3/13,3.95%,ACE2;ROCK1;ADCY6
prerank,cortical cytoskeleton organization (GO:0030865),-0.4104798072385314,-1.2718446294502612,0.12179487179487179,0.5421020012708416,1.0,17/41,22.24%,FMNL2;ROCK2;RHOBTB1;RHOQ;DLG1;EZR;RHOA;RHOB;FHOD1;TRPV4;LLGL2;RHOH;RHOC;PPP2R3C;PLEK;RHOBTB2;LCP1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.44639041703140825,-1.2716662617192103,0.16263736263736264,0.5416041077394929,1.0,4/30,5.04%,PPP1R13B;FHIT;DDX5;ACER2
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3677094394844036,1.271314204159656,0.09370988446726572,0.71884163165779,1.0,38/291,9.15%,GUCY1B1;PTPRK;MEF2C;PID1;RORB;SPAAR;GNG2;PDE3A;RAPGEF2;RORA;GPER1;CPEB1;NR1H3;IL1B;FFAR2;NCF1;AXL;NCOA3;ADCY6;AKAP6;BRINP1;CXCL10;TNIP2;PDE4B;CXCL5;HCN2;CACTIN;RAP1A;FAM210B;IRS1;MTOR;BRINP3;RYR3;HCN3;HTRA2;PKD2;LYN;PDGFB
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.552427827480362,1.270987666091281,0.21218487394957983,0.7181738114843945,1.0,5/17,10.01%,WASF3;ABI2;WASF2;CTNNA2;NCKAP1
prerank,negative regulation of macrophage activation (GO:0043031),0.5558420835789144,1.2703174007570923,0.23221757322175732,0.7183609158984343,1.0,5/16,6.03%,NR1H3;LRFN5;LDLR;TAFA3;IL4
prerank,circulatory system development (GO:0072359),0.40566570194673596,1.2702467791878915,0.14440993788819875,0.7170807403209721,1.0,13/118,3.07%,ADAP2;CACNA1C;PTEN;PLCE1;MEF2C;HEY2;NOTCH1;NF1;FGF12;ERBB4;UTY;PIK3CA;ECE1
prerank,endothelial cell migration (GO:0043542),-0.4205052151207845,-1.2701983370320549,0.12663755458515283,0.544592258861971,1.0,14/37,9.70%,FSTL1;CDH5;NRP1;DPP4;NOS3;PXN;ID1;CCN3;RHOA;CYP1B1;STAT1;LGALS8;PLXND1;CDH13
prerank,metanephros development (GO:0001656),-0.45333185125537895,-1.269762493678001,0.16025641025641027,0.5449448197930834,1.0,9/26,14.82%,CTSH;BMP7;OSR1;BMP4;FOXD1;SIX1;PTCH1;SOX17;PKD1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.5324606805408844,-1.2697301339548785,0.1833648393194707,0.5440896053313223,1.0,4/13,20.51%,PLA2G4A;MGLL;ABHD16A;DGAT2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.48218801047905363,1.2692884362248098,0.1878453038674033,0.7181162364352953,1.0,5/36,3.58%,PIGU;NOTCH1;ERBB4;CRLF3;SH2B3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5570603131522964,-1.26926145049708,0.17712177121771217,0.5443779134404837,1.0,3/12,16.54%,RBP4;STRAP;TLR4
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.5307685018015718,-1.269162406990023,0.18582375478927204,0.5437064101160242,1.0,3/13,13.00%,RHOQ;LRRK2;RAN
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.47454945225012446,1.2689826936983588,0.20287253141831238,0.7174715811435457,1.0,10/40,10.93%,SGIP1;VTN;LDLRAP1;WASL;ATAD1;IL4;PPT1;HIP1;DGKD;AHI1
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4966954438046561,-1.2673945033594316,0.17208413001912046,0.5472788412720857,1.0,8/16,31.51%,APPL2;ACADL;CEACAM1;ERLIN2;BRCA1;SIRT4;TRIB3;APOC1
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.4405076043328058,-1.267232400810101,0.15824175824175823,0.5467549189363052,1.0,9/31,22.30%,PLCB1;IL16;LGALS9;MAPK14;PLCG2;TLR4;SYK;MDK;CCL19
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5117706708800663,-1.266820146498127,0.19879518072289157,0.5469328168711357,1.0,4/16,12.45%,PRKAG2;APPL2;ACADL;PPARA
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.394993719800563,1.2665669993050408,0.1376281112737921,0.7219953617799376,1.0,8/138,2.82%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4877729681608364,-1.2664405329684716,0.1937269372693727,0.5470601888693087,1.0,4/18,6.78%,CAMK1D;SLIT2;IL6R;PTK2B
prerank,regulation of stem cell population maintenance (GO:2000036),0.5428706200542355,1.2664230000596117,0.22198275862068967,0.7209164679286684,1.0,4/18,5.75%,NODAL;PTN;NCOA3;CNOT2
prerank,early endosome to Golgi transport (GO:0034498),-0.5513508968377567,-1.2662264078518348,0.19402985074626866,0.5466907394059992,1.0,7/11,22.31%,TRAPPC10;LMAN1;SURF4;RAB6A;SNX8;TMED9;SNX2
prerank,adherens junction organization (GO:0034332),0.46040605143739405,1.266156708717484,0.18549747048903878,0.7201297502875582,1.0,14/48,10.27%,CDH2;CDH4;JAM3;VCL;FERMT2;CADM2;CDH8;CDH22;CDH20;CDH19;CDH7;CSK;CDH10;CDH18
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5489881170545061,-1.266055291881777,0.1643835616438356,0.5462575018634808,1.0,4/12,11.59%,ESR1;STAT3;ZC3H12A;TGFB1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5388825913198153,1.2656513399271068,0.226890756302521,0.7200248358817821,1.0,2/21,0.84%,MBOAT2;PLA1A
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5857896604952298,1.2631369126351977,0.2310838445807771,0.7235571226188241,1.0,1/11,0.50%,CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5857896604952298,1.2631369126351977,0.2310838445807771,0.7235571226188241,1.0,1/11,0.50%,CASQ2
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.531869023883637,-1.262886031758863,0.1896551724137931,0.5539814612206448,1.0,9/14,33.30%,ENTPD1;ENTPD5;ENTPD2;NUDT16;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,cAMP metabolic process (GO:0046058),0.5862356130261183,1.2621369895990977,0.24109014675052412,0.7246541717150845,1.0,6/13,9.84%,PDE4D;ADCY8;ADCY3;ADCY6;ADCY9;EPHA2
prerank,regulation of lipid kinase activity (GO:0043550),0.5801908843762058,1.2616570709265489,0.22567287784679088,0.7244698385623141,1.0,3/11,11.67%,PIK3R1;RBL1;RB1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4776926500206315,1.2610390250402945,0.18617021276595744,0.7246026346466932,1.0,11/39,17.43%,MYO1B;WASL;ACTN4;MYO6;TRAK1;TRAK2;PPFIA2;RAB1A;NDE1;HTT;HAP1
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.41418376486811576,1.260769748599817,0.1525974025974026,0.7237769542842691,1.0,17/93,11.50%,PDE4D;PTEN;DMD;NCK2;TNKS1BP1;FNIP2;PDCD10;SPRY2;INPP5J;SNCA;CAPRIN2;RIPK2;PRKD2;CNOT9;DDIT4;BRAF;PAK1
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.44256789362946886,-1.2607402853512186,0.1452991452991453,0.5590516017457722,1.0,5/28,2.82%,EPHA4;APOE;APP;SHANK3;ADCY1
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5542037016307635,-1.2605006539919588,0.20036764705882354,0.5587232807224579,1.0,5/10,18.14%,DIP2B;FLCN;PRKAA2;KLF15;PARK7
prerank,calcium ion transport into cytosol (GO:0060402),0.5190418839919521,1.260246516401964,0.22396856581532418,0.723715845046561,1.0,4/21,9.80%,CACNA1C;CACNA2D1;RYR2;GRIN2B
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5599955322989209,1.2602464601551981,0.2329896907216495,0.7222855765780894,1.0,2/16,5.34%,TNFRSF21;TRIB2
prerank,regulation of mononuclear cell migration (GO:0071675),0.5306687548315223,1.2600689904685767,0.23809523809523808,0.7213194559274687,1.0,3/23,1.34%,IL34;BMP5;PTK2
prerank,striated muscle cell differentiation (GO:0051146),0.561552120807957,1.259328901853616,0.24945770065075923,0.7217792287305327,1.0,5/16,6.68%,MEF2C;NRG1;SORT1;POPDC3;SIK1
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3719133063469141,-1.25901740386354,0.10669975186104218,0.5616645490970917,1.0,21/67,11.21%,SULF1;FLT1;NRP2;ROCK2;NRP1;ELMO1;VAV2;CYFIP2;SHB;BAIAP2;PXN;VEGFD;VEGFC;CLEC14A;RHOA;MAPK14;PTK2B;PIK3CB;DAB2IP;KDR;ITGB3
prerank,calcium ion import across plasma membrane (GO:0098703),0.556918009302861,1.2579325236408778,0.23828920570264767,0.723837416001318,1.0,3/14,4.63%,TRPV2;CACNA2D1;SLC24A2
prerank,positive regulation of proteolysis (GO:0045862),-0.39149909347703804,-1.257550889577148,0.12857142857142856,0.5646072294010428,1.0,14/55,12.85%,CTSH;CCBE1;APOE;CYFIP2;SNX9;ADAM9;CTSC;RCN3;TNFRSF1B;CASP8;ZC3H12A;TBC1D10A;FGFR4;FBXW11
prerank,regulation of programmed cell death (GO:0043067),-0.32312441811942244,-1.2574184169055764,0.06896551724137931,0.5640249747219014,1.0,61/161,28.84%,DAPK1;MECOM;PPP1R13B;STEAP3;ACTN2;TGM2;GAS1;FBXO10;LRRK2;TRIM24;IGFBP3;ACER2;RARG;ACER3;STAT1;BIRC3;ANP32E;TPT1;ANP32B;AKT1;CTSB;BCL2L11;PRDX2;BNIP3L;NME1;ACTN1;ATM;CALR;LRP8;BNIP3;PLSCR3;CASP6;BID;RIPK1;PRELID1;ALK;AGT;VCP;LGALS1;SLK;USP36;LCMT1;OSGIN1;PTPN6;STK26;NTF3;PSMC5;RPS3;PLK5;PRKN;TP53;FAS;CRADD;APAF1;SRA1;DAPK2;ABL1;CLU;NUP62;FANK1;ANP32A
prerank,myoblast differentiation (GO:0045445),-0.5157548594799625,-1.2573165222925327,0.20306513409961685,0.5633274670594444,1.0,5/14,7.35%,IGF1;MBNL1;DDX5;TCF7L2;HINFP
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4476156032492728,-1.2571713170022052,0.1731958762886598,0.5627549966285713,1.0,8/26,8.75%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;CCND3;UBE2E2;AKT1
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.26971640980026806,-1.2560479868451915,0.0,0.5649826099769628,1.0,250/1082,18.14%,NFIB;AUTS2;BMP6;IGF1;DAB2;ZMIZ1;PBX1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;COL1A1;DCN;NFAT5;WNT4;WWOX;HDAC4;GLI2;TBL1XR1;NFIX;CREB5;IL31RA;CDK8;BMP7;RHOQ;SP100;GLIS3;ELF2;FOXO1;APOE;OSR1;FOXO3;APP;MDFIC;ZIC2;NFIA;NR3C1;HDAC8;KAT6B;HIVEP3;ERG;ITGA6;HOXB3;RARB;MLXIP;ESR1;FGFR2;BMPR2;ELF1;BMP4;ELF4;MEOX2;TGFBR1;KLF4;PLAGL1;KAT2B;TCF4;TCF7L2;FOXC2;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;CDH1;LEF1;ACVR1;FZD2;KLF2;MLLT3;SBNO2;THRB;RGMB;HOXA5;CREB3L2;SKI;PCGF5;ZFPM2;PARP9;DCAF6;IGF2;SSBP2;ARRB1;QRICH1;NIBAN2;ARNT2;AR;FGF1;BRD7;RARG;YAP1;TMF1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;INO80;HLF;TET3;PRDM16;FOXC1;IRF2;GLIS1;LMO2;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;PGR;KLF10;SFR1;TBX1;SSBP3;FZD4;TFCP2;ZBTB18;FIZ1;AKT1;DTX3L;RREB1;IL33;HIF1A;TNFRSF1A;TRIM16;NLRC5;FOXK1;CDH13;NR4A2;MMS19;FZD7;FLCN;ATF6;FOSL2;CD38;PHF10;DAB2IP;IL18;KARS1;ZC3H12A;ZKSCAN3;ESRRG;FHOD1;EIF5A;PML;MAVS;GATA2;BRCA2;CEBPG;KDM3A;GLI3;TGFB1;NSD1;ELK3;BCL9L;AHR;HDAC1;ATXN7L3;ZIC3;RELA;PPARA;ID2;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;FBXW11;PRDM11;UBB;ATOH8;CLOCK;LPIN3;MET;MEIS2;SPP1;MPND;HDAC5;RET;TAL1;SOX17;HSF2;SFRP1;SMARCC1;POU2F1;MAZ;MAPK3;HOXC4;PKD1;CDK9;HOXB7;HIPK2;DYRK1B;NKX6-1;SNAI1;ZFPM1;CREB3;JUND;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;RNF187;HHEX;MEIS1;HMGB2;SOX18;KDM6B;TLR4;RNASEL;USF2;ZMIZ2;SIRT7;JUNB;MYRF;SIRT2;HNRNPAB;ATF1;MED21;RIPK1;WNT11;PTOV1;NFIL3;RAI1;SLC9A1;FZD1;HMGN1;NFKBIA;NFYB;CSRNP3;NPAS2;MAFF;SOX12;CEBPB;KLF15;PARK7
prerank,negative regulation of ATP metabolic process (GO:1903579),0.550985075761343,1.2559767323407747,0.24335378323108384,0.727372416251782,1.0,2/17,0.85%,PID1;CBFA2T3
prerank,blood vessel morphogenesis (GO:0048514),-0.3863661748553308,-1.2557427552251499,0.11479028697571744,0.5649021337897484,1.0,17/54,8.16%,TGFBR3;FLT1;EFNB2;NRP1;LAMA1;CCBE1;CAV1;ITGB8;TGFBR2;TGFBR1;SMAD7;ID1;RAMP2;RASIP1;CYP1B1;TBX1;STRA6
prerank,organophosphate ester transport (GO:0015748),0.5269180454284788,1.2552258312103437,0.24520255863539445,0.7278526380663134,1.0,3/24,3.38%,PITPNC1;SCARB1;LDLR
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4971881559360768,-1.2547582299082283,0.20747663551401868,0.5665872074509695,1.0,2/17,3.14%,PLA2G4A;LPGAT1
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.48684543085410353,1.254572105778449,0.22160148975791433,0.7279852241245887,1.0,9/31,11.85%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.3909556828617306,1.254501132455407,0.14473684210526316,0.7267352068444778,1.0,26/152,9.86%,S1PR3;PTH1R;ADGRL3;TBXA2R;UCN2;ADORA2A;GPER1;GNAZ;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;HTR1B;CXCL10;OPRK1;ADCY9;WASF2;CACNA1D;GPR37;AKAP12;GRK5;ADGRB3;GNA12;ADGRE5;NPY1R
prerank,defense response to protozoan (GO:0042832),-0.5460892433774547,-1.2543079810081246,0.1784313725490196,0.5668230310647926,1.0,8/12,32.86%,GBP4;GBP6;GBP7;GBP2;MYD88;LYST;CD40;BATF2
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.47590958713831666,1.2539112755982416,0.19337979094076654,0.7267824776306168,1.0,4/38,3.58%,PTEN;PHLPP1;GPER1;SH2B3
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5322677770656985,1.253903957234415,0.23694779116465864,0.7253886104154054,1.0,2/21,1.34%,IL34;PTK2
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3542859885368777,-1.2535951322861172,0.09319899244332494,0.567748714575163,1.0,39/80,33.62%,PLPP3;ERGIC1;COPZ2;TAPBP;KLC1;COPA;RINT1;GOLPH3;ATP9A;UVRAG;ZW10;SURF4;SCYL1;NAPA;RER1;BNIP1;STX18;RAB6A;COPB1;TMED9;TMED2;CENPE;ARFGAP2;PICK1;TMEM115;KIF26A;ERGIC3;ARF4;USE1;KIF4A;ATP9B;TMED10;KIF1C;NBAS;SCFD1;KIF23;KIF18A;KLC2;DNAJC28
prerank,neuron migration (GO:0001764),0.45544669653878644,1.2535861088430502,0.1853211009174312,0.7247954666321654,1.0,14/48,10.61%,MEF2C;ADGRL3;RAPGEF2;MARK1;ASTN1;FGF13;DNER;ASTN2;NTRK2;TUBB2B;CCK;MARK2;DDIT4;SPOCK1
prerank,response to cadmium ion (GO:0046686),-0.44344425429347817,-1.2527063068665285,0.17768595041322313,0.5692300043005568,1.0,12/26,20.00%,EGFR;AKT1;MAPK3;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,regulation of MAPK cascade (GO:0043408),-0.3253288474591207,-1.2525301822065182,0.07407407407407407,0.5687924175052655,1.0,39/157,14.52%,TGFBR3;IGF1;FN1;EGFR;FLT1;ROCK2;EPHA7;NTRK3;LPAR1;TEK;IQGAP1;CAV1;JCAD;KSR1;FGFR2;NRK;PTPRJ;IGF1R;GSDME;IGF2;IAPP;DUSP1;TBX1;ADRA1B;TAOK2;KIT;EPHA8;DAB2IP;KDR;P2RX7;MYOC;PPEF2;FLT4;CCN1;PRDM11;PLCG2;RET;CAV2;MAPK3
prerank,epithelial to mesenchymal transition (GO:0001837),0.4627337656394421,1.2522309314376463,0.17697594501718214,0.7268920640689807,1.0,6/47,2.15%,LIMS1;HEY2;HEYL;NOTCH1;TBX3;ROCK1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.5595826752736326,1.252085571499909,0.24261603375527427,0.7258426347306848,1.0,6/15,17.43%,BCAR1;SORT1;NTRK2;DDIT4;SOS1;HAP1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5413003075145889,-1.251972560317815,0.1977401129943503,0.569421541738308,1.0,4/12,8.86%,F3;APOD;PTPRJ;HGS
prerank,regulation of gene expression (GO:0010468),-0.2710193707000783,-1.251648486838512,0.0,0.5692844281986678,1.0,185/903,13.90%,BMP6;AFDN;BNC2;PRDM6;NOTCH2;IGF1;ROBO1;SLC24A3;FOXN3;ZNF423;FN1;AFF3;SMAD3;SMARCA2;CDH5;EFEMP1;ROCK2;FOXP1;AHNAK;WNT4;NTRK3;GSN;HDAC4;DENND4A;CTSH;WWC2;CHD7;OCLN;BMP7;APOE;OSR1;APP;NFIA;NR3C1;F3;KAT6B;WNT6;CLDN5;ITGB8;XDH;SUFU;MBNL1;ESR1;NOS3;BMP4;GJA1;EZR;PRRX2;TGFBR1;FOXD1;ANGPT1;KLF4;CSF1;CDH1;LEF1;TAF1;RAMP2;SBNO2;CD34;HOXA5;ADAM10;SMO;PARP9;CNOT7;IGF2;MED26;SSBP2;GAS6;TAPBP;GTF2IRD1;ARNT2;RBM20;WWP2;AR;FGF1;RAB27A;CREM;LGALS9;PARP14;YAP1;MOV10;SFRP4;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;SIX1;WNT5A;MAPK14;FOXC1;IRF2;SLC7A5;CHD3;STAT3;HINFP;AFF2;NR2C2;PGR;TFRC;NOCT;ZNF219;ACTG1;ERC1;AFF1;DTNBP1;IGF2BP2;POLR2A;ATRAID;TRRAP;GON4L;PIK3CB;NOVA2;NOS1AP;SON;VSX1;AKT1;HGS;RREB1;IL33;REXO4;HIF1A;PCBP2;TLE1;CCN4;CRABP2;CARM1;FLOT2;TULP3;FZD7;FLCN;CASP8;EMILIN1;SEC16B;ZC3H12A;PRDM5;SLC39A8;KDR;ESRRG;PML;ANXA7;TRIM27;P2RX7;GATA2;VPS35;BRCA2;PATZ1;CLK1;RPL11;NFYC;HINT1;PUM1;TGFB1;NSD1;AHR;HDAC1;FGFR4;EPHX2;TMEM119;EPHB2;MBNL2;RELA;GRSF1;ID2;NOVA1;YBX3;SRSF10;ZNF462;ATM;PRKAB1;PRDM11;CALR;GLRX2;ATOH8;TDG;CLOCK;PTHLH;WNT16;TRIM39;PLCG2;LARP1;HDAC5;TICAM1;SOX17;SFRP1
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5118049606130985,1.2513652134317212,0.24151696606786427,0.726278779521849,1.0,8/27,7.20%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5454989421898572,-1.2511835804820524,0.20955882352941177,0.5696582125308567,1.0,7/11,27.83%,GSN;LGALS9;PARK7;PLAUR;PIH1D1;FAS;PRR7
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.48055201374654183,1.2504319340318684,0.2180746561886051,0.7271018304419026,1.0,4/34,2.79%,PDGFRB;RGCC;IL1B;CUL3
prerank,positive regulation of phospholipase C activity (GO:0010863),0.4690980686276164,1.250261969597988,0.19925512104283055,0.7261215368239321,1.0,6/40,7.15%,PDGFRB;EDNRA;ARHGAP6;FGF2;NTRK2;HRAS
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.510234124914052,1.2502080028500457,0.23412698412698413,0.7248795137603441,1.0,3/24,2.80%,MEF2C;CDH2;NRG1
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5133636936572483,1.2501141579721757,0.2205607476635514,0.7237225883957455,1.0,4/31,9.11%,GLMN;TNFRSF21;CD300A;LYN
prerank,regulation of inflammatory response (GO:0050727),-0.31528457443345126,-1.2498604155242197,0.051094890510948905,0.5723471136942273,1.0,45/190,12.45%,ADAMTS12;CDH5;FOXP1;PTGIS;TEK;APOE;CASP12;APP;IL15;IL1R1;SNX6;SEMA7A;KLF4;ANXA1;PDCD4;SBNO2;IL16;LACC1;CCN3;LPCAT3;CASP4;WNT5A;TNFRSF1B;ENPP3;MFHAS1;PIK3AP1;CD47;BIRC3;TMSB4X;PRKCD;DAGLB;C1QTNF3;USP18;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;METRNL;VPS35;MGLL;PTGS2;RELA;PPARA
prerank,Rac protein signal transduction (GO:0016601),0.5307124835699867,1.2498133014272617,0.24,0.7231212044180967,1.0,4/18,10.01%,EPS8;ABI2;HACE1;NCKAP1
prerank,motor neuron axon guidance (GO:0008045),0.5684168168908834,1.2489226955548887,0.2551867219917012,0.72397649161262,1.0,2/15,1.80%,CHN1;SLIT1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.35342772236582776,-1.2481005043570736,0.12129380053908356,0.5762869900071133,1.0,35/88,23.51%,TRABD2B;SMAD3;CDH5;BMP7;SDCBP;SMPD3;PDCD6IP;SYNPO2;SDC4;SYNPO;FNIP1;TFRC;HGS;BCL2L11;EMILIN1;DAB2IP;RAB7A;TGFB1;SH3GLB1;PFN1;TAL1;SDC1;BID;TPR;STX18;PARK7;VCP;RHOC;SYK;PLEK;VEGFA;PIH1D1;SLX4;ICE1;ERCC1
prerank,regulation of multicellular organismal development (GO:2000026),0.5110840907274904,1.2479103474762132,0.22857142857142856,0.7251259888965974,1.0,3/25,2.62%,SPAAR;PTN;GBX2
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.47637555044107827,-1.2478437422544937,0.18269230769230768,0.5761191357386027,1.0,4/20,2.33%,FMNL2;ROCK2;RHOQ;DLG1
prerank,glucose import (GO:0046323),0.5512511593568813,1.2476261752996107,0.2516703786191537,0.7244659858205493,1.0,4/13,8.28%,SLC5A1;SORT1;SLC27A4;SLC2A3
prerank,actin filament polymerization (GO:0030041),0.4961215727168511,1.24723118015396,0.20616570327552985,0.7240489377514423,1.0,6/29,3.93%,ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5951301836802249,1.2470313671659057,0.23903508771929824,0.7231754373977387,1.0,3/13,6.40%,HEY2;NOTCH1;RYR2
prerank,cartilage development (GO:0051216),-0.3839464764757207,-1.2469893977887145,0.13986013986013987,0.5774509456008081,1.0,10/49,5.47%,NFIB;SULF1;ZBTB16;OSR1;ITGB8;BMP4;CREB3L2;SLC39A14;CCN3;SULF2
prerank,regulation of anoikis (GO:2000209),0.5432875878402891,1.2465361823804977,0.22810590631364563,0.7229479631481116,1.0,8/19,12.52%,NOTCH1;PTK2;PIK3CA;ITGB1;SIK1;SNAI2;ANKRD13C;SRC
prerank,positive regulation of gene expression (GO:0010628),-0.28212272665810706,-1.2464298980584014,0.011494252873563218,0.5781101306109727,1.0,93/442,13.39%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;EGFR;SAMD4A;CDH5;ROCK2;NTRK3;GSN;CTSH;OCLN;BMP7;OSR1;APP;IL15;F3;WNT6;VIM;CLDN5;ITGB8;NOS3;THBS1;BMP4;GJA1;EZR;TGFBR1;FOXD1;ANGPT1;LARP4B;KLF4;DDX5;KAT2B;CSF1;LEF1;RAMP2;NIBAN1;CD34;HOXA5;SMO;MED26;GAS6;RBM20;AR;FGF1;RAB27A;LGALS9;YAP1;MOV10;SFRP4;WNT5A;MAPK14;STAT3;HINFP;RPS4X;BAZ1B;TFRC;ACTG1;DTNBP1;POLR2A;PIK3CB;C1QTNF3;NOS1AP;AKT1;HGS;UPF3A;IL33;HIF1A;TLE1;EMILIN1;SEC16B;ZC3H12A;P2RX7;GATA2;VPS35;RPL11;ERN1;TGFB1;FGFR4;EPHX2;TMEM119;EPHB2;CPEB3;ID2;POLR2F;ATM;PRKAB1;WNT16;RPL26;PLCG2
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4632241428151455,1.2460087569219793,0.2088724584103512,0.7228257399185194,1.0,8/39,7.15%,PIK3CD;PIK3R1;PIP4K2A;PIK3CA;ITPKB;SOCS5;PIP4K2C;PIK3C2A
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3817173832871138,-1.245585429568083,0.14965986394557823,0.5795261909014067,1.0,18/51,27.56%,APP;IL16;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;LPL;CCL19;EGR1;MYD88;PYDC1;FZD5
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4157089408140522,-1.245574748986398,0.18303571428571427,0.578600001100914,1.0,15/36,27.21%,SGMS1;TGFBR1;DEPTOR;NR4A2;DAB2IP;TRIM39;QARS1;PPIA;MAZ;TMBIM6;TPD52L1;RPS3;FAS;CRADD;DAPK2
prerank,negative chemotaxis (GO:0050919),-0.4265597689701974,-1.2453147476196293,0.15695067264573992,0.5783564606784563,1.0,14/33,16.62%,ROBO1;EPHA7;SEMA3D;SEMA6A;SEMA3C;SLIT2;SEMA7A;RHOA;SEMA3E;ITGB3;SEMA3B;NTN1;SEMA3G;SEMA6B
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.4694930343618599,1.2446047042898998,0.2204007285974499,0.7248568415810553,1.0,3/40,1.57%,PID1;SLC25A33;CCN6
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.42808422268232404,1.2444662856519155,0.19224555735056542,0.7238541840101134,1.0,21/75,11.85%,PTEN;SPRY4;PRKAR1B;NF1;IL1B;SH2B3;PKIA;SPRY2;HEXIM1;CD300A;TESK1;UCHL1;PRKAR2B;PRKAR2A;INCA1;NR2F2;LYN;PRKAR1A;LATS2;RB1;APC
prerank,response to hydroxyurea (GO:0072710),0.6031033875920742,1.244084872002346,0.25995316159250587,0.723364274592281,1.0,6/11,19.55%,KAT7;TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,positive regulation of nervous system development (GO:0051962),0.4666825466926218,1.2440603056622983,0.21554770318021202,0.7220723546443851,1.0,13/42,15.28%,CLSTN1;GPER1;NRXN1;CLSTN3;LIG4;IL1RAPL1;CUX2;SPEN;EPHB1;SLITRK2;NLGN3;SYNDIG1;FAIM
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.32280212537923786,-1.244058455966732,0.08191126279863481,0.5809557650564915,1.0,56/148,26.74%,PRKAG2;PPP1R13B;TAF1;RBBP7;BRD7;KMT5A;MAP2K6;RPS20;MAPK14;CHD3;AKT1;MEAF6;CCNG1;RPL37;EHMT1;PML;PIP4K2B;RPL11;PAK1IP1;HDAC1;PRKAG3;MDM2;ATM;PRKAB1;RPA1;RAD50;HIPK2;RPS15;TAF4B;RPL23;PRKAA2;TP53RK;PDPK1;PPP2R5C;RFC3;CHD5;TAF9B;CDK5RAP3;RFFL;TOP3A;PRKAG1;BRPF1;TAF5;USP2;RMI2;CHEK2;STK11;TTC5;BRCA1;RPA3;RRS1;L3MBTL1;TP53;HUS1;TAF11;TPX2
prerank,positive regulation of viral life cycle (GO:1903902),0.5264911128917296,1.2438658052752933,0.25101214574898784,0.7212239580269896,1.0,4/22,8.52%,TMPRSS4;AXL;CHMP2B;TMPRSS2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.46242092339386537,1.2438457524527893,0.19101123595505617,0.7199275156713167,1.0,10/39,10.61%,GCNT2;NOTCH1;AJAP1;SPRY4;CORO2B;ACTN4;AP1AR;MAP4K4;JAG1;SPOCK1
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.41323832687563367,-1.2436985449350164,0.14870689655172414,0.581121824378965,1.0,15/39,22.26%,RPS14;RPS19;RPS5;RPS16;RPS24;RPS27;MRPS7;RPS15;RPS6;RPS25;RPSA;RPS7;RIOK2;RRP7A;RPS27L
prerank,regulation of apoptotic process (GO:0042981),-0.2730236051625245,-1.2433864038146631,0.009433962264150943,0.5810376050659206,1.0,135/676,14.32%,NOTCH2;IGF1;DAB2;DAPK1;UNC13B;PAWR;FSTL1;EGFR;SMAD6;FHL2;CTSH;AKAP13;PPP1R13B;IL31RA;TIAM2;PDPN;TEK;STEAP3;FOXO1;SH3RF1;OSR1;FOXO3;ACTN2;ARHGEF3;SLIT2;ANXA4;NUPR1;ITGA6;ANXA5;MYO18A;TGM2;VAV2;STK17B;USP47;THBS1;BMP4;IL6ST;GAS1;IGF1R;RASSF2;ANGPT1;TXNDC5;FBXO10;MCF2L;ANXA1;ARHGEF2;LEF1;SOCS2;CFLAR;TRIM24;HOXA5;ADAM10;IGFBP3;ACER2;GAS6;QRICH1;NIBAN2;TNFSF10;NAA35;IAPP;RARG;ZFAND6;RNF144B;SFRP4;WNT5A;CCND2;ANO6;PTK2B;PLK2;EGLN2;CYP1B1;PTPA;STAT1;CARD14;RHOB;HSPA5;SH3RF2;TFRC;BIRC3;ANP32E;TRIO;GOLPH3;ERC1;IFIT2;ADAMTSL4;ARHGEF1;TPT1;ERCC5;SON;ANP32B;AIFM1;TIAM1;AKT1;BAG3;MCL1;CTSB;UTP11;BCL2L11;PRDX2;EGLN3;IFIT3;FLCN;ATF6;CASP8;CD38;GCLC;DAB2IP;FGD4;KDR;ARHGDIA;BNIP3L;PLEKHG5;HDAC1;NME1;RELA;ACTN1;FLT4;ATM;GATA6;CBX4;TRIM35;UBB;CALR;PPID;ARHGEF18;LRP8;SPHK1;ARHGEF19;PIM3;BNIP3;SFRP1;RPL10;PPIA;HYPK;IP6K2
prerank,negative regulation of cell migration (GO:0030336),-0.3296008070870191,-1.2433762756256705,0.07987220447284345,0.5801237674359466,1.0,28/137,7.28%,AFDN;MCC;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;COL3A1;CLIC4;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;PTPRJ;GJA1;MAGI2;SRGAP3;SRGAP2;SMAD7;CDH1;IGFBP3;PTPRG;SCAI;ACVRL1;CYP1B1;RHOB
prerank,chondrocyte differentiation (GO:0002062),-0.42449242961655304,-1.243233407801047,0.1879049676025918,0.5795726597601871,1.0,9/32,5.47%,NFIB;SULF1;OSR1;BMPR2;BMP4;CREB3L2;SLC39A14;CCN3;SULF2
prerank,cellular response to cytokine stimulus (GO:0071345),-0.28742179714188215,-1.242737639689977,0.016304347826086956,0.5798777512035618,1.0,100/416,15.89%,DAPK1;COL1A2;DPYSL3;FN1;SMAD3;ADAMTS12;LEPR;NFAT5;PTPN14;PTPN13;ST3GAL6;PTGIS;IL31RA;FOXO1;FOXO3;F3;IL1R1;IL6R;VIM;LBP;IL6ST;PTPRJ;LRCH1;GHR;ANXA1;CSF1;ARHGEF2;LEF1;SOCS2;VCAM1;GSDME;SBNO2;IL16;IRAK2;CXCL12;GAS6;ZFAND6;LGALS9;STAT2;MAOA;GREM2;IRF1;WNT5A;CCL15;TNFRSF1B;ICAM1;RHOA;FOXC1;WNK1;STAT1;STAT3;CCL14;CD47;STX3;GBP4;DUSP1;RAPGEF1;PIK3CB;AKT1;KIT;MCL1;IRGM;HIF1A;TNFRSF1A;BCL2L11;LAMA5;IFIT1;IRAK3;DAB2IP;IL18;STX1A;ZC3H12A;GBP6;GBP5;TGFB1;PTGS2;INPP5D;CCL25;GBP7;RELA;S1PR1;YBX3;FLT3LG;UBB;LRP8;CCND1;FER;OXSR1;UBE2G2;SFRP1;POU2F1;CDK9;CNTFR;IFITM2;GBP2;MMP2;SDC1;CCL13;IL10RB;CDKN1B
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5734925505566558,1.2423295953995965,0.23870967741935484,0.7222637554995167,1.0,4/12,14.03%,CASQ2;RYR2;CASQ1;ANK2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.48781084271927905,-1.2420384055339115,0.19811320754716982,0.580900863735437,1.0,4/18,4.15%,VGLL4;APOE;EZR;CTSC
prerank,leukocyte tethering or rolling (GO:0050901),0.5528567814578464,1.2415546247811207,0.2437137330754352,0.7227583669266259,1.0,3/17,5.53%,ITGA4;ROCK1;ITGB1
prerank,DNA strand elongation (GO:0022616),0.548428209695052,1.2410381505586479,0.2625250501002004,0.7226716461579247,1.0,5/18,10.98%,DCLRE1B;GINS1;GINS3;GINS4;MCM7
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5124527040851896,-1.240478781682814,0.21195652173913043,0.5843852179038407,1.0,1/14,0.08%,AUTS2
prerank,response to peptide hormone (GO:0043434),-0.39394474282308434,-1.2397696811008136,0.15242494226327943,0.5853183284323201,1.0,10/43,9.53%,TGFBR3;ROCK2;IGFBP5;CAV1;ANXA1;STAT2;STAT1;STAT3;AKT1;TRIM16
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.495424430433299,1.239684538767173,0.2237354085603113,0.7245651262853011,1.0,3/27,2.02%,CSPG4;CHST3;CHST7
prerank,regulation of intracellular signal transduction (GO:1902531),0.345946157647449,1.2392991663424513,0.09189842805320435,0.7241867110530151,1.0,75/420,12.41%,DLC1;STARD8;CHN1;PIP5K1B;PTEN;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;PRDM1;ARHGAP6;ARHGAP32;PHLPP1;ARHGEF6;LBH;ARHGAP1;PRKAR1B;SPRED1;IL1B;PTPN22;PIP4K2A;STARD13;ARAP2;RAC3;TRAF5;AKAP6;MINK1;RIT2;SYDE1;PEX5L;ROS1;PIP4K2C;NTRK2;PRKAR2B;ARHGEF12;TAOK3;ARHGEF26;SOS2;SLC15A2;TRAF3;PAK6;RAD1;STK3;ARHGDIB;MTOR;PRKAR2A;AKAP12;GNA12;ANKRD54;MAP4K4;PRKD2;ARHGEF9;LYN;ARHGAP35;PAK5;INPP5B;AKAP7;ATR;PRKAR1A;TBP;TAF6;DDIT4;KAT6A;ARHGEF7;PAK3;HIPK1;NUAK1;PAK1;EP300;ARHGEF4;WWC1;TTI1;ARHGAP9;ARHGAP26
prerank,cellular response to virus (GO:0098586),-0.4289827357377656,-1.2389440920867225,0.19098712446351931,0.5865854741747994,1.0,8/30,10.78%,GSDME;LGALS9;MAPK14;LGALS8;IRGM;HIF1A;ZC3H12A;EIF5A
prerank,regulation of histone modification (GO:0031056),-0.5303024004154978,-1.2388202519127198,0.23290203327171904,0.5859339228115873,1.0,5/13,18.14%,IGF2;FLCN;NNMT;CDK9;PARK7
prerank,activation of phospholipase C activity (GO:0007202),0.482799540551339,1.2388145745065247,0.2138728323699422,0.7239908120458267,1.0,2/29,1.07%,EDNRA;ARHGAP6
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4562778122121331,-1.2384984711664506,0.19161676646706588,0.5858827205941378,1.0,10/22,17.38%,PDGFD;RASSF2;ACE;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC
prerank,amide transport (GO:0042886),-0.451833548147702,-1.2384561207967402,0.16455696202531644,0.5850837137912709,1.0,7/26,10.88%,PDPN;PLTP;CERT1;ABCG2;SLC5A6;SLC38A5;DISP1
prerank,glycoprotein metabolic process (GO:0009100),-0.38088459790783463,-1.2381503510008731,0.15056179775280898,0.585005382635151,1.0,20/53,20.12%,ST3GAL4;LARGE1;MAN1C1;ADAMTS9;ST3GAL2;MAN2A1;ST6GALNAC3;STT3B;GOLPH3;FUT8;HIF1A;ST8SIA2;ST6GALNAC6;GCNT1;GANAB;MANBA;PARK7;GAL3ST2;NGLY1;ST8SIA5
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.3897314973314374,-1.2379096664393272,0.16930022573363432,0.5847628094847794,1.0,17/45,27.56%,APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;LPL;CCL19;EGR1;MYD88;PYDC1;FZD5
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.4637190985496482,-1.237529831555376,0.21146245059288538,0.5848298337190059,1.0,6/20,14.13%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.41829534574789345,-1.2373803275359916,0.1686746987951807,0.5843316664509587,1.0,11/33,13.57%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;STXBP4;CCND3;UBE2E2;AKT1;PLCG2;CCND1
prerank,regulation of neuron projection development (GO:0010975),0.38129484059607915,1.2366337171808812,0.14305949008498584,0.7280507603128501,1.0,36/163,11.73%,CHN1;SERPINI1;PTEN;CDH2;RAPGEF2;ROR1;RTN4RL1;PTPN9;MARK1;SCARF1;LRRC4C;PTN;ABI2;PLPPR5;ADCY6;NTNG2;ATP1B2;RIT2;MYLIP;NTRK2;CSMD3;RAP1A;FUT9;IL1RAPL1;MARK2;LYN;ARHGAP35;CTNNA2;TOX;ABL2;SPOCK1;BRSK1;PAK3;PAK1;EP300;PLXNB3
prerank,amino acid transmembrane transport (GO:0003333),0.4627454998475096,1.2362073858811806,0.19576719576719576,0.7277418560709391,1.0,1/45,0.03%,SLC38A11
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.4183476866580589,-1.2355038951912165,0.18454935622317598,0.5884954146715531,1.0,16/34,13.40%,FLT1;NRP1;SEMA6A;GAS1;ANXA1;RAMP2;VEGFD;VEGFC;MAPK14;FOXC1;DAB2IP;KDR;ERN1;RELA;FLT4;SPHK1
prerank,regulation of protein phosphorylation (GO:0001932),-0.3038585156281971,-1.235406483480727,0.04291845493562232,0.5878224562175355,1.0,67/256,14.82%,DAB2;FN1;EGFR;LEPR;CDH5;ROCK2;EPHA7;NTRK3;PTPN13;FBLN1;PLPP3;OCLN;BMP7;TEK;PECAM1;APP;SLIT2;XDH;BMP4;ANGPT1;LRRK2;LRP6;NIBAN1;VEGFD;IGFBP3;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;STAT2;BMPER;EFNA5;CCND2;CARD14;FNIP1;CCND3;TFRC;TBX1;WDFY2;AKT1;IRGM;FLCN;DAB2IP;ZC3H12A;KDR;PML;MAVS;ITGB3;TGFB1;NSD1;TMEM119;EPHB2;FLT4;CCDC88C;CCN1;TWF1;CDK2AP1;CCND1;FER;LIMCH1;NDUFS4;PPIA;FXR2;MAPK3;CORO1C
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.4985582805150153,-1.2343907209339766,0.216796875,0.5896792838022881,1.0,4/16,12.42%,ST3GAL4;NFAT5;RHOA;RELA
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.45136990885913175,-1.2343010617948296,0.18930041152263374,0.5889817879632526,1.0,3/23,3.49%,ERRFI1;CAV1;SNX6
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.40991505186152244,-1.234092132499543,0.17745302713987474,0.5886047696014283,1.0,10/36,16.31%,MECOM;FOXO1;DLG1;EZR;SH3RF2;DUSP1;QARS1;PPIA;DUSP10;SIRPA
prerank,regulation of lamellipodium organization (GO:1902743),0.551014155562297,1.2331940212325823,0.24898785425101214,0.7338417009673418,1.0,2/14,2.30%,CARMIL1;WAS
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.41614294303125987,-1.2331559961245675,0.1608695652173913,0.5901991250493549,1.0,13/37,16.89%,PRKAG2;CEMIP;BMP7;APP;SMAD7;CALM2;PARD3;IRGM;TGFB1;PPEF2;SPHK1;CALM1;SIRT2
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.43170631360065276,1.2323997802666224,0.19387755102040816,0.7344942483864022,1.0,7/67,3.88%,CARMIL1;UTRN;LIMS1;ECM2;CDK6;FERMT2;RAC3
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.4741282548056875,1.2322876486799146,0.24403669724770644,0.7334410821806264,1.0,9/33,11.85%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,defense response to virus (GO:0051607),0.40541779324754246,1.2321053772175568,0.1926040061633282,0.732528552717116,1.0,1/100,0.01%,ABCC9
prerank,mucosal immune response (GO:0002385),0.5424632764359112,1.2318040847593068,0.25732217573221755,0.7319379613447721,1.0,3/15,6.03%,FFAR2;CAMP;IL4
prerank,fatty acid elongation (GO:0030497),-0.5165253795223627,-1.2312550262586295,0.21095334685598377,0.594516991758879,1.0,3/13,5.61%,ELOVL7;HACD4;HACD3
prerank,regulation of cell-matrix adhesion (GO:0001952),0.42577694183244075,1.2304138173437384,0.1969178082191781,0.73402203625311,1.0,9/64,4.29%,UTRN;CDK6;AJAP1;PTK2;VCL;PEAK1;ROCK1;NF1;MINK1
prerank,clathrin-dependent endocytosis (GO:0072583),0.5004831399000993,1.2303982142528676,0.23735408560311283,0.7327522158770131,1.0,1/26,0.11%,SGIP1
prerank,negative regulation of cell development (GO:0010721),-0.4387072735578574,-1.2291738179386065,0.17364016736401675,0.5993140373500906,1.0,4/25,5.51%,IGF1;FBN1;B2M;APPL2
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5993329609886912,1.2290664332074204,0.2769556025369979,0.7346316491360045,1.0,2/10,1.19%,FAP;NOTCH1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.4269241913409094,-1.2289806247297292,0.2052313883299799,0.5989354658667824,1.0,6/27,6.75%,IGF1;FN1;PDGFRA;GAS6;WNT5A;S100A6
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.25727714619373376,-1.2287168996517273,0.0,0.5987212338132362,1.0,372/1667,18.25%,NFIB;AUTS2;BMP6;TSHZ2;FOXP2;PRDM6;IGF1;DAB2;ZMIZ1;PBX1;PKNOX2;MAF;AEBP1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;SMAD6;DCN;NFAT5;KDM7A;FOXP1;ZKSCAN2;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;CREB5;ZFHX4;CDK8;RHOQ;LCOR;SP100;TGFA;GLIS3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;APOE;OSR1;KLF3;SKIL;FOXO3;APP;ZIC2;NFIA;NR3C1;DLG1;HDAC8;KAT6B;HIVEP3;CAV1;ANXA4;ERG;ITGA6;HOXB3;RARB;MLXIP;SUFU;ESR1;FGFR2;ZIC5;BMPR2;SMURF2;VGLL3;ELF1;BMP4;MAFG;ELF4;MEOX2;ZBTB7C;EZR;PRRX2;RPS14;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;DDX5;KAT2B;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;LEF1;ACVR1;KLF2;ETV6;TAF1;ID1;HDAC9;SBNO2;THRB;MXI1;HOXA5;ZHX3;CREB3L2;SKI;ZNF23;SP140;PCGF5;SDCBP;ZFPM2;PARP9;DCAF6;IGF2;GATAD2A;HDGFL3;MED26;SSBP2;ARRB1;HOXA3;GTF2IRD1;TEAD4;ARNT2;WWP2;AR;FGF1;BRD7;RARG;CREM;YAP1;STAT2;FOXP4;TMF1;HIF3A;PRRX1;MOV10;GLIS2;SOX13;THRAP3;BHLHE40;KMT5A;ACVRL1;ATXN1;IRF1;TEAD1;MIDEAS;SIX1;WNT5A;BAZ1A;ATN1;INO80;ZNF292;PRKCB;HLF;KDM5B;HOXC6;TET3;PRDM16;MAPK14;ID3;FOXC1;IRF2;GLIS1;LMO2;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;IFRD1;PGR;IFI27;BAZ1B;KLF10;ZNF219;TBX1;RTF1;SSBP3;ZBTB8A;TFCP2;IRF9;ZBTB18;FIZ1;BAZ2B;BBS7;KIT;FOXL1;LHX6;RREB1;IL33;HIF1A;TADA1;TNFRSF1A;MKX;RCOR3;TWIST2;TADA2A;NLRC5;FOXK1;CDH13;NR4A2;FLCN;ATF6;BHLHE41;FOSL2;PHF10;IKZF1;DAB2IP;HOXB9;TFCP2L1;IL18;ZC3H12A;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;FHOD1;ZFHX2;EIF5A;KLF12;TRIM27;SIX5;MAVS;MDFI;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;KDM3A;GLI3;FOXQ1;TGFB1;NSD1;ELK3;MED27;PTCH1;ZMYM5;BCL9L;AHR;HDAC1;LRRFIP1;ZSCAN22;ATXN7L3;MDM2;ZIC3;RELA;CPEB3;PPARA;CHD2;ID2;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;CBX4;SP110;UBB;CALR;ATOH8;ZGPAT;PPID;CLOCK;LPIN3;MET;MEIS2;ZNF585A;ZNF585B;EZH1;CCND1;MPND;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;TOX4;RPL10;CREB3L1;SMARCC1;ENO1;SLTM;POU2F1;MAZ;ZBTB4;MAPK3;HOXC4;TTC21B;PKD1;HOXB5;CDK9;HOXB7;HIPK2;PCGF3;BEND3;NKX6-1;SNAI1;ZFPM1;CREB3;YEATS2;JUND;RPL23;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;HHEX;MEIS1;HMGB2;SOX18;KDM6B;PHF21A;HCFC2;MNT;TLR4;RNASEL;USF2;ZMIZ2;ZFP69;TNRC6A;ZNF436;SIRT7;JUNB;SIRT2;ATF1;TSHZ1;MED21;RIPK1;FBXL19;PTOV1;NFIL3;PSIP1;RAI1;TPR;SLC9A1;NFKBIA;NFYB;ZFP14;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;CC2D1A;CEBPB;KLF15;PARK7;CIR1;ELP3
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.38945957973256545,-1.228091513685727,0.1654501216545012,0.5995516166559828,1.0,15/47,19.00%,APOE;FOXO3;APP;KLF4;CSF1;AKT1;ATXN2;VPS35;TGFB1;TCOF1;RPL10;GEMIN5;NFKBIA;AGT;AGTR1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5442570753338645,-1.2254219540239122,0.22735674676524953,0.6059809636341436,1.0,5/11,16.17%,NOS3;AKT1;GCH1;PTS;CALM1
prerank,positive regulation of GTPase activity (GO:0043547),0.36823251340050245,1.224158946202207,0.16194331983805668,0.7453612377875818,1.0,35/188,10.04%,ARHGAP42;RGS6;TBC1D1;LIMS1;DOCK10;RAPGEF2;RASGRP2;FERMT2;SIPA1;NF1;PLXNB1;SH3BP1;GRTP1;GARNL3;AGRN;TBC1D30;SLC27A4;SYDE1;MAPRE2;ITGB1;TBC1D12;RIC1;ARHGEF26;RAP1A;RUNDC1;HRAS;RGS7;RALGAPA1;TBC1D2B;RAB11FIP2;MTSS2;MAP4K4;TBC1D10C;EPHA2;RGS10
prerank,cristae formation (GO:0042407),-0.4354426808272329,-1.2241294601296258,0.1898989898989899,0.6087216534785183,1.0,10/27,16.08%,ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;AFG3L2
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.4358384672678895,1.2235996727358507,0.20905923344947736,0.7453714560815141,1.0,15/59,15.83%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;LIPH;LIPC;SRR;GATM;OSBPL7;GAMT;HSD3B7;MLYCD;ACOX2
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.43783095979709813,-1.2232313597942364,0.1949685534591195,0.610191584077868,1.0,8/26,19.03%,IGF1;FHL2;LMCD1;PLCG2;HOMER3;SLC9A1;EFHB;CHP1
prerank,regulation of myoblast fusion (GO:1901739),-0.5360112886146317,-1.223207756444916,0.21923076923076923,0.6093157169569473,1.0,4/11,15.60%,CFLAR;MAPK14;EHD1;EHD2
prerank,regulation of T cell mediated immunity (GO:0002709),0.5825483875472133,1.222933661574546,0.2588495575221239,0.7456743061166541,1.0,2/10,2.62%,WAS;IL1B
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.3256081910353575,-1.222630737035159,0.1188118811881188,0.6099354992590179,1.0,31/129,16.27%,RNF220;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;FGFR2;SMURF2;USP47;RNF146;LRRK2;TNKS2;LYPD6;SFRP4;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;PSMB4;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;GSKIP;PSME3;HHEX;PLEKHA4
prerank,peptidyl-methionine modification (GO:0018206),0.5679858051757805,1.2219296061200402,0.26229508196721313,0.7468268149940795,1.0,4/12,18.38%,METAP2;NAA30;NAA15;METAP1
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5487096898545804,-1.221872716866666,0.236983842010772,0.6110010647586042,1.0,4/10,16.54%,NAMPT;IL33;KDR;TLR4
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4820177781992399,1.2215732920978233,0.23484848484848486,0.7462831589548691,1.0,2/29,1.77%,MBOAT2;NR1H3
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5396291981373897,1.221396575546493,0.26875,0.745429557489976,1.0,3/17,1.19%,HEY2;HEYL;NOTCH1
prerank,calcium ion import into cytosol (GO:1902656),0.5388263475236235,1.221089088780701,0.25918367346938775,0.7448121056414421,1.0,3/15,4.63%,TRPV2;CACNA2D1;SLC24A2
prerank,cellular response to osmotic stress (GO:0071470),0.5250715513415943,1.2210498160730903,0.24708171206225682,0.7436167349592154,1.0,6/21,9.02%,MYLK;RCSD1;STK39;SCN2A;DDX3X;PKD2
prerank,excitatory postsynaptic potential (GO:0060079),0.5296442486599414,1.2210052910589868,0.2545454545454545,0.7423906184503195,1.0,3/19,3.41%,MEF2C;MPP2;CHRNA3
prerank,negative regulation of cell motility (GO:2000146),-0.33523845587678663,-1.2209233378086062,0.12716763005780346,0.6127251862132439,1.0,28/108,9.91%,AFDN;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;CLIC4;FBLN1;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;PTPRJ;MAGI2;SRGAP3;SRGAP2;SMAD7;CDH1;SCAI;ACVRL1;CYP1B1;RHOB;CCDC125;ADAM15;ZMYND8;FLCN
prerank,regulation of protein kinase B signaling (GO:0051896),0.36609513952110706,1.2208482668898908,0.14789687924016282,0.7414483587809246,1.0,20/193,5.97%,PDGFRB;PTEN;PIK3CD;GAB1;GCNT2;PHLPP1;PTK2;PIK3R1;SEMA5A;GPER1;FERMT2;ERBB4;NRG1;PIK3CA;SH2B3;AXL;FGF2;SPRY2;ITGB1;NTRK2
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5571445288344484,-1.220347375826355,0.21973929236499068,0.6135028980123505,1.0,3/10,8.86%,APOD;PTPRJ;HGS
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.49400837077524157,-1.2203337094460291,0.23243243243243245,0.6125958611908476,1.0,5/15,9.53%,PRKCH;BMP4;SFRP4;FOXC1;TRIM16
prerank,epithelium development (GO:0060429),-0.334470773636161,-1.220031404107657,0.1282798833819242,0.6124504415913119,1.0,27/107,16.15%,ALDH1A2;ERRFI1;WNT4;OSR1;ANXA4;FGFR2;MEOX2;CPT1A;CD34;SMO;RCN3;CNN3;SIX1;STAT1;TBX1;CTSB;KDR;ANXA7;TGFB1;PTCH1;GATA6;MFSD2A;SOX17;BDH2;PKD1;CASP6;SOX18
prerank,positive regulation of synaptic transmission (GO:0050806),0.4184940906237297,1.2193853533122385,0.20764119601328904,0.7436561799377303,1.0,19/72,11.13%,CLSTN1;GPER1;MPP2;NRXN1;CACNG7;NMU;ADCY8;RIMS1;CLSTN3;SLC24A2;RIMS2;CHRNA7;SYT1;KCTD13;NFATC4;ZDHHC2;GRIN2B;BAIAP3;STX4
prerank,synaptic membrane adhesion (GO:0099560),0.5627085969422462,1.2189119433310498,0.2599118942731278,0.7436138493088699,1.0,4/14,12.82%,LRRC4C;LRFN5;SLITRK1;SLITRK2
prerank,organic substance transport (GO:0071702),-0.3274853715758496,-1.2178811369657185,0.1352112676056338,0.6174041406451178,1.0,27/121,13.15%,ABCA1;SLC47A1;SLCO2B1;PLTP;SLCO2A1;CALCRL;ABCG2;ABCA9;RAMP2;SLC22A6;RCN3;TXNIP;SLC22A4;ABCA3;ABCA4;TOM1;CUBN;SPNS2;SLC50A1;SLC22A5;ARRDC1;DISP1;RAB7A;SLC35F3;ATP8A1;SLC22A18;MFSD2A
prerank,negative regulation of innate immune response (GO:0045824),-0.41397378625478676,-1.2174900571855614,0.19959266802443992,0.617581886884652,1.0,9/34,10.16%,SERPING1;CNOT7;STAT2;RPS19;USP15;USP18;NLRC5;IRAK3;SAMHD1
prerank,regulation of ion transport (GO:0043269),0.4116000221586402,1.217445093917485,0.2180327868852459,0.7458732293249425,1.0,15/76,11.38%,KCNJ8;NEDD4L;KCNJ12;CLDN10;CHRNA3;NKAIN2;ANK3;SNCA;SIK1;STC1;PDZK1;SYT1;KCNJ3;KCNJ6;SYT2
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5764594267023337,1.2165825203447687,0.2693156732891832,0.7467480308667979,1.0,2/10,3.58%,PRKG1;SH2B3
prerank,regulation of cholesterol storage (GO:0010885),0.5524176708486134,1.2163824990540795,0.2601626016260163,0.745985841110101,1.0,5/15,5.46%,NR1H3;SCARB1;PPARD;SREBF2;MSR1
prerank,negative regulation of peptidase activity (GO:0010466),0.4474093099172212,1.2158512937330683,0.2314487632508834,0.7459758543186316,1.0,3/47,1.04%,SERPINI1;SERPINB8;VTN
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.41509881323618,-1.2156097401455366,0.20169851380042464,0.6219906555001764,1.0,8/29,15.72%,JAM2;CXCL12;GAS6;LGALS9;ANO6;CALR;CREB3;SERPINE1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.464049582661125,1.2155617082263497,0.24714828897338403,0.7454263137162457,1.0,6/34,7.08%,PDE4D;SCN5A;PDE4B;RYR2;ATP2A2;STC1
prerank,sodium ion import across plasma membrane (GO:0098719),0.526588897078793,1.2147192856619624,0.25481798715203424,0.7461125681940385,1.0,4/17,8.33%,SLC12A2;SLC5A1;HCN2;SLC9A7
prerank,positive regulation of DNA repair (GO:0045739),-0.3915827587354569,-1.21451980674611,0.17713004484304934,0.6241696783886522,1.0,4/46,3.02%,EYA2;EYA1;EGFR;EYA4
prerank,positive regulation of macrophage migration (GO:1905523),0.525477911458236,1.2144828203163296,0.26411290322580644,0.7453114898402948,1.0,2/19,1.34%,IL34;PTK2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5049605704342836,-1.2144329594527956,0.23541247484909456,0.6234702906749937,1.0,3/13,5.61%,ELOVL7;HACD4;HACD3
prerank,regulation of cell population proliferation (GO:0042127),0.32724661336021915,1.2136926997808861,0.07457627118644068,0.7459627818488859,1.0,63/691,7.20%,DLC1;PTPRK;ITGA1;PDGFRB;ACE2;PTEN;TBX2;IL34;S1PR3;LIMS1;GLMN;RERG;CBFA2T3;IGFBP7;RAPGEF2;GCNT2;CDK6;BMP5;NOTCH1;COL4A3;SLC25A33;PTK2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;TNS2;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;CADM4;TBX6;ETS1;MECP2;SH2B3;MYO16;PDCD10;FGF2;SPDYA;RPS6KA2;GAS8;TSPAN31;FABP3;TNFRSF8;TFAP2B;CXCR2;CXCL10;NTRK2;NUPR2;IL4;CXCL5;AGO3;SOX4;CHRNA7;EMP2;CDCA7;HRAS;IRS1
prerank,regulation of macrophage activation (GO:0043030),-0.4308370657008961,-1.2131383367292785,0.2153209109730849,0.6261410788059449,1.0,12/30,16.54%,IL31RA;LBP;MYO18A;THBS1;WNT5A;MFHAS1;IL33;KARS1;ZC3H12A;SPHK1;CD200;TLR4
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.43087596232051784,-1.2130727307227143,0.1991701244813278,0.6254049881385473,1.0,10/26,24.17%,PRKAG2;ADIPOR2;LPGAT1;ACADL;PRKAA2;CEACAM1;ERLIN2;ADIPOR1;SLC45A3;BRCA1
prerank,positive regulation of DNA replication (GO:0045740),-0.49537641456569725,-1.2130045558543716,0.23756906077348067,0.6246234375489541,1.0,2/16,1.10%,EGFR;GLI2
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.38877702655781243,-1.2128579887235036,0.19909502262443438,0.6240398782808982,1.0,10/42,16.54%,IL6R;LBP;RPS19;IRGM;GSDMD;OPTN;SERPINE1;HMGB2;MR1;TLR4
prerank,chromatin organization (GO:0006325),-0.3186720400550858,-1.2127089784154985,0.11641791044776119,0.6235124396786759,1.0,33/132,20.44%,SMARCA2;MECOM;HDAC4;HDAC8;ESR1;SETD7;KAT2B;BAZ1A;INO80;KDM5B;PRDM16;BPTF;BAZ1B;BAZ2B;TADA2A;EHMT1;JARID2;HDAC1;EZH1;MPND;HDAC5;SMARCC1;SNAI1;HMGB2;KDM6B;HCFC2;HMGN1;EZH2;SMARCAD1;SETDB1;HP1BP3;RSF1;MCM3AP
prerank,glucan catabolic process (GO:0009251),-0.49283264429896084,-1.2127014765077009,0.23809523809523808,0.6225863782361102,1.0,7/15,26.97%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL
prerank,wound healing (GO:0042060),-0.36653856112075434,-1.2125350501262717,0.1473429951690821,0.6220830538961304,1.0,15/62,11.21%,IGF1;COL3A1;SMAD3;MYOF;PDGFRA;MACF1;TGFBR1;PLEC;CFLAR;FGF1;WNT5A;PRCP;FZD7;PPL;ITGB3
prerank,limb development (GO:0060173),-0.427006514559358,-1.2125274129746113,0.1961206896551724,0.6211737845173442,1.0,9/28,11.87%,SMOC1;CHD7;PCSK5;KAT2B;RSPO2;INTU;ZNRF3;GLI3;PTCH1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5335351758008303,-1.2124148880569054,0.2504638218923933,0.6204900976269164,1.0,5/11,22.11%,P2RX7;TMEM119;SFRP1;GPR137;UBASH3B
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3563892085859814,-1.2123691899209557,0.16062176165803108,0.6197039605833258,1.0,22/67,14.89%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;PDGFRA;TEK;IL15;FGFR2;IGF1R;GHR;DDR1;PTK2B;KIT;BMX;KDR;FGFR4;EPHB2;FLT4;FER;MAPK3;PKDCC
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5001704370532506,-1.212190929280347,0.2199630314232902,0.6192820546874874,1.0,3/14,10.09%,THBS1;CMKLR1;IRAK3
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.49290985811432186,-1.2119146248944226,0.22417153996101363,0.6190933350346857,1.0,4/14,6.71%,SEC23A;SEC24D;SEC31A;SEC24A
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5466473657541954,1.2117777597592043,0.25732217573221755,0.7493953097791618,1.0,3/14,3.06%,PIK3CD;GAB1;PIK3CA
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5724082749955923,1.2117140327707179,0.2484472049689441,0.7482304025795292,1.0,7/11,26.81%,MSH3;TIMELESS;BLM;FBXO5;TIPIN;FBH1;SMARCAL1
prerank,gene expression (GO:0010467),-0.28323748980770436,-1.2116726778728548,0.05699481865284974,0.6188464493422048,1.0,126/348,26.69%,CELF2;TSPAN5;RBMS2;RPLP1;RPS14;THRB;RPL9;RPS12;ATXN1;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;GOLPH3;RPS11;POLR2A;RPL13;SMG6;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;NR4A2;MMS19;RPL37;NXF1;RPL11;RPS18;PWP1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;POLR2F;NOVA1;MEF2A;RPL28;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;DTX1;MRPL52;DNAJB11;RPL10A;MRPL24;AGFG1;NUP98;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;HHEX;RPL31;RNASEL;SRSF2;SMG5;RPS25;POLR2E;SNRNP40;TPR;RPL15;RPSA;RPS7;SRSF6;RPL38;RPLP0;RPL27;E2F1;NUP88;THOC1;RRBP1;UPF2;RPL36A;MCM3AP;NUP214;THAP1;HNRNPL;DEDD2;RPS26;SRSF5;RPL35A;FIP1L1;NXT1;NUP37;THOC7;FARSB;RPS29;DHX8;RPL8;RPL36;POLR2G;MRPL35;ALKBH5;SRSF11;PPP5C;RPS3;RRAGC;HNRNPF;RPL13A;NUP155;EPC1;ABCF1;DDX54;ASMT;TSPAN33;MRPL34
prerank,positive regulation of receptor internalization (GO:0002092),-0.44870691280081865,-1.2115603179123704,0.21325051759834368,0.6182249812689561,1.0,5/22,7.39%,ANGPT1;MAGI2;ARRB1;SFRP4;SCYL2
prerank,protein localization to plasma membrane (GO:0072659),-0.3231983988373754,-1.2112060907325584,0.11858974358974358,0.6183264505305212,1.0,28/129,12.07%,TSPAN5;AFDN;ROCK2;ATP1B3;TTC7B;ACTN2;DLG1;FYB1;BSG;EZR;FCHO2;RAB11A;LRP6;CDH1;EFR3B;RAMP2;GAS6;SMURF1;S100A10;EHD1;TNFRSF1A;KCNB1;C2CD5;FLOT2;SLMAP;RAB8A;PTCH1;F11R
prerank,response to estradiol (GO:0032355),0.4825360503553549,1.2109011472899276,0.26011560693641617,0.7488809960501572,1.0,4/31,3.87%,GGT5;GGT1;GPER1;NCOA3
prerank,cellular response to light stimulus (GO:0071482),0.4203394886976163,1.2105444813502202,0.21934369602763384,0.7484911407732673,1.0,15/66,17.97%,PTPRK;OPN1MW;OPN1MW3;CASP9;ERCC4;ATR;EP300;RRH;OPN3;PDE6A;DHX36;PARP1;FMR1;RHNO1;SAG
prerank,regulation of mitochondrial translation (GO:0070129),0.5194976341950834,1.2105004412576794,0.2627450980392157,0.7473060005967673,1.0,11/21,21.14%,FASTKD2;MRPS27;NSUN3;MALSU1;FASTKD3;MTG2;TRMT10C;RMND1;C1QBP;ALKBH1;TSFM
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4897600731928386,-1.2101164023712419,0.22326454033771106,0.620355421277803,1.0,4/15,15.71%,SMAD7;IRAK3;TGFB1;HFE
prerank,engulfment of apoptotic cell (GO:0043652),-0.49508259208816385,-1.2099703718721186,0.24478178368121442,0.6198545826126656,1.0,5/15,22.19%,RHOBTB1;THBS1;MEGF10;RHOH;RHOBTB2
prerank,cellular protein-containing complex assembly (GO:0034622),0.36894842486577306,1.2098733782348094,0.1819526627218935,0.7475996558985657,1.0,13/160,7.30%,SGIP1;CASQ2;DMD;HIGD1B;NCK2;IMMP2L;NRG1;CHRNA3;PSMG3;CENPW;SNCA;PIK3C2A;BIN1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.28870061580972284,-1.2096986481837093,0.054945054945054944,0.6197183286261319,1.0,80/348,14.86%,PRKAG2;BMP6;IGF1;DAB2;PDGFD;EGFR;LEPR;ROCK2;NRP1;NTRK3;CEMIP;BMP7;TEK;IQGAP1;PECAM1;APP;IL15;CAV1;IL6R;BMPR2;BMP4;ITGA5;PTPRJ;SNX9;TGFBR1;RASSF2;ANGPT1;LRRK2;GHR;CSF1;ARHGEF2;ACVR1;NIBAN1;VEGFD;SDCBP;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;ACVRL1;TOM1L1;EFNA5;CCND2;PTK2B;CARD14;CALM2;FNIP1;CCND3;TFRC;ALS2;TBX1;WDFY2;TAOK2;AKT1;IRGM;FLCN;KDR;AKAP9;MAVS;ITGB3;TGFB1;TMEM119;TWSG1;FLT4;CCN1;CDK2AP1;LRP8;PLCG2;SPHK1;CCND1;TXN;LIMCH1;PPIA;HSP90AB1;FXR2;MAPK3;RAD50;CDK9
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.49249692917299775,-1.209195804707352,0.22709923664122136,0.6201845197150538,1.0,4/15,8.36%,DAB2;BMP2K;SCYL2;PIK3CB
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5033402956416062,-1.2089730523997613,0.25992063492063494,0.6198223352683058,1.0,3/14,11.54%,DDX60;USP15;PUM1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.4317852190252605,1.2083163977803728,0.21403508771929824,0.7499702781996519,1.0,17/60,15.03%,PTEN;HEY2;MECP2;MED10;MED13;AGO3;CDKN1A;CCNC;RUNX2;MED1;TNRC6C;MED20;TNRC6B;MED4;ATF7IP;DHX36;MED6
prerank,negative regulation of endopeptidase activity (GO:0010951),0.44367454983165827,1.208268577316363,0.25945017182130586,0.7488056392814644,1.0,9/47,10.61%,SERPINI1;SERPINB8;VTN;SERPINA10;BIN1;PCID2;SPOCK3;SERPINA2;SPOCK1
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.4003067776275088,-1.2079005967472907,0.18859649122807018,0.6219683719780383,1.0,13/37,27.01%,APOE;RIN3;SDCBP;ATXN2;OPTN;ITGB3;SIRT2;MT3;ANKRD13D;BRCA1;ANKRD13A;PRKN;EDNRB
prerank,positive regulation of cell division (GO:0051781),-0.40057400329424364,-1.206623812263743,0.20279720279720279,0.624541856474181,1.0,8/38,10.29%,PKP4;FGFR2;CDC14A;FGF1;PRKCE;RHOA;SVIL;SPAST
prerank,glycoprotein biosynthetic process (GO:0009101),-0.350078249820523,-1.2064200159777645,0.16101694915254236,0.6241665743967717,1.0,16/79,10.55%,IGF1;CHST11;ST3GAL4;LARGE1;ST3GAL6;BMPR2;ST3GAL2;CSGALNACT1;ST3GAL3;GOLPH3;MGAT1;ST6GALNAC2;FOXL1;B3GALNT1;SERP2;ST8SIA2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.5710533590163696,1.2062017429670164,0.25116279069767444,0.7525885924663758,1.0,4/10,10.38%,DGKH;GAP43;PRKD3;DGKD
prerank,histone deubiquitination (GO:0016578),-0.4662147541706241,-1.206090518697608,0.2326923076923077,0.6241852968046151,1.0,6/18,20.82%,USP15;TRRAP;ATXN7L3;USP49;USP22;USP36
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4795111781663478,-1.206084841000015,0.24489795918367346,0.6232709705759238,1.0,1/16,0.08%,AUTS2
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5295832189407551,1.2060813291859918,0.26666666666666666,0.7515967540659789,1.0,3/18,5.53%,ITGA4;ROCK1;ITGB1
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36299251252747317,-1.2057299778557464,0.1561712846347607,0.6232679113424388,1.0,10/59,5.06%,SDK1;ROBO1;HMCN1;PECAM1;BSG;PTPRM;MPZL2;CDH1;SDK2;PALLD
prerank,protein deacetylation (GO:0006476),-0.39713194077693487,-1.2051903416253766,0.17848970251716248,0.6238631159434485,1.0,14/41,21.43%,HDAC4;TBL1XR1;HDAC7;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3;MORF4L2;SIN3A
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5145507047079896,1.205124621903788,0.2740899357601713,0.7525878559174822,1.0,4/17,2.62%,S1PR3;VCL;ROCK1;IL1B
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.4911819766813451,-1.2048752356820038,0.23583180987202926,0.6238165276013088,1.0,9/14,29.65%,SUFU;TMSB4X;MDFI;PKD1;NFKBIA;PSMD10;G3BP2;NFKBIE;KEAP1
prerank,mitotic DNA replication (GO:1902969),0.5725592294414804,1.2047637694567108,0.28870292887029286,0.7521282196222382,1.0,4/10,10.98%,GINS1;GINS3;MCM6;MCM2
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4723005590062368,1.2046432597464252,0.24208566108007448,0.7511422445120209,1.0,15/35,18.08%,PCDHB11;ATP2C1;CDH8;CDH22;CDH20;CDH19;CDH7;CDH10;CDH18;CDH12;PCDHB16;PCDHGB4;CDH6;PCDHGC3;DCHS1
prerank,peptide biosynthetic process (GO:0043043),-0.31181722646803517,-1.2044110248811077,0.10638297872340426,0.6242125367024769,1.0,63/153,19.06%,PCSK5;RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;RPS11;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;MRPL52;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;CARNS1;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;GGT7
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5728448050923791,1.2041933468895338,0.28421052631578947,0.7509531873742514,1.0,3/10,5.21%,PID1;IL1B;GRB10
prerank,regulation of protein dephosphorylation (GO:0035304),0.4606852407424082,1.2041753671132729,0.23948811700182815,0.7497171110808446,1.0,1/37,0.07%,DLC1
prerank,negative regulation of cellular process (GO:0048523),0.3278962140012993,1.2040339023279452,0.11316397228637413,0.748799452430524,1.0,49/521,6.56%,DLC1;PTPRK;ITGA1;PTEN;GLMN;RERG;CBFA2T3;APBB2;IGFBP7;RAPGEF2;TNFRSF21;CDK6;DYSF;BMP5;NOTCH1;COL4A3;NCK2;SEMA5A;RGCC;CCN6;GPER1;NR1H3;SLIT3;FRK;MYH9;TNS2;FERMT2;SIPA1;SPEF1;FOXM1;ERBB4;IL1B;PLXNB1;ETS1;CRLF3;SH2B3;MYO16;FGF2;RPS6KA2;BRINP1;GAS8;FABP3;TNFRSF8;TFAP2B;NUPR2;CBLL1;DDX3X;CAPRIN2;SOX4
prerank,negative regulation of signaling receptor activity (GO:2000272),0.4962359905073792,1.2036581499789976,0.2718631178707224,0.7485244034159998,1.0,3/25,5.24%,ACE2;CNRIP1;SOCS5
prerank,epidermis development (GO:0008544),-0.36107596811578146,-1.203385058482703,0.17123287671232876,0.6260539201291656,1.0,20/56,23.46%,SVEP1;CCN2;FGFR2;EMP1;CRABP2;FLOT2;LAMA3;HDAC1;GATA6;ALDH3A2;PTHLH;UGCG;PLOD1;LAMC2;FABP5;EDA2R;KRTDAP;GLI1;EDAR;DSP
prerank,negative regulation of protein processing (GO:0010955),-0.5204586411716834,-1.2033334582831505,0.24436090225563908,0.6252576179108145,1.0,6/12,19.73%,THBS1;GAS1;LRRK2;SERPINE1;TMEM59;SERPINE2
prerank,regulation of cytokinesis (GO:0032465),-0.34653866498886426,-1.2033248112616641,0.15168539325842698,0.6243722689052945,1.0,18/78,16.17%,PKP4;RAB11A;KIF13A;CDC14A;PRKCE;RHOA;PLK2;CALM2;ZFYVE19;BECN1;SVIL;FLCN;SPAST;SH3GLB1;GIT1;UVRAG;MYO19;CALM1
prerank,protein-containing complex assembly (GO:0065003),-0.28841700321234004,-1.2032071896462684,0.05150214592274678,0.6237615742473825,1.0,66/259,16.08%,AFDN;FBXL7;FN1;OCLN;TGFA;CD2AP;MCU;SEC23A;SEC24D;SLC2A1;SNX9;TCF7L2;TLE4;LRRK2;LEF1;CTSC;SEC31A;ADAM10;CXCL12;TAPBP;REPS2;TRAPPC10;YAP1;TEAD1;ANO6;SEC24A;PTK2B;PLEKHA7;TRRAP;TIAM1;PARD3;TLE2;TNFRSF1A;TLE1;CARD10;CASP8;USO1;SEC16B;GSDMD;ZC3H12A;COL16A1;PML;P2RX7;LMAN1;GPAA1;BCL9L;HDAC1;TRAPPC4;MDM2;TRAPPC3;PPID;SKAP2;SPG7;ZW10;ELOB;F5;GEMIN5;ANKRD28;MCFD2;CLDN1;PYGO2;CAPZA2;HFE;SEC23IP;NAPA;AFG3L2
prerank,glycine transport (GO:0015816),-0.5439703473716606,-1.2029504168769156,0.2413127413127413,0.6235414684392819,1.0,4/10,20.15%,SLC6A9;SLC25A38;SLC38A5;SLC36A1
prerank,establishment of melanosome localization (GO:0032401),-0.4708977190105749,-1.2029088587185082,0.21686746987951808,0.6227680559497161,1.0,7/19,20.78%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,regulation of signal transduction (GO:0009966),0.36006548823473,1.202664901203793,0.17553956834532375,0.7497404288261809,1.0,18/190,5.31%,RGS5;RGS4;RGS6;PLCE1;IGFBP7;RORA;NCK2;SEMA5A;RGS3;TSPAN15;CD46;GRK3;RGS11;IFT81;TSPAN12;SREBF2;SOCS5;OGT
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.4550828432565059,-1.2025002950904244,0.23017408123791103,0.622091285082846,1.0,6/20,15.20%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,glutathione derivative metabolic process (GO:1901685),-0.4550828432565059,-1.2025002950904244,0.23017408123791103,0.622091285082846,1.0,6/20,15.20%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,renal absorption (GO:0070293),-0.5371477483604827,-1.2024313254925991,0.25889328063241107,0.6213766964134841,1.0,3/10,10.37%,GSN;WNK4;KCNQ1
prerank,dorsal/ventral pattern formation (GO:0009953),-0.4380689666918768,-1.2021168259989683,0.2231237322515213,0.6213360505732224,1.0,8/20,15.76%,GLI2;ACVR1;ACVRL1;NBL1;MDFI;PTCH1;SFRP1;BMPR1A
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5594354737644808,1.2019783887772812,0.2968421052631579,0.7501232019332243,1.0,1/13,0.21%,CSPG4
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.48733467416481674,1.201670315823398,0.2803921568627451,0.7496105978889082,1.0,8/28,7.20%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,positive regulation of protein binding (GO:0032092),-0.364143340306253,-1.201530277756509,0.1619718309859155,0.6220712643264942,1.0,20/56,15.71%,APOE;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;RPL11;ADD1;RAN;PKD1;HIPK2;HFE
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5210266259878557,-1.2012047101309251,0.22445255474452555,0.6220442301212501,1.0,8/12,39.18%,RAB27A;CYBA;PLCG2;TLR4;CD36;TLR6;ZNF205;SLC5A3
prerank,heart trabecula morphogenesis (GO:0061384),-0.47457690760276744,-1.2010513282492448,0.24236252545824846,0.6215830769380112,1.0,7/18,7.21%,TGFBR3;BMP7;TEK;ADGRG6;RBP4;TGFBR1;FKBP1A
prerank,metal ion export (GO:0070839),0.46826942718203257,1.2010460650676662,0.2320754716981132,0.7498598435564104,1.0,7/31,7.70%,ATP1A2;ATP1A4;FXYD2;KCNE4;ATP7A;ATP1B2;KCNE5
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4320618384459548,-1.200685250960347,0.22264875239923224,0.6216403238033589,1.0,7/25,20.49%,APP;RIN3;SDCBP;ATXN2;ITGB3;NEU3;ANKRD13D
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.33929020998820164,-1.200555940066478,0.14246575342465753,0.6210688236819271,1.0,24/88,20.55%,DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;CST3;IGF2BP2;ATRAID;AKT1;DAB2IP;CPEB3;CALR;LARP1;CNOT8;RGP1;FXR2;CLN8;PAIP2B;EIF4E2;TYMS;SERPINE2;CDK5RAP3
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.4523093684877931,-1.2000812753609442,0.2379110251450677,0.6215253496945669,1.0,6/20,18.52%,IGF1;NIBAN2;FOXC1;TGFB1;PARK7;LAMTOR5
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4915100368355847,1.2000672925124727,0.269449715370019,0.7509797976152938,1.0,4/28,3.94%,ATP2A3;MAP3K5;CHAC1;ITPR1
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5686577208877116,1.19998399264249,0.28085106382978725,0.749907282472413,1.0,2/10,3.42%,NR1H3;ABCD2
prerank,brain morphogenesis (GO:0048854),0.5667667934030026,1.199975977204158,0.27312775330396477,0.7486661326890366,1.0,1/12,0.42%,PTEN
prerank,protein localization to nucleus (GO:0034504),-0.3282227586478717,-1.1999326450087369,0.12312312312312312,0.6210659739836878,1.0,40/102,31.13%,COL1A1;BMP7;BMP4;APPL2;SIX1;STAT3;AKT1;PINX1;TOR1AIP1;PML;RPL11;IPO7;FAM53C;IPO13;MDM2;RAN;CALR;GBP2;HHEX;NXT2;IPO8;TPR;NUP88;SYK;NUP214;NXT1;YWHAE;RRS1;NUP155;RANBP17;MSX1;EIF4ENIF1;MORC3;CSE1L;NUP62;PTTG1IP;TNPO2;WRN;PAF1;HEATR3
prerank,regulation of viral genome replication (GO:0045069),-0.36166181763090505,-1.1993594343423155,0.18791946308724833,0.6217654913820052,1.0,30/56,36.96%,CNOT7;IFITM3;HACD3;OAS2;IFIT1;MAVS;PPARA;PPID;LARP1;PPIA;DDB1;IFITM2;RNASEL;RSAD2;SRPK1;NR5A2;TRIM6;SRPK2;PLSCR1;ISG15;ADARB1;ILF3;BST2;PARP10;OASL;FAM111A;PPIE;RAD23A;ISG20;PROX1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5615707157626117,1.198501145058248,0.29338842975206614,0.7509950127352114,1.0,3/12,3.34%,SEMA5A;PIK3CA;SH3BP1
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5850557128754563,1.1985008617744597,0.2890295358649789,0.749745742694817,1.0,4/10,17.30%,CPEB1;NCBP2;DHX36;HSF1
prerank,DNA conformation change (GO:0071103),-0.48284501146778447,-1.198281575614467,0.2346368715083799,0.6238198426254878,1.0,10/17,31.61%,TOP2B;HHEX;HMGB2;TOP3A;TOP2A;HAT1;ERCC3;ABL1;TOP1;NAA10
prerank,modified amino acid transport (GO:0072337),0.5365518506988454,1.1981894710040124,0.28210526315789475,0.7492501791351779,1.0,3/15,3.11%,SLC16A12;SLC1A4;SLC19A1
prerank,negative regulation of viral genome replication (GO:0045071),-0.39119824980789286,-1.198149006648363,0.20045558086560364,0.6233145839615284,1.0,22/40,36.96%,IFITM3;OAS2;IFIT1;MAVS;IFITM2;RNASEL;RSAD2;SETDB1;MPHOSPH8;SRPK1;INPP5K;TRIM6;SRPK2;PLSCR1;ISG15;ILF3;BST2;PARP10;OASL;FAM111A;ISG20;PROX1
prerank,post-translational protein modification (GO:0043687),-0.28179377177782183,-1.1977507407484134,0.06818181818181818,0.6235214287894667,1.0,98/332,21.65%,FBXL7;FBN1;FN1;FSTL1;ZBTB16;IGFBP5;APOE;APP;CP;BMP4;FBXO10;RAB11A;ITIH2;PTP4A2;CSF1;STT3A;ASB2;SOCS2;SPSB1;IGFBP4;RBBP7;ADAM10;IGFBP3;DCAF6;GAS6;HIF3A;VWA1;P4HB;SERPIND1;TNC;KLHL2;CALU;STT3B;CST3;MSLN;OBSL1;DCAF11;GOLM1;HIF1A;RAB2A;NOTUM;PRSS23;ASB7;MXRA8;KLHL5;PSME2;CUL4A;ASB5;RAB8A;CKAP4;COPS4;PSMB4;CCN1;FBXW11;COPS8;SPP1;ELOB;F5;LTBP1;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;SCG3;NEURL2;RCN1;UBA3;FBXL14;SUMF2;DNAJC3;PSME3;APLP2;PDIA6;ASB1;DCAF4;CCDC8;FBXL19;SPSB4;SPSB2;QSOX1;PSMD4;DCAF8;UBE2M;HSP90B1;PSMA2;FBXO41;ASB6;LGALS1;PSMD3;FAM20C;PSMB7;WSB2;CISH;FSTL3;GAN;ELOC;CUL5
prerank,regulation of neuron projection arborization (GO:0150011),-0.4937056276607254,-1.197749873204036,0.25405405405405407,0.6226385888372941,1.0,7/15,17.63%,MACF1;MOV10;WNT5A;MYO9A;FZD4;MFSD2A;MAP3K13
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5142554805799431,-1.1976710196751954,0.2541743970315399,0.6219944681394562,1.0,7/13,34.63%,ENPP1;SULT1A1;TPST1;TPST2;SULT4A1;ABHD14B;SULT2B1
prerank,camera-type eye morphogenesis (GO:0048593),0.5806356774937312,1.1971817969813494,0.27233115468409586,0.7504432758997671,1.0,2/10,2.17%,TBX2;NF1
prerank,negative regulation of phosphorylation (GO:0042326),0.4010112509517096,1.1968964876929773,0.20711974110032363,0.7499051294409652,1.0,7/85,3.06%,DYNLL1;PTEN;PID1;CBFA2T3;ROCK1;PRR5L;CADM4
prerank,epidermal cell differentiation (GO:0009913),-0.3915289590266139,-1.1967744492862171,0.22767857142857142,0.6235811958890295,1.0,15/41,25.94%,CLIC4;ANXA1;ADAM9;WNT5A;TXNIP;HDAC1;GATA6;WNT16;UGCG;GLI1;DSP;ERCC2;USH2A;ERCC3;CTNNB1
prerank,regulation of B cell activation (GO:0050864),0.49283119032208744,1.1963323015759284,0.26506024096385544,0.7500478582113587,1.0,3/25,6.03%,SH3KBP1;TNIP2;IL4
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.4796739392126771,-1.1960758277223027,0.25296442687747034,0.6246796923068609,1.0,5/15,22.24%,OSBPL8;PPARA;PLIN2;OSBPL11;LPL
prerank,neural crest cell migration (GO:0001755),-0.39756957675478843,-1.1960329961043918,0.1978494623655914,0.6239185981718579,1.0,13/36,16.62%,FN1;NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;TBX1;SEMA3B;RADIL;CORO1C;SEMA3G;SEMA6B
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.46458140159387307,-1.1959600277267803,0.24150943396226415,0.6232589628062334,1.0,5/18,7.32%,IL6R;IL6ST;YAP1;STAT1;STAT3
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5490401991967354,1.1958768596395448,0.2760084925690021,0.7498985001689459,1.0,3/14,11.11%,LIMS1;EMP2;LOXL3
prerank,regulation of protein processing (GO:0070613),-0.44018569461834445,-1.1950015858112415,0.2372549019607843,0.6249766641423512,1.0,4/21,5.88%,CCBE1;GAS1;LRRK2;RNF139
prerank,glycogen catabolic process (GO:0005980),-0.48346615896720113,-1.19491049989983,0.2578740157480315,0.6243566955849496,1.0,9/15,34.04%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL;RB1CC1;STBD1
prerank,organic anion transport (GO:0015711),-0.3455442658905135,-1.1946427579356282,0.16623376623376623,0.6242533582192165,1.0,16/76,10.69%,ABCC4;SLCO2B1;SLC16A2;SLC26A7;SLCO2A1;SLC4A10;SLCO1C1;ABCG2;SLC22A6;ABCC6;SLC25A17;SLC25A4;SLC39A8;MGST1;SLC25A24;SLC35A2
prerank,cellular response to amyloid-beta (GO:1904646),-0.39802922201776914,-1.1942486107251151,0.20901639344262296,0.6245406413565131,1.0,9/35,6.55%,IGF1;EPHA4;APP;GJA1;IGF1R;SNX6;VCAM1;CASP4;ICAM1
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4940095773841992,1.1941023365570722,0.26653696498054474,0.7529328782374202,1.0,9/25,18.54%,MEF2C;MPP2;CHRNA3;GRIN2B;NLGN3;INSYN2A;GRIN2A;GSK3B;GRID2
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5479305176530818,1.1938767504751047,0.2809917355371901,0.7522245058262023,1.0,1/11,0.83%,NEDD4L
prerank,regulation of T cell proliferation (GO:0042129),0.4287917847725994,1.1937929023884448,0.22773972602739725,0.7511752679536335,1.0,5/61,2.84%,GLMN;TNFRSF21;NCK2;IL1B;CD46
prerank,cholesterol homeostasis (GO:0042632),0.41998711742881284,1.192388030924136,0.25165562913907286,0.7532529010043495,1.0,9/64,6.95%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.4648731779759373,-1.1917420882346057,0.24862888482632542,0.6305377077973462,1.0,13/18,36.48%,AKT1;HIF1A;PPIA;PARK7;NONO;PRKN;BAG5;SOD2;HSPB1;PINK1;MAPK7;VNN1;NME5
prerank,regulation of cellular component movement (GO:0051270),-0.3821405461486844,-1.1916209954353774,0.2156398104265403,0.6299900335045462,1.0,12/49,7.41%,TGFBR3;EGFR;ROCK2;PDPN;SP100;DIAPH1;ARHGAP18;TGFBR1;CD9;ARAP1;RHOA;RPS19
prerank,camera-type eye development (GO:0043010),-0.42691037859921543,-1.1915576784051911,0.2475442043222004,0.6292815391947012,1.0,9/25,8.16%,FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;FBN2;CYP1B1;STRA6
prerank,muscle tissue development (GO:0060537),-0.4987923098938528,-1.1913424312161374,0.2546583850931677,0.6289694103487595,1.0,7/13,11.87%,BMP4;SMO;PGM5;CSRP2;STRA6;POGLUT1;PTCH1
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.489378760388901,1.1912301980186906,0.25349301397205587,0.7547995914733866,1.0,4/24,3.65%,PLCE1;PIK3R1;PIK3CA;ABI2
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5271112738150706,-1.1909974750677839,0.24555160142348753,0.6289943954935936,1.0,6/11,25.64%,HIF1A;PARK7;NONO;NR4A3;RACK1;PRKN
prerank,sodium ion transport (GO:0006814),0.39075989798647576,1.1909143891879876,0.22772277227722773,0.7543126611988226,1.0,17/85,9.02%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;SLC5A1;FGF13;SLC24A4;SLC24A2;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;HCN3;SLC6A15;SCN9A;PKD2
prerank,alpha-amino acid catabolic process (GO:1901606),-0.42162239785989764,-1.1909137439571016,0.22435897435897437,0.6283322084179847,1.0,14/29,36.32%,DDO;ALDH4A1;PRODH;CBS;HOGA1;KYNU;MTRR;BLMH;FAH;ACADSB;HGD;IL4I1;HAAO;HSD17B10
prerank,negative regulation of binding (GO:0051100),-0.34139407783151204,-1.1907786366918671,0.17119565217391305,0.6278053624655635,1.0,27/81,22.97%,DAB2;ARHGAP28;SP100;CAV1;LRRK2;LEF1;SMO;PRKCD;IFIT2;AKT1;IFIT1;MDFI;DNAJB2;ACTB;ZFPM1;TMBIM6;MITD1;STYX;NFKBIA;EFHB;PARK7;E2F1;CTNNBIP1;RSF1;BAG2;PLN;CFHR2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.2960981190324351,-1.190653360016504,0.084,0.6272799759202129,1.0,69/234,19.21%,ANXA3;SMAD3;HDAC4;CAMK1D;PLPP3;PRKCH;APP;ZIC2;CAV1;ADCY1;ESR1;NOD1;LRP6;ARHGEF2;FZD2;CFLAR;TAF1;SMO;IRAK2;AR;LGALS9;WNT5A;IKBKE;PRKCZ;PRKCB;CARD14;STAT3;TFRC;ERC1;FZD4;AKT1;KIT;FLOT2;IRAK3;IL18;TRIM27;MAVS;CEBPG;CAMK2A;RELA;TNFRSF11A;UBB;LRP8;CLOCK;PLCG2;SPHK1;FER;HDAC5;TICAM1;PPIA;HIPK2;NKX6-1;CD200;TLR4;TRIM8;RIPK1;FZD1;MAP3K13;NFKBIA;EDA;PARK7;STK36;TRIM14;ALK;LAMTOR5;AGT;TRIM41;EDA2R;PPARGC1A
prerank,regulation of B cell differentiation (GO:0045577),-0.46304653963072984,-1.1905876384366187,0.23193916349809887,0.6266043307957894,1.0,8/17,25.76%,MMP14;ID2;SFRP1;ZFP36L2;PPP2R3C;SYK;XBP1;NCKAP1L
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.48033105341038707,-1.1905013170735144,0.2620817843866171,0.6259877519739018,1.0,5/16,6.69%,RANBP3L;PLCB1;BOC;IGFBP3;MAPK14
prerank,epithelial cell morphogenesis (GO:0003382),-0.46849709139197715,-1.190441471058688,0.23586744639376217,0.6253095778345322,1.0,6/17,13.46%,COL22A1;RILPL1;COL18A1;COL15A1;CCDC88C;MET
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.34994456895286086,-1.1902172484092097,0.19047619047619047,0.6250634017501813,1.0,20/61,24.70%,PRKAG2;CAV1;PSME2;FGFR4;PPARA;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,regulation of neuron differentiation (GO:0045664),0.4038351304912243,1.1900343284314607,0.23181049069373943,0.7551969887388528,1.0,12/76,9.43%,MEF2C;HEYL;ZEB1;ZFHX3;ROCK1;MOSMO;BRINP1;CNTN4;BIN1;BEND6;BRINP3;MED1
prerank,transition metal ion homeostasis (GO:0055076),-0.4043840253695157,-1.1896190127054713,0.23284823284823286,0.6258093816591799,1.0,8/28,19.09%,CP;B2M;NEO1;SLC39A14;FTL;BDH2;HFE;MT3
prerank,actin filament organization (GO:0007015),0.3733139829007729,1.1893529813502837,0.19653179190751446,0.7555729462245615,1.0,26/151,10.80%,MYO1B;EPS8;CARMIL1;MPRIP;BCAR1;RND3;WAS;CORO7;SH3BP1;ABI2;RAC3;SPIRE1;WASL;TMOD1;TMOD3;EMP2;PLS3;SPTA1;MYO6;CORO1A;MARCKS;ERMN;HIP1;LMOD1;ARPC4;GAS2
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.5105286251154257,-1.1893456164969431,0.24470134874759153,0.6247403967688585,1.0,3/12,19.03%,FHL2;HOMER3;CHP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.5105286251154257,-1.1893456164969431,0.24470134874759153,0.6247403967688585,1.0,3/12,19.03%,FHL2;HOMER3;CHP1
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.47565634527449946,-1.1890499066664746,0.2537313432835821,0.6247110023783283,1.0,7/16,11.82%,APOE;NPR3;PIK3CB;NOS1AP;AKT1;HIF1A;GCH1
prerank,positive regulation of viral genome replication (GO:0045070),-0.41405960588666924,-1.1889624778403767,0.2318548387096774,0.6241013867816977,1.0,13/29,25.11%,CNOT7;HACD3;TOP2B;IFIT1;PPARA;PPID;LARP1;PPIA;DDB1;SRPK1;NR5A2;TOP2A;SRPK2
prerank,response to lipid (GO:0033993),-0.32662844577387296,-1.1887809661825877,0.14619883040935672,0.6237457295798395,1.0,32/105,16.83%,SMAD6;FOXP1;CTSH;FOXO1;FOXO3;LBP;RBP4;ESR1;NOS3;ANXA1;SOCS2;ACER2;RARG;LGALS9;ALPL;STAT3;NOCT;TRIM16;IRAK3;TGFB1;GCH1;FGFR4;PPARA;GATA6;TNFRSF11A;SPP1;FER;MAPKAPK3;NOS1;HMGB2;TLR4;PELI1
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4378861178361988,-1.1876574746204127,0.22355289421157684,0.625967026218353,1.0,4/23,2.83%,CAMK1D;MCU;SLIT2;DPP4
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.4401654877814795,-1.1874439905001877,0.21825396825396826,0.6256631671946128,1.0,8/21,20.46%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,regulation of chondrocyte differentiation (GO:0032330),0.4858053690935124,1.1872775928521206,0.2637795275590551,0.7593971286693899,1.0,3/24,1.50%,SOX5;MBOAT2;TRPS1
prerank,regulation of neutrophil migration (GO:1902622),0.5673498412855312,1.1870153401539236,0.3170731707317073,0.7588024949178648,1.0,1/10,1.44%,JAM3
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5204098122798064,-1.1869689438984083,0.24773960216998192,0.6260926047481233,1.0,7/11,25.35%,PDPN;RREB1;CORO1C;ENPP2;ARPIN;KANK1;CD44
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.4295816399357452,-1.1869221112414234,0.22755741127348644,0.6253696773648402,1.0,11/27,25.76%,GAS6;ARRB1;C1QTNF3;IRAK3;ZC3H12A;CD200;SIRPA;TLR4;PTPN6;CD200R1;NCKAP1L
prerank,sterol homeostasis (GO:0055092),0.41745694536499534,1.1867434313211924,0.2508250825082508,0.7582853924652759,1.0,9/65,6.95%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,positive regulation of innate immune response (GO:0045089),-0.41314750205895606,-1.1865357349198218,0.21485943775100402,0.625517393141943,1.0,7/30,11.55%,LBP;WNT5A;RPS19;IFI35;NLRC5;MAVS;GBP5
prerank,phosphorylation (GO:0016310),0.3327243973795133,1.185697007027233,0.12653562653562653,0.7596858678731823,1.0,74/385,11.79%,DGKB;LIMD1;PRKG1;MAP3K20;PIK3CD;CDK6;DGKH;MAP3K5;SNRK;PEAK1;PKN1;FRK;DGKG;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;PIK3CA;LIMK1;RPS6KA4;GRK3;CDK15;CDC42BPA;STK39;STK38L;JAK1;MINK1;RYK;TESK2;TRIB2;ROS1;NEK1;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;STK24;STK3;MTOR;GRK5;ACVR2B;MARK2;CSK;MAP4K4;XYLB;PRKD2;LYN;PDGFB;GK;CSNK1E;MAP4K1;BIRC6;PAK5;COQ8A;MAPK10;NEK6;GNPTG;DGKD;DYRK3;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PAK1;TEC;NLK
prerank,GTP metabolic process (GO:0046039),-0.47478249173542175,-1.1856531533990409,0.26045627376425856,0.6270357293464977,1.0,3/15,13.00%,RHOQ;LRRK2;RAN
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.44693419842541304,-1.185296108705351,0.2621359223300971,0.6271308102842339,1.0,4/19,7.04%,LBP;LGALS9;PRKCE;PIK3AP1
prerank,ventricular septum morphogenesis (GO:0060412),-0.4194265574880877,-1.1851975831788066,0.22916666666666666,0.6265434891234909,1.0,10/27,4.79%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMPR2;BMP4;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,cellular response to peptide (GO:1901653),-0.3576371289789657,-1.185072716860332,0.18990384615384615,0.6260544236210719,1.0,13/56,6.55%,IGF1;EPHA4;APP;CAV1;VIM;GJA1;IGF1R;SNX6;NOD1;ARHGEF2;VCAM1;CASP4;ICAM1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5591023333953812,1.184465317318485,0.30112359550561796,0.7613933571835401,1.0,1/11,0.50%,IL34
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5122658397098904,1.184411649615876,0.2894736842105263,0.7602929825640677,1.0,5/19,8.96%,PLCE1;INPP5A;PPP3CA;GPR62;NFATC4
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3751353600459128,1.1839923154018037,0.20300751879699247,0.7600931382625469,1.0,16/124,9.76%,FRY;CARMIL1;RAPGEF2;MAP2;ROCK1;CNTNAP2;RYK;ATP1B2;LAMB1;CNTN4;BLOC1S1;FAM161A;PKD2;LYN;TMEM108;PLP1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.38473864034249583,-1.1839866168588786,0.20302375809935205,0.6280887880970587,1.0,14/43,22.82%,IGF1;LBP;CD34;GAS6;LGALS9;IRAK3;ZC3H12A;TRIM27;SIRPA;TLR4;DICER1;CD274;RARA;PTPN6
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.25072033300754476,-1.1838523108574632,0.0,0.6276034784756015,1.0,385/1645,19.35%,NFIB;TSHZ2;BNC2;FOXP2;IGF1;ZMIZ1;PBX1;PKNOX2;FOXN3;ZNF423;MAF;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;SMAD6;COL1A1;EFEMP1;NFAT5;KDM7A;FOXP1;ZKSCAN2;WNT4;HDAC4;DENND4A;GLI2;CUX1;TBL1XR1;NFIX;WWC2;CREB5;IL31RA;CHD7;ZFHX4;BMP7;LCOR;SP100;TGFA;GLIS3;VGLL4;RBFOX2;DKK3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;APOE;OSR1;KLF3;FOXO3;MDFIC;ZIC2;NFIA;NR3C1;KAT6B;HIVEP3;ANXA4;ERG;HOXB3;MLXIP;SUFU;ESR1;ZIC5;SMURF2;USP47;VGLL3;ELF1;BMP4;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;TGFBR1;SNX6;FOXD1;TBX15;KLF4;PLAGL1;DDX5;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;LRP6;NFATC1;SMAD7;CDH1;LEF1;ACVR1;FZD2;KLF2;ETV6;ID1;MLLT3;PDCD4;HDAC9;SBNO2;MXI1;RGMB;HOXA5;ZHX3;CREB3L2;ZNF23;SP140;PCGF5;ZFPM2;PARP9;CNOT7;IGF2;GATAD2A;HDGFL3;MED26;SSBP2;GAS6;ARRB1;HOXA3;GTF2IRD1;TEAD4;QRICH1;NIBAN2;ARNT2;WWP2;AR;BRD7;DAP;SCMH1;CREM;YAP1;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;PFDN5;KMT5A;ACVRL1;ATXN1;IRF1;TEAD1;MIDEAS;SIX1;WNT5A;BAZ1A;CDK17;ZNF292;PRKCB;HLF;KDM5B;HOXC6;PRDM16;MAPK14;ID3;FOXC1;IRF2;GLIS1;SFMBT1;CHD3;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;IFRD1;PGR;BAZ1B;KLF10;SFR1;ZNF219;TBX1;ERC1;POLR2A;FZD4;ZBTB8A;TRRAP;GON4L;TFCP2;IRF9;ZBTB18;VSX1;BAZ2B;AKT1;DTX3L;BBS7;KIT;FOXL1;LHX6;RREB1;TLE2;REXO4;HIF1A;CBFA2T2;TADA1;MKX;ZMYND15;RCOR3;TRIM16;TLE1;TWIST2;TADA2A;FOXK1;CRABP2;CARM1;NR4A2;MMS19;TULP3;FZD7;ATF6;BHLHE41;EHMT1;FOSL2;CD38;PHF10;IKZF1;GCLC;DAB2IP;HOXB9;TFCP2L1;JARID2;KARS1;PRDM5;ZKSCAN7;ZKSCAN3;SLC39A8;TGIF1;ESRRG;ZFHX2;PML;KLF12;SIX5;GATA2;BRCA2;CEBPG;PATZ1;ZSCAN25;NFYC;HINT1;BACH2;KDM3A;GLI3;FOXQ1;TGFB1;NSD1;ELK3;MED27;AHR;HDAC1;LRRFIP1;ZSCAN22;ATXN7L3;MDM2;ZIC3;RELA;PPARA;CHD2;ID2;MEF2A;SRSF10;USF1;GATA6;CBX4;FBXW11;PRDM11;SP110;CALR;GLRX2;ATOH8;ZGPAT;CLOCK;MEIS2;SPP1;ZNF585A;ZNF585B;HDAC5;RET;ZNF568;TAL1;SOX17;RFX2;HSF2;SFRP1;QARS1;DACH2;TOX4;CREB3L1;SMARCC1;ENO1;SLTM;POU2F1;MAZ;ZBTB4;HOXC4;TTC21B;HOXB5;HOXB7;HIPK2;DYRK1B;PCGF3;SOX7;WWP1;NKX6-1;SNAI1;CREB3;YEATS2;JUND;SREBF1;CDKN1B;NOS1;NKRF;L3MBTL2;RNF187;HHEX;MEIS1;HMGB2;SOX18;HCFC2;MNT;USF2;ZMIZ2;ZFP69;ZNF436;JUNB;MYRF;SIRT2;HNRNPAB;ASCC1;ATF1;TSHZ1;TCIM;MED21;FBXL19;WNT11;NFIL3;PSIP1;RAI1;ACTR8;FZD1;NFYB;ZFP14;CSRNP3;NFXL1;NPAS2;MAFF;SOX12;RRP8;NR6A1;CC2D1A;RHOH;CEBPB;KLF15;BASP1;CIR1;ELP3;PCGF6;POU5F2;TYMS;AGT;EZH2;PLAG1;YAF2;ZSCAN2;BRF2;SBNO1;ATF7;HMGN5;MT3;PIM2;SCML4;PPARGC1A;E2F1;ZFX;ETV4;IRF2BPL;THOC1;ZFP57
prerank,glycosaminoglycan catabolic process (GO:0006027),0.42369943821241307,1.1838214436254781,0.2434325744308231,0.7592882673370631,1.0,11/55,6.34%,CSPG4;SDC2;CEMIP2;SDC3;HYAL4;AGRN;FGF2;ACAN;GPC5;GPC3;GNS
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.41908820618251175,1.183662351027884,0.24280575539568344,0.7584399165148028,1.0,9/60,11.66%,PDGFRB;RGCC;FGF2;TNKS;PARM1;PRKD2;PDGFB;ATR;HNRNPA1
prerank,anion transmembrane transport (GO:0098656),-0.3505561606700435,-1.1828036616775115,0.17330210772833723,0.62966940617927,1.0,19/67,16.02%,SLC13A4;SLC6A13;SLC13A3;SLC1A3;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A4;SLC5A6;SLC25A38;SLC38A5;SLC39A8;SLC35A2;SLC3A2;SLC25A19;SLC25A22;SLC7A1;ARL6IP5
prerank,triglyceride homeostasis (GO:0070328),0.48574758952256614,1.182176023109829,0.28516377649325625,0.7607897172665671,1.0,4/26,6.95%,RORA;NR1H3;SCARB1;LIPC
prerank,P-body assembly (GO:0033962),0.5530413888535242,1.1820808351945582,0.29896907216494845,0.7598354802074202,1.0,2/12,5.17%,LIMD1;LSM3
prerank,cellular response to nutrient levels (GO:0031669),-0.3529925430951551,-1.1817306908959069,0.18652849740932642,0.6317087546473467,1.0,24/62,25.26%,LAMP2;FOXO1;BMPR2;LRRK2;WIPI2;FNIP1;CLEC16A;KLF10;KCNB1;FLCN;PPARA;MFSD2A;SFRP1;SREBF1;PRKAA2;RRAGB;ZFYVE1;FAM107A;XBP1;LPL;STK26;RIPOR1;ATG7;RRAGC
prerank,heterocycle biosynthetic process (GO:0018130),-0.5006658875372275,-1.1816586963214464,0.2807017543859649,0.6310705089823748,1.0,9/14,40.49%,GCH1;PYCR2;NOXRED1;GPHN;PYCR1;MOCS2;ALOX5;NFS1;PYCR3
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.4684523417145894,-1.181316749052924,0.2637571157495256,0.6311636653690877,1.0,4/16,6.22%,BMP4;FOXD1;FGF1;SIX1
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5373180761780868,1.1808231838777454,0.2853881278538813,0.761676888081428,1.0,3/12,5.93%,DMD;ATP1B2;ANK3
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.4448778282574706,-1.1808086167788165,0.2608695652173913,0.6317129564511119,1.0,5/21,5.39%,BMP6;DAB2;BMP4;TGFBR1;CCN3
prerank,positive regulation of protein modification process (GO:0031401),-0.29691561982268455,-1.1806249476207837,0.11895910780669144,0.6313417601840899,1.0,55/203,14.52%,DAB2;TRABD2B;EGFR;LEPR;CDH5;ROCK2;NTRK3;TEK;PECAM1;APP;BMP4;ANGPT1;LRRK2;NIBAN1;VEGFD;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;ACE;EFNA5;RAB3GAP1;CCND2;PTPA;CARD14;CALM2;FNIP1;CCND3;TFRC;TBX1;PRKCD;WDFY2;NOS1AP;AKT1;PPP1R16B;IRGM;FLCN;KDR;MAVS;ITGB3;TGFB1;TMEM119;FLT4;CCN1;CDK2AP1;CCND1;ATG10;TXN;NNMT;LIMCH1;PPIA;FXR2;MAPK3
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5017601201160746,-1.1798561147800382,0.2788104089219331,0.6326026923350868,1.0,5/12,12.09%,GMDS;CSGALNACT1;FUT8;EXTL2;GFPT2
prerank,ether lipid metabolic process (GO:0046485),-0.49566171367078765,-1.1797196161133554,0.25239005736137665,0.6321284648345293,1.0,4/14,11.23%,AGMO;NCEH1;PLA2G6;LIPE
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.33924520585971635,-1.1796998732494481,0.16237113402061856,0.6313384734255256,1.0,30/72,30.76%,ELF1;CFLAR;IRAK2;GAS6;STAT1;BIRC3;USP18;TNFRSF1A;CASP8;IRAK3;SPHK1;HSP90AB1;VRK2;RNASEL;RIPK1;AGPAT2;PTPN2;IKBKG;SYK;SIGIRR;PTPN6;CBFB;ZBP1;RACK1;LIFR;TAX1BP1;IL7;SOCS1;TRADD;AGPAT1
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3638275861191846,1.179445263910828,0.2055800293685756,0.7637012344513845,1.0,21/151,7.63%,PDGFRB;SLC30A10;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ERBB4;PTPN22;ACKR3;FGF2;SPRY2;CARD9;NTRK2;HTR2C;CHRNA7;RAP1A;HRAS;FGF10
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5414162799057064,1.1794211566773294,0.31643002028397565,0.7625369662829429,1.0,4/14,4.18%,TBXA2R;NOTCH1;STARD13;PDCD10
prerank,establishment of epithelial cell polarity (GO:0090162),-0.45219043642862095,-1.1789721994013094,0.2515090543259557,0.6325468213667713,1.0,8/19,16.57%,MYO18A;EZR;RHOA;MYO9A;GOLPH3;PARD3;OPHN1;CYTH1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.4833152190176442,1.178759797938343,0.2871900826446281,0.7628337581016724,1.0,3/24,5.46%,COX4I2;PID1;SLC25A13
prerank,regulation of JNK cascade (GO:0046328),-0.32198938771322716,-1.178590378916426,0.16338028169014085,0.6327395808117652,1.0,18/101,10.23%,TGFBR3;PLCB1;EGFR;MECOM;CCN2;SH3RF1;APP;IGF1R;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP
prerank,regulation of neuron migration (GO:2001222),-0.4242687686841726,-1.1781475921682651,0.2579957356076759,0.6331230678655152,1.0,5/26,4.01%,PHACTR1;COL3A1;SEMA6A;SRGAP2;ARHGEF2
prerank,positive regulation of metabolic process (GO:0009893),-0.32211556146649684,-1.1774364241668807,0.1588235294117647,0.6342013782056924,1.0,35/103,20.98%,LEPR;CAMK1D;ADIPOR2;CAV1;GJA1;IGF1R;APPL2;PRDM16;CPT2;GNAS;CMKLR1;ACACA;EHMT1;IL18;ESRRG;ACADL;KDM3A;UCP2;PRKAB1;BEND3;KDM6B;CNOT3;FABP5;MFAP2;PDGFC;DYNC1H1;ADRB2;CEBPB;GADD45G;ACACB;PPARGC1A;SYK;ADIPOR1;ALMS1;DECR1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.4801989349287217,1.177368069501158,0.26195028680688337,0.7649305904198299,1.0,4/27,4.24%,PDGFRB;PTK2;AGAP2;FGF2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.3504741270574924,-1.1771089202862808,0.1969309462915601,0.6341871481378136,1.0,21/68,13.90%,WNT4;PLPP3;WNT6;CAV1;TCF7L2;LRRK2;LRP6;LEF1;FZD2;WNT9A;RARG;SFRP4;WNT5A;SCYL2;FZD4;NR4A2;FZD7;BCL9L;WNT5B;WNT16;SFRP1
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.42952638946902627,-1.1766857691694306,0.25910064239828695,0.63438558596077,1.0,13/27,30.68%,NFAT5;RHOA;CD47;RELA;SIRPA;CYRIB;MDK;NR4A3;ITGB2;CD44;HAS2;CCR2;CCL2
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.4701716673657152,-1.1763604867306827,0.27115384615384613,0.634441934091512,1.0,4/17,5.66%,PODXL;FOXC2;ADAM9;PIEZO1
prerank,striated muscle tissue development (GO:0014706),0.4685982432365057,1.1762089421805546,0.2902621722846442,0.7664962439384114,1.0,6/29,7.45%,TBX2;MEF2C;BMP5;POPDC3;SGCZ;IGSF8
prerank,positive regulation of cell killing (GO:0031343),-0.49511915064469975,-1.1760250493042823,0.25862068965517243,0.6345069702206555,1.0,5/13,19.92%,WNT5A;FZD7;CYBA;NOX1;SYK
prerank,atrial septum development (GO:0003283),0.545079907192696,1.1755115127671372,0.30105263157894735,0.766988281265999,1.0,2/13,1.22%,HEY2;TBX20
prerank,sensory perception of chemical stimulus (GO:0007606),0.5199600092534233,1.1747844443572184,0.302713987473904,0.7675722767761587,1.0,3/15,6.84%,ADCY3;SLC24A4;UBR3
prerank,regulation of RNA metabolic process (GO:0051252),-0.350683477065599,-1.1743643064280664,0.2062780269058296,0.6382031877681923,1.0,15/59,12.59%,AHNAK;MBNL1;RBM20;TNFRSF1B;AFF2;IGF2BP2;RC3H2;NOVA2;SON;OAS2;PCBP2;CLK1;MBNL2;GRSF1;NOVA1
prerank,organelle transport along microtubule (GO:0072384),0.4665057137697422,1.1743103073332497,0.27218934911242604,0.7675489354573346,1.0,10/31,17.43%,ARHGAP21;BICD2;UXT;TRAK1;TRAK2;COPG2;RAB1A;NDE1;HTT;HAP1
prerank,regulation of myotube differentiation (GO:0010830),-0.4364650998727859,-1.17409418662518,0.27233115468409586,0.6381309208112028,1.0,11/24,13.65%,HDAC4;HDAC9;CCN3;PIEZO1;MAPK14;MMP14;DMPK;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5601184635494354,1.1737942328453994,0.30585683297180044,0.7676273648929712,1.0,6/10,16.37%,MAPRE2;FGF10;MTOR;MAP4K4;IQSEC1;EPB41L4B
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.4844680104087743,-1.1736231693548698,0.2787524366471735,0.6385913364547773,1.0,3/15,6.22%,BMP4;SMO;SIX1
prerank,transport along microtubule (GO:0010970),0.5344631688044328,1.1734540273456495,0.30462184873949577,0.7672345299076616,1.0,5/13,16.41%,ARHGAP21;DYNC1I2;CAMSAP3;COPG2;APBA1
prerank,protein catabolic process (GO:0030163),-0.3498159993612718,-1.1730542844150682,0.2182254196642686,0.6393699175373626,1.0,24/59,25.64%,LAMP2;APOE;ADAMTS9;TRIM24;DENND3;STT3B;IDE;DAB2IP;UBE2G2;DDB1;CEACAM1;MANBA;CLN8;RIPK1;VCP;NGLY1;TPP1;CLN6;CLN5;CLPX;FBXO17;CHEK2;CTSD;PRKN
prerank,cardiac muscle tissue development (GO:0048738),0.4314419116537105,1.1727486760630192,0.2751322751322751,0.767677881968829,1.0,9/50,6.97%,TBX2;HEY2;BMP5;NOTCH1;TBX20;NRG1;SCN5A;SIK1;SGCZ
prerank,detection of mechanical stimulus (GO:0050982),0.4923974113462414,1.1726194329550843,0.30337078651685395,0.7667716815922249,1.0,2/19,1.34%,CDH2;PTK2
prerank,histone modification (GO:0016570),-0.32496373405803286,-1.1724232287945608,0.1838006230529595,0.6402737517912024,1.0,28/109,21.43%,EYA2;EYA1;HDAC4;TBL1XR1;KAT6B;EYA4;HDAC9;MIDEAS;BAZ1B;PRKCD;TRRAP;RCOR3;CARM1;EHMT1;PRDM5;NSD1;HDAC1;ATXN7L3;HDAC5;SIRT7;SIRT2;PARK7;EZH2;MT3;USP22;MORF4L2;USP36;SIN3A
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.47923942420834026,1.1722060224023128,0.2953667953667954,0.7665645065623522,1.0,5/27,5.52%,UTRN;NEDD4L;FGF12;FXYD2;SCN5A
prerank,bile acid and bile salt transport (GO:0015721),-0.4187111310451286,-1.1721025793846827,0.26043737574552683,0.6402707568533841,1.0,3/24,3.90%,ABCC4;SLCO2B1;SLCO1C1
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4629213079954638,-1.1720895948052128,0.27977315689981097,0.6394666287644787,1.0,5/18,17.11%,HDAC7;EZR;CD34;TRIM27;HOMER3
prerank,macromolecule catabolic process (GO:0009057),-0.41360971940472174,-1.1718833113831317,0.2578616352201258,0.6391921638057638,1.0,12/26,22.40%,TRIM24;SMURF1;BECN1;IDE;TGFB1;SH3GLB1;UVRAG;CLN8;TPP1;CLN6;CLN5;CLPX
prerank,calcium import into the mitochondrion (GO:0036444),-0.5372031543216811,-1.171640765999756,0.2906764168190128,0.6390013749105857,1.0,6/10,19.67%,MCU;MCUB;AFG3L2;MICU2;MICU1;MAIP1
prerank,metal ion homeostasis (GO:0055065),0.4539900618477403,1.1715541500030937,0.2984790874524715,0.7669759935313709,1.0,10/40,13.22%,SLC12A2;SLC12A6;TFAP2B;ANK3;SNCA;LETM1;COX11;SLC12A5;FAM20A;SLC12A4
prerank,leukocyte cell-cell adhesion (GO:0007159),0.483801220744711,1.1715414979972105,0.299009900990099,0.7658078996168184,1.0,3/24,5.53%,ITGA4;ROCK1;ITGB1
prerank,carbohydrate homeostasis (GO:0033500),-0.34484041744334554,-1.1714867420585324,0.20512820512820512,0.6385901362447726,1.0,18/67,20.34%,LEPR;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;KCNB1;FGFR4;USF1;RPS6;PRKAA2;BACE2;PARK7;PTPN2;TENT4B;ADIPOR1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5027667676280819,-1.1708096946528854,0.2881679389312977,0.6396665075468924,1.0,5/12,17.23%,HSPA5;INSIG2;GPAA1;RER1;TAPT1
prerank,error-prone translesion synthesis (GO:0042276),-0.4387511513078154,-1.1705110243045806,0.26232741617357,0.6396875196220214,1.0,13/21,36.71%,REV1;POLH;UBB;RPA1;RFC3;POLI;POLE2;RFC1;RPA3;PCNA;RFC5;MAD2L2;PRIMPOL
prerank,long-chain fatty acid transport (GO:0015909),-0.40783963046328425,-1.1703692863266173,0.244,0.6392335509381658,1.0,10/30,18.86%,PRKAG2;APOE;CPT1A;SLC25A20;CPT2;ACACA;MFSD2A;PRKAA2;FABP5;ACACB
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.4922532013782007,-1.1699882186623443,0.28171641791044777,0.6394199207114124,1.0,6/13,27.51%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,triglyceride catabolic process (GO:0019433),0.49449278713861,1.1699785499737183,0.28450106157112526,0.7683595016799886,1.0,3/19,6.95%,FABP3;LIPH;LIPC
prerank,cellular response to ATP (GO:0071318),-0.48600857653697943,-1.1699580129361278,0.2926356589147287,0.6386641848142007,1.0,6/14,25.05%,TAF1;P2RX4;P2RX7;P2RY1;HSP90B1;P2RY12
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.43729791413825075,1.1698225301570069,0.26881720430107525,0.767531837751925,1.0,9/47,6.20%,CARMIL1;LIMS1;PTK2;SPRY4;FERMT2;RAC3;ACTN4;TESK1;AP1AR
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3569744485175098,1.169792533722319,0.21518987341772153,0.766415686777609,1.0,8/166,2.82%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,O-glycan processing (GO:0016266),-0.36241516507950056,-1.1695402691696377,0.22627737226277372,0.6389532147222776,1.0,7/54,9.97%,GXYLT2;ST3GAL4;ST3GAL1;ST3GAL2;ST3GAL3;ST6GALNAC2;GALNT12
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2980463063016612,-1.1687367030366134,0.125,0.640334834313202,1.0,37/161,14.35%,MCC;DAB2;IGFBP2;BICC1;TMEM64;DKK3;APOE;CAV1;IGFBP6;NKD1;TCF7L2;TLE4;LRP6;MLLT3;IGFBP4;SFRP4;SOX13;PFDN5;WNT5A;SCYL2;AMFR;FZD4;TLE2;TLE1;NOTUM;DAB2IP;ZNRF3;PSME2;GLI3;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8
prerank,positive regulation of viral process (GO:0048524),-0.3495119785314221,-1.1681856116948082,0.22935779816513763,0.6409935818050762,1.0,22/60,25.11%,MDFIC;CNOT7;HACD3;POLR2A;IFIT1;RAB7A;PPARA;POLR2F;PPID;LARP1;PPIA;DDB1;KPNA6;CDK9;POLR2E;RSF1;SRPK1;NR5A2;NELFCD;POLR2G;TBC1D20;SRPK2
prerank,positive regulation of reproductive process (GO:2000243),0.46750543530724004,1.1680142696944436,0.3,0.7695982364423891,1.0,5/31,5.01%,PDE3A;CACNA1H;TACR2;TACR1;SYDE1
prerank,pancreas development (GO:0031016),-0.5046774410621245,-1.1678752480922967,0.2967032967032967,0.6409652873056992,1.0,4/12,15.33%,TCF7L2;ZIC3;MET;NKX6-1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5424251566329032,1.1677982544158914,0.3041575492341357,0.7688946778572332,1.0,1/12,0.88%,APOBEC1
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4674277430590347,-1.167288020168428,0.2975970425138632,0.6417650326216755,1.0,5/15,7.21%,MAGI2;SMAD7;ACVR1;SKI;FKBP1A
prerank,B cell activation (GO:0042113),0.4169816527619563,1.1669139815785403,0.2521440823327616,0.7698539446370555,1.0,3/68,0.77%,ITGA4;MEF2C;PIK3CD
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5590287653341011,1.1668880971742035,0.29809725158562367,0.7687328060155786,1.0,5/10,9.01%,VTN;IL1B;GRB10;ARNT;PRKD2
prerank,iron ion transmembrane transport (GO:0034755),-0.5233417647601902,-1.16658296559353,0.2820976491862568,0.6427963276151583,1.0,3/10,10.60%,SCARA5;SLC39A14;SLC39A8
prerank,peroxisome organization (GO:0007031),0.4846275832138459,1.1658317234558173,0.28105906313645623,0.7701108357367924,1.0,9/25,15.58%,ABCD2;PEX7;PEX1;TMEM135;MFF;PEX3;PEX19;LONP2;PEX12
prerank,thymus development (GO:0048538),-0.4910108484211295,-1.1656792450189135,0.2706766917293233,0.6443345214101438,1.0,4/13,16.39%,TGFBR1;SIX1;TBX1;EPHB3
prerank,pulmonary valve development (GO:0003177),-0.4644261249426176,-1.1655404916218755,0.258130081300813,0.643901857480652,1.0,11/18,9.40%,NOTCH2;ROBO1;SMAD6;SLIT2;NOS3;BMPR2;BMP4;NFATC1;TNFRSF1B;STRA6;TNFRSF1A
prerank,regulation of double-strand break repair (GO:2000779),0.4474253402359865,1.1655210476193638,0.2751322751322751,0.7696895411074064,1.0,12/39,17.60%,WAS;FOXM1;SPIRE1;FMN2;DEK;SLF2;TIMELESS;OTUB1;PPP4C;MRNIP;RPA2;DDX11
prerank,cellular response to interleukin-6 (GO:0071354),-0.415995671943501,-1.1653556755330636,0.2571428571428571,0.6435645209151538,1.0,8/26,7.32%,ST3GAL6;PTGIS;IL6R;IL6ST;SBNO2;YAP1;STAT1;STAT3
prerank,oligosaccharide metabolic process (GO:0009311),-0.36379504738380103,-1.1652642318681927,0.21396396396396397,0.6429571395046326,1.0,15/46,20.12%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST6GALNAC3;ST3GAL3;FUT8;ST8SIA2;NAGA;ST6GALNAC6;MANBA;MAN2C1;MAN2B2;NEU3;ST8SIA5
prerank,positive regulation of cellular metabolic process (GO:0031325),0.384719536060297,1.1650644854489072,0.24203821656050956,0.7696539053892465,1.0,9/98,6.29%,PDGFRB;ACE2;PID1;NR1H3;ECE1;PPARD;ATAD1;IL4;SNCA
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.47108406203897835,1.1650250681860213,0.298828125,0.7685798638338375,1.0,4/31,1.19%,LIMD1;RORB;CDK6;NOTCH1
prerank,negative regulation of chemotaxis (GO:0050922),-0.39961939123994367,-1.1649293277001576,0.2542016806722689,0.6430832386180414,1.0,7/31,3.63%,ROBO1;SEMA3D;SEMA6A;SEMA3C;SLIT2;THBS1;SEMA7A
prerank,neuron projection morphogenesis (GO:0048812),0.367403716596311,1.1645702514584262,0.21764705882352942,0.7685117070622492,1.0,30/137,12.15%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;MINK1;CNTNAP2;NTNG2;RYK;CNTN4;SLITRK5;NYAP2;ANK3;TAOK3;CCK;SLITRK1;MAP4K4;CTNNA2;NCKAP1;BRSK1;PAK3;PAK1;ZDHHC17;EPHB1
prerank,regulation of sensory perception of pain (GO:0051930),-0.5093410780803143,-1.1638600846908762,0.3060428849902534,0.6450806176069056,1.0,4/11,11.07%,CCN3;TMEM100;ZFHX2;MGLL
prerank,epiboly involved in wound healing (GO:0090505),-0.4591532386906759,-1.1630048520238834,0.2697768762677485,0.6465473850655054,1.0,10/16,25.35%,PDPN;DDR1;RHOA;CCN1;CEACAM1;CD151;RHOC;TMEFF2;LCP1;CD44
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.329849840287083,-1.1626880083466786,0.2125984251968504,0.6465393632269404,1.0,24/80,19.74%,EPHA4;SAMD4A;ROCK2;VIM;SLC2A13;THBS1;LARP4B;NIBAN1;SMPD3;NSMAF;RPS4X;PRKCD;PLA2G6;UPF3A;TNFRSF1A;RELA;CPEB3;RPL26;FXR2;ELAVL1;SIRT3;ZCCHC4;NAT10;METTL5
prerank,regulation of cellular respiration (GO:0043457),0.5143829280562213,1.1624152180511982,0.310838445807771,0.7725494250383073,1.0,3/17,6.03%,CBFA2T3;NOA1;IL4
prerank,neutrophil activation involved in immune response (GO:0002283),-0.2650133032647567,-1.1624010843457757,0.0851063829787234,0.6464888580572925,1.0,119/428,21.44%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;SYK;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.32718690219313423,-1.1623194865412168,0.1742857142857143,0.645902196781322,1.0,30/91,20.00%,BMP6;APP;CP;SCARA5;ABCG2;SLC39A14;ATOX1;SLC39A13;SLC39A10;TFRC;ATP6V1G1;ACO1;FTL;SLC39A8;NEDD8;ATP6V0A2;HFE;CYB561A3;SLC30A1;FRRS1;FTH1;MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,central nervous system neuron differentiation (GO:0021953),0.4574650741928612,1.16193205769545,0.27715355805243447,0.7725685035079993,1.0,10/33,12.91%,MAP2;ATP7A;CEND1;RYK;NTRK2;SOX4;MDGA2;TOX;SPOCK1;ZC4H2
prerank,ameboidal-type cell migration (GO:0001667),0.41821390397383956,1.161562034081732,0.2822719449225473,0.772294963324193,1.0,9/51,7.87%,ITGA4;SEMA6D;SEMA5A;PKN1;ERBB4;SEMA6C;GPC3;PDLIM1;NANOS1
prerank,keratinocyte differentiation (GO:0030216),-0.4132157446706998,-1.1610489194871636,0.24503311258278146,0.648392162449082,1.0,7/29,13.66%,CLIC4;ANXA1;ADAM9;WNT5A;TXNIP;WNT16;UGCG
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.45051655276604796,-1.160985247557408,0.2878787878787879,0.6477184835251757,1.0,2/19,0.11%,BMP6;AFDN
prerank,negative regulation of cell adhesion (GO:0007162),-0.3369668529080684,-1.1608783833222267,0.2135678391959799,0.6471931051789201,1.0,22/72,12.29%,PLXNA2;FBLN1;SEMA6A;PODXL;PLXNA4;ANGPT1;CDH1;ADAM10;ACER2;ACVRL1;RHOA;CYP1B1;DUSP1;FZD4;TGFBI;PLXND1;CDH13;FZD7;ARHGDIA;CD164;TGFB1;EPHB2
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.5161205153417276,-1.1606841255342262,0.29182156133828996,0.6468745986349606,1.0,7/10,40.85%,ABCA3;MFSD2A;MTMR3;MTMR1;PHB2;MTMR4;GNB3
prerank,cellular response to oxygen levels (GO:0071453),-0.537321281998803,-1.1605652291936468,0.27717391304347827,0.6463811287739382,1.0,7/10,27.55%,ATP6V1G1;ATP6V0A2;CCDC115;TMEM199;PICK1;ATP6AP1;ATP6V0D1
prerank,neutrophil degranulation (GO:0043312),-0.2640110944543937,-1.1603648953170496,0.10638297872340426,0.646091122828649,1.0,118/425,21.44%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5017002571272551,1.1603029335088262,0.29979035639413,0.7740151832971515,1.0,7/20,13.07%,LIMD1;AJUBA;AGO3;TNRC6C;EIF6;TNRC6B;CELF1
prerank,acute-phase response (GO:0006953),-0.49880931806421647,-1.1598231729427262,0.2795497185741088,0.6467023030260559,1.0,5/12,25.16%,IL6R;LBP;CEBPB;SIGIRR;PLSCR1
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.4958475117651665,-1.1596532477791448,0.29245283018867924,0.6463621911825927,1.0,6/13,28.72%,TGFBR2;GLI3;PNP;CBFB;NCKAP1L;SOCS1
prerank,negative regulation of anoikis (GO:2000811),0.5275018174347312,1.1595414495890959,0.3191489361702128,0.7746384467611787,1.0,6/14,12.52%,NOTCH1;PTK2;PIK3CA;ITGB1;SNAI2;SRC
prerank,positive regulation of secretion by cell (GO:1903532),-0.33960165063627723,-1.1591297202560091,0.2245430809399478,0.6469771009066027,1.0,20/70,15.90%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;RAB27A;P2RX4;GOLPH3;DTNBP1;MYH10;KCNB1;STX1A;TGFB1;GRK2;PPID;PPIA;EDN3;SYTL4
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5308023217601698,-1.1587058442401883,0.3114754098360656,0.647298432998191,1.0,3/10,18.15%,BMP4;FZD7;BASP1
prerank,selective autophagy (GO:0061912),0.4264502361186119,1.158178985938212,0.2881646655231561,0.7766996046714146,1.0,1/56,0.06%,DYNLL1
prerank,regulation of insulin secretion (GO:0050796),0.3827792086139758,1.1581447698238134,0.24605678233438485,0.775577638259643,1.0,14/101,7.38%,CACNA1C;RAPGEF4;PER2;GPER1;ITPR2;IL1B;GIPR;SNAP25;ITPR1;TFAP2B;SOX4;RAP1A;IRS1;CACNA1D
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4668790463238713,-1.1581213565061246,0.28651685393258425,0.648029266976435,1.0,6/15,28.70%,CD55;GLI3;PNP;SYK;HSPH1;CCR2
prerank,cellular component maintenance (GO:0043954),-0.4896356632399969,-1.1577469206688678,0.301707779886148,0.6482007402186144,1.0,3/12,14.79%,IGF1R;ITGA3;CLDN1
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5091027265713766,-1.1574538731672708,0.30113636363636365,0.6481434796327381,1.0,7/11,34.90%,P4HB;PARK7;STK26;PRKN;LANCL1;PINK1;MMP3
prerank,negative regulation of dephosphorylation (GO:0035305),-0.44988630195630597,-1.157419977862913,0.26899383983572894,0.6474398307922831,1.0,8/18,23.86%,MFHAS1;PTPA;SH3RF2;PPP1R16B;CHP1;ARPP19;SH2D4A;INPP5K
prerank,glucose homeostasis (GO:0042593),-0.3243120024801027,-1.1572950724165343,0.18489583333333334,0.6469670574002908,1.0,22/83,20.34%,LEPR;FOXO1;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;HK2;HIF1A;KCNB1;FOXK1;FGFR4;USF1;RPS6;PRKAA2;BACE2;PARK7;PPARGC1A;PTPN2;ADIPOR1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3943869280824153,-1.1572118690393647,0.2670807453416149,0.6464011436071292,1.0,6/31,7.21%,TGFBR3;FGFR2;TGFBR1;SMAD7;ZFPM2;FKBP1A
prerank,negative regulation of protein catabolic process (GO:0042177),-0.38007004660097415,-1.1570435078366101,0.25733634311512416,0.6460416440203224,1.0,15/40,22.14%,TIMP3;EGFR;PTPN3;TIMP2;CST3;ATRAID;IRAK3;DAB2IP;PRKCG;RGP1;TIMP4;SIRT2;SNX3;CDK5RAP3;AZIN1
prerank,positive regulation of cell projection organization (GO:0031346),-0.3120651766762099,-1.1565032904048167,0.18873239436619718,0.6466874640624479,1.0,24/115,9.28%,PLXNA2;ROBO1;DPYSL3;EPHA3;NTRK3;CUX1;CAMK1D;TIAM2;APOE;PLXNA4;SLIT2;ITGA6;MAGI2;ARSB;NDNF;WNT5A;RHOA;PTK2B;RAPGEF1;FZD4;OBSL1;TIAM1;PLXND1;CBFA2T2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.39106780738663005,-1.1562458099816015,0.2557651991614256,0.6465509693428848,1.0,17/38,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,regulation of axon regeneration (GO:0048679),0.5375201706345027,1.1561988412321496,0.30148619957537154,0.7790122684363158,1.0,4/12,8.00%,RTN4RL1;SCARF1;PTN;STK24
prerank,negative regulation of receptor binding (GO:1900121),0.5589496116529452,1.1561835129346811,0.30201342281879195,0.7778739417743965,1.0,2/10,6.59%,ATP2A3;ATP2A2
prerank,glycine metabolic process (GO:0006544),0.5315240832596206,1.1560641053955625,0.3247311827956989,0.7770231109537087,1.0,5/12,15.53%,BAAT;GCSH;GLYAT;GCAT;DLD
prerank,regulation of endopeptidase activity (GO:0052548),0.4107523957973094,1.1554834859240033,0.27303754266211605,0.7772039951338473,1.0,3/59,1.04%,SERPINI1;SERPINB8;VTN
prerank,chromatin remodeling (GO:0006338),-0.31927800445912063,-1.1550306107810098,0.1907356948228883,0.6489679994430411,1.0,28/100,22.86%,SMARCA2;HDAC4;ESR1;KAT2B;BAZ1A;INO80;KDM5B;CHD3;BPTF;BAZ1B;BAZ2B;TADA2A;JARID2;HDAC1;EZH1;MPND;HDAC5;ACTB;SMARCC1;KDM6B;HCFC2;ACTR8;SMARCAD1;RSF1;CHRAC1;MBD2;PIH1D1;SMARCA4
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.3509840253982438,-1.1545394683953547,0.251131221719457,0.6495251254383507,1.0,23/54,35.93%,CFLAR;GAS6;CASP4;BIRC3;TNFRSF1A;CASP8;SPHK1;RIPK1;PTPN2;IKBKG;SYK;RFFL;RACK1;PRKN;PYDC1;TAX1BP1;HSPA1B;LAPTM5;TRADD;SPATA2;ADAM17;FADD;PELI3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.38131505766860035,-1.1544065889878843,0.2603938730853392,0.6490882753941959,1.0,8/35,3.21%,SULF1;FLT1;APOE;SPARC;CAV1;XDH;PTPRM;THBS1
prerank,generation of neurons (GO:0048699),0.3437509275145068,1.1541323290690775,0.22727272727272727,0.7791994769451643,1.0,30/190,12.04%,MEF2C;HEY2;ADGRL3;HEYL;RAPGEF2;CDK6;PER2;MARK1;IL1B;ASTN1;FGF13;DNER;RYK;ASTN2;TAFA3;NTRK2;TUBB2B;CCK;FUT9;IL1RAPL1;MARK2;RNF112;LHX4;RUNX2;DDIT4;SPOCK1;BRSK1;WNT3;YTHDF2;MYT1L
prerank,regulation of innate immune response (GO:0045088),-0.3554727017890874,-1.1540057511621027,0.2426470588235294,0.6493138810826211,1.0,15/57,16.60%,PARP9;APPL2;IRF1;ERAP1;BIRC3;USP18;IFI35;RNF135;CASP8;IRAK3;SAMHD1;GBP5;LRP8;HSP90AB1;RNASEL
prerank,neurogenesis (GO:0022008),0.43067745049177764,1.1539413614892033,0.27037037037037037,0.7784703338161655,1.0,12/43,14.08%,CDK6;BTBD3;CHAC1;ROGDI;RYK;BTBD6;TRAK1;SPOCK1;TRAK2;EPHB1;RITA1;SIX4
prerank,positive regulation of T cell proliferation (GO:0042102),-0.35451791064081895,-1.1536575298391591,0.2585812356979405,0.6494606534283236,1.0,8/55,7.75%,IGF1;IGFBP2;IL15;IL6ST;ANXA1;VCAM1;IGF2;TFRC
prerank,regulation of striated muscle contraction (GO:0006942),0.45570713587514766,1.153391682023714,0.2829076620825147,0.7785124321623959,1.0,4/27,7.49%,DMD;ATP1A2;RYR2;MYL3
prerank,cellular protein catabolic process (GO:0044257),-0.3434793844656522,-1.153098528686137,0.22604422604422605,0.6501941301963658,1.0,19/59,13.89%,ADAMTS12;CTSH;CAPN2;CTSC;DENND3;AP2A2;CLTA;CTSB;CASP8;IDE;DAB2IP;RAB7A;BNIP3L;CTSS;TCIRG1;MDM2;AP2A1;BNIP3;UBE2G2
prerank,neutrophil mediated immunity (GO:0002446),-0.2625044627713279,-1.1529730704978418,0.1005586592178771,0.649705171410003,1.0,119/432,21.44%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;ACE;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,positive regulation of protein processing (GO:0010954),-0.4418228254583091,-1.152774167295908,0.292,0.649448649397948,1.0,4/19,5.46%,GSN;CCBE1;CLEC3B;LPCAT3
prerank,regulation of cell aging (GO:0090342),0.543850727208386,1.1527673802768028,0.3242630385487528,0.7787759119244708,1.0,5/11,20.78%,FOXM1;NEK6;NUAK1;RSL1D1;NEK4
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.4506428797227803,-1.1527159080508909,0.28937007874015747,0.6487841341675833,1.0,6/19,14.15%,WNT4;VIM;BMP4;EMILIN1;TGFB1;CREB3L1
prerank,regulation of macrophage differentiation (GO:0045649),0.5225207992344852,1.1520485941318397,0.3137254901960784,0.7793509285985969,1.0,1/15,0.50%,IL34
prerank,superoxide anion generation (GO:0042554),0.5302704711221861,1.1517273525579208,0.3017241379310345,0.7789605379632797,1.0,3/13,9.84%,NCF2;NCF1;NOX3
prerank,positive regulation of heart contraction (GO:0045823),0.4758568906998879,1.150835369198045,0.2845528455284553,0.7797901583550575,1.0,3/19,6.59%,ATP1A2;RYR2;ATP2A2
prerank,regulation of amyloid fibril formation (GO:1905906),-0.46338048040724433,-1.1501045959735523,0.30451127819548873,0.6548081507127916,1.0,4/15,5.98%,APOE;APP;IAPP;PFDN5
prerank,diterpenoid metabolic process (GO:0016101),-0.34888632672814496,-1.1499702985226072,0.24299065420560748,0.6543432200199539,1.0,10/55,8.16%,ALDH1A1;RBP1;APOE;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;ABCA4;STRA6
prerank,cardiac cell development (GO:0055006),0.5546745337823076,1.1496109184380547,0.3318777292576419,0.781487368221998,1.0,3/11,9.27%,NOTCH1;MYH11;JAG1
prerank,proteolysis (GO:0006508),0.33940718495641903,1.1493343844233612,0.22987012987012986,0.7809716194906654,1.0,23/252,6.31%,ENPEP;GGT5;TMPRSS4;FAP;NAALAD2;GGT1;CPM;METAP2;TMPRSS7;USP25;ADAM19;ATG4A;ECE1;MMP15;ANPEP;TASP1;SVBP;CTSF;ACAN;PSMB11;OGT;DESI1;DESI2
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.256454407223885,-1.1490585654179697,0.05555555555555555,0.6559395716088976,1.0,140/509,19.79%,IGF1;PDGFD;FN1;EGFR;FLT1;DCN;ROCK2;NFAT5;PDGFRA;NTRK3;AKAP13;LPAR1;OSBPL8;VWF;TEK;TGFA;IQGAP1;APP;F3;CAV1;NUPR1;JCAD;SASH1;KSR1;ESR1;TGM2;FGFR2;THBS1;PTPRJ;GJA1;IGF1R;TGFBR1;ANGPT1;MAP3K14;NR3C2;TCF7L2;NOD1;ADGRV1;CFLAR;PDCD4;GSDME;IGF2;DDX60;GAS6;TNFSF10;FGF1;IAPP;LGALS9;WNT5A;RPS20;IKBKE;RHOA;PRKCB;KL;PLK2;MFHAS1;PIK3AP1;FNIP1;FKBP1A;P2RX4;TFRC;BIRC3;EEF1D;TBX1;GOLPH3;USP15;PIK3CB;ADRA1B;NOS1AP;KIT;TNFRSF19;FRS2;ECM1;TNFRSF1A;BCL2L11;IFI35;CDH13;BECN1;EPHA8;FLCN;RPL37;CASP8;DAB2IP;IL18;KDR;TRIM27;MYOC;MAVS;PUM1;TGFB1;TNFAIP8L3;TRIP6;PLEKHG5;FGFR4;RELA;FLT4;FLT3LG;WNT16;PLCG2;SPHK1;MET;RET;TICAM1;TXN;HSP90AB1;CAV2;MAZ;VAPA;RPS15;RPL23;TLR4;PELI1;BID;TRIM8;BCAP31;TCIM;RIPK1;WNT11;PDGFC;TRAF3IP2;ROR2;MAP3K3;PDPK1;ADRB2;CC2D1A;RRAGB;PARK7;TRIM14;LAMTOR5;AGT;CANT1;MST1R;BBC3;PIK3R5;PIM2;EDA2R;LGALS1;CHD5;IKBKG;RHOC
prerank,Rho protein signal transduction (GO:0007266),0.42499496128466524,1.1487348318693829,0.29949238578680204,0.7812929505484595,1.0,9/53,4.60%,EPS8;ARHGAP6;ARHGAP1;ROCK1;WAS;LIMK1;CDC42EP1;RTKN;EPS8L1
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.352978472594043,-1.1486348392144956,0.2408256880733945,0.6563175828301546,1.0,20/51,14.78%,ROCK2;NRP1;LPAR1;CCN2;TGFBR1;SORBS3;PXN;ARHGEF10L;SYNPO2;SYNPO;RHOA;CD47;S100A10;FHOD1;MYOC;PFN1;EVL;SFRP1;LIMCH1;ARHGEF15
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.380400480707623,-1.1485826396318477,0.24618736383442266,0.655648763768139,1.0,8/41,10.88%,IGF1;LBP;CD34;GAS6;LGALS9;IRAK3;ZC3H12A;TRIM27
prerank,histone H3-K36 demethylation (GO:0070544),-0.5258541150591851,-1.1484090810329535,0.2938856015779093,0.6553193798607366,1.0,1/10,0.92%,KDM7A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5495960873740213,1.1482834734923943,0.3298538622129436,0.7812293877458683,1.0,1/10,0.56%,SOX5
prerank,ceramide catabolic process (GO:0046514),-0.4792727734225088,-1.1479107927543566,0.31094049904030713,0.6557834915161109,1.0,5/14,11.63%,ACER2;HEXA;HEXB;ACER3;NAGA
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3567004587527286,-1.1478226911718403,0.23043478260869565,0.6552354903339925,1.0,18/49,27.21%,SGMS1;CAV1;NUPR1;GSDME;P4HB;MCL1;BCL2L11;BECN1;BID;BCAP31;BBC3;PLAUR;EIF2AK3;NDUFA13;BCL2L1;RACK1;TP53;DAPK2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.33375842897574753,-1.147661307104534,0.2169576059850374,0.6548902260069712,1.0,22/75,11.21%,NRP2;NRP1;TEK;F3;PLCG1;JCAD;BMPR2;BMP4;TGFBR1;VEGFD;VEGFC;IGF2;WNT5A;AKT1;PPP1R16B;HIF1A;ECM1;CDH13;FGFBP1;KDR;GATA2;ITGB3
prerank,positive regulation of cholesterol transport (GO:0032376),-0.4047736083181136,-1.1475149104596991,0.2775423728813559,0.654494489488586,1.0,9/27,20.46%,PLTP;APOE;CAV1;LPCAT3;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,ovarian follicle development (GO:0001541),-0.49025725440763823,-1.1473007184089328,0.29791271347248577,0.6542574821104951,1.0,7/13,28.25%,KIT;EIF2B2;CEBPB;VEGFA;EIF2B5;FOXL2;EIF2B4
prerank,monocarboxylic acid transport (GO:0015718),-0.3504950964786076,-1.1471144151437942,0.24429223744292236,0.6539658228093455,1.0,11/51,6.17%,ABCC4;SLC6A13;SLCO2B1;SLC16A2;SLC6A12;SLCO2A1;SLCO1C1;ABCG2;SLC16A1;SLC16A6;SLC16A11
prerank,cardiac muscle cell differentiation (GO:0055007),0.49021598551388956,1.147050864630528,0.3231083844580777,0.7829939820370247,1.0,4/21,6.68%,MEF2C;MYH11;NRG1;SIK1
prerank,regulation of neurotransmitter transport (GO:0051588),0.5126608755498105,1.1470367840224924,0.3276595744680851,0.7818631315391219,1.0,3/16,6.12%,MEF2C;RIMS1;SYN1
prerank,regulation of axonogenesis (GO:0050770),0.41464622265667284,1.1468767329884808,0.2792321116928447,0.7810609894749377,1.0,16/51,11.73%,CHN1;PTEN;CDH2;LINGO1;LRRC4C;PLXNB1;METRN;NTRK2;ROBO2;SLITRK1;MARK2;ARHGAP35;BRSK1;PAK3;PAK1;PLXNB3
prerank,cellular senescence (GO:0090398),0.4851398409746136,1.1468291202484273,0.3047034764826176,0.7800142538635317,1.0,5/27,10.83%,TBX2;TBX3;HRAS;CDKN1A;KAT6A
prerank,positive regulation of locomotion (GO:0040017),0.46111315587898877,1.1465803154381031,0.30425963488843816,0.7794308361694213,1.0,1/27,0.19%,PDGFRB
prerank,activation of protein kinase activity (GO:0032147),-0.30923170521555016,-1.146437295143532,0.19540229885057472,0.6549717024217554,1.0,27/106,14.13%,IGF1;NTRK3;ADCY5;OSBPL8;ADCY1;TGFBR2;NRK;ANGPT1;GHR;GAS6;FGF1;ADCY7;TOM1L1;WNT5A;PTK2B;CARD14;PRKCD;PRRC1;TAOK2;AKT1;CARD10;IL18;ITGB3;COPS8;PRKACB;TXN;PPIA
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.4532676221603793,-1.1456368448063325,0.2879684418145957,0.6562761451104114,1.0,6/15,22.24%,PRKCH;CSF1;IL18;AGT;AGTR1;LPL
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.49908999664183984,1.145394753348159,0.31315240083507306,0.7811389983012732,1.0,2/19,2.35%,NDST3;EXTL3
prerank,I-kappaB phosphorylation (GO:0007252),-0.5147629943089652,-1.1450690716024077,0.30570902394106814,0.6569789091853534,1.0,7/10,43.72%,ERC1;DAB2IP;TLR4;TLR7;MAP3K7;TLR2;TLR3
prerank,energy reserve metabolic process (GO:0006112),-0.44022854815716905,-1.1448700083433856,0.3175542406311637,0.656736324357766,1.0,3/19,1.80%,PRKAG2;LEPR;PHKB
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.3725441474049274,1.1446194960333436,0.265625,0.7817771220069583,1.0,16/102,8.24%,CYSLTR2;SLC30A10;SLC25A33;PIK3R1;GPER1;CPEB1;PRKAR1B;RAB8B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;IRS1;GOT1;PRKAR2A
prerank,regulation of keratinocyte proliferation (GO:0010837),0.47924143401468555,1.1444832410020835,0.31388329979879276,0.7809429215296209,1.0,1/22,0.16%,PTPRK
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4700084245390108,-1.1437546964223766,0.3089887640449438,0.6587997864297186,1.0,8/14,24.02%,AKT1;NNMT;DDB1;PPARGC1A;PTPN2;ARPP19;AKT2;SLC45A3
prerank,detection of visible light (GO:0009584),-0.4673390428710975,-1.143288364536262,0.3288973384030418,0.6592188724459294,1.0,5/16,26.05%,ABCA4;RP1;CACNA2D4;TULP1;GNAQ
prerank,ceramide transport (GO:0035627),-0.499083250590374,-1.1430465104519587,0.2974910394265233,0.6590612993775623,1.0,3/12,10.06%,PLTP;CERT1;PSAP
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5300909972915853,1.1427613820992029,0.32091097308488614,0.783989036771358,1.0,2/12,0.65%,MEF2C;PRKG1
prerank,regulation of cytoplasmic translation (GO:2000765),0.5094886170770783,1.1426758350693935,0.32388663967611336,0.7830637155616536,1.0,6/14,16.87%,CPEB1;RBM24;CPEB4;DHX36;FMR1;PKM
prerank,positive regulation of developmental process (GO:0051094),-0.29466520497630727,-1.1414363372422052,0.18118466898954705,0.6624913449379192,1.0,50/164,22.58%,PLCB1;ZBTB16;DCN;BMP7;CCN2;SLC6A6;APOE;MCU;SHANK3;BMPR2;SMURF2;BMP4;GJA1;FOXD1;ACVR1;ADGRL1;NIBAN2;AR;WNT5A;NR2C2;TFRC;FZD4;RREB1;DAB2IP;KDR;VPS35;TMEM119;CPEB3;LRP8;SHLD1;BNIP3;HSP90AB1;KMT5C;CORO1C;EDN3;BMPR1A;TAPT1;MAP3K13;CEBPB;BASP1;ALK;ZDHHC15;TRPM4;NUMA1;ENPP2;MDK;XBP1;SRF;VEGFA;DDHD1
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.25603498231585886,-1.1412495998783063,0.06504065040650407,0.6621716890543395,1.0,143/532,20.34%,COL1A2;FN1;PLCB1;LEPR;IL31RA;SP100;FOXO1;FOXO3;ADIPOR2;IL15;F3;IL1R1;IL6R;VIM;LBP;ANXA2;IL6ST;PTPRJ;B2M;MAP3K14;RAP1B;NOD1;GHR;ANXA1;CSF1;SOCS2;VCAM1;PDCD4;PITPNA;TNFRSF11B;IL16;IRAK2;CXCL12;IFITM3;APPL2;YAP1;STAT2;MAOA;GREM2;P4HB;IRF1;CCL15;TNFRSF1B;ICAM1;MAP3K8;PTK2B;FOXC1;IRF2;STAT1;CARD14;STAT3;CCL14;STX3;TALDO1;IFI27;BIRC3;TMSB4X;PRKCD;RAPGEF1;IFIT2;PIK3CB;IRF9;AKT1;KIT;MCL1;IL33;HIF1A;OAS2;TNFRSF1A;BCL2L11;IL17RA;IFI35;IFIT3;LAMA5;IFIT1;IRAK3;SAMHD1;IL18;STX1A;EIF5A;PML;PSME2;CAMK2A;TGFB1;PTGS2;INPP5D;CCL25;RELA;S1PR1;PSMB4;FBXW11;FLT3LG;TNFRSF11A;UBB;LRP8;CCND1;FER;UGCG;PSMB1;PPIA;PSMD11;IP6K2;PSMD8;POU2F1;MAPK3;CNTFR;IFITM2;GBP2;MMP2;SDC1;CCL13;IL10RB;PSME3;CEACAM1;CDKN1B;JAGN1;RNASEL;PELI1;JUNB;TRIM8;RIPK1;CSF3R;TRAF3IP2;RSAD2;NFKBIA;MAP3K3;EDA;PSMD4;RPLP0;HSP90B1;PSMA2;IL17RE;CSF2RA;MT3;EDA2R;IL20RB;NDN;CANX;IKBKG;SYK;PSMD3;CSF1R;ADIPOR1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.4717264374907857,1.1412324034965424,0.324853228962818,0.7853985016650322,1.0,5/24,5.37%,LIMS1;PIK3R1;FERMT2;ROCK1;MAPRE2
prerank,mitochondrial genome maintenance (GO:0000002),0.5517085670320269,1.1411954030688913,0.33958333333333335,0.7843302486272438,1.0,2/11,2.36%,SLC25A33;AKT3
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4462904535857836,1.141144090597247,0.27956989247311825,0.7833016033432547,1.0,4/34,4.24%,PDGFRB;PTK2;PIK3R1;FGF2
prerank,regulation of B cell apoptotic process (GO:0002902),-0.4901870984149883,-1.1411069410975632,0.3157894736842105,0.6617649558654746,1.0,2/12,7.16%,FOXP1;FNIP1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.3935915913222822,-1.140723429781415,0.2980561555075594,0.6620530783718919,1.0,18/32,13.65%,JCAD;HDAC7;THBS1;MEOX2;KLF4;FOXC2;ANXA1;HDAC9;RHOA;MAP2K5;CARD10;FGFBP1;KDR;GATA2;PTGS2;RHOJ;SRPX2;HDAC5
prerank,pharyngeal system development (GO:0060037),-0.46586358415945667,-1.1406864440999558,0.3018867924528302,0.661354026159119,1.0,7/15,15.76%,BMP7;BMPR2;BMP4;TGFBR1;TBX1;PTCH1;BMPR1A
prerank,positive regulation of cilium assembly (GO:0045724),0.49972180336274913,1.140650238141579,0.3410041841004184,0.7833652541625391,1.0,9/18,18.59%,ARHGAP35;FUZ;CEP120;KCTD17;CEP135;HTT;HAP1;MARK4;SEPTIN9
prerank,macrophage migration (GO:1905517),-0.4852881082058374,-1.1401525520730325,0.312015503875969,0.6619337036849681,1.0,8/13,38.70%,P2RX4;P2RY12;EDNRB;CCR2;CKLF;CCL2;CXCL17;CCL5
prerank,regulation of cell death (GO:0010941),-0.3178056259642573,-1.1399323113700581,0.24031007751937986,0.6617212402969905,1.0,33/94,19.09%,BMP7;CCN2;RRAS2;BMP4;SRGAP2;LRRK2;RILPL1;ACER2;CCN3;TNFRSF1B;ACER3;PRODH;CCN4;BECN1;ZC3H12A;SLC25A24;CHMP4B;VPS35;BNIP3L;CCN1;UBB;WNT16;BNIP3;CDKN1B;PARP16;CCN5;WNT11;NPAS2;SRSF6;PARK7;RAB29;CHP1;MT3
prerank,negative regulation of immune effector process (GO:0002698),-0.47807796281531467,-1.1399058921487935,0.31433823529411764,0.6609959531191378,1.0,5/13,13.59%,CD55;ENPP3;RPS19;CD47;FER
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3658104418944964,-1.1395801679565385,0.2583518930957684,0.6610242798034697,1.0,12/41,20.19%,PLA2G4A;PTGS1;CYP1B1;DAGLB;GPX4;ACOX1;MGLL;GSTM2;ELOVL1;GPX1;ALOX12;EPHX1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.31539400376781535,-1.1389332349168335,0.20396600566572237,0.6619527012719084,1.0,36/93,23.63%,PLCB1;CCN2;SH3RF1;APP;SASH1;XDH;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP;ZC3H12A;RELL1;FLT4;WNT16;SPHK1;MAPK8IP1;HIPK2;ARL6IP5;MAP3K4;RIPK1;GADD45G;EDA2R;TPD52L1;CCL19;VEGFA;EDAR;KLHDC10;SEMA4C;GADD45B;DUSP15
prerank,stress-activated MAPK cascade (GO:0051403),0.40154070506691186,1.1379220592666828,0.2816666666666667,0.7887126653086928,1.0,7/61,7.58%,MAP3K20;MAP3K5;ARHGEF6;BTRC;MINK1;TNIP2;RIPK2
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5009082102058123,1.1376736770654867,0.3138401559454191,0.7881415091782193,1.0,4/15,9.94%,CHST3;CHST7;CHST2;CHST5
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5281456408499547,1.1373610611314637,0.31063829787234043,0.7877326849296878,1.0,3/10,9.22%,OGT;ZNF692;SDHAF3
prerank,negative regulation of TOR signaling (GO:0032007),0.4432590350597774,1.1370179209972728,0.31992687385740404,0.7874337317196353,1.0,9/36,14.30%,SPAAR;UBR1;SESN3;AKT1S1;NPRL3;DDIT4;UBR2;NPRL2;PRKAA1
prerank,regulation of secretion by cell (GO:1903530),0.40958485441931214,1.1370110663477524,0.2849264705882353,0.7863087420232147,1.0,12/54,11.13%,MEF2C;RAB8B;RHBDF1;RIMS1;RIMS2;RAB3B;SYN1;RIC1;LGI3;SYT1;STXBP5L;STX4
prerank,response to acidic pH (GO:0010447),-0.4685453134917351,-1.1370070770910181,0.3066914498141264,0.6664371093899388,1.0,6/13,24.98%,CTSS;RAB11FIP5;SLC9A1;CHP1;GPR4;PKD1L3
prerank,cytoplasmic microtubule organization (GO:0031122),-0.34618017899575837,-1.1369398816753786,0.26904761904761904,0.6658387316301789,1.0,15/54,20.68%,FIGN;DLG1;EZR;CLIP4;RAB11A;LIMK2;RHOA;SPAST;TRPV4;CCDC88C;TUBGCP5;DYNC1H1;CHP1;SLK;NUMA1
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.4871833886445237,-1.136433172263182,0.30623818525519847,0.6663241961728922,1.0,6/12,8.75%,PLCB1;SLIT2;CCN3;NBL1;DUSP1;AKT1
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.47288634562632537,-1.1362057337502594,0.324577861163227,0.6661043841507652,1.0,5/14,13.61%,ADAM10;WNT5A;PTK2B;WNK1;OXSR1
prerank,extracellular transport (GO:0006858),-0.48117438372205484,-1.1357326971519732,0.30474452554744524,0.6665936476013624,1.0,9/13,39.68%,WWP2;ARRDC1;SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,oxoacid metabolic process (GO:0043436),-0.40457326304431107,-1.13569155694759,0.30985915492957744,0.6659100782547264,1.0,9/27,25.86%,DDO;ENPP1;SULT1A1;TPST1;AGXT;TPST2;PPA1;SULT4A1;GRHPR
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4696940559899012,-1.1353449063107377,0.32245681381957775,0.6660345005378827,1.0,4/14,11.08%,ATP1B3;ACTN2;AKAP9;LRRC38
prerank,negative regulation of cell death (GO:0060548),-0.32412285462719964,-1.1352321134774674,0.2349570200573066,0.6655793876160118,1.0,30/88,19.69%,MECOM;BMP7;CCN2;BMP4;SRGAP2;LRRK2;CSF1;CD34;CCN3;TNFRSF1B;AKT1;CCN4;BECN1;CHMP4B;CHMP4A;VPS35;BNIP3L;CCN1;WNT16;BNIP3;PARP16;CD200;CCN5;WNT11;NPAS2;SRSF6;PARK7;MT3;PPARGC1A;IKBKG
prerank,nuclear migration (GO:0007097),-0.4700932311670273,-1.1348187264754825,0.2870722433460076,0.6659063391112742,1.0,6/13,23.08%,CLMN;SYNE3;SYNE2;FBXW11;DYNC1H1;PAFAH1B1
prerank,regulation of defense response (GO:0031347),-0.329891357644677,-1.1346288305842218,0.24598930481283424,0.6656585477086295,1.0,26/76,13.27%,ADAMTS12;FOXP1;APOE;CASP12;IL1R1;SEMA7A;ANXA1;SBNO2;LACC1;APPL2;CASP4;IRF1;WNT5A;PIK3AP1;ERAP1;BIRC3;TMSB4X;DAGLB;USP18;RNF135;CASP8;SAMHD1;MGLL;PTGS2;RELA;LRP8
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.4685168854001728,-1.1340673639528527,0.3171171171171171,0.6664511137728029,1.0,4/14,16.74%,MOXD1;DAGLB;NOS1;SLC22A2
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3421055600004045,1.1336172513317544,0.24373259052924792,0.7933524700908678,1.0,12/198,4.57%,INPP4B;PTEN;PLCE1;LIMD1;IMPA2;PIK3CD;INPP5A;PIP4K2A;PIK3CA;PLPPR5;PPP3CA;ITPKB
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.4750681227575185,-1.1335757514205849,0.28544423440453687,0.6669438004806912,1.0,1/13,0.32%,ZMIZ1
prerank,Wnt signaling pathway (GO:0016055),-0.31917119229326507,-1.1335146183842866,0.20708446866485014,0.6663485791399132,1.0,27/92,13.90%,NXN;WNT4;PLPP3;WNT6;CPE;TCF7L2;LRRK2;LRP6;LEF1;FZD2;WNT9A;RARG;SFRP4;WNT5A;CSNK1G2;FZD4;USP34;NR4A2;FZD7;VPS35;BCL9L;WNT5B;CCDC88C;UBB;WNT16;PLCG2;SFRP1
prerank,peptide metabolic process (GO:0006518),0.38706521517084735,1.1333860543400598,0.2900158478605388,0.7927787433204381,1.0,6/75,4.12%,ENPEP;DMD;GGT1;CPM;ANPEP;GSTT2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.47518354812666064,-1.1333015060862714,0.332703213610586,0.666150765580513,1.0,4/12,9.83%,ROCK2;APOE;FKBP1A;FLOT2
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.492918849962997,-1.1332994130110985,0.3271375464684015,0.6653853490648216,1.0,1/11,0.32%,ZMIZ1
prerank,negative regulation of cell projection organization (GO:0031345),0.41463759471217315,1.1331972951405955,0.2956989247311828,0.7920754491589507,1.0,7/48,5.15%,PTEN;RAPGEF2;RTN4RL1;PTPN9;ADCY6;SPRY2;MYLIP
prerank,regulation of protein localization to centrosome (GO:1904779),0.5382905811038917,1.1330536777128188,0.34237995824634654,0.7913112302352784,1.0,4/10,18.48%,UBXN2B;APC;GSK3B;MARK4
prerank,response to tumor necrosis factor (GO:0034612),0.37444733596765756,1.1326914467555407,0.27228525121555913,0.7910558957862339,1.0,5/91,1.63%,GGT5;PID1;GGT1;TNFRSF21;GPER1
prerank,negative regulation of transposition (GO:0010529),-0.4562239104426887,-1.132595402217034,0.3134920634920635,0.6664599375624874,1.0,5/16,19.72%,TUT4;MOV10;TUT7;SIRT7;SMYD5
prerank,purine ribonucleotide catabolic process (GO:0009154),0.47939322346411584,1.132406199214801,0.34237995824634654,0.7906411772346675,1.0,2/21,2.42%,PDE4D;PDE9A
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.4059958891176245,-1.1323190047339446,0.30387931034482757,0.6664373639115301,1.0,6/26,17.56%,EPHA4;ROCK2;STAT3;PSME2;PSME3;PRELID1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4638578486423981,1.1322011266807532,0.31176470588235294,0.7900293858351111,1.0,6/23,6.89%,GNG2;ADCY6;PDE4B;SNCA;RYR2;GABPA
prerank,N-glycan processing (GO:0006491),0.49697552662807953,1.1320519629564751,0.3095723014256619,0.7892456342389322,1.0,3/18,2.99%,PRKCSH;ST8SIA4;ST8SIA1
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.522842418864896,1.131800857096788,0.32217573221757323,0.7887536445057731,1.0,4/13,9.94%,CHST3;CHST7;CHST2;CHST5
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3566905015958474,-1.1314872151058526,0.24942263279445728,0.6676995386208661,1.0,25/46,36.58%,PIEZO2;MAP3K14;MAP3K1;PIEZO1;IRF1;TNFRSF1A;CASP8;F11R;BNIP3;MAPK3;TLR4;SLC9A1;MYD88;FAS;CRADD;BCL10;CD40;LTBR;KCNK4;TLR7;FADD;CHEK1;TNFRSF10B;AQP1;TLR5
prerank,positive regulation of interferon-gamma production (GO:0032729),0.41786491097209044,1.1313212832457735,0.29304029304029305,0.7887266566940739,1.0,5/48,8.17%,PDE4D;IL1B;PTPN22;PDE4B;IL12RB1
prerank,intracellular protein transport (GO:0006886),-0.26989685821755766,-1.1311479143292444,0.14423076923076922,0.6678666493959661,1.0,122/304,29.60%,RANBP3L;LAMP2;KIF13B;ARL4A;SGSM2;TBC1D22A;SNX9;SNX6;ARHGEF2;KIF13A;TLK1;SEC31A;COPZ2;RABGAP1L;APPL2;STX7;SMURF1;USP6NL;TBC1D8B;GGA2;STAT3;STX3;COPA;ARFIP2;CCHCR1;EHD1;TBC1D8;RASSF9;AP3B1;AKT1;BAG3;C2CD5;AP4M1;RAB21;STX1A;USO1;STX6;VPS35;LMAN1;RAB7A;RPL11;TBC1D10A;TGFB1;IPO7;FAM53C;IPO13;AP2A1;SCFD2;RAN;CALR;EVI5;ARL5A;SURF4;TBC1D2;PKD1;SEC23IP;NAPA;TBC1D25;RAB3GAP2;NXT2;IPO8;RAB18;HOMER3;TBC1D13;TPR;AP4E1;SAR1A;RAB29;RAB6A;STX2;RAB32;HPS4;CHP1;SAR1B;NUP88;SNX8;RABL3;MAIP1;YWHAH;VPS26C;ARFIP1;VPS28;SYK;TMED9;NUP214;TBC1D14;RAB24;AP3D1;TMED2;WDR11;ACD;NXT1;AP4B1;LTBP2;AKT2;XPO4;TBC1D22B;STX17;TBC1D5;SEC31B;NUP155;ARL4D;TBC1D4;PICK1;RANBP17;TBC1D17;EIF4ENIF1;TBC1D16;RAB19;STX19;SEC16A;CSE1L;PREB;EIF2D;NUP62;ARF4;PTTG1IP;LAPTM5;CTTN;RAB22A;TMED1;TNPO2
prerank,sensory perception of taste (GO:0050909),0.5404720906568142,1.1310187174438182,0.3294930875576037,0.788379248197236,1.0,3/10,12.30%,TAS1R1;ASIC2;ASIC3
prerank,myeloid cell development (GO:0061515),-0.4425790497013088,-1.1309420751915924,0.30739299610894943,0.6676465332426357,1.0,5/18,11.69%,FOXP1;APP;ANXA2;KIT;ALAS1
prerank,response to interleukin-4 (GO:0070670),-0.5068859786860863,-1.1307603531343566,0.3400735294117647,0.6673741161335959,1.0,4/10,24.38%,LEF1;XBP1;SHPK;TCF7
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.477738386317208,-1.1305841438441935,0.31669865642994244,0.6671023252707837,1.0,6/14,19.92%,CD55;TGFBR2;LGALS9;IL18;CD81;SYK
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.48105073418045297,-1.1304345349998137,0.31675874769797424,0.6666820948337187,1.0,4/13,3.45%,BMP6;DAB2;BMP4;TGFBR1
prerank,positive regulation of actin filament polymerization (GO:0030838),0.4171950575113352,1.1303344336927406,0.29981718464351004,0.7888875425639056,1.0,9/44,10.58%,CARMIL1;NCK2;VASP;CDC42EP1;SPIRE1;BIN1;NCKAP1;LMOD1;ARPC4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.4499793701169877,-1.1303176915419575,0.2819548872180451,0.6662166201427485,1.0,5/17,15.33%,BMP4;SFRP4;TMEM100;ATOH8;NKX6-1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.4625060949647344,-1.1299908468038613,0.3265720081135903,0.6662829961133979,1.0,4/15,6.31%,APOE;SNX9;ADAM9;TNFRSF1B
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.36328808120827255,1.1298486375827876,0.2956381260096931,0.7888604796676347,1.0,16/95,16.52%,DYNLL1;PRKAR2B;SCLT1;CSNK1E;DYNC1I2;CEP41;AHI1;NPHP4;CEP97;TUBB4A;TCTN3;DCTN1;DCTN3;CEP76;CEP135;NDE1
prerank,regulation of microglial cell activation (GO:1903978),0.5101741331396671,1.1297043691099202,0.3646055437100213,0.7880495850158099,1.0,3/15,6.28%,LDLR;TAFA3;TTBK1
prerank,glycerophospholipid metabolic process (GO:0006650),0.38157259700273505,1.1291804581668134,0.3034825870646766,0.7880680455985053,1.0,10/75,10.75%,PDGFRB;PLA1A;DGKH;GPCPD1;CPNE7;ABHD3;PLAAT1;GDPD1;PIGZ;PLA2G4E
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3881123318811084,-1.1291440828117658,0.2927835051546392,0.6677092393967458,1.0,11/29,29.08%,SMAD3;TUT4;TUT7;PUM1;SNIP1;AGO1;DICER1;ZC3H7B;ZC3H7A;SMAD2;AGO2
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.3506058083911287,1.1291034552581827,0.2658959537572254,0.7871368031751625,1.0,15/150,5.53%,PDGFRB;PIK3CD;GAB1;GCNT2;PTK2;PIK3R1;SEMA5A;FERMT2;ERBB4;NRG1;PIK3CA;AXL;FGF2;SPRY2;ITGB1
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.39303381174494784,1.129032622719437,0.2791095890410959,0.7862031434600403,1.0,12/65,10.90%,ITGA1;SH3KBP1;AFAP1L2;GPER1;RHBDF1;SPRY2;EPN1;MVB12A;CNOT9;HIP1;DGKD;ARHGEF7
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3750081031934226,-1.129022963626722,0.26639344262295084,0.6672326743251356,1.0,12/37,18.14%,FHIT;TAF1;SDCBP;PML;RPL11;TRIM39;HSP90AB1;HIPK2;RPL23;HFE;RPS7;PARK7
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4855300585261253,-1.1287510083537844,0.336996336996337,0.6671660603181669,1.0,7/12,31.51%,ACADL;CEACAM1;ERLIN2;BRCA1;PIBF1;TRIB3;APOC1
prerank,cellular response to unfolded protein (GO:0034620),-0.3999377908879975,-1.1285633060795073,0.3138075313807531,0.6669068859797758,1.0,11/26,28.08%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;PRKN;HSPA1B
prerank,positive regulation of phagocytosis (GO:0050766),-0.35719334407930237,-1.1285034333626403,0.251131221719457,0.6662977357405226,1.0,13/47,13.32%,CAMK1D;IL15;MYO18A;PTPRJ;GAS6;RAB27A;APPL2;ANO6;CD47;GATA2;C4B;CALR;CYBA
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.370293390278926,1.1284757752755932,0.29901960784313725,0.7864104995559726,1.0,13/83,16.52%,DYNLL1;PRKAR2B;CSNK1E;DYNC1I2;CEP41;DYRK3;TUBB4A;DCTN1;DCTN3;CEP76;KCNH5;CEP135;NDE1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4640670821411902,1.1280378777811932,0.34291581108829566,0.7863028960779125,1.0,5/23,9.95%,SLC12A2;SLC12A6;TFAP2B;SLC9A7;SLC12A5
prerank,triglyceride metabolic process (GO:0006641),-0.36202587846832013,-1.1279970012377256,0.26730310262529833,0.6668614408000366,1.0,4/48,3.14%,APOE;AGMO;CAV1;LPGAT1
prerank,cellular response to interleukin-12 (GO:0071349),-0.3543304533634796,-1.1277949962980827,0.2752688172043011,0.666646740402324,1.0,8/48,7.60%,PLCB1;ANXA2;RAP1B;PDCD4;PITPNA;P4HB;CD47;TALDO1
prerank,response to amyloid-beta (GO:1904645),-0.36115086049573997,-1.1276611095446443,0.28603603603603606,0.6662546650326582,1.0,9/44,6.55%,IGF1;EPHA4;APP;GJA1;IGF1R;SNX6;VCAM1;CASP4;ICAM1
prerank,aortic valve morphogenesis (GO:0003180),0.4545065052062474,1.1269505802038398,0.3262135922330097,0.7878293113171312,1.0,6/30,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,regulation of actomyosin structure organization (GO:0110020),-0.4683385603294818,-1.1268669401823168,0.33268858800773693,0.6676210508012971,1.0,5/13,10.75%,ROCK2;AKAP13;ASAP3;ACTG1;FHOD1
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.42104036666218675,-1.1266314906992156,0.3014256619144603,0.6675228358417563,1.0,10/21,22.45%,IGF1;IGFBP5;GJA1;ADAMTS1;ERN1;MMP2;BMPR1A;P2RY6;DNMT1;NR4A3
prerank,positive regulation of T cell activation (GO:0050870),-0.33333345177745277,-1.126550126976348,0.24504950495049505,0.666994357508099,1.0,19/62,22.30%,ZMIZ1;IL15;IL6ST;ANXA1;VCAM1;LGALS9;CD47;TFRC;FLOT2;SLC7A1;SIRPA;CYRIB;RHOH;PNP;CD81;MDK;CD274;XBP1;CCL19
prerank,heme catabolic process (GO:0042167),-0.4658756751734607,-1.1265287915262938,0.3321616871704745,0.6655506274266814,1.0,2/14,3.98%,SLCO2B1;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.4658756751734607,-1.1265287915262938,0.3321616871704745,0.6655506274266814,1.0,2/14,3.98%,SLCO2B1;ABCG2
prerank,negative regulation of macroautophagy (GO:0016242),-0.399751444893419,-1.1260788505777515,0.2824742268041237,0.6659750724856401,1.0,8/26,11.15%,NUPR1;LRRK2;CLEC16A;NRBP2;AKT1;CHMP4B;CHMP4A;PHF23
prerank,glycogen metabolic process (GO:0005977),-0.39983640084901284,-1.126066371294564,0.2914046121593291,0.6652591321874688,1.0,4/27,6.28%,PRKAG2;PHKB;PHKA2;PYGB
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.46562519946136033,-1.1255332619559473,0.33657587548638135,0.6659498609998205,1.0,3/15,3.30%,IGF1;ROCK2;IL6ST
prerank,regulation of protein metabolic process (GO:0051246),-0.35448199374562994,-1.1254902426317666,0.2853932584269663,0.6653110137831633,1.0,14/44,14.34%,ROCK2;APOE;APP;KLF4;KLF2;LTBP4;ACE;FKBP1A;MAP2K5;HGS;VPS35;MDM2;HSP90AB1;NEDD8
prerank,nerve growth factor signaling pathway (GO:0038180),0.5400286059182374,1.1252513430614854,0.32096069868995636,0.7907609159469066,1.0,2/10,6.90%,RAPGEF2;RAP1A
prerank,regulation of lipid storage (GO:0010883),-0.4115382741383758,-1.124601673558566,0.2876984126984127,0.666853084799272,1.0,9/22,30.54%,IKBKE;ZC3H12A;ITGB3;FTO;NFKBIA;PTPN2;LPL;C3;HILPDA
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.38122073803499146,-1.1236548646859645,0.29653679653679654,0.6685824246036621,1.0,13/31,28.08%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;DNAJB12;PRKN;ATXN3;HSPA1B
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3344347705312883,1.1226121746658013,0.25105189340813466,0.795985891989802,1.0,15/190,3.94%,PDE4D;PTEN;LIMD1;PDE3A;PHLPP1;RORA;UBR1;GPER1;DGKG;NF1;SPRED1;SH3BP1;SH2B3;BCL2L10;ITPR1
prerank,positive regulation of response to stimulus (GO:0048584),-0.36246671008901205,-1.1224953496422798,0.2765072765072765,0.6707565990084654,1.0,9/40,17.63%,IL15;B2M;WNT5A;PRKCD;MAVS;YPEL3;FXR2;HOMER1;RSAD2
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.43031588924905073,1.1224273504986275,0.30798479087452474,0.7952690240554865,1.0,8/32,11.07%,TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA;PKD2;CASQ1
prerank,toxin transport (GO:1901998),-0.4993038496729034,-1.1222205702513364,0.32270916334661354,0.6707825343057827,1.0,4/10,18.29%,ANTXR2;ADAM10;SLC22A2;RAB29
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.43672001859971166,-1.12193323494299,0.3133208255159475,0.6708221679461067,1.0,4/18,14.52%,DAB2;EZR;RAB21;MAPK3
prerank,regulation of fibrinolysis (GO:0051917),0.5104264275159618,1.121808174673504,0.35714285714285715,0.7955731170966972,1.0,1/13,0.68%,FAP
prerank,monocyte differentiation (GO:0030224),-0.4940085572366546,-1.1216459762721247,0.32149532710280376,0.6708454738187056,1.0,3/10,4.16%,IL31RA;BMP4;PIR
prerank,regulation of hydrolase activity (GO:0051336),-0.32784719935797435,-1.1214539217474722,0.2625,0.6705767462035,1.0,20/71,13.19%,PLXNA2;EPHA4;EPHA3;FGD5;FGD6;SIPA1L1;PLXNA4;CHN2;CAV1;VAV2;RASIP1;EFNA5;RAB3GAP1;PLXND1;DAB2IP;ADAP1;FGD4;CAMK2A;FBXW11;TDG
prerank,negative regulation of developmental growth (GO:0048640),0.4410720219706646,1.121219791461025,0.3235294117647059,0.7958165067589589,1.0,10/30,16.81%,PTEN;MAP2;FGF13;CDKN1A;WWC1;FGFR3;MAG;TRIM46;RNF6;SLC6A4
prerank,regulation of B cell proliferation (GO:0030888),0.4267619127294776,1.1211845905002706,0.3302238805970149,0.7947828419456178,1.0,4/44,6.03%,MEF2C;TNFRSF21;CD300A;IL4
prerank,cell projection assembly (GO:0030031),-0.42324197780219,-1.121139209849106,0.31910569105691056,0.6706526220486193,1.0,6/22,18.10%,GSN;RHOQ;PARVB;RHOJ;PARVA;RHOH
prerank,positive regulation of exocytosis (GO:0045921),-0.3744855303092393,-1.1208284996170024,0.29273504273504275,0.6707071639512224,1.0,16/35,30.44%,SDCBP;SMPD3;PDCD6IP;RAB27A;SDC4;HGS;RAB7A;SDC1;SYTL4;RAB2B;EXPH5;RAB3D;ATP6AP1;RAB3A;ATP13A2;CADPS2
prerank,eosinophil migration (GO:0072677),-0.46198044089501344,-1.1207469012049442,0.3440453686200378,0.6694233281974795,1.0,11/14,52.25%,CCL13;CCL2;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.46198044089501344,-1.1207469012049442,0.3440453686200378,0.6694233281974795,1.0,11/14,52.25%,CCL13;CCL2;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,regulation of extracellular matrix organization (GO:1903053),0.5032712737946017,1.1206280215521243,0.35196687370600416,0.7949831307449283,1.0,5/15,11.67%,FAP;NOTCH1;RIC1;EFEMP2;RB1
prerank,positive regulation of transferase activity (GO:0051347),-0.2944626497247779,-1.120371741879153,0.22033898305084745,0.6696837946920154,1.0,39/142,18.96%,EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;LMO4;TEK;FGFR2;EPHB4;IGF1R;KLF4;IGF2;DDR1;TIE1;DTX3L;KIT;NAF1;EPHA8;KDR;TGFB1;FGFR4;EPHB2;FLT4;MET;RET;HSP90AB1;MAPK3;RAD50;SERINC1;CD200;MAP3K4;EPHB3;ROR2;ARRDC4;ALK;MST1R;RFC3
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4770435320240956,1.1203360034630256,0.35039370078740156,0.7945346507062049,1.0,4/19,7.42%,SLC19A1;DHFR;GGH;MTHFD2
prerank,negative regulation of insulin secretion (GO:0046676),-0.44184594462178217,-1.1199906316070394,0.32983193277310924,0.6699387263216343,1.0,9/17,29.25%,CCN3;KCNB1;PIM3;SFRP1;MIDN;SIRT4;PRKN;ADRA2A;CHGA
prerank,melanosome localization (GO:0032400),-0.4276686770709909,-1.1196399978787124,0.3038229376257545,0.6700507098852669,1.0,7/21,20.78%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,negative regulation of developmental process (GO:0051093),0.38941685532383946,1.1195582877181547,0.30307941653160453,0.7952468746037721,1.0,6/69,2.56%,TBX2;HEY2;CDK6;NOTCH1;ROCK1;FOXM1
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5174045831764812,-1.1195577979149034,0.35567970204841715,0.6695255175830181,1.0,3/10,10.31%,ROCK2;IL15;IL18
prerank,histone mRNA catabolic process (GO:0071044),-0.4618637074127936,-1.1193983949069155,0.32592592592592595,0.6692040884550262,1.0,6/15,20.22%,TUT4;TUT7;MTPAP;ATM;XRN1;TENT4B
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.46203063979016723,1.1192370543207424,0.32796780684104626,0.7948525204957194,1.0,7/25,11.14%,CACNA1C;CTNNA3;FGF13;RYR2;ATP2A2;TBX18;RANGRF
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5122658346126506,1.1191293807469913,0.33263157894736844,0.7940017027939452,1.0,6/14,19.05%,WAS;FANCB;TIMELESS;PARP1;MRNIP;FUS
prerank,mRNA splice site selection (GO:0006376),-0.3946671582660048,-1.1190839529735777,0.3037974683544304,0.669309107423432,1.0,10/30,27.11%,CELF2;LUC7L;SRSF10;PSIP1;SRSF6;SRSF5;SF3A3;CELF5;PUF60;SNRPC
prerank,ventricular septum development (GO:0003281),-0.3717868911688565,-1.1189901948930643,0.28633405639913234,0.6688407044710839,1.0,9/37,4.79%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMPR2;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.37873391179174726,-1.1187827657073415,0.28832951945080093,0.6686319076051319,1.0,11/32,25.85%,PPP1R13B;FHIT;DDX5;PML;HINT1;HIPK2;RRP8;RPS27L;STK11;TMEM109;TP53
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.4427986140338598,-1.1186925476479412,0.31589147286821706,0.6681259196038548,1.0,2/17,2.01%,CAMK1D;MCU
prerank,cellular response to interleukin-1 (GO:0071347),-0.2926078150931671,-1.1181727593025446,0.22448979591836735,0.6686973036473628,1.0,45/143,24.89%,PLCB1;ADAMTS12;PTGIS;IL1R1;NOD1;IRAK2;CCL15;MAP3K8;CCL14;CD47;HIF1A;IRAK3;DAB2IP;ZC3H12A;PSME2;CCL25;RELA;PSMB4;FBXW11;UBB;SFRP1;PSMB1;PSMD11;PSMD8;MAPK3;GBP2;CCL13;PSME3;SIRPA;PELI1;NFKBIA;MAP3K3;PSMD4;PSMA2;IKBKG;PSMD3;PSMB7;CCL19;PSMC2;GBP3;USP10;PSMC5;EGR1;PSMD10;MYD88
prerank,regulation of cell development (GO:0060284),0.4234635871102957,1.117786153418996,0.32222222222222224,0.7960083835490673,1.0,4/36,2.62%,HEY2;HEYL;PER2;IL1B
prerank,regulation of secretion (GO:0051046),0.5065244865301798,1.1170857001430103,0.33403361344537813,0.7964926651834993,1.0,4/13,8.18%,NRG1;OPRK1;FGF10;MYO6
prerank,positive regulation of actin nucleation (GO:0051127),0.5117869140064222,1.116960315129685,0.334070796460177,0.7957293107613315,1.0,4/11,10.01%,WASF3;ABI2;WASF2;NCKAP1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.4422429967092557,-1.1165348177216845,0.3319838056680162,0.6720778635403005,1.0,8/18,13.65%,HDAC4;CCN3;FRS2;FZD7;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.4362602103282548,-1.1163919210167175,0.31285988483685223,0.6717168739059454,1.0,3/19,6.17%,DDO;ALDH7A1;ASPA
prerank,cellular response to alcohol (GO:0097306),-0.36410423849060675,-1.1162686523486047,0.3080459770114943,0.6712697292838637,1.0,15/42,13.90%,ADCY5;ADCY1;LRP6;CDH1;SMO;GRAMD1C;GRAMD1A;ADCY7;GOLPH3;ADAM15;CTNNA1;PTCH1;AHR;LARP1;SFRP1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3469965116439351,-1.1160531076562392,0.2548076923076923,0.6711049067011576,1.0,13/50,13.40%,EGFR;NFAT5;APP;SASH1;NR3C2;NOD1;PDCD4;LGALS9;RHOA;IFI35;TRIP6;RELA;SPHK1
prerank,maintenance of protein localization in organelle (GO:0072595),-0.42891948310263744,-1.1154182982251442,0.35067437379576105,0.67204259986863,1.0,9/19,34.51%,HSPA5;HK2;AKT1;PML;TAPT1;HK1;MORC3;PINK1;BCL3
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.35916273030874485,1.1152909450995154,0.2960122699386503,0.7984878289045697,1.0,13/108,6.87%,DLC1;ATP2A3;MAP3K5;COL4A3;GPER1;NODAL;GRAMD4;BCL2L10;CARD9;SNCA;DDX3X;BCL2L13;CASP9
prerank,organelle organization (GO:0006996),0.31401069240744733,1.1149335863974785,0.2567237163814181,0.7982654408977266,1.0,64/388,11.77%,MAST4;PLCE1;LIMD1;ARHGAP21;ARHGAP10;SH3KBP1;SYNE1;SLC25A33;DPYSL2;MARK1;WASF3;SIPA1;ABCD2;PTCD2;TMCC1;TOR1B;ABI2;SORT1;ATP7A;MREG;WASL;COG7;FMNL3;CENPW;FANCG;PEX7;AJUBA;ATP8B2;COG1;CLASP2;FAF2;YTHDF3;ESRRA;CHMP2B;ARFGEF1;HACE1;GABPA;LIG4;BIN1;PAK6;PIKFYVE;VPS18;BLZF1;PEX1;TFAM;RAB38;FAM161A;RNF112;MIA3;PKD2;ZMYM3;TMED7;PAK5;VPS11;UBXN2B;TMED4;KIF3A;DYRK3;TMEM135;ARHGEF7;STX4;KIF5C;PACSIN3;YTHDF2
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4310669224429269,-1.1147200011144758,0.32815533980582523,0.6731674362229809,1.0,2/18,2.01%,CAMK1D;MCU
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4597628740236648,1.1145565768036567,0.3333333333333333,0.7980350778192179,1.0,3/23,3.49%,NOTCH1;ERBB4;CRLF3
prerank,embryonic hemopoiesis (GO:0035162),-0.48199802529668967,-1.1143841146833326,0.3465909090909091,0.6733290606722966,1.0,6/12,15.40%,TGFBR2;KIT;KDR;FLT3LG;TAL1;ZFPM1
prerank,regulation of AMPA receptor activity (GO:2000311),0.4561792708461939,1.1140771560835039,0.3140655105973025,0.7981029663404573,1.0,3/25,4.29%,MEF2C;CACNG7;MINK1
prerank,endothelial tube morphogenesis (GO:0061154),-0.498742962882325,-1.113594340997555,0.34962406015037595,0.6746303004190697,1.0,4/10,7.28%,BMP4;ACVRL1;RHOA;RHOB
prerank,MAPK cascade (GO:0000165),0.32486157641660635,1.1128600869571488,0.2496798975672215,0.7998683320714571,1.0,55/295,13.55%,PDGFRB;MEF2C;MAP3K20;RAPGEF2;MAP3K5;PTK2;PIK3R1;BTRC;RASGRP3;IL17RD;NF1;SPRED1;GFRA2;ERBB4;IL1B;CUL3;NRG1;PIK3CA;IL2RA;RBX1;SPTBN1;RASAL2;JAK1;FGF13;FGF2;MINK1;RIT2;PSMB11;SPTB;TNIP2;TAOK3;PSMF1;SPTA1;HRAS;IRS1;FGF10;PPP1CC;MAP4K4;PDGFB;GRIN2B;DLG2;RGL3;BRAF;KBTBD7;PAK1;RASGEF1A;PSME4;RGL1;GFRA1;DLG3;FGFR3;RASA3;NRG4;SYNGAP1;RASA1
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.4702260297240851,-1.112600527036528,0.35477582846003897,0.6765309232765458,1.0,7/12,24.85%,ACTG1;LAMA5;LAMA3;ACTB;VANGL2;ZDHHC7;SCRIB
prerank,positive regulation of mitochondrial translation (GO:0070131),0.5158581458231987,1.1124971676407682,0.3626609442060086,0.7996000804856696,1.0,6/14,16.51%,FASTKD2;MRPS27;FASTKD3;TRMT10C;RMND1;C1QBP
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5041349518996954,-1.1122202464483808,0.3381818181818182,0.676801389259868,1.0,5/11,31.27%,LGALS9;TWSG1;CD274;CBFB;VSIR
prerank,import into nucleus (GO:0051170),-0.3233726492946942,-1.1122163968421335,0.26737967914438504,0.676072187156583,1.0,29/73,29.60%,APPL2;STAT3;GEMIN7;AKT1;BACH2;IPO7;FAM53C;IPO13;RAN;GEMIN5;SNRPF;NXT2;IPO8;SNRPD1;SNRPD2;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;SNRPB;EIF4ENIF1;SNRPE;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4542403983558777,1.1121380627524986,0.34285714285714286,0.7993776920537965,1.0,2/28,1.34%,PTEN;PTK2
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4447018091716103,1.1119235335424906,0.3416506717850288,0.7988099688832835,1.0,3/30,2.02%,CSPG4;CHST3;CHST7
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4914232070323073,1.1118569789351573,0.32916666666666666,0.7978739916280392,1.0,3/17,11.86%,COX4I2;COX4I1;COX5A
prerank,cellular response to hydroxyurea (GO:0072711),0.5445214010513834,1.1118313359148446,0.3682983682983683,0.7968725294929702,1.0,5/10,19.55%,TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,negative regulation of transmembrane transport (GO:0034763),-0.49922324974797894,-1.1112872302494439,0.3373253493013972,0.677728606390741,1.0,4/10,8.75%,THBS1;CTTNBP2NL;PRKCB;AKT1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.428426748262551,-1.1109255447885162,0.3346303501945525,0.6779823621671829,1.0,6/19,20.30%,ENPP1;SLC26A2;PAPSS2;SULT1A1;TPST1;TPST2
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.3688783195481463,-1.1108442855437848,0.30973451327433627,0.6774853608989081,1.0,13/32,19.26%,IGF1;APP;NUPR1;TMSB4X;HIF1A;P2RX7;PPARA;ENTPD5;ENO1;BEND3;PRKAA2;PPARGC1A;VCP
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.40259281761147914,-1.1104298733200484,0.3408624229979466,0.6777714663747544,1.0,7/25,13.39%,CD55;B2M;LACC1;WNT5A;SLC7A5;KIT;PLCG2
prerank,response to fatty acid (GO:0070542),0.49059317425270255,1.1100632592205464,0.36507936507936506,0.7999232554067445,1.0,3/17,7.20%,PID1;FFAR2;IRS1
prerank,protein glycosylation (GO:0006486),-0.2944507548561325,-1.109382442643892,0.2310126582278481,0.6797618075032473,1.0,35/125,20.99%,ST3GAL4;LARGE1;B4GALT1;ST3GAL6;MAN1C1;ST3GAL1;ST3GAL2;EOGT;STT3A;PLOD2;ST3GAL3;TET3;STT3B;FUT8;MGAT1;ST6GALNAC2;B3GALNT1;SERP2;ST8SIA2;SLC39A8;POGLUT1;MGAT2;GFPT2;ENTPD5;ALG6;PLOD1;AQP11;ST3GAL5;RPN2;GFPT1;DOLPP1;ST8SIA5;PLOD3;B3GALNT2;MOGS
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3742383294367766,1.1092449761852077,0.3140495867768595,0.8007329213192271,1.0,11/74,5.26%,PTEN;GCNT2;BMP5;RGCC;PHLDB2;FERMT2;IL17RD;SPRED1;IL1B;SPRY2;CLASP2
prerank,synaptonemal complex assembly (GO:0007130),0.49676256960316334,1.1087484311086926,0.33739837398373984,0.7997455890170067,1.0,5/15,17.01%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,synaptonemal complex organization (GO:0070193),0.49676256960316334,1.1087484311086926,0.33739837398373984,0.7997455890170067,1.0,5/15,17.01%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,organic cation transport (GO:0015695),-0.4181507995335954,-1.108569657466965,0.35080645161290325,0.6811194800446723,1.0,9/20,20.26%,SLC47A1;SLC22A4;SLC22A5;SLC22A18;SLC25A19;SLC22A2;SLC25A26;SLC25A29;SEC14L1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.443697990111969,1.1084641389580545,0.3264150943396226,0.799315457810048,1.0,4/25,9.19%,NDST3;B3GALT1;FUT9;B3GNT8
prerank,embryonic eye morphogenesis (GO:0048048),-0.4900778220399282,-1.1082545564550084,0.3557312252964427,0.6812441252820021,1.0,6/11,6.60%,FBN1;EFEMP1;MFAP5;LRP6;RARG;FBN2
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.510240672730782,1.1078336540121052,0.36210526315789476,0.7996528455689679,1.0,3/13,8.40%,CACNA1H;SCAMP5;SYT1
prerank,T cell mediated immunity (GO:0002456),-0.46195574415183416,-1.1078046501543597,0.33911368015414256,0.6816633619429083,1.0,2/13,2.13%,CTSH;CD55
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.3305728680203582,-1.1077857375754048,0.271264367816092,0.6809864797876066,1.0,11/56,8.75%,PLCB1;EGFR;RAB11A;ANXA1;ADAMTS1;CDC16;CCND2;CCND3;RAD51B;UBE2E2;AKT1
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.45353422114330977,1.106693740924725,0.32926829268292684,0.8011998913645324,1.0,7/26,10.94%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7;TMEM108;CUX2
prerank,steroid biosynthetic process (GO:0006694),0.3963740651532326,1.1062793620958706,0.3298429319371728,0.8010555512893398,1.0,17/56,15.83%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6;SQLE;LSS;DHCR7;STAR;TM7SF2;PRLR;SRD5A1;CYP11B1;OSBPL7;HSD3B7;HMGCR;ACOX2
prerank,catecholamine metabolic process (GO:0006584),-0.44654785830611476,-1.1061497807046998,0.3659491193737769,0.6844314253452126,1.0,1/14,0.58%,SNCAIP
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.49436562783701676,1.10614338498205,0.3888888888888889,0.8002923390147412,1.0,2/16,1.99%,CLDN10;CLDN15
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.3928195449477939,-1.1057443963922795,0.33958333333333335,0.68478471624198,1.0,15/27,39.14%,MAP3K1;IRAK2;IRAK3;UBB;TLR4;MYD88;MAP3K7;CD36;LY96;TLR6;TLR1;TLR5;TAB2;CD14;TLR2
prerank,innate immune response in mucosa (GO:0002227),0.5248130705461046,1.105485139130521,0.34782608695652173,0.8007117022247549,1.0,2/10,6.03%,CAMP;IL4
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4937311268690581,-1.1052788637845303,0.33826247689463956,0.6852642761366371,1.0,1/10,2.26%,ST3GAL1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.41209520972219293,1.1048603820504146,0.33094812164579607,0.801163455912159,1.0,14/44,15.83%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;SQLE;PSAT1;DHCR7;TM7SF2;OSBPL7;HSD3B7;HMGCR;ACOX2
prerank,development of primary male sexual characteristics (GO:0046546),-0.37040848135143845,-1.1042666751845605,0.2923728813559322,0.6872044353919184,1.0,6/34,12.77%,WNT4;LHFPL2;AR;WNT5A;KIT;GATA6
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2981739868951352,-1.1040940869783595,0.26912181303116145,0.6869294272376315,1.0,43/113,25.85%,UNC13B;TRABD2B;ABCA1;CDH5;ESR1;RAP1B;ASAP1;PIEZO1;RASIP1;FNIP1;TFRC;ERCC5;BCL2L11;DAB2IP;CUL4A;GBP5;TGFB1;SH3GLB1;ATM;TAL1;DDB1;RPA1;TLR4;BID;PARK7;VCP;RHOC;SYK;PLEK;LCP1;VEGFA;PIH1D1;ICE1;ERCC1;PSMC2;ERCC2;PSMC5;RPA3;MYD88;RPS3;RACK1;ERCC3;TP53
prerank,positive regulation of protein depolymerization (GO:1901881),0.5205942720495513,1.103539897356734,0.345679012345679,0.8030925907451151,1.0,3/11,11.94%,SEMA5A;NES;CFL2
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4564232479796699,1.1029833575376577,0.36585365853658536,0.8033620971205492,1.0,7/21,13.12%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,regulation of superoxide anion generation (GO:0032928),-0.45479407923519927,-1.1029812887820956,0.34935304990757854,0.6889795363260409,1.0,6/14,27.51%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,intermediate filament organization (GO:0045109),-0.43518713845407053,-1.1023824609219446,0.34689922480620156,0.6898308373244258,1.0,6/17,28.88%,VIM;GFAP;DNAJB6;BFSP1;DSP;BFSP2
prerank,lymphocyte proliferation (GO:0046651),0.4668826379671538,1.1022439631222323,0.36016096579476864,0.8039789823649325,1.0,1/22,0.63%,MEF2C
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3767166779313307,-1.1021661248279726,0.3235908141962422,0.6896492685984147,1.0,11/30,18.79%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,aspartate family amino acid metabolic process (GO:0009066),0.4788957319853455,1.1012163418929821,0.3441295546558704,0.8052585391376315,1.0,4/18,8.11%,NAALAD2;SLC25A13;MSRA;GOT1
prerank,cellular response to copper ion (GO:0071280),-0.4392498599866541,-1.1006410283058679,0.3301526717557252,0.6928258737121175,1.0,9/16,20.00%,MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,renal water homeostasis (GO:0003091),0.4619982582416128,1.100566194114424,0.3423076923076923,0.8056346619322016,1.0,10/23,10.18%,PRKAR1B;ADCY8;ADCY3;ADCY6;TFAP2B;PRKAR2B;ADCY9;PRKAR2A;RAB11FIP2;PRKAR1A
prerank,negative regulation of protein binding (GO:0032091),0.3793795069635733,1.099973510053731,0.3338735818476499,0.8059266701475342,1.0,11/71,9.33%,ITGA4;ATP2A3;MAP2;ROCK1;GNL3L;TTBK1;ATP2A2;CDKN1A;NES;PDGFB;CSNK1E
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3865980922065547,1.0996700681360745,0.3175438596491228,0.8055538610193071,1.0,14/69,14.08%,SLC30A10;MEF2C;AGAP2;UNC5B;NTRK2;LIG4;PPT1;NFATC4;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,renal filtration (GO:0097205),-0.49401213169799846,-1.099418364092471,0.3320754716981132,0.6952166444445139,1.0,5/10,6.49%,SULF1;ITGA3;CD34;SULF2;TBC1D8B
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5068026753075379,1.0990990883962646,0.3649789029535865,0.805813228781171,1.0,2/11,8.17%,CARD9;IL12RB1
prerank,regulation of cilium movement (GO:0003352),-0.48611082843838793,-1.0990988772148502,0.35583941605839414,0.6953626260382803,1.0,6/10,39.28%,CFAP43;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,negative regulation of defense response (GO:0031348),-0.3106139787647923,-1.0989023964432583,0.27877237851662406,0.6951047463215211,1.0,17/77,12.45%,CDH5;PTGIS;TEK;APOE;KLF4;CCN3;LPCAT3;ENPP3;MFHAS1;PRKCD;C1QTNF3;PCBP2;TNFRSF1A;IRAK3;METRNL;VPS35;PPARA
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3548312601206689,-1.0988531406677695,0.30973451327433627,0.6944952721075471,1.0,11/40,8.71%,DAB2;SMAD3;COL1A1;PDPN;TGFBR2;TGFBR1;TCF7L2;LEF1;SDCBP;FOXC1;TIAM1
prerank,neuron development (GO:0048666),0.3436773677630158,1.0987551653840535,0.30857142857142855,0.805530255000957,1.0,20/141,9.76%,FRY;MEF2C;RAPGEF2;MAP2;ETV1;ROCK1;ATP7A;CNTNAP2;RYK;LAMB1;CNTN4;NTRK2;B4GALT6;PPT1;TENM4;BLOC1S1;LYN;TMEM108;ACTL6B;PLP1
prerank,insulin receptor signaling pathway (GO:0008286),-0.3253557625848583,-1.098686761659241,0.3036144578313253,0.6942116146931011,1.0,22/69,15.25%,SORBS1;RHOQ;FOXO1;IGF1R;BAIAP2;FOXC2;AP3S1;ATP6V0A4;IGF2;SLC39A14;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;ATP6V0A1;TCIRG1;FER;CAV2;ATP6V0A2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5018066322047343,-1.0983508512559932,0.36059479553903345,0.6943899865522857,1.0,4/10,28.72%,SH3RF1;CBFB;NCKAP1L;SOCS1
prerank,regulation of inclusion body assembly (GO:0090083),-0.48303220926761964,-1.0982573985114363,0.34615384615384615,0.6939061158052791,1.0,4/11,15.71%,SNCAIP;DNAJB2;DNAJB6;DNAJA4
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.43315253932444325,-1.0982104584981651,0.3404669260700389,0.6932910323374131,1.0,5/16,11.02%,JCAD;THBS1;PPP1R16B;FGFBP1;GATA2
prerank,platelet aggregation (GO:0070527),-0.3749198478697794,-1.0978870051301857,0.315450643776824,0.6933636632493689,1.0,10/33,14.13%,FN1;PDGFRA;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;ACTB;PPIA
prerank,response to gamma radiation (GO:0010332),0.45043128987739256,1.0973238282386693,0.3463035019455253,0.8077377694826949,1.0,8/24,17.88%,MAP3K20;LIG4;HRAS;ATR;FANCD2;PRKAA1;HSF1;TLK2
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.5032542808048425,-1.0972128781638313,0.35208711433756806,0.6943492238262605,1.0,4/10,20.81%,PLA2G4A;PLA2G6;PLA2G15;ENPP2
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5065935345819792,1.0970327679804521,0.3705357142857143,0.8073043821777064,1.0,2/12,5.14%,PARP8;TNKS
prerank,anterior/posterior axis specification (GO:0009948),0.4897504588308339,1.0968116083640458,0.360082304526749,0.8067119317029882,1.0,4/15,15.63%,TBX3;CDX1;WLS;TASOR
prerank,icosanoid metabolic process (GO:0006690),0.40885243522966075,1.0967736788757054,0.32656826568265684,0.8057351715361896,1.0,2/40,0.87%,GGT5;GGT1
prerank,somite development (GO:0061053),-0.46856093602708443,-1.0967522821705455,0.3698630136986301,0.694818392355787,1.0,3/11,11.87%,MEOX2;SMO;PTCH1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4316732532314171,1.0965828152655537,0.3660377358490566,0.8050946452660518,1.0,5/34,5.83%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.40851020621442985,-1.0963580192835949,0.3193116634799235,0.6951372618563803,1.0,5/24,9.53%,ERRFI1;ROCK2;PRKCH;FOXC1;TRIM16
prerank,phosphatidylserine metabolic process (GO:0006658),0.43496225985119924,1.0956624287810501,0.3568627450980392,0.806218159014811,1.0,2/32,0.84%,MBOAT2;PLA1A
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.31603538030878076,1.0955828446150775,0.3051948051948052,0.8053431461692454,1.0,25/260,6.90%,DYNLL1;CARMIL1;RAPGEF2;AIF1L;NOTCH1;ARHGEF6;MYLK;VCL;DZIP1L;IFT43;RILPL2;SPEF1;RAB8B;TTLL3;CYS1;MINK1;TTC36;IFT81;CCDC57;IFT20;ITGB1;NEK1;SCLT1;EMP2;RAP1A
prerank,negative regulation of viral life cycle (GO:1903901),-0.4537194089479306,-1.094802754206736,0.3611650485436893,0.6984174559168537,1.0,7/15,22.66%,GSN;LY6E;IFITM3;PPIA;IFITM2;SNX3;TRIM11
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4646884050485114,-1.094237287385434,0.3395872420262664,0.6991272632188645,1.0,4/13,16.54%,NAMPT;IL33;KDR;TLR4
prerank,positive regulation of cell population proliferation (GO:0008284),0.30521915182763915,1.0942230599011202,0.2597560975609756,0.8074253553516242,1.0,47/423,7.92%,PDGFRB;PTEN;TBX2;IL34;S1PR3;MEF2C;PID1;GCNT2;CDK6;BMP5;NOTCH1;TBX20;SLC25A33;RBPMS2;PTK2;GPER1;LAMC1;TBX3;NODAL;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;TBX6;MECP2;PDCD10;FGF2;SPDYA;LAMB1;SCN5A;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;CXCL5;SOX4;CHRNA7;EMP2;LIG4;HRAS;IRS1;FGF10;CDKN1A;NES
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.3837527558462116,-1.0941556734491091,0.3276595744680851,0.698609669266719,1.0,13/31,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,positive regulation of neuron projection development (GO:0010976),0.3724427988529666,1.0935367730230632,0.3274760383386581,0.8079862649347972,1.0,22/85,11.73%,SERPINI1;RAPGEF2;BMP5;ROR1;SCARF1;PTN;PLPPR5;ATP1B2;RIT2;NTRK2;CAPRIN2;RAP1A;FUT9;MARK2;LYN;ARHGAP35;TOX;ABL2;VLDLR;CUX2;EP300;PLXNB3
prerank,positive regulation of cytokinesis (GO:0032467),-0.37477581564918305,-1.0926401434734339,0.304635761589404,0.7018501805188635,1.0,6/32,10.29%,PKP4;CDC14A;PRKCE;RHOA;SVIL;SPAST
prerank,receptor-mediated endocytosis (GO:0006898),0.3399557763154292,1.0926351866602948,0.32805755395683456,0.809020766235931,1.0,22/132,10.80%,SGIP1;COLEC12;IGF2R;SCARB1;SCARF1;LDLRAP1;LDLR;GRK3;ACKR3;LRP1B;AP1G1;MSR1;ITGB1;CXCR2;SNCA;PPT1;PIKFYVE;AP2S1;TMEM108;AP2B1;RABEPK;VLDLR
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.45808292063866163,-1.091925143804349,0.3766478342749529,0.7029389587911404,1.0,4/13,10.61%,NRP1;TGFBR2;SEMA3E;KDR
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.3016161420973917,-1.091748462793571,0.27956989247311825,0.7026760400352275,1.0,31/90,20.98%,LEPR;ADIPOR2;CAV1;GJA1;IGF1R;APPL2;PRDM16;CPT2;GNAS;CMKLR1;EHMT1;IL18;ESRRG;ACADL;KDM3A;UCP2;PRKAB1;KDM6B;CNOT3;FABP5;MFAP2;PDGFC;DYNC1H1;ADRB2;CEBPB;GADD45G;PPARGC1A;SYK;ADIPOR1;ALMS1;DECR1
prerank,cardiac myofibril assembly (GO:0055003),0.5041260938588978,1.0900668257766073,0.3611111111111111,0.8138702130857037,1.0,1/15,0.19%,PDGFRB
prerank,nuclear membrane organization (GO:0071763),0.47064415422969275,1.0898274344845806,0.37675350701402804,0.8133227231195157,1.0,6/19,16.33%,GPER1;TOR1B;UBXN2B;EMD;DCTN1;TOR1A
prerank,protein insertion into membrane (GO:0051205),-0.3705113865824345,-1.08968714999758,0.34549356223175964,0.7073120478513423,1.0,12/32,24.11%,EGFR;APP;TRAM2;STX1A;ALDH3A2;VAPA;REEP1;GET1;MAIP1;SEC61B;WDR83OS;CCDC47
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3891306745907708,-1.0887611139535323,0.3473684210526316,0.70819151393611,1.0,6/23,15.04%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3891306745907708,-1.0887611139535323,0.3473684210526316,0.70819151393611,1.0,6/23,15.04%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,protein localization to membrane (GO:0072657),0.32824761259779534,1.0884869579188383,0.3168724279835391,0.8154693795408965,1.0,35/187,11.68%,LIN7A;ITGA4;CACNB2;RAPGEF2;FERMT2;ROCK1;RFTN1;PTN;RAB8B;TSPAN15;NRXN1;SPTBN1;AGRN;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;RAB38;EHD3;ZDHHC2;NKD2;EPHA2;TSPAN17;DLG2;ARL5C;NPC1;BRAF;NDC1;KCNIP4;PPIL2
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4783783763898435,1.0884019145922326,0.3540856031128405,0.8146274636136973,1.0,2/16,3.70%,SLC25A33;ATP7A
prerank,response to lipopolysaccharide (GO:0032496),0.3450035383988499,1.0881465272122817,0.3213728549141966,0.814132146165377,1.0,15/138,6.42%,GGT5;MEF2C;GGT1;NR1H3;SCARB1;IL1B;PTPN22;AXL;CXCL10;OTUD5;TNIP2;PDE4B;CXCL5;SNCA;CACTIN
prerank,actin crosslink formation (GO:0051764),0.5091042630335963,1.0870716463573447,0.3728448275862069,0.8156266429727356,1.0,1/12,0.31%,EPS8
prerank,photoreceptor cell development (GO:0042461),0.48734442525359956,1.0869576589271879,0.38412017167381973,0.8148190204623552,1.0,1/14,0.82%,RORB
prerank,carboxylic acid transport (GO:0046942),-0.33278135943597037,-1.0868600871125595,0.29280397022332505,0.7124012783919783,1.0,18/55,15.93%,SLC6A13;SLC13A3;SLC16A2;SLC6A6;SLC6A12;SLC16A1;SLC16A6;SLC16A11;SLC6A9;SLC7A5;PSAP;SLC38A5;SLC3A2;SLC38A6;SLC16A13;LLGL2;SLC66A1;SLC7A1
prerank,negative regulation of response to wounding (GO:1903035),0.4550390142957458,1.0867336870897875,0.366,0.8142745487551084,1.0,3/19,4.24%,AJAP1;RTN4RL1;FGF2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4479207904910735,-1.0866982215272165,0.3762575452716298,0.7120473779498017,1.0,10/15,43.78%,MDM2;TAF9B;CD44;PRKN;PTTG1IP;KDM1A;CD74;MUC1;TAF9;MIF
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.44473555828841327,-1.0860921555095668,0.37667304015296366,0.7129307413786282,1.0,5/16,14.15%,WNT4;VIM;BMP4;TGFB1;CREB3L1
prerank,inner ear morphogenesis (GO:0042472),-0.403750512203747,-1.0860366982464598,0.33925049309664695,0.7123357753781967,1.0,6/22,12.29%,CHD7;FGFR2;SIX1;TTC39C;TBX1;EPHB2
prerank,plasma membrane invagination (GO:0099024),-0.37678926048318073,-1.0857799540486068,0.3504273504273504,0.7122773406516628,1.0,5/29,6.58%,GULP1;GSN;ELMO1;SNX9;RHOA
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.40613819987110034,1.0855740796951283,0.3692022263450835,0.8159488158617116,1.0,6/39,6.03%,ITGA4;SEMA5A;RGCC;GPER1;TNIP2;IL4
prerank,coenzyme A biosynthetic process (GO:0015937),0.5103066970563638,1.0850901392841064,0.37583892617449666,0.8139643360160276,1.0,6/11,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5103066970563638,1.0850901392841064,0.37583892617449666,0.8139643360160276,1.0,6/11,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5103066970563638,1.0850901392841064,0.37583892617449666,0.8139643360160276,1.0,6/11,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.43166169892540873,1.0849216372819734,0.3192771084337349,0.8132534435157286,1.0,2/27,2.21%,PLA2R1;SPRED1
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38313444984591316,-1.0844876291021295,0.34934497816593885,0.7149066457518801,1.0,9/27,19.00%,ABCA1;PRKCH;CSF1;IL18;ITGB3;PPARA;NFKBIA;AGT;AGTR1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3400492449179013,-1.0843655488640795,0.29009433962264153,0.7144779842914745,1.0,23/52,29.31%,PPP1R13B;NPEPPS;TFDP2;CASP8;SH3GLB1;TOMM7;SAE1;PPP3CC;LEPROT;BID;BBC3;HPS4;E2F1;YWHAH;USP36;BAP1;YWHAE;TP53;SFN;FZD5;TFDP1;RHOU;NMT1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.39064025832808086,-1.0843296390209287,0.3444676409185804,0.7138607761557835,1.0,8/26,11.88%,ROCK2;ASAP3;SHANK3;SYNPO2;SYNPO;ACTG1;FHOD1;PFN1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.36567919638906227,1.0841310963187059,0.3235772357723577,0.8140092996341659,1.0,10/80,4.60%,EPS8;PLCE1;PIK3R1;PIK3CA;CDC42EP1;ABI2;PLPPR5;WASL;AGRN;EPS8L1
prerank,regulation of fibroblast proliferation (GO:0048145),-0.3449403248045831,-1.0839945530860509,0.32400932400932403,0.7139510144850612,1.0,15/45,19.25%,IGF1;FN1;PDGFRA;SKI;GAS6;WNT5A;S100A6;DAB2IP;SPHK1;SFRP1;NDUFS4;PDGFC;FTH1;AGT;E2F1
prerank,negative regulation of phagocytosis (GO:0050765),0.48907259254724955,1.0836970390090268,0.388646288209607,0.8139137810310291,1.0,3/17,6.72%,DYSF;CD300A;APPL1
prerank,positive regulation of protein import (GO:1904591),-0.37363943975244823,-1.083484494851199,0.3313253012048193,0.7145240442809632,1.0,10/30,17.87%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN;TPR;PDCD5
prerank,phospholipid dephosphorylation (GO:0046839),0.4167603497970398,1.0832498949097615,0.3704379562043796,0.8139122600032619,1.0,13/37,19.66%,PTEN;PLPPR5;INPP5J;MTMR12;MTMR7;INPP5B;SACM1L;MTMR11;PLPPR2;PIP4P1;PLPPR1;SGPP1;TPTE
prerank,response to glucocorticoid (GO:0051384),-0.38609543268588664,-1.0831803256600767,0.3473895582329317,0.7145754149070106,1.0,5/26,9.51%,NR3C1;SLIT2;ANXA1;ADAM9;BCL2L11
prerank,negative regulation of cell activation (GO:0050866),-0.4453331483192977,-1.0829802042143422,0.36553030303030304,0.7143885634566366,1.0,4/14,3.29%,PDGFRA;APOE;NOS3;THBD
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3192482108441231,-1.082768659883764,0.3157894736842105,0.7141871568628332,1.0,16/66,13.00%,SMAD3;CDH1;LIMK2;PARP9;YAP1;TFRC;PRKCD;AKT1;DTX3L;BAG3;PINX1;CARD10;ZC3H12A;MAVS;TGFB1;RAN
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.4852107915144761,-1.0826904060056262,0.3877917414721723,0.7136785097163205,1.0,3/10,10.02%,SETD7;KMT5A;EHMT1
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.418781219567234,1.0826202614926872,0.38372093023255816,0.8142807095556573,1.0,10/32,13.12%,MAP2;SPEF1;FGF13;NAV3;CLASP2;SNCA;CAMSAP3;APC;TUBB4A;APC2
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.3933744114165243,-1.0826045839650604,0.3484251968503937,0.7132064552255797,1.0,9/24,12.65%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4
prerank,apoptotic cell clearance (GO:0043277),-0.38287085405098414,-1.0821494734976367,0.346723044397463,0.7137228842462713,1.0,6/30,5.09%,RHOBTB1;TGM2;THBS1;TXNDC5;ANXA1;GAS6
prerank,extracellular matrix assembly (GO:0085029),0.4418518298949303,1.0821475710665083,0.3643724696356275,0.8144189955605813,1.0,6/23,5.23%,TNXB;MYH11;ATP7A;PXDN;NTNG2;LAMB1
prerank,sterol transport (GO:0015918),0.45895536374454393,1.0820970386287747,0.3558282208588957,0.8135033882047389,1.0,5/19,10.78%,LDLRAP1;ARV1;LDLR;MSR1;NPC1
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.37902785621576573,-1.0818268342908608,0.3531827515400411,0.7138102365430947,1.0,13/29,25.22%,CNOT7;STAT2;WNT5A;USP18;NLRC5;SAMHD1;MAVS;HSP90AB1;RNASEL;PTPN2;PTPN6;TRIM6;ZBP1
prerank,regulation of neuroblast proliferation (GO:1902692),0.483115332466662,1.0817506718950214,0.3752535496957404,0.8132464563455625,1.0,3/15,4.96%,NF1;PTN;TAFA3
prerank,regulation of microtubule nucleation (GO:0010968),0.5136624546359931,1.0810666317968662,0.37748344370860926,0.8137876977542948,1.0,5/10,13.85%,MECP2;ARHGEF7;RANGRF;PAK1;DCTN1
prerank,ether lipid biosynthetic process (GO:0008611),-0.4840992083069118,-1.0807243396120976,0.3607843137254902,0.7160330409950758,1.0,1/10,1.12%,PLA2G4A
prerank,iron ion transport (GO:0006826),-0.3412770008582313,-1.080700972990376,0.3392461197339246,0.7153572160556649,1.0,14/47,18.23%,STEAP3;CP;SCARA5;ATP6V0A4;SLC39A14;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2;HFE;REP15;FTH1
prerank,estrogen metabolic process (GO:0008210),-0.4362738868706024,-1.0803243600426806,0.35177865612648224,0.715573843377659,1.0,4/15,18.71%,CYP1B1;SULT1A1;HSD17B7;HSD17B8
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.3162098402938316,-1.079878536728489,0.32587064676616917,0.7160419205566497,1.0,16/64,17.80%,PLA2G4A;CPT1A;CYP1B1;CPT2;DAGLB;GPX4;ACOX1;MGLL;ACADL;PTGS2;EPHX2;GSTM2;ELOVL1;GPX1;ACSL4;ALOX12
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.47820092750901155,-1.0798150427198294,0.36622390891840606,0.7154820110252067,1.0,5/11,26.43%,KCNJ2;KCNQ1;ATP1A1;YWHAE;KCNH2
prerank,membrane lipid catabolic process (GO:0046466),-0.48446423354086854,-1.0788594845735637,0.3780260707635009,0.7172538989505322,1.0,6/10,24.73%,CYP1B1;FUCA1;NAGA;ENPP2;SGPL1;PDXDC1
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.391674693103765,-1.0787323451665174,0.36435643564356435,0.7168279800958248,1.0,3/24,2.53%,EPHA7;FOXO3;NUPR1
prerank,regulation of lamellipodium assembly (GO:0010591),0.41666036245917015,1.078282961828426,0.38961038961038963,0.8190669029823802,1.0,9/34,11.73%,PLCE1;PIK3R1;WAS;PIK3CA;ABI2;WASF2;EPHA2;NCKAP1;PLXNB3
prerank,sodium ion transmembrane transport (GO:0035725),0.35497607082276583,1.0777501833872962,0.35665529010238906,0.8192288426037801,1.0,18/84,9.02%,SLC12A2;ATP1A2;ATP1A4;SLC5A1;FXYD2;SLC24A4;SLC24A2;SCN2A;ATP1B2;SCN5A;ASIC2;HCN2;SCN8A;SLC9A7;HCN3;SLC6A15;SCN9A;PKD2
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.3723810831019734,-1.077465180839653,0.34811529933481156,0.7196063316616083,1.0,15/34,19.25%,SMAD3;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;TRIO;FLCN;ANKRD26;GATA2;TGFB1;ZFPM1;SIRT2;ZFP36L2;E2F1
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4069100652185357,1.0773066790495636,0.35185185185185186,0.8192489029192294,1.0,4/39,5.98%,ITGA1;SH3KBP1;SPRY2;EPN1
prerank,brain development (GO:0007420),0.3366276329255342,1.0772082083745995,0.33525179856115106,0.8184324728508805,1.0,24/136,10.88%,PTEN;ADGRL3;PCDH18;CDH2;RAPGEF2;ZFHX3;NF1;HESX1;COL4A1;TMX2;UGP2;JHY;CNTNAP2;ROGDI;CNTN4;PPT1;NCOA6;NES;ROBO2;UFM1;GRIN2B;CTNNA2;DDIT4;SOX6
prerank,positive regulation of cell cycle process (GO:0090068),0.35849652212446964,1.0765016009668553,0.3400309119010819,0.8190619633430497,1.0,12/91,10.17%,PDGFRB;MAP3K20;RGCC;IL1B;CUL3;OPN1MW;CSPP1;PCID2;PDGFB;CDC14B;UBXN2B;NUSAP1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4047687765899757,1.076432913592746,0.3763440860215054,0.8181925819214969,1.0,9/43,7.20%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;OGT;PIP4K2C;IRS1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.48847746712388945,-1.0763413917957452,0.3813868613138686,0.7217712268876854,1.0,5/10,27.29%,CSGALNACT1;PXYLP1;DSEL;XYLT1;B3GAT3
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4253506608371089,1.0762490771203495,0.3575525812619503,0.8175742481177646,1.0,8/29,17.01%,MEI4;MEIOB;REC8;TEX12;FANCD2;TRIP13;STAG3;SYCP2
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.23461632813749966,-1.07610363367249,0.10465116279069768,0.7216331733094161,1.0,191/834,18.14%,NFIB;AUTS2;BMP6;IGF1;DAB2;ZMIZ1;PBX1;SMAD3;SMARCA2;EGFR;DCN;NFAT5;WWOX;HDAC4;GLI2;TBL1XR1;NFIX;CDK8;RHOQ;GLIS3;FOXO1;MICAL2;OSR1;FOXO3;APP;NFIA;NR3C1;HDAC8;KAT6B;ERG;ITGA6;HOXB3;RARB;MLXIP;ESR1;FGFR2;BMPR2;ELF1;BMP4;ELF4;MEOX2;KLF4;PLAGL1;KAT2B;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;LEF1;ACVR1;KLF2;SBNO2;THRB;HOXA5;SKI;PCGF5;ZFPM2;DCAF6;IGF2;SSBP2;ARRB1;ARNT2;AR;FGF1;RARG;YAP1;TMF1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;INO80;HLF;TET3;FOXC1;IRF2;GLIS1;LMO2;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;PGR;KLF10;TBX1;SSBP3;TFCP2;ZBTB18;FIZ1;PLXND1;RREB1;IL33;HIF1A;TNFRSF1A;NLRC5;CDH13;NR4A2;FLCN;ATF6;FOSL2;PHF10;DAB2IP;IL18;ZC3H12A;FHOD1;EIF5A;MAVS;GATA2;CEBPG;GLI3;TGFB1;ELK3;BCL9L;AHR;HDAC1;ZIC3;RELA;PPARA;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;UBB;ATOH8;CLOCK;LPIN3;MET;MEIS2;MPND;HDAC5;TAL1;SOX17;HSF2;POU2F1;MAPK3;HOXC4;PKD1;CDK9;HOXB7;HIPK2;NKX6-1;ZFPM1;CREB3;JUND;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;HHEX;MEIS1;HMGB2;SOX18;KDM6B;TLR4;RNASEL;USF2;ZMIZ2;SIRT7;JUNB;SIRT2;ATF1;MED21;RIPK1;PTOV1;SLC9A1;NFKBIA;NFYB;CSRNP3;NPAS2;MAFF;SOX12;CEBPB;KLF15;PARK7
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.34268537117772924,-1.0760956761276663,0.34811529933481156,0.7209318066657201,1.0,7/46,7.60%,PLCB1;ANXA2;RAP1B;PDCD4;PITPNA;P4HB;TALDO1
prerank,regulation of ruffle assembly (GO:1900027),0.44726425668159264,1.0760080682400108,0.3720472440944882,0.8171340378332965,1.0,3/23,7.15%,EPS8;EPS8L1;HRAS
prerank,regulation of protein ubiquitination (GO:0031396),-0.2926582161775258,-1.0756662113257074,0.2727272727272727,0.7213285080682998,1.0,43/108,28.93%,NXN;HDAC8;CAV1;SASH1;TGFBR1;ANGPT1;LRRK2;SMAD7;ARRB1;FKBP1A;SH3RF2;BIRC3;AKT1;PINX1;IVNS1ABP;PRKCG;PHF23;DNAJB2;FANCI;UBB;SPHK1;HSP90AB1;WASHC1;SIRT7;PARK7;CHP1;VPS28;CDK5RAP3;UBXN1;FAM107A;BAG2;BRCA1;PSMD10;RPS3;CENPX;PRKN;BAG5;BCL10;PRR7;HSPA1B;PTTG1IP;LAPTM5;ISG15
prerank,serine family amino acid metabolic process (GO:0009069),0.474616851414033,1.0754083694622616,0.4,0.8174868064147002,1.0,6/16,12.63%,CTH;BAAT;SEPHS2;GLYAT;SRR;DAO
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.41166167763416645,1.0751898005765823,0.3517857142857143,0.8169457253898587,1.0,14/37,19.43%,PHLDB2;ROCK1;CLASP2;MAPRE2;TPPP;MARK2;BICD2;CAMSAP3;PHLDB1;PRKAA1;CDK2AP2;TRAF3IP1;GSK3B;STMN4
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3454973203082722,1.075058920049504,0.335423197492163,0.8162491432333083,1.0,8/112,2.10%,PTPRK;SOX5;LIMS1;MEF2C;PDE3A;GCNT2;PTK2;FERMT2
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.25435704492566635,-1.0747943695485012,0.26804123711340205,0.7228707776268533,1.0,91/327,21.05%,BNC2;ZMIZ1;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;NFIA;NR3C1;KAT6B;SUFU;ESR1;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;SIX1;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;ZNF219;ERC1;POLR2A;TRRAP;GON4L;VSX1;RREB1;REXO4;HIF1A;CRABP2;CARM1;TULP3;FZD7;SLC39A8;ESRRG;PML;BRCA2;PATZ1;NFYC;HINT1;NSD1;AHR;RELA;SRSF10;CALR;GLRX2;CLOCK;SOX17;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;ASCC1;NFIL3;ACTR8;NFYB;NFXL1;SOX12;RHOH;CEBPB;EZH2;PLAG1;YAF2;SBNO1;ATF7;HMGN5;PPARGC1A;E2F1;NONO;HP1BP3;NAB2;NFATC2;NIF3L1;THAP1;TEAD2;LMX1B
prerank,negative regulation of vascular permeability (GO:0043116),-0.4500805889599248,-1.0747581080117703,0.37037037037037035,0.7222481363951017,1.0,6/12,6.44%,SLIT2;CLDN5;PTPRJ;ANGPT1;RAMP2;DDAH1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45406094750946296,-1.074530892203444,0.4010989010989011,0.7220911360854649,1.0,3/12,5.98%,APOE;IAPP;PFDN5
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4776015353779393,-1.0743125777443134,0.39042357274401474,0.7219659801931687,1.0,2/11,1.06%,AFDN;TJP2
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3849047266937759,-1.0741597538328196,0.36088709677419356,0.7216059744995289,1.0,10/26,14.01%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4;SARS1
prerank,neutrophil activation (GO:0042119),-0.45635644223541005,-1.0739473738259313,0.3787878787878788,0.7214309879451055,1.0,4/12,21.19%,IL15;PRKCD;SYK;TYROBP
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37238860002426527,-1.073674084484311,0.3620689655172414,0.7214079075207286,1.0,11/29,18.55%,WWOX;CAV1;THBS1;TNFSF10;PPP2R1B;PML;RET;SFRP1;BID;RIPK1;AGT
prerank,positive regulation of double-strand break repair (GO:2000781),0.4141836820883786,1.0736234649110272,0.36952380952380953,0.818504005800055,1.0,15/39,19.05%,WAS;FOXM1;SPIRE1;FMN2;FANCB;SLF2;TIMELESS;SETMAR;PRKDC;SHLD3;KMT5B;PARP1;MRNIP;DDX11;FUS
prerank,aortic valve development (GO:0003176),0.41977522172457693,1.0735927575643318,0.3500931098696462,0.8175401090022079,1.0,6/34,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.48765345545926747,-1.0735567282229852,0.4,0.7209721593187902,1.0,4/11,10.42%,ANXA1;SMAD7;RC3H2;ZC3H12A
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.3065035041390287,-1.0731714234845846,0.3125,0.7212375227922803,1.0,13/80,8.75%,DAPK1;EPHA7;UACA;SH3RF1;USP47;THBS1;KLF4;NOD1;GAS6;TNFSF10;FNIP1;MAP2K5;AKT1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.4753079774621696,-1.0729154812173858,0.3716475095785441,0.7211531456364024,1.0,4/11,17.16%,ITM2A;NECAB1;ITM2C;BACE2
prerank,central nervous system development (GO:0007417),0.31262401067916806,1.0726340561525094,0.30158730158730157,0.8187541170205479,1.0,44/250,11.11%,SERPINI1;PTEN;ADGRL3;PCDH18;CDH2;ADORA2A;TBX3;ZFHX3;NF1;HESX1;COL4A1;TMX2;UGP2;TBX6;GRIK1;JHY;CNTNAP2;DNER;ACAN;ROGDI;CNTN4;MOG;ASIC2;TPPP;SOX4;ANKLE2;LIG4;CNTN6;PPT1;NCOA6;NES;ROBO2;ADAM23;PKD2;UFM1;MARCKS;GRIN2B;NCKAP1;DDIT4;SPOCK1;SOX6;AHI1;IL1RAPL2;LOXL3
prerank,positive regulation of growth (GO:0045927),-0.31699712708225564,-1.0717354373652355,0.2979274611398964,0.7235568082748051,1.0,14/64,13.90%,PLCB1;EGFR;USP47;TGFBR1;ADAM10;SDCBP;INO80;H3-3A;MMP14;AKT1;MFSD2A;DDX49;SPHK1;SFRP1
prerank,cellular response to glucose starvation (GO:0042149),-0.34194048512302583,-1.0717258551976725,0.3634361233480176,0.7228670895167713,1.0,15/41,21.83%,PRKAG2;FOXO3;ITFG2;HSPA5;BECN1;ZC3H12A;SH3GLB1;PRKAG3;PRKAA2;MTMR3;RRP8;KPTN;PRKAG1;XBP1;EIF2AK3
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2700831186288315,-1.0716671851292054,0.26119402985074625,0.7222847579728483,1.0,62/171,27.73%,SMAD3;IQGAP1;PTPN3;APP;GAS1;SDCBP;CDC16;FOXC1;MAEA;OBSL1;BTG3;PSME2;ANAPC4;TGFB1;MDM2;SMOC2;PSMB4;TRIM35;SPHK1;MEIS2;PIM3;TAL1;PSMB1;PSMD11;CAV2;DDB1;PSMD8;CDK9;EIF4EBP1;PSME3;CDKN1B;RNF40;CCDC8;ANAPC16;PSMD4;FZR1;PSMA2;PIM2;USP22;PSMD3;CDC27;CDK5RAP3;THAP1;PSMB7;ANAPC5;CUL9;CDKN1C;USP2;PSMC2;ERCC2;TMEM8B;PSMC5;CDK11B;PSMD10;SCRIB;L3MBTL1;ERCC3;ANGEL2;SRA1;NEK7;PSMD7;MKI67
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.41946602379692083,-1.071637519983658,0.38910505836575876,0.7216389278608355,1.0,12/18,34.23%,DCN;MCU;KDR;VPS35;BNIP3;DDHD1;RALBP1;PRKN;RALA;DNM1L;MIEF2;PINK1
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.3475745591291183,-1.07153186489729,0.35391923990498814,0.7211848246633012,1.0,16/46,12.98%,ALDH1A1;ZNF423;LGR4;IL15;ADAMTS5;NPR3;FOXC2;ID1;ACOT11;MAP2K6;LNPEP;NOVA2;FLCN;IP6K1;NOVA1;PGAM5
prerank,digestive tract morphogenesis (GO:0048546),-0.43986606736397676,-1.0714684749298709,0.3891891891891892,0.7206570809273724,1.0,7/14,16.39%,PDGFRA;FGFR2;STRA6;BBS7;ID2;SOX17;EPHB3
prerank,regulation of fibroblast migration (GO:0010762),0.45957171251312456,1.071326640516573,0.3885480572597137,0.820784490782053,1.0,7/20,10.90%,PTK2;PRR5L;FGF2;ITGB1;APPL1;GNA12;ARHGEF7
prerank,DNA dealkylation (GO:0035510),-0.474004917731185,-1.0705828841395866,0.3945841392649903,0.7213013946204659,1.0,6/10,35.71%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.474004917731185,-1.0705828841395866,0.3945841392649903,0.7213013946204659,1.0,6/10,35.71%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,regulation of microtubule-based movement (GO:0060632),0.49410856221462895,1.0702975020564605,0.36909871244635195,0.8220927571372961,1.0,1/11,1.46%,MAP2
prerank,positive regulation of protein metabolic process (GO:0051247),-0.2911055405580826,-1.0697619012135249,0.32831325301204817,0.7225998684132917,1.0,34/110,19.90%,ROCK2;FOXO1;APOE;APP;SMURF2;NKD1;KLF4;CSF1;KLF2;WWP2;SMURF1;WNT5A;SLC6A9;PLK2;EGLN2;MAP2K5;AKT1;IDE;DAB2IP;IL18;RAB7A;ASB5;TGFB1;DDB1;PAEP;WWP1;CDKN1B;NFKBIA;OAZ1;FZR1;AGT;AGTR1;VCP;VPS28
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3619707090249453,-1.0697187732546538,0.3575757575757576,0.7219908083462933,1.0,9/32,12.29%,DAPK1;ACTN2;APP;DLG1;SLC6A9;PTK2B;CAPN1;CAMK2A;EPHB2
prerank,negative regulation of MAPK cascade (GO:0043409),-0.3020672355404191,-1.0695529362354737,0.32673267326732675,0.7217261493648922,1.0,28/87,16.54%,TIMP3;FBLN1;BMP7;SEMA6A;FOXO1;APOE;DLG1;CAV1;BMP4;PTPRJ;EZR;DUSP1;PRKCD;PIK3CB;FLCN;IRAK3;EMILIN1;DAB2IP;P2RX7;PPEF2;EPHB2;DUSP7;QARS1;PPIA;CNKSR3;DUSP10;SIRPA;TLR4
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.4433735359100405,-1.0692824601201714,0.41275797373358347,0.721674363624057,1.0,7/13,23.89%,IL6ST;STAT1;STAT3;OAS2;CANX;TYK2;CRLF1
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4304049867117238,1.0692391303200106,0.38104089219330856,0.8234611558053881,1.0,5/29,9.15%,PDGFRB;PTK2;FGF2;IRS1;PDGFB
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.40318967096459035,-1.0688410726712039,0.37890625,0.7221022062147606,1.0,7/20,24.75%,ADAM9;ADAM10;TGFB1;RELA;PSEN2;MBTPS1;NCSTN
prerank,plasma membrane repair (GO:0001778),0.5000297160584914,1.0685004721269569,0.38636363636363635,0.8241419844312307,1.0,2/13,1.97%,DYSF;MYH9
prerank,cellular response to interleukin-4 (GO:0071353),-0.4790368530817796,-1.0684550375252175,0.3874538745387454,0.7223161697628816,1.0,4/10,24.38%,LEF1;XBP1;SHPK;TCF7
prerank,negative regulation of GTPase activity (GO:0034260),-0.4018466413749642,-1.0683845900106248,0.3887733887733888,0.7217952990673931,1.0,10/22,24.09%,LRCH1;LRRK2;WNK1;CPEB2;DAB2IP;F11R;GMIP;SH3BP4;TMED2;RDX
prerank,regulation of phosphorylation (GO:0042325),0.34377403935633777,1.0682661553608424,0.3378995433789954,0.8236730105096705,1.0,25/120,11.83%,DYNLL1;GLMN;PTK2;ROCK1;FNIP2;CADM4;GRM5;NUP43;OGT;SLC2A6;TESK1;IL4;ANKLE2;EMP2;CDKN1A;NUP35;LYN;GCK;PRKRIP1;MCM7;SEC13;EIF6;NDC1;EP300;BTBD10
prerank,protein localization to cilium (GO:0061512),-0.3669731590170605,-1.0682576604879968,0.36607142857142855,0.7214230729756752,1.0,13/32,29.53%,ZNF423;EHD1;ARL3;TULP3;SNX10;TTC21B;RAB29;WDR35;TULP1;TMEM107;BBS9;IFT122;ATP6V1D
prerank,triglyceride biosynthetic process (GO:0019432),-0.41798472373714446,-1.068037412331902,0.40425531914893614,0.7212881978095731,1.0,2/18,3.14%,AGMO;LPGAT1
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.3769209783252593,-1.0679741080556409,0.36639676113360325,0.7207126993475194,1.0,8/28,13.00%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.4103833487924703,-1.0679308703387516,0.3733075435203095,0.7201449207794504,1.0,6/20,16.99%,TGM2;RAP1GDS1;PML;TMCO1;SELENOK;BCAP31
prerank,positive regulation of response to external stimulus (GO:0032103),-0.28075981558522867,-1.0673810430176438,0.29754601226993865,0.720825904003987,1.0,33/128,19.00%,BMP6;APP;IL15;SASH1;THBS1;THBD;PDCD4;IL16;DDX60;WNT5A;CD47;STX3;USP15;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;PUM1;GBP5;TGFB1;USF1;CYBA;CD180;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGT;AGTR1
prerank,peptidyl-asparagine modification (GO:0018196),-0.3651319004758769,-1.0673637485611678,0.3682008368200837,0.7201560800654484,1.0,11/31,18.79%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,regulation of protein secretion (GO:0050708),0.33855193202677564,1.0670551996260693,0.35311572700296734,0.8253323927378041,1.0,18/119,9.86%,CACNA1C;SLC12A2;RAPGEF4;PER2;ITPR2;IL1B;GIPR;RHBDF1;SNAP25;ITPR1;FRMD4A;TFAP2B;RAP1A;CACNA1D;ACHE;GCK;MYOM1;CACNA1A
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2735641519019875,-1.0669919889552608,0.3128834355828221,0.7204294121000501,1.0,41/149,19.69%,PRKCH;APP;CAV1;NOD1;ARHGEF2;CFLAR;IRAK2;AR;LGALS9;WNT5A;PRKCZ;PRKCB;CARD14;STAT3;TFRC;ERC1;FLOT2;IRAK3;IL18;TRIM27;CAMK2A;RELA;TNFRSF11A;UBB;CLOCK;SPHK1;FER;TICAM1;PPIA;TLR4;TRIM8;RIPK1;MAP3K13;NFKBIA;EDA;TRIM14;ALK;LAMTOR5;AGT;EDA2R;IKBKG
prerank,antibacterial humoral response (GO:0019731),0.46502164172714006,1.0665694467371816,0.3760504201680672,0.8254860896809578,1.0,8/16,24.35%,WFDC3;CAMP;RNASE6;DMBT1;SLPI;JCHAIN;ANG;RNASE7
prerank,positive regulation of viral transcription (GO:0050434),-0.38997944702639586,-1.066463727474969,0.3712574850299401,0.7210687326742704,1.0,10/25,30.31%,MDFIC;POLR2A;POLR2F;CDK9;POLR2E;RSF1;NELFCD;POLR2G;CTDP1;SUPT4H1
prerank,regulation of protein polymerization (GO:0032271),0.40977276878133967,1.0662789182341728,0.3803088803088803,0.8251310263811784,1.0,9/35,13.98%,PLEKHG2;MAP2;ESAM;TTBK1;TPPP;CAMSAP3;PAK3;RASA1;ABITRAM
prerank,pulmonary valve morphogenesis (GO:0003184),0.46670919314916054,1.0662168511159444,0.384928716904277,0.8242635680851698,1.0,4/17,1.22%,HEY2;HEYL;NOTCH1;TBX20
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.4362406089016768,-1.0660536581494633,0.39723320158102765,0.7213876398760163,1.0,4/15,5.80%,ITGA5;KLF4;FGF1;BMPER
prerank,icosanoid biosynthetic process (GO:0046456),-0.47281930237789904,-1.0660286862111124,0.39184397163120566,0.7207493648619573,1.0,1/10,1.12%,PLA2G4A
prerank,gliogenesis (GO:0042063),0.4773166883738291,1.0656791484517973,0.4166666666666667,0.824410297248503,1.0,3/15,4.28%,CDH2;CDK6;METRN
prerank,positive regulation of macrophage activation (GO:0043032),-0.42167509340300274,-1.0656439996824731,0.416,0.7209905078486524,1.0,5/17,10.34%,LBP;THBS1;WNT5A;IL33;KARS1
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.506499736783219,1.0656423630250176,0.40717299578059074,0.8234786965741263,1.0,3/11,5.96%,COLEC12;RFTN1;TNIP2
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.24918906260636392,-1.0654482048409961,0.23163841807909605,0.7207560123354876,1.0,98/366,21.05%,BNC2;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;FOXO3;APP;NFIA;NR3C1;KAT6B;SUFU;ESR1;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;TOM1L1;SIX1;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;ZNF219;ERC1;POLR2A;TRRAP;GON4L;VSX1;RREB1;REXO4;HIF1A;CRABP2;CARM1;ATXN2;TULP3;FZD7;SLC39A8;ESRRG;PML;BRCA2;PATZ1;NFYC;HINT1;NSD1;AHR;RELA;TCOF1;SRSF10;CALR;GLRX2;CLOCK;SOX17;RPL10;GEMIN5;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;SMC3;ASCC1;NFIL3;ACTR8;NFYB;NFXL1;SOX12;RHOH;CEBPB;EZH2;PLAG1;YAF2;SBNO1;ATF7;HMGN5;PPARGC1A;E2F1;RABL3;NONO;HP1BP3;NAB2;NFATC2;THAP1;TEAD2;LMX1B
prerank,defense response to bacterium (GO:0042742),-0.295001969649286,-1.0653150328843264,0.3,0.7204032963725957,1.0,23/105,16.54%,ANXA3;IL6R;LBP;NOD1;RPS19;GBP4;PRKCD;PLA2G6;IRGM;STAB1;OAS2;PGLYRP1;GSDMD;MAVS;GBP6;OPTN;RPL39;GBP7;GBP2;SERPINE1;HMGB2;MR1;TLR4
prerank,atrial septum morphogenesis (GO:0060413),0.5093561082757747,1.0652896104443759,0.38444924406047515,0.8232631169722618,1.0,2/10,1.22%,HEY2;TBX20
prerank,translesion synthesis (GO:0019985),-0.3430551400729728,-1.064893065289433,0.35141509433962265,0.7208137567458212,1.0,20/42,32.01%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;UBE2L6;POLI;USP43;POLE2;RFC1;USP10;RPA3;POLD1;ISG15;DTL;PCNA;PARP10;RFC5
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.4406280390927845,1.0646426412424932,0.381139489194499,0.823731263123415,1.0,6/25,13.05%,AFAP1L2;GPER1;CNOT9;HIP1;DGKD;BCAR3
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.4215655429035726,-1.0644264456699675,0.38735177865612647,0.7212875332037175,1.0,6/17,18.26%,APOE;FGF1;LPCAT3;RAN;SREBF1;ERLIN2
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.42380206329077186,-1.0643991562368416,0.3817829457364341,0.7206454705264213,1.0,4/16,8.36%,AUTS2;ARHGAP17;ALS2;PIK3CB
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.4279781982832255,-1.0637116412389538,0.3963782696177062,0.7217063216088416,1.0,5/16,10.44%,DPYSL3;DPYD;UPP2;UPB1;NT5E
prerank,muscle cell development (GO:0055001),0.4275953819928418,1.0632296835975963,0.38961038961038963,0.825987529847248,1.0,4/30,2.04%,DMD;HEY2;DYSF;MYH11
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.36369350910490256,1.0632190294183579,0.36787564766839376,0.8250059696550707,1.0,7/73,6.87%,DLC1;ATP2A3;COL4A3;BCL2L10;SNCA;BCL2L13;CASP9
prerank,regulation of hippo signaling (GO:0035330),0.4532737418498036,1.0630940393310504,0.36511156186612576,0.824264286845234,1.0,3/17,4.97%,LIMD1;SCHIP1;AJUBA
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.3790507664076229,1.063036268722912,0.3706293706293706,0.8233932556540519,1.0,17/59,15.03%,PTEN;MECP2;MED10;MED13;AGO3;CDKN1A;CCNC;RUNX2;MED1;MITF;TNRC6C;MED20;BCLAF1;THRA;TNRC6B;MED4;MED6
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.47229040888455415,-1.0630188567373346,0.38846153846153847,0.7227878724110086,1.0,3/10,7.99%,RARB;RARG;TBX1
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.34809757623986126,1.0629555192829239,0.35968992248062015,0.822570202096482,1.0,12/101,7.15%,PDGFRB;IL34;RAPGEF2;RGCC;FERMT2;IL1B;PDCD10;FGF2;SPDYA;SNCA;DDX3X;HRAS
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44305662561129133,-1.0629015920882185,0.3931947069943289,0.7223713730320085,1.0,5/15,15.88%,EGFR;CDH13;RHBDF2;FER;CEACAM1
prerank,connective tissue development (GO:0061448),-0.35581725011953746,-1.062872675271635,0.3717391304347826,0.7217480471769393,1.0,7/35,7.49%,SULF1;ZBTB16;ITGB8;CREB3L2;SULF2;SLC39A13;NAMPT
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4626207221262988,-1.0625682176642042,0.39162112932604737,0.7218119591057859,1.0,6/11,30.75%,FOLH1;LCMT1;ATG7;ATG12;AGBL1;ICMT
prerank,histone H3-K9 demethylation (GO:0033169),-0.45847051252499604,-1.0624719609072504,0.4058252427184466,0.721346877348365,1.0,2/11,11.47%,KDM7A;KDM3A
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4790384853047597,-1.0621648014039489,0.40111940298507465,0.7214628104201242,1.0,5/10,19.35%,DNMT3A;PCGF5;IGF2;PCGF3;ZFP57
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.46122872565254325,-1.0620492767701084,0.4144486692015209,0.721062517690767,1.0,3/12,5.43%,GSN;LY6E;IFITM3
prerank,positive regulation of cell cycle (GO:0045787),-0.31829854493895077,-1.06185861300826,0.34306569343065696,0.7208416462707816,1.0,19/62,15.89%,EGFR;APP;NUPR1;FGFR2;LRP6;CCND2;CCND3;AKT1;RPS15A;MDM2;SMOC2;CALR;SPHK1;MEIS2;CCND1;TAL1;PKD1;EIF4EBP1;CDKN1B
prerank,dermatan sulfate metabolic process (GO:0030205),0.49261887293265155,1.0610340370871856,0.39918533604887985,0.8259535417290459,1.0,1/13,0.21%,CSPG4
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.43558213988252414,1.0601822720333383,0.3807615230460922,0.8268031998391834,1.0,3/22,4.80%,PLA2R1;SPRED1;HEXIM1
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3401108170182968,-1.0600940627680744,0.3638344226579521,0.724576786867015,1.0,7/41,7.44%,AFDN;PLPP3;BMP7;PODXL;SMAD7;PIEZO1;CD47
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.444232446161102,1.0599651745059295,0.38461538461538464,0.8263031352086552,1.0,4/20,6.87%,BCL2L10;IL4;APPL1;CASP9
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.43336799394142017,1.0597154861559535,0.395112016293279,0.8258651227717144,1.0,1/23,0.56%,MBOAT2
prerank,cellular response to organonitrogen compound (GO:0071417),0.3535306738504452,1.0595497436035595,0.38769230769230767,0.825228523159792,1.0,14/99,9.02%,MEF2C;SPAAR;PDE3A;RAPGEF2;CPEB1;AKAP6;GABRG2;HTR1B;HCN2;RAP1A;MTOR;RYR3;HCN3;PKD2
prerank,calcium-mediated signaling (GO:0019722),0.34831153773989976,1.0595138859441984,0.3730407523510972,0.8243041080196911,1.0,11/93,8.21%,CACNA1C;PLCE1;CCRL2;ACKR3;GRM5;PPP3CA;CXCR2;RYR2;ATP2A2;ACKR2;CCR9
prerank,response to chemokine (GO:1990868),0.48596931252078834,1.058884223813975,0.3881856540084388,0.8247468738757647,1.0,3/13,3.66%,SLC12A2;SH2B3;STK39
prerank,inflammatory response (GO:0006954),0.3179889756933686,1.0584079566841247,0.3506139154160982,0.8248155825810555,1.0,20/195,9.30%,GGT5;PIK3CD;TBXA2R;AFAP1L2;ADORA2A;IL1B;CD96;CCRL2;IL2RA;ADCY8;TACR1;CXCR2;CXCL10;IL4;CXCL5;KLRG1;RIPK2;NFATC4;IL22;ADGRE5
prerank,cell proliferation in forebrain (GO:0021846),0.5053702987082493,1.0577775197441084,0.3991130820399113,0.8253182106424036,1.0,4/10,19.42%,HOOK3;AKNA;CEP120;DOCK7
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.38360681008974395,1.057564416059164,0.3898305084745763,0.8248392589770452,1.0,8/54,4.24%,MEF2C;RGCC;NF1;AKT3;SH3BP1;ETS1;MECP2;FGF2
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.40164590873400396,-1.057491083677626,0.375968992248062,0.730419756250757,1.0,5/20,10.31%,CD55;IL1R1;B2M;PRKCZ;IL18
prerank,cardiac conduction system development (GO:0003161),-0.38421857877654764,-1.0573836627632125,0.39737991266375544,0.7300006067021299,1.0,4/24,3.37%,NOTCH2;GJB6;BMP4;GJA1
prerank,zinc ion transport (GO:0006829),0.4480063000912013,1.0572508900012012,0.38223938223938225,0.8245101167046083,1.0,1/21,0.46%,SLC30A10
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.2787583374491018,-1.0572418860882216,0.3431372549019608,0.7296498018250412,1.0,42/124,21.25%,PLCB1;WNT4;SMURF2;TCF7L2;NFATC1;LEF1;FZD2;AP2A2;MOV10;SFRP4;SMURF1;WNT5A;RHOA;PLCB3;FZD4;TIAM1;FZD7;PSME2;CAMK2A;PFN1;AP2A1;PSMB4;CCDC88C;ARHGEF19;SFRP1;PSMB1;PSMD11;PSMD8;FZD8;PSME3;CALM1;TNRC6A;WNT11;ROR2;FZD1;PSMD4;PSMA2;AGO1;PSMD3;PPP3CB;PSMB7;VANGL2
prerank,regulation of lymphocyte differentiation (GO:0045619),0.4616570367740322,1.057009671943128,0.3772455089820359,0.8240752509096175,1.0,1/18,1.07%,PRDM1
prerank,negative regulation of response to external stimulus (GO:0032102),0.3397097473784551,1.0568136990824126,0.36932707355242567,0.8235350428066976,1.0,12/105,7.27%,PTEN;AJAP1;RORA;RTN4RL1;GPER1;NR1H3;LRFN5;PPARD;FGF2;IL4;CACTIN;AOAH
prerank,histone acetylation (GO:0016573),-0.3099266606176284,-1.056710285384093,0.35714285714285715,0.7303096822633308,1.0,26/69,25.98%,KAT6B;KAT2B;LEF1;KAT14;TRRAP;TADA1;MEAF6;TRIM16;TADA2A;BRCA2;BEND3;YEATS2;NAA40;BRPF3;CHD5;MORF4L2;BRPF1;BRD1;TAF5;HAT1;SGF29;BRD8;JADE1;ING4;ATF2;EPC1
prerank,regulation of cell differentiation (GO:0045595),0.32767348488571996,1.0563669611379027,0.35942028985507246,0.8236132980525342,1.0,17/148,7.30%,MBOAT2;HEY2;CDK6;PTK2;TRPS1;PHLDB2;ZFHX3;ROCK1;NF1;NR1D2;HEMGN;MOSMO;CLASP2;TFAP2B;SIK1;EMP2;BIN1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.3341024755463364,-1.0562995993888635,0.3488888888888889,0.7306323082194861,1.0,12/47,16.31%,ROCK2;WNT4;PTGIS;CAV1;CD34;C1QTNF3;ZC3H12A;ACADL;PGP;SNAI1;CEACAM1;SIRPA
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.3065860925029597,-1.0561914100463103,0.35910224438902744,0.7301889005486427,1.0,14/78,8.75%,SORBS1;DAB2;EPHA3;EGFR;PRKCH;RHOQ;DLG1;ITGA3;AR;STX7;PRKCE;STX3;MMP14;AKT1
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.45056405083502904,1.0560952613108268,0.3950617283950617,0.8232646914158782,1.0,2/20,2.70%,GGT1;CHAC1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.32276569196647487,-1.0559536721231366,0.3620309050772627,0.7300838266256938,1.0,5/53,3.83%,EYA2;EYA1;EGFR;EYA4;DDX5
prerank,negative regulation of receptor internalization (GO:0002091),-0.45536519529682506,-1.0555670530121306,0.43169398907103823,0.7304132140835873,1.0,3/12,9.79%,RIN3;SDCBP;ATXN2
prerank,neural crest cell development (GO:0014032),0.387134714512249,1.0551704359752871,0.39138240574506283,0.8244523923180428,1.0,6/44,4.82%,CDH2;SEMA6D;SEMA5A;ERBB4;NRG1;SEMA6C
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.34943523927345227,-1.055147174382104,0.3813559322033898,0.7308304491731267,1.0,10/36,18.14%,NRP1;TGFA;SHANK3;TAF1;HIF1A;HDAC1;EPHB2;HFE;ADRB2;PARK7
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.4769693951777578,1.0549371898137647,0.39361702127659576,0.8239870425299801,1.0,3/14,4.76%,ZEB1;SPRED1;SPRY2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.40411382171508936,-1.054892785882501,0.4086444007858546,0.7307708576107657,1.0,8/19,21.81%,ZMIZ1;GAS6;MMP14;RHOH;PPP2R3C;SYK;MDK;XBP1
prerank,positive regulation of cellular process (GO:0048522),0.2871618707671971,1.054808432414903,0.3302646720368239,0.8233177096512126,1.0,52/565,7.78%,TRPC3;PDGFRB;PTEN;TBX2;IL34;S1PR3;IL15RA;GCNT2;COLEC12;BMP5;NOTCH1;SLC25A33;PTK2;GPER1;TBX3;ZFHX3;MERTK;PABIR1;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;TBX6;ETS1;MECP2;AKAP6;PPP3CA;PDCD10;FGF2;CIDEB;SPDYA;ACTN4;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;CXCL5;DDX3X;TPPP;RYR2;SOX4;CHRNA7;SUPV3L1;EMP2;HRAS;IRS1;RIPK2;FGF10;NCMAP
prerank,negative regulation of organelle assembly (GO:1902116),-0.3489204270955049,-1.0547623769801335,0.3707093821510298,0.7304187964604687,1.0,10/35,16.06%,NUPR1;KAT2B;LRRK2;LIMK2;YAP1;CHMP4B;CHMP4A;PHF23;TCHP;NBDY
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.4961321409641613,1.0545016953223088,0.4094650205761317,0.8229753874532996,1.0,1/12,0.21%,CSPG4
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4283706107762627,-1.0544478374811659,0.4123314065510597,0.7305117076278769,1.0,5/17,14.15%,WNT4;VIM;BMP4;TGFB1;CREB3L1
prerank,regulation of glycolytic process (GO:0006110),-0.30505399867767846,-1.0539358946584767,0.34615384615384615,0.731146021126046,1.0,5/68,2.53%,PRKAG2;IGF1;HDAC4;APP;NUPR1
prerank,activation of GTPase activity (GO:0090630),0.35226338558394926,1.053885799763968,0.37717908082408874,0.8233883663991286,1.0,16/89,9.84%,ARHGAP42;TBC1D1;SIPA1;GRTP1;GARNL3;TBC1D30;SLC27A4;SYDE1;TBC1D12;ARHGEF26;RUNDC1;RALGAPA1;TBC1D2B;MTSS2;TBC1D10C;EPHA2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.4108082290602004,1.0537963176812497,0.38878504672897196,0.8225986676607492,1.0,6/36,4.24%,MEF2C;NOTCH1;RGCC;MECP2;SVBP;FGF2
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4915767908584262,1.0532480825047632,0.38963963963963966,0.8228665277498199,1.0,2/10,2.78%,NR1H3;PTPN22
prerank,cell chemotaxis (GO:0060326),0.3708169117970641,1.0530271027872207,0.3840947546531303,0.8224106248833907,1.0,12/60,12.15%,PDGFRB;SEMA5A;BCAR1;CCRL2;ACKR3;CXCR2;ACKR2;CCR9;PDGFB;EPHA2;PLXNB3;EPHB1
prerank,regulation of acrosome reaction (GO:0060046),0.4999350750387149,1.05301124350798,0.40131578947368424,0.8214605032267224,1.0,2/10,5.05%,CACNA1H;SERPINA10
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.4354263478630049,1.0527970493423104,0.3991683991683992,0.8209427266319711,1.0,7/24,14.91%,NOTCH1;ERBB4;CRLF3;IL4;PRLR;OCIAD1;JAK2
prerank,phospholipid metabolic process (GO:0006644),-0.29774998841658273,-1.0524009514470338,0.3492462311557789,0.7344462657308584,1.0,28/71,34.98%,PLA2G4A;PLPP3;AGPAT4;SMPD3;GPX4;PIP4K2B;TNFAIP8L3;PLPP1;PLA2G15;PGP;PLCD1;CLN8;AGPAT2;ENPP2;LPL;PLPPR4;PLPP2;PLBD2;PLA2G4F;MBOAT1;SMPD1;AGPAT1;ANGPTL3;LGALS13;FITM2;FADS1;ABHD12;PLA2G5
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.2830437768394956,-1.0523482708352385,0.3210227272727273,0.733888555371273,1.0,39/110,28.76%,TRABD2B;ABCA1;CDH5;GSN;APOE;IAPP;PRKCZ;FNIP1;HSPA5;TFRC;IRGM;BCL2L11;GFAP;DAB2IP;TGFB1;SH3GLB1;TAL1;NAPA;BID;PARK7;SAR1A;SAR1B;VCP;RHOC;SYK;LCMT1;HJURP;VEGFA;PIH1D1;ICE1;HCK;RPS3;RACK1;AIDA;BIK;CLU;PREB;SLF1;MPP7
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4568905618808956,1.0515766476456179,0.39748953974895396,0.8227423348898586,1.0,2/20,1.04%,PDGFRB;VTN
prerank,sterol metabolic process (GO:0016125),-0.3147733528586489,-1.0515121751749112,0.3619047619047619,0.7354295909422349,1.0,11/60,12.15%,PRKAG2;ABCA1;APOE;CYP26B1;LBR;LIPA;CYP27A1;CYP1B1;OSBPL1A;INSIG2;STARD3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3751420092563887,-1.0511540516588043,0.38650306748466257,0.7356527386414715,1.0,7/25,13.56%,SLIT2;CAPZB;LIMK2;YAP1;PRKCD;EVL;TCHP
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3357749467549222,-1.0507520992793382,0.3665893271461717,0.7359494482671902,1.0,10/48,10.16%,ROBO1;SLIT2;CNOT7;GAS6;PARP14;STAT2;USP18;NLRC5;IRAK3;SAMHD1
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3110467459550429,1.0507295996265686,0.3676268861454047,0.8236668530430641,1.0,25/214,7.15%,PDGFRB;PTEN;SLC30A10;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;SPRED1;ERBB4;IL1B;PTPN22;ACKR3;FGF2;SPRY2;CARD9;ROS1;NTRK2;HTR2C;CHRNA7;YWHAZ;RAP1A;HRAS
prerank,cholesterol efflux (GO:0033344),-0.3931255966950453,-1.0503432014690333,0.37924151696606784,0.736261436683819,1.0,3/20,6.77%,ABCA1;APOE;NPC2
prerank,positive regulation of vasculogenesis (GO:2001214),0.5143880262721842,1.0502037082971791,0.4188034188034188,0.8238576630984944,1.0,3/10,6.90%,RAPGEF2;RIN2;RAP1A
prerank,mitotic cell cycle phase transition (GO:0044772),0.31336125316922764,1.0500059539717517,0.3645251396648045,0.8233310672314199,1.0,35/204,16.52%,DYNLL1;EPS8;CDK6;BTRC;FOXM1;CUL3;CRLF3;PPP2R2A;SPDYA;CCDC57;AJUBA;CLASP2;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;TACC3;BRSK1;LATS2;RB1;TUBB4A;PPP1R12A;CDK14;DCTN1;EIF4E;ANAPC7;CCNH;SKP1;DCTN3;CEP76;CCNE1;CEP135;NDE1
prerank,cellular response to estrogen stimulus (GO:0071391),-0.4397469434062246,-1.0499503230618414,0.4392523364485981,0.736562287869618,1.0,8/14,29.32%,TRIM24;AR;SFR1;SFRP1;NCOA4;RARA;SRA1;SERPINB9
prerank,positive regulation of chemokine production (GO:0032722),-0.3362320908662404,-1.049903261598693,0.3927765237020316,0.735981495779656,1.0,9/44,10.93%,APP;IL6R;LGALS9;WNT5A;IL33;HIF1A;IL17RA;IL18;MAVS
prerank,regulation of receptor binding (GO:1900120),0.5044757898406264,1.049797188002048,0.4067796610169492,0.8227930746123763,1.0,2/10,6.59%,ATP2A3;ATP2A2
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4313792322402442,-1.0493675002107306,0.40643863179074446,0.7366126636785016,1.0,5/15,21.19%,ADAM9;MAPK14;EHD1;EHD2;TYROBP
prerank,stress fiber assembly (GO:0043149),-0.4269979318124558,-1.0491623256005447,0.4205607476635514,0.7357001794307259,1.0,6/15,7.87%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,contractile actin filament bundle assembly (GO:0030038),-0.4269979318124558,-1.0491623256005447,0.4205607476635514,0.7357001794307259,1.0,6/15,7.87%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,positive regulation of protein catabolic process (GO:0045732),-0.2966303577604944,-1.0488073190358702,0.3701657458563536,0.7359150988512296,1.0,19/84,11.45%,VGLL4;FOXO1;APOE;SMURF2;EZR;SNX9;NKD1;ADAM9;WWP2;SMURF1;WNT5A;TNFRSF1B;PLK2;EGLN2;IDE;DAB2IP;VPS35;RAB7A;ASB5
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.483911754223991,1.048766639590587,0.3926247288503254,0.82422754491796,1.0,1/11,0.63%,MEF2C
prerank,skeletal muscle organ development (GO:0060538),-0.38370165876480716,-1.048450557569091,0.4046610169491525,0.736187309367409,1.0,9/26,10.88%,LARGE1;CAV1;CFLAR;MYL6;SIX1;STRA6;ZBTB18;SVIL;DISP1
prerank,positive regulation of cell adhesion (GO:0045785),-0.3021510464824246,-1.0482460927482748,0.379746835443038,0.7359758827701903,1.0,19/74,13.68%,AFDN;EPHA4;VIT;TGM2;PTPRJ;FOXC2;ADAM9;SMAD7;CXCL12;NDNF;P4HB;CD47;STX3;FBLN2;FLCN;ATM;CHRD;MEGF10;RET
prerank,negative regulation of hippo signaling (GO:0035331),0.4729288716337074,1.0481568976453162,0.3831967213114754,0.8246374315487528,1.0,2/12,4.97%,LIMD1;AJUBA
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3322845550781821,-1.048034752335973,0.40401785714285715,0.735865365484421,1.0,12/50,10.98%,NXN;HDAC8;CAV1;SMAD7;TAF1;ARRB1;SH3RF2;AKT1;DTX3L;PINX1;IVNS1ABP;PRKCG
prerank,regulation of sodium ion transport (GO:0002028),-0.35420847583816584,-1.047855853547248,0.37763713080168776,0.7356682334756867,1.0,15/34,21.00%,SNTA1;DLG1;WNK4;WNK1;GPD1L;P2RX4;AHCYL1;SLMAP;P2RX7;ATP1A1;CNKSR3;NOS1;YWHAH;NKAIN4;SCN3B
prerank,regulation of cell cycle (GO:0051726),0.30537067190742145,1.047457830842862,0.3599476439790576,0.8252331486569154,1.0,39/271,11.89%,PTPRK;FAP;MAP3K20;APBB2;CDK6;NOTCH1;AFAP1L2;PER2;RGCC;GPER1;TBX3;SIPA1;FOXM1;CRLF3;RPS6KA2;BRINP1;NUPR2;SIK1;HRAS;BIN1;FGF10;CDKN1A;GRK5;RNF112;HTRA2;PKD2;TTLL12;CDC14B;NEK6;TAF6;CITED2;ASAH2;WDR12;SETMAR;RPRD1B;EP300;RB1;APC;SND1
prerank,response to estrogen (GO:0043627),-0.35880069259861325,-1.0474455003536265,0.36909871244635195,0.7360431190727054,1.0,13/31,30.34%,CAV1;ESR1;TRIM24;AR;SFR1;SFRP1;NCOA4;RARA;BRCA1;KRT19;SRA1;SERPINB9;RBBP5
prerank,positive regulation of hydrolase activity (GO:0051345),0.3279017414173318,1.0474042209836592,0.3830703012912482,0.8243757581530563,1.0,20/137,8.81%,RGS6;LIMS1;DOCK10;RAPGEF2;RASGRP2;MTCL1;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;RIC1;RAP1A;HRAS;RGS7;RAB11FIP2;MAP4K4
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.31079808834815664,-1.0472048262960787,0.3903061224489796,0.7360163754027712,1.0,21/65,24.70%,FBXL7;FHL1;USP47;CHFR;ZFYVE19;PINX1;PSME2;NABP1;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;CDK5RAP3;PSMB7;PSMC2;PSMC5;PSMD10
prerank,heme biosynthetic process (GO:0006783),-0.3904412095177616,-1.0471118413811826,0.40576923076923077,0.7355859960355747,1.0,13/22,33.86%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.37659417323819877,-1.0461639420353483,0.4098360655737705,0.7372636330086221,1.0,6/24,7.64%,NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.3997490304603297,-1.0461017256354195,0.3941908713692946,0.7367423119325451,1.0,8/18,21.19%,LBP;SBNO2;ENPP3;IFI35;KARS1;PLCG2;SYK;TYROBP
prerank,zinc ion transmembrane transport (GO:0071577),0.44043633556276734,1.0457491543171662,0.4042145593869732,0.8271218468518445,1.0,1/22,0.46%,SLC30A10
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.4520668292856436,1.0456739352936724,0.4279835390946502,0.8263217672517215,1.0,5/20,11.99%,BMP5;GPER1;SIK1;PRMT3;ERLIN1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3598288105126782,-1.0455175596130084,0.39059304703476483,0.737572148270244,1.0,3/30,2.98%,NOTCH2;IGF1;TGM2
prerank,negative regulation of ossification (GO:0030279),0.43954447194233615,1.045451379054717,0.39711934156378603,0.8258703287390395,1.0,2/23,1.19%,MEF2C;NOTCH1
prerank,DNA biosynthetic process (GO:0071897),-0.41497636472576965,-1.0442983762384697,0.391713747645951,0.7399904822534349,1.0,8/16,30.13%,POLH;PPIA;TYMS;RFC3;POLA1;CDKN2D;POLD1;WRN
prerank,postsynaptic membrane organization (GO:0001941),0.4507497246610615,1.043876860877314,0.39166666666666666,0.8283713670983557,1.0,2/17,3.16%,CEL;NRXN1
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3569578760048854,1.0435843589434266,0.3963210702341137,0.8280634382082289,1.0,11/70,13.43%,MBOAT2;NR1H3;SLC44A2;LIPC;ABHD3;PLAAT1;ACHE;STARD7;PLA2G4E;CHKB;ABHD4
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.4661415966062923,1.043562064081618,0.39330543933054396,0.8271473317193541,1.0,5/13,11.20%,UBA2;DESI1;DESI2;UBA1;UBA6
prerank,regulation of immune response (GO:0050776),-0.2764879618224596,-1.0434956947311578,0.33226837060702874,0.7413753971149607,1.0,20/135,10.16%,COL1A2;COL3A1;COL1A1;FOXP1;CXADR;IL15;CLEC2D;B2M;VCAM1;CD34;APPL2;ADCY7;IRF1;ICAM1;FKBP1A;ERAP1;BIRC3;RNF135;CASP8;SAMHD1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3156917172834071,1.043368895153839,0.37679083094555876,0.8266180206949609,1.0,27/166,9.25%,PDGFRB;PTH1R;PLD1;RGCC;NR1H3;SCARB1;ZEB2;IL1B;LDLR;ATP7A;FGF2;FABP3;YTHDF3;SNCA;DDX3X;SOX4;APPL1;KAT7;IRS1;NMD3;MTOR;EIF3C;ARNT;PRKD2;PKD2;PDGFB;GCK
prerank,peptidyl-tyrosine modification (GO:0018212),-0.31779428126273856,-1.0430486882724415,0.36496350364963503,0.7417816318564459,1.0,8/56,3.02%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;PDGFRA;TEK;FGFR2
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4659556209993533,-1.042540677903537,0.41838649155722324,0.7423757307710136,1.0,4/10,13.61%,ADAM10;WNT5A;WNK1;OXSR1
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.41815577102788387,-1.0422990396708474,0.4247104247104247,0.7423423162581778,1.0,5/16,17.82%,PHKB;PHKA2;PYGB;CALM1;GAA
prerank,regulation of interleukin-8 production (GO:0032677),-0.30355231940226557,-1.0418631897259507,0.35714285714285715,0.7427941151881929,1.0,19/69,18.52%,F3;ANXA4;LBP;KLF4;NOD1;ANXA1;ARRB1;LGALS9;STAT3;MAP2K5;TMSB4X;MAVS;RELA;SSC5D;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.29354322421243384,-1.0417803694161554,0.3726027397260274,0.7423066768560611,1.0,15/84,14.50%,IGF1;DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;IGF2BP2;CPEB3;CALR;SPHK1;LARP1;CNOT8;FXR2
prerank,intestinal absorption (GO:0050892),-0.44171991093435536,-1.0416407016730354,0.408,0.7419781149449179,1.0,4/13,13.66%,TJP2;KCNQ1;F11R;UGCG
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.43141486200495116,-1.041639448113752,0.3860294117647059,0.74129632730443,1.0,10/13,28.17%,SEC16B;EDEM2;TMEM30A;TM9SF4;BCAP31;SAR1A;SAR1B;CD81;SEC16A;EDEM1
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.40761405123382954,-1.0412286879983668,0.392578125,0.741645393089846,1.0,5/18,21.45%,FBN1;TCTA;GPR137;TLR4;FSTL3
prerank,motile cilium assembly (GO:0044458),0.483969474470876,1.0411530758006546,0.43736263736263736,0.8305593316674715,1.0,1/12,2.33%,RSPH6A
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.458188371911813,1.0411367337621684,0.40124740124740127,0.8296455924620848,1.0,2/16,1.91%,PDGFRB;BCAR1
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3641839223034061,-1.041041089686673,0.41350210970464135,0.7414099878785095,1.0,14/29,26.62%,LIMA1;SLIT2;SHANK3;KANK3;PRKCD;FKBP4;PFN1;TWF1;CYRIB;SSH3;ARPIN;KANK1;PRKN;SMAD4
prerank,regulation of myoblast differentiation (GO:0045661),0.41339985747268837,1.0407736226553472,0.41316270566727603,0.8295026984753808,1.0,5/32,4.38%,MEF2C;NOTCH1;TBX3;RBM24;SOSTDC1
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44841775609026874,-1.0401770018267544,0.4099264705882353,0.7429146044604107,1.0,6/12,13.65%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33043626215593097,1.0399243396008904,0.40294117647058825,0.8304963697817874,1.0,15/125,10.99%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;DYNC1I2;NEK6;NUSAP1;TACC3;TUBG2;XPO1;SEC13
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.3386131263901584,-1.0399231538826788,0.3752665245202559,0.74287477384782,1.0,10/39,12.45%,BMP6;PODXL;KLF4;CDH1;FXYD5;WNK1;MAP2K5;AKT1;TGFB1;PPARA
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4041351162752133,-1.039664325812685,0.41467889908256883,0.7428565800920073,1.0,6/18,14.09%,VGLL4;EZR;ATRAID;DAB2IP;VPS35;RGP1
prerank,cellular response to gamma radiation (GO:0071480),0.4503751065576389,1.0396283269403763,0.42424242424242425,0.830196745156383,1.0,3/17,10.12%,MAP3K20;HRAS;ATR
prerank,negative regulation of protein depolymerization (GO:1901880),0.419637774837075,1.0396269786774215,0.4127906976744186,0.8292422181350924,1.0,8/24,13.12%,SPEF1;PIK3CA;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31746934678120203,-1.0390375697392147,0.4121951219512195,0.743737112591289,1.0,17/55,24.70%,FBXL7;FHL1;USP47;PINX1;PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;PSMC2;PSMC5;PSMD10
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.46882376165908646,-1.0386196763574729,0.42357274401473294,0.7440984247321308,1.0,2/10,15.88%,LGALS9;CEACAM1
prerank,neural tube development (GO:0021915),-0.42022941579099526,-1.038565344625788,0.42178217821782177,0.7435374506138103,1.0,4/15,14.82%,ALDH1A2;TGFB1;PTCH1;PKD1
prerank,sympathetic nervous system development (GO:0048485),-0.42032336342469956,-1.0384094722414134,0.40874524714828897,0.7432322519184043,1.0,2/15,1.02%,NRP2;NRP1
prerank,cellular response to insulin stimulus (GO:0032869),-0.275660743207615,-1.0372451379600955,0.3651685393258427,0.745539223181641,1.0,31/124,14.30%,SORBS1;RHOQ;FOXO1;ENPP1;IGF1R;BAIAP2;KAT2B;FOXC2;AP3S1;ATP6V0A4;HDAC9;IGF2;SLC39A14;SYAP1;CPEB2;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;INSIG2;RAB8A;ATP6V0A1;TCIRG1;USF1;LPIN3;FER;HDAC5;CAV2
prerank,peptidyl-proline modification (GO:0018208),-0.37527957981472004,-1.03640441362049,0.42355371900826444,0.7470086651119786,1.0,9/25,22.83%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA;FKBP7;PPIL1;FKBP10
prerank,sulfur compound biosynthetic process (GO:0044272),0.33842923692742716,1.03616883053388,0.39906832298136646,0.8360437961183645,1.0,13/104,7.23%,CSPG4;GGT5;GGT1;CHST3;GGTA1;CHST7;CHAC1;CTH;ACAN;SLC26A1;B4GALT6;TPK1;CHST2
prerank,positive regulation of protein polymerization (GO:0032273),0.3590709005037146,1.0361125615981102,0.38528896672504376,0.8351990681397278,1.0,11/65,11.50%,CARMIL1;NCK2;VASP;CDC42EP1;NAV3;TTBK1;TPPP;BIN1;NCKAP1;LMOD1;PAK1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.31067044009530603,-1.0357507884379822,0.3793859649122807,0.7479489563241175,1.0,14/59,17.70%,ROCK2;MAP3K14;IRAK2;BIRC3;ERC1;AKT1;TNFRSF1A;DAB2IP;RELA;UBB;TICAM1;TLR4;RIPK1;NFKBIA
prerank,axonal fasciculation (GO:0007413),-0.44059309709196376,-1.0356094777040148,0.43953934740882916,0.7476102707560689,1.0,2/12,0.65%,EPHA4;EPHA3
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3711948001346527,-1.035499406969456,0.3971774193548387,0.7472090584324746,1.0,4/26,3.49%,ERRFI1;TGFA;APP;SNX6
prerank,myofibril assembly (GO:0030239),0.39421653872354645,1.035405892729871,0.41316270566727603,0.8358676912012378,1.0,3/42,5.35%,PDGFRB;TMOD1;TMOD3
prerank,mitotic cytokinesis (GO:0000281),-0.330349300371494,-1.0353782122533803,0.391705069124424,0.7468279083018752,1.0,18/47,19.79%,ROCK2;SNX9;PDCD6IP;USP8;RHOB;MYH10;SON;ARL3;TTC19;SPAST;EFHC1;CHMP4B;EFHC2;MITD1;KLHDC8B;STAMBP;CIT;RHOC
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.43542412562268984,-1.0350204746682437,0.4411214953271028,0.7471011161120116,1.0,5/13,14.53%,APP;SHANK3;ADCY1;EPHB2;SHISA7
prerank,cellular response to organic cyclic compound (GO:0071407),0.32549989494984916,1.0350009947460344,0.39461883408071746,0.8358636987208568,1.0,22/141,9.43%,MEF2C;GNG2;PDE3A;RAPGEF2;ATP1A2;RORA;GPER1;IL1B;ADCY8;ADCY3;NCOA3;ADCY6;AKAP6;GABRG2;HCN2;RAP1A;FAM210B;RYR3;HCN3;PKD2;PDGFB;MED1
prerank,sphingosine biosynthetic process (GO:0046512),-0.4478906284528913,-1.0347764121570417,0.4250474383301708,0.746363409287436,1.0,4/11,14.16%,ACER2;ACER3;SPHK1;SPTLC2
prerank,sphingoid biosynthetic process (GO:0046520),-0.4478906284528913,-1.0347764121570417,0.4250474383301708,0.746363409287436,1.0,4/11,14.16%,ACER2;ACER3;SPHK1;SPTLC2
prerank,regulation of protein binding (GO:0043393),-0.2790127409051039,-1.0346687206692713,0.3504273504273504,0.745927631936939,1.0,34/114,18.14%,DAB2;HDAC4;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;FKBP1A;AMFR;PRKCD;IFIT2;TIAM1;AKT1;DTX3L;IFIT1;IDE;RPL11;DNAJB2;ADD1;RAN;HDAC5;ACTB;PKD1;HIPK2;ZFPM1;TMBIM6;HFE;MITD1;STYX;EFHB;PARK7
prerank,positive regulation of stem cell proliferation (GO:2000648),0.45621027346691356,1.0337578537375534,0.4079207920792079,0.837739246745562,1.0,5/17,15.97%,FERMT2;N4BP2L2;KAT7;HNRNPU;CCNE1
prerank,regulation of potassium ion transport (GO:0043266),0.41379006283997344,1.033735994200416,0.4255725190839695,0.836833904322347,1.0,8/31,11.54%,CASQ2;DPP10;KCNAB3;ANK3;CACNA1D;KCNE5;KCNIP1;KCNIP4
prerank,pentose-phosphate shunt (GO:0006098),-0.451903740929771,-1.0331798770904181,0.439622641509434,0.7490135089137449,1.0,6/11,23.00%,TALDO1;DERA;PGD;RPIA;PGLS;SHPK
prerank,regulation of phagocytosis (GO:0050764),0.37813616048271287,1.0329912834231305,0.4165232358003442,0.8375744026817337,1.0,5/53,2.62%,IL15RA;DYSF;SCARB1;MERTK;IL1B
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.39494321510932573,-1.0326998667483953,0.42524271844660194,0.7494950116827048,1.0,2/19,2.01%,CAMK1D;MCU
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.28924680482688453,-1.032517964321625,0.39622641509433965,0.7493002449297854,1.0,14/87,14.52%,FLRT2;RBFOX2;FGFR2;FGF1;NDNF;KL;TBX1;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;SFRP1;MAPK3
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.4046373997865411,-1.0321885368030017,0.41967871485943775,0.7494573670633331,1.0,5/18,21.54%,NR3C1;ANXA1;BCL2L11;ZFP36L2;FAM107A
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4949914118243076,1.0321623918758636,0.4329896907216495,0.838442102256131,1.0,3/10,9.11%,RAPGEF2;AXL;LYN
prerank,reverse cholesterol transport (GO:0043691),-0.43862842292953164,-1.0321283599985878,0.4266409266409266,0.7489450705432192,1.0,2/13,1.96%,ABCA1;APOE
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.3884726066410073,-1.0318269334808616,0.41975308641975306,0.7490155119150124,1.0,10/24,21.87%,DNMT3A;RBBP7;H3-3A;JARID2;TRIM27;PPHLN1;EZH2;SMYD5;MPHOSPH8;DNMT1
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.4333770431164931,-1.0317193356953644,0.44731977818853974,0.7485871451643175,1.0,4/12,16.27%,ESR1;ZC3H12A;TGFB1;ELAVL1
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38570609867519984,-1.0317136014359274,0.4048582995951417,0.7479280467200229,1.0,4/22,5.79%,AEBP1;AKAP13;APOE;MAP1B
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.4156277940325162,-1.031384025869445,0.4417293233082707,0.7481138534337676,1.0,9/16,30.27%,CAV1;PARP14;HGS;LEPROT;PTPN2;ADIPOR1;PIBF1;SOCS1;INPP5F
prerank,protein homotetramerization (GO:0051289),-0.3221885058377756,-1.0309947819730076,0.42042755344418054,0.7484259217835539,1.0,10/49,11.55%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;ACACA;SAMHD1;GBP5
prerank,T cell homeostasis (GO:0043029),-0.46663737367396896,-1.030708946972582,0.4337568058076225,0.7484864746502555,1.0,10/10,53.37%,AKT1;PPP2R3C;NCKAP1L;FAS;FADD;JAK3;ZC3H8;FOXP3;RIPK3;PMAIP1
prerank,negative regulation of signal transduction (GO:0009968),0.29902501625676753,1.030693125420632,0.40106951871657753,0.8407659453496545,1.0,26/249,6.75%,NOTCH3;PTEN;PID1;BMP5;SPRY4;BTRC;TNS2;IL1B;CHAC1;TSPAN15;PIP4K2A;CADM4;FGF2;SOSTDC1;SPRY2;SLC27A4;MOSMO;SIAH2;GRB10;SOCS5;GPC3;PIP4K2C;SNCA;CACTIN;APPL1;KCTD6
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.4369149595100712,1.0306784813200514,0.42178217821782177,0.8398469927261809,1.0,2/21,2.35%,NDST3;EXTL3
prerank,regulation of cell motility (GO:2000145),-0.2777890497277958,-1.030471618898158,0.40869565217391307,0.7484075126475023,1.0,19/121,8.75%,PLXNA2;EGFR;ROCK2;LMO4;FBLN1;PLXNA4;MACF1;DIAPH1;ARHGAP18;FGF1;SPOCK2;CAVIN1;RHOA;RHOB;TMSB4X;TBCCD1;CCDC125;PLXND1;AKT1
prerank,cholesterol transport (GO:0030301),0.3826739498918846,1.0300704934339977,0.39361702127659576,0.8402462877232277,1.0,7/45,6.95%,CEL;SCARB1;LDLRAP1;LDLR;MSR1;ABCA5;LIPC
prerank,regulation of protein kinase activity (GO:0045859),0.33460605665925774,1.0297584102099202,0.3977987421383648,0.8400184055101505,1.0,16/106,9.48%,PLCE1;RAPGEF2;PTK2;PPM1E;NF1;SPRED1;AGAP2;SPDYA;TRIB2;DBNDD2;SNCA;RAP1A;AKT1S1;CDKN1A;ANKRD54;TARBP2
prerank,regulation of protein kinase A signaling (GO:0010738),0.4337527877628698,1.0297232003413792,0.41359223300970877,0.8391542978317202,1.0,7/20,10.18%,PRKAR1B;AKAP6;PRKAR2B;PRKAR2A;AKAP12;AKAP7;PRKAR1A
prerank,activation of protein kinase A activity (GO:0034199),0.4597129264882832,1.029537608795456,0.3995943204868154,0.8386203243025959,1.0,8/16,10.18%,PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.42750969254483545,-1.0294963565779987,0.42971887550200805,0.7501203136598588,1.0,12/14,42.35%,RELA;RAB29;IKBKG;CD81;RPS3;BCL10;KCNN4;CARD11;TRAT1;CD226;TESPA1;LCK
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.4232903315823823,1.0293740551513573,0.41154562383612664,0.838039864844543,1.0,7/24,9.01%,VTN;IL1B;CADM4;GRB10;TMEM204;ARNT;PRKD2
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.3644837724598548,-1.029108175838193,0.39791666666666664,0.7503894256286651,1.0,8/26,11.82%,POR;APOE;NPR3;PIK3CB;NOS1AP;AKT1;HIF1A;GCH1
prerank,catecholamine biosynthetic process (GO:0042423),-0.45520929673318544,-1.028983528406195,0.45811051693404636,0.7500299092875428,1.0,3/11,17.95%,MOXD1;GCH1;DDC
prerank,fibrinolysis (GO:0042730),-0.43177870193402257,-1.0287916165017883,0.4340659340659341,0.7498369256330011,1.0,9/13,52.37%,SERPINE1;PLAUR;HRG;PLAT;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.37639887051304954,1.0286789789103077,0.4442446043165468,0.8386457406052502,1.0,10/48,10.94%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1;CAPRIN2;IL1RAPL1;DOCK1;ARHGEF7;CUX2
prerank,negative regulation of protein kinase activity (GO:0006469),-0.28716002808803526,-1.028246169203648,0.40310077519379844,0.7505039517790741,1.0,37/88,29.20%,PRKAG2;PTPRB;CAV1;DEPTOR;LRP6;SLC8A3;DTNBP1;AKT1;DAB2IP;TRIM27;CEP85;QARS1;PPIA;CORO1C;GSKIP;DUSP10;CEACAM1;CDKN1B;PDPK1;PARK7;CHP1;TRIB1;CDK5RAP3;UBASH3B;CDKN1C;INPP5K;SH3BP5;PYDC1;GNAQ;PAK2;SFN;TRIB3;ABL1;PPM1F;PTPRQ;ADARB1;DUSP26
prerank,regulation of MAP kinase activity (GO:0043405),0.34134618636069197,1.0275719454016106,0.3990536277602524,0.8402182467580751,1.0,12/92,6.00%,PDGFRB;IL34;SPRY4;NF1;IL1B;SH2B3;PDCD10;FGF2;SPRY2;TRIB2;CD300A;UCHL1
prerank,AMP metabolic process (GO:0046033),-0.44449255597011605,-1.0275053019838296,0.43564356435643564,0.7517374006654525,1.0,5/13,20.92%,AMPD3;XDH;NT5E;NT5C1A;ADSS1
prerank,establishment of vesicle localization (GO:0051650),-0.40461185609639594,-1.0267742989487605,0.43186180422264875,0.7529616761454841,1.0,4/18,5.45%,RAB11A;LIMK2;RAB27A;CCDC186
prerank,cellular protein localization (GO:0034613),0.2993535896119284,1.026022911668039,0.41160949868073876,0.8428077075975267,1.0,43/285,11.87%,PTPRK;TBC1D1;DMD;HEY2;PIGU;JAM3;VCL;FERMT2;STX16;GRTP1;COG7;CNTNAP2;COX18;TBC1D30;ESAM;GAS8;GGA3;ARL4C;DNAJC27;TBC1D12;RIC1;EMP2;RUNDC1;FGF10;RAB28;MYO6;TBC1D2B;RAB38;TBC1D10C;TMED7;TMED4;BICD2;STXBP2;ARL5C;AHI1;SEC13;STX4;ARFRP1;WLS;AXIN2;ERP29;COPB2;TBC1D9B
prerank,regulation of protein sumoylation (GO:0033233),-0.40795253987545693,-1.0259269668587088,0.43263757115749524,0.7543849217995439,1.0,2/17,1.09%,ZMIZ1;HDAC4
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.4577563361671743,-1.0257683045422883,0.46950092421441775,0.7534346385486044,1.0,5/10,20.58%,NFAT5;NFATC1;PPP3CC;PPP3CB;NFATC2
prerank,calcineurin-mediated signaling (GO:0097720),-0.4577563361671743,-1.0257683045422883,0.46950092421441775,0.7534346385486044,1.0,5/10,20.58%,NFAT5;NFATC1;PPP3CC;PPP3CB;NFATC2
prerank,cellular response to ketone (GO:1901655),-0.3471046992505509,-1.0255898602049003,0.42316258351893093,0.7532328805540153,1.0,11/35,13.90%,ROCK2;ADCY5;NR3C1;ADCY1;AR;GOLPH3;ADAM15;AHR;SPP1;LARP1;SFRP1
prerank,multivesicular body organization (GO:0036257),-0.3549454379257356,-1.0252171642058692,0.4824561403508772,0.7534750178226859,1.0,6/31,10.71%,RAB11A;PDCD6IP;RAB27A;HGS;CHMP4B;CHMP4A
prerank,regulation of GTPase activity (GO:0043087),0.3128800601381665,1.024933301929797,0.41585535465924894,0.8443204336662149,1.0,22/177,7.64%,CHN1;RGS6;LIMS1;PRKG1;DOCK10;RAPGEF2;PTK2;RASGRP2;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;NTRK2;ARFGEF1;RIC1;RAP1A;HRAS;RGS7
prerank,cellular response to starvation (GO:0009267),-0.2658121062536796,-1.0247279551502693,0.3815789473684211,0.7540171128108549,1.0,49/147,26.47%,PRKAG2;LAMP2;FOXO1;FOXO3;BMPR2;LRRK2;DAP;WIPI2;FNIP1;ITFG2;HSPA5;CLEC16A;KLF10;ATP6V1G1;BECN1;DAPL1;FLCN;ATP6V0B;ZC3H12A;SH3GLB1;TCIRG1;PRKAG3;PPARA;MFSD2A;SFRP1;MAPK3;SREBF1;PRKAA2;MTMR3;GABARAPL1;RRP8;RRAGB;CEBPB;LAMTOR5;ZFYVE1;KPTN;PRKAG1;XBP1;EIF2AK3;ATP6V1F;STK26;RIPOR1;ATG7;RRAGC;TP53;ATF2;FAS;EIF2AK4;PICK1
prerank,autonomic nervous system development (GO:0048483),-0.40508860793297935,-1.0245864542052094,0.4327485380116959,0.7537202872047405,1.0,2/17,1.02%,FN1;NRP1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.4668626507560696,-1.0245291767347515,0.4461538461538462,0.753197363045961,1.0,4/10,31.89%,ALDH7A1;HNMT;SMOX;DMGDH
prerank,cytoplasmic translational initiation (GO:0002183),-0.39872076768731335,-1.024511694619509,0.4501915708812261,0.7525666005236337,1.0,10/17,37.97%,EIF4A1;EIF2S2;DENR;EIF4A2;EIF2D;EIF3D;DHX29;RBM4;EIF4B;EIF3I
prerank,regulation of intracellular transport (GO:0032386),-0.32760608865471613,-1.0244792711477322,0.40315315315315314,0.7519735028184571,1.0,14/38,22.24%,GAS1;LRRK2;RNF139;NDEL1;RINT1;ATP9A;TTC21B;REEP5;DYNC1H1;DYNLT2B;DNAJC30;NUP214;NUMA1;LCP1
prerank,dephosphorylation (GO:0016311),0.31855374847522927,1.0239632535660061,0.4108983799705449,0.845575445096739,1.0,11/147,4.73%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;PTPN22;SSH2;PLPPR5;PPP3CA;PPP2R2A;PTPN4
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4027547081303832,-1.0237323495431903,0.4516765285996055,0.7531432532365251,1.0,3/18,2.97%,EGFR;LCOR;ESR1
prerank,lipoprotein catabolic process (GO:0042159),-0.45373016564759094,-1.0236418100801237,0.4455252918287938,0.7527114324753681,1.0,8/11,28.98%,APOE;LYPLA1;NOTUM;ABHD17C;LYPLAL1;LYPLA2;CTSD;ABHD17A
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.428489930102295,-1.023588620027784,0.4329501915708812,0.7521907127294541,1.0,2/13,3.49%,ERRFI1;SNX6
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.47398172509287445,1.0233470056751952,0.42424242424242425,0.8460222435842929,1.0,3/13,10.48%,RCL1;TBL3;NOP14
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.45105160612598943,1.0223051786892718,0.4385593220338983,0.8473802453171202,1.0,4/16,13.00%,NCBP2;CACTIN;PRPF39;DDX23
prerank,negative regulation of DNA binding (GO:0043392),0.41447125480361097,1.021675702149978,0.4268774703557312,0.8477666823767364,1.0,3/28,5.14%,HEY2;PER2;TNKS
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.44151499448877746,-1.021283190108776,0.4398496240601504,0.7573459734555894,1.0,8/12,43.78%,RPL26;TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,membrane repolarization (GO:0086009),0.4523266575873839,1.020939367905099,0.4327731092436975,0.8484897936860702,1.0,4/15,7.70%,ATP1A2;KCNE4;ATP1B2;KCNE5
prerank,response to organic cyclic compound (GO:0014070),0.37690196855052394,1.0209203747574889,0.4283246977547496,0.847573629049462,1.0,4/52,4.36%,GGT5;GGT1;IL1B;DHFR
prerank,negative regulation of cell growth (GO:0030308),-0.27260563162027834,-1.0201501048990722,0.4123076923076923,0.7595759935341354,1.0,28/121,14.32%,SMAD3;SMARCA2;VGLL4;FHL1;ENPP1;SLIT2;BMPR2;PTPRJ;GJA1;RBBP7;CCN3;NPR1;ACVRL1;NDRG3;OSGIN2;DIP2B;ADAM15;FLCN;ULK2;PML;DNAJB2;TGFB1;PRDM11;TCHP;SOX17;SFRP1;ENO1;IP6K2
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.38138175604576424,-1.0201090806976048,0.428,0.7590024675856745,1.0,3/21,4.13%,CAV1;LRP6;FZD2
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.38993854415224405,-1.0199134004925787,0.4217557251908397,0.7588059807533261,1.0,7/19,19.84%,MAOB;ACOX1;PRDX2;CYBA;GPX1;PARK7;NOX1
prerank,positive regulation of B cell activation (GO:0050871),0.3829720482946299,1.0190504395024305,0.4380610412926391,0.8508643297188792,1.0,4/50,6.03%,MEF2C;SH3KBP1;TNIP2;IL4
prerank,cellular glucose homeostasis (GO:0001678),-0.32817508213266333,-1.0184154081158467,0.42332613390928725,0.7618450072638807,1.0,10/41,11.51%,UNC13B;FOXO1;IGF1R;SLC39A14;GAS6;HK2;HIF1A;KCNB1;FOXK1;ERN1
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4484689907786742,-1.0181867635398494,0.4386973180076628,0.7617610459546447,1.0,5/12,29.52%,AKT1;PPP1R3B;PPP1R3F;INPP5K;KHK
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3194873123662154,-1.017743685538486,0.42206235011990406,0.762213850854394,1.0,14/51,14.55%,BMP7;GAS7;NRK;SRGAP2;LRRK2;NBL1;ALS2;TRIO;DTNBP1;TAOK2;DAB2IP;DCLK1;UBB;ANKRD27
prerank,negative regulation of complement activation (GO:0045916),-0.4554623466568524,-1.0164205293123953,0.43822393822393824,0.764861340594712,1.0,2/10,2.13%,SERPING1;CD55
prerank,transferrin transport (GO:0033572),-0.3400962396528938,-1.0163601665581714,0.44421487603305787,0.7643360576126491,1.0,16/33,29.53%,STEAP3;ATP6V0A4;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2;HFE;REP15;MCOLN1;ATP6V1F;ATP6AP1;ATP6V0D1;ATP6V0C;ATP6V1D
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3780105390724823,1.0162118323858256,0.42385321100917434,0.8562482122512322,1.0,5/43,5.98%,ITGA1;SH3KBP1;SPRY2;SOCS5;EPN1
prerank,regulation of chromatin organization (GO:1902275),-0.43108744407804106,-1.0161255159016676,0.4644808743169399,0.7642170089296123,1.0,3/14,5.02%,TLK1;MLLT3;IGF2
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.4138111094001137,-1.0156230484802056,0.4330097087378641,0.7647783125266747,1.0,3/14,5.47%,SULF1;THBS1;SULF2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.438135662515144,1.0155730709551882,0.4460580912863071,0.8567275787254265,1.0,3/19,2.15%,LIMS1;FERMT2;ROCK1
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.35029733278636677,1.0154175355444965,0.4326923076923077,0.856144958321683,1.0,12/76,9.72%,PTEN;CBFA2T3;PTK2;PABIR1;RBX1;SOCS5;TRIB2;RCHY1;ZER1;DET1;CSNK1E;NKD2
prerank,positive regulation of programmed cell death (GO:0043068),-0.24337149189067261,-1.0150795828096073,0.40329218106995884,0.7654917081154828,1.0,64/272,17.87%,DAPK1;UNC13B;PAWR;AKAP13;TIAM2;FOXO1;FOXO3;ARHGEF3;SLIT2;ITGA6;TGM2;VAV2;STK17B;BMP4;RASSF2;MCF2L;LRRK2;ARHGEF2;HOXA5;IGFBP3;QRICH1;TNFSF10;IAPP;RARG;SFRP4;ANO6;CYP1B1;PTPA;RHOB;TRIO;IFIT2;ADAMTSL4;ARHGEF1;AIFM1;TIAM1;UTP11;BCL2L11;FLCN;ATF6;CASP8;DAB2IP;FGD4;BNIP3L;PLEKHG5;ATM;TRIM35;UBB;PPID;ARHGEF18;ARHGEF19;BNIP3;SFRP1;IP6K2;RASGRF2;RPS6;ARL6IP5;NET1;BID;GNA13;RIPK1;STPG1;PSEN2;CSRNP3;PDCD5
prerank,cellular response to reactive oxygen species (GO:0034614),0.3630164824091487,1.014847756769121,0.4423407917383821,0.8564637117738177,1.0,3/59,3.21%,PTPRK;MAP3K5;NCF1
prerank,sphingolipid catabolic process (GO:0030149),-0.4031856754184335,-1.0148069204668793,0.43843283582089554,0.7655180822972938,1.0,8/15,25.61%,ACER2;ACER3;SPHK1;SMPDL3A;ENPP2;SGPL1;PDXDC1;GLA
prerank,regulation of protein modification process (GO:0031399),-0.31591678676575086,-1.0147427530474855,0.44988864142538976,0.765011057694222,1.0,15/50,14.86%,FN1;CDH5;KAT2B;IGF2;STAT2;FNIP1;PPP1R16B;FLCN;PML;CCDC88C;FER;ATG10;NDUFS4;CORO1C;CDK9
prerank,negative regulation of type I interferon production (GO:0032480),-0.3331768049733955,-1.0146897582622014,0.4444444444444444,0.7644747688960724,1.0,16/40,28.93%,IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;PPM1B;SIRPA;UBA7;NPLOC4;UBE2L6;RNF216;REL;PTPRS;TAX1BP1;ISG15
prerank,T-helper cell differentiation (GO:0042093),-0.4135880200831391,-1.0146410388100502,0.428842504743833,0.7639316384985603,1.0,4/14,16.10%,FOXP1;LEF1;ZFPM1;TMEM98
prerank,axonal transport (GO:0098930),-0.3391446723692534,-1.0135737334945705,0.4298245614035088,0.7658871626485395,1.0,12/36,23.08%,AP3S1;KIF1B;DTNBP1;AP3B1;HIF1A;RAB21;SPAST;FBXW11;BLOC1S6;DYNC1H1;AP3D1;PAFAH1B1
prerank,regulation of actin filament polymerization (GO:0030833),0.3513945971158196,1.013281955888251,0.4317789291882556,0.8589955398058132,1.0,12/69,10.90%,CARMIL1;PLEKHG2;NCK2;VASP;SSH2;CDC42EP1;ESAM;ARFGEF1;BIN1;NCKAP1;LMOD1;PAK3
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.4167341627186865,1.012410619873851,0.4231536926147705,0.8589920539470691,1.0,5/22,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.4167341627186865,1.012410619873851,0.4231536926147705,0.8589920539470691,1.0,5/22,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23
prerank,cell differentiation in hindbrain (GO:0021533),0.48346425178867813,1.0124099589501518,0.4439746300211416,0.8580405986188381,1.0,2/11,4.05%,ATP7A;CEND1
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.35658673224186127,-1.0123524902157441,0.4543610547667343,0.7682776916557172,1.0,11/27,25.91%,RNASE4;NYNRIN;ZC3H12A;ERN1;XRN1;TOE1;DICER1;NUDT16;ZC3H12B;POP1;NHP2
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2818600055389147,1.0123144283964378,0.4363411619283066,0.8572877359368116,1.0,25/417,3.39%,PTPRK;KCTD1;TBX2;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NRG1;NR1D2;NAB1;CBX5;PHC3;PHC2;MECP2
prerank,protein kinase B signaling (GO:0043491),0.4261697561743927,1.012084306478558,0.4517374517374517,0.8568824805741505,1.0,2/23,2.62%,PTEN;IL1B
prerank,positive regulation of defense response (GO:0031349),-0.2809382962352499,-1.0120762230405247,0.416,0.7682850427282095,1.0,29/89,25.22%,APP;IL15;PDCD4;IL16;WNT5A;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;GBP5;CYBA;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;NPAS2;AGT;AGTR1;MDK;LPL;POLR3D;GPR4;PLSCR1;ZBP1
prerank,negative regulation of JNK cascade (GO:0046329),-0.35404688655330224,-1.011928913158779,0.4343220338983051,0.7679922328322331,1.0,11/31,27.71%,MECOM;PDCD4;SH3RF2;MAPK8IP1;DUSP10;SIRPA;ZMYND11;HIPK3;PRKN;AIDA;DACT1
prerank,regulation of gastrulation (GO:0010470),0.4380542460041886,1.01187167052714,0.44612068965517243,0.8564147545528259,1.0,4/14,13.10%,PHLDB2;CLASP2;TENM4;PHLDB1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.4385480533934807,1.0117622292706474,0.45020746887966806,0.8557156404782059,1.0,8/21,21.29%,MED13;MED1;MITF;BCLAF1;MED4;DHX36;MED30;MED16
prerank,negative regulation of cation channel activity (GO:2001258),0.4118965412336403,1.010917898050854,0.4536489151873767,0.8567054738323372,1.0,1/26,0.50%,CASQ2
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.31551416304952645,-1.0108288441808044,0.43155452436194897,0.7699935949550009,1.0,9/52,14.50%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;MBNL2;NOVA1;FXR2
prerank,lymphocyte differentiation (GO:0030098),0.3591861951088615,1.0108027640201949,0.433389544688027,0.8560302797257104,1.0,10/68,6.77%,ITGA4;PIK3CD;PTPN22;AXL;GPR89A;GPR89B;ITGB1;IL4;SOX4;KAT7
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.295045536446682,-1.0106687045486054,0.45112781954887216,0.769724945588184,1.0,11/72,14.52%,FLRT2;RBFOX2;FGFR2;FGF1;KL;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;MAPK3
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.3807632294958514,-1.0104350384014817,0.45161290322580644,0.7696711483140815,1.0,8/20,19.67%,MCU;SLC8A3;MCUB;SPG7;AFG3L2;MICU2;MICU1;MAIP1
prerank,regulation of nervous system process (GO:0031644),-0.387074787343085,-1.010346128882683,0.44271844660194176,0.7692343858494343,1.0,4/18,4.79%,ROCK2;APP;NOS3;SLC8A3
prerank,positive regulation of cell death (GO:0010942),-0.3035776696085119,-1.010236582606977,0.4482758620689655,0.768818620833187,1.0,9/59,8.22%,EFNB2;SLC6A13;SLC6A6;BMP4;LRRK2;ACER2;RARG;WNT5A;PRODH
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.27614771856367837,-1.0101491179085273,0.44972067039106145,0.7683650425895058,1.0,34/104,28.17%,KSR1;LRP6;SLC8A3;CCND2;RHOA;CALM2;SYAP1;CCND3;AKT1;HGS;IRGM;CCNG1;DAB2IP;PPEF2;UVRAG;CCND1;ACTB;CDKN1B;PARP16;CALM1;ADRB2;EZH2;TRIB1;CSF1R;CDK5RAP3;PIH1D1;CCNF;SERTAD1;CDK7;CDC25A;CDKN2D;TRIB3;ABL1;RPTOR
prerank,glycerol metabolic process (GO:0006071),0.47783520050038986,1.0098018903673038,0.421875,0.8572935968994128,1.0,3/10,9.26%,COQ2;GOT1;GK
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4184717704725595,1.009520042002848,0.46108949416342415,0.8569806185340679,1.0,2/25,1.37%,HEY2;PER2
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.45597850894390224,1.0091511126045858,0.45161290322580644,0.8569122598929124,1.0,1/15,0.21%,CSPG4
prerank,positive regulation of MAP kinase activity (GO:0043406),0.35422208574241104,1.0091473432778861,0.43564356435643564,0.8559745281179956,1.0,7/66,7.15%,PDGFRB;IL34;MAP3K5;PDCD10;FGF2;TAOK3;HRAS
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.39504321396043546,-1.0083844482894382,0.46808510638297873,0.7721563953997392,1.0,7/16,17.23%,LRRK2;HSPA5;SEC16B;BCAP29;VAPA;BCAP31;TAPT1
prerank,hemidesmosome assembly (GO:0031581),-0.44713307889336784,-1.0083425285868357,0.4696969696969697,0.7715939952003533,1.0,6/11,17.17%,ITGA6;PLEC;ITGB4;LAMA3;LAMC2;CD151
prerank,ephrin receptor signaling pathway (GO:0048013),0.3452949630596628,1.0080887740173146,0.44992050874403816,0.8574698665193512,1.0,25/82,13.55%,CHN1;KALRN;PTK2;SDC2;NCK2;ROCK1;WASL;ARPC5;ANKS1B;HRAS;AP2S1;LYN;GRIN2B;EPHA2;AP2B1;ARPC4;ARHGEF7;PAK3;EPHA10;PAK1;EPHB1;SRC;PSEN1;ARPC1A;RASA1
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.3778889549451643,-1.0078232626425068,0.453781512605042,0.7721844881745309,1.0,4/22,12.45%,SORBS1;APOE;AKT1;PPARA
prerank,muscle cell migration (GO:0014812),-0.45585271753816853,-1.007263850744469,0.4726930320150659,0.7729563524098797,1.0,5/10,13.36%,CCN3;SIX1;DDR1;ITGB3;MEGF10
prerank,monocarboxylic acid catabolic process (GO:0072329),0.43288684253243115,1.007074520152948,0.45643153526970953,0.8587766380733824,1.0,2/21,4.22%,CEL;PPARD
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.45441492754863916,1.0069917326651514,0.44988864142538976,0.8580083823554724,1.0,4/15,9.01%,NOTCH1;SEMA5A;FGF2;PRKD2
prerank,positive regulation of JNK cascade (GO:0046330),-0.29603932022915413,-1.0069086463644559,0.4584450402144772,0.7731754148710795,1.0,18/70,15.04%,PLCB1;CCN2;SH3RF1;APP;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP;FLT4;WNT16;MAPK8IP1;HIPK2
prerank,positive regulation of histone methylation (GO:0031062),-0.3610040590898431,-1.0061910734146717,0.4472049689440994,0.774336084284509,1.0,1/24,0.08%,AUTS2
prerank,Rap protein signal transduction (GO:0032486),0.45687101661155266,1.0055595303091425,0.4334763948497854,0.8603427411900554,1.0,2/10,6.90%,RAPGEF2;RAP1A
prerank,sister chromatid segregation (GO:0000819),-0.35050410834347484,-1.005312527341386,0.42358078602620086,0.775737003548782,1.0,21/31,37.96%,INO80;TOP2B;NCAPG2;RAN;ZW10;SMC4;CENPK;SMC1A;DSN1;TOP2A;SPAG5;KIF18B;KIFC1;NSL1;NDC80;CDCA8;SGO1;KIF18A;PLK1;KLHL22;ESPL1
prerank,nucleosome assembly (GO:0006334),-0.3433190359438447,-1.0049503964686437,0.4451219512195122,0.7759655639365445,1.0,17/31,36.43%,KAT6B;UBN1;H3-3A;ANP32B;HMGB2;RSF1;NAP1L2;BRD2;HAT1;ASF1A;CHAF1A;NAA60;SPTY2D1;IPO4;ATRX;ASF1B;GRWD1
prerank,positive regulation of dendrite development (GO:1900006),0.4866436412685322,1.0045198319046318,0.47433264887063653,0.8617124428157843,1.0,2/10,2.51%,BMP5;PTN
prerank,establishment of protein localization to organelle (GO:0072594),-0.2948146217152675,-1.004252584201542,0.44751381215469616,0.7769364042967689,1.0,35/72,37.21%,LAMP2;RAB11A;APPL2;STAT3;HK2;AKT1;IPO7;FAM53C;IPO13;RAN;NXT2;IPO8;TPR;LAMP5;NUP88;SYK;NUP214;ZDHHC15;NXT1;NUP155;RANBP17;EIF4ENIF1;HK1;CSE1L;NUP62;PTTG1IP;TNPO2;HEATR3;RALA;IPO4;PINK1;PHB2;FAM53B;SPRN;NUP153
prerank,fatty acid oxidation (GO:0019395),-0.3095187873000189,-1.0037245218453075,0.46206896551724136,0.7775169020619608,1.0,17/57,20.98%,ADIPOR2;CPT2;SLC25A17;ACOX1;ECI2;ACADL;ALDH3A2;AUH;BDH2;ACAD10;ECHDC2;ACADS;ALOX12;ILVBL;PPARGC1A;ADIPOR1;DECR1
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.29161368828226847,-1.0035279559995338,0.45408163265306123,0.7773416473640943,1.0,15/71,14.35%,ADAMTS12;CTSH;CAPN2;CTSC;PDCD6IP;CHFR;CTSB;CASP8;IDE;CHMP4B;CTSS;MDM2;UBB;NEDD8;DDB1
prerank,endothelial cell development (GO:0001885),0.41448273187439133,1.0035063827467687,0.4367588932806324,0.8629776418586128,1.0,2/25,1.01%,PDE4D;RAPGEF2
prerank,regulation of neuron apoptotic process (GO:0043523),0.33214238932270207,1.003504806148876,0.43221690590111644,0.8620394789542295,1.0,19/96,14.08%,SLC30A10;MEF2C;NF1;AGAP2;UNC5B;TFAP2B;NTRK2;LIG4;AKT1S1;PPT1;NFATC4;GRM4;TRIM2;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,myoblast fusion (GO:0007520),-0.41956986857098677,-1.0034984118771344,0.4867924528301887,0.7767443460039268,1.0,7/12,19.74%,JAM2;ADAMTS5;CD9;ADAMTS15;PTGFRN;NOS1;CD81
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4672857608647044,1.0031876383433154,0.43777777777777777,0.86183966624335,1.0,2/12,5.19%,RMDN1;CHAMP1
prerank,regulation of cellular component biogenesis (GO:0044087),-0.3262964488935936,-1.0029070186767706,0.44956140350877194,0.7775626186239653,1.0,10/39,10.23%,SNCAIP;ROCK2;APOE;EZR;RAP1B;RAPGEF1;TIE1;IRGM;GFAP;DAB2IP
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.35604613858838163,-1.0027992431546027,0.46218487394957986,0.7771783862864939,1.0,8/29,19.69%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.36706813856716586,-1.002765269304278,0.4641434262948207,0.776614127261003,1.0,5/24,13.00%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.41258388735259527,-1.002508723518615,0.46047430830039526,0.7765905045873439,1.0,5/14,14.73%,EZR;RHOA;MYO9A;PATJ;OPHN1
prerank,liver development (GO:0001889),-0.3377844127540238,-1.0025070388795647,0.47280334728033474,0.7759384641572903,1.0,4/32,4.44%,TGFBR3;WNT4;ANXA1;LSR
prerank,myeloid leukocyte differentiation (GO:0002573),-0.2956105767133605,-1.0023534415590891,0.45990566037735847,0.7756650428449894,1.0,14/65,10.80%,FOXP1;IL31RA;IL15;TGFBR2;BMP4;CSF1;LEF1;PIR;SBNO2;LGALS9;MAPK14;KIT;CASP8;PML
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.260438766679151,-1.00233444556919,0.46646341463414637,0.7750622764775865,1.0,41/132,27.76%,CELF2;RPS14;LUC7L;RPS19;GEMIN7;EIF2S2;DENR;NAF1;RPL11;RPS5;STRAP;RPL24;SRSF10;RPS27;MRPS7;RAMAC;RPL10;GEMIN5;HSP90AB1;RPS15;SNRPF;SNRPD1;SNRPD2;RPSA;SRSF6;RPL38;RPLP0;DICER1;SRPK1;RRP7A;RPS27L;SRSF5;WDR77;CELF5;RRS1;SRPK2;PUF60;PRPF19;SNRPC;SNRPB;SNRPE
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.353781055762347,-1.0013511731573428,0.455531453362256,0.7767312504031955,1.0,6/30,10.97%,VAMP5;MACF1;KIF13A;GGA2;GOLPH3;OPTN
prerank,negative regulation of response to stimulus (GO:0048585),0.35823253191110377,1.001205803556571,0.433389544688027,0.865443316537627,1.0,6/60,5.24%,SLC30A10;CDK6;NR1H3;AKT3;SH2B3;SOCS5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),-0.28067585591444527,-0.999826163310799,0.4613333333333333,0.7799433663320384,1.0,29/88,18.23%,CLINT1;STXBP6;APP;GOLGB1;VPS13A;TXNDC5;VPS35L;DNAJC6;ARRB1;SNAP23;EXOC4;DTNBP1;EXOC6;HGS;CLTA;ARL3;AP4M1;FTL;EXOC5;PUM1;AP2A1;AP1B1;MON2;DOP1B;NAPA;ARFGEF2;BLOC1S6;AP4E1;FTH1
prerank,positive regulation of vacuole organization (GO:0044090),-0.44587628904563104,-0.9997114103270411,0.4861111111111111,0.7795228517928688,1.0,5/10,16.80%,ANXA2;RAB3GAP1;PIP4K2B;SH3GLB1;RAB3GAP2
prerank,protein dephosphorylation (GO:0006470),0.3120048999204163,0.9996928609600184,0.44728915662650603,0.8677971304860316,1.0,11/135,4.73%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;TNS2;PTPN22;SSH2;PPP3CA;PPP2R2A;PTPN4
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.31925847284517733,-0.999537778338894,0.45558086560364464,0.7792598381864977,1.0,12/47,16.02%,TGFBR3;EGFR;FOXO1;IGF1R;LGALS9;TAOK2;DAB2IP;MAPK8IP1;QARS1;PPIA;MAPK3;ARL6IP5
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4081864157697032,-0.999284651210035,0.4849699398797595,0.7792369752581901,1.0,8/15,24.89%,STAT3;HIF1A;IL17RA;GBP5;TICAM1;TLR4;IL17D;MYD88
prerank,negative regulation of cellular component organization (GO:0051129),0.34106102507535896,0.9991815906746236,0.446843853820598,0.8680547780295517,1.0,7/74,6.30%,CARMIL1;FAP;WASL;SACS;SPRY2;SCAMP5;DDX3X
prerank,melanosome transport (GO:0032402),-0.39533979907888683,-0.9990505815703088,0.48023715415019763,0.7784583798279502,1.0,6/18,20.78%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,pigment granule transport (GO:0051904),-0.39533979907888683,-0.9990505815703088,0.48023715415019763,0.7784583798279502,1.0,6/18,20.78%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,negative regulation of ion transport (GO:0043271),0.41496402592779297,0.9987324390360277,0.43846153846153846,0.8680742841315258,1.0,4/24,7.08%,CASQ2;HTR1B;SNCA;STC1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.40754353194258586,-0.9983961428472673,0.466796875,0.7787659228772554,1.0,5/15,21.45%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.40754353194258586,-0.9983961428472673,0.466796875,0.7787659228772554,1.0,5/15,21.45%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1
prerank,positive regulation of organelle assembly (GO:1902117),-0.3215909474245899,-0.9983390056073574,0.4726477024070022,0.7782558315597152,1.0,17/44,22.51%,ASAP1;SDCBP;PDCD6IP;SDC4;RAB3GAP1;PIP4K2B;SH3GLB1;SDC1;G3BP1;RAB3GAP2;TAPT1;DYNC1H1;STX18;NUMA1;PLK4;LCP1;CCP110
prerank,modulation by host of viral genome replication (GO:0044827),-0.42256689766900185,-0.9982222299206244,0.4708171206225681,0.7778883818707882,1.0,7/13,26.14%,IFI27;ZC3H12A;VAPA;FBXL2;TBC1D20;PRKN;EIF2AK4
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.3495875356103558,-0.9981204063566603,0.46916299559471364,0.7775018461690487,1.0,8/29,16.19%,APOE;APP;SLC4A10;RAB3GAP1;CAMK2A;EPHB2;SHISA7;MCTP1
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.4402928527051653,0.9981183349211171,0.4300202839756592,0.8684269718517028,1.0,4/18,10.98%,GINS1;GINS3;GINS4;MCM7
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.39180704885366224,-0.9979273568611939,0.4777777777777778,0.7773203123920119,1.0,5/16,14.39%,PARP9;DTX3L;PARP3;SHLD1;KMT5C
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.32899152096414225,-0.9978114769819418,0.4594594594594595,0.7769414553333157,1.0,18/40,28.30%,IGF1;TNFSF10;AKT1;BCL2L11;BNIP3;PLSCR3;BID;GPX1;PRELID1;PDCD5;BBC3;PLAUR;PSMD10;BCL2L1;PRKN;TP53;BIK;CLU
prerank,epithelial cell migration (GO:0010631),0.38251180258874445,0.9972204788620432,0.44095940959409596,0.8693885003919553,1.0,8/37,7.87%,FAP;PKN1;ROCK1;ZEB2;PIK3CA;STARD13;TESK1;NANOS1
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.45328608020453676,-0.9971229631764179,0.48674242424242425,0.7778939937596947,1.0,3/10,10.42%,SMAD7;RC3H2;ZC3H12A
prerank,natural killer cell mediated immunity (GO:0002228),-0.40319167004757034,-0.9968875819997668,0.4616822429906542,0.7777901970268386,1.0,10/15,48.69%,CEBPG;ULBP1;RAET1E;TUBB4B;LYST;PLEKHM2;KIF5B;SLAMF7;KLRD1;KLRK1
prerank,protein localization to vacuole (GO:0072665),-0.4213660822627521,-0.9964602520012482,0.49523809523809526,0.7781677256570554,1.0,5/13,19.80%,SH3GLB1;LAMTOR5;SH3BP4;CD81;KPTN
prerank,membrane lipid metabolic process (GO:0006643),-0.3650455128184975,-0.9961059292895375,0.4875717017208413,0.7783896641008267,1.0,5/22,16.00%,ST3GAL6;AGMO;CYP1B1;SPHK1;SERINC1
prerank,cellular response to lipid (GO:0071396),0.30036974058477495,0.9960110910244523,0.46565934065934067,0.8710767510104652,1.0,27/191,9.44%,MEF2C;PID1;RORB;ATP1A2;RORA;GPER1;NR1H3;IL1B;FFAR2;ADCY8;ADCY3;AXL;NCOA3;ADCY6;BRINP1;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN;FAM210B;IRS1;BRINP3;HTRA2;LYN;MED1;MAP4K1
prerank,regulation of cellular pH (GO:0030641),-0.3512731684161736,-0.9959310599122488,0.47390396659707723,0.7781448732689588,1.0,9/29,19.03%,SLC9A2;SLC4A10;LACC1;SLC9A9;TM9SF4;SLC9B1;SLC9A1;SLC4A2;CHP1
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.31111523059403107,0.9956611886427567,0.4576523031203566,0.8708969056093494,1.0,23/129,16.52%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;BRSK1;TUBB4A;PPP1R12A;CDK14;DCTN1;CCNH;SKP1;DCTN3;CEP76;CEP135;NDE1
prerank,positive regulation of chemotaxis (GO:0050921),0.3623325953216892,0.9956424841408071,0.44981412639405205,0.8699940775286784,1.0,4/43,4.24%,PDGFRB;SEMA5A;PTN;FGF2
prerank,protein targeting to lysosome (GO:0006622),-0.3795983095724776,-0.9952258756421245,0.46893787575150303,0.779232235397333,1.0,9/20,30.52%,LAMP2;HGS;AP4M1;RAB7A;ZFYVE16;NCOA4;CLU;LAPTM5;NEDD4
prerank,steroid catabolic process (GO:0006706),-0.45207457158998177,-0.9951176107791125,0.46833013435700577,0.7788577187100482,1.0,10/10,54.83%,SPP1;YWHAH;HSD17B14;HSD17B11;HSD11B1;CYP27B1;CYP24A1;FGF23;CYP19A1;HSD17B6
prerank,apoptotic process (GO:0006915),0.2979530254322082,0.9937358740262187,0.46685082872928174,0.8732215995945946,1.0,36/203,12.77%,DLC1;FAP;TNFRSF21;TNFAIP1;ARHGEF6;ADORA2A;FASTKD2;IL1B;PIK3CA;IL2RA;AKAP1;PRUNE2;BCL2L10;PPARD;CIDEB;SCN2A;OGT;BCL2L13;CASP9;LIG4;PAK6;CDIP1;STK3;MTOR;BNIP2;PAK5;NCKAP1;HIP1;DDIT4;MCM2;IFT57;EP300;BCLAF1;MRPS30;FAM162A;YARS1
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.3884955222416071,0.9933380353002093,0.4646840148698885,0.8731497418276029,1.0,1/33,0.50%,IL34
prerank,DNA integrity checkpoint signaling (GO:0031570),0.38759995880069126,0.9931139305426175,0.4462081128747795,0.8726857943339769,1.0,7/36,14.26%,MAP3K20;RAD1;TIMELESS;ATR;SETMAR;RAD17;ATRIP
prerank,regulation of translational initiation (GO:0006446),0.35387913657347125,0.9930848410293655,0.44932432432432434,0.8718166153054293,1.0,10/63,6.30%,NCK2;EIF4EBP2;EIF4EBP3;DAZL;RPS6KB2;MTIF2;BOLL;YTHDF3;NCBP2;DDX3X
prerank,RNA interference (GO:0016246),0.4455219869942153,0.9930546883751817,0.48068669527896996,0.8709493014679303,1.0,5/17,13.07%,CLP1;AGO3;TARBP2;TSN;CELF1
prerank,homologous chromosome segregation (GO:0045143),0.4042233016755342,0.9919549954330864,0.447265625,0.8725226992648649,1.0,5/20,12.97%,FMN2;MEI4;MEIOB;PTTG1;FANCD2
prerank,nitrogen compound transport (GO:0071705),-0.2581092664927275,-0.9914954033231199,0.4528301886792453,0.7870760019334239,1.0,36/141,20.26%,SLC7A11;SLC6A13;PDPN;SLC6A6;CERT1;SLC6A12;CALCRL;ABCG2;SLC7A2;RAMP2;RCN3;TXNIP;SLC7A7;SLC22A4;SLC7A5;TOM1;CUBN;SLC7A14;SLC22A5;SLC38A5;ARRDC1;RAB7A;SLC3A2;SLC35F3;TMEM30A;SLC7A1;ARL6IP5;SLC22A2;SLC52A3;ATP11B;ARRDC4;HSP90B1;SLC43A1;SLC25A29;SLC36A1;SEC14L1
prerank,membrane organization (GO:0061024),0.29101085374244157,0.9913519747840989,0.4820717131474104,0.8728923166925322,1.0,47/227,15.41%,SGIP1;DYSF;SH3KBP1;IGF2R;FNBP1;LDLRAP1;ATP2C1;LDLR;SPTBN1;TMCC1;TOR1B;WASL;RIMS1;COX18;SYNGR1;ARPC5;ANK3;EPN1;CHMP2B;HACE1;SGCZ;PIK3C2A;BIN1;PPT1;SYT1;AP2S1;AP2B1;UBXN2B;HIP1;CPTP;ARPC4;NPC1;SYP;SYT2;KIF20A;EMD;DVL2;SERP1;VTI1B;ARPC1A;FCHO1;ANK2;VPS33B;RAB5A;MYADM;CHMP3;PLEKHA3
prerank,cellular lipid catabolic process (GO:0044242),0.40079989997429627,0.9912918716004985,0.47484909456740443,0.87209070340494,1.0,3/27,7.27%,CEL;PPARD;AOAH
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.36489945529246204,-0.9911436673793256,0.4723320158102767,0.7873249453662312,1.0,14/24,33.86%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;SUCLA2;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,regulation of chemotaxis (GO:0050920),0.38510610922768723,0.9909767714696585,0.458984375,0.8718677560138158,1.0,1/30,0.19%,PDGFRB
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.43114248428817453,0.9904269505719259,0.448559670781893,0.8721662781519128,1.0,2/17,1.04%,PDGFRB;VTN
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.42699518868087893,-0.9902210820379374,0.49162011173184356,0.7888998713502533,1.0,5/12,27.39%,SMO;SIX1;AGT;VEGFA;GDNF
prerank,growth hormone receptor signaling pathway (GO:0060396),0.4569322482936238,0.9902204494320546,0.46555323590814196,0.8717559483968663,1.0,6/14,14.91%,PTK2;PIK3R1;LYN;PRLR;PTPN1;JAK2
prerank,negative regulation of neuron death (GO:1901215),0.33248273030486813,0.9901677675357052,0.46381578947368424,0.8709522948730533,1.0,19/93,14.08%,SLC30A10;MEF2C;AGAP2;UNC5B;INPP5A;NTRK2;SNCA;LIG4;PPT1;NFATC4;HTRA2;CPEB4;BTBD10;SET;KDM2B;RASA1;TRAF2;MAG;SIX4
prerank,cellular response to acid chemical (GO:0071229),0.41733335570217006,0.9900613270170193,0.4642857142857143,0.8702473691124034,1.0,2/27,1.65%,SPAAR;CPEB1
prerank,adipose tissue development (GO:0060612),-0.4380338427094087,-0.9900098991553012,0.49034749034749037,0.7887784425012508,1.0,5/11,21.81%,NAMPT;SPTLC2;DYRK1B;DGAT2;XBP1
prerank,negative regulation of DNA replication (GO:0008156),0.4631804532437163,0.9896212444308323,0.4747252747252747,0.8702565501384395,1.0,5/13,17.24%,ATR;WAPL;CDAN1;RAD17;TERF1
prerank,positive regulation of potassium ion transport (GO:0043268),0.3847197416274034,0.9895960062274187,0.42730496453900707,0.8693839642611185,1.0,7/38,10.26%,GNG2;KCNJ12;KCNMB1;AKAP6;KCNE5;KCNJ3;KCNJ6
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.44861349750015067,0.9893370069948336,0.45610278372591007,0.8690527147655419,1.0,5/13,14.55%,KPNA4;NUP35;CBLB;KPNA1;RANBP2
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4311235830324209,0.9887908415790866,0.44377510040160645,0.8693747363258776,1.0,7/18,12.33%,SLC1A4;GRIK1;GRID1;GRIA2;CDH8;GRIK5;GRIK2
prerank,ncRNA 3'-end processing (GO:0043628),0.4491326873536783,0.9887711245346191,0.4407484407484408,0.8684897696087579,1.0,3/14,14.00%,INTS6L;SSB;INTS12
prerank,vasculature development (GO:0001944),0.43575573250691146,0.9885586599576475,0.4692144373673036,0.8680641132979731,1.0,2/16,3.06%,PDGFRB;PIK3CA
prerank,retina homeostasis (GO:0001895),-0.36078721282448467,-0.9885519367980834,0.49808429118773945,0.7916654067200751,1.0,8/23,23.39%,B2M;ACTG1;POC1B;ACTB;POTEF;WHRN;TULP1;CDH3
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.48408649535336795,0.9883444151272565,0.4641255605381166,0.8676280264470252,1.0,2/10,1.54%,NOTCH1;RGCC
prerank,negative regulation of lipid storage (GO:0010888),-0.37687932444088795,-0.9882899887319938,0.4673469387755102,0.7916577072881239,1.0,6/19,19.45%,ABCA1;OSBPL8;ITGB3;PPARA;NFKBIA;PTPN2
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3140133951375058,-0.9882725032826432,0.4730941704035874,0.7910362314758751,1.0,15/42,29.02%,SMARCA2;INO80;CHD3;ANP32E;HDAC1;ACTB;SMARCC1;ACTR8;SMARCAD1;MBD2;SMARCA4;RNF8;ACTR5;SMARCD2;SMARCA1
prerank,hexose transmembrane transport (GO:0008645),0.4203858811484605,0.9881436213139548,0.47516198704103674,0.8671381581354034,1.0,6/21,12.50%,SLC5A1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,lipid transport (GO:0006869),0.32300787956783356,0.9878342271390993,0.45307443365695793,0.8668857981143187,1.0,11/97,6.57%,PITPNC1;SLCO3A1;SCARB1;SLC51B;LDLR;ABCD2;PPARD;SLC27A4;FABP3;ABCA5;PRELID3A
prerank,toll-like receptor signaling pathway (GO:0002224),-0.28445929942224735,-0.9878301187821882,0.476878612716763,0.7914240441636935,1.0,21/84,19.69%,SCARA3;LBP;MAP3K1;IRAK2;LGALS9;PIK3AP1;BIRC3;CTSB;SFTPA2;SFTPA1;CASP8;IRAK3;CTSS;UBB;PLCG2;TICAM1;MAPKAPK3;TLR4;RIPK1;HSP90B1;IKBKG
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3629636747995832,-0.987775174425471,0.4766734279918864,0.7908952880896917,1.0,6/22,3.02%,FLT1;PDGFRA;NTRK3;PLCG1;ESR1;FGFR2
prerank,lysosome localization (GO:0032418),0.3772024696413793,0.9877142466478966,0.46473779385171793,0.8662302188816184,1.0,2/37,1.97%,PIK3CD;MYH9
prerank,endochondral bone morphogenesis (GO:0060350),0.4516071772005683,0.9872319172463545,0.46120689655172414,0.8663319019485158,1.0,1/11,0.63%,MEF2C
prerank,lytic vacuole organization (GO:0080171),-0.3411130794247322,-0.9870810256598839,0.4723926380368098,0.7919631847595469,1.0,12/32,27.23%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN6;CLN5;MBTPS1;ACP3;MYO7A
prerank,cellular response to hexose stimulus (GO:0071331),-0.36126739846805805,-0.9867113761399199,0.47764227642276424,0.7921767249986447,1.0,6/23,11.51%,UNC13B;IGF1R;SLC39A14;GAS6;KCNB1;ERN1
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.30911822217545354,-0.9865752312209686,0.5070422535211268,0.7918560971385084,1.0,11/54,11.29%,NXN;HDAC8;CAV1;SMAD7;ARRB1;SH3RF2;AKT1;PINX1;IVNS1ABP;PRKCG;RPL11
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.31349033467135873,-0.9865114521752466,0.48775055679287305,0.7913766288190123,1.0,14/45,21.12%,EGFR;BMP4;DDX5;RBM20;POLR2A;ERN1;TGFB1;RELA;GRSF1;PNPT1;SIRT7;RIPK1;ZC3H18;RIOK2
prerank,negative regulation of leukocyte migration (GO:0002686),0.4817851740575211,0.9862326845773886,0.45134575569358176,0.8675791541047613,1.0,2/10,5.44%,BMP5;CD300A
prerank,cell cycle G2/M phase transition (GO:0044839),0.30761310678617054,0.9862292964775339,0.47767857142857145,0.866672540453779,1.0,23/130,16.52%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;BRSK1;TUBB4A;PPP1R12A;CDK14;DCTN1;CCNH;SKP1;DCTN3;CEP76;CEP135;NDE1
prerank,positive regulation of cellular respiration (GO:1901857),-0.4400768102164314,-0.9860273248269811,0.5142857142857142,0.7919472576997496,1.0,8/11,34.23%,NUPR1;IL10RB;PRELID1;PARK7;VCP;IFNAR1;IFNLR1;PINK1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.44388259344846664,-0.9858953101781671,0.5164835164835165,0.7916073755879357,1.0,2/10,16.38%,ADGRV1;WHRN
prerank,neuron differentiation (GO:0030182),-0.25320568204388233,-0.98559152398549,0.49158249158249157,0.7916687071194769,1.0,26/165,13.66%,PBX1;WNT4;GLI2;PBX3;WNT6;DTNB;TGFBR1;LRP6;FZD2;WNT9A;WNT5A;HS6ST1;WNK1;NRBP2;FZD4;VSX1;LHX6;NR4A2;FZD7;WNT5B;ITM2C;ID2;ATOH8;WNT16;MET;UGCG
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3784611674036648,0.9855861936028669,0.4685185185185185,0.8670986475600595,1.0,4/38,3.81%,IL34;NCK2;DOK7;GRM5
prerank,cholesterol metabolic process (GO:0008203),0.34196581380946267,0.9854663710769238,0.47386172006745364,0.8664603210387861,1.0,13/68,13.32%,CEL;SCARF1;LDLRAP1;ARV1;PPARD;ABCA5;IL4;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;CYP11B1
prerank,cellular response to leucine starvation (GO:1990253),0.4805982411237355,0.9854262666809054,0.4672489082969432,0.8656540521059256,1.0,3/10,16.48%,SESN3;MTOR;IMPACT
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.24992265038259537,-0.9853941735238094,0.48026315789473684,0.7914700928325121,1.0,35/170,16.98%,PRDM6;IGF1;AFF3;ROCK2;FOXP1;APOE;APP;CDH1;TAPBP;HINFP;AFF2;AFF1;IGF2BP2;ATRAID;NOVA2;HIF1A;PCBP2;ZC3H12A;PRDM5;TRIM27;AHR;NOVA1;YBX3;ZNF462;PRDM11;PTHLH;TRIM39;TRIM17;EDN3;RNF187;KDM6B;MTMR3;SIRPA;CAVIN4;HNRNPAB
prerank,protein polyglutamylation (GO:0018095),0.46593132367967016,0.9852164824114192,0.46361746361746364,0.865183933006071,1.0,6/11,20.78%,TTLL11;CEP41;TPGS1;CFAP20;TTLL5;TTLL7
prerank,protein transport (GO:0015031),-0.23187428085782016,-0.9851957673493428,0.4790697674418605,0.7913296021246973,1.0,93/332,22.33%,ABCA1;VAMP5;LAMP2;STEAP3;APOE;MACF1;ARL4A;SGSM2;TBC1D22A;SNX9;SNX6;CALCRL;ARHGEF2;KIF13A;TLK1;ATP6V0A4;SEC31A;RAMP2;COPZ2;RABGAP1L;RCN3;STX7;USP6NL;TBC1D8B;TXNIP;PRKCB;GGA2;STX3;COPA;ARFIP2;TFRC;TOM1;GOLPH3;ATP6V1G1;EHD1;TBC1D8;AP3B1;AP4M1;RAB21;ATP6V0B;TMEM167A;STX1A;USO1;STX6;ARRDC1;OPTN;VPS35;RAB7A;TBC1D10A;RAB8A;ATP6V0A1;TCIRG1;AP2A1;UNC119B;SCFD2;EVI5;ARL5A;TBC1D2;ATP6V0A2;HFE;SEC23IP;NAPA;ARL6IP5;TBC1D25;RAB3GAP2;RAB18;TBC1D13;REP15;ARRDC4;SAR1A;RAB29;RAB6A;STX2;HSP90B1;RAB32;PPY;SAR1B;SNX8;RABL3;CANX;YWHAH;VPS26C;ARFIP1;TMED9;MCOLN1;TBC1D14;RAB24;AP3D1;ATP6V1F;TMED2;TANGO2;WDR11;ACD
prerank,anterior/posterior pattern specification (GO:0009952),-0.30710157679810435,-0.9851675834499863,0.4732142857142857,0.7907493366238367,1.0,17/53,16.05%,HOXB6;PCSK5;HOXB3;BMPR2;TGFBR1;HOXA5;SKI;HOXA3;BHLHE40;HOXC6;TBX1;BHLHE41;HOXB9;HOXC4;HOXB5;HOXB7;HHEX
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.29744788770549624,-0.9842116588116092,0.4880952380952381,0.7924525103212874,1.0,14/56,12.52%,ROCK2;SNX9;PDCD6IP;RHOA;USP8;RHOB;MYH10;SON;ARL3;TTC19;SPAST;EFHC1;CHMP4B;EFHC2
prerank,sensory perception of sound (GO:0007605),0.322764080963212,0.9838727817191494,0.4644628099173554,0.8671879982635402,1.0,3/88,1.30%,GRM7;COL4A3;ROR1
prerank,lipoxygenase pathway (GO:0019372),-0.4100994638637506,-0.9838376364784923,0.5029585798816568,0.7926867838676143,1.0,5/14,17.80%,GPX4;PTGS2;PON3;GPX1;ALOX12
prerank,double-strand break repair via break-induced replication (GO:0000727),0.4580723405572095,0.9836719111707546,0.4636752136752137,0.8667806572160938,1.0,4/12,10.98%,GINS4;MCM6;MCM7;MCM2
prerank,transepithelial transport (GO:0070633),0.42956129545681665,0.9834387844718125,0.47216494845360824,0.8663611260390427,1.0,1/15,0.64%,SLC12A2
prerank,response to muramyl dipeptide (GO:0032495),-0.43126785981085203,-0.9833653933873832,0.4972067039106145,0.7931986613806619,1.0,3/12,4.01%,VIM;NOD1;ARHGEF2
prerank,positive regulation of MAPK cascade (GO:0043410),0.28704824688557445,0.9832578860834078,0.49206349206349204,0.8658624561012243,1.0,27/245,7.15%,PDGFRB;SLC30A10;IL34;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ROCK1;ERBB4;PTPN22;ACKR3;PDCD10;FGF2;PELI2;RYK;SPRY2;RIT2;CARD9;NTRK2;HTR2C;TAOK3;CHRNA7;RAP1A;HRAS
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3613068950639527,-0.9829201099980034,0.49320388349514566,0.7936466590014143,1.0,4/22,14.59%,BMP7;B2M;CALR;DTX1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.4345571539635605,0.9829110919404793,0.45278969957081544,0.8657254314623523,1.0,6/17,13.98%,PDCD10;CARD9;TAOK3;LYN;SCIMP;STK25
prerank,protein homooligomerization (GO:0051260),-0.26197736288949536,-0.9827440261369941,0.4971590909090909,0.7934521300820397,1.0,27/114,16.55%,ALDH1A2;RNF213;KCNJ2;SCARA5;B2M;CLYBL;PDCD6IP;APPL2;SSBP1;UPB1;ALS2;EHD1;GLRA3;GLS;RNF135;ACACA;SAMHD1;SPAST;GSDMD;DISP1;GBP5;ATL2;NINJ1;BEND3;AQP11;ELAVL1;PNPT1
prerank,response to amino acid (GO:0043200),0.4000374703518778,0.9827357875606862,0.48120300751879697,0.8651894628899611,1.0,2/31,1.65%,SPAAR;CPEB1
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.43175891056972193,-0.9827191727341237,0.47309833024118736,0.7928574649091467,1.0,8/11,41.74%,P2RX4;CDH13;PLCG2;TREM2;P2RX3;TRAT1;CCL4;NEUROD2
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.3253726149155871,-0.9824915966644969,0.460093896713615,0.7927504833759026,1.0,10/40,16.46%,LBP;GBP4;PGLYRP1;GSDMD;GBP6;RPL39;GBP7;GBP2;HMGB2;MR1
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.35440953194384556,0.9818209172556553,0.4660714285714286,0.8663073672525397,1.0,14/52,11.14%,PIK3R1;EPB41L2;PTPN9;GPER1;EPB41;SPTBN1;DPP10;ITGB1;EFCAB7;STAC;NKD2;EPHA2;STX4;RANGRF
prerank,protein phosphorylation (GO:0006468),0.27052361538739517,0.981512798351083,0.5076023391812865,0.8660906273300549,1.0,78/479,11.79%,PDGFRB;MAST4;PRKG1;MAP3K20;PIK3CD;CDK6;MAP3K5;PTK2;SNRK;PEAK1;PKN1;FRK;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;ERBB4;LIMK1;RPS6KA4;GRK3;CDK15;ABI2;CDC42BPA;STK39;STK38L;JAK1;RPS6KB2;MINK1;CSNK1G1;RYK;RPS6KA2;TESK2;TNKS;TRIB2;ROS1;NEK1;NTRK2;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;STK24;STK3;MTOR;GRK5;ACVR2B;MARK2;CSK;MAP4K4;PRKD2;LYN;PDGFB;CSNK1E;MAP4K1;BIRC6;PAK5;COQ8A;MAPK10;NEK6;ATR;DYRK3;ABL2;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PRKX;PAK1;TEC;NLK
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.3289326315103151,-0.981270214682163,0.4923413566739606,0.7950953070777702,1.0,12/38,17.31%,SP100;NOS3;THBS1;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SFRP1;SERPINE1;RIPK1;GPX1
prerank,regulation of DNA metabolic process (GO:0051052),-0.3147405751293383,-0.9811278380264377,0.4912663755458515,0.7948092360582536,1.0,12/44,20.58%,HDAC8;TOM1L1;SMG6;POLH;MPV17;CDK9;WDR18;SIRT7;SMG5;SMARCAD1;THOC1;MPHOSPH8
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.32682671137515573,-0.980755615205185,0.4842105263157895,0.795010068031174,1.0,11/33,16.85%,GLUL;DDAH1;ALDH4A1;PRODH;GLS;DGLUCY;GCLC;SLC39A8;OAT;NIT2;FPGS
prerank,microvillus organization (GO:0032528),0.44882368483862634,0.9806513144608936,0.47844827586206895,0.8670729299360522,1.0,4/13,8.81%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,steroid metabolic process (GO:0008202),0.333645431028086,0.9805958273385943,0.4513422818791946,0.8662973894599407,1.0,10/72,13.32%,CYP7B1;RDH5;ARV1;BAAT;NPC1;LSS;STAR;PRLR;SRD5A1;CYP11B1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.456541139555026,0.9803276772843605,0.4431554524361949,0.8660037455689317,1.0,3/12,16.08%,GNL3L;CCT7;CCT3
prerank,cell-cell junction organization (GO:0045216),0.3303860287252025,0.9802679658885565,0.4657320872274143,0.8652327545641086,1.0,11/79,7.13%,GJC1;LIMS1;CDH2;CDH4;CADM2;GJA4;CDH8;CDH22;CDH20;CDH19;CDH7
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.467327559433717,0.9801423376038959,0.4890829694323144,0.8646246574391326,1.0,5/10,26.78%,PDE6A;SAG;CNGB1;PDE6B;GNB1
prerank,regulation of mitotic nuclear division (GO:0007088),0.34801966746584073,0.9798879538471926,0.46507666098807493,0.8642535348314013,1.0,3/55,2.62%,PDGFRB;RGCC;IL1B
prerank,negative regulation of multicellular organismal process (GO:0051241),0.29485224618135736,0.979564785712218,0.4741847826086957,0.8640478275234394,1.0,14/199,3.11%,PLCL1;PTEN;MEF2C;HEY2;BMP5;NOTCH1;RGCC;NR1H3;NODAL;IL17RD;ROCK1;SPRED1;IL1B;RPS6KA4
prerank,peroxisomal membrane transport (GO:0015919),0.3945520948684772,0.9794047273989508,0.4603174603174603,0.8634942813177611,1.0,8/27,15.58%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;PEX12
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4674477558654316,0.9790625580443783,0.4924078091106291,0.8633191504224058,1.0,6/10,24.79%,DERL3;UBAC2;INSIG1;ERLEC1;OS9;YOD1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.3854476297384609,-0.9786197562662501,0.4877126654064272,0.7995477161957285,1.0,10/17,35.05%,MDM2;SNAI1;RFFL;PSMD10;CD44;PRKN;TWIST1;PTTG1IP;KDM1A;CD74
prerank,protein autophosphorylation (GO:0046777),-0.2526293050673965,-0.9783501855991902,0.5016835016835017,0.7995383188634222,1.0,47/157,21.22%,DAPK1;EPHA4;EGFR;FLT1;PDGFRA;TEK;FGFR2;STK17B;EPHB4;IGF1R;LRRK2;TAF1;DDR1;PTK2B;TAOK2;AKT1;KIT;STK10;EPHA8;BMX;ULK2;KDR;CAMK2A;MKNK2;ERN1;FGFR4;FLT4;ATM;PIM3;FER;OXSR1;MAPK3;MAPKAPK3;VRK2;EPHB3;RIPK1;MAP3K13;MAP3K3;PDPK1;ALK;PIM2;FES;SLK;CSF1R;RIOK2;PASK;CAD
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.4582970324528563,0.9781867899435789,0.4794816414686825,0.8643630870086584,1.0,3/11,9.11%,JAK1;ANK3;LYN
prerank,response to molecule of bacterial origin (GO:0002237),0.33868639319407945,0.978023013531348,0.47692307692307695,0.8638429817818944,1.0,6/69,6.29%,GGT5;GGT1;IL1B;PTPN22;OTUD5;SNCA
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.3858744262767869,-0.9778616240391254,0.4948453608247423,0.8000477521219606,1.0,5/17,16.54%,CD55;STAT3;IL18;BACH2;TLR4
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.3849664703558528,0.9778532052130864,0.478515625,0.8633504801474169,1.0,7/33,13.05%,AFAP1L2;GPER1;NCF1;CNOT9;HIP1;DGKD;BCAR3
prerank,error-free translesion synthesis (GO:0070987),-0.3615647688718193,-0.9778192150971066,0.487551867219917,0.7995086944286887,1.0,12/22,32.01%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,protein processing (GO:0016485),0.3218744206116675,0.9775307981960457,0.4823717948717949,0.8631305026424178,1.0,6/102,3.07%,TMPRSS4;GGT1;CPM;METAP2;ADAM19;ECE1
prerank,neuron apoptotic process (GO:0051402),0.412183290421485,0.9774036637941671,0.47489539748953974,0.8625319696629021,1.0,3/19,6.89%,TNFRSF21;SCN2A;LIG4
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.4154117135059257,-0.9770102693040805,0.4972477064220184,0.800804252183311,1.0,4/12,22.00%,AR;TGFB1;AP2A1;TMEFF2
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4062367332397398,0.9768370825912142,0.46830265848670755,0.8628287443589298,1.0,5/24,7.40%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.35670459623421336,-0.9768077945024647,0.4957805907172996,0.8006427644828124,1.0,5/22,12.56%,SLC16A2;LRRK2;APPL2;GATA2;ID2
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.399871803467517,0.9763293368668257,0.46833013435700577,0.8630592930056935,1.0,4/23,4.10%,MEF2C;NRG1;RBM24;AKAP6
prerank,cellular protein modification process (GO:0006464),0.25881938314271985,0.9762142113612307,0.562565720294427,0.8624298839631505,1.0,129/983,11.24%,ART3;PTPRK;PTEN;PRKG1;CEL;MAP3K20;PIK3CD;PIGU;PARP8;CDH2;PRKCSH;IGFBP7;GCNT2;CDK6;MAP3K5;SDC2;METAP2;ST8SIA4;SNRK;PTPN9;MFGE8;LAMC1;PEAK1;PPM1E;PKN1;FRK;WSB1;BTRC;MARK1;USP25;PRKAR1B;HUNK;MERTK;NUAK2;PTAR1;ROCK1;AKT3;FNIP2;PTPN22;CUL3;SSH2;CTH;ST8SIA1;LIMK1;RPS6KA4;MMP15;CHML;RBX1;GRK3;CDK15;CDC42BPA;STK39;STK38L;COG7;JAK1;PPP3CA;MINK1;PPP2R2A;PTPN4;RYK;EPAS1;PSMB11;TESK2;SERPINA10;TNKS;SPARCL1;LAMB1;SOCS5;GPC3;TRIB2;ROS1;NEK1;TTBK1;ATE1;ASB8;TAOK3;MSRA;SIK1;PSMF1;KCTD6;YWHAZ;B3GALT1;PAK6;LMTK3;UBE2E1;PTPRT;STK24;STK3;PPP1CC;MTOR;GRK5;STC2;FUT9;ACVR2B;HLCS;RAB38;MARK2;CSK;MAP4K4;MIA3;PRKD2;LYN;PDGFB;ANO8;B3GNT8;OARD1;CSNK1E;MTMR7;MAP4K1;BIRC6;CDC14B;PAK5;COQ8A;MAPK10;NEK6;CHST5;BTBD6;SOCS6;DYRK3;ABL2;GAD1;BRSK1;NPC1;PAK3;HIPK1;BRAF;NUAK1;LATS2;KBTBD7
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.47131368848305516,0.9756963615075241,0.45353982300884954,0.8627022085278865,1.0,3/10,7.70%,KCNE4;ANK3;KCNE5
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4360869070940254,0.9754317685926284,0.4810126582278481,0.8623724703893005,1.0,5/15,14.09%,HECW2;NEK6;TACC3;PTTG1;ANAPC7
prerank,establishment of protein localization to membrane (GO:0090150),-0.29141863427786757,-0.9747680942614724,0.49382716049382713,0.8049793817512146,1.0,16/66,17.70%,AFDN;EGFR;SYNE3;RAB11A;SDCBP;RAB3GAP1;NACA;TAOK2;PARD3;ZDHHC24;REEP1;AQP11;FRMPD1;RAB3GAP2;BID;MICALL1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.34659070489174715,-0.9747377783485519,0.4957446808510638,0.8043965294863422,1.0,8/30,19.69%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.44701378590232843,0.9746226950077214,0.4745762711864407,0.8633386921031629,1.0,2/12,4.99%,IL1B;CARD9
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.27041134545511114,-0.974509565815483,0.49008498583569404,0.8043146749100404,1.0,30/101,19.74%,SAMD4A;VGLL4;VIM;THBS1;CYFIP2;EZR;LARP4B;KLF4;CSF1;NIBAN1;RPS4X;AKT1;UPF3A;CASP8;VPS35;TBC1D10A;TGFB1;FGFR4;CPEB3;FBXW11;RPL26;ATG10;FXR2;ELAVL1;NFKBIA;AGT;ZCCHC4;AGTR1;NAT10;METTL5
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.42665581886883763,-0.9739508102679926,0.5159474671669794,0.8049842380437433,1.0,3/11,7.32%,IL6ST;STAT1;STAT3
prerank,muscle filament sliding (GO:0030049),0.37538196247481054,0.9736474820196324,0.48880597014925375,0.8636972140442752,1.0,3/38,7.49%,DMD;TMOD1;MYL3
prerank,actin-myosin filament sliding (GO:0033275),0.37538196247481054,0.9736474820196324,0.48880597014925375,0.8636972140442752,1.0,3/38,7.49%,DMD;TMOD1;MYL3
prerank,positive regulation of hormone secretion (GO:0046887),-0.38102802870265173,-0.9736215912449888,0.5068493150684932,0.8051093129178278,1.0,10/17,39.36%,C1QTNF3;SPP1;EDN3;HFE;VAMP8;GRP;SNX4;EDN1;NMB;SOX11
prerank,modification-dependent protein catabolic process (GO:0019941),-0.24300083294758207,-0.9735999086771321,0.5411764705882353,0.804512924060245,1.0,54/193,21.81%,FBXL7;RNF213;SMURF2;FBXO10;RNF146;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;RNF144B;TTC3;SMURF1;CDC16;AMFR;RC3H2;CHFR;RNF185;DTX3L;KCTD10;ZNRF3;ARRDC1;UBE4B;ANAPC4;RNF125;MDM2;WDR81;UBB;UBE2G2;PSMD11;NEDD8;DDB1;FBXL14;ANKIB1;RNF40;UBR4;SPSB4;SPSB2;ANAPC16;FZR1;NPLOC4;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RNF126;ANAPC5;ELOC;RBBP6;XBP1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3950323557855707,-0.9735418249839226,0.5027223230490018,0.8039903720522147,1.0,5/14,26.61%,ACOX1;ECI2;ACOX3;AMACR;CROT
prerank,nucleic acid-templated transcription (GO:0097659),-0.31889127769056425,-0.9733350756172431,0.4978448275862069,0.8038318579214139,1.0,15/42,25.98%,THRB;POLR2A;NR4A2;MMS19;PWP1;POLR2F;MEF2A;DTX1;POLR2E;E2F1;THAP1;POLR2G;PPP5C;RRAGC;EPC1
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.31707714870030573,-0.9732219698805883,0.497787610619469,0.8034517219518049,1.0,6/39,9.96%,MCU;MYRIP;RBP4;TCF7L2;NNAT;NLGN2
prerank,negative regulation of histone methylation (GO:0031061),-0.44651720738767936,-0.9729662376546214,0.5162523900573613,0.8034572506877035,1.0,6/10,38.25%,JARID2;DNMT1;BRCA1;AASS;KDM1A;PHF1
prerank,negative regulation of lipid metabolic process (GO:0045833),0.40634536641734725,0.9728045568064235,0.4675834970530452,0.8645849555197476,1.0,2/22,2.62%,GPER1;IL1B
prerank,cranial nerve development (GO:0021545),-0.4337708451238224,-0.9727086009772778,0.526508226691042,0.8033928166567134,1.0,1/11,1.45%,CHD7
prerank,regulation of interferon-gamma production (GO:0032649),0.3359685993670553,0.9725117639495119,0.4820846905537459,0.8643706966275706,1.0,6/71,8.17%,PDE4D;IL1B;PTPN22;AXL;PDE4B;IL12RB1
prerank,GPI anchor metabolic process (GO:0006505),0.4000754750174973,0.9722692703679928,0.4559386973180077,0.8640521089686692,1.0,6/26,16.62%,PIGU;PIGO;PIGZ;DPM3;PIGH;PGAP1
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.45254638224457244,0.9717137403122528,0.4824742268041237,0.864408112179121,1.0,5/12,22.72%,KAT7;WRNIP1;BLM;METTL4;TIPIN
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.4077296764895514,0.9716649541953297,0.4703476482617587,0.8636349743579562,1.0,4/21,2.15%,PTK2;VCL;PEAK1;ROCK1
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.3304239069029553,0.9716455364076713,0.48494983277591974,0.8619530461833318,1.0,10/78,11.88%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.3304239069029553,0.9716455364076713,0.48494983277591974,0.8619530461833318,1.0,10/78,11.88%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.29153889401239547,-0.9715591581122563,0.5175644028103045,0.8055410231379071,1.0,36/62,37.09%,LRRK2;ARHGEF2;CXCL12;TPT1;AKT1;MCL1;MDM2;YBX3;PPIA;CREB3L1;ENO1;SNAI1;CREB3;TMBIM6;PARK7;PLAUR;XBP1;NDUFA13;BCL2L1;PRKN;BAG5;CDKN2D;SOD2;CLU;SYVN1;PTTG1IP;HSPB1;HYOU1;RTKN2;PINK1;MAPK7;EPO;VNN1;PPIF;NME5;HERPUD1
prerank,negative regulation of hydrolase activity (GO:0051346),-0.30482393859288137,-0.9714494121845302,0.5144927536231884,0.805166108731265,1.0,18/49,24.09%,LRCH1;LRRK2;SLC39A14;WNK1;CPEB2;SH3RF2;CST3;ECM1;DAB2IP;CAMK2A;F11R;GMIP;NOS1;SH3BP4;CHP1;TMED2;SH2D4A;RDX
prerank,regulation of cation transmembrane transport (GO:1904062),0.381609955206048,0.9714280345220103,0.4866920152091255,0.8615315583569516,1.0,11/29,13.71%,FGF12;DPP10;KCNAB3;SCN5A;CACNA1D;PDZK1;KCNE5;KCNIP1;RANGRF;KCNIP4;SLC30A5
prerank,RNA metabolic process (GO:0016070),0.30831247973235804,0.9707836743633392,0.4916286149162861,0.8620121844864329,1.0,30/127,15.02%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;PCBP3;NCBP2;ADARB2;AGO3;DDX3X;HNRNPR;SUPV3L1;XRN2;PAPOLA;RBMS1;RNASE6;POLR2C;PCBP1;HNRNPA1;SND1;HNRNPUL1;LAGE3;PABPC4;FASTKD1;HNRNPU;RNASEH1;LSM8;HNRNPC;HNRNPH2;DHX36
prerank,DNA damage checkpoint signaling (GO:0000077),0.39032933497986294,0.9706839607142389,0.48534798534798534,0.8613403854334158,1.0,5/28,14.26%,MAP3K20;RAD1;ATR;RAD17;ATRIP
prerank,acylglycerol biosynthetic process (GO:0046463),0.4034228126449239,0.970669329156661,0.4852941176470588,0.8605059870088827,1.0,1/23,0.48%,PLCE1
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.378354429815706,0.9705336122726493,0.4715909090909091,0.8599453333245574,1.0,16/31,26.75%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;TOMM40;PEX12;PEX2;TOMM70;DNAJC19;PEX5;PAM16;PEX6;TIMM17A;DNLZ;TIMM17B
prerank,positive regulation of T cell differentiation (GO:0045582),-0.3288788123995096,-0.9703595086027571,0.5132743362831859,0.8070491073029508,1.0,10/36,21.81%,ZMIZ1;GLI2;LEF1;GLI3;DUSP10;SOX12;RHOH;PNP;MDK;XBP1
prerank,regulation of intracellular pH (GO:0051453),-0.3277157571057553,-0.9702657413021771,0.5117773019271948,0.8066190545030778,1.0,10/34,19.84%,SLC9A2;SLC4A10;LRRK2;SLC9A9;TM9SF4;SLC9B1;SLC9A1;SLC4A2;CHP1;NOX1
prerank,hippo signaling (GO:0035329),-0.3496293360996726,-0.9701683254976072,0.5020833333333333,0.8061861150755661,1.0,4/26,6.19%,TJP2;TEAD4;YAP1;TEAD1
prerank,regulation of myelination (GO:0031641),0.40243421620132924,0.9700611815477914,0.47717842323651455,0.8600921290295375,1.0,6/25,10.50%,TNFRSF21;PTN;TPPP;NCMAP;TENM4;NKX6-2
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.43273590539796836,-0.9700210351050781,0.5226860254083484,0.8058841790013145,1.0,7/11,33.33%,LRP6;WNT5A;NR4A2;FZD1;CTNNB1;LMX1A;WNT2
prerank,gene silencing by miRNA (GO:0035195),0.3822902065715534,0.9699121405767447,0.46360153256704983,0.8595499796436755,1.0,7/32,12.88%,LIMD1;AJUBA;AGO3;TARBP2;TNRC6C;EIF6;TNRC6B
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3632706727571613,0.9697823875128031,0.4677137870855148,0.8589776818371382,1.0,8/44,10.26%,GNG2;KCNJ12;KCNMB1;AKAP6;ATP1B2;KCNE5;KCNJ3;KCNJ6
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3170716311759777,0.9697696644052715,0.4738562091503268,0.8581515813867607,1.0,3/85,1.30%,GRM7;COL4A3;ROR1
prerank,sulfur amino acid catabolic process (GO:0000098),0.473852249393075,0.9697666867580977,0.5021367521367521,0.8573013013563938,1.0,2/10,5.21%,CTH;TXN2
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3978486047374929,0.9696232562438867,0.4770992366412214,0.8567614178080221,1.0,4/27,8.10%,PER2;CRTC1;SIK1;PPP1CC
prerank,regulation of phospholipase C activity (GO:1900274),0.4315278191413706,0.9694642940752466,0.47878787878787876,0.8562608239940661,1.0,3/15,7.15%,PDGFRB;FGF2;HRAS
prerank,macrophage activation (GO:0042116),-0.3281150182466731,-0.9694304008466633,0.5182186234817814,0.8066779068566847,1.0,5/34,4.91%,FOXP1;APP;LBP;SBNO2;CD93
prerank,"transcription, DNA-templated (GO:0006351)",-0.23944497307069,-0.9694029375866519,0.5088967971530249,0.8061069379822932,1.0,64/207,26.26%,MAF;NFIX;GLIS3;FOXO3;TSC22D1;DDX5;PIR;TAF1;MLLT3;TRIM24;THRB;NOCT;RTF1;POLR2A;IRF9;RREB1;PMF1;NR4A2;MMS19;IVNS1ABP;PWP1;POLR2F;MEF2A;POLR3GL;EAF1;ELOB;DTX1;CDK9;TAF4B;GTF3C2;MNT;GTF3C5;POLR2E;TBPL1;BRF2;E2F1;GTF3C1;TAF9B;TEFM;POLRMT;UBTF;TCEA1;RSF1;TTF1;THAP1;NFE2L3;MRPL12;ELOC;XBP1;NELFCD;CEBPD;TAF5;HSF2BP;HIPK3;CBFB;ERCC2;POLR2G;PPP5C;RRAGC;CDK7;ERCC3;TP53;EPC1;TAF11
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.3502543689860818,-0.9694013279592375,0.5076045627376425,0.805471876645437,1.0,4/24,13.20%,PLA2G4A;LPGAT1;ABCA3;PLA2G15
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4022364680849619,-0.9692712156088722,0.5121495327102804,0.8051474460521214,1.0,7/13,29.65%,SUFU;MDFI;PKD1;NFKBIA;DBN1;NFKBIE;KEAP1
prerank,positive regulation of cellular component movement (GO:0051272),-0.35339771889085186,-0.9687361242068371,0.5295358649789029,0.8057863277360805,1.0,12/24,26.37%,PDPN;TGFBR1;SPOCK2;CAVIN1;RPS19;NTN1;CSF1R;CCL19;VEGFA;STK11;AKT2;TWIST1
prerank,protein import (GO:0017038),-0.27809945921756474,-0.968437084816137,0.4812680115273775,0.8058849950505341,1.0,32/84,29.60%,LAMP2;APOE;APPL2;STAT3;SLC25A17;AKT1;IPO7;PXMP2;FAM53C;IPO13;ALDH3A2;RAN;ACBD5;GDAP1;PXMP4;NXT2;IPO8;TPR;TOMM22;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;PEX26;CLU;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,protein deubiquitination (GO:0016579),-0.23386382120465776,-0.9683944228140413,0.5185185185185185,0.8053444344980443,1.0,79/242,27.57%,SMAD3;ESR1;SMURF2;USP47;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;INO80;RHOA;USP8;BIRC3;USP15;TRRAP;USP18;HGS;IL33;HIF1A;FOXK1;BECN1;USP34;ZC3H12A;USP35;USP11;USP5;PSME2;MINDY1;ATXN7L3;MDM2;USP49;PSMB4;UBB;INO80D;ACTB;PSMB1;PSMD11;NEDD8;PSMD8;PSME3;RIPK1;ACTR8;NFKBIA;ADRB2;PSMD4;STAMBP;PSMA2;BABAM2;VCP;TAF9B;IKBKG;USP22;SNX3;PSMD3;USP36;PSMB7;BABAM1;CCP110;BAP1;USP2;PSMC2;BRCA1;USP10;PSMC5;PSMD10;SUDS3;ACTR5;PRKN;ABRAXAS2;TP53;CDC25A;MINDY2;SMAD4;SENP8;INO80E;ATXN3;ENY2;PSMD7
prerank,chromatin assembly (GO:0031497),-0.3176514230836885,-0.9680752488002276,0.5021834061135371,0.8054743369522606,1.0,16/38,31.99%,KAT6B;H3-3A;ANP32B;EZH1;HMGB2;CTCF;RSF1;NAP1L2;BRD2;ASF1A;CHAF1A;TP53;POLE3;PAF1;NAA60;SPTY2D1
prerank,regulation of RNA splicing (GO:0043484),-0.28491186712128347,-0.9680024277193607,0.5276497695852534,0.8050129425754526,1.0,23/69,26.65%,AHNAK;MBNL1;RBM20;AFF2;RPS13;POLR2A;SON;CLK1;ERN1;MBNL2;GRSF1;SRSF10;TMBIM6;AHNAK2;PTBP3;HNRNPL;SRPK1;RPS26;ZNF326;SRPK2;HNRNPF;CLK3;CWC22
prerank,positive regulation of apoptotic process (GO:0043065),0.27701501180925514,0.9676923661718807,0.5296442687747036,0.8592008369801661,1.0,31/293,9.08%,DLC1;ARHGEF17;FAP;MAP3K20;KALRN;PLEKHG2;MAP3K5;ARHGEF6;GPER1;NF1;RYBP;RPS6KA2;SLC27A4;ITGB1;TNFRSF8;TFAP2B;SNCA;DDX3X;ARHGEF12;SOX4;ARHGEF26;SIK1;CASP9;SOS2;BIN1;RNPS1;STK3;TNFAIP8;HTRA2;ARHGEF9;CCAR2
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.3911997633842347,0.9676253768332195,0.4608030592734226,0.858485051697119,1.0,4/28,10.43%,MAP2;CLASP2;MAPRE2;CAMSAP3
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.42006790814068473,-0.9675150486037417,0.5151515151515151,0.8055767930643334,1.0,3/12,8.00%,DPYSL3;DPYD;CTPS1
prerank,protein destabilization (GO:0031648),-0.32782101338546726,-0.9674626863212239,0.5085106382978724,0.8050664987920372,1.0,9/32,14.46%,GSN;CTSH;RNF139;IRGM;MDM2;CCDC88C;FBXW11;SOX17;SERF2
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3784368629425251,-0.9674187630910583,0.5126050420168067,0.8045640834206937,1.0,8/18,29.25%,CCN3;KCNB1;SFRP1;MIDN;SIRT4;PRKN;ADRA2A;CHGA
prerank,negative regulation of protein phosphorylation (GO:0001933),0.2955040890827417,0.9672150930802382,0.49416909620991256,0.8584751436027747,1.0,17/150,6.42%,PDE4D;PTEN;DMD;PID1;NCK2;PPM1E;NF1;SPRED1;PRR5L;CADM4;SPRY2;TRIB2;INPP5J;TESK1;DBNDD2;SNCA;CACTIN
prerank,histone H3 deacetylation (GO:0070932),-0.38226872242994314,-0.9667842882647667,0.5079365079365079,0.8055094634861709,1.0,7/15,19.29%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT7;SIRT2;SMARCAD1
prerank,positive regulation of wound healing (GO:0090303),0.37911857330578747,0.9667570053571476,0.49070631970260226,0.8586166301152736,1.0,8/36,8.14%,VTN;PTK2;MYLK;FERMT2;ITGB1;ARFGEF1;HRAS;MTOR
prerank,cellular response to chemokine (GO:1990869),0.3599872055746798,0.9666301631115035,0.4886561954624782,0.858059193724744,1.0,6/46,6.10%,SLC12A2;SH2B3;STK39;ACKR3;CXCL10;CXCL5
prerank,nucleosome organization (GO:0034728),-0.2964213967266618,-0.9663810216333837,0.5150812064965197,0.8058231052309297,1.0,26/55,36.77%,KAT6B;INO80;BPTF;H3-3A;ANP32E;ANP32B;SMARCC1;HMGB2;CTCF;RSF1;MCM3AP;NAP1L2;BRD2;SMARCA4;RNF8;ASF1A;CHAF1A;SMARCD2;POLE3;PAF1;NAA60;SPTY2D1;ZNHIT1;ATRX;GRWD1;SRCAP
prerank,innate immune response (GO:0045087),0.2849253853084206,0.9662772096724304,0.5006675567423231,0.8579242810303431,1.0,26/217,9.50%,PIK3CD;COLEC12;NCF2;PTK2;FRK;NCF1;MID2;AKAP1;ANKHD1;WFDC3;CARD9;CAMP;TRIM43;TRIM62;CXCL10;IL4;SNCA;DDX3X;RIPK2;RNASE6;ALPK1;CORO1A;ZDHHC1;TIFA;LYN;CR2
prerank,protein-containing complex subunit organization (GO:0043933),0.3115123683336983,0.9651847230127786,0.5084745762711864,0.8594613022448044,1.0,7/109,3.96%,LIN7A;LAMC1;WASF3;WAS;WIPF1;WASL;RIMS1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.35485058158548316,-0.9651730130914637,0.4908350305498982,0.8080951825519235,1.0,8/23,20.55%,WEE1;PLK2;CHFR;ZFYVE19;NABP1;ZW10;PRCC;CDK5RAP3
prerank,endodermal cell fate commitment (GO:0001711),-0.4259507622709211,-0.9650060204210404,0.5112359550561798,0.8078590014463883,1.0,2/10,13.79%,RTF1;SOX17
prerank,sterol biosynthetic process (GO:0016126),-0.3332266946563926,-0.9649400814488637,0.5097613882863341,0.80739423191457,1.0,2/33,3.11%,PRKAG2;LBR
prerank,regulation of steroid metabolic process (GO:0019218),0.3964714020844886,0.9647283257070983,0.47368421052631576,0.8596365277538464,1.0,6/23,17.83%,RORA;ARV1;STAR;ASAH1;RORC;FMO5
prerank,rRNA transcription (GO:0009303),-0.379133873494898,-0.9645497142461392,0.5019011406844106,0.807682527621114,1.0,6/17,19.53%,CAVIN1;TCOF1;GTF3C2;GTF3C5;SIRT7;GTF3C1
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.33561372315221105,-0.9642772537038863,0.5347368421052632,0.8077022045874545,1.0,5/31,3.94%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2
prerank,histone deacetylation (GO:0016575),-0.3055765365857906,-0.9642659234900444,0.5144124168514412,0.8071007214698717,1.0,14/43,21.43%,HDAC4;TBL1XR1;HDAC8;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SMARCAD1;MORF4L2;SIN3A
prerank,genitalia development (GO:0048806),-0.4135839216867935,-0.9641419544849239,0.5244360902255639,0.8067600263276079,1.0,4/12,14.82%,CHD7;WNT5A;STRA6;PKD1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.32720541449482776,0.9637238713670686,0.49748743718592964,0.8608570043409635,1.0,10/79,11.88%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.36549480097746756,0.96369179989091,0.5102803738317757,0.8600836246507576,1.0,9/41,13.16%,IL34;DOK7;NCF1;GRM5;NTRK2;PDGFB;SRC;DLG3;PTPN1
prerank,cellular response to retinoic acid (GO:0071300),-0.31350131040051077,-0.9631581594545743,0.5189309576837416,0.8084487477768254,1.0,11/42,13.68%,EPHA3;WNT6;WNT9A;WNT5A;PTK2B;TBX1;FZD4;FZD7;WNT5B;ATM;RET
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.44286376029859154,-0.9628612965455144,0.5229681978798587,0.8085142164306286,1.0,5/10,20.68%,PRKCH;FOXC1;TRIM16;ETV4;NUMA1
prerank,gas transport (GO:0015669),0.46433621545112885,0.9622953180539484,0.49141630901287553,0.862222601008002,1.0,1/10,3.53%,MB
prerank,membrane protein proteolysis (GO:0033619),-0.317362036422971,-0.9622217965164014,0.49887640449438203,0.80936166511739,1.0,10/37,17.55%,CTSH;ADAM9;ADAM10;ERAP1;TGFB1;RELA;RET;AFG3L2;BACE2;PSEN2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.4308464067227914,-0.9615575620461689,0.5298651252408478,0.8103469307246836,1.0,4/10,14.73%,EZR;RHOA;MYO9A;OPHN1
prerank,regulation of integrin activation (GO:0033623),0.43127499524765006,0.9601493806005217,0.4957805907172996,0.8658846990879633,1.0,3/15,6.84%,JAM3;FERMT2;FBLIM1
prerank,UV-damage excision repair (GO:0070914),-0.41497525303673666,-0.9601484209216182,0.5229885057471264,0.8129876900202484,1.0,5/12,26.01%,INO80;DDB1;ERCC1;ACTR5;POLA1
prerank,negative regulation of neuron projection development (GO:0010977),0.3431899920080599,0.9598741953106388,0.499151103565365,0.865630724423494,1.0,6/56,5.15%,PTEN;RTN4RL1;PTPN9;LINGO1;ADCY6;MYLIP
prerank,regulation of translation (GO:0006417),-0.24146992096897776,-0.9594093506859104,0.5486111111111112,0.8141345975638077,1.0,52/173,26.14%,DAPK1;SAMD4A;IGFBP5;FOXO3;APP;VIM;THBS1;LARP4B;NIBAN1;CNOT7;RNF139;CTIF;DDX6;RPS4X;IGF2BP2;UPF3A;ATXN2;EIF4G3;CPEB3;TCOF1;CALR;RPL26;LARP1;EIF4A2;CNOT8;RPL10;GEMIN5;FXR2;EIF5B;ELAVL1;EIF2B2;PAIP2B;EIF4E2;TYMS;ZCCHC4;EIF1B;NAT10;METTL5;PASK;EIF2AK3;RPS27L;MIF4GD;CSDE1;SAMD4B;MTRF1;RPS6KA3;EIF3B;RPS3;MTG1;RACK1;RPL13A;EIF2AK4
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.2952965400786328,-0.9590300671748786,0.5384615384615384,0.8143734799138096,1.0,13/56,18.59%,LBP;NOD1;IRAK2;LACC1;CTSB;SFTPA2;SFTPA1;CTSS;UBB;PLCG2;MAPKAPK3;TLR4;HSP90B1
prerank,regulation of blood coagulation (GO:0030193),0.3799619961412437,0.9587243185621896,0.4590818363273453,0.867258334946175,1.0,2/27,1.04%,FAP;VTN
prerank,protein acetylation (GO:0006473),-0.33979544369485654,-0.9587191036905699,0.5347368421052632,0.8144270454934727,1.0,11/30,24.92%,FOXO1;KAT2B;NAA35;CLOCK;SPHK1;NAA40;NAT10;NAT9;NAA80;HAT1;ING4
prerank,phosphate ion homeostasis (GO:0055062),-0.43947609252255054,-0.9584785003851286,0.524074074074074,0.8143881274617794,1.0,3/10,12.18%,ENPP1;SFRP4;FGFR4
prerank,regulation of membrane depolarization (GO:0003254),-0.37261245830094847,-0.9584422632263851,0.5333333333333333,0.8138510457581989,1.0,5/18,7.01%,PTPN3;FHL1;LRRK2;SMAD7;GPD1L
prerank,Golgi inheritance (GO:0048313),0.45117593503501197,0.9583600939739495,0.46304347826086956,0.8671637648697073,1.0,3/11,13.98%,PDCD10;YWHAZ;STK25
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.391214267512292,-0.9583499682736254,0.511070110701107,0.8134270737178444,1.0,5/15,10.16%,CNOT7;STAT2;USP18;NLRC5;SAMHD1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4347648524636375,0.958198403159402,0.5009940357852882,0.8666573303602944,1.0,3/14,8.74%,IL1B;FFAR2;OSMR
prerank,positive regulation of B cell proliferation (GO:0030890),0.3928309952038929,0.9581124751148901,0.5,0.8659919467777043,1.0,2/29,6.03%,MEF2C;IL4
prerank,response to exogenous dsRNA (GO:0043330),0.419710392609816,0.9579880665767014,0.5009746588693957,0.865394220731071,1.0,2/18,2.48%,COLEC12;RFTN1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.40255795170896336,-0.957794455681047,0.5155925155925156,0.8141021510103409,1.0,5/13,16.05%,NIBAN2;HGS;EMILIN1;DAB2IP;HHEX
prerank,synaptic vesicle cycle (GO:0099504),0.3786420267069662,0.9574135171690413,0.4801587301587302,0.8657562958196056,1.0,10/30,18.25%,SNAP25;RIMS1;SNCA;SLC32A1;BRSK1;RAB5A;SYNDIG1;CDK5;VAMP2;CPLX1
prerank,regulation of mRNA metabolic process (GO:1903311),0.4487892574498782,0.9574057344764649,0.48478260869565215,0.8649299073476502,1.0,2/11,4.16%,PTCD2;SRPK3
prerank,necroptotic process (GO:0070266),-0.3843449622914797,-0.9573434331292335,0.5138339920948617,0.814500709382384,1.0,5/16,17.18%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.41289102386448184,-0.9572975216808228,0.5190839694656488,0.8139599970890807,1.0,7/12,31.77%,HSPA5;CHMP4B;CHMP4A;SEC61A1;SEC61B;SEC63;GET3
prerank,regulation of cell cycle process (GO:0010564),-0.2571555566674531,-0.9572453793852854,0.5304347826086957,0.8134374760165077,1.0,34/104,28.47%,RAB11A;KIF13A;PLK2;CALM2;OBSL1;BECN1;FLCN;SH3GLB1;GIT1;UVRAG;CEP85;SFRP1;CAV2;DBF4;MYO19;CALM1;CCDC8;DYNC1H1;NUMA1;PLK4;CUL9;CETN2;CCP110;NUDT16;RMI2;BCL2L1;L3MBTL1;PLK5;KLHL21;CTNNB1;FSD1;SPAG5;MKI67;KLHL9
prerank,protein modification process (GO:0036211),-0.27512464038994733,-0.9570487095090183,0.5365853658536586,0.8132608197930694,1.0,24/76,24.89%,ST3GAL6;ST3GAL1;CPE;YES1;PHKA2;PLOD2;WWP2;SEPHS1;DUSP12;ST8SIA2;NEDD8;UBA3;FBXL2;MANBA;UBA7;RPN2;UBE2M;UBE2L6;PHEX;LCMT1;BAP1;AKT2;LOX;UBL4A
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.3894831974444801,0.9570405066814369,0.5,0.8648529568555172,1.0,2/25,0.67%,PTH1R;GLMN
prerank,response to ionizing radiation (GO:0010212),-0.27771220737444235,-0.9559656213092763,0.5207253886010362,0.8151852199889511,1.0,23/70,26.23%,EYA1;ANXA1;INO80;MAPK14;RHOB;EEF1D;NHEJ1;NABP1;ATM;CLOCK;XRCC4;INIP;NET1;BABAM2;IKBIP;BABAM1;RAD51;STK11;RNF8;BRAT1;BRCA1;TP53;HUS1
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.44161911065394477,0.9557105573900121,0.5050100200400801,0.8667504514303367,1.0,5/12,15.79%,HOOK3;BICD2;KIF3A;DCTN1;CEP19
prerank,double-strand break repair (GO:0006302),-0.24377418451158145,-0.9551294801020087,0.5903225806451613,0.8165318637226955,1.0,49/158,26.31%,EYA1;PARP9;INO80;POLM;RAD51B;BAZ1B;SFR1;ERCC5;DCLRE1C;DTX3L;PARP3;NHEJ1;SAMHD1;BRCA2;NABP1;AP5Z1;ATM;XRCC4;RPA1;RAD50;PAXX;HMGB2;CYREN;ACTR8;BABAM2;VCP;SMARCAD1;PIAS4;RECQL;RAD52;UBXN1;BABAM1;RAD51C;MCM8;BAP1;SLX4;RAD51;ERCC1;CHEK2;RNF8;BRCA1;RPA3;ZSWIM7;PPP5C;RAD54B;ACTR5;POLA1;HUS1;APLF
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.38878520734865124,-0.9544613309315139,0.5130111524163569,0.8175442801840699,1.0,9/15,27.90%,SMAD7;DTX3L;RPL11;RPL23;RPS7;PARK7;BAG2;BAG5;ABL1
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.41428019241348946,-0.9544309401122911,0.5615384615384615,0.8169847083755447,1.0,4/12,15.54%,CLCN2;LPCAT3;RAN;SREBF1
prerank,positive regulation of ERAD pathway (GO:1904294),-0.40517147455552005,-0.9544025418126568,0.5185909980430529,0.8164320455031085,1.0,7/13,37.09%,CAV1;RNF185;BCAP31;ATXN3;USP13;RNFT1;HERPUD1
prerank,organelle assembly (GO:0070925),0.2690303016330201,0.9543619125488376,0.5515151515151515,0.8688171667637611,1.0,47/385,11.81%,DYNLL1;LIMD1;STARD9;NOTCH1;DZIP1L;IFT43;RILPL2;CDS2;RAB8B;TTLL3;CYS1;TMOD1;TTC36;IFT81;CCDC57;CENPW;TNKS;LSM3;IFT20;TMOD3;MAPRE2;YTHDF3;NEK1;RBM14;ATG16L1;CHMP2B;DDX3X;SCLT1;ATP2A2;CORO1A;RAB38;FAM161A;EHD3;MVB12A;CDC14B;TP53INP2;NEK6;UBXN2B;KIF3A;CEP41;LMOD1;SQLE;POGZ;AHI1;CCDC66;YTHDF2;CFAP20
prerank,response to copper ion (GO:0046688),-0.36357115275167906,-0.9541747035414574,0.53125,0.8163194828174063,1.0,9/20,20.00%,MT3;MT1X;MT1M;MT1H;MT1F;MT1A;MT1E;MT1G;MT1B
prerank,response to unfolded protein (GO:0006986),-0.29655580100423146,-0.9541340296407467,0.5071090047393365,0.8157897414503607,1.0,18/48,28.08%,SERPINH1;HSPB8;STT3B;HSPA5;BAG3;DAB2IP;OPTN;ERN1;DNAJB2;HSP90AB1;TMBIM6;DNAJB5;HSPA13;HSPA9;HSPB2;PRKN;HSPH1;HSPA1B
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4013690031424267,0.9540541272365956,0.49411764705882355,0.8686463896982057,1.0,9/24,17.72%,TTLL3;TTLL11;NAA11;CEP41;TPGS1;CFAP20;PARP1;TTLL10;TTLL5
prerank,negative regulation of microtubule polymerization (GO:0031115),0.44159734002476536,0.9537122046551112,0.4879120879120879,0.8685756722493262,1.0,4/12,12.85%,MAP2;SNCA;ARHGEF7;TUBB4A
prerank,cell junction organization (GO:0034330),0.3268974246588956,0.9531580381862246,0.5337620578778135,0.8688854250211551,1.0,13/71,7.88%,LIMS1;APBB2;VASP;FERMT2;RAB8B;SH3BP1;RAB39B;GRM5;AGRN;SNCA;CHRNA7;FBLIM1;PPFIBP2
prerank,regulation of platelet aggregation (GO:0090330),0.4161530476835903,0.95269512928467,0.48282828282828283,0.8690067593936315,1.0,2/17,3.58%,PRKG1;SH2B3
prerank,plasma membrane organization (GO:0007009),-0.28077647135435346,-0.9521430733455382,0.542997542997543,0.8199670603605369,1.0,19/61,18.44%,MYOF;COL5A1;SNX9;CAVIN2;FNBP1L;PLSCR2;A4GALT;ANO6;TLCD2;PLSCR4;CHMP4A;P2RX7;UGCG;EHD2;AHNAK2;PLSCR3;SYTL4;MICALL1;STX2
prerank,regulation of cell size (GO:0008361),0.3898874844423751,0.95209639139403,0.4860557768924303,0.8694382816478832,1.0,3/23,8.14%,PTEN;AKT1S1;MTOR
prerank,regulation of muscle cell differentiation (GO:0051147),0.3759378232741163,0.9518737266203227,0.47058823529411764,0.8690837291370859,1.0,2/31,0.93%,MEF2C;CDH2
prerank,cellular respiration (GO:0045333),0.3650842373232551,0.9517007203454263,0.49906191369606,0.8685883262127327,1.0,11/41,18.71%,COX4I2;UQCRFS1;SLC25A13;BLOC1S1;UQCRC2;ETFB;ETFA;MTFR1;ETFDH;OXA1L;NDUFA5
prerank,lipid homeostasis (GO:0055088),-0.28881985763228,-0.9515525693197534,0.5566502463054187,0.8208016893819559,1.0,15/57,21.81%,ABCA1;RBP1;APOE;RCN3;TLCD2;ACOX1;USF1;ADCK1;ACOX3;PRKAA2;USF2;CLN8;ORMDL3;DGAT2;XBP1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3970198752565422,-0.9511670109474257,0.5622568093385214,0.8210663708432893,1.0,3/13,13.00%,HIF1A;SPAST;UBB
prerank,melanosome organization (GO:0032438),-0.33579996832689174,-0.9511253245877624,0.5247933884297521,0.8205526637236362,1.0,9/26,21.45%,SHROOM2;KIF13A;DTNBP1;AP3B1;BLOC1S6;RAB29;RAB32;HPS4;AP3D1
prerank,cellular response to calcium ion (GO:0071277),0.3335233609880432,0.9510134257530796,0.5105263157894737,0.8692966272676309,1.0,14/67,11.38%,MEF2C;RASGRP2;ADCY8;ITPKB;CPNE7;SCN5A;SYT1;RYR3;PKD2;HPCA;CPNE4;BRAF;CHP2;SYT2
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.3828493064034304,-0.9508322749772554,0.5389105058365758,0.8206307294509342,1.0,8/15,25.85%,TCF7L2;GAS6;ANP32B;BAG3;TPR;YWHAE;XPO4;TP53
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.30327278476239705,-0.9507903079821687,0.5351473922902494,0.8200992610432912,1.0,11/46,13.00%,SMAD3;TCF7L2;CDH1;GAS6;PRKCD;ANP32B;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,JNK cascade (GO:0007254),0.36130167758551823,0.9504405041365209,0.4972677595628415,0.8697296527856855,1.0,5/40,9.85%,MAP3K5;ARHGEF6;MINK1;RIPK2;MAPK10
prerank,monocarboxylic acid metabolic process (GO:0032787),0.29858527175357863,0.949979112802179,0.5118694362017804,0.8698529160423961,1.0,17/117,11.98%,GGT5;GGT1;PER2;SLC16A3;ACSF2;PPARD;BAAT;ACOT12;SLC27A4;AOAH;HLCS;MCCC1;ACOT2;NPC1;PDHX;GLYAT;GATM
prerank,negative regulation of viral process (GO:0048525),-0.2888806441103958,-0.9498330126459059,0.5642857142857143,0.8217342300064572,1.0,28/57,33.45%,IFITM3;STAT1;OAS2;IFIT1;PML;TRIM27;MAVS;TRIM35;PPIA;IFITM2;RNASEL;TRIM8;RSAD2;TRIM14;SRPK1;TRIM11;TRIM6;SRPK2;PLSCR1;ISG15;ILF3;ZFP36;BST2;TRIM21;PARP10;OASL;TRIM13;FAM111A
prerank,phagosome acidification (GO:0090383),-0.3423252966745276,-0.9496966528263384,0.5126582278481012,0.8214384098575379,1.0,16/26,39.23%,ATP6V0A4;ATP6V1G1;ATP6V0B;RAB7A;ATP6V0A1;TCIRG1;ATP6V0A2;ATP6V1F;ATP6V0D1;ATP6V0C;ATP6V1D;RAB20;ATP6V1E1;ATP6V0D2;ATP6V1G2;RAB39A
prerank,regulation of lymphocyte migration (GO:2000401),-0.430419692665811,-0.9496073082636577,0.5378787878787878,0.8210154447404794,1.0,3/10,9.46%,JAM2;AKT1;STK10
prerank,stem cell differentiation (GO:0048863),-0.3104585515536607,-0.9494593447057471,0.5177777777777778,0.8207462976044018,1.0,10/39,14.15%,OSR1;FGFR2;LRP6;MLLT3;ACE;KIT;JARID2;PUM1;SFRP1;PSMD11
prerank,cellular response to ionizing radiation (GO:0071479),0.3464179547269515,0.9493551450939202,0.48845470692717585,0.8703052066840097,1.0,13/47,17.88%,MAP3K20;TNKS1BP1;LIG4;HRAS;CDKN1A;RAD1;ATR;TANK;NIPBL;BLM;HSF1;RHNO1;TLK2
prerank,regulation of acute inflammatory response (GO:0002673),0.41210000291289156,0.9481742366159027,0.48140900195694714,0.8720165941981376,1.0,3/18,8.74%,FFAR2;IL4;OSMR
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4183965600547913,0.9478901743208854,0.4876543209876543,0.8717280188378773,1.0,5/18,9.01%,CRTC1;RPS6KA4;ADCY8;CRTC3;PRKD2
prerank,regulation of osteoclast differentiation (GO:0045670),-0.32718545976761393,-0.9475364334824893,0.5274725274725275,0.8245108399590567,1.0,8/33,22.11%,FBN1;CSF1;TCTA;GPR137;TLR4;CEBPB;FSTL3;UBASH3B
prerank,lysine catabolic process (GO:0006554),-0.41148440127583774,-0.9473893806219444,0.5383211678832117,0.823588527591117,1.0,5/12,28.69%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,lysine metabolic process (GO:0006553),-0.41148440127583774,-0.9473893806219444,0.5383211678832117,0.823588527591117,1.0,5/12,28.69%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,glial cell development (GO:0021782),0.38454924320211314,0.9473657479370705,0.5,0.8720169095846508,1.0,4/25,6.56%,CDK6;NF1;TPPP;SOX4
prerank,negative regulation of platelet activation (GO:0010544),-0.3731986836242367,-0.9471853145250752,0.5355731225296443,0.8234436450086475,1.0,6/16,8.02%,PDGFRA;APOE;NOS3;THBD;CD9;PRKCD
prerank,regulation of chromatin binding (GO:0035561),-0.4294961736945436,-0.9469554205558388,0.5409836065573771,0.8233501299171383,1.0,2/10,8.83%,PARP9;DTX3L
prerank,microvillus assembly (GO:0030033),0.43503436196730205,0.9468414599132374,0.5042918454935622,0.8722778419605022,1.0,4/14,8.81%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4628722956421061,0.9467969759755619,0.5041666666666667,0.8715509300147388,1.0,1/10,2.01%,DCLRE1B
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2513166832184872,-0.9467644334647523,0.5806451612903226,0.8231664665793278,1.0,37/121,24.70%,SAMD4A;VIM;CNOT7;MOV10;PRKCD;IGF2BP2;RC3H2;AKT1;ZC3H12A;PSME2;PUM1;PSMB4;UBB;CNOT8;PSMB1;PSMD11;PSMD8;FXR2;EXOSC5;PSME3;XRN1;ELAVL1;PNPT1;PSMD4;PSMA2;CSDC2;ZFP36L2;PSMD3;NUP214;PSMB7;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMC5;PSMD10
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4137773722685722,0.9467618702654561,0.5078125,0.8707835243797671,1.0,2/18,9.11%,BCAR1;LYN
prerank,positive regulation of cell development (GO:0010720),0.3708631757071012,0.9464719414272786,0.4885057471264368,0.8705291010111663,1.0,2/31,1.63%,PDE3A;GPER1
prerank,positive regulation of multicellular organismal process (GO:0051240),0.26976760939645494,0.9464352878133008,0.5456852791878173,0.8697692537324461,1.0,26/308,6.25%,SOX5;PLA2R1;GLMN;PIK3CD;TBXA2R;GCNT2;SMTNL2;PER2;RGCC;NODAL;FERMT2;TRPV2;ROCK1;PTN;IL1B;NCOA3;G0S2;PPARGC1B;FGF2;EPAS1;CARD9;SYDE1;GRB10;OGT;IL4;SCAMP5
prerank,protein localization to cell junction (GO:1902414),0.39955025909090314,0.9463605428468982,0.4883268482490272,0.8690994966894194,1.0,6/22,15.16%,JAM3;FERMT2;JAK1;KIF3A;NPHS1;CGNL1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.43878204439832447,0.9462858507980136,0.47161572052401746,0.8684429365231562,1.0,1/11,0.90%,PARP8
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4085057677384995,-0.9459719600028782,0.5284090909090909,0.8243781177486597,1.0,8/12,35.84%,LRRK2;CLN6;CCDC115;CLN5;TMEM199;TMEM165;CLN3;ATP6AP2
prerank,regulation of cell junction assembly (GO:1901888),0.37504880600817714,0.9454099963445524,0.5084388185654009,0.8694371339427218,1.0,3/27,2.15%,MEF2C;RAPGEF2;ROCK1
prerank,mammary gland development (GO:0030879),-0.34775465348706625,-0.9451977050485699,0.5240963855421686,0.8255581598829536,1.0,3/21,2.43%,WNT4;GLI2;CAV1
prerank,regulation of intracellular protein transport (GO:0033157),-0.320283382533873,-0.9449177824063025,0.5147679324894515,0.8255797537580762,1.0,16/32,28.78%,PTPN14;BMP4;NDEL1;IFI27;TGFB1;RUFY3;SIRT7;TPR;OAZ1;RAB29;LCP1;RIPOR1;ICE1;ZFAND1;B3GAT3;ATP13A2
prerank,cellular response to sterol (GO:0036315),-0.40132979198016405,-0.9447751520590988,0.5347091932457786,0.8252735187138175,1.0,6/13,11.87%,LRP6;SMO;GRAMD1C;GRAMD1A;INSIG2;PTCH1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.34090130870232427,0.9443620032865694,0.5220458553791887,0.870732002735978,1.0,15/62,12.88%,MEF2C;CDK6;MYL9;HOXA9;AGO3;LYN;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;EP300;RBM15;CTR9;TNRC6B
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.32212022528750545,0.9437786300233143,0.5015576323987538,0.8710929662332404,1.0,16/78,15.97%,PTEN;RGCC;SPDYA;HEXIM1;CDKN1A;INCA1;PKD2;NR2F2;PDGFB;CCNYL1;LATS2;APC;CCNH;BLM;GTF2H1;CCNE1
prerank,smooth muscle tissue development (GO:0048745),0.44762823150250486,0.9431786388068266,0.5190677966101694,0.8714999001412121,1.0,2/10,2.17%,MYLK;NF1
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3376511343830555,0.9426767889152173,0.535,0.8717509746760133,1.0,11/57,9.80%,MAP3K5;GPER1;NODAL;GRAMD4;CIDEB;CARD9;TTBK1;DDX3X;RIPK2;HTRA2;GRIN2B
prerank,cilium organization (GO:0044782),0.27877507770625176,0.9422936466845855,0.5433604336043361,0.8717391052100886,1.0,22/210,11.23%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RAB8B;TTLL3;CYS1;TTC36;IFT81;CCDC57;IFT20;NEK1;SCLT1;FAM161A;EHD3;PKD2;CDC14B;KIF3A;CEP41;AHI1;CCDC66
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.3703567284364542,-0.9419031504817499,0.5708582834331337,0.8313846267732421,1.0,4/18,13.81%,SLC25A4;CAMK2A;SPG7;BNIP3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3352173354724357,0.9410392588629559,0.5099099099099099,0.8735957883551532,1.0,6/63,7.63%,MEF2C;NCK2;IL1B;CD46;IL4;FGF10
prerank,regulation of dendritic spine development (GO:0060998),0.41097387131441787,0.9408894998999873,0.5289421157684631,0.8731148728286396,1.0,1/19,0.63%,MEF2C
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3760492439887817,0.9407432448164555,0.5203094777562862,0.8726196686145145,1.0,3/28,7.63%,SH3KBP1;TNIP2;FGF10
prerank,Golgi organization (GO:0007030),0.3092313770840097,0.9404706293715984,0.5333333333333333,0.8723489202928797,1.0,31/112,17.74%,ARHGAP21;SYNE1;STX16;COG7;PDCD10;ATP8B2;COG1;CLASP2;VTI1A;ARFGEF1;HACE1;YWHAZ;BLZF1;TMED7;UBXN2B;TMED4;ARHGEF7;VPS51;GCC2;TRIP11;VTI1B;STK25;TJAP1;VMP1;RAB1A;PRKD1;HTT;CSNK1A1;GORASP1;GOLGA8B;GOLGA5
prerank,regulation of protein catabolic process (GO:0042176),-0.25580202439149896,-0.9398869140305249,0.5796703296703297,0.8355455726384409,1.0,29/99,20.01%,EGFR;FOXO1;SMURF2;NKD1;WWP2;SMURF1;WNT5A;PLK2;EGLN2;HGS;EEF1A1;IRAK3;GFAP;IDE;DAB2IP;PRKCG;RAB7A;ASB5;MDM2;DDB1;WWP1;CDKN1B;SIRT2;ODC1;OAZ1;FZR1;VCP;VPS28;SNX3
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.3790585543437709,-0.9396289570046272,0.5610236220472441,0.8355019253032809,1.0,9/16,34.56%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,protein localization to cell periphery (GO:1990778),0.2980904176688319,0.9392040469275983,0.5476190476190477,0.8740985923947173,1.0,21/133,10.43%,LIN7A;CACNB2;RAPGEF2;ROCK1;RAB8B;TSPAN15;SPTBN1;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;EHD3;ZDHHC2;NKD2;EPHA2;TSPAN17
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.4174271979378499,-0.9390874462919896,0.5498154981549815,0.8361331187497806,1.0,7/10,35.09%,AKT1;TICAM1;TLR4;MYD88;TREM2;CD36;TLR6
prerank,hyaluronan metabolic process (GO:0030212),0.3831429935553616,0.9387415694862056,0.5220883534136547,0.8742234911196795,1.0,4/23,4.24%,CEMIP2;IL1B;HYAL4;FGF2
prerank,cilium assembly (GO:0060271),0.2660773996178654,0.9383205406822573,0.5799492385786802,0.8742833903777705,1.0,54/297,17.75%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RSPH6A;RAB8B;TTLL3;CYS1;JHY;TTC36;IFT81;CCDC57;GAS8;IFT20;NEK1;PRKAR2B;SCLT1;RSPH1;LRGUK;CFAP46;FAM161A;EHD3;CSNK1E;DYNC1I2;CDC14B;KIF3A;CEP41;AHI1;IFT57;NPHP4;CCDC66;CFAP20;KIF3C;CEP97;FUZ;TUBB4A;TRIP11;TCTN3;DCTN1;CEP126;IFT80;DCTN3;MAK;CEP76;CEP19;CEP135;RAB1A;NDE1;TNPO1;TRAF3IP1;CEP162;TTC8;PTPDC1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.37067942587003666,-0.9380406363906125,0.5447154471544715,0.8380340551288276,1.0,5/16,19.90%,TMEM50A;CHMP4B;CHMP4A;LEPROT;VPS28
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3987937585130349,-0.9373957248552635,0.5425925925925926,0.8382566612917748,1.0,1/12,0.24%,IGF1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3987937585130349,-0.9373957248552635,0.5425925925925926,0.8382566612917748,1.0,1/12,0.24%,IGF1
prerank,hydrogen peroxide catabolic process (GO:0042744),0.43359598142538724,0.9371839950886404,0.5303030303030303,0.8758263181213835,1.0,2/11,7.33%,PXDN;GPX3
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3537177892911556,0.9368166552923015,0.5511669658886894,0.8758031666893845,1.0,5/44,3.09%,CARMIL1;RGCC;PPM1E;FERMT2;LIMK1
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.35430079482215787,-0.9365045392812111,0.5662650602409639,0.8397262744011467,1.0,8/20,16.62%,SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;SEMA3B;SEMA3G;SEMA6B
prerank,cellular response to radiation (GO:0071478),0.3510947817186939,0.9364024177882615,0.5209471766848816,0.8758404472534457,1.0,10/40,14.32%,TNKS1BP1;OPN1MW;OPN1MW3;LIG4;CDKN1A;RAD1;RRH;OPN3;TANK;BLM
prerank,negative regulation of establishment of protein localization (GO:1904950),0.4493020206318332,0.9361817806465889,0.47578947368421054,0.8754603618581798,1.0,2/10,3.97%,NDFIP2;CORO2B
prerank,programmed necrotic cell death (GO:0097300),-0.36593758882225674,-0.9360853388325068,0.5470588235294118,0.8401157392730397,1.0,10/18,38.60%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1;DNM1L;LY96;PPIF;CD14;CYLD
prerank,peptidyl-serine modification (GO:0018209),0.2846958095750887,0.9360796569169156,0.5664233576642336,0.8748423978202037,1.0,30/166,11.26%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;MBOAT4;GALNT13;GALNT1;MTOR;MARK2;PRKD2;NAA11;PDGFB;CSNK1E;MAP4K1;NEK6;ATR;DYRK3;BRSK1;HIPK1;LATS2;PRKX
prerank,regulation of vasculature development (GO:1901342),0.3814624794664463,0.9358307665658039,0.5310734463276836,0.8745618131763361,1.0,6/26,9.84%,NF1;ETS1;FGF2;TSPAN12;EMP2;EPHA2
prerank,protein targeting to peroxisome (GO:0006625),0.36939653137180184,0.935576434869724,0.5088757396449705,0.8742508359910103,1.0,9/29,15.58%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;LONP2;PEX12
prerank,establishment of endothelial barrier (GO:0061028),0.36930269482437506,0.9355056658376789,0.5180722891566265,0.8735664426953954,1.0,2/29,1.01%,PDE4D;RAPGEF2
prerank,response to prostaglandin E (GO:0034695),0.4552973285013041,0.9351202827083811,0.5322245322245323,0.8735422143890788,1.0,2/10,3.95%,GNG2;ADCY6
prerank,cellular response to UV (GO:0034644),0.3167892208140588,0.935017375536677,0.5344,0.8729747468166578,1.0,20/76,21.76%,PTPRK;CASP9;CDKN1A;ERCC4;ATR;EP300;OPN3;DHX36;PARP1;XPC;IMPACT;FMR1;RHNO1;MMP1;SDE2;DDB2;CREBBP;HYAL1;EIF2S1;CERS1
prerank,regulation of actin nucleation (GO:0051125),-0.4002691516889057,-0.9349720080244727,0.5355086372360844,0.8420646740034549,1.0,5/12,26.47%,GSN;ARFIP2;ARFIP1;ARPIN;PICK1
prerank,positive regulation of cation channel activity (GO:2001259),-0.30331170934329416,-0.9349699926962498,0.5665914221218962,0.8414369615606788,1.0,11/40,18.45%,ACTN2;SHANK3;CALM2;TMSB4X;LRRC38;CTSS;EPHB2;GSTM2;CALM1;ADRB2;P2RY6
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.43395051690811837,-0.9348214935976452,0.5802919708029197,0.8411729014229629,1.0,3/10,10.31%,LGALS9;PRKCZ;IL18
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.3409029690977901,0.9346628752823607,0.5225694444444444,0.8728986681594776,1.0,11/49,12.88%,MEF2C;MYL9;AGO3;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;EP300;RBM15;TNRC6B
prerank,smoothened signaling pathway (GO:0007224),-0.31443002228226924,-0.9343827479092769,0.5869120654396728,0.8415617908166486,1.0,9/32,22.43%,GLI2;SMO;GLI3;PTCH1;HIPK2;EVC2;STK36;GLI1;TMEM17
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.4016523435689774,-0.9341438697092445,0.5604838709677419,0.8414778549039174,1.0,5/12,22.09%,WNK1;AKT1;PPARA;MDK;ASS1
prerank,T cell activation involved in immune response (GO:0002286),-0.40019034495144035,-0.9340407324043606,0.5521821631878557,0.8411068823026431,1.0,4/12,26.14%,ICAM1;MDK;LCP1;EIF2AK4
prerank,positive regulation of axon extension (GO:0045773),-0.34936530734997706,-0.9339881307456703,0.5652173913043478,0.8405913141476657,1.0,10/22,22.32%,NRP1;MACF1;SEMA7A;NTN1;RUFY3;MAP3K13;ZFYVE27;MEGF8;DBN1;VEGFA
prerank,regulation of protein targeting to membrane (GO:0090313),0.3795538662732528,0.9337931290249136,0.5316205533596838,0.873820780732915,1.0,5/28,7.40%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.34241480814154146,-0.9337339946589163,0.5469387755102041,0.8405502137478895,1.0,5/22,13.40%,IL15;SLC7A5;IL18;TGFB1;SPHK1
prerank,response to insulin (GO:0032868),-0.2682724590815324,-0.9336378962692312,0.5618279569892473,0.8401522842856092,1.0,17/80,13.65%,SORBS1;RHOQ;FOXO1;ENPP1;KAT2B;HDAC9;SLC39A14;SYAP1;CPEB2;AKT1;C2CD5;INSIG2;RAB8A;USF1;LPIN3;FER;HDAC5
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.3895206346005107,-0.9334903873311923,0.5680473372781065,0.839887218948348,1.0,7/13,24.27%,ABCA1;CD9;CDH13;CD81;SYK;LPL;ITGB2
prerank,cellular response to dsRNA (GO:0071359),0.41893030903579737,0.9333793010393978,0.5169660678642715,0.8738620499947968,1.0,1/15,1.09%,COLEC12
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.35031730656368243,-0.9331606810731091,0.5669291338582677,0.8400056755537083,1.0,3/20,5.47%,SULF1;THBS1;SULF2
prerank,fat cell differentiation (GO:0045444),-0.28268925878203155,-0.9331312514977524,0.5875299760191847,0.8394401936642539,1.0,13/57,13.22%,SMAD6;OSBPL8;FOXO1;KLF4;TCF7L2;PRDM16;ERAP1;C1QTNF3;BBS7;NR4A2;METRNL;WNT5B;TMEM120B
prerank,cellular response to glucose stimulus (GO:0071333),-0.3268885229136649,-0.9327453687267682,0.5603448275862069,0.8396966267068183,1.0,8/30,15.76%,UNC13B;IGF1R;SLC39A14;GAS6;KCNB1;ERN1;RAB11FIP5;PRKAA2
prerank,transcription by RNA polymerase II (GO:0006366),0.2671000279984596,0.932726871535596,0.6005121638924455,0.874371454880456,1.0,50/305,16.45%,NOTCH3;SOX5;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2;PPARD;CLP1;ESRRA;NCBP2;LSM10;PAPOLA;NR2C1;DEK;POLR2C;PCID2;MED1;RNMT;PAX5;TBP;TAF6;MAML3;SYMPK;MED20;RPRD1B;DRAP1;THRA;CTR9;TRIP11;EAF2;PHAX;INTS1;GTF2H5;INTS12;TRIP13;CCNH;MED4;SNAPC2;RORC;MAML1;RXRB;GTF2H1;TAF5L;PARP1;GTF2E1;NFX1;HDAC10
prerank,lysosome organization (GO:0007040),-0.313823429950871,-0.9323850725735168,0.5524193548387096,0.8398742204191709,1.0,13/36,27.23%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN6;CLN5;MBTPS1;TMEM165;ACP3;MYO7A
prerank,negative regulation of cell division (GO:0051782),-0.4003697421576977,-0.9320620162228812,0.5820610687022901,0.8399914996099263,1.0,2/11,8.51%,TXNIP;ZFYVE19
prerank,regulation of ATP biosynthetic process (GO:2001169),0.4085991046486999,0.9314830942309089,0.5149700598802395,0.876074241295752,1.0,2/16,6.03%,PID1;IL4
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.43150286348318734,-0.9314586147596945,0.5637065637065637,0.8407903291900821,1.0,2/10,2.81%,APP;SHANK3
prerank,positive regulation of protein deacetylation (GO:0090312),-0.38258502924707605,-0.9313546377257974,0.5483271375464684,0.8404120781749141,1.0,4/14,23.38%,SAP30BP;FNTA;NNMT;CTBP1
prerank,photoperiodism (GO:0009648),0.3783307837048474,0.9311387349024356,0.5344827586206896,0.8759923281196542,1.0,4/28,8.10%,PER2;CRTC1;SIK1;PPP1CC
prerank,myotube differentiation (GO:0014902),0.4052342833721185,0.9309137350767769,0.5119047619047619,0.8756597257897724,1.0,3/17,3.69%,MEF2C;CACNA1H;SORT1
prerank,regulation of microtubule depolymerization (GO:0031114),0.3748359620890949,0.9300336114586947,0.5099206349206349,0.8766320625070637,1.0,7/25,13.12%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,response to glucose (GO:0009749),-0.2958895842646374,-0.9297103447201377,0.5951219512195122,0.8436102044815815,1.0,6/46,5.09%,UNC13B;THBS1;IGF1R;TCF7L2;SLC39A14;GAS6
prerank,GPI anchor biosynthetic process (GO:0006506),0.37523429734351693,0.9294112822845711,0.49812734082397003,0.8771092845083702,1.0,7/30,16.62%,PIGU;PIGO;PIGZ;DPM3;PIGH;PIGX;PGAP1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.410830257983614,0.9292901455457429,0.5165289256198347,0.8765454141455189,1.0,4/15,9.33%,DAAM2;SPEF1;GPC3;CSNK1E
prerank,amyloid-beta metabolic process (GO:0050435),-0.3744200321403507,-0.9292888148991938,0.571992110453649,0.843956361190048,1.0,6/16,24.75%,ACE;IDE;BACE2;PSEN2;APEH;NCSTN
prerank,regulation of transport (GO:0051049),-0.31088324043710897,-0.929118963013352,0.5481171548117155,0.843720353036712,1.0,8/36,16.02%,LEPR;NRP1;RAB11A;LRRK2;ACTG1;ACTB;REEP5;ARL6IP5
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.24088246006035594,-0.9290448893314357,0.6308139534883721,0.8432837591930415,1.0,57/144,28.12%,SMAD3;PPP1R13B;CEMIP;NPEPPS;TCF7L2;TFDP2;CDH1;GAS6;PRKCD;ANP32B;BAG3;KCNB1;C2CD5;CASP8;SEC16B;ZC3H12A;MAVS;TGFB1;SH3GLB1;TOMM7;SAE1;RAN;TMEM30A;PPP3CC;TM9SF4;RUFY3;LEPROT;BID;TPR;OAZ1;SAR1A;RAB29;BBC3;HPS4;CHP1;SAR1B;E2F1;CD81;YWHAH;USP36;BAP1;RIPOR1;ICE1;AKT2;ITGB2;YWHAE;XPO4;ZFAND1;AKAP5;TP53;B3GAT3;SFN;ITGAM;FZD5;HCLS1;SEC16A;TFDP1
prerank,regulation of protein acetylation (GO:1901983),0.42987741267719665,0.9288897669201501,0.5142857142857142,0.8765566468470348,1.0,8/12,29.89%,DDX3X;FAM161A;GSK3B;CAMK1;TERF2IP;RAPGEF3;CEP295;SIRT1
prerank,fatty acid catabolic process (GO:0009062),0.32301551978326243,0.9286810502435963,0.5424610051993067,0.8761945675625671,1.0,8/67,8.23%,CEL;ABCD2;SLC27A2;PPARD;HADHB;SLC27A4;ABHD3;ECI1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3684135544137073,0.9282154891545883,0.5294117647058824,0.8763419444637376,1.0,8/28,13.98%,PLEKHG2;WAS;SH3BP1;ESAM;ARHGAP35;PAK3;RASA1;ABITRAM
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.43209937345303484,-0.9281862892919265,0.5703422053231939,0.8446059425485022,1.0,2/10,7.41%,QRICH1;HSPA5
prerank,regulation of rRNA processing (GO:2000232),-0.3732669749346754,-0.9280426188868182,0.5445920303605313,0.8443218908526858,1.0,6/16,24.10%,KAT2B;SIRT7;USP36;RIOK2;NUDT16;TRMT112
prerank,phospholipid transport (GO:0015914),0.3333031753412325,0.9278691207803761,0.5446265938069217,0.8762719032368176,1.0,5/52,6.57%,PITPNC1;SCARB1;LDLR;ATP8B2;PRELID3A
prerank,myelination (GO:0042552),0.33248979877820994,0.9276574303944627,0.505338078291815,0.8758946486378925,1.0,7/46,6.51%,TNFRSF21;NF1;ABCD2;SCN2A;B4GALT6;TPPP;SCN8A
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.30863844664019,0.9273709239127533,0.5514950166112956,0.8756773639453523,1.0,14/86,11.94%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1;NAV3;BIN1;EFEMP2;NCKAP1;LMOD1;PAK1;RB1;CFL2
prerank,hepaticobiliary system development (GO:0061008),-0.34577231872723585,-0.9271236315618238,0.5836575875486382,0.8458070423822257,1.0,3/20,4.44%,TGFBR3;WNT4;LSR
prerank,actomyosin structure organization (GO:0031032),0.3184550974404105,0.9268696993404069,0.5252525252525253,0.8759296681190089,1.0,17/75,11.07%,TNFAIP1;EPB41L2;MYH9;ROCK1;CUL3;EPB41;ITGB5;CDC42BPA;TMOD1;PDCD10;TMOD3;ITGB1;PDLIM1;KCTD13;ALKBH4;LMOD1;CASQ1
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.2803872707468552,0.9265036322614473,0.5912208504801097,0.8758782908125332,1.0,29/185,16.52%,DYNLL1;HECW2;RGCC;BTRC;CUL3;PSMB11;PRKAR2B;APPL1;PSMF1;UBE2E1;CSNK1E;DYNC1I2;CDC14B;NEK6;CEP41;PSME4;TUBB4A;ANAPC2;DCTN1;ANAPC7;SKP1;DCTN3;MAD2L1;CEP76;KCNH5;XPC;PSMB5;CEP135;NDE1
prerank,positive regulation of bone resorption (GO:0045780),-0.4074056079977897,-0.9263812666359338,0.5872093023255814,0.8469489199056592,1.0,8/11,40.74%,TNFRSF11A;SPP1;SYK;ATP6AP1;PRKCA;DEF8;MC4R;ADAM8
prerank,regulation of p38MAPK cascade (GO:1900744),-0.30553592024996723,-0.9262684150985093,0.5585215605749486,0.8466124771545949,1.0,13/35,16.34%,DLG1;SASH1;XDH;EZR;LGALS9;MFHAS1;DUSP1;DAB2IP;ZC3H12A;RELL1;SPHK1;DUSP10;MAP3K4
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.32016182969637397,-0.9262313711662342,0.569672131147541,0.8460640864131377,1.0,6/29,12.45%,TGFBR3;FGFR2;SMAD7;FKBP1A;TGFB1;S1PR1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.2693623665144996,-0.9261185448962219,0.5802469135802469,0.8457007084544945,1.0,15/72,13.17%,CDH5;APOE;LIMA1;SLIT2;SHANK3;ARHGEF2;KANK3;HDGFL3;IAPP;PFDN5;PRKCD;EMILIN1;EML2;PFN1;TWF1
prerank,protein localization to centrosome (GO:0071539),-0.3709835847590077,-0.9255544326961597,0.5603112840466926,0.8463589045946821,1.0,7/17,30.06%,GOLGB1;SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.3844813349268069,0.9254026161016468,0.5241779497098646,0.877405577342148,1.0,9/22,17.43%,AKAP6;RYR2;STAC;PKD2;CASQ1;ANK2;VMP1;HTT;HAP1
prerank,regulation of axon guidance (GO:1902667),-0.4221060504900823,-0.9249012286336065,0.5559633027522936,0.8472173834611872,1.0,2/10,11.43%,NRP1;ZSWIM6
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.4146889846867867,-0.9246960297847613,0.5483271375464684,0.847087207363018,1.0,4/10,27.50%,HK2;GFPT2;GFPT1;HK1
prerank,angiogenesis involved in wound healing (GO:0060055),-0.40940171421399835,-0.9246331788490864,0.5570342205323194,0.8465948420439382,1.0,7/11,11.21%,ADIPOR2;CD34;NDNF;PRCP;KDR;GATA2;ITGB3
prerank,positive regulation of transmembrane transport (GO:0034764),-0.38335487700527393,-0.9242526737830047,0.5553398058252427,0.846857879997103,1.0,5/13,22.45%,ANO6;C2CD5;P2RX7;AZIN1;NR4A3
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.32589408551384536,-0.9240252880608747,0.5757575757575758,0.8467669069625806,1.0,8/30,21.54%,CD34;LGALS9;PRKCZ;STAT3;PLCG2;TLR4;SYK;CD274
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.38133057197720666,0.9239567622203385,0.52046783625731,0.8795844781175758,1.0,2/22,2.62%,GCNT2;IL1B
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4149234566950106,0.9235749964945627,0.5111561866125761,0.8795830230447377,1.0,3/15,7.20%,LDLRAP1;PPARD;IRS1
prerank,regulation of mRNA polyadenylation (GO:1900363),0.4060665203245053,0.9234432999280078,0.5370370370370371,0.8790565501605937,1.0,6/17,18.89%,CPEB1;NCBP2;CPSF6;CTR9;HSF1;CPSF7
prerank,cellular response to exogenous dsRNA (GO:0071360),0.4432324850239712,0.9227859570183506,0.5423728813559322,0.8795719631441712,1.0,1/12,1.09%,COLEC12
prerank,glial cell differentiation (GO:0010001),-0.3265118724431922,-0.9220871597425452,0.594704684317719,0.8506567632479196,1.0,4/28,7.32%,NFIB;ADGRG6;SLC8A3;STAT3
prerank,regulation of biomineral tissue development (GO:0070167),0.38338898438423413,0.9216888498577928,0.49795918367346936,0.8809707422890717,1.0,3/26,2.15%,HEY2;NOTCH1;ROCK1
prerank,L-amino acid transport (GO:0015807),-0.33092513242417126,-0.9215824404308238,0.5854166666666667,0.85119297833245,1.0,10/28,22.09%,SLC1A3;SLC7A2;SLC7A5;SLC38A5;SLC3A2;SLC25A22;SLC7A1;ARL6IP5;SLC36A1;SLC1A1
prerank,mRNA polyadenylation (GO:0006378),-0.3236002562166391,-0.9214930432573754,0.5979591836734693,0.8501434225139187,1.0,12/26,31.08%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,RNA polyadenylation (GO:0043631),-0.3236002562166391,-0.9214930432573754,0.5979591836734693,0.8501434225139187,1.0,12/26,31.08%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,phospholipid biosynthetic process (GO:0008654),-0.3067698352821323,-0.9211960539731312,0.5753715498938429,0.8502003223648836,1.0,3/36,2.90%,SGMS1;AGPAT4;SGMS2
prerank,regulation of proteolysis (GO:0030162),-0.2978370347306206,-0.9211806469144954,0.5793269230769231,0.8496094896311088,1.0,14/48,19.73%,CAV1;CYFIP2;LTBP4;RNF139;CST3;AKT1;CASP8;TBC1D10A;FGFR4;FBXW11;NEDD8;CLN8;PLAUR;SERPINE2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2831554402652259,0.9211337467123523,0.5684830633284241,0.8812921158643456,1.0,31/153,13.45%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;PIKFYVE;MTOR;MARK2;PRKD2;PDGFB;CSNK1E;MAP4K1;NEK6;ATR;DYRK3;BRSK1;HIPK1;LATS2;PRKX;NLK;PRKDC;RPS6KA6;MKNK1
prerank,cellular zinc ion homeostasis (GO:0006882),0.37415741714971107,0.9210579827465818,0.5488721804511278,0.8806529212511238,1.0,1/26,0.46%,SLC30A10
prerank,negative regulation of B cell activation (GO:0050869),0.39161445648647786,0.9207190031966132,0.5345528455284553,0.8805830399368229,1.0,3/21,9.11%,TNFRSF21;CD300A;LYN
prerank,protein-containing complex disassembly (GO:0032984),-0.2790546761834723,-0.92027768249548,0.6155717761557178,0.8510330477577589,1.0,11/54,21.44%,LAMP2;CAV1;LRP6;FZD2;WIPI2;UVRAG;RPL23;GABARAPL1;FZD1;VCP;VAMP8
prerank,protein modification by small protein removal (GO:0070646),-0.22236886452821292,-0.9202603190548413,0.7186147186147186,0.8504506456778573,1.0,79/252,26.95%,SMAD3;ESR1;SMURF2;USP47;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;INO80;RHOA;USP8;BIRC3;USP15;TRRAP;USP18;HGS;IL33;HIF1A;FOXK1;BECN1;USP34;ZC3H12A;USP35;USP11;USP5;PSME2;SENP3;MDM2;COPS4;USP49;PSMB4;UBB;COPS8;INO80D;ACTB;PSMB1;PSMD11;NEDD8;PSMD8;PSME3;RIPK1;ACTR8;NFKBIA;ADRB2;PSMD4;STAMBP;PSMA2;BABAM2;VCP;TAF9B;IKBKG;USP22;SNX3;PSMD3;USP36;PSMB7;BABAM1;CCP110;BAP1;USP2;PSMC2;BRCA1;USP10;PSMC5;PSMD10;COPS7A;SUDS3;ACTR5;PRKN;ABRAXAS2;TP53;CDC25A;SMAD4;SENP8;INO80E;COPS2;ATXN3
prerank,heterochromatin assembly (GO:0031507),-0.35210034892894293,-0.9196785398140925,0.5914396887159533,0.8511868824513675,1.0,7/20,22.13%,H3-3A;HDAC1;EZH1;BEND3;SIRT2;RRP8;MBD2
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.40392953775576534,-0.9194685294801077,0.58195211786372,0.8510305538477667,1.0,8/11,37.68%,PPHLN1;TPR;SETDB1;MPHOSPH8;DNMT1;SIRT6;SETDB2;TRIM28
prerank,dicarboxylic acid metabolic process (GO:0043648),0.33177924907419076,0.9192754228013166,0.5424610051993067,0.8827424105079114,1.0,6/52,9.22%,GGT1;SLC19A1;DHFR;MTHFD2;GOT1;SDHAF3
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.33983680647842873,-0.9192218408188645,0.5728952772073922,0.8509486899274117,1.0,6/23,17.80%,GPX4;GSTM1;PTGS2;EPHX2;GSTM2;ALOX12
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3818830764760098,0.9191303329459857,0.5506692160611855,0.8822683400178005,1.0,7/23,15.58%,MAP3K5;TAOK3;PAK1;TRAF6;DVL2;TRAF2;DVL3
prerank,vesicle organization (GO:0016050),-0.28143981200690205,-0.9189133448070116,0.5887850467289719,0.8510096043513381,1.0,14/46,19.11%,CAV1;FNBP1L;CD34;SRGN;USP8;ALS2;ALS2CL;CAV2;SNX10;PHETA1;ARFGEF2;ZFYVE16;SAR1A;SAR1B
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.409894240829383,0.9186684294413962,0.5525773195876289,0.8824922407475386,1.0,2/15,4.22%,NR1H3;PPARD
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4153519137064323,-0.9185555525551975,0.5849056603773585,0.8511632946828602,1.0,3/10,10.09%,KLF4;MAP2K5;IRAK3
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.28343768882737846,-0.9184813445991848,0.6111111111111112,0.8506981145514301,1.0,5/49,7.41%,LDLRAD4;SMAD6;IAPP;PRKCZ;HSPA5
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.4368859426741134,0.918413295904271,0.509594882729211,0.8813861102765544,1.0,2/11,4.10%,IL2RA;JAK1
prerank,cellular response to interleukin-2 (GO:0071352),0.4368859426741134,0.918413295904271,0.509594882729211,0.8813861102765544,1.0,2/11,4.10%,IL2RA;JAK1
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.25333126356401436,-0.9182350251920934,0.6239782016348774,0.8506614681695229,1.0,31/85,24.70%,SMURF2;MAGI2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMB1;PSMD11;PSMD8;PSME3;WNT11;ROR2;FZD1;PSMD4;PSMA2;PSMD3;PSMB7;VANGL2;AP2M1;PSMC2;PSMC5;PSMD10
prerank,positive regulation of immune system process (GO:0002684),0.3989204396341074,0.9179813385994654,0.5404255319148936,0.8814501389122403,1.0,1/16,0.77%,PIK3CD
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.37904539741601995,-0.9179415167843624,0.5767097966728281,0.8507094090015382,1.0,4/14,25.83%,GAS6;PTPN2;RFFL;PYDC1
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.4098836443868251,-0.9179191939306468,0.5617760617760618,0.8501424168872271,1.0,7/11,43.78%,TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.36205445992880675,0.9178326411589082,0.5208333333333334,0.880143922435343,1.0,7/29,15.91%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.36205445992880675,0.9178326411589082,0.5208333333333334,0.880143922435343,1.0,7/29,15.91%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,diol biosynthetic process (GO:0034312),-0.37334377513014305,-0.9177568524513198,0.5847953216374269,0.8498871082571078,1.0,5/15,14.16%,ACER2;ACER3;GCH1;SPHK1;SPTLC2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.22797980822407105,-0.9177082838391646,0.6893939393939394,0.8493710083876854,1.0,53/208,19.79%,AKAP13;LPAR1;ESR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;ZFAND6;LGALS9;WNT5A;IKBKE;RHOA;PRKCB;PLK2;STAT1;FKBP1A;TFRC;BIRC3;EEF1D;TNFRSF19;ECM1;TNFRSF1A;TLE1;CASP8;DAB2IP;ZC3H12A;TRIM27;MAVS;OPTN;PLEKHG5;RELA;TRIM39;PLCG2;TICAM1;VAPA;PPM1B;PELI1;TRIM8;RIPK1;TRAF3IP2;MAP3K3;PDPK1;CC2D1A;RHOH;TRIM14;LAMTOR5;CANT1;PIM2;EDA2R;LGALS1;IKBKG;RHOC
prerank,protein lipidation (GO:0006497),0.32797530421990984,0.9176350155371423,0.5580589254766031,0.879763064186068,1.0,13/59,14.22%,PIGU;ZDHHC14;PIGO;ZDHHC1;ZDHHC2;PIGZ;ZDHHC16;DPM3;ZDHHC17;ZDHHC21;ZDHHC23;HHAT;PIGH
prerank,folic acid metabolic process (GO:0046655),0.3944307503743369,0.9174716535394432,0.5098425196850394,0.8793152315921142,1.0,3/18,7.42%,SLC19A1;DHFR;MTHFD2
prerank,positive chemotaxis (GO:0050918),-0.3627146004866319,-0.9174475576406843,0.5754716981132075,0.8493143833764313,1.0,3/17,3.53%,NRP1;PTPRJ;ANGPT1
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3966089752383924,-0.9173219774703807,0.6074074074074074,0.8489687109952441,1.0,8/13,35.05%,MDM2;SNAI1;PSMD10;CD44;TWIST1;PTTG1IP;KDM1A;CD74
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.25140633894964093,0.9157631323645952,0.6611177170035671,0.8821009182141,1.0,81/497,14.20%,PTPRK;KCTD1;TBX2;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NRG1;NR1D2;NAB1;CBX5;PHC3;PHC2;MECP2;PPARD;DHFR;PHC1;HEXIM1;TFAP2B;IL4;ARID5A;DDX3X;SFPQ;CBX3;KAT7;CDKN1A;NANOS1;TRIM33;MYB;NR2F2;RUNX2;CCAR2;PDGFB;MTERF3;CNOT9;TIMELESS;PSPC1;ATR;EID1;RLIM;CITED2;NKX6-2;MALSU1;WAPL;KAT6A;SFMBT2;LOXL3;SAMD13;RB1;RBM15;SPEN;BCLAF1;RCOR1;FOXS1;THRA;SET;TRAF6;CRY1;CDAN1;TSC22D4;DMAP1;CNOT10;PAIP2;LSM14A;NIPBL;SFRP2;CIART;SIX4;PUS7;RAD17
prerank,negative regulation by host of viral process (GO:0044793),-0.4161869020973923,-0.9157130358502844,0.591254752851711,0.8519489540075075,1.0,4/10,26.14%,ZC3H12A;VAPA;PRKN;EIF2AK4
prerank,response to cAMP (GO:0051591),-0.2999465024757867,-0.9156872041205832,0.6055045871559633,0.8513891853362849,1.0,10/37,14.05%,IGFBP5;EZR;RAP1B;STAT1;RAPGEF1;KCNQ1;AKAP9;AHR;SLC5A5;NDUFS4
prerank,tetrahydrofolate metabolic process (GO:0046653),0.44681642483075223,0.9153067926241604,0.5497835497835498,0.8822138086873645,1.0,2/10,7.42%,DHFR;MTHFD2
prerank,melanocyte differentiation (GO:0030318),0.43215320042964106,0.915241949467741,0.5365296803652968,0.881534430738259,1.0,2/11,3.79%,MEF2C;MREG
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.40617916842752444,0.9151840493879038,0.5427974947807933,0.8808538647257418,1.0,2/14,4.99%,IL1B;CARD9
prerank,regulation of protein localization to membrane (GO:1905475),0.3534652808062028,0.914943091768969,0.52734375,0.8805786624500649,1.0,9/28,13.36%,LDLRAP1;SPTBN1;GPC5;GPC3;APPL1;PDZK1;ZDHHC2;NECAB2;VTI1B
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.2548611446510484,-0.9148542602024022,0.6131578947368421,0.8526170043488142,1.0,15/98,10.08%,SORBS1;EPHA3;EGFR;PPP1R13B;PRKCH;CEMIP;DLG1;TFDP2;ITGA3;PRKCE;STX3;AKT1;KCNB1;C2CD5;CASP8
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2837043508097823,-0.914679146546303,0.6139534883720931,0.8523967318826852,1.0,20/54,31.36%,NSA2;SDAD1;RPL11;PAK1IP1;RPL24;RPL14;RPL26;RPL10;RPL7;RPL10A;EBNA1BP2;RPLP0;MRPL1;RPL35A;RRS1;NHP2;MAK16;RPF1;HEATR3;RPL23A
prerank,regulation of transferase activity (GO:0051338),-0.36016160284730875,-0.9145872880798787,0.5615384615384615,0.8519952095828766,1.0,5/17,19.15%,SMG6;PINX1;NLRC5;ATM;PPP1R3F
prerank,regulation of cellular component organization (GO:0051128),0.290165870604164,0.9133534461957176,0.5761194029850746,0.8829878142124118,1.0,28/135,14.56%,PLCE1;RAPGEF2;RASGRP2;BCAR1;ROCK1;STK38L;NRG3;RIT2;ROS1;RAP1A;MTOR;AP2S1;PAK5;ALKBH4;ERMN;HIP1;NCLN;CAMSAP3;ABL2;SPOCK1;PACSIN3;SLITRK2;PTPN1;HNRNPU;TRAF2;URI1;RAB5A;ANKRA2
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3055716835656361,-0.9132923234550772,0.5746102449888641,0.8542198557051583,1.0,9/36,8.23%,PLCB1;TCF7L2;NFATC1;LEF1;FZD2;MOV10;WNT5A;PLCB3;FZD4
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.43105566007879736,0.9128899807386786,0.5410526315789473,0.8831130127579141,1.0,6/10,22.21%,CBARP;GPR35;FMR1;GNB5;CALM3;DRD2
prerank,positive regulation of cartilage development (GO:0061036),0.3956928918406195,0.912727616381338,0.5390781563126252,0.882650993366953,1.0,1/17,0.56%,SOX5
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37074450613857296,-0.9126959425436761,0.5745454545454546,0.8548893190468877,1.0,8/15,30.32%,CNOT7;CPEB3;TNRC6A;TENT4B;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3139477668552189,0.9122871731824038,0.5402843601895735,0.8827586910436456,1.0,10/74,12.13%,LIMD1;NOTCH1;RBX1;EPAS1;PSMB11;PSMF1;ARNT;CITED2;EP300;PSME4
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4229659260611472,0.9118977871102636,0.5357142857142857,0.8827871655711058,1.0,3/12,6.28%,IL1B;TAFA3;TTBK1
prerank,glycosaminoglycan metabolic process (GO:0030203),0.3240523820635883,0.9106174057267987,0.5419463087248322,0.8845255989033387,1.0,8/54,6.34%,GCNT2;SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.39714542281888654,0.9105843630758734,0.5402061855670103,0.883806579205235,1.0,3/15,6.95%,SCARB1;ABCA5;LIPC
prerank,regulation of cellular protein localization (GO:1903827),0.33838805143354517,0.9101613181807624,0.5615942028985508,0.8838539485169762,1.0,12/45,17.55%,MAP2;GPC5;GPC3;CSNK1E;CCDC66;PTPN1;PRKAA1;TRIM46;DVL3;PARP1;TOR1A;TRIM67
prerank,regulation of vacuole organization (GO:0044088),0.39551742598647144,0.9100063848124548,0.5379876796714579,0.8834024861798968,1.0,9/20,18.62%,IFT20;TBC1D12;PIKFYVE;NPRL3;NPRL2;UBQLN2;RAB5A;RAB1B;ENO2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.28123500428918835,0.9095955934386359,0.592274678111588,0.8834803307176193,1.0,24/159,8.63%,ADGRL3;CDH2;CDH4;CLDN10;CLDN15;PCDHB11;LRRC4C;ATP2C1;LRFN5;IGSF11;CNTN4;ITGB1;CDH8;CDH22;CRB1;CDH20;CDH19;CDH7;CNTN6;PTPRT;ROBO2;TENM4;IL1RAPL1;SLITRK1
prerank,cochlea morphogenesis (GO:0090103),0.4320498625786069,0.9093466618338292,0.5406593406593406,0.8831967499437758,1.0,5/10,20.13%,MYO3B;TBX18;HPN;PAX2;HOXA1
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.34229160351033694,0.9092848876643308,0.5732600732600732,0.8825439792869002,1.0,5/43,5.74%,PDGFRB;RBPMS2;LDLRAP1;FGF2;HTR1B
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3370735748964791,-0.9091839457601834,0.6027131782945736,0.8621236223609764,1.0,2/20,1.64%,DAB2;RHOQ
prerank,Golgi to lysosome transport (GO:0090160),0.4324142855434887,0.9091614491268959,0.5379609544468547,0.882026320425838,1.0,4/11,12.86%,SORT1;AP1G1;EHD3;ANKFY1
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3628727455740421,-0.9091423534999362,0.5872420262664165,0.8615738396261193,1.0,6/15,25.83%,NYNRIN;ZC3H12A;DICER1;NUDT16;ZC3H12B;POP1
prerank,negative regulation of lymphocyte activation (GO:0051250),0.38247213425595483,0.9088794001384649,0.5390781563126252,0.8818429800761679,1.0,2/21,3.86%,PTPN22;PAG1
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.41188415951552837,-0.9087976650363109,0.581056466302368,0.861727602147908,1.0,6/10,35.16%,HDAC5;PIH1D1;BRCA1;SMAD4;SPHK2;CHEK1
prerank,positive regulation of DNA metabolic process (GO:0051054),0.32529652890910654,0.9085136714615303,0.5929824561403508,0.8818000113499495,1.0,9/61,10.14%,PDGFRB;RGCC;MECP2;FGF2;FGF10;EYA3;PRKD2;PDGFB;TOX
prerank,organonitrogen compound catabolic process (GO:1901565),0.32442484889770795,0.9082859600894188,0.5628318584070796,0.8814654140977852,1.0,8/57,8.14%,ENPEP;CTH;ANPEP;TXN2;LIPC;PPT1;TRHDE;MTOR
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.4376152425487537,0.9075550079833042,0.559652928416486,0.8821889887441,1.0,2/11,3.80%,MERTK;AXL
prerank,histone H2A ubiquitination (GO:0033522),0.39037039955413105,0.9074949371369484,0.5601577909270217,0.881558714439628,1.0,8/17,21.96%,RYBP;UBR2;KDM2B;SKP1;TRIM37;UBE2B;DDB2;UBE2A
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.31228227025164657,-0.9070290435548786,0.6016771488469602,0.8650260064000077,1.0,7/31,22.38%,RBP4;TFRC;EPHB2;SHLD1;KMT5C;XBP1;CLCF1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.37634360546675427,0.90686103020686,0.5461847389558233,0.882083033282829,1.0,7/23,18.38%,METAP2;GUCY2D;PDE6A;GRK4;GUCY2F;SAG;METAP1
prerank,response to nutrient levels (GO:0031667),0.3942986472650706,0.9067978144229282,0.5410821643286573,0.8814342694185143,1.0,4/17,17.36%,UCN2;MTOR;PRKAA1;RPS6KB1
prerank,protein kinase A signaling (GO:0010737),-0.38795302321597547,-0.9065098491010917,0.5789473684210527,0.8655769231807967,1.0,8/12,41.91%,EZR;PRKACB;LCP1;RDX;PRKACA;RAB13;TCP11X2;TCP11
prerank,cell differentiation in spinal cord (GO:0021515),0.4280376498210399,0.9064716117192873,0.5655021834061136,0.881340729320233,1.0,4/10,12.91%,SOX4;MDGA2;SOX6;ZC4H2
prerank,negative regulation of gluconeogenesis (GO:0045721),0.41583937120735237,0.906469047971648,0.5303030303030303,0.8805710880484102,1.0,4/11,13.27%,SIK1;GCK;EP300;CRY1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.26114196557168345,-0.9060612821045394,0.6459948320413437,0.8659858385028564,1.0,13/76,13.40%,HDAC4;CAV1;ANGPT1;LRRK2;SMAD7;FKBP1A;BIRC3;ZC3H12A;PHF23;FANCI;SAE1;UBB;SPHK1
prerank,regulation of viral entry into host cell (GO:0046596),0.361166497804703,0.9059822157994902,0.555984555984556,0.8807730950317999,1.0,4/30,8.52%,TMPRSS4;MID2;TRIM62;TMPRSS2
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.38986026054935735,0.9059173807283007,0.555992141453831,0.8801395342284188,1.0,5/21,7.70%,KCNE4;CACNA2D1;SCN5A;CACNA1D;KCNE5
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4263725064910639,0.9059124229975046,0.5541666666666667,0.8793784620111267,1.0,2/13,6.03%,PID1;IL4
prerank,regulation of response to external stimulus (GO:0032101),0.2872851221234227,0.9057650490944827,0.5866261398176292,0.878916491365007,1.0,8/121,3.73%,ACE2;GGT1;SPAAR;IL1RL2;METAP2;PTPN22;NR1D2;GUCY2D
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.42146892655367224,0.905515580341291,0.5507900677200903,0.8778995433448216,1.0,11/11,57.88%,CCT7;CCT3;LARP7;DKC1;TCP1;CCT6A;CCT4;MEPCE;CCT8;CCT2;CCT5
prerank,regulation of protein localization to Cajal body (GO:1904869),0.42146892655367224,0.905515580341291,0.5507900677200903,0.8778995433448216,1.0,11/11,57.88%,CCT7;CCT3;LARP7;DKC1;TCP1;CCT6A;CCT4;MEPCE;CCT8;CCT2;CCT5
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3185815807171034,-0.9054438779517967,0.579957356076759,0.8666795959611038,1.0,8/29,24.96%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;LSM7
prerank,inositol phosphate biosynthetic process (GO:0032958),0.41891903496959026,0.9051813285442589,0.5192743764172335,0.8777956793790803,1.0,4/11,15.48%,FGF2;ITPKB;IPMK;IPPK
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.42032432259443725,0.90497376254245,0.5408388520971302,0.877446806389336,1.0,2/12,2.06%,HEYL;NODAL
prerank,cellular amide metabolic process (GO:0043603),-0.24835474384771147,-0.904788997031455,0.6648501362397821,0.86749974942781,1.0,25/102,20.02%,AEBP1;PLPP3;PCCA;ST3GAL1;CPE;SMPD3;ACOT11;NAAA;NSMAF;PCCB;CPXM2;SLC5A6;CPXM1;ALDH1L1;PLPP1;PLA2G15;NNMT;ACOT6;ACOT9;FPGS;CLN8;NIT1;ORMDL3;GNE;CPD
prerank,response to reactive oxygen species (GO:0000302),0.32323017844849433,0.9042132598342755,0.6054421768707483,0.87823370402559,1.0,3/54,4.18%,PTPRK;NCF1;PDCD10
prerank,cellular response to oxidative stress (GO:0034599),0.28841908814978073,0.9030692351929437,0.6208955223880597,0.8797168818148775,1.0,12/118,9.02%,PTPRK;PLA2R1;NCF2;PRR5L;NCF1;SOD3;SNCA;MSRA;GPX3;ARNT;HTRA2;PKD2
prerank,negative regulation of metabolic process (GO:0009892),0.3250158546177998,0.9029396060778829,0.5831903945111492,0.8792184922364721,1.0,4/54,2.62%,PLCL1;NOTCH1;NR1H3;IL1B
prerank,actin polymerization or depolymerization (GO:0008154),0.32499161770743457,0.9028833662750932,0.5801393728222997,0.8785777918853059,1.0,7/50,3.93%,ARHGAP6;WASF3;WAS;CORO7;ABI2;SPIRE1;WASL
prerank,polarized epithelial cell differentiation (GO:0030859),-0.38043403350062643,-0.9027962248753636,0.5928853754940712,0.8712738067637604,1.0,7/13,28.85%,EZR;RHOA;MYO9A;OPHN1;ZDHHC7;SCRIB;RAP2A
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3123792404666161,-0.9016799883950866,0.6091703056768559,0.8731927654345147,1.0,9/31,24.96%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;POLR2G;LSM7
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.258212239775132,-0.9011834578286141,0.6347607052896725,0.8736339546451575,1.0,29/80,22.31%,SGSM2;SNX6;TRAPPC10;SNX32;ERC1;VPS50;STX6;TRIM27;VPS35;LMAN1;RAB7A;TBC1D10A;EVI5;RGP1;SURF4;WASHC1;PHETA1;HEATR5A;RAB29;RAB6A;VPS52;SNX8;SNX3;SPAG9;TMED9;TBC1D14;RNF126;CLN5;SNX2
prerank,regulation of isotype switching (GO:0045191),-0.374436764116417,-0.9011718760005568,0.5949367088607594,0.8730295494670998,1.0,4/14,14.39%,TFRC;PARP3;SHLD1;KMT5C
prerank,receptor metabolic process (GO:0043112),-0.2788302192296987,-0.9008955207376803,0.6325581395348837,0.8730239577189044,1.0,17/53,19.92%,CAV1;CALCRL;RAMP2;CD9;DNM3;SMURF1;TFRC;BECN1;TGFB1;SH3GLB1;GRK2;UVRAG;PHETA1;ARFGEF2;REP15;CD81;SYK
prerank,histone H2A acetylation (GO:0043968),-0.36075097361937825,-0.9006073605444959,0.5962264150943396,0.8730215649967443,1.0,7/16,28.35%,TRRAP;MEAF6;NAA40;MORF4L2;BRD8;EPC1;SPHK2
prerank,negative regulation of telomere maintenance (GO:0032205),-0.36661910540912435,-0.9005413564512619,0.6045627376425855,0.8725631798465262,1.0,7/15,23.51%,TNKS2;SMG6;PINX1;ATM;RAD50;SLX4;ERCC1
prerank,long-chain fatty acid import into cell (GO:0044539),0.4287400710323944,0.9005070180749387,0.5456570155902004,0.8825633524763479,1.0,5/10,21.36%,SLC27A2;SLC27A4;SPX;RPS6KB1;ACSL1
prerank,male gonad development (GO:0008584),-0.3020274126051834,-0.9004824802474815,0.6400862068965517,0.872057649514696,1.0,11/34,29.06%,WNT4;AR;WNT5A;KIT;GATA6;NCOA4;CSDE1;COL9A3;ADAM21;BIK;WNT2B
prerank,cellular response to fluid shear stress (GO:0071498),0.4295252419977274,0.9003665442917793,0.5695652173913044,0.8820808782706847,1.0,3/12,9.02%,MEF2C;SREBF2;PKD2
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.42952852875852143,0.9001121483526405,0.5582417582417583,0.8817994797445052,1.0,4/10,14.37%,BEGAIN;DLGAP2;NPTXR;DLGAP1
prerank,regulation of microtubule-based process (GO:0032886),0.3469685818287932,0.8996393700996733,0.575187969924812,0.8819923652190444,1.0,15/36,18.48%,PHLDB2;ROCK1;CLASP2;TPPP;MARK2;BICD2;CAMSAP3;APC;PHLDB1;PRKAA1;MAP10;CDK2AP2;TRAF3IP1;GSK3B;MARK4
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.3223399209665402,0.8995928425551255,0.5724258289703316,0.8813233706218867,1.0,18/57,16.77%,MEF2C;BEGAIN;CACNG7;MINK1;GRIA2;NETO1;GRIN2B;DLG2;GSG1L;DLGAP2;DLG3;NPTXR;DLGAP1;SHISA8;GRIN2A;GRIA1;GRIA4;SHISA6
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.43909766191040794,0.8994071793793431,0.5555555555555556,0.8801613288200008,1.0,1/10,0.85%,CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),0.43909766191040794,0.8994071793793431,0.5555555555555556,0.8801613288200008,1.0,1/10,0.85%,CBFA2T3
prerank,protein ubiquitination (GO:0016567),-0.20625536633519095,-0.8991639953995039,0.8698630136986302,0.8743398496951887,1.0,113/471,21.98%,RNF220;FBXL7;PDZRN3;SH3RF1;RNF213;SASH1;HERC6;NPEPPS;SMURF2;FBXO10;RNF38;RNF146;ZNRF1;ASB2;TAF1;RNF43;TRIM24;SPSB1;RNF19A;ARRB1;TNKS2;WWP2;RNF144B;HIF3A;RNF139;SMURF1;CDC16;KLHL2;SH3RF3;SH3RF2;RNF103;AMFR;UBE2E2;LNPEP;RTF1;RC3H2;NHLRC3;CHFR;MKRN2;RNF185;DTX3L;HIF1A;KCTD10;RNF135;MGRN1;ZNRF3;ARRDC1;TRIM27;USP5;PSME2;UBE4B;CUL4A;ASB5;RNF125;MDM2;TRIM63;PSMB4;UBE2Q2;FBXW11;TRIM35;BRAP;UBB;RNF181;TRIM39;ELOB;UBE2G2;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;DTX1;TRIM17;RNF115;WWP1;FBXL14;ANKIB1;FBXL2;PSME3;RNF187;ASB1;RNF40;PELI1;UBE3D;FBXL19;SPSB4;SPSB2;ANAPC16;ARRDC4;PSMD4;LONRF1;TRIM14;TRIM47;PSMA2;TRIM41;FBXO41;VCP;USP22;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RMND5A;RNF126;PSMB7;GAN;ELOC;CUL5;RBBP6;RNF182;CUL9;DZIP3
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.3525789459217846,-0.8991277510682695,0.5909090909090909,0.8738075238609128,1.0,4/19,10.61%,PTPRJ;VCAM1;ADGRL1;KDR
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.3766333786547899,-0.8981032994840252,0.6138059701492538,0.875403983811394,1.0,8/14,39.05%,HSPA5;BCL2L11;DAB2IP;TMEM33;BFAR;FICD;BAX;UFL1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.3648759579732218,0.8977530708734143,0.564453125,0.8826964335974065,1.0,9/26,14.44%,HEYL;NODAL;CNOT2;VPS18;CNOT9;VPS11;KANK2;CRY1;STRN3
prerank,chromatin assembly or disassembly (GO:0006333),-0.38654570677934175,-0.8970925460842237,0.6127819548872181,0.8770188312035366,1.0,1/11,2.35%,HDAC8
prerank,protein localization to lysosome (GO:0061462),-0.31810770161027535,-0.8970734562644952,0.6434599156118144,0.8764508106498656,1.0,12/28,30.52%,HGS;AP4M1;RAB7A;ZFYVE16;LAMTOR5;SH3BP4;CD81;KPTN;NCOA4;ATP13A2;LAPTM5;NEDD4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.43303996439916204,0.8967608843154231,0.5548523206751055,0.8839331284899449,1.0,2/10,7.30%,ATP1A2;BIN1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.35846152287883326,-0.8967542153328603,0.6057142857142858,0.8765205674419336,1.0,3/17,3.26%,OSR1;CAV1;MAFG
prerank,neutrophil chemotaxis (GO:0030593),0.3250855009479741,0.8962050539682265,0.6098418277680141,0.8842867174230662,1.0,6/53,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.25654907617104356,-0.8958568570007034,0.681265206812652,0.8778268044029244,1.0,13/73,14.30%,EGFR;NTRK3;APP;CAV1;GAS6;FNIP1;TFRC;AKT1;IRGM;AKAP9;TGFB1;TXN;HSP90AB1
prerank,neuron remodeling (GO:0016322),-0.4037877717783225,-0.8958491993711878,0.5898876404494382,0.8772221884852033,1.0,3/10,9.74%,APP;ANKS1A;EPHA8
prerank,copper ion transport (GO:0006825),-0.3869225556822469,-0.8952903780935809,0.5948434622467772,0.8777836006037311,1.0,2/11,5.21%,STEAP3;ATOX1
prerank,mitochondrion localization (GO:0051646),0.39097111246028227,0.8951997424942792,0.5362595419847328,0.8855206799126468,1.0,6/19,17.43%,MARK1;MARK2;TRAK1;TRAK2;MFN1;HAP1
prerank,homeostasis of number of cells (GO:0048872),0.4232520327706004,0.8941092912198622,0.5833333333333334,0.8869843168338386,1.0,2/12,4.99%,NOTCH1;CARD9
prerank,vitamin transport (GO:0051180),-0.3107826724630352,-0.8940823725234702,0.6021052631578947,0.8798289229009343,1.0,10/29,25.92%,PDPN;ABCG2;CUBN;SLC5A6;SLC35F3;SLC52A3;SLC19A2;SLC52A1;CD320;SLC25A32
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.31379919047914623,-0.8938449036139582,0.6309794988610479,0.879721360547221,1.0,7/32,14.11%,FOXO3;APP;PRKCD;ATXN2;TCOF1;RPL10;GEMIN5
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.30463085728036465,0.8931630651183439,0.6026711185308848,0.8881207320324299,1.0,6/76,3.29%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.4332133038372372,0.8928482778343412,0.5777777777777777,0.887978256453013,1.0,4/10,17.06%,CCAR2;ETAA1;CRY1;RPA2
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.25177991523964466,-0.8925789017534042,0.6906666666666667,0.8818801208889676,1.0,35/85,28.30%,DAB2;NUPR1;LRRK2;SMAD7;TAF1;RNF19A;RNF144B;SH3RF2;RNF185;BBS7;DAB2IP;USP5;ECSCR;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;RNF19B;PSMC2;PSMC5;PSMD10;RACK1;PRKN;ATXN3;CEBPA;TRIB3;HSPA1B;CLU
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.3206206359343122,0.8923618579402703,0.5842490842490843,0.8881970398560722,1.0,13/52,11.14%,PIK3R1;PTPN9;GPER1;ATP2C1;SPTBN1;DPP10;ITGB1;STAC;ZDHHC2;NKD2;EPHA2;STX4;RANGRF
prerank,regulation of kinase activity (GO:0043549),0.30131408183365427,0.8920084295524562,0.6046153846153847,0.8881245818609343,1.0,19/89,13.28%,PDGFRB;PLCE1;ROR1;MERTK;ERBB4;AXL;RYK;ROS1;NTRK2;EMP2;ANKRD54;EPHA2;EPHA10;RBL1;RB1;EPHB1;FGFR3;NPRL2;HNRNPU
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.29636397245386664,0.8918333188535509,0.6035031847133758,0.8877240587123597,1.0,17/100,10.67%,GLMN;CBFA2T3;PABIR1;RBX1;RYBP;SOCS5;OGT;TRIB2;DESI1;RCHY1;ZER1;GNA12;CCAR2;DET1;CSNK1E;NKD2;XPO1
prerank,regulation of telomere capping (GO:1904353),-0.3240873973140279,-0.8918087149265863,0.6182170542635659,0.8829292031231256,1.0,6/23,16.34%,TNKS2;SMG6;ATM;MAPK3;RAD50;MAP3K4
prerank,histone H4-K16 acetylation (GO:0043984),0.3765290818292427,0.891368394602,0.5596707818930041,0.8879003597740734,1.0,8/19,19.14%,OGT;KAT7;KANSL3;KANSL1;KMT2A;MSL2;MCRS1;WDR5
prerank,regulation of dephosphorylation (GO:0035303),-0.3590540650507611,-0.8910904041010851,0.6135084427767354,0.8838663791447714,1.0,6/15,23.86%,SMG6;PPP1R16B;MTMR3;SMG5;CDK5RAP3;INPP5K
prerank,spliceosomal complex assembly (GO:0000245),-0.28369660435788147,-0.8909837324148653,0.636986301369863,0.8834819783688548,1.0,14/46,27.76%,CELF2;LUC7L;SRSF10;SNRPD1;SNRPD2;SRSF6;SRPK1;SRSF5;SF3A3;CELF5;SRPK2;PUF60;PRPF19;SNRPE
prerank,natural killer cell activation (GO:0030101),0.3729226002150684,0.8907628748324748,0.5626168224299065,0.8883282034308102,1.0,4/23,10.14%,PIK3CD;AXL;KAT7;TOX
prerank,heart process (GO:0003015),-0.3719629909768294,-0.8906810462660264,0.6222664015904572,0.8835132145691101,1.0,2/14,5.88%,SGCD;ACE
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.29373656021688893,-0.8906719157409166,0.6415094339622641,0.882914723287926,1.0,13/38,24.22%,ESR1;STAT1;TLE1;CASP8;DAB2IP;ZC3H12A;TRIM39;PPM1B;RIPK1;RHOH;ZMYND11;MAPKBP1;USP10
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.3653408040947481,-0.8903892386657402,0.6033834586466166,0.882888109422901,1.0,2/14,6.31%,IGF1;TNFRSF1B
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3013341915936124,0.8902398321977805,0.6022012578616353,0.8886275885081477,1.0,14/87,12.13%,PTEN;CDK6;RGCC;RBX1;MYO16;PSMB11;PSMF1;CDKN1A;PKD2;KANK2;RBL1;RB1;APC;PSME4
prerank,zinc ion homeostasis (GO:0055069),0.3623057167117367,0.8897973353701408,0.5985130111524164,0.8887109641215359,1.0,1/28,0.46%,SLC30A10
prerank,cell projection organization (GO:0030030),-0.31304635477047105,-0.8895230377236006,0.6517094017094017,0.8840814033105246,1.0,3/30,3.44%,GSN;RHOQ;PARVB
prerank,protein maturation (GO:0051604),0.29095233384378305,0.8891547680631221,0.6309341500765697,0.8892171894294661,1.0,8/95,5.31%,TMPRSS4;CPM;METAP2;ADAM19;TSPAN15;ECE1;TASP1;OGT
prerank,regulation of trophoblast cell migration (GO:1901163),0.4080547382802833,0.8891254100547699,0.5798687089715536,0.8885118727427315,1.0,4/14,8.05%,NODAL;SYDE1;YTHDF3;ARHGDIB
prerank,cognition (GO:0050890),-0.28683353935205386,-0.8891052585422637,0.6645833333333333,0.8843564053144084,1.0,6/42,8.16%,ST3GAL4;CHD7;APP;SOBP;SHROOM4;STRA6
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3928124571844663,0.8890178834036522,0.5548387096774193,0.887964776334245,1.0,3/17,6.95%,NR1H3;SORT1;LIPC
prerank,negative regulation of protein modification process (GO:0031400),0.2973501254380768,0.8889319643607513,0.6031746031746031,0.8873713944484821,1.0,5/79,3.06%,PTEN;DMD;PID1;PRR5L;CADM4
prerank,positive regulation of protein kinase activity (GO:0045860),0.2770076206632173,0.8886261500106675,0.6510263929618768,0.8872348162949677,1.0,29/148,13.16%,IL34;RAPGEF2;PTK2;AGAP2;DOK7;GRM5;PDCD10;MINK1;SPDYA;TTBK1;SNCA;DDX3X;TAOK3;EMP2;RAP1A;PAK6;CDKN1A;STK3;MARK2;MAP4K4;PDGFB;PAK5;PAK3;ETAA1;PAK1;SRC;DLG3;TRAF6;PTPN1
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.27805605698985786,-0.8881327775389244,0.6444444444444445,0.8858240644065004,1.0,18/46,29.72%,HK2;AIFM1;AKT1;TOMM7;GDAP1;DNAJC15;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;TIMM9;TIMM44;HK1;TIMM50;TIMM10;TSPO
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.39841833570322904,-0.8879820511033618,0.627151051625239,0.885536652003831,1.0,3/10,8.75%,APOD;LRCH1;AKT1
prerank,receptor internalization (GO:0031623),-0.2857267113681464,-0.8877743429080877,0.634703196347032,0.8853366436369926,1.0,8/44,7.75%,CAV1;CALCRL;RAMP2;CD9;DNM3;ARRB1;SCYL2;TFRC
prerank,female gonad development (GO:0008585),-0.3390612086705417,-0.8877320415216139,0.621301775147929,0.8848157831977628,1.0,8/19,28.25%,KIT;EIF2B2;CEBPB;VEGFA;EIF2B5;FOXL2;COL9A3;EIF2B4
prerank,eye photoreceptor cell differentiation (GO:0001754),0.40881634541062356,0.8872915570492462,0.5602536997885835,0.8891261301461112,1.0,1/12,0.82%,RORB
prerank,positive regulation of neuron death (GO:1901216),-0.28245221168785417,-0.8872618604263574,0.6703056768558951,0.8852231519841081,1.0,5/46,6.25%,EFNB2;EPHA7;FOXO3;NUPR1;WNT5A
prerank,regulation of leukocyte migration (GO:0002685),-0.3521518225157638,-0.8871882290146208,0.6153846153846154,0.8847617603782907,1.0,8/16,38.15%,ANXA1;RHOH;CD81;VEGFA;NCKAP1L;HMOX1;BST1;RAC2
prerank,regulation of primary metabolic process (GO:0080090),-0.23433659563330664,-0.8871502564249173,0.7376543209876543,0.8842251972081989,1.0,38/126,24.70%,ROCK2;TBL1XR1;APOE;CHD9;CARM1;ACACA;PSAP;PSME2;NFYC;TNFAIP8L3;FGFR4;PLPP1;PPARA;ID2;PSMB4;PRKAB1;PSMB1;PSMD11;IDI1;PSMD8;SREBF1;PSME3;ZFP69;ODC1;NFYB;OAZ1;PSMD4;PSMA2;ACACB;PSMD3;ADIPOR1;PSMB7;SIN3A;AZIN1;PSMC2;HELZ2;PSMC5;PSMD10
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.3047466047700052,-0.8868848096979465,0.6185344827586207,0.8842189432541577,1.0,10/32,24.17%,FOXN3;RINT1;TAOK2;ATM;TRIM39;FZR1;BABAM2;CDK5RAP3;BABAM1;BRCA1
prerank,cellular response to hormone stimulus (GO:0032870),0.3138529626715486,0.8863782489037816,0.613126079447323,0.8901535678126631,1.0,10/69,9.43%,MEF2C;ATP1A2;GPER1;CACNA1H;SLIT3;NCOA3;ARID5A;ROBO2;GCK;MED1
prerank,positive regulation of leukocyte migration (GO:0002687),0.35913868564561097,0.8863004057305558,0.5822306238185255,0.8895588247755465,1.0,4/27,9.00%,JAM3;PTN;IL4;MIA3
prerank,protein stabilization (GO:0050821),-0.22552480772676228,-0.8859763457528897,0.7718120805369127,0.8856059222737965,1.0,56/168,28.91%,IGF1;EPHA4;ATP1B3;LAMP2;PLPP3;RASSF2;SMAD7;TAF1;STXBP4;PRKCD;BAG3;IRGM;FLOT2;RAB21;RPL11;PFN1;WDR81;CALR;TRIM39;SOX17;HYPK;HSP90AB1;PARVA;RPL23;SUGT1;RPS7;PARK7;HPS4;CHP1;MT3;PIM2;PPARGC1A;RABL3;GET1;TAF9B;USP36;TYROBP;BAG2;TMEM88;IFT46;MCM8;USP2;CHEK2;ZSWIM7;CDK7;PRKN;GNAQ;BAG5;MSX1;CRTAP;SEC16A;HSPA1B;MORC3;CLU;SYVN1;BAG1
prerank,L-glutamate transmembrane transport (GO:0015813),-0.41297077477122823,-0.8859551375110595,0.6432532347504621,0.8850301139049027,1.0,4/10,22.09%,SLC1A3;SLC25A22;ARL6IP5;SLC1A1
prerank,granulocyte differentiation (GO:0030851),0.3795581215143526,0.8858733314438401,0.5622489959839357,0.8896438074524893,1.0,4/18,11.61%,CBFA2T3;CDKN1A;DEK;EP300
prerank,regulation of presynapse assembly (GO:1905606),0.3875420889371872,0.8856241183427292,0.5732484076433121,0.8886277873250709,1.0,6/18,12.82%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,regulation of presynapse organization (GO:0099174),0.3875420889371872,0.8856241183427292,0.5732484076433121,0.8886277873250709,1.0,6/18,12.82%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,negative regulation of protein polymerization (GO:0032272),-0.3137196444390165,-0.8853957405223796,0.6306122448979592,0.8856780342904732,1.0,7/27,13.17%,CDH5;SLIT2;KANK3;PRKCD;EML2;PFN1;TWF1
prerank,mitochondrial transport (GO:0006839),-0.27261861890409544,-0.8851166957486414,0.6497797356828194,0.885693374484977,1.0,19/53,24.75%,MTX2;SLC25A4;SLC25A24;TOMM7;STARD3;SPG7;BNIP3;GDAP1;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;MAIP1;TIMM9;TMEM14A;TIMM44;BCL2L1
prerank,regulation of embryonic development (GO:0045995),-0.3028951851382387,-0.8850307271777345,0.6497695852534562,0.8852728192102637,1.0,7/34,13.79%,PLCB1;NIBAN2;NR2C2;EHMT1;POGLUT1;TDG;SOX17
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.40470955618039783,0.8848437927757263,0.5776805251641138,0.8894599266422425,1.0,3/13,11.13%,AP1G1;IL4;STX4
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.3679486522586275,-0.8848317814650403,0.6338289962825279,0.885086967983768,1.0,3/14,14.39%,TFRC;SHLD1;KMT5C
prerank,determination of bilateral symmetry (GO:0009855),0.3726017638827612,0.8846289498779367,0.5914179104477612,0.8891456544287047,1.0,3/25,10.34%,NOTCH1;PKD2;CITED2
prerank,response to steroid hormone (GO:0048545),-0.3073319560241765,-0.884569438308767,0.6475409836065574,0.8850296237129894,1.0,8/31,13.64%,NR3C1;CAV1;THBS1;AR;YAP1;TGFB1;ATP1A1;ATP1A3
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.32916618785118346,-0.8841427838253095,0.6331360946745562,0.8853319832795696,1.0,14/23,27.43%,ENPP1;SUFU;GLIS2;TULP3;MGRN1;GLI3;PTCH1;VCP;MEGF8;RACK1;RFX4;GPR161;PTCH2;IFT122
prerank,negative regulation of growth (GO:0045926),0.27650965284965423,0.8841403503474465,0.647239263803681,0.8893454085214172,1.0,7/121,3.49%,TMPRSS4;RERG;APBB2;NOTCH1;SLIT3;SIPA1;CRLF3
prerank,cell junction maintenance (GO:0034331),-0.36393072475396815,-0.88394071123425,0.6218809980806143,0.8851550157404492,1.0,8/14,36.87%,NLGN2;CLDN1;CSF1R;CBLN2;F2R;PRTN3;CBLN1;PARD6A
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3723018882880935,0.8837966132259341,0.5676767676767677,0.8892483057560754,1.0,9/18,18.00%,RIMS1;RIMS2;SYN1;RAP1A;VPS18;RAB5A;PREPL;FMR1;GSK3B
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.30126561772895366,0.8837575185121902,0.5938566552901023,0.8885829510734166,1.0,14/66,11.85%,PTEN;CDK6;RGCC;MYO16;DDX3X;LSM10;APPL1;FGF10;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.41363331702968337,0.8837194111288615,0.5401785714285714,0.8879104319100407,1.0,1/12,0.75%,DOCK10
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.2636983587506305,-0.8836302717142924,0.6882494004796164,0.8851807380485939,1.0,13/59,15.07%,ROCK2;TGFBR2;TGFBR1;LRRK2;ACVR1;TAF1;WNK1;PRKCD;AKT1;CAMK2A;OXSR1;HIPK2;DYRK1B
prerank,regulation of ATP metabolic process (GO:1903578),0.3240908795474692,0.8835783810487849,0.6080402010050251,0.8874362255559237,1.0,12/54,11.71%,SLC25A33;ATP7A;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300;ATP5IF1
prerank,response to interleukin-6 (GO:0070741),-0.39129680477311174,-0.8833312762236379,0.6322463768115942,0.8852227020936128,1.0,3/10,4.49%,ST3GAL6;PTGIS;SBNO2
prerank,protein alkylation (GO:0008213),0.37325197274981414,0.8832102573371344,0.5772200772200772,0.887347070884328,1.0,7/22,16.76%,METTL21A;EEF1AKMT1;PRMT1;METTL22;PRMT3;FAM98A;SNRPD3
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.25275437385410143,-0.8831593029680496,0.7038961038961039,0.8849849860740014,1.0,12/84,15.04%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;SON;MBNL2;NOVA1;SRSF10;FXR2;NUP98
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32658894064803634,0.882725982108162,0.6120527306967984,0.8875706205489379,1.0,4/46,4.76%,PTEN;GPER1;SPRED1;SPRY2
prerank,barbed-end actin filament capping (GO:0051016),0.38180033091266996,0.8822400509968998,0.5725646123260437,0.8870835046889854,1.0,1/18,0.31%,EPS8
prerank,actin filament capping (GO:0051693),0.38180033091266996,0.8822400509968998,0.5725646123260437,0.8870835046889854,1.0,1/18,0.31%,EPS8
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.3296252541177834,-0.8821774181366765,0.6189516129032258,0.8864071415956578,1.0,3/22,5.73%,CD55;B2M;STX7
prerank,negative regulation of MAP kinase activity (GO:0043407),0.32687222703091634,0.8820776720038442,0.5982456140350877,0.8866621916567704,1.0,8/44,6.00%,SPRY4;NF1;IL1B;PTPN22;SH2B3;SPRY2;CD300A;UCHL1
prerank,regulation of interleukin-13 production (GO:0032656),0.3992951256486825,0.8816453927967952,0.5655913978494623,0.8867455374394468,1.0,2/13,6.03%,TNFRSF21;IL4
prerank,positive regulation of lipid storage (GO:0010884),0.3724900069593631,0.8815356780501005,0.5984405458089669,0.8862429115315421,1.0,4/21,9.22%,SCARB1;SREBF2;MSR1;VSTM2A
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.22630587551421996,-0.881504173522861,0.7945205479452054,0.8872402407562696,1.0,40/158,19.79%,AKAP13;LPAR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;LGALS9;IKBKE;RHOA;PRKCB;PLK2;FKBP1A;TFRC;BIRC3;EEF1D;TNFRSF19;ECM1;TNFRSF1A;CASP8;TRIM27;MAVS;PLEKHG5;RELA;TICAM1;VAPA;PELI1;TRIM8;RIPK1;TRAF3IP2;MAP3K3;CC2D1A;TRIM14;LAMTOR5;CANT1;PIM2;EDA2R;LGALS1;IKBKG;RHOC
prerank,regulation of lipid metabolic process (GO:0019216),-0.2446629182031487,-0.8814379154929509,0.7205128205128205,0.8867689595395316,1.0,14/88,12.56%,PRKAG2;TBL1XR1;CHD9;CAV1;NPC2;CARM1;ACACA;PSAP;NFYC;TNFAIP8L3;FGFR4;PLPP1;PPARA;ID2
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.37140723529957076,-0.8813483704038461,0.62152133580705,0.8863647584733119,1.0,5/13,16.55%,CNOT7;MOV10;ZC3H12A;CNOT8;PNPT1
prerank,regulation of protein localization (GO:0032880),-0.2686121572601863,-0.8812316703056812,0.6573426573426573,0.8859927630380924,1.0,11/58,14.65%,AFDN;DLG1;RABGAP1L;USP8;FKBP1A;STX6;TRIM27;ITGB3;DNAJB6;HSP90AB1;TRIM17
prerank,response to progesterone (GO:0032570),-0.34339238118006954,-0.8811607453790995,0.6155339805825243,0.8855279441896625,1.0,4/18,11.59%,CAV1;THBS1;YAP1;TGFB1
prerank,positive regulation of integrin activation (GO:0033625),-0.39437655127052207,-0.8811428171083658,0.6177536231884058,0.8849535351890891,1.0,3/11,6.15%,RAP1B;PIEZO1;RASIP1
prerank,negative regulation of axon extension (GO:0030517),0.3497111445990551,0.8809588052490748,0.5741811175337187,0.8866479208976771,1.0,4/30,4.82%,SEMA6D;MAP2;SEMA5A;SEMA6C
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.4056959516515897,0.880730818724291,0.5643153526970954,0.8863351919587057,1.0,5/14,18.54%,ADK;ADSL;PPAT;IMPDH2;RFK
prerank,positive regulation of dendritic spine development (GO:0060999),-0.33521870589298663,-0.880434671810806,0.64453125,0.8858666179008178,1.0,4/20,13.27%,APOE;SHANK3;CPEB3;LRP8
prerank,positive regulation of cell growth (GO:0030307),-0.2460128798408605,-0.8799733244125597,0.7245989304812834,0.8862573024810637,1.0,20/96,16.42%,IGF1;EGFR;MACF1;USP47;TGFBR1;SEMA7A;ADAM10;SDCBP;SMURF1;INO80;H3-3A;MMP14;AKT1;MFSD2A;DDX49;SPHK1;SFRP1;CXCL16;NTN1;RUFY3
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.3293992637415909,-0.8797156542025649,0.6281800391389433,0.8861220505238803,1.0,4/22,6.93%,LACC1;WNT5A;TNFRSF1B;SLC7A5
prerank,mononuclear cell differentiation (GO:1903131),-0.3153132850022403,-0.8797051986163175,0.6884210526315789,0.8855418930116985,1.0,4/24,5.09%,IL31RA;BMP4;PIR;GAS6
prerank,negative regulation of protein metabolic process (GO:0051248),-0.27623724763751956,-0.8793391481418042,0.6413301662707839,0.8856631272099489,1.0,10/48,14.66%,EGFR;APOE;IAPP;PFDN5;FLOT2;IRAK3;PRKCG;ITGB3;HSP90AB1;PFDN2
prerank,regulation of cholesterol efflux (GO:0010874),-0.306373903528955,-0.8789562454050196,0.6355748373101953,0.8858218109243063,1.0,8/30,20.46%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,water transport (GO:0006833),-0.3723516787651686,-0.8781968589412557,0.6361904761904762,0.8867911478965609,1.0,1/12,1.41%,PDPN
prerank,endomembrane system organization (GO:0010256),0.2704740868456438,0.8774482661486053,0.6915629322268326,0.8919964957742668,1.0,45/178,17.74%,ARHGAP21;DYSF;SYNE1;SPTBN1;TMCC1;TOR1B;COG7;SYNGR1;ATP8B2;COG1;CLASP2;ANK3;CHMP2B;ARFGEF1;HACE1;VPS18;BLZF1;HOOK3;RNF112;MIA3;TMED7;VPS11;UBXN2B;TMED4;AKTIP;ARHGEF7;SYP;VPS51;PLEKHJ1;WASHC5;TRIP11;USP50;SERP1;TJAP1;VPS33B;VMP1;RAB1A;TOR1A;PRKD1;HTT;CSNK1A1;DNM1;GORASP1;GOLGA8B;GOLGA5
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.4058005281225151,0.8773136478578597,0.5838779956427015,0.8915366545221223,1.0,3/12,13.32%,CACNA1H;STAR;CYP11B1
prerank,ribosome assembly (GO:0042255),-0.27464198889948777,-0.8772467900477899,0.6651270207852193,0.8882183612853929,1.0,14/47,22.26%,RPS14;RPS19;RPL11;RPS5;RPL24;RPS27;MRPS7;RPL10;RPS15;RPSA;RPLP0;MPV17L2;RRP7A;RPS27L
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.20397362401857846,-0.8769412242177399,0.9267015706806283,0.888262354463228,1.0,86/341,21.81%,FBXL7;TBL1XR1;RNF213;SMURF2;FBXO10;RNF146;ZNRF1;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;WWP2;RNF144B;TTC3;SMURF1;TOM1L1;CDC16;MAEA;AMFR;IFI27;RC3H2;NHLRC3;DCAF11;CHFR;RNF185;DTX3L;KCTD10;PCBP2;ZNRF3;ARRDC1;PML;PSME2;UBE4B;ANAPC4;CUL4A;RNF125;MDM2;WDR81;PSMB4;FBXW11;CLOCK;UBE2G2;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;RNF115;WWP1;FBXL14;ANKIB1;PSME3;RNF187;RNF40;UBR4;PELI1;SIRT2;UBE3D;FBXL19;SPSB4;SPSB2;ANAPC16;PSMD4;FZR1;PPP2R5C;PSMA2;NPLOC4;VCP;RNF217;VPS28;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RMND5A;RNF126;PSMB7;UBXN1;ANAPC5;ELOC;RBBP6;XBP1
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3831923065440735,-0.8763901461478889,0.6242884250474383,0.8888107977137424,1.0,4/11,13.61%,ADAM10;WNT5A;WNK1;OXSR1
prerank,multivesicular body assembly (GO:0036258),-0.3042496594055376,-0.8763388136009702,0.6473118279569893,0.8882904867965657,1.0,5/30,10.71%,RAB11A;PDCD6IP;HGS;CHMP4B;CHMP4A
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.272016012085093,-0.8761446131016631,0.6806526806526807,0.887472792423131,1.0,18/56,26.22%,NDUFV3;DMAC2;NDUFAF5;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.272016012085093,-0.8761446131016631,0.6806526806526807,0.887472792423131,1.0,18/56,26.22%,NDUFV3;DMAC2;NDUFAF5;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,cellular copper ion homeostasis (GO:0006878),-0.357505564018238,-0.8757532508200014,0.6697588126159555,0.8876591515146199,1.0,2/14,5.21%,APP;ATOX1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.31718775345314476,-0.8752377326490349,0.638,0.8880993222604375,1.0,10/22,23.23%,SASH1;XDH;MFHAS1;ZC3H12A;RELL1;SPHK1;MAP3K4;GADD45G;VEGFA;GADD45B
prerank,regulation of TORC1 signaling (GO:1903432),0.34823999432868513,0.8747885458461312,0.5913200723327305,0.8957938842698062,1.0,2/33,2.38%,SPAAR;SESN3
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.37413088653676607,-0.8746316176232579,0.6388888888888888,0.8887348405014883,1.0,5/13,21.19%,GPD1L;STX3;HSP90AB1;TM9SF4;TYROBP
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.2699718467860388,-0.8742432108457269,0.6782178217821783,0.8888856734267404,1.0,17/52,24.96%,SAMD4A;CNOT7;TUT4;TUT7;EDC3;DDX6;RC3H2;CNOT8;EXOSC5;CNOT3;PNLDC1;LSM5;CNOT11;PAN3;EXOSC7;SAMD4B;LSM7
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.39510137778861015,0.8735209971506291,0.582,0.8975076784857502,1.0,2/15,5.26%,FAP;CLASP2
prerank,regulation of exocytosis (GO:0017157),0.32337515229077524,0.8728769807183855,0.6091081593927894,0.8980500609074445,1.0,17/46,18.98%,RAB8B;CLASP2;RIMS2;RAB3B;SNCA;LGI3;SYT1;IL1RAPL1;STXBP5L;STX4;RAB5A;CHMP3;HAP1;VAMP2;CPLX1;STXBP5;CADPS
prerank,positive regulation of establishment of protein localization (GO:1904951),0.36892890453739735,0.872730505781381,0.5905349794238683,0.8975777980141689,1.0,5/19,16.20%,CORO2B;CEP120;CCT7;CCT3;CEP135
prerank,protein tetramerization (GO:0051262),-0.2558864256021444,-0.8717931632592975,0.6982968369829684,0.8933519337180633,1.0,18/67,20.76%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;ACACA;SAMHD1;GBP5;KCNC3;PKD1;HOMER1;HSD17B8;ACACB;TRPM4;FARSA;MCOLN1
prerank,proteoglycan biosynthetic process (GO:0030166),0.339563702551369,0.8717801069747111,0.5895522388059702,0.8987103280393872,1.0,2/31,2.35%,NDST3;EXTL3
prerank,regulation of endocytosis (GO:0030100),0.30757663640153693,0.8717303561924126,0.656896551724138,0.8980683875722617,1.0,15/61,14.52%,NEDD4L;ROCK1;RIT2;GPC3;CBLL1;SCAMP5;SNCA;AP2S1;HIP1;ABL2;PACSIN3;SRC;PTPN1;ABCA7;RAB5A
prerank,mitochondrial protein processing (GO:0034982),0.4093574524714557,0.8716011403204491,0.5995623632385121,0.897601732456012,1.0,4/11,17.40%,IMMP2L;YME1L1;MIPEP;PMPCB
prerank,T cell activation (GO:0042110),0.308213447995192,0.871310309354445,0.6293245469522241,0.8973951133572567,1.0,8/69,6.56%,PIK3CD;NCK2;PTPN22;PPP3CA;GPR89A;GPR89B;IL4;SOX4
prerank,ncRNA export from nucleus (GO:0097064),0.3410314792667409,0.8710898360362099,0.5909090909090909,0.8970681939198524,1.0,11/36,17.70%,NUP43;NOL6;NCBP2;SSB;NUP35;SEC13;NDC1;PHAX;RANBP2;TSC1;NUP133
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3094916071661516,-0.8708493195068743,0.6588983050847458,0.8946818388241377,1.0,11/27,23.22%,VPS13A;GOLPH3;VPS13D;OBSL1;OPTN;GBP5;ARL5A;RAB6A;ZDHHC15;GAK;RIPOR1
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.3376202919354668,-0.8706389530808337,0.6524271844660194,0.894481596205479,1.0,6/18,19.00%,POR;EDN3;PARK7;SIRT3;AGT;AGTR1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.33608317366345064,-0.8699081713966592,0.6446280991735537,0.8953970887169131,1.0,2/19,1.96%,IGF1;APOE
prerank,epithelial tube morphogenesis (GO:0060562),0.342679197882552,0.8698545111856246,0.5898989898989899,0.8987629381448994,1.0,9/32,11.50%,MEF2C;TBX20;COL4A1;RYR2;FGF10;PRKD2;PKD2;PRKX;PAK1
prerank,T cell differentiation (GO:0030217),0.3353034159471596,0.8697390767151862,0.5996275605214153,0.8982344439746168,1.0,6/40,6.89%,PIK3CD;PTPN22;GPR89A;GPR89B;SOX4;LIG4
prerank,inner dynein arm assembly (GO:0036159),-0.38839504925651813,-0.8696536550436649,0.6478102189781022,0.8953173671118759,1.0,9/11,57.91%,CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73;ZMYND10;DNAAF5
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.302095688672411,-0.8694632072328476,0.7024291497975709,0.8951140656115476,1.0,12/30,28.89%,FHIT;SDCBP;RPL11;TRIM39;HSP90AB1;HFE;STYX;PARK7;UBXN1;BAG5;EIF3H;USP14
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.37255585158018223,-0.8693653740691701,0.649812734082397,0.8946888553634058,1.0,5/12,18.44%,SNAP23;STX3;STX1A;SNAP47;STX2
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.4093325041560408,0.8690743263286467,0.5917525773195876,0.8987744102536646,1.0,6/12,25.78%,FADS2;ELOVL2;HSD17B4;ACSL1;ABCD1;ELOVL5
prerank,protein import into mitochondrial matrix (GO:0030150),0.3737575237644807,0.8690390382125864,0.6028513238289206,0.8981058790008043,1.0,10/18,26.75%,GRPEL2;TOMM40L;TIMM23;TOMM40;TOMM70;DNAJC19;PAM16;TIMM17A;DNLZ;TIMM17B
prerank,myelination in peripheral nervous system (GO:0022011),-0.3667532534167778,-0.8689751351736028,0.62426614481409,0.8948886435762589,1.0,6/13,20.39%,ADGRG6;SKI;PARD3;MYOC;SIRT2;DICER1
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.4078069114273042,0.8689309645045306,0.5764192139737991,0.8968398767224696,1.0,3/12,6.20%,SPRY4;ACTN4;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.4078069114273042,0.8689309645045306,0.5764192139737991,0.8968398767224696,1.0,3/12,6.20%,SPRY4;ACTN4;AP1AR
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.3140006701134705,-0.8685411604376961,0.6728778467908902,0.8951472294204917,1.0,2/24,1.64%,DAB2;RHOQ
prerank,signal peptide processing (GO:0006465),-0.38463001506900973,-0.8678651462926509,0.65,0.8958670951552211,1.0,4/11,24.35%,PCSK5;SPCS1;CLN5;SEC11C
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.35826725270664517,-0.8667722161343799,0.634862385321101,0.8974050160010538,1.0,3/14,7.96%,ENPP1;ENPP3;CMPK1
prerank,response to hydrogen peroxide (GO:0042542),-0.2748549684125696,-0.8666943380997939,0.71875,0.8969676024448276,1.0,13/45,18.14%,ANXA1;ADAM9;CYP1B1;RHOB;PRKCD;RELA;GLRX2;SIRPA;NET1;RIPK1;GPX1;OSER1;PARK7
prerank,lipid droplet formation (GO:0140042),0.4141040003589068,0.8664599425611942,0.5640495867768595,0.9010158994641085,1.0,2/10,10.56%,CDS2;SQLE
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.3624720708793848,0.8662254661457469,0.594541910331384,0.9007521215291905,1.0,13/24,23.20%,GNL3L;TNKS;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PARP1;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3576181831152429,-0.8661895093942417,0.6514285714285715,0.8973902398743921,1.0,11/14,51.18%,CSF1;TYROBP;ATP6AP1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3017917333556357,0.8658012686422492,0.6499189627228525,0.9008010093150842,1.0,16/67,16.84%,TBC1D1;PLD1;WAS;IFT20;MYO10;TBC1D2B;GAP43;TBC1D10C;EPHA2;TBC1D9B;TBC1D19;ABITRAM;RAB5A;TBC1D10B;FSCN1;FMR1
prerank,negative regulation of RNA splicing (GO:0033119),-0.3323529158165094,-0.8657629750288759,0.632,0.8976243799072668,1.0,7/19,21.95%,RPS13;SRSF10;TMBIM6;SRSF6;PTBP3;PCBP4;RPS26
prerank,regulation of cell projection organization (GO:0031344),-0.3676451498377222,-0.8654148204112961,0.6628787878787878,0.8977360207445062,1.0,4/13,13.15%,MACF1;MOV10;MYO9A;MFSD2A
prerank,positive regulation of catalytic activity (GO:0043085),-0.2871461484384928,-0.8652121027436901,0.6666666666666666,0.8975106019031984,1.0,14/37,27.90%,CAV1;IGF2;MAPK14;SSBP1;NHEJ1;FGFR4;XRCC4;MAPK3;PSEN2;MT3;MSH6;NCSTN;B3GAT3;ABL1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.33105927879177344,-0.8650729979924924,0.6626262626262627,0.8972011275012002,1.0,7/21,21.40%,SMO;EVC;TTC23;SFRP1;STK36;TXNDC15;GLI1
prerank,mesoderm development (GO:0007498),0.37913435531716777,0.8650623636485771,0.5860566448801743,0.901496524480875,1.0,3/18,3.37%,TBX3;TCF15;TBX6
prerank,protein deneddylation (GO:0000338),-0.3924459166900276,-0.8641097851235375,0.6491228070175439,0.8985472531014647,1.0,4/10,26.75%,COPS4;COPS8;COPS7A;COPS2
prerank,regulation of lipid catabolic process (GO:0050994),0.36523365908192795,0.8639290543018912,0.5845213849287169,0.9029654309308303,1.0,7/19,23.39%,IL1B;RARRES2;PRKAA1;LONP2;PDE3B;TYSND1;ABCD1
prerank,positive regulation of TOR signaling (GO:0032008),-0.2826405846456423,-0.8639023178457768,0.6880530973451328,0.8983879364945989,1.0,19/40,37.49%,GAS6;FNIP1;CLEC16A;GOLPH3;FLCN;GPR137;SIK3;RRAGB;LAMTOR5;PIH1D1;RRAGC;NCKAP1L;RPTOR;TREM2;HTR6;SLC38A9;WDR59;RRAGD;KLHL22
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.40720839744900295,0.8635652456306011,0.6032719836400818,0.9029515571383047,1.0,1/11,1.19%,NOTCH1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.31695680861394526,0.8635244819620131,0.62478184991274,0.9022955164072185,1.0,3/51,2.51%,IL34;PTK2;PTN
prerank,carbohydrate derivative transport (GO:1901264),-0.340793230607989,-0.863501411054377,0.6710526315789473,0.8985723550114803,1.0,6/18,14.56%,PLTP;LBP;NPC2;MFSD2A;SLC25A19;SLC29A1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.34968784635444794,0.8620118832957897,0.5787321063394683,0.904527672195303,1.0,13/27,24.87%,RIMS1;RIMS2;SYT1;SYT2;SYT12;SYT11;VAMP2;SYT13;SYT3;ARL8B;VAMP7;SYT6;SYT10
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3608028580714176,-0.861743028098934,0.6538461538461539,0.9015779689257492,1.0,7/13,30.32%,CNOT7;CPEB3;TNRC6A;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,neuron projection fasciculation (GO:0106030),0.4015465222761949,0.8614508639068921,0.5835051546391753,0.9049482667128301,1.0,3/10,9.18%,SEMA5A;CNTN4;ARHGAP35
prerank,regulation of urine volume (GO:0035809),-0.3840144856379756,-0.8612996777044778,0.6615678776290631,0.9018741037616876,1.0,2/10,5.57%,NPR3;NPR1
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3463104122799354,-0.8612437143614173,0.6530612244897959,0.9013814067173809,1.0,10/17,39.33%,BID;BBC3;BCL2L1;SFN;TIMM50;SOD2;CLU;DNM1L;BAX;GGCT
prerank,sodium-independent organic anion transport (GO:0043252),0.4124757308358719,0.8611068163411678,0.5918803418803419,0.9048276316862491,1.0,2/10,4.44%,SLCO3A1;SLCO5A1
prerank,regulation of interleukin-10 production (GO:0032653),0.3192520560429705,0.8608546397890773,0.6025179856115108,0.9045831163490639,1.0,4/44,6.03%,TNFRSF21;CD46;TRIB2;IL4
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3433111672455518,-0.860582790345877,0.6653919694072657,0.9020776021505597,1.0,6/16,16.95%,TNKS2;SMG6;NAF1;PINX1;ATM;SMG5
prerank,regulation of coagulation (GO:0050818),-0.37751133083056276,-0.8597796086126,0.6678635547576302,0.9030485607778407,1.0,5/11,31.67%,CAV1;EPHB2;PROCR;F2R;HRG
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4017293394719026,0.8596544255216502,0.5847457627118644,0.906243126334704,1.0,4/11,22.70%,IL4;JAK2;HDAC2;TAF7
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2970709114864715,0.8587938331876044,0.6381578947368421,0.9071885134861912,1.0,17/70,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,negative regulation of cholesterol transport (GO:0032375),0.4201104234020116,0.8586986672848446,0.6092436974789915,0.9066383341759694,1.0,1/10,5.07%,SREBF2
prerank,regulation of cellular localization (GO:0060341),-0.27243662581202893,-0.8581385984866507,0.6972477064220184,0.9056780231258215,1.0,6/46,7.02%,GSN;ADCY5;LRRK2;PARD6G;EFNA5;STXBP4
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.3738052344915208,-0.8580683588985677,0.6320422535211268,0.905199812299079,1.0,5/11,27.51%,MAVS;TICAM1;TYROBP;ITGB2;ITGAM
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.29698589974375067,0.8580092178011077,0.6335504885993485,0.907226845788139,1.0,17/71,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.31160289499465765,-0.8578366836817147,0.6631578947368421,0.9050392525912028,1.0,5/26,13.00%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,cellular response to hypoxia (GO:0071456),0.2686656900443228,0.8576457616595345,0.6750741839762612,0.9072052588297516,1.0,10/126,4.92%,LIMD1;RORA;RGCC;CPEB1;RBX1;KCND2;FMN2;SCN2A;EPAS1;PSMB11
prerank,autophagy of nucleus (GO:0044804),-0.34185878126400926,-0.8574752417478324,0.6534446764091858,0.905118749214706,1.0,5/16,24.93%,WIPI2;ULK2;ATG2A;ATG7;ATG12
prerank,positive regulation of telomere maintenance (GO:0032206),-0.2924207362605366,-0.8571293014041576,0.6964656964656964,0.9052287533562686,1.0,10/31,23.51%,TNKS2;NAF1;PML;ATM;MAPK3;RAD50;MAP3K4;MAP2K7;SLX4;ERCC1
prerank,intracellular cholesterol transport (GO:0032367),-0.34214576958596893,-0.8570417220475686,0.6483931947069943,0.9047856951468098,1.0,3/15,6.77%,ABCA1;LRP6;NPC2
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.38159099227773297,-0.857013455194419,0.6611721611721612,0.9042298842493028,1.0,3/10,20.26%,RNF125;NPLOC4;SEC14L1
prerank,cellular response to cAMP (GO:0071320),0.3438230895977691,0.8549518828118822,0.6282051282051282,0.9116904532838322,1.0,6/30,9.02%,RAPGEF2;AKAP6;HCN2;RAP1A;HCN3;PKD2
prerank,protein modification by small protein conjugation (GO:0032446),-0.19791473400984252,-0.8548828133145379,0.9583333333333334,0.9078500649981115,1.0,79/361,20.63%,RNF220;FBXL7;EYA1;PDZRN3;RNF213;SMURF2;FBXO10;RNF38;ASB2;RNF43;TRIM24;SPSB1;ARRB1;WWP2;HIF3A;RNF139;SMURF1;CDC16;KLHL2;RNF103;AMFR;RTF1;CHFR;MKRN2;DTX3L;HIF1A;KCTD10;RNF135;STX1A;MGRN1;ZNRF3;ARRDC1;TRIM27;USP5;CUL4A;ASB5;MDM2;TRIM63;UBE2Q2;SAE1;FBXW11;TRIM35;BRAP;UBB;RNF181;TRIM39;ATG10;ELOB;UBE2G2;NEDD8;DDB1;DTX1;TRIM17;NUP98;UBA3;WWP1;FBXL2;RNF187;ASB1;RNF40;SPSB4;TPR;UBA7;SPSB2;ANAPC16;ARRDC4;TRIM14;UBE2M;TRIM47;TRIM41;VCP;NUP88;PIAS4;CDC27;RNF144A;URM1;NUP214;CDK5RAP3;TRPM4
prerank,protein complex oligomerization (GO:0051259),-0.24209097940512947,-0.8545183359031665,0.7671957671957672,0.9079698741082535,1.0,22/85,17.51%,MCU;RNF213;PDCD6IP;UPB1;ALS2;EHD1;GLRA3;RNF135;SPAST;GSDMD;ZC3H12A;ATL2;TMEM120B;KCNC3;NINJ1;CLDN1;BEND3;AQP11;HOMER1;ELAVL1;PNPT1;SLC9A1
prerank,regulation of cellular metabolic process (GO:0031323),0.32100196875008213,0.8544519571552847,0.6293706293706294,0.9119316172948919,1.0,2/45,2.56%,PID1;FOXM1
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.27514408212477326,-0.8542653930897046,0.6741573033707865,0.9078699877011019,1.0,14/42,23.89%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;EARS2;VARS2;FARSA;PPA1;FARSB
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3630157964478396,-0.8541437604455899,0.6423076923076924,0.9075307639154231,1.0,6/13,25.47%,LRRK2;MET;TXN;PARK7;NR4A3;RACK1
prerank,response to light stimulus (GO:0009416),0.3029922389808387,0.8540094270888621,0.6431034482758621,0.9120208378026486,1.0,20/55,23.01%,OPN1MW;OPN1MW3;TYR;ERCC4;CCAR2;MAPK10;BRSK1;RRH;OPN3;USP1;CRY1;UVSSA;ERCC8;CPT1B;UBE2B;DDB2;COPS3;UBE2A;DRD2;CIRBP
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4023056304890403,0.8539647682934385,0.6224489795918368,0.9113781251803578,1.0,3/11,8.00%,MAP3K5;PDCD10;STK24
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.27540148366990613,-0.8533529116116175,0.6873614190687362,0.9085260385686537,1.0,15/39,28.74%,ABCA1;STEAP3;RCN3;GOLPH3;TMEM167A;RAB8A;PPY;CANX;TANGO2;TVP23B;LTBP2;RAB3D;ARL4D;PREB;RAB3A
prerank,regulation of complement activation (GO:0030449),0.3185850846892028,0.8530038881909234,0.6290909090909091,0.9125470683966018,1.0,6/40,9.50%,VTN;IL1B;CD46;C7;SUSD4;CR2
prerank,negative regulation of translational initiation (GO:0045947),0.3935169810261393,0.852796066210311,0.6334012219959266,0.9121993818825431,1.0,2/13,2.94%,EIF4EBP2;EIF4EBP3
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3284930503277528,-0.852736388796943,0.6953125,0.9091434388750098,1.0,4/18,11.59%,SMAD3;PDPN;EMILIN1;TGFB1
prerank,mRNA catabolic process (GO:0006402),-0.269336093201773,-0.8527204199744766,0.7201834862385321,0.908570989487704,1.0,14/44,23.10%,DDX5;TUT4;THRAP3;TUT7;ERN1;NUDT12;XRN1;NBDY;PNPT1;LSM5;ZFP36L2;AGO1;NUDT16;DHX34
prerank,DNA methylation or demethylation (GO:0044728),-0.32954638656511237,-0.852684525863625,0.6923076923076923,0.9074417075484991,1.0,4/19,15.22%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,DNA alkylation (GO:0006305),-0.32954638656511237,-0.852684525863625,0.6923076923076923,0.9074417075484991,1.0,4/19,15.22%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,ganglioside biosynthetic process (GO:0001574),-0.34596033277963806,-0.8526710606400615,0.6561922365988909,0.9068626320390196,1.0,5/15,11.77%,ST3GAL1;ST3GAL2;ST6GALNAC3;ST8SIA2;ST6GALNAC6
prerank,positive regulation of developmental growth (GO:0048639),0.3097810130133254,0.8525532134534642,0.6570915619389587,0.9119252588908567,1.0,5/49,5.27%,NEDD4L;LIMK1;AGRN;RIMS1;RIMS2
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2918232591336885,-0.8523557797400771,0.6932270916334662,0.9069031739948212,1.0,14/32,28.30%,HK2;IFIT2;VPS35;CAMK2A;BNIP3;BID;BBC3;BCL2L1;NDUFS1;BIK;SFN;TIMM50;SOD2;CLU
prerank,mitochondrial gene expression (GO:0140053),0.31315540646351786,0.8521982137288224,0.6197440585009141,0.9118357402786519,1.0,16/42,20.03%,SLC25A33;FASTKD2;NOA1;TFAM;GATB;GFM2;PTCD3;IARS2;GATC;MRPS34;MRPS12;MRPS18B;TFB2M;MRPS17;MRPL47;MRPL2
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.3637799239198062,0.8520916143216084,0.6212424849699398,0.9112866947421345,1.0,8/20,18.01%,CHRNA3;AGRN;CHRNA7;RGS10;CHRNB2;RGS8;CHRM3;CHRM2
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35166227716131515,0.8518317655417823,0.6410256410256411,0.911052185963059,1.0,13/29,20.38%,CNOT2;KCTD6;VPS18;UFM1;CNOT9;VPS11;KANK2;PAK1;STRN3;CNOT1;DDRGK1;KMT2D;WBP2
prerank,mitotic cytokinetic process (GO:1902410),-0.3240975867473638,-0.8515905971053879,0.6712598425196851,0.9077988292190019,1.0,6/20,17.89%,PDCD6IP;RHOA;CHMP4B;CHMP4A;MITD1;KLHDC8B
prerank,monosaccharide transmembrane transport (GO:0015749),0.37556722723824437,0.8515430845203131,0.5991471215351812,0.910863443861564,1.0,5/16,16.92%,SLC5A1;SLC2A6;SLC2A9;SLC23A2;SLC23A1
prerank,N-terminal protein amino acid modification (GO:0031365),0.37497036955109436,0.851324476204284,0.620253164556962,0.9105425484807972,1.0,5/14,21.24%,METAP2;NAA11;NAA15;METAP1;NTMT1
prerank,protein secretion (GO:0009306),-0.2589284503246197,-0.8512684497791811,0.75,0.9078216959312301,1.0,8/56,11.75%,ABCA1;STEAP3;PCSK5;ANXA1;RCN3;GOLPH3;TMEM167A;RAB8A
prerank,snRNA processing (GO:0016180),0.37052209749054565,0.8510834187229577,0.582,0.9102976956097859,1.0,3/16,14.00%,INTS6L;INTS1;INTS12
prerank,positive regulation of cytokine production (GO:0001819),0.24640476120696583,0.8507629375071157,0.7589285714285714,0.9101984175892849,1.0,14/292,3.56%,PDE4D;PLA2R1;GLMN;PIK3CD;RORA;AFAP1L2;RGCC;NODAL;RFTN1;IL1B;PTPN22;CD46;FFAR2;SPTBN1
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36611851466164624,0.8498955124543711,0.5935727788279773,0.9111564033539329,1.0,3/19,7.20%,IL1B;ABCD2;IRS1
prerank,negative regulation of translation (GO:0017148),-0.23849398392516008,-0.8498255455331027,0.7875354107648725,0.9101044822987778,1.0,21/87,18.48%,DAPK1;SAMD4A;ROCK2;IGFBP5;CNOT7;RNF139;DDX6;CPEB2;IGF2BP2;PUM1;CPEB3;CALR;LARP1;CNOT8;FTO;FXR2;EIF4EBP1;TPR;PAIP2B;EIF4E2;TYMS
prerank,presynaptic endocytosis (GO:0140238),0.35141412774051134,0.8492500714298227,0.6131687242798354,0.9116622205051299,1.0,7/24,17.69%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;VAMP2
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3165685535849712,-0.8491466245834896,0.6771653543307087,0.9108330891798244,1.0,2/20,1.64%,DAB2;RHOQ
prerank,proteasome assembly (GO:0043248),-0.382474473976131,-0.8485094394091152,0.6702702702702703,0.9114832650937801,1.0,4/11,24.70%,POMP;PSMD11;PSMD4;PSMD10
prerank,granulocyte chemotaxis (GO:0071621),0.3048082099621454,0.8484119637497065,0.6736842105263158,0.912492739734327,1.0,6/55,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3378163835227342,0.8483074533933783,0.599609375,0.9119707689208079,1.0,3/30,2.06%,HEYL;PKN1;NODAL
prerank,DNA methylation (GO:0006306),-0.3166719046912138,-0.8480985752681339,0.692156862745098,0.9116658563442055,1.0,8/23,27.28%,DNMT3A;GATAD2A;EHMT1;BEND3;ZFP57;DNMT1;PICK1;MTRR
prerank,regulation of axon extension (GO:0030516),-0.2801779865679294,-0.84771021068521,0.7017937219730942,0.9118585229683028,1.0,16/37,28.94%,APOE;MACF1;SEMA7A;DIP2B;NTN1;RUFY3;SEMA3G;MAP3K13;MT3;ZFYVE27;DBN1;SIN3A;PTPRS;RTN4R;ABL1;CTTN
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.2916007148926387,0.8470436092189267,0.6558966074313409,0.9137045350228832,1.0,17/73,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,positive regulation of type 2 immune response (GO:0002830),-0.36113719913972764,-0.8464042122041887,0.6774809160305344,0.9138417560960981,1.0,5/14,22.35%,PRKCZ;IL18;RSAD2;CD81;RARA
prerank,negative regulation of viral transcription (GO:0032897),0.38757035255842853,0.8459527731151415,0.6004016064257028,0.9150929132751467,1.0,3/13,5.49%,MID2;HEXIM1;TRIM62
prerank,response to axon injury (GO:0048678),-0.32661140753363277,-0.8458405702617415,0.6850393700787402,0.9143263520480032,1.0,3/18,7.43%,DPYSL3;APOD;P2RX4
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.34883625161872023,0.8457379620520523,0.626,0.9147630839543612,1.0,2/23,4.24%,PIK3CD;FGF2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.28321787702537554,-0.8454550208558242,0.7317073170731707,0.9144580597389884,1.0,7/33,13.04%,ESR1;DDX5;AR;KLK2;H3-3A;CARM1;CALR
prerank,cellular response to lipopolysaccharide (GO:0071222),0.27813810467282934,0.8452903948204578,0.7037617554858934,0.914886537618041,1.0,10/101,6.42%,MEF2C;NR1H3;IL1B;PTPN22;AXL;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN
prerank,negative regulation of calcium ion transport (GO:0051926),0.38447817072345575,0.8449552992962395,0.615071283095723,0.9148000086447299,1.0,4/15,15.50%,ATP1A2;STC1;PACSIN3;CBARP
prerank,B cell mediated immunity (GO:0019724),0.4069598758082611,0.8446963106417745,0.6106194690265486,0.9145474916156647,1.0,2/10,18.74%,CARD9;CD27
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.250981046985257,-0.8439265187618298,0.7518796992481203,0.9167524241239666,1.0,18/68,24.88%,RHOQ;ENPP1;AMPD3;LRRK2;ACOT11;SULT1A1;HINT1;RAN;PTHLH;ACOT6;ACOT9;TPST1;TPST2;ADSS1;DBI;NT5C2;OXSM;SULT4A1
prerank,cardiolipin metabolic process (GO:0032048),-0.35674223288935647,-0.8436071462241754,0.6629834254143646,0.9167692657298779,1.0,3/13,15.83%,PLA2G4A;PLA2G6;PLSCR3
prerank,mitochondrion distribution (GO:0048311),-0.358163848294883,-0.8431401317651573,0.681214421252372,0.9170312220862018,1.0,3/12,15.88%,LRRK2;MEF2A;MSTO1
prerank,cellular response to nitrogen compound (GO:1901699),-0.3271779550416939,-0.84215411346405,0.696911196911197,0.9183064791456778,1.0,1/20,0.88%,ROCK2
prerank,membrane depolarization (GO:0051899),0.3256210204655062,0.8421334247101225,0.6216216216216216,0.9187344614547757,1.0,9/32,14.69%,CACNA1H;SCN2A;SCN5A;SCN8A;SCN9A;CACNA1A;ATP5IF1;SCN1A;CHRNB2
prerank,neutral amino acid transport (GO:0015804),-0.3006928647795117,-0.841584674342155,0.7167381974248928,0.9188023727245701,1.0,11/28,22.34%,SLC6A6;SLC6A9;SLC7A5;SLC38A5;SLC3A2;SLC38A6;LLGL2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,mitotic sister chromatid cohesion (GO:0007064),0.37261935508268446,0.8413974997969917,0.5987525987525988,0.9194637053872764,1.0,5/16,13.84%,REC8;POGZ;MAU2;RB1;NIPBL
prerank,long-term synaptic potentiation (GO:0060291),-0.3129158684676804,-0.8411838773050985,0.6847195357833655,0.9189474814436025,1.0,5/21,8.84%,SLC8A3;PRKCZ;PTK2B;PLK2;GRIN2D
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.3783847844211109,-0.8410195456780079,0.6773547094188377,0.9186561149029473,1.0,4/10,25.85%,ESR1;PSMC2;PSMC5;TP53
prerank,hyaluronan catabolic process (GO:0030214),0.3595437613689183,0.8408703108609185,0.6278118609406953,0.9197294532938042,1.0,3/18,4.24%,CEMIP2;HYAL4;FGF2
prerank,mitotic spindle organization (GO:0007052),0.26063437306146825,0.8408231571467334,0.7435897435897436,0.9190829245196283,1.0,21/153,15.10%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;DYNC1I2;NEK6;TUBG2;XPO1;TOGARAM2;SEC13;NUDC;MZT1;KIFC2;LSM14A;RANBP2;CEP126;MAD2L1
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.24448825230079152,-0.8408213744534603,0.771712158808933,0.9184543776165588,1.0,27/72,30.73%,POLR2A;ERCC5;CUL4A;COPS4;POLR2F;UBB;COPS8;DDB1;RPA1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;ERCC1;ERCC2;RPA3;POLR2G;COPS7A;CDK7;ERCC3;COPS2;PRPF19;POLD1;MNAT1;GTF2H3;PCNA
prerank,positive regulation of translation (GO:0045727),0.2759632779553413,0.8406304840938528,0.6924265842349304,0.9187193546579828,1.0,33/94,20.20%,PLD1;FASTKD2;DAZL;RPS6KB2;MRPS27;BOLL;YTHDF3;DDX3X;SOX4;MTOR;EIF3C;EIF6;YTHDF2;FASTKD3;PRKDC;TRMT10C;UPF3B;LARP6;DHX36;RMND1;C1QBP;FMR1;PKM;RPS6KB1;PRR16;NSUN5;HNRNPD;HABP4;POLR2D;EEF2;EIF3E;RBM3;POLDIP3
prerank,regulation of regulated secretory pathway (GO:1903305),0.3257044113232408,0.8402735514353491,0.6592592592592592,0.9186380699971712,1.0,12/34,18.00%,RIMS1;RIMS2;SYN1;VPS18;SYT1;SYT2;RAB5A;PREPL;SYT12;SYT11;SYT13;GSK3B
prerank,peptidyl-lysine modification (GO:0018205),-0.23258674960835127,-0.840081333762715,0.7923497267759563,0.9192668928271224,1.0,24/99,20.63%,EYA1;HDAC4;LOXL1;KAT2B;HDAC9;PLOD2;NNAT;STX1A;SENP3;SAE1;NUP98;PLOD1;P3H4;SIRT7;SIRT2;TPR;PARK7;SIRT3;NUP88;PIAS4;ETFBKMT;NUP214;PLOD3;TRPM4
prerank,regulation of cell growth (GO:0001558),0.2496952591913482,0.8398234837276687,0.7726027397260274,0.9187476431885819,1.0,19/204,8.14%,PLCE1;RERG;APBB2;SLC25A33;RASGRP2;SLIT3;BCAR1;SIPA1;PABIR1;CRLF3;NRG3;AKAP6;ROS1;DDX3X;CAPRIN2;SUPV3L1;PPT1;CDKN1A;MTOR
prerank,snRNA 3'-end processing (GO:0034472),0.351383899360368,0.8396322868533188,0.6126482213438735,0.9183802439986151,1.0,4/19,17.93%,INTS6L;INTS1;INTS12;USB1
prerank,positive regulation of lipid localization (GO:1905954),-0.36965782189058793,-0.8394016673024206,0.6916058394160584,0.9199409965612632,1.0,5/11,30.54%,IKBKE;ZC3H12A;LPL;C3;HILPDA
prerank,RNA processing (GO:0006396),0.25265875602967536,0.8391810108162129,0.741506646971935,0.918484892468219,1.0,45/176,20.43%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;DHX15;LSM3;NCBP2;ADARB2;SFPQ;HNRNPR;SRRM1;XRN2;RNPS1;CPSF6;TCERG1;RBMS1;SNRNP25;PRPF6;CCAR2;DDX47;SCNM1;HNRNPUL1;PABPC4;DDX23;CELF1;HNRNPU;HNRNPC;KIN;LSM1;SF3B3;SNRPD3;KHSRP;USB1;HNRNPD;LIN28B;FUS;SNRNP48;HNRNPA2B1;RBM3;RNGTT;PPP2R1A;LUC7L3;SRRM4;LSM6
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.34410525647073376,-0.8390688771895943,0.7013232514177694,0.9199527388867298,1.0,7/15,25.43%,CPEB2;ZC3H12A;MKNK2;VCP;GSTO2;ATF3;ZFAND1
prerank,sensory perception (GO:0007600),0.3079236025351632,0.8389354970872119,0.6415770609318996,0.9182038714244862,1.0,11/45,17.78%,ADORA2A;TRPV2;OPRK1;CHRNA7;SCN9A;TMEM150C;ASIC3;CHRNB2;NIPSNAP1;TTC8;GNAL
prerank,nuclear export (GO:0051168),-0.23765874222551148,-0.8387654251088681,0.7936507936507936,0.9199586288101671,1.0,26/80,30.81%,RANBP3L;ATXN1;SMURF1;CCHCR1;NXF1;TGFB1;RAN;CALR;PKD1;SRSF2;TPR;SRSF6;CHP1;THOC1;NUP214;SRSF5;THOC7;XPO4;SRSF11;NUP155;RANBP17;CSE1L;NUP62;THOC5;XPO5;LSG1
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3665387946316849,0.8384648406978061,0.6457023060796646,0.9184180459284641,1.0,2/17,1.63%,ATP1A2;GPER1
prerank,mesoderm formation (GO:0001707),0.3609021768818905,0.8380130777752602,0.5874730021598272,0.9185315975362963,1.0,3/17,6.96%,TBX20;ITGB1;ITGA8
prerank,regulation of nuclear division (GO:0051783),-0.31557583964651303,-0.8379861229423967,0.7175257731958763,0.920841692034573,1.0,7/20,32.09%,OBSL1;CAV2;CCDC8;CUL9;L3MBTL1;MKI67;CUL7
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.3888418772289065,0.837823800162517,0.6152263374485597,0.9174537001667633,1.0,2/13,4.10%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.3888418772289065,0.837823800162517,0.6152263374485597,0.9174537001667633,1.0,2/13,4.10%,IL15RA;JAK1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3164388997106821,-0.8377007401961715,0.703187250996016,0.920800359605477,1.0,9/21,20.83%,SAMD4A;CNOT7;TUT4;TUT7;CNOT8;CNOT3;PNLDC1;CNOT11;PAN3
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.3502864619086217,-0.8375415310664841,0.6857142857142857,0.9204794473858011,1.0,3/13,12.42%,NFAT5;RHOA;RELA
prerank,regulation of cilium assembly (GO:1902017),0.2949144107868862,0.8373343941496005,0.6736672051696284,0.9176994959089813,1.0,15/62,16.80%,TBC1D1;TBC1D30;IFT20;TESK1;TBC1D2B;ARHGAP35;TBC1D10C;TBC1D9B;CEP97;FUZ;TBC1D19;CEP120;TBC1D10B;KCTD17;HTT
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2869833963735596,-0.8372886244951577,0.7290836653386454,0.9203379762593294,1.0,14/30,25.95%,NOS3;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SERPINE1;RIPK1;GPX1;PARK7;RFFL;BRCA1;BCL2L1;FAS
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3498030734062179,0.8371955937621199,0.6480769230769231,0.9172338596567525,1.0,4/21,7.01%,SPRY4;SH3BP1;SPRY2;LZTR1
prerank,regulation of establishment of protein localization (GO:0070201),0.38493522781133843,0.8371284331919177,0.6285097192224622,0.9166360038801707,1.0,3/14,16.20%,CORO2B;CEP120;CEP135
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.38054910976212636,0.837105763978186,0.6339113680154143,0.9159589577632362,1.0,3/14,5.50%,ELAVL4;DAZL;BOLL
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.2432158542113678,-0.8370109811329479,0.7937649880095923,0.920274506452275,1.0,15/70,18.04%,SMAD3;IL6R;TNFRSF1B;IFI27;BAG3;MCL1;TNFRSF1A;CASP8;DAB2IP;P2RX7;TGFB1;BID;RIPK1;PDPK1;DEDD
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.2793337261081866,0.8367830217937174,0.7009493670886076,0.9158680293838476,1.0,15/94,9.84%,ATP2A3;MAP3K5;FNIP2;CHAC1;CUL3;BCL2L10;ITPR1;CIDEB;SCN2A;DDX3X;CASP9;CDKN1A;STK24;HTRA2;EPHA2
prerank,basement membrane organization (GO:0071711),0.3902617750120944,0.8364079925733134,0.625,0.9158298783358827,1.0,5/14,5.23%,NID1;COL4A1;PXDN;NTNG2;LAMB1
prerank,regulation of mRNA stability (GO:0043488),-0.2178252052571443,-0.836324104229073,0.8866666666666667,0.9209509951988,1.0,40/145,24.70%,SAMD4A;ROCK2;VIM;THRAP3;NOCT;PRKCD;IGF2BP2;RC3H2;AKT1;PSME2;PUM1;TENT5A;PSMB4;UBB;LARP1;PSMB1;PSMD11;FTO;PSMD8;FXR2;EXOSC5;PSME3;XRN1;ELAVL1;PSMD4;PSMA2;CSDC2;ZFP36L2;E2F1;TENT5C;PSMD3;NUP214;PSMB7;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMC5;PSMD10
prerank,aminoglycan biosynthetic process (GO:0006023),0.30031658769794684,0.8358753824792201,0.6718213058419243,0.9161003345201919,1.0,8/49,9.19%,GCNT2;SDC2;SDC3;AGRN;GPC5;GPC3;B3GALT1;B3GNT8
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.36047200742879176,-0.8355775266951788,0.6850828729281768,0.9217362806105933,1.0,7/11,35.34%,UBN1;H3-3A;HAT1;ASF1A;IPO4;ATRX;ASF1B
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.30242685619664667,-0.8352086162314677,0.7083333333333334,0.9218360698384436,1.0,10/26,22.35%,FBN1;TCTA;C1QC;ZFPM1;GPR137;CEACAM1;TLR4;PTPN2;FSTL3;RARA
prerank,transcription by RNA polymerase I (GO:0006360),-0.28078546164610896,-0.8350830030449008,0.7329059829059829,0.9214881697949119,1.0,14/34,30.61%,TAF1;CAVIN1;TCOF1;POLR2F;MAPK3;POLR2E;UBTF;TTF1;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,relaxation of cardiac muscle (GO:0055119),0.37239661800227175,0.8349327086096938,0.5995893223819302,0.9171095994875572,1.0,2/13,3.06%,ATP1A2;PIK3CA
prerank,macrophage chemotaxis (GO:0048246),-0.37916632817119855,-0.8344256076625566,0.6933333333333334,0.9220678815049489,1.0,5/10,38.70%,EDNRB;CKLF;CCL2;CXCL17;CCL5
prerank,cellular response to metal ion (GO:0071248),0.2636460372166077,0.8343486940567146,0.7149321266968326,0.9174157376875295,1.0,20/123,11.38%,MEF2C;SLC12A2;RASGRP2;CACNA1H;NCF1;ADCY8;ITPKB;CPNE7;SCN5A;ANK3;SNCA;SYT1;RYR3;PKD2;HPCA;DLG2;CPNE4;BRAF;CHP2;SYT2
prerank,myeloid cell differentiation (GO:0030099),-0.2622442198485728,-0.8338174493523699,0.7569444444444444,0.9225772963708662,1.0,18/47,27.92%,ZBTB16;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;TAL1;HIPK2;ZFPM1;PTPN2;HSPA9;ACIN1;TET2;RASGRP4;ALAS2;CEBPA;HCLS1
prerank,mRNA modification (GO:0016556),0.3536688681551489,0.8337940971881124,0.6222222222222222,0.9177472819221245,1.0,8/22,19.99%,TRMT61A;CBLL1;TRUB1;TRMT10C;PUS7;NSUN2;ZC3H13;WTAP
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3414844579536211,-0.8337149081975677,0.6854545454545454,0.9221622624724681,1.0,5/14,22.33%,TNKS2;PINX1;BRCA2;TPP1;ACD
prerank,mRNA destabilization (GO:0061157),-0.274070926619237,-0.8334817833411029,0.7268722466960352,0.9219836278276745,1.0,9/38,14.25%,ROCK2;TUT4;MOV10;TUT7;RC3H2;ZC3H12A;PUM1;CPEB3;FTO
prerank,sarcomere organization (GO:0045214),-0.294491839368487,-0.8333897000291625,0.7186147186147186,0.9215593911264542,1.0,13/27,40.62%,ACTN2;CSRP2;MYOM2;KRT19;CAPN3;MYPN;MYLK3;FHOD3;TNNT3;TCAP;OBSCN;MYH6;CSRP1
prerank,protein palmitoylation (GO:0018345),0.3320372700898423,0.8333172963462986,0.6384180790960452,0.9179650614580681,1.0,8/30,13.52%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;ZDHHC23;HHAT
prerank,Golgi ribbon formation (GO:0090161),-0.3549140231152606,-0.8324652195994972,0.6918604651162791,0.9226523787487897,1.0,4/13,10.97%,MYO18A;GOLPH3;STX6;OPTN
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.24339943361171423,-0.8322013344346437,0.7655367231638418,0.9225423736045734,1.0,28/70,28.39%,B2M;TAPBP;SNAP23;LNPEP;PSME2;PSMB4;CALR;CYBA;PSMB1;PSMD11;PSMD8;PDIA3;PSME3;PSMD4;PSMA2;IKBKG;PSMD3;CYBB;PSMB7;VAMP8;PSMC2;PSMC5;TAP2;PSMD10;FCGR1A;PSMD7;TAP1;MFSD6
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.36467499940042036,0.83205496017468,0.6146245059288538,0.9196395817844123,1.0,7/17,13.82%,ROCK1;GGA3;NTRK2;CHRNA7;BIN1;RTN1;ABCA7
prerank,regulation of organelle organization (GO:0033043),-0.23664805916044546,-0.8318120230679141,0.7893333333333333,0.9226742594664098,1.0,26/80,24.09%,CLIC4;DIAPH1;EZR;CAPN2;ARMH3;USP6NL;CLEC16A;GOLPH3;AKAP9;MAVS;VPS35;LMAN1;F11R;SURF4;MAPK3;TBC1D25;SIRT7;STX18;SAR1A;SAR1B;TMED9;TMEM33;STMN3;NEXN;CAPN6;RDX
prerank,intracellular sterol transport (GO:0032366),-0.3448792219776544,-0.8317870284322338,0.6868131868131868,0.9221215809651104,1.0,3/13,13.54%,ABCA1;NPC2;STARD4
prerank,SNARE complex assembly (GO:0035493),-0.38583792295749264,-0.8317162920040212,0.712280701754386,0.9216524958607172,1.0,3/10,21.44%,STXBP6;UVRAG;VAMP8
prerank,DNA double-strand break processing (GO:0000729),-0.3266456427726885,-0.8316311008190669,0.699047619047619,0.9212164255459365,1.0,6/18,24.17%,ATM;RAD50;SMARCAD1;RAD52;SLX4;BRCA1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.28290959583115305,-0.8315250937583318,0.7396061269146609,0.9208313009007201,1.0,15/33,29.82%,FOXO3;HOXA5;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2;FES;BRD1;RAB7B;NCKAP1L;MTURN;HSPA1B;ACVR2A
prerank,peptidyl-lysine methylation (GO:0018022),-0.2929271349546735,-0.8308231969010081,0.7202380952380952,0.9214940017443127,1.0,4/26,10.02%,SMYD3;SETD7;KMT5A;EHMT1
prerank,membrane raft organization (GO:0031579),0.3802550055321198,0.8306814961422945,0.6149068322981367,0.9214985408738305,1.0,6/15,14.92%,RFTN1;EMP2;PPT1;NPC1;ABCA7;MYADM
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3253296744885115,0.83053761354258,0.6396226415094339,0.9210454584195241,1.0,14/30,24.88%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;NSDHL;MVK;FDFT1;ACAA2;CYP51A1;FDPS
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.2986719358872357,-0.8300830660953894,0.7142857142857143,0.9222608046588401,1.0,3/24,6.10%,BMPR2;NIBAN2;ACVRL1
prerank,copper ion homeostasis (GO:0055070),-0.32359492398555234,-0.8297079263048758,0.7142857142857143,0.922336243724982,1.0,2/17,5.21%,APP;ATOX1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.2610956912077015,-0.8296296925227478,0.7437641723356009,0.9218903643441929,1.0,16/49,23.73%,ADAMTS9;DENND3;STT3B;SIDT2;IDE;DAB2IP;DNASE1L1;UBE2G2;PNPT1;MANBA;RIPK1;NGLY1;DFFB;FBXO17;CHEK2;EXOSC7
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2784238243215904,-0.8294027539098389,0.7145833333333333,0.9216961731919149,1.0,10/33,18.14%,ANXA1;CYP1B1;RHOB;PRKCD;RELA;SIRPA;NET1;RIPK1;OSER1;PARK7
prerank,relaxation of muscle (GO:0090075),0.3784806831696955,0.8286284929490875,0.6252676659528907,0.9239457312070609,1.0,2/13,3.06%,ATP1A2;PIK3CA
prerank,regulation of steroid biosynthetic process (GO:0050810),0.39554653559593433,0.8283072206167549,0.6306306306306306,0.9237866919885442,1.0,1/11,1.15%,BMP5
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.2998140782324996,-0.8275714471069974,0.7242798353909465,0.924459206232014,1.0,7/26,20.68%,OCLN;AKAP9;TRPV4;MET;TOGARAM1;FES;NUMA1
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.25376964526969736,-0.8271744966701836,0.8009708737864077,0.9245459427164029,1.0,22/52,32.09%,SEC31A;HSPA5;ERN1;ADD1;EXTL2;DNAJB11;DNAJC3;PARP16;PDIA6;PDIA5;GFPT1;TPP1;XBP1;SHC1;ATP6V0D1;EDEM1;PREB;SYVN1;YIF1A;ZBTB17;HYOU1;CUL7
prerank,early endosome to late endosome transport (GO:0045022),-0.32034836695988245,-0.8269128474632876,0.6759443339960238,0.9244241834472877,1.0,5/20,14.55%,EEA1;BECN1;RAB7A;WDR81;ANKRD27
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3453573948537944,0.826883678980156,0.6472945891783567,0.925750746165047,1.0,4/22,9.23%,RAPGEF2;NTRK2;RAP1A;TMEM108
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.36220719374122556,-0.8259154851561925,0.6813186813186813,0.9256136341735384,1.0,4/11,12.59%,IGF2BP2;NOVA2;PCBP2;NOVA1
prerank,superoxide metabolic process (GO:0006801),0.33038471205652,0.8258790057019302,0.686046511627907,0.9269629660306212,1.0,4/29,5.97%,NCF2;NCF1;ATP7A;SOD3
prerank,TOR signaling (GO:0031929),0.3330530503070202,0.8250236253439206,0.6792452830188679,0.9278613792649589,1.0,5/26,8.92%,EIF4EBP2;PRR5L;RPS6KB2;MTOR;NPRL3
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.37363088234670355,0.8247400767950502,0.6326963906581741,0.9277011821902122,1.0,3/15,9.01%,SEMA5A;FGF2;PRKD2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.29718428155305887,0.8240797109631266,0.6672597864768683,0.9281252682476832,1.0,11/48,12.69%,FNIP2;BCL2L10;CIDEB;CASP9;CDIP1;HTRA2;EPHA2;DDIT4;HIPK1;EP300;PRKDC
prerank,positive regulation of neuron migration (GO:2001224),0.3994114567363765,0.8240279765818004,0.6333333333333333,0.9274875759228404,1.0,1/11,1.01%,RAPGEF2
prerank,positive regulation of immune response (GO:0050778),-0.244857345481024,-0.8239697124609765,0.8110599078341014,0.9285180057414297,1.0,16/64,28.35%,IL15;IL6ST;LGALS9;IFI35;KARS1;GBP5;CYBA;RSAD2;CD81;XBP1;POLR3D;ITGB2;PLSCR1;EIF2AK4;ITGAM;SPHK2
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.35558945908449047,0.823852623025086,0.6365546218487395,0.927077336398463,1.0,5/18,20.21%,COX18;FASTKD3;COX20;OXA1L;SURF1
prerank,regulation of RNA export from nucleus (GO:0046831),0.3960188033707752,0.8235725400986273,0.6522727272727272,0.9268864093445374,1.0,2/11,7.48%,NCBP2;CPSF6
prerank,negative regulation of catalytic activity (GO:0043086),0.3404756482905096,0.8225160195438075,0.65625,0.9281375175100337,1.0,5/24,13.42%,NOTCH1;NES;CCAR2;ATP5IF1;PPP1R12A
prerank,positive regulation of isotype switching (GO:0045830),-0.3352223004580387,-0.8224092525294044,0.6975881261595547,0.9307732695266637,1.0,6/15,22.40%,TFRC;TGFB1;SHLD1;KMT5C;CLCF1;TNFSF13
prerank,regulation of histone methylation (GO:0031060),-0.3522145618397741,-0.8215203024435856,0.7128712871287128,0.9318585362058045,1.0,7/13,31.34%,JARID2;NSD1;NNMT;PIH1D1;AASS;PAF1;TET1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.2908931693704032,0.8210209765721127,0.7023411371237458,0.9302393212932869,1.0,8/62,11.46%,LIMD1;NUP43;AJUBA;DND1;POLR2C;NUP35;SEC13;NDC1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.3659718643520083,0.8209405321202073,0.6448979591836734,0.9296611438208383,1.0,4/17,7.70%,KCNE4;CACNA2D1;SCN5A;KCNE5
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.36709857722247774,-0.8208983653112351,0.7083333333333334,0.9323499518550998,1.0,2/10,6.62%,APPL2;ANO6
prerank,RNA destabilization (GO:0050779),0.3530691861025139,0.8208241906683519,0.6434262948207171,0.9291556062539686,1.0,5/18,13.07%,ROCK1;RBM24;YTHDF3;YTHDF2;CELF1
prerank,positive regulation of transport (GO:0051050),0.2762649189168419,0.8207893037670435,0.7119741100323624,0.9284998807162329,1.0,8/85,6.29%,NEDD4L;IL15RA;NR1H3;MERTK;IL1B;GPC3;CBLL1;SNCA
prerank,regulation of hormone secretion (GO:0046883),-0.33798614829786744,-0.8206532862781687,0.7011070110701108,0.9322122705632643,1.0,2/15,3.96%,SNX6;ANXA1
prerank,mitochondrion organization (GO:0007005),0.2500531038590332,0.8205345012127767,0.7850208044382802,0.9282860092663723,1.0,16/165,8.56%,PID1;HIGD1B;SLC25A33;IMMP2L;AKT3;PLD6;PTCD2;ATP7A;FANCG;ESRRA;SUPV3L1;GABPA;TIMM22;MTFP1;TFAM;RAB38
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3259049853331113,-0.8202883893984628,0.7434343434343434,0.9322686751088138,1.0,9/17,34.56%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,histone methylation (GO:0016571),-0.2939128001923941,-0.819788329905577,0.7176220806794055,0.9325565548331859,1.0,9/26,25.80%,SMYD3;CARM1;EHMT1;NSD1;SIRT7;EZH2;SETD6;TRMT112;FBL
prerank,response to X-ray (GO:0010165),-0.3410222586177605,-0.8196550747686421,0.7109375,0.9321911651688407,1.0,4/14,20.29%,ANXA1;ATM;XRCC4;IKBIP
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3543466428547103,-0.8192226600452862,0.7384615384615385,0.9324182466969838,1.0,4/12,17.70%,ABCA1;ITGB3;PPARA;NFKBIA
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.25854235545044707,0.8191765330949772,0.7563909774436091,0.9301283835144056,1.0,17/122,9.25%,PDGFRB;PLD1;RGCC;IL1B;FGF2;YTHDF3;IL4;DDX3X;SOX4;KAT7;IRS1;NMD3;MTOR;EIF3C;PRKD2;PDGFB;GCK
prerank,endosome organization (GO:0007032),-0.25991509068719154,-0.818513315321404,0.7539863325740319,0.9330752517665103,1.0,10/41,16.20%,EEA1;RAB27A;USP8;ALS2;ALS2CL;CLCN3;SNX10;CORO1C;PHETA1;ARFGEF2
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.2970186663350789,-0.8183179724300009,0.721881390593047,0.9328154038946783,1.0,6/23,14.30%,PARP9;PARP14;STAT1;IRGM;NLRC5;HSP90AB1
prerank,hexose metabolic process (GO:0019318),-0.268227764216094,-0.8180148802150123,0.7611607142857143,0.9327483477965429,1.0,18/39,33.43%,APOD;SORD;FUCA1;SLC35A2;CHST15;AKR1A1;GAA;FPGT;ALDOA;BRAT1;GALT;FUCA2;HK1;GDPGP1;KHK;IRS2;DCXR;CHST1
prerank,positive regulation of nervous system process (GO:0031646),-0.3266740116431971,-0.8178559242734926,0.7334630350194552,0.9324386451128294,1.0,4/18,9.96%,UNC13B;TNFRSF1B;PARD3;NLGN2
prerank,protein oxidation (GO:0018158),-0.35623958861467986,-0.8178057710325115,0.6913123844731978,0.9319342797014438,1.0,1/11,1.62%,LOXL1
prerank,actin nucleation (GO:0045010),0.34669056906683193,0.8175552631738089,0.6398390342052314,0.9323688866041693,1.0,6/21,13.39%,SPIRE1;ARPC5;ARPC5L;LMOD1;ARPC4;ARPC1A
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.3576338228950386,0.8174972535513145,0.6431718061674009,0.931759438915794,1.0,6/14,15.63%,AK8;NMNAT3;AK7;AK5;AK4;AK3
prerank,organelle fusion (GO:0048284),0.3404943272264621,0.8173199214113006,0.6473988439306358,0.9313905864440704,1.0,7/22,15.80%,PLD6;VPS18;VPS11;STX4;MFF;MFN1;MIEF1
prerank,regulation of cytoplasmic transport (GO:1903649),-0.36497504245955714,-0.8170880465441963,0.7067395264116576,0.9326370032824762,1.0,3/11,14.52%,LRRK2;ATP9A;MAPK3
prerank,neutrophil migration (GO:1990266),0.2905024427336661,0.816788857968542,0.7145328719723183,0.9316364268624046,1.0,6/58,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,gluconeogenesis (GO:0006094),0.30033394859226636,0.8166529439137776,0.6731141199226306,0.9311941843673625,1.0,7/39,15.44%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.30408883528125463,-0.8163499186715916,0.7146067415730337,0.9333027092463834,1.0,4/21,9.00%,MFHAS1;PTPA;FKBP1A;PPP1R16B
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.3642670791382134,0.8163238169478741,0.6492693110647182,0.9310903855286927,1.0,2/17,6.93%,RAPGEF2;ADCY9
prerank,neuromuscular junction development (GO:0007528),0.33587244812122385,0.8162394456920259,0.6633858267716536,0.9305308027712017,1.0,5/24,7.88%,CACNB2;DOK7;AGRN;ANK3;PPFIBP2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.368095396711964,-0.8157919940173828,0.7001733102253033,0.9336716516807708,1.0,1/10,1.69%,TGFA
prerank,dendritic cell differentiation (GO:0097028),-0.3009265949878656,-0.8154455214547722,0.7278350515463917,0.9337047734365573,1.0,3/22,5.50%,TGFBR2;GAS6;LGALS9
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.36838727694527285,-0.8152049726546592,0.7022900763358778,0.9335066475084852,1.0,5/10,22.97%,LRRK2;TXN;RIPK1;PARK7;STK26
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3319699790535816,-0.8149369055003073,0.716390423572744,0.9334154691123117,1.0,4/15,19.01%,ENTPD1;CMPK1;ENTPD5;ENTPD2
prerank,negative regulation of hemostasis (GO:1900047),-0.3503865985427299,-0.814724763636936,0.714828897338403,0.9332142449152437,1.0,3/12,4.57%,APOE;THBD;CD34
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.35118999031950227,-0.8146921950671399,0.7073170731707317,0.9326858231423838,1.0,1/12,0.40%,UNC13B
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.23632262811028978,-0.8141734651953276,0.8157894736842105,0.9330234328380592,1.0,31/78,28.30%,DAB2;CAV1;LRRK2;SMAD7;TAF1;RNF19A;RNF144B;SH3RF2;BBS7;USP5;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;BCAP31;FZR1;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;RNF19B;PSMD10;RACK1;PRKN;CEBPA;TRIB3;HSPA1B;CLU
prerank,entry into host (GO:0044409),-0.3366183862559087,-0.8136428500790908,0.7044609665427509,0.9333570932063227,1.0,7/13,32.50%,CDH1;MET;PPIA;CTNNB1;CXCR4;GRB2;CTNND1
prerank,myeloid dendritic cell activation (GO:0001773),-0.3518996802771147,-0.813399591987641,0.7173076923076923,0.9331824744123265,1.0,1/12,3.00%,TGFBR2
prerank,protein import into peroxisome membrane (GO:0045046),0.3414173043629982,0.8129488777676425,0.668724279835391,0.9359310546553257,1.0,6/22,15.58%,RAB8B;ABCD2;ATAD1;PEX3;PEX19;PEX12
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.238344437067677,-0.8124449757496475,0.8052256532066508,0.9342315206976212,1.0,21/73,20.58%,HDAC4;DNMT3A;KAT2B;RBBP7;IGF2;BAZ1B;H3-3A;JARID2;TRIM27;POLR2F;TDG;HDAC5;ACTB;PPHLN1;POLR2E;GPX1;EZH2;ZFP57;SMYD5;CTCF;MPHOSPH8
prerank,skeletal muscle contraction (GO:0003009),0.34014901030371825,0.8124420350227963,0.6392156862745098,0.9361225847056028,1.0,2/19,8.91%,RCSD1;STAC
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.30130076425062435,-0.8123100673446478,0.7197452229299363,0.9338856222183398,1.0,3/22,7.21%,ROCK2;PTPA;FKBP1A
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.2251036760484934,-0.8121024489805748,0.852760736196319,0.9336603805768635,1.0,29/94,24.89%,PLCB1;IL1R1;NOD1;IRAK2;MAP3K8;IRAK3;PSME2;RELA;PSMB4;FBXW11;UBB;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;PELI1;NFKBIA;MAP3K3;PSMD4;PSMA2;IKBKG;PSMD3;PSMB7;PSMC2;PSMC5;EGR1;PSMD10;MYD88
prerank,negative regulation of kinase activity (GO:0033673),-0.24232322880541304,-0.812036459178096,0.8255528255528255,0.9331965333049069,1.0,25/62,27.97%,PRKAG2;DEPTOR;LRP6;DTNBP1;AKT1;TRIM27;CEP85;QARS1;PPIA;GSKIP;CEACAM1;CDKN1B;PDPK1;PARK7;CHP1;TRIB1;UBASH3B;CDKN1C;INPP5K;PYDC1;GNAQ;PAK2;SFN;TRIB3;PPM1F
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.36437170379503925,-0.8116789996205711,0.7007168458781362,0.9326354842705022,1.0,2/10,21.33%,CACNA2D4;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.36437170379503925,-0.8116789996205711,0.7007168458781362,0.9326354842705022,1.0,2/10,21.33%,CACNA2D4;TULP1
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3817448498893804,0.8116748029302031,0.625,0.9368336078976871,1.0,4/12,9.65%,PTPN22;CD300A;LYN;PAX5
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3110466362076175,-0.8113161678793233,0.7564356435643564,0.9326556401586084,1.0,3/20,13.54%,WNT4;C1QTNF3;PGP
prerank,negative regulation of catabolic process (GO:0009895),0.3051595770010466,0.8110349709094129,0.7107142857142857,0.9373217302845991,1.0,4/47,4.05%,CBFA2T3;AGAP2;IL1B;FMN2
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3181165003285986,0.8108585865935304,0.6813186813186813,0.9369402553887731,1.0,10/35,14.57%,CDK6;ETS1;FAM210B;ANKRD54;ARNT;LYN;MED1;PRMT1;PRKDC;ABCB10
prerank,neuron fate commitment (GO:0048663),-0.3406459382249934,-0.8106058357548699,0.7243346007604563,0.9333429830195447,1.0,8/14,44.36%,TGFBR1;ID2;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.30537120340693175,-0.8104006521556686,0.732,0.9331070196173772,1.0,6/20,21.77%,ACACA;FAR2;ACSL4;HSD17B8;DGAT2;GCDH
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3605958608190384,0.8103853160184569,0.6576200417536534,0.9371093067862268,1.0,10/19,23.20%,GNL3L;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3461556835340288,0.810221404018474,0.6398390342052314,0.9366768226167037,1.0,3/18,8.09%,LDLRAP1;ADAM19;ACHE
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3447506285260997,-0.809664313939999,0.6754221388367729,0.9337778209896636,1.0,2/13,7.04%,IRAK2;PIK3AP1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.2258301722484511,-0.8094546386786565,0.8377581120943953,0.9335621674009706,1.0,29/91,25.85%,TAF1;MN1;CDC16;PSME2;ANAPC4;PSMB4;TRIM39;PSMB1;PSMD11;DDB1;PSMD8;DBF4;PSME3;CDKN1B;TCIM;ANAPC16;PSMD4;FZR1;PSMA2;PSMD3;CDC27;PSMB7;ANAPC5;PSMC2;ERCC2;PSMC5;PSMD10;ERCC3;TP53
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.30156511011273485,-0.8090474363470058,0.7434869739478958,0.9336746621091648,1.0,2/21,7.80%,EPHA7;BIRC3
prerank,mitotic spindle assembly (GO:0090307),-0.25803077118818873,-0.809018658660591,0.7797356828193832,0.9331400519037504,1.0,18/42,33.68%,RAB11A;RHOA;SMC3;TOGARAM1;SMC1A;CEP192;CHEK2;ABRAXAS2;MISP;ARHGEF10;PIBF1;TPX2;KIFC1;STAG2;KIF4A;GOLGA2;KIF23;PRC1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.31391719622625636,-0.8088383864288208,0.7203883495145631,0.9328372228028143,1.0,4/17,15.72%,CXCL12;ANO6;CREB3;SERPINE1
prerank,microtubule anchoring at centrosome (GO:0034454),0.3874215096583613,0.8088300950529178,0.6383838383838384,0.9384455101925239,1.0,5/10,21.22%,HOOK3;KIF3A;DCTN1;CEP19;CCDC68
prerank,chromosome organization (GO:0051276),-0.22162320803403213,-0.8086700007557376,0.8536585365853658,0.9325487271858915,1.0,36/99,31.23%,HDAC8;SETD7;TCF7L2;TOP2B;H3-3A;EHMT1;CUL4A;HDAC1;COPS4;UBB;COPS8;EZH1;HDAC5;DDB1;CENPT;HHEX;HMGB2;HMGN1;EZH2;CETN2;TOP2A;SMARCA4;MSH6;SATB1;BRWD1;COPS7A;L3MBTL1;NUP155;COPS2;CENPH;ABL1;NDC80;POLE3;SUPT4H1;DOT1L;CDCA8
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.27095589612451193,0.8086687886521798,0.7425431711145997,0.9380283056785633,1.0,9/95,6.42%,MEF2C;NR1H3;IL1B;AXL;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN
prerank,cholesterol biosynthetic process (GO:0006695),0.31694829484087556,0.8082893030659941,0.6698292220113852,0.9380322818289203,1.0,14/31,24.88%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;NSDHL;MVK;FDFT1;ACAA2;CYP51A1;FDPS
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.29971207728124005,-0.8080109238550822,0.7134268537074149,0.9331002122858381,1.0,7/21,23.00%,TALDO1;HK2;DERA;PGD;RPIA;PGLS;SHPK
prerank,regulation of lymphocyte activation (GO:0051249),0.3700130008652859,0.8078666772389187,0.6708860759493671,0.9380715537492409,1.0,1/12,3.86%,PAG1
prerank,protein insertion into ER membrane (GO:0045048),-0.27086458294730337,-0.8077687419566445,0.7573033707865169,0.9329485096037045,1.0,16/37,32.57%,APP;TRAM2;EMC2;STX1A;ALDH3A2;VAPA;GET1;SEC61B;EMC6;WDR83OS;CCDC47;UBL4A;TRAM1;HMOX1;GET3;MMGT1
prerank,protein polyubiquitination (GO:0000209),-0.1934723094859443,-0.8076413856271425,0.9858490566037735,0.9325991920199909,1.0,86/297,25.94%,FBXL7;RNF213;SASH1;HERC6;NPEPPS;SMURF2;FBXO10;RNF146;ZNRF1;TAF1;SPSB1;RNF19A;TNKS2;WWP2;RNF144B;TTC3;SMURF1;CDC16;AMFR;IFI27;UBE2E2;LNPEP;RC3H2;NHLRC3;CHFR;DTX3L;RNF135;TRIM27;PSME2;UBE4B;ANAPC4;RNF125;MDM2;PSMB4;UBE2Q2;FBXW11;UBB;UBE2G2;PSMB1;PSMD11;PSMD8;RNF115;WWP1;FBXL14;ANKIB1;PSME3;RNF187;PELI1;UBE3D;FBXL19;TRAF3IP2;PSMD4;LONRF1;TRIM14;FZR1;PSMA2;FBXO41;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RMND5A;RNF126;PSMB7;ANAPC5;RBBP6;DZIP3;FBXO17;CCNF;DDA1;RNF19B;PSMC2;CBFB;RNF8;TRIM6;RNF216;BRCA1;PSMC5;PSMD10;BFAR;DCAF15;PRKN;UBE2H;CTNNB1
prerank,piRNA metabolic process (GO:0034587),0.3507083935456187,0.8073252509149167,0.6673684210526316,0.9383536210477708,1.0,3/19,14.98%,PLD6;TDRKH;EXD1
prerank,regulation of glucose metabolic process (GO:0010906),0.30983430570952397,0.8072802191891448,0.6770642201834862,0.937727617437149,1.0,5/34,9.22%,RORA;OGT;IRS1;ZNF692;SDHAF3
prerank,DNA repair (GO:0006281),-0.1912262913592602,-0.8071553366062338,0.9764150943396226,0.9328600563964536,1.0,90/284,31.01%,EYA1;USP47;ASCC3;PARP9;PDS5B;INO80;HINFP;RAD51B;BAZ1B;TRRAP;ERCC5;DCLRE1C;DTX3L;PARP3;REXO4;MMS19;BRCA2;NABP1;POLH;APEX2;FANCI;ATM;UBB;UVRAG;TDG;XRCC4;FTO;DDB1;INIP;RPA1;KMT5C;ADPRS;RAD50;ASCC1;ACTR8;PARK7;RFC3;BABAM2;VCP;PIAS4;SMC1A;RECQL;RAD52;POLI;UBXN1;POLE2;BABAM1;CETN2;RAD51C;NEIL3;BAP1;SLX4;EXO5;RMI2;RAD51;ERCC1;CHEK2;ERCC2;MSH6;RNF8;ASF1A;BRCA1;RPA3;ALKBH5;PPP5C;CENPX;ACTR5;NUDT1;ERCC3;TP53;POLA1;NEIL1;HUS1;APLF;CDKN2D;ATXN3;POLD1;FANCM;FANCA;ABL1;WDR33;MNAT1;EID3;WRN;GTF2H3;UBE2V1;DOT1L;PCNA;EXO1;HERC2
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.37835838695412916,0.8070588901701826,0.6701902748414377,0.9374215885218642,1.0,4/12,17.68%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,dendrite self-avoidance (GO:0070593),-0.3194639439682275,-0.8069389412430983,0.7323420074349443,0.9326468750945222,1.0,3/16,10.18%,BSG;PALLD;ROBO4
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2315611244970948,-0.8061779945307317,0.844559585492228,0.9333321493967074,1.0,23/72,25.27%,MAP3K14;CARD14;BIRC3;AKT1;CARD10;PSME2;RELA;PSMB4;FBXW11;COPS8;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;DICER1;PSMB7;PSMC2;PSMC5;PSMD10;REL
prerank,regulation of interleukin-17 production (GO:0032660),-0.2804202164458957,-0.8061309703219195,0.7653508771929824,0.9328326975276793,1.0,6/31,16.54%,IL15;SLC7A5;IL18;TGFB1;SPHK1;TLR4
prerank,maintenance of protein location in nucleus (GO:0051457),0.33633861352590494,0.8052189656933649,0.6719681908548708,0.9400317861923737,1.0,1/20,1.25%,SYNE1
prerank,regulation of vesicle-mediated transport (GO:0060627),0.2681292092951339,0.8051759931488934,0.747557003257329,0.9394032284977647,1.0,25/91,18.92%,PLD1;SCARB1;RAB8B;RIT2;RIMS2;RAB3B;LGI3;SYT1;AP2S1;HIP1;ABL2;STXBP5L;STX4;DENND10;PACSIN3;SRC;PTPN1;RAB5A;CHMP3;MAPK1;HAP1;VAMP2;CPLX1;STXBP5;RAB33B
prerank,histone H4-K5 acetylation (GO:0043981),0.35043627291403284,0.8047045521104044,0.6470588235294118,0.9388634201510355,1.0,6/15,19.14%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,histone H4-K8 acetylation (GO:0043982),0.35043627291403284,0.8047045521104044,0.6470588235294118,0.9388634201510355,1.0,6/15,19.14%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,regulation of telomere maintenance (GO:0032204),-0.29035895615961316,-0.8046531081531855,0.7377690802348337,0.9347529165524281,1.0,5/26,16.95%,HDAC8;SMG6;PML;RAD50;SMG5
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.2845201234693729,-0.8041485843992893,0.7405764966740577,0.9350275967945225,1.0,7/26,14.98%,APP;MDM2;SMOC2;SPHK1;MEIS2;TAL1;EIF4EBP1
prerank,mRNA methylation (GO:0080009),0.3647074049495901,0.803913818322353,0.640973630831643,0.9396218201015594,1.0,6/15,19.99%,TRMT61A;CBLL1;TRMT10C;NSUN2;ZC3H13;WTAP
prerank,lymphocyte mediated immunity (GO:0002449),0.3725176243626819,0.8037280538366999,0.6554621848739496,0.9392402288323565,1.0,2/12,9.27%,CD46;JAG1
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.29712636938960174,-0.8036385886148767,0.7566037735849057,0.9341450773756951,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.29712636938960174,-0.8036385886148767,0.7566037735849057,0.9341450773756951,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.29712636938960174,-0.8036385886148767,0.7566037735849057,0.9341450773756951,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3443422846143842,0.8034959240250897,0.6715481171548117,0.9389629724947337,1.0,6/18,15.84%,LDLRAP1;SPTBN1;APPL1;ZDHHC2;VTI1B;CDK5
prerank,cilium-dependent cell motility (GO:0060285),-0.30619907729826573,-0.803379536476774,0.7338551859099804,0.9340117573092791,1.0,11/22,35.79%,EFHC1;EFHC2;DNAH3;DNAH8;DRC1;CCDC65;DNAH2;DNAAF2;TEKT2;CFAP44;DNAH17
prerank,amide biosynthetic process (GO:0043604),-0.2536777939223561,-0.8032028007519888,0.7888631090487239,0.9337208814878345,1.0,4/47,2.90%,PAM;PCSK5;SGMS1;SGMS2
prerank,protein-DNA complex assembly (GO:0065004),-0.21727227057360649,-0.8030486772536409,0.8952380952380953,0.9333854285747524,1.0,35/116,25.65%,KAT6B;TCF4;H3-3A;ERCC5;ANP32B;PSME2;CUL4A;PSMB4;UBB;PSMB1;PSMD11;DDB1;PSMD8;RPA1;PSME3;HMGB2;PSMD4;PSMA2;PSMD3;RSF1;PSMB7;NAP1L2;CETN2;MCM8;BRD2;RAD51;PSMC2;ERCC2;ASF1A;CHAF1A;PSMC5;RPA3;PSMD10;CDK7;ERCC3
prerank,integrated stress response signaling (GO:0140467),-0.33394194072482847,-0.8029239810687826,0.7200772200772201,0.9330275900092442,1.0,5/14,30.68%,QRICH1;HSPA5;EIF2AK3;EIF2AK4;CCL2
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.3583327435611441,0.8026454105802956,0.6955602536997886,0.9397909495407767,1.0,1/16,1.29%,RORA
prerank,gonad development (GO:0008406),-0.2587742172378595,-0.8026386795595297,0.7902869757174393,0.9329111692675109,1.0,11/41,26.76%,WNT4;AR;WNT5A;KIT;GATA6;BASP1;NCOA4;CSDE1;COL9A3;ADAM21;BIK
prerank,regulation of mast cell activation (GO:0033003),0.3827195480512814,0.8023702397713791,0.6594827586206896,0.9395661706403103,1.0,4/10,23.84%,LYN;CD84;TSLP;MILR1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.23981912023826407,-0.8021584898963565,0.841743119266055,0.9331930514286506,1.0,23/62,31.82%,MLLT3;RTF1;POLR2A;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;CDK7;ERCC3;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,oligodendrocyte development (GO:0014003),0.34891790440673176,0.8016592856037938,0.6395604395604395,0.9401087615810475,1.0,4/15,10.86%,B4GALT6;TPPP;PLP1;EIF2B3
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.369743249677028,0.8015072913232065,0.6509635974304069,0.939686590050182,1.0,3/11,15.02%,NCBP2;PAPOLA;DHX36
prerank,protein localization to chromosome (GO:0034502),-0.27149487637581493,-0.8011262272910673,0.7603305785123967,0.9343186880846603,1.0,10/34,22.52%,ESR1;TNKS2;PARP3;PINX1;XRCC4;RPA1;TPP1;CTCF;ACD;MCM8
prerank,positive regulation of cellular protein localization (GO:1903829),-0.23519921585664386,-0.800997711219396,0.8614609571788413,0.933952196614073,1.0,21/69,21.83%,LIMK2;PARP9;YAP1;GPD1L;STX3;TFRC;AKT1;DTX3L;CARD10;TGFB1;HSP90AB1;PRKAA2;TM9SF4;PARK7;LAMTOR5;ORMDL3;VPS28;CDK5RAP3;NUMA1;TYROBP;EIF2AK3
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2740489149976375,-0.800803457204028,0.7739872068230277,0.9336777635413153,1.0,5/34,9.91%,ROCK2;ACTN2;MFHAS1;CTNNA1;FLCN
prerank,cell-cell junction maintenance (GO:0045217),0.37197812192715163,0.8004227122926425,0.6876310272536688,0.9409015254630768,1.0,1/11,2.10%,FERMT2
prerank,protein import into nucleus (GO:0006606),-0.23905944912127683,-0.8001881441149541,0.8210526315789474,0.9341429594965268,1.0,24/66,29.60%,APPL2;STAT3;AKT1;IPO7;FAM53C;IPO13;RAN;RGPD1;KPNA6;RPL23;NXT2;IPO8;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,protein localization to mitochondrion (GO:0070585),-0.35893209199938275,-0.8001393097080628,0.7398058252427184,0.9336630553810176,1.0,8/11,34.23%,LRRK2;HK2;AKT1;MAIP1;HK1;ISG15;RALA;PINK1
prerank,positive regulation of protein maturation (GO:1903319),-0.35733135694369733,-0.7998105806974581,0.738404452690167,0.9336003704841401,1.0,1/11,1.79%,CCBE1
prerank,ion homeostasis (GO:0050801),0.30847427511680553,0.7994501353150518,0.6711798839458414,0.941964393977944,1.0,2/30,3.50%,NEDD4L;UNC80
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.326075471332982,0.79886623045914,0.6953125,0.9423078531708825,1.0,5/23,13.27%,CBFA2T3;SIK1;GCK;EP300;CRY1
prerank,respiratory chain complex IV assembly (GO:0008535),0.3359475602897018,0.7986052956114961,0.6605691056910569,0.9420453641804469,1.0,6/21,20.21%,COX18;FASTKD3;COA6;COX20;OXA1L;SURF1
prerank,regulation of receptor recycling (GO:0001919),0.3546217095190819,0.7985982742305842,0.6599099099099099,0.9413489403452336,1.0,3/16,6.29%,ECE1;AP1AR;SNCA
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.27050893881457544,-0.7984546231891487,0.7710583153347732,0.9352190611098403,1.0,8/34,15.74%,PTPRB;PTPN13;PTPRJ;DUSP1;DUSP16;PGP;DUSP7;DUSP10
prerank,regulation of establishment of planar polarity (GO:0090175),-0.21998168031686188,-0.7981640182075845,0.8784530386740331,0.9351287186217129,1.0,30/88,24.70%,SMURF2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMB1;PSMD11;PSMD8;PSME3;WNT11;ROR2;FZD1;PSMD4;PSMA2;PSMD3;PSMB7;VANGL2;AP2M1;PSMC2;PSMC5;PSMD10
prerank,negative regulation of endocytosis (GO:0045806),0.32906851779312896,0.797965345623458,0.6632653061224489,0.9417536119574567,1.0,11/24,23.37%,NR1H3;CD300A;SCAMP5;PACSIN3;ABCA7;SYT11;PRKD1;SNX33;LILRB1;PICALM;ARF6
prerank,cAMP biosynthetic process (GO:0006171),0.38988981354094815,0.7976415364739559,0.6767895878524945,0.9416251026814743,1.0,4/10,6.93%,ADCY8;ADCY3;ADCY6;ADCY9
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.23512397640238467,-0.7971205328803707,0.8259860788863109,0.9362613721322375,1.0,21/68,27.28%,AOX1;PCCA;ENPP1;SLC2A1;PCCB;CUBN;SLC5A6;ALDH1L1;SLC25A19;NNMT;FPGS;SLC52A3;CYB5R3;SLC19A2;SLC52A1;GSTO2;CD320;SLC25A32;PDXK;PNPO;MTRR
prerank,ganglioside metabolic process (GO:0001573),-0.2991513336020726,-0.7967025833894333,0.736328125,0.9363673327774928,1.0,8/20,21.68%,ST6GALNAC3;HEXA;HEXB;ST8SIA2;ST6GALNAC6;ST3GAL5;NEU3;CLN6
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.31325190799097385,-0.7962927348055798,0.755877034358047,0.9364724782458965,1.0,2/17,3.38%,PTPRJ;EZR
prerank,apical protein localization (GO:0045176),-0.36346613447031756,-0.7961747499547471,0.7375478927203065,0.9361021166939081,1.0,2/10,3.09%,SHROOM2;SHROOM3
prerank,T cell proliferation (GO:0042098),-0.33823163397085154,-0.796168801139608,0.7251461988304093,0.9355377919436935,1.0,7/13,42.31%,CTPS1;LMBR1L;PPP3CB;DOCK8;PIK3CG;TNFRSF4;CRTAM
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3290127597393167,0.7960831161086693,0.6923076923076923,0.9437643855523924,1.0,4/22,9.11%,NR1H3;PTPN22;APPL1;LYN
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.24740801130362614,-0.7956120558209256,0.8225419664268585,0.9358416539351282,1.0,13/49,19.92%,F3;LBP;NOD1;LGALS9;STAT3;MAVS;RELA;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5;SYK
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.346481088759318,0.7955972510722062,0.6680080482897385,0.943938156467981,1.0,5/17,13.73%,SPRED1;CADM4;SPRY2;DDIT4;SPRED2
prerank,erythrocyte development (GO:0048821),0.38107453886181664,0.7955838548023907,0.6513157894736842,0.9432515853152618,1.0,3/10,14.57%,SH2B3;MED1;ABCB10
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3504520443137656,0.7954980503611189,0.7020833333333333,0.9427026153616014,1.0,1/18,1.34%,PIK3R1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3232996839591134,0.7948258656990131,0.677734375,0.9431936800068739,1.0,3/22,2.42%,NOTCH1;ROCK1;PDE9A
prerank,regulation of TOR signaling (GO:0032006),0.28324174034115246,0.7942677096739372,0.7313691507798961,0.9435083898301803,1.0,15/67,16.23%,UBR1;PIK3CA;ROS1;AKT1S1;GNA12;NPRL3;DDIT4;DYRK3;SEC13;UBR2;TTI1;NPRL2;PRKAA1;MIOS;TSC1
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.35664646913179,-0.7940602858035065,0.7200736648250461,0.9378291664046486,1.0,4/10,21.77%,IVD;ACADL;ACADS;GCDH
prerank,base-excision repair (GO:0006284),-0.24965902307188287,-0.793767947951643,0.8281622911694511,0.9377260554012454,1.0,16/48,32.01%,USP47;ERCC5;APEX2;TDG;RPA1;ADPRS;RFC3;RFC1;NEIL3;RPA3;NEIL1;NTHL1;POLD1;WRN;PCNA;RFC5
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.3109394217914129,0.7930102558285436,0.6884920634920635,0.945082994060179,1.0,6/33,11.05%,PTK2;JAM3;RAC3;LYN;EPHA2;SNAI2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.27010765687688826,0.7925502412043861,0.7457627118644068,0.9451799499889152,1.0,7/65,4.85%,RORA;RGCC;CPEB1;KCND2;FMN2;SCN2A;EPAS1
prerank,protein localization to chromatin (GO:0071168),-0.30610746255189447,-0.7924280363573258,0.7611650485436893,0.9393275724889784,1.0,5/18,23.55%,ESR1;PPHLN1;MCM8;PIH1D1;SGF29
prerank,Golgi to endosome transport (GO:0006895),0.3491817799928057,0.7921516064912552,0.6989010989010989,0.9451898092573737,1.0,3/16,6.20%,CORO7;SORT1;AP1AR
prerank,mitochondrion disassembly (GO:0061726),-0.26066753934667247,-0.7920993502211189,0.7945205479452054,0.9392625747653706,1.0,9/34,25.64%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG7;ATG12;PRKN
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.3241507413159184,-0.7917340295115932,0.7333333333333333,0.9392378978726008,1.0,5/14,22.35%,ANXA1;PRKCZ;IL18;CCL19;RARA
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34171598934012865,0.7914278329396047,0.6882591093117408,0.9457269524978636,1.0,4/20,11.61%,NOTCH1;CHD6;RUNX2;EP300
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.37789092159824855,0.7911920872474164,0.668903803131991,0.9454268748004584,1.0,2/11,9.66%,UQCRFS1;UQCRC2
prerank,protein neddylation (GO:0045116),0.3624710462975159,0.7908554469832093,0.650319829424307,0.9453265897663677,1.0,6/13,23.42%,RBX1;DCUN1D2;UBE2F;RNF7;DCUN1D4;DCUN1D1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.33057750641566597,0.7903967523300366,0.6792079207920793,0.9454501401866038,1.0,3/20,5.07%,LDLRAP1;ARV1;SREBF2
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.3478352975478268,-0.7901865582063942,0.7586837294332724,0.9411089081831574,1.0,2/10,7.32%,GHR;STAT3
prerank,glutamate metabolic process (GO:0006536),0.3317292791226802,0.789939132421397,0.693069306930693,0.945588717885902,1.0,4/19,11.93%,GGT1;GOT1;GAD1;GLS2
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.37017594569935364,0.7896023318951118,0.6638477801268499,0.9454878747777808,1.0,1/10,2.89%,EMC7
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.22864743200341314,-0.7893584040058231,0.8589108910891089,0.9418358978098281,1.0,21/72,25.65%,ENPP1;EDC3;RNASE4;ERCC5;REXO4;ZC3H12A;CUL4A;DNASE1L1;UBB;DDB1;RPA1;RAD50;SPO11;RFC3;PNRC2;DICER1;RFC1;ERCC1;ERCC2;RPA3;ERCC3
prerank,nucleotide-excision repair (GO:0006289),-0.21775359859574772,-0.7891856359532472,0.9050131926121372,0.9415400972884461,1.0,32/101,27.15%,POLR2A;ERCC5;MMS19;BRCA2;CUL4A;COPS4;POLR2F;UBB;COPS8;DDB1;RPA1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;CETN2;SLX4;ERCC1;ERCC2;RPA3;POLR2G;COPS7A;CDK7;ERCC3;TP53;POLA1;HUS1;COPS2;ATXN3;PRPF19;POLD1
prerank,anterograde axonal transport (GO:0008089),-0.26043799229814746,-0.7891631265663912,0.7995642701525054,0.9409963094027546,1.0,6/37,10.29%,AP3S1;KIF1B;DTNBP1;AP3B1;RAB21;SPAST
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.2778107700956354,-0.7885506298326771,0.7955010224948875,0.9413779678027999,1.0,14/30,28.89%,CXCL12;TPT1;MDM2;SNAI1;THOC1;PSMD10;BCL2L1;RPS3;CD44;TWIST1;CDKN2D;CLU;PTTG1IP;THOC5
prerank,response to sterol (GO:0036314),0.3699126010388011,0.7883687393553711,0.6808035714285714,0.9469065988673182,1.0,1/11,1.29%,RORA
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.37289869930005043,0.7882902966892811,0.672093023255814,0.9463601983570863,1.0,3/11,11.50%,BCAR1;HPN;PAK1
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.33932353702538076,0.7878654241900163,0.6680584551148225,0.9463572533976553,1.0,1/16,1.63%,GPER1
prerank,neuron projection organization (GO:0106027),0.3427152437808221,0.7876967767933369,0.6860986547085202,0.9459820513994676,1.0,7/15,23.39%,ABCD2;CHRNA7;PSEN1;DCTN1;GSK3B;LGMN;ABCD1
prerank,regulation of pseudopodium assembly (GO:0031272),0.3749891278132535,0.7874098424691038,0.665943600867679,0.9450819869105727,1.0,3/10,15.91%,CDC42EP1;APC;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3749891278132535,0.7874098424691038,0.665943600867679,0.9450819869105727,1.0,3/10,15.91%,CDC42EP1;APC;CDC42EP4
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.3351116957023601,0.7869999713187052,0.705050505050505,0.9451746584225801,1.0,6/20,9.97%,RGCC;SPDYA;TTBK1;PKD2;PDGFB;CCNYL1
prerank,negative regulation of coagulation (GO:0050819),-0.32395088069908934,-0.786485785572811,0.7325800376647834,0.9440486559975256,1.0,3/14,4.57%,APOE;THBD;CD34
prerank,regulation of gluconeogenesis (GO:0006111),0.3105920885293505,0.786133340412096,0.7250996015936255,0.9459530320863494,1.0,7/27,13.27%,OGT;SIK1;ZNF692;SDHAF3;GCK;EP300;CRY1
prerank,spinal cord development (GO:0021510),-0.3398776757059915,-0.7860003897561194,0.7495361781076066,0.9442616038527919,1.0,2/12,2.85%,GLI2;VIT
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.29700083695697915,-0.7859995758537116,0.7782340862422998,0.9436896557986106,1.0,8/20,19.21%,ARRB1;BRD7;DIP2B;TADA2A;MAPK3;PRKAA2;NOS1;PPARGC1A
prerank,neuromuscular synaptic transmission (GO:0007274),0.3431228420089992,0.7859388655210273,0.6760259179265659,0.9455886945799513,1.0,4/18,8.50%,CHRNA3;ERC2;RIMBP2;SLC5A7
prerank,T cell differentiation in thymus (GO:0033077),-0.3228470396760639,-0.7859215636350058,0.7584905660377359,0.9432242221973497,1.0,7/14,34.85%,GLI3;MR1;ZFP36L2;RABL3;ADAM17;FADD;SHH
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3299482440628031,-0.7858251044790788,0.7390476190476191,0.9428183323304181,1.0,5/14,29.55%,ETNK2;LPIN3;ETNK1;ETNPPL;CHKA
prerank,regulation of DNA replication (GO:0006275),-0.2410375605530089,-0.7855952877507208,0.8488888888888889,0.9426053494440777,1.0,3/49,6.10%,EGFR;GLI2;ACVRL1
prerank,macrophage activation involved in immune response (GO:0002281),0.36531719146761554,0.7854138598163805,0.7155172413793104,0.9457929611136151,1.0,1/13,1.12%,DYSF
prerank,ncRNA transcription (GO:0098781),-0.3276782349021914,-0.78535077940322,0.7523105360443623,0.9424318966189735,1.0,3/13,19.53%,CAVIN1;SIRT7;GTF3C1
prerank,polyamine metabolic process (GO:0006595),0.36489997774590155,0.7853064706568591,0.6744186046511628,0.9452935890814067,1.0,4/13,16.45%,OAZ2;DHPS;AOC1;HDAC10
prerank,regulation of spindle organization (GO:0090224),-0.3016108259380559,-0.7849199123960355,0.775,0.9425631687238216,1.0,7/18,28.51%,PARP3;DYNC1H1;NUMA1;GNAI1;TPX2;FSD1;NUP62
prerank,peptidyl-threonine modification (GO:0018210),0.27138715904812977,0.7845335230508721,0.7613240418118467,0.9459274578907426,1.0,15/66,12.69%,GALNTL6;ROCK1;CDC42BPA;STK39;TNKS;TTBK1;GALNT13;GALNT1;MARK2;PRKD2;DYRK3;HIPK1;NLK;GALNT4;PRKDC
prerank,regulation of cellular catabolic process (GO:0031329),-0.23563934409278223,-0.7844271938631635,0.8498789346246973,0.9427598824715959,1.0,12/62,16.24%,DAPK1;NUPR1;LRRK2;WDR41;ACER2;PSAP;PIP4K2B;RAB8A;ATM;FBXL2;GPR137;MTMR3
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.37168887797568684,0.7843222062224343,0.689873417721519,0.9449261305310671,1.0,4/10,10.80%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.37168887797568684,0.7843222062224343,0.689873417721519,0.9449261305310671,1.0,4/10,10.80%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,coenzyme A metabolic process (GO:0015936),0.34874164232484073,0.7842337595418658,0.6916299559471366,0.9443706844116664,1.0,6/14,25.58%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,nucleocytoplasmic transport (GO:0006913),-0.2516126747214217,-0.7837957949733839,0.8326180257510729,0.9431415506273597,1.0,9/40,16.92%,ATXN1;GEMIN7;BACH2;GEMIN5;NUP98;SNRPF;NXT2;SNRPD1;SNRPD2
prerank,positive regulation of cell aging (GO:0090343),-0.3497900509775629,-0.7827036066158641,0.74373795761079,0.9442961772834685,1.0,2/11,13.89%,B2M;YPEL3
prerank,positive regulation of cellular senescence (GO:2000774),-0.35997477077161694,-0.7824980167085536,0.7410207939508506,0.9440803735300198,1.0,2/10,13.89%,B2M;YPEL3
prerank,macroautophagy (GO:0016236),0.25343220363681823,0.7820388229042432,0.8032305433186491,0.9475445654595089,1.0,36/118,22.98%,DYNLL1;PIP4K2A;ATG16L1;CHMP2B;MTMR14;MVB12A;MTERF3;SRC;VTI1B;UBXN6;PRKAA1;PLEKHM1;VPS33B;MFN1;TOMM40;CHMP3;HDAC10;EI24;PIK3C3;ULK3;SNF8;LIX1L;VTA1;GABARAP;NBR1;PRKAB2;CSNK2A2;TOMM70;VPS37B;GABARAPL2;ATG13;ARL8B;VPS16;VAMP7;VPS36;VDAC1
prerank,regulation of response to oxidative stress (GO:1902882),-0.34395644187615293,-0.7818343409643153,0.7216117216117216,0.9445394908828191,1.0,7/11,41.03%,MCTP1;GGT7;PRKN;PINK1;ALOX5;HEBP2;AIFM2
prerank,response to interferon-alpha (GO:0035455),-0.3135248621462814,-0.781180585402918,0.7441016333938294,0.9450108659181133,1.0,4/16,17.48%,GAS6;IFITM3;IFITM2;TPR
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3183544805475215,-0.7808336153732567,0.7371428571428571,0.944935182167217,1.0,5/15,14.51%,ARPC2;IQGAP2;ARPC1B;TRIM27;WASHC1
prerank,retinal metabolic process (GO:0042574),-0.3434680948752705,-0.7803170634869222,0.7402597402597403,0.945203045496019,1.0,2/12,7.95%,CYP1B1;ABCA4
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3445135854456644,0.7802324091094284,0.6945010183299389,0.9499606923369636,1.0,2/17,6.25%,CACNA1H;SCAMP5
prerank,ceramide biosynthetic process (GO:0046513),-0.2508318769028124,-0.7790566688007142,0.8073593073593074,0.946554178163867,1.0,9/40,16.93%,SGMS1;SGMS2;ST6GALNAC3;ST8SIA2;DEGS2;ST6GALNAC6;SPTLC2;ST3GAL5;CLN8
prerank,regulation of autophagosome assembly (GO:2000785),0.30920391142075365,0.7789435538859067,0.7432675044883303,0.9514296456507914,1.0,11/33,14.52%,PIP4K2A;IFT20;FEZ2;PIP4K2C;TBC1D12;PIKFYVE;NPRL3;NPRL2;FEZ1;UBQLN2;RAB5A
prerank,regulation of pH (GO:0006885),-0.3359648502658217,-0.7784452394412066,0.750465549348231,0.9468846467904952,1.0,4/11,17.51%,ATP6V0A4;LACC1;CLCN3;SLC9A1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.28087355840914713,-0.7783867072752363,0.8024691358024691,0.9464167817630917,1.0,5/25,13.39%,LRRK2;P2RX4;CMKLR1;CDH13;PLCG2
prerank,regulation of T cell differentiation (GO:0045580),0.31022922987185275,0.7782392368837132,0.7244367417677643,0.9519280814940563,1.0,3/33,6.03%,PRDM1;IL2RA;IL4
prerank,regulation of lipase activity (GO:0060191),-0.33541325257056126,-0.7779115221329468,0.7653631284916201,0.9465796514069563,1.0,2/13,6.58%,PCSK5;RHOA
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.3033393412192009,-0.7777865450004551,0.7753036437246964,0.9461931014523597,1.0,1/18,0.60%,PLCB1
prerank,positive regulation of catabolic process (GO:0009896),0.2708073648076559,0.7772789047330059,0.7658536585365854,0.9528679504358698,1.0,6/65,6.86%,NEDD4L;HECW2;IL1B;OAZ2;GPC3;HACE1
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20813389106234048,-0.7772351200768991,0.9395973154362416,0.946476022612958,1.0,35/114,25.85%,FOXO3;MAP3K14;TNFRSF11B;TNFRSF1B;PTK2B;STAT1;CARD14;BIRC3;TMSB4X;TNFRSF1A;EIF5A;PSME2;RELA;PSMB4;TNFRSF11A;PSMB1;PSMD11;PSMD8;PSME3;RIPK1;NFKBIA;EDA;PSMD4;PSMA2;EDA2R;PSMD3;PSMB7;EDAR;TNFSF13;PSMC2;PSMC5;PSMD10;TNFSF8;PYDC1;TP53
prerank,regulation of ERAD pathway (GO:1904292),0.3624156435220592,0.7771965931637211,0.6739606126914661,0.9523293220227145,1.0,1/11,1.93%,USP25
prerank,sulfur amino acid metabolic process (GO:0000096),0.3242373316705687,0.7771261739055327,0.725897920604915,0.9517609155778372,1.0,3/24,6.61%,CTH;TXN2;MSRA
prerank,peptidyl-lysine acetylation (GO:0018394),0.3764280911694814,0.7771048600257525,0.6931330472103004,0.9511062658661099,1.0,3/10,11.61%,KAT7;BLOC1S1;EP300
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2993504029685574,-0.7770721329337361,0.7874762808349146,0.9461838845695595,1.0,3/18,10.02%,SETD7;SETD1B;EHMT1
prerank,histone mRNA metabolic process (GO:0008334),-0.275049174178352,-0.7768878868630912,0.7780082987551867,0.9458874048725877,1.0,10/27,27.76%,TUT4;TUT7;MTPAP;ATM;SNRPF;XRN1;TENT4B;SNRPB;CPSF2;SNRPE
prerank,cellular response to pH (GO:0071467),-0.3058144940583867,-0.7767275475192637,0.7843137254901961,0.945555109965547,1.0,7/17,31.93%,RAB11FIP5;SLC9A1;CHP1;MCOLN1;PKD1L3;HVCN1;KCNK4
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2720329256088231,-0.7766250589504389,0.8159509202453987,0.9451388662031457,1.0,13/30,30.27%,CAV1;PARP14;PRKCZ;PRKCD;SFRP1;PTPN2;SAMSN1;PTPN6;NTF3;SH3BP5;PIBF1;SOCS1;INPP5F
prerank,mitotic recombination (GO:0006312),-0.3172376654854011,-0.7762899977742331,0.7549407114624506,0.9450790361536267,1.0,7/15,25.36%,TEP1;RAD50;TPRKB;RAD52;RAD51;ERCC1;RAD54B
prerank,regulation of neuron death (GO:1901214),0.26331009894889496,0.776178085036388,0.7790697674418605,0.9519641375237997,1.0,14/82,12.15%,MEF2C;MAP3K5;INPP5A;SNCA;CHRNA7;AKT1S1;HTRA2;GRM4;GRIN2B;SARM1;DDIT4;TRIM2;BTBD10;EPHB1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2603674421627506,0.7760780344330871,0.7705192629815746,0.9514601699492133,1.0,15/83,15.97%,CDK6;CUL3;CDK15;CRLF3;DHFR;SPDYA;CDKN1A;NPAT;LATS2;RB1;CDK14;EIF4E;CCNH;CDK5;CCNE1
prerank,rRNA methylation (GO:0031167),0.31574662528733666,0.7760522448829796,0.6853002070393375,0.9508117010192275,1.0,3/22,5.31%,MRM3;FBLL1;NSUN3
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3288570676801413,-0.7759116708716745,0.7699443413729128,0.9450747726801187,1.0,3/13,10.93%,GAS6;WNT5A;MAVS
prerank,mitochondrial transcription (GO:0006390),0.37767738834746223,0.7749738739803765,0.6919917864476386,0.9520171331122175,1.0,2/10,8.22%,SLC25A33;TFAM
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.2838890291345261,-0.7749250677605953,0.782435129740519,0.9459812932812509,1.0,6/23,22.35%,GAS6;LGALS9;ZC3H12A;TLR4;CD274;RARA
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2565845096556194,-0.7745267050003127,0.8252212389380531,0.9460199047079959,1.0,14/38,27.17%,RBBP7;UBN1;CENPC;H3-3A;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;HAT1;ASF1A;CENPX;CENPH
prerank,cytosolic transport (GO:0016482),0.24977363000641722,0.7743286681961198,0.8290322580645161,0.9524607491015762,1.0,26/108,15.95%,DENND2A;STX16;CORO7;SORT1;AP1G1;VTI1A;RIC1;EMP2;PIKFYVE;HOOK3;EHD3;TBC1D10C;BAIAP3;AKTIP;ARFRP1;VPS51;PLEKHJ1;GCC2;ANKFY1;VTI1B;DCTN1;RAB5A;PREPL;RHOBTB3;TMEM87B;TBC1D10B
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.22754119382253907,-0.7737710864712988,0.8746594005449592,0.9465697134263866,1.0,26/67,28.08%,B2M;TAPBP;SNAP23;PSME2;PSMB4;CALR;CYBA;PSMB1;PSMD11;PSMD8;PDIA3;PSME3;PSMD4;PSMA2;IKBKG;PSMD3;CYBB;PSMB7;VAMP8;PSMC2;PSMC5;TAP2;PSMD10;FCGR1A;PSMD7;TAP1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3316048468350211,0.7736035214525784,0.7078189300411523,0.9530221151190827,1.0,6/19,12.56%,MTCL1;CRB1;MARK2;DLG2;PARD3B;DLG3
prerank,myelin assembly (GO:0032288),0.37125106528114904,0.7732026599463042,0.7115384615384616,0.9530241078963383,1.0,3/10,8.39%,TPPP;NCMAP;TENM4
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2971800647721695,0.7728634092855251,0.7420560747663552,0.9529182131175544,1.0,8/33,19.25%,CLP1;NCBP2;LSM10;PAPOLA;SYMPK;SNRPD3;CPSF7;MED18
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3202715697729117,0.7722453406090541,0.732943469785575,0.9533121266366906,1.0,2/24,1.93%,NR1H3;USP25
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.2929837152123375,0.7721998258481435,0.73224043715847,0.9527113975657083,1.0,10/42,19.05%,WAS;FANCB;TIMELESS;CGAS;SHLD3;PPP4C;PARP1;MRNIP;RPA2;FUS
prerank,B cell differentiation (GO:0030183),0.2897960661823898,0.7721001614912789,0.7395264116575592,0.9521830874017805,1.0,3/46,6.03%,ITGA4;ITGB1;IL4
prerank,skeletal muscle tissue development (GO:0007519),0.30914083293270694,0.7716507199024997,0.7300380228136882,0.9522507370723916,1.0,3/32,7.45%,MEF2C;POPDC3;IGSF8
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.30944314373960946,0.7710720060829672,0.7121212121212122,0.9525397188858854,1.0,2/27,4.97%,LIMD1;AJUBA
prerank,tRNA methylation (GO:0030488),0.3008478925519505,0.7709112775383195,0.7132616487455197,0.9521207346840841,1.0,13/34,24.31%,TRMT61A;TRMT5;TRMT1;THUMPD2;TRMT10C;MTO1;NSUN2;METTL6;TRMT1L;DALRD3;GTPBP3;TRMT10A;TRDMT1
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.313564215283523,-0.7708721098859133,0.7708333333333334,0.9502491999346901,1.0,5/16,11.77%,LARGE1;ST6GALNAC3;A4GALT;ST8SIA2;ST6GALNAC6
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.3644556471587601,0.7705189318712624,0.6942675159235668,0.952140718665558,1.0,1/12,1.34%,PIK3R1
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21823710099839946,-0.7704870453470986,0.8916666666666667,0.9502432030952513,1.0,34/88,33.53%,FBXL7;PSME2;DMAC2;CUL4A;PSMB4;FBXW11;PSMB1;PSMD11;PSMD8;FBXL14;FBXL2;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;CUL5;FBXO17;CCNF;PSMC2;PSMC5;PSMD10;FBXL12;FBXL6;PSMD7;FBXL13;FBXL22;KIF14;FBXO44;FBXO38;PSMD12;PSMB9;FBXL20;FBXO2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.35009663278113473,0.7704376888997866,0.7258771929824561,0.9516018700721236,1.0,2/12,3.70%,OAZ2;ATP7A
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.33534161733995194,0.7700540822122466,0.7038539553752535,0.9515483859889801,1.0,3/18,9.00%,PTPN22;PAG1;MIA3
prerank,positive regulation of intracellular transport (GO:0032388),-0.25177264436065905,-0.7698333095508257,0.829004329004329,0.9505929789777305,1.0,17/38,27.29%,ACTN2;EHD1;EHD2;RUFY3;TPR;DYNC1H1;STX18;OAZ1;RAB29;NUMA1;RIPOR1;ICE1;STK11;TBC1D20;ZFAND1;SPAG5;B3GAT3
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.23318213421558376,-0.7697502297448342,0.8765432098765432,0.9501486677328967,1.0,17/57,26.23%,FOXN3;RINT1;TAOK2;ATM;TRIM39;CCND1;FZR1;BABAM2;CDK5RAP3;BABAM1;RPS27L;CHEK2;BRCA1;STK33;TP53;ATF2;HUS1
prerank,protein K48-linked ubiquitination (GO:0070936),0.2772895334740274,0.7695947429993416,0.755632582322357,0.9516142756487231,1.0,9/54,11.86%,NEDD4L;CUL3;RBX1;UBE2E3;HACE1;UBE2E1;UBE2G1;KBTBD7;UBE3A
prerank,non-motile cilium assembly (GO:1905515),-0.2652976415710441,-0.7690665012583711,0.7835990888382688,0.9505978992394907,1.0,11/30,29.18%,TOGARAM1;TMEM216;VANGL2;TBC1D32;TMEM17;C2CD3;TMEM107;PIBF1;IFT122;DISC1;CCDC13
prerank,positive regulation of DNA recombination (GO:0045911),0.31007382911981124,0.7687130036804142,0.7022058823529411,0.9524446907801672,1.0,8/27,19.05%,WAS;FANCB;TIMELESS;SHLD3;KMT5B;PARP1;MRNIP;FUS
prerank,regulation of phosphatase activity (GO:0010921),-0.28201459540281615,-0.7686694408264964,0.8152610441767069,0.9506422525121392,1.0,7/24,23.32%,PTPA;SH3RF2;HSP90B1;TIPRL;CHP1;CDK5RAP3;SH2D4A
prerank,negative regulation of hormone secretion (GO:0046888),-0.3407516171494252,-0.7685988864382132,0.7635009310986964,0.9501541723077923,1.0,3/10,14.97%,GJA1;RAB11FIP1;RAB11FIP5
prerank,regulation of mast cell degranulation (GO:0043304),0.34571288979583925,0.7680099063109878,0.6931106471816284,0.9529581680055665,1.0,4/14,10.09%,CD300A;IL4;LYN;STXBP2
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.23105391562752176,-0.7678547124164485,0.8761261261261262,0.9506411272721641,1.0,18/58,26.97%,POLM;DCLRE1C;NHEJ1;ATM;UVRAG;XRCC4;RAD50;PAXX;HMGB2;CYREN;BABAM2;PIAS4;BABAM1;ERCC1;RNF8;BRCA1;POLA1;PRPF19
prerank,response to organonitrogen compound (GO:0010243),-0.25059799396630517,-0.7657639014772576,0.8365591397849462,0.9531077893247414,1.0,14/38,30.30%,RCN3;RNF139;GLRA3;RNF185;IRAK3;VCP;DNAJB12;CCDC47;KYNU;RRAGC;PRKN;TRPM2;SYVN1;MEAK7
prerank,neurotransmitter uptake (GO:0001504),0.34887547657319806,0.7648990383827086,0.704,0.9575394182371865,1.0,2/12,3.78%,ATP1A2;SNAP25
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2827641100667281,-0.7640021976883047,0.8020618556701031,0.955056016111976,1.0,11/23,31.02%,LMAN1;SURF4;HSP90B1;NPLOC4;VCP;TMED9;SEC61B;SEC16A;PREB;SYVN1;AUP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2745863412532878,-0.7637186058853457,0.8008130081300813,0.9549172418459122,1.0,7/25,16.14%,FOXO3;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.298589777638831,0.7636904721587974,0.7495145631067961,0.9588792876410401,1.0,1/33,0.42%,PTEN
prerank,regulation of astrocyte differentiation (GO:0048710),0.3607792810144633,0.7635806171469988,0.7008928571428571,0.9583715511652047,1.0,2/12,7.30%,NOTCH1;BIN1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.33707310947367886,-0.7635698973794829,0.7757009345794392,0.9545672377447728,1.0,3/11,19.18%,GFPT2;UAP1;GFPT1
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2704786560157541,-0.762435668158681,0.8210116731517509,0.9556177194126299,1.0,14/26,36.48%,LRRK2;AKT1;TXN;PPIA;PARK7;PRKN;BAG5;SOD2;HSPB1;PINK1;PYCR1;MAPK7;VNN1;NME5
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3206883370195089,0.7619107299926273,0.7585513078470825,0.9605378577043951,1.0,6/26,15.88%,HECW2;CUL3;NEK6;RB1;ANAPC7;NSMCE2
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3308965212372212,-0.7615718991517959,0.7813084112149533,0.9563300546702059,1.0,1/11,5.85%,WIPI2
prerank,protein hydroxylation (GO:0018126),-0.3053736495730761,-0.7612691331872984,0.7796296296296297,0.9562107005777469,1.0,5/15,20.61%,PLOD2;EGLN3;PLOD1;P3H4;PLOD3
prerank,histone lysine methylation (GO:0034968),-0.259294495491177,-0.761254902104193,0.8175824175824176,0.9556663925075536,1.0,18/33,40.84%,SMYD3;SETD1B;PRDM5;EZH2;SETDB1;SETD6;WDR5B;TRMT112;RBBP5;DOT1L;WDR82;ASH2L;KDM6A;DYDC2;SETDB2;DPY30;N6AMT1;SMYD2
prerank,signal transduction in response to DNA damage (GO:0042770),0.2781950350376773,0.7610042744804525,0.7738095238095238,0.9613474980050766,1.0,7/49,14.26%,MAP3K20;CASP9;RAD1;MYO6;ATR;RAD17;ATRIP
prerank,proteasomal protein catabolic process (GO:0010498),0.22537063743132785,0.7604647613368768,0.8780487804878049,0.9615641773533099,1.0,27/201,12.49%,NEDD4L;TNFAIP1;HECW2;BTRC;TRIM9;CUL3;RBX1;PSMB11;SIAH2;UCHL1;SPOPL;FBXO45;ATE1;PSMF1;HACE1;SIAH3;KCTD13;HECW1;UBE2G1;UBXN2B;SOCS6;KBTBD7;TRIM2;SPOP;KCTD5;PSME4;APPBP2
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2991742947142681,-0.7604498132133023,0.8043912175648703,0.9556811366688557,1.0,10/17,33.01%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;IL7;SOCS1;IRS2;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),-0.2991742947142681,-0.7604498132133023,0.8043912175648703,0.9556811366688557,1.0,10/17,33.01%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;IL7;SOCS1;IRS2;STAT5B;IL2RG
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.24431775383945348,-0.7604345639032305,0.8311688311688312,0.9551348039380378,1.0,9/40,17.83%,KMT5A;PRKCD;IER3;MCL1;POLH;FXR2;CDK9;SIRT7;NPAS2
prerank,telomere capping (GO:0016233),0.35290518889951156,0.7602343871775608,0.7060085836909872,0.9612675475544813,1.0,5/16,22.11%,DCLRE1B;PRKDC;TERF1;TINF2;CTC1
prerank,membrane fusion (GO:0061025),0.2990659285843046,0.7602303782590528,0.7626811594202898,0.9605879785672182,1.0,9/33,17.69%,DYSF;RIMS1;HACE1;UBXN2B;VTI1B;VPS33B;GCA;DNM1;VAMP2
prerank,protein targeting (GO:0006605),-0.20632817260447747,-0.7593937337596557,0.953757225433526,0.9560374948563062,1.0,42/118,29.95%,LAMP2;KIF13B;SDCBP;ZFAND6;NACA;RASSF9;TAOK2;PARD3;AP4M1;RPL11;TOMM7;ZDHHC24;GDAP1;AQP11;TIMM13;BCAP31;HOMER3;TOMM22;MICALL1;SPCS1;AP4E1;HPS4;TIMM8B;TOMM34;TOMM5;SEC61A1;ZDHHC15;TIMM9;VPS37D;AP4B1;LTBP2;TIMM44;ZDHHC7;YIF1B;RABGEF1;RAB3IP;EDEM1;ZDHHC12;TIMM10;SRP14;TSPO;SEC63
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.2428933568667265,-0.7591557096453861,0.8519362186788155,0.9557921750882752,1.0,11/43,21.71%,FOXN3;RINT1;CHFR;TAOK2;NABP1;ATM;TRIM39;FZR1;BABAM2;CDK5RAP3;BABAM1
prerank,nucleotide biosynthetic process (GO:0009165),-0.2940117385652705,-0.7587872258043499,0.8,0.9557421421606398,1.0,7/18,22.56%,ME1;PRPS2;NMNAT1;PRPS1;PRPS1L1;PNP;RRM2B
prerank,amino sugar biosynthetic process (GO:0046349),-0.3329215721476076,-0.7579686814787321,0.8,0.9563281725555637,1.0,3/12,19.18%,GFPT2;UAP1;GFPT1
prerank,protein trimerization (GO:0070206),-0.3175998106390419,-0.7577781860973396,0.7616387337057728,0.9554457477584051,1.0,4/14,16.55%,SCARA5;CLYBL;DISP1;PNPT1
prerank,protein homotrimerization (GO:0070207),-0.3175998106390419,-0.7577781860973396,0.7616387337057728,0.9554457477584051,1.0,4/14,16.55%,SCARA5;CLYBL;DISP1;PNPT1
prerank,nucleoside salvage (GO:0043174),0.3718591805889865,0.7577333010612807,0.7208791208791209,0.9639496282936053,1.0,3/10,8.19%,TK1;TK2;DCK
prerank,regulation of phosphate metabolic process (GO:0019220),0.34069830419587344,0.757379919399903,0.7033898305084746,0.9638369839263122,1.0,5/16,14.20%,IL4;MCM7;SMG7;PSEN1;RAD17
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.34849739039449906,-0.7571585334408687,0.7759259259259259,0.9557601411304403,1.0,2/10,6.25%,LRP6;WNT5A
prerank,negative regulation of cell cycle process (GO:0010948),-0.22359299624639603,-0.7570140273207566,0.8835616438356164,0.9554140370805029,1.0,9/61,10.23%,BMP7;TOM1L2;BMP4;TFDP2;RBBP7;TOM1L1;ZFYVE19;EHMT1;DAB2IP
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.24873089575507273,-0.7569074218118578,0.8400900900900901,0.9549895639438609,1.0,14/38,29.11%,NPEPPS;LRRK2;LMAN1;SH3GLB1;TOMM7;SAE1;SREBF1;LEPROT;HPS4;USP36;BAP1;PRKN;FZD5;RHOU
prerank,cellular response to chemical stress (GO:0062197),-0.21328869754524363,-0.7566690024430268,0.9122340425531915,0.954761098529133,1.0,41/96,30.88%,FOXO1;FOXO3;CAV1;LRRK2;CPEB2;PRDX2;ZC3H12A;SLC25A24;VKORC1L1;TRPV4;ATM;CYBA;PPIA;VRK2;PRKAA2;PNPT1;SIRT2;GPX1;PARK7;STX2;BRF2;MT3;PPARGC1A;NOX1;RAD52;CYBB;TXNRD2;PYCR2;ATG7;ZFAND1;FAS;PRDX1;SOD2;ABL1;HSPA1B;ATP13A2;GSR;NUDT2;KEAP1;AIF1;CHCHD2
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.23803097808910312,-0.7549024763737087,0.8662131519274376,0.9566212728437785,1.0,7/48,17.26%,ZMIZ1;KAT2B;BAZ1B;POLR2F;ACTB;ZMIZ2;POLR2E
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3035138277434273,0.7547233603434665,0.7385496183206107,0.9675162638822641,1.0,8/31,17.73%,CACNA1H;SCAMP5;SYT1;SYT2;CBARP;SYT12;SYT11;SYT13
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.34034525625439715,0.7541685553636633,0.7468619246861925,0.9677511338176288,1.0,2/13,7.48%,NCBP2;CPSF6
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.34429705138254857,0.7538401651673088,0.7474332648870636,0.9676246093057963,1.0,4/13,17.68%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,microtubule polymerization or depolymerization (GO:0031109),0.30655241207058553,0.7532714779038227,0.7494908350305499,0.9679072611307785,1.0,3/25,6.38%,NCKAP5;FGF13;TPPP
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.33637181191300514,-0.7532650620526864,0.7747747747747747,0.9583029916764472,1.0,5/10,34.57%,JARID2;DNMT1;BRCA1;KDM1A;ATRX
prerank,DNA metabolic process (GO:0006259),-0.18213470175176547,-0.7531117878027508,0.9954954954954955,0.9579577221465327,1.0,109/270,37.68%,SP100;TCF7L2;PDS5B;INO80;HINFP;RAD51B;TOP2B;TRRAP;ERCC5;PARP3;REXO4;MMS19;SAMHD1;NT5E;NABP1;POLH;DNASE1L1;ATM;UBB;RAN;UVRAG;GLRX2;TDG;DDB1;INIP;RPA1;KMT5C;ADPRS;RAD50;DBF4;CBS;HMGB2;SIRT7;PARK7;TYMS;RFC3;VCP;SMARCAD1;SMC1A;RECQL;RAD52;POLI;TOP3A;DFFB;POLE2;RFC1;DNMT1;TOP2A;RAD51C;ACD;NEIL3;MCM8;SLX4;RMI2;RAD51;CDC45;ERCC1;MSH6;ASF1A;BRCA1;RPA3;SRPK2;NUDT1;ERCC3;POLA1;NEIL1;HUS1;NTHL1;POLD1;PRIM2;FANCA;TOP1;MCM3;MNAT1;EID3;POLE3;WRN;MCM5;GTF2H3;MCM10;DOT1L;PCNA;EXO1;DMC1;RAD54L;RFC5;FANCL;RAD51AP1;HUS1B;RECQL5;UHRF2;LONP1;CDC34;CHEK1;UHRF1;RAD51D;MGMT;FANCC;TOPBP1;ENDOG;PRIMPOL;CDK1;CDC6;ZRANB3;FEN1;DCTPP1;DNASE2;TICRR;TRIM28
prerank,linoleic acid metabolic process (GO:0043651),0.32934490609261646,0.752531276544804,0.7402061855670103,0.9684562807643997,1.0,1/17,2.03%,FADS2
prerank,synaptic vesicle recycling (GO:0036465),0.29897615462686244,0.7521684203550921,0.7373540856031129,0.9683542206913743,1.0,7/31,15.84%,CEL;SNCA;SYT1;SYT2;NLGN3;RAB5A;CDK5
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.2766199731663468,-0.7518413062078568,0.8235294117647058,0.9591418606617549,1.0,12/22,31.43%,DUSP1;DUSP16;DUSP7;PPM1B;DUSP10;PPM1G;PPP5C;PPM1F;PPP1CA;DUSP8;DUSP4;DUSP18
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.29488229727449394,0.7512998020309373,0.7412451361867705,0.9690660310693027,1.0,2/33,2.01%,TNKS1BP1;DCLRE1B
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.2900210346703277,-0.7506190704478768,0.7974413646055437,0.960177429719773,1.0,6/20,16.54%,LBP;PRKCE;IL18;TGFB1;TICAM1;TLR4
prerank,negative regulation of locomotion (GO:0040013),-0.3269616144244054,-0.7500890896309591,0.7536764705882353,0.960305657087447,1.0,4/12,19.45%,FBLN1;CCDC125;FRMD5;PTPN2
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.2779803585891042,0.7500342186598885,0.7845303867403315,0.9704597293208406,1.0,14/44,18.07%,ROCK1;PRR5L;RBM24;YTHDF3;NANOS1;TNRC6C;YTHDF2;TNRC6B;CELF1;DHX36;CNOT1;RC3H1;KHSRP;ZC3HAV1
prerank,nucleic acid metabolic process (GO:0090304),-0.22224037504286465,-0.7500277380533489,0.9149425287356322,0.9598358799896601,1.0,12/69,14.80%,RBFOX2;ENPP1;POLR2A;PCBP2;ATXN2;MMS19;NT5E;DNASE1L1;POLR2F;RAN;DDX24;RAD50
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22278132019225397,-0.7492990689276058,0.9145496535796767,0.9602175256467184,1.0,23/64,31.82%,MLLT3;RTF1;POLR2A;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;CDK7;ERCC3;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,regulation of JUN kinase activity (GO:0043506),0.2976317270673423,0.7489274655670748,0.7884615384615384,0.9716265144441351,1.0,8/33,15.58%,MAP3K5;PTPN22;TAOK3;PAK1;TRAF6;DVL2;TRAF2;DVL3
prerank,cell cycle G1/S phase transition (GO:0044843),0.2608241406418662,0.7485955543632989,0.8003442340791739,0.9715212409772206,1.0,9/61,14.27%,CDK6;CUL3;CRLF3;SPDYA;CDKN1A;LATS2;RB1;EIF4E;CCNH
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.29811646780425144,0.7483096483119287,0.789272030651341,0.9713012793396884,1.0,7/32,16.24%,SLC44A2;ABHD3;ACHE;STARD7;CHKB;LPCAT1;LPIN2
prerank,histone lysine demethylation (GO:0070076),-0.2712581339527081,-0.7481101240792928,0.8326180257510729,0.9613022626694034,1.0,4/25,16.16%,KDM7A;KDM5B;KDM3A;KDM6B
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.30001641255964095,0.7476579224140496,0.7562380038387716,0.9716680173286476,1.0,5/29,8.14%,NR1H3;SCARB1;LDLR;FABP3;MTOR
prerank,secondary alcohol metabolic process (GO:1902652),-0.23872307131267606,-0.7475135645805303,0.8538812785388128,0.9615665083262434,1.0,9/42,21.68%,ABCA1;APOE;CYP27A1;OSBPL1A;STARD3;IDH3G;CLN8;EBP;CLN6
prerank,carboxylic acid catabolic process (GO:0046395),-0.31927174724721835,-0.7471904054013486,0.8015122873345936,0.9614399754545678,1.0,8/12,53.15%,PON3;BCKDK;IL4I1;AMDHD2;GNPDA1;PON1;ACOT4;RENBP
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.29445587010404595,-0.7469261337924619,0.7963302752293578,0.9612028363194607,1.0,10/17,36.48%,P4HB;AKT1;PPIA;BAG5;SOD2;HSPB1;TREM2;MAPK7;VNN1;NME5
prerank,rRNA catabolic process (GO:0016075),0.3259614083890782,0.7467579545099543,0.7207392197125256,0.9724097672183141,1.0,2/16,10.41%,PELO;TRIR
prerank,interstrand cross-link repair (GO:0036297),0.273175018924648,0.7467085972218298,0.806282722513089,0.9718005281861604,1.0,12/53,17.06%,DCLRE1B;FANCF;FANCG;FANCB;ERCC4;ATR;USP1;FANCE;FANCD2;ATRIP;XRCC3;RPA2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.2988677474749941,-0.7455856825124992,0.8055009823182712,0.9624257674697898,1.0,7/16,37.22%,HMGB2;DICER1;DFFB;FOXL2;EXOG;ENDOG;DNASE2
prerank,RNA catabolic process (GO:0006401),0.26943297887138706,0.7455792383673757,0.7884940778341794,0.9728815353682706,1.0,14/46,20.43%,AGO3;SUPV3L1;XRN2;RNASE6;YTHDF2;SND1;PABPC4;RNASEH1;RNH1;CNOT10;DIS3L2;LSM2;HNRNPD;LSM6
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28544686593150986,0.7451120695384766,0.7603143418467584,0.9729235803768127,1.0,5/36,6.46%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,vacuolar acidification (GO:0007035),-0.28516883128491555,-0.7450315091689467,0.8336673346693386,0.962609355851412,1.0,9/21,27.55%,ATP6V0A4;ATP6V0A1;TCIRG1;ATP6V0A2;CLN6;CCDC115;CLN5;TMEM199;ATP6V0D1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.2683583350657009,0.745011094268209,0.8027210884353742,0.9724239624360295,1.0,7/53,10.67%,GLMN;RHBDF1;ALAD;DESI1;PSMF1;GNA12;XPO1
prerank,tryptophan metabolic process (GO:0006568),0.35091799248578065,0.7448221499630092,0.7109704641350211,0.9720525037160004,1.0,1/11,3.70%,ATP7A
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3129164433024987,-0.7447584876228888,0.792910447761194,0.9624083705439882,1.0,3/13,17.91%,STX7;MR1;CYRIB
prerank,positive regulation of chromosome organization (GO:2001252),0.33597021072782723,0.7440544423178685,0.7160751565762005,0.9726007496771304,1.0,5/15,17.60%,LIG4;SHCBP1L;PPP1R10;DHX36;DDX11
prerank,covalent chromatin modification (GO:0016569),-0.30520822806968695,-0.7437278700410274,0.7927272727272727,0.9631884358142777,1.0,5/14,22.13%,HDAC1;SIRT7;PARK7;MT3;MBD2
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.33889931052860917,-0.7425890744150224,0.7818181818181819,0.9641085590263219,1.0,6/10,51.18%,TLR4;NCKAP1L;VSIR;IL12A;FOXP3;IL12B
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.33872413756013275,0.74211297019806,0.7100840336134454,0.9749564627141625,1.0,1/13,1.15%,BMP5
prerank,neuromuscular process controlling balance (GO:0050885),0.3431561281223604,0.7420175039611858,0.7325842696629213,0.9744054435979715,1.0,1/12,3.16%,NRXN1
prerank,autophagosome maturation (GO:0097352),-0.25180581314885153,-0.7418303840994083,0.8427672955974843,0.9645212199399461,1.0,7/32,21.44%,LAMP2;WIPI2;UVRAG;CALM1;GABARAPL1;VCP;VAMP8
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.22808253999622013,-0.74180841123771,0.8961352657004831,0.9639886799648029,1.0,17/50,31.12%,CCND2;CCND3;CCNG1;CCND1;ACTB;HSP90AB1;CDKN1B;CDK5RAP3;CDKN1C;CCNF;SERTAD1;CDK7;CDC25A;CDKN2D;MNAT1;CDKN3;CDKN2B
prerank,regulation of hemopoiesis (GO:1903706),0.36340100036270534,0.741548160320662,0.7328918322295805,0.974428713682626,1.0,1/10,2.51%,PTN
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.2778123279473424,-0.7411203268083687,0.8301526717557252,0.9637368668932454,1.0,9/20,36.32%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.2778123279473424,-0.7411203268083687,0.8301526717557252,0.9637368668932454,1.0,9/20,36.32%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.3126984354254164,0.7410311728245409,0.7224409448818898,0.9745564385271366,1.0,2/21,2.53%,MYH9;ADAM19
prerank,response to hexose (GO:0009746),-0.26437428843918154,-0.7407065958039806,0.8259109311740891,0.9637323028392712,1.0,2/25,3.88%,THBS1;TCF7L2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.25038685317392284,-0.7392397905502769,0.8521560574948666,0.9650444473271644,1.0,13/33,29.29%,PTPRJ;EZR;RELA;CEACAM1;RAB29;PTPN2;IKBKG;CD81;DGKZ;RPS3;BCL10;LAPTM5;KCNN4
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.35207112358348813,0.7390602353821502,0.7032710280373832,0.9770423714975311,1.0,1/10,1.44%,JAM3
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21394910488524313,0.7390497268333375,0.9440203562340967,0.9763739729025869,1.0,55/314,16.30%,NEDD4L;TNFAIP1;UBR1;HECW2;BTRC;TRIM9;FAM8A1;CUL3;RBX1;DERL3;PSMB11;SIAH2;FAF2;FOXRED2;UCHL1;SPOPL;FBXO45;PSMF1;UBR3;HACE1;SGTB;UBE2J2;UBE2E1;SIAH3;KCTD13;HECW1;UBE2G1;UBXN2B;PTTG1;KBTBD7;TRIM2;RB1;ERLIN1;UBR2;SPOP;KCTD5;PSME4;RNF121;APPBP2;ANAPC2;RMND5B;ANAPC7;UBQLN2;DNAJC18;SKP1;AMN1;ARMC8;FAF1;MAD2L1;RNF103-CHMP3;ZFAND2A;KCTD17;PSMB5;ERCC8;TMUB2
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.3289821356950112,-0.7380946681730641,0.8190127970749543,0.9659416594269459,1.0,5/10,26.72%,PDCD4;MAPK8IP1;DUSP10;HIPK3;AIDA
prerank,proton transmembrane transport (GO:1902600),0.2839544065814076,0.7380753628605896,0.7867647058823529,0.9772262045859238,1.0,3/36,6.14%,ATP1A2;ATP1A4;ATP6V0E2
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.27243122505522765,-0.7375524619495316,0.83984375,0.9660515707562859,1.0,12/21,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.28589766909561304,0.7371534542471986,0.783203125,0.9779505898227574,1.0,6/36,9.08%,USP25;RYBP;OGT;ALAD;PSMF1;CCAR2
prerank,polyol biosynthetic process (GO:0046173),-0.2922713230670205,-0.7371527135301431,0.8074074074074075,0.9660075535062349,1.0,5/16,14.32%,CYP27A1;ACER3;IP6K1;ISYNA1;IP6K2
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.26218428226879087,-0.7366714124386547,0.8361702127659575,0.966087590748965,1.0,7/23,29.00%,ELOVL7;FAR2;ELOVL1;ACSL4;DGAT2;ACSBG1;ACSF3
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.31854429717720106,-0.7361764191731139,0.8023032629558541,0.9661869000797849,1.0,4/11,20.34%,CAV1;HGS;LEPROT;ADIPOR1
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.2645254505501827,-0.7359989899069923,0.8631790744466801,0.9658512920913591,1.0,6/27,18.14%,NAAA;ETNK2;PLA2G6;PLA2G15;LPIN3;ETNK1
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.28261421566085226,-0.732838829964803,0.8174603174603174,0.9692555422601778,1.0,13/18,44.83%,RAB11A;RAD51B;CCND1;RAD51C;CDC25A;DTL;CDC25B;CDK1;RCC2;CCNB1;BRD4;CDC25C;VPS4B
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.2597071974832077,-0.732342406093194,0.8478260869565217,0.9693154830792223,1.0,11/26,33.55%,PCBP2;IRAK3;PPM1B;SIRT2;TRIB1;SIGIRR;LYAR;MAPKBP1;TRIM21;RNF26;ITCH
prerank,regulation of G0 to G1 transition (GO:0070316),0.2730620805740891,0.7311020654527041,0.800376647834275,0.9866072650035275,1.0,5/38,6.46%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3277644356883518,-0.7299149644753549,0.8069216757741348,0.9717059711559998,1.0,4/10,24.62%,HDAC4;SAE1;PIAS4;PIAS3
prerank,regulation of endocytic recycling (GO:2001135),-0.32336895963927637,-0.7294441897147587,0.791828793774319,0.9717322527249455,1.0,4/11,15.60%,ACTN2;EHD1;ATP9A;EHD2
prerank,positive regulation of sodium ion transport (GO:0010765),0.3339324646210782,0.7286878426988178,0.7373068432671082,0.9896562040658672,1.0,3/12,7.25%,SCN5A;ANK3;PRSS8
prerank,mitotic sister chromatid segregation (GO:0000070),-0.2039875632090118,-0.7283401353132155,0.9453125,0.9725169009223449,1.0,37/98,33.68%,RAB11A;PDCD6IP;KMT5A;PDS5B;INO80;PINX1;BECN1;CHMP4B;CHMP4A;NCAPG2;RAN;ZW10;SMC4;CENPK;SMC1A;DSN1;CENPE;RRS1;PIBF1;SPAG5;KIF18B;KIFC1;CHMP5;NUP62;NSL1;NDC80;DCTN2;KIF14;CDCA8;CEP55;SGO1;EML3;KIF23;KIF18A;CSNK2B;CHMP6;PRC1
prerank,fatty acid beta-oxidation (GO:0006635),-0.22388105534484737,-0.7278992815980313,0.896774193548387,0.9724944701529871,1.0,14/51,21.77%,IVD;CPT2;SLC25A17;ACOX1;ECI2;ACADL;AUH;BDH2;ACAD10;ACOX3;ECHDC2;ACADS;DECR1;GCDH
prerank,Fc receptor signaling pathway (GO:0038093),-0.19539031346969898,-0.7269861026854084,0.9735294117647059,0.9730104933693013,1.0,39/110,28.98%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;KIT;PSME2;RELA;PSMB4;FBXW11;PLCG2;FER;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;CALM1;PDPK1;PSMD4;PSMA2;IKBKG;SYK;PSMD3;PPP3CB;NFATC2;PSMB7;LCP2;MAP2K7;PSMC2;SHC1;PSMC5;PSMD10;BCL10;PAK2;PSMD7;MAPK9;VAV3;JUN
prerank,regulation of stem cell differentiation (GO:2000736),0.24676019031335727,0.7269299947236608,0.8589540412044374,0.9916075712552128,1.0,23/89,19.85%,NOTCH1;TCF15;PTN;RBM24;PSMB11;PSMF1;MYB;JAG1;TCF12;YTHDF2;PSME4;PRKDC;OCIAD1;HNRNPU;PUS7;KMT2A;PSMB5;NSUN2;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2
prerank,membrane repolarization during action potential (GO:0086011),-0.30537901030811454,-0.7264330035730069,0.8282442748091603,0.9731393518833187,1.0,3/13,13.63%,KCNJ2;KCNQ1;ATP1A1
prerank,chemical homeostasis (GO:0048878),0.25219496503817485,0.7259595380280357,0.8451178451178452,0.9923379756928772,1.0,3/61,2.82%,NEDD4L;NR1H3;NR1D2
prerank,nuclear membrane reassembly (GO:0031468),0.26618176686754236,0.7258642020343594,0.8268251273344652,0.9918002240505444,1.0,15/54,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;UBXN2B;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.26697149832440425,0.7255503091384565,0.8184931506849316,0.9915925218720809,1.0,14/45,19.76%,GCNT2;GRM5;NANOS1;ZC3H10;YTHDC1;METTL18;EIF4E;PUM3;TSC1;MATR3;RC3H1;METAP1;DDX25;RBM3
prerank,striated muscle cell development (GO:0055002),0.33309726454480215,0.7251908970411671,0.7516778523489933,0.9914558899914222,1.0,3/14,10.32%,TMOD1;TMOD3;LMOD1
prerank,protein acylation (GO:0043543),-0.2407936765491231,-0.724120020695923,0.9013157894736842,0.9753082779404189,1.0,13/38,24.92%,GLUL;FOXO1;KAT2B;SELENOK;CLOCK;SPHK1;NAT10;ZDHHC8;ZDHHC15;NAT9;NAA80;ZDHHC7;ING4
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22511919385652296,0.723894255928191,0.9097525473071325,0.9927582998279103,1.0,6/146,6.74%,DYNLL1;RBX1;MECP2;PSMB11;PRKAR2B;PSMF1
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.33889810503574513,0.7238498271439062,0.7603305785123967,0.9921330838019033,1.0,2/12,8.17%,IL1B;IL12RB1
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3186311821272001,0.7227864846705294,0.773784355179704,0.9930304776784005,1.0,2/16,7.63%,PTPN22;FGF10
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.29218115243354076,0.7226490594796884,0.7964774951076321,0.9925452530960408,1.0,7/27,11.61%,PHF20L1;KAT7;MRGBP;TAF6;KAT6A;RUVBL1;EP300
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.26544048842763734,-0.7224876032674774,0.8410041841004184,0.9766415250005606,1.0,8/23,26.75%,CUL4A;COPS4;UBB;COPS8;DDB1;CETN2;COPS7A;COPS2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.33314710002644865,0.7219525172603807,0.7665903890160183,0.9928514559093757,1.0,2/13,4.79%,AXL;AP1G1
prerank,histone monoubiquitination (GO:0010390),0.2992012808161568,0.7217192160495026,0.7842003853564548,0.9925160406217831,1.0,6/24,16.09%,RYBP;UBE2E1;CTR9;KDM2B;SKP1;TRIM37
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.22218591267137608,-0.7216254609397608,0.9067357512953368,0.9770687320305947,1.0,17/53,24.70%,PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;BCKDK;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,global genome nucleotide-excision repair (GO:0070911),0.29287902927933823,0.7211819290599893,0.780718336483932,0.9926247336324463,1.0,9/26,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.29753127691117837,-0.7203588743209159,0.8317399617590823,0.9780355405946762,1.0,4/14,19.45%,PARP9;STAT1;HSP90AB1;PTPN2
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.30281914121117914,-0.7197320480520911,0.8317214700193424,0.9782123806080215,1.0,3/15,9.51%,NR3C1;ANXA1;BCL2L11
prerank,regulation of oxidoreductase activity (GO:0051341),0.3188767782828304,0.7193819603935308,0.7412008281573499,0.9945831951571011,1.0,2/13,10.51%,ATP7A;ABL2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.21896569835730106,0.7192071366201048,0.9294781382228491,0.9941399147979787,1.0,25/173,14.03%,DYNLL1;CUL3;SPTBN1;COG7;COG1;SPTB;ANK3;VTI1A;SPTA1;GOLT1A;MIA3;DYNC1I2;TMED7;KLHL12;TMED4;COL7A1;SEC13;RANGRF;COPB2;PROC;TRIP11;VTI1B;COG6;DCTN1;ANK2
prerank,tRNA aminoacylation (GO:0043039),-0.23878492500909423,-0.7188660627709498,0.8862144420131292,0.9786821128732404,1.0,11/37,23.89%,LARS2;RARS2;KARS1;CARS1;QARS1;SARS1;HARS1;MARS2;FARSA;PPA1;FARSB
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.31932180699478935,0.7187415310709212,0.7610993657505285,0.9941344231713403,1.0,5/17,9.97%,RGCC;SPDYA;PKD2;PDGFB;CCNYL1
prerank,autophagy of peroxisome (GO:0030242),-0.3086240726650903,-0.7184965773528458,0.8305084745762712,0.9785565002260329,1.0,2/12,13.31%,ATM;ACBD5
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3290050336857338,0.71846357422306,0.7446351931330472,0.9938473420196472,1.0,6/13,18.43%,CIDEB;RIPK2;PERP;GRIN2A;ASPH;NLRC4
prerank,homocysteine metabolic process (GO:0050667),0.34352456691296385,0.7184482858835652,0.7597402597402597,0.993186273102848,1.0,1/11,2.95%,CTH
prerank,positive regulation of secretion (GO:0051047),-0.3155572989964005,-0.7182062346891682,0.7889908256880734,0.978336427484106,1.0,4/11,37.94%,NPR1;XBP1;AQP1;SCIN
prerank,regulation of immune effector process (GO:0002697),0.2687308052972525,0.7182003535010997,0.8059701492537313,0.9928620886952929,1.0,5/41,9.50%,VTN;CD46;C7;SUSD4;CR2
prerank,positive regulation of mRNA processing (GO:0050685),0.3042242036303145,0.7178468544665421,0.7762096774193549,0.9926754762181923,1.0,9/21,27.16%,NCBP2;TRA2A;DAZAP1;DHX36;RBMX;RBM3;CIRBP;LEO1;SNW1
prerank,microtubule nucleation (GO:0007020),0.3097036568833277,0.7174344666056306,0.7742574257425743,0.9926187781114448,1.0,4/20,10.49%,CCDC57;CLASP2;TPPP;TUBG2
prerank,protein heterooligomerization (GO:0051291),0.3101949723385511,0.71664777156952,0.7730061349693251,0.9930914863804433,1.0,7/17,21.35%,CPSF6;MAT2A;PKD2;GRIN2B;KCNC2;CPSF7;GRIN1
prerank,ncRNA catabolic process (GO:0034661),-0.2543386919527273,-0.7159215109647061,0.864406779661017,0.9804675683118338,1.0,8/28,25.83%,TUT4;EXOSC5;XRN1;TENT4B;DEDD2;NUDT16;EXOSC7;POP1
prerank,bicarbonate transport (GO:0015701),-0.25469416799179534,-0.7154080925893669,0.8631578947368421,0.9804707643763082,1.0,2/25,3.27%,SLC26A7;SLC4A10
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.1924904780590157,-0.7153309583975268,0.9823529411764705,0.9799979192646611,1.0,39/109,28.98%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;PSME2;RELA;PSMB4;FBXW11;PLCG2;FER;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;CALM1;PDPK1;PSMD4;PSMA2;IKBKG;SYK;PSMD3;PPP3CB;NFATC2;PSMB7;LCP2;NR4A3;MAP2K7;PSMC2;SHC1;PSMC5;PSMD10;BCL10;PAK2;PSMD7;MAPK9;VAV3;JUN
prerank,response to ethanol (GO:0045471),0.32208522013159363,0.714922984934516,0.7422222222222222,0.994914186595158,1.0,5/14,22.35%,GRIN2B;CHRNB2;GRIN2A;GRIN1;SOD1
prerank,electron transport chain (GO:0022900),-0.29212799316466365,-0.7143926674082784,0.8528368794326241,0.9805071201300304,1.0,4/15,19.21%,POR;PDIA5;CYB561;PPARGC1A
prerank,V(D)J recombination (GO:0033151),0.32923621141383164,0.7143482037173866,0.7420814479638009,0.9950786713876988,1.0,2/11,12.69%,LIG4;PRKDC
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.29686508192652605,0.7139298244918262,0.7914110429447853,0.994998420501506,1.0,5/20,15.11%,GRK3;SNCA;CRY1;APLP1;YWHAB
prerank,mammary gland epithelium development (GO:0061180),-0.295956228916019,-0.7139218008365956,0.8477842003853564,0.9804854298745649,1.0,6/14,24.85%,WNT4;AKT1;ID2;CSF1R;AKT2;SCRIB
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.23670454712767158,-0.7139144619554025,0.909297052154195,0.9799363030932525,1.0,16/37,32.01%,ERCC5;CUL4A;UBB;DDB1;RPA1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;NTHL1;POLD1;GTF2H3;PCNA;RFC5
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2599494443825422,0.7134749196062319,0.8461538461538461,0.994976456388492,1.0,7/50,6.75%,RORA;BTRC;IFT81;MOSMO;GAS8;GPC3;KCTD6
prerank,gastrulation (GO:0007369),0.31578598741270075,0.7132905882654693,0.7649572649572649,0.9945555187909355,1.0,3/15,15.63%,GPC3;LMBRD1;TASOR
prerank,endocytic recycling (GO:0032456),0.25765516129960475,0.713120012266552,0.8378378378378378,0.9941192567299889,1.0,1/50,0.58%,ANKRD50
prerank,carbohydrate transport (GO:0008643),0.3426079205698136,0.7130073447251607,0.7297872340425532,0.9935937546524399,1.0,3/11,16.92%,SLC5A1;SLC23A2;SLC23A1
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3190998892099804,0.7127710410403424,0.7620041753653445,0.9932509634257762,1.0,9/14,26.81%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SAP18;SRSF12;SRSF4;SFSWAP
prerank,zymogen activation (GO:0031638),0.2736575411966089,0.7126897142354276,0.813780260707635,0.9926773373324637,1.0,3/39,7.58%,GGT1;CIDEB;RIPK2
prerank,organelle fission (GO:0048285),0.2951117385651359,0.7125936485354251,0.7947761194029851,0.9921301088324205,1.0,8/24,17.53%,TMCC1;MTFP1;WASHC5;MFF;PEX19;MTFR1;MIEF1;DNM1
prerank,morphogenesis of an epithelium (GO:0002009),0.2927272300116701,0.7122904281651914,0.7969052224371374,0.9919017674781072,1.0,6/25,12.92%,VCL;TIMELESS;TBX18;AHI1;PRKX;KDM2B
prerank,axonemal dynein complex assembly (GO:0070286),-0.25060306179769853,-0.712280458137302,0.8938223938223938,0.9812500552020175,1.0,19/28,48.80%,DNAH8;ODAD2;DRC1;ODAD3;DNAL1;CCDC65;DNAAF2;DNAI4;TTC12;CFAP100;DNAH17;CCDC40;DNAAF4;ODAD1;DNAH1;DNAAF3;DNAAF1;DNAI3;CFAP73
prerank,modulation by symbiont of entry into host (GO:0052372),-0.2908597241504358,-0.7116897468938972,0.8210735586481114,0.9813539681939829,1.0,6/16,31.20%,CAV1;TRIM27;TRIM14;TRIM6;FUCA2;TRIM21
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.30450494718669185,0.7109962227212098,0.7819706498951782,0.9931159688732213,1.0,2/20,4.19%,CDK6;HOXA9
prerank,RNA methylation (GO:0001510),0.24971261837381414,0.7108455728983937,0.8644628099173554,0.9926511165488314,1.0,19/60,24.31%,FBLL1;NSUN3;TRMT61A;TRMT5;CBLL1;THUMPD2;RBM15;TRMT10C;MTO1;TFB2M;NSUN2;NSUN5;ZC3H13;WTAP;METTL6;DIMT1;GTPBP3;TRMT10A;TRDMT1
prerank,tRNA export from nucleus (GO:0006409),0.28298623053987326,0.7099408471278912,0.8050541516245487,0.9925754553656114,1.0,7/32,14.55%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.28298623053987326,0.7099408471278912,0.8050541516245487,0.9925754553656114,1.0,7/32,14.55%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,negative regulation of immune system process (GO:0002683),0.31647643796635644,0.7094379851238152,0.7857142857142857,0.9926282038042632,1.0,2/16,9.11%,GPER1;LYN
prerank,immunoglobulin mediated immune response (GO:0016064),0.3465457155122083,0.709399496420913,0.7639198218262806,0.9920101642419584,1.0,1/10,4.99%,CARD9
prerank,regulation of viral release from host cell (GO:1902186),0.3020461659083865,0.7076069772434781,0.7945205479452054,0.9939053818270783,1.0,3/21,6.20%,MID2;TRIM62;CHMP2B
prerank,regulation of viral transcription (GO:0046782),-0.23240502990802564,-0.7073808779873948,0.9178947368421052,0.9854762970726199,1.0,16/39,31.20%,MDFIC;IFITM3;POLR2A;TRIM27;POLR2F;CDK9;POLR2E;TRIM14;RSF1;NELFCD;TRIM11;POLR2G;CTDP1;SUPT4H1;ZFP36;TRIM21
prerank,protein O-linked glycosylation via serine (GO:0018242),0.3472512004339554,0.7072150265958582,0.7537796976241901,0.9938043689850159,1.0,3/10,12.29%,GALNT13;GALNT1;GALNT4
prerank,regulation of small molecule metabolic process (GO:0062012),0.2830771532710925,0.7070683325627553,0.8084291187739464,0.9933370146029709,1.0,2/28,3.04%,RORA;ARV1
prerank,negative regulation of mRNA processing (GO:0050686),0.31578680336679404,0.7068406356553352,0.7707423580786026,0.9929707793912637,1.0,9/15,26.81%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SAP18;SRSF12;SRSF4;SFSWAP
prerank,regulation of telomerase activity (GO:0051972),-0.226597151506772,-0.7067389464988587,0.9134396355353075,0.9856202762316295,1.0,14/45,26.85%,KLF4;SMG6;NAF1;PINX1;ATM;HSP90AB1;MAPK3;MAP3K4;ACD;MAP2K7;WRAP53;TP53;CTNNB1;NEK7
prerank,telomere maintenance via recombination (GO:0000722),-0.3123389638186019,-0.706417694326372,0.8292682926829268,0.9854102728848847,1.0,5/11,23.51%,TEP1;RAD50;TPRKB;RAD51;ERCC1
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.24285149373508697,-0.7059411445519311,0.8706365503080082,0.9853408123747297,1.0,11/30,31.24%,HSPA5;ENTPD5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,positive regulation of protein acetylation (GO:1901985),0.3272084186411344,0.7059229913903443,0.7489451476793249,0.9936110379462741,1.0,3/12,14.30%,DDX3X;FAM161A;PRKAA1
prerank,response to UV (GO:0009411),0.2276156305363506,0.7057650781476914,0.8992248062015504,0.9931508074695583,1.0,1/95,0.16%,PTPRK
prerank,tryptophan catabolic process (GO:0006569),-0.30632866929582814,-0.7053780140803494,0.8374291115311909,0.9854091176725136,1.0,10/11,57.20%,AFMID;KYNU;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,protein K11-linked ubiquitination (GO:0070979),-0.24718752021925564,-0.7042778139996022,0.8819875776397516,0.9860537816155988,1.0,8/27,25.78%,CDC16;UBE2E2;ANAPC4;FZR1;CDC27;ANAPC5;PRKN;UBE2H
prerank,embryonic axis specification (GO:0000578),-0.2840416858185543,-0.7041510091632104,0.854251012145749,0.9856437327170711,1.0,1/15,0.78%,SMAD6
prerank,regulation of defense response to virus by host (GO:0050691),0.2763319215915206,0.7039965282391489,0.8081395348837209,0.995020051779037,1.0,6/30,10.05%,PTPN22;IL4;IL12RB1;ZDHHC1;TARBP2;CGAS
prerank,mRNA stabilization (GO:0048255),0.27513231620512174,0.703892673163108,0.8516579406631762,0.9944870468968927,1.0,9/40,14.25%,RBM24;ELAVL4;DAZL;BOLL;DND1;AXIN2;HNRNPU;TENT5D;HNRNPC
prerank,regulation of protein transport (GO:0051223),-0.24674024446108103,-0.7036909823363207,0.8706140350877193,0.9855635290940561,1.0,9/27,22.24%,WWP2;NDEL1;DISP1;RHBDF2;LLGL2;CHP1;ARFIP1;SNX3;LCP1
prerank,midbody abscission (GO:0061952),-0.28360681422740086,-0.703663703287525,0.87374749498998,0.9850352047423949,1.0,4/17,16.82%,PDCD6IP;CHMP4B;CHMP4A;MITD1
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.24198269480159068,-0.703206708725382,0.8930131004366813,0.984954803082474,1.0,12/32,30.61%,TAF1;CAVIN1;POLR2F;MAPK3;POLR2E;UBTF;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,alpha-amino acid metabolic process (GO:1901605),0.2625310470984497,0.702904371075684,0.8288770053475936,0.9951975531752597,1.0,6/45,11.93%,NAALAD2;ATP7A;SLC25A13;GOT1;SRR;GLS2
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2992901644447812,0.7028071198689423,0.7964774951076321,0.994654295398398,1.0,2/22,3.27%,CD46;IL2RA
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.25724822577736695,-0.7023286554814422,0.888663967611336,0.9853247266817867,1.0,8/24,32.01%,UBB;RPA1;RFC3;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,magnesium ion transport (GO:0015693),-0.30505506427366824,-0.7021146071477097,0.8324125230202578,0.9850040943772764,1.0,1/12,4.08%,SLC41A1
prerank,alanine transport (GO:0032328),0.3466930883514809,0.7015924254301634,0.7663157894736842,0.9956764205892908,1.0,1/10,2.19%,SLC1A4
prerank,phagosome-lysosome fusion (GO:0090385),-0.3145765640881721,-0.7010165954485226,0.8246628131021194,0.9855864346394682,1.0,7/10,39.23%,RAB7A;RAB7B;SYT7;RAB20;CLN3;PLA2G5;RAB39A
prerank,regulation of mRNA processing (GO:0050684),0.2778905121231175,0.7005949127445847,0.8246628131021194,0.9963931196716901,1.0,8/32,17.68%,PTCD2;SRPK3;PAPOLA;KHDRBS2;YTHDC1;SAFB2;QKI;LARP7
prerank,regulation of store-operated calcium entry (GO:2001256),0.33385653239879837,0.700251113002648,0.785234899328859,0.9962123612804228,1.0,4/10,16.17%,STIM1;CASQ1;SLC8B1;CD84
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.3019717971595074,-0.7000563984327033,0.849721706864564,0.9860330237131741,1.0,3/11,18.05%,ARRB1;GRK2;ADRB2
prerank,dopaminergic neuron differentiation (GO:0071542),-0.2698051053377625,-0.6993587338452575,0.856,0.9862179059907364,1.0,8/19,34.85%,LRP6;NR4A2;LMX1B;VEGFA;CTNNB1;LMX1A;WNT2;SHH
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.2245821438219344,-0.6988972573329338,0.9119047619047619,0.9861503517794769,1.0,1/41,0.05%,PRKAG2
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.32050968247100026,-0.6988325265025811,0.86996336996337,0.985670082571506,1.0,4/10,28.30%,HSP90AB1;NAB2;EGR1;CLU
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.23678215346037096,-0.698253894092515,0.8946280991735537,0.9857257355188592,1.0,4/34,6.93%,RBP4;LACC1;WNT5A;SLC7A5
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.24276521049728284,-0.69787431483636,0.8914405010438413,0.9855654051444711,1.0,9/30,22.75%,NPEPPS;SH3GLB1;TOMM7;SAE1;LEPROT;PDCD5;HPS4;USP36;BAP1
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2743100832783256,0.6976358701331478,0.8415094339622642,0.9990977138151159,1.0,4/32,7.89%,CAMP;CXCL10;CXCL5;RNASE6
prerank,regulation of synapse organization (GO:0050807),0.2951776864586009,0.697541309733962,0.8316430020283976,0.998541643138154,1.0,4/26,9.91%,MEF2C;YWHAZ;IL1RAPL1;CTNNA2
prerank,spliceosomal snRNP assembly (GO:0000387),-0.23001917793212515,-0.6975298166764333,0.9188034188034188,0.9853373065350696,1.0,13/38,27.76%,GEMIN7;STRAP;SRSF10;GEMIN5;PRPF3;SNRPF;SNRPD1;SNRPD2;WDR77;PRPF19;SNRPC;SNRPB;SNRPE
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.3232302498505896,0.6974581941778134,0.7925311203319502,0.9979779129144082,1.0,4/12,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.2882644164681522,-0.6974158576470415,0.8314176245210728,0.9848830965180417,1.0,6/13,19.74%,SEC16B;TMEM30A;TM9SF4;SAR1A;SAR1B;CD81
prerank,neuron maturation (GO:0042551),0.2944877226053712,0.6972135934312991,0.8089171974522293,0.9976507621061366,1.0,4/18,9.39%,SCARF1;B4GALT6;ADGRB3;ACTL6B
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.29307496190800475,0.6971980931005342,0.8113948919449901,0.99633620027679,1.0,9/21,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.29307496190800475,0.6971980931005342,0.8113948919449901,0.99633620027679,1.0,9/21,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.26902136552266576,-0.6971647665698215,0.8460038986354775,0.9845758245045749,1.0,5/19,22.61%,CUX1;OBSL1;LRP8;DBN1;SS18L1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.3148900697828886,-0.6971160831613431,0.8429602888086642,0.984069791733009,1.0,5/10,25.85%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,autophagy of mitochondrion (GO:0000422),-0.22362064997759726,-0.6968976376614334,0.9059633027522935,0.9837400941087878,1.0,13/38,35.29%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG7;ATG12;PRKN;ATG14;RB1CC1;PINK1;PHB2
prerank,regulation of organelle assembly (GO:1902115),0.23731538314401726,0.6965470556681794,0.896,0.9965575584083028,1.0,15/73,15.95%,TBC1D1;IFT20;TBC1D12;PIKFYVE;TBC1D2B;NPRL3;TBC1D10C;VPS11;TBC1D9B;NPRL2;TBC1D19;UBQLN2;RAB5A;CEP76;TBC1D10B
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.2659360524817443,-0.6957457682734263,0.8472505091649695,0.9843838469020452,1.0,5/18,29.00%,ELOVL7;ELOVL1;ACSL4;ACSBG1;ACSF3
prerank,respiratory electron transport chain (GO:0022904),0.3224690031649704,0.6956861945702378,0.7680851063829788,0.9970850272544919,1.0,6/14,18.71%,UQCRFS1;SLC25A13;ETFB;ETFA;ETFDH;NDUFA5
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.21332838584354513,-0.695572514368993,0.9363207547169812,0.9840054337957367,1.0,30/57,37.12%,DCN;MCU;TNFSF10;BCL2L11;KDR;VPS35;BNIP3;ADCK1;BID;PDCD5;PARK7;BBC3;PPARGC1A;PLAUR;DDHD1;RALBP1;PRKN;TP53;BIK;TREM2;RALA;DNM1L;MIEF2;HRK;PINK1;PPIF;ZNF205;AURKA;HIP1R;BAX
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24258166148368726,-0.6953510264067558,0.893569844789357,0.9836731925759225,1.0,8/29,29.00%,ELOVL7;ACACA;ELOVL1;ACSL4;HSD17B8;GCDH;ACSBG1;ACSF3
prerank,epithelial cell development (GO:0002064),0.29509380706750543,0.6942354928503458,0.7849898580121704,0.9983892566999277,1.0,2/20,5.43%,RILPL2;ROS1
prerank,translational termination (GO:0006415),-0.18965655454343708,-0.6933194549336238,0.9798270893371758,0.9852128152932221,1.0,29/95,29.23%,MRPL33;MRRF;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL46;MRPL39;MTRF1L;MRPL17;MRPL12;MRPL1;MRPS26;APEH;MTRF1;TRMT112;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49
prerank,histone H4 acetylation (GO:0043967),-0.2198433213004708,-0.6932680924450054,0.9267241379310345,0.9847181401312562,1.0,16/47,25.98%,LEF1;TRRAP;MEAF6;TRIM16;BRCA2;KANSL2;BEND3;NAA40;CHD5;MORF4L2;HAT1;BRD8;JADE1;ING4;ATF2;EPC1
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.2851800912976668,-0.6930865445197271,0.8427184466019417,0.9843747962240103,1.0,3/14,13.17%,CARD14;CARD10;COPS8
prerank,cellular response to tumor necrosis factor (GO:0071356),0.21261007105262375,0.6930768059792907,0.9572413793103448,0.9993008786451012,1.0,12/175,7.96%,LIMS1;PID1;TNFRSF21;GPER1;TRAF5;PSMB11;ACTN4;TNFRSF8;CACTIN;PSMF1;TRAF3;CDIP1
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.2765481284083033,-0.6923567725896218,0.8587360594795539,0.9845258121318164,1.0,2/16,5.33%,KAT2B;NAA35
prerank,cobalamin metabolic process (GO:0009235),0.30140573249794034,0.6920071808843291,0.8078512396694215,0.999998660961783,1.0,3/17,13.83%,MMADHC;MMAB;LMBRD1
prerank,positive regulation of rRNA processing (GO:2000234),-0.3145947126522784,-0.6918560544769348,0.8410351201478743,0.9844698051909998,1.0,3/10,24.10%,SIRT7;RIOK2;TRMT112
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.28028462028195666,-0.6914783137057482,0.8599605522682445,0.984267082471477,1.0,6/16,29.45%,AMPD3;ATIC;LHPP;ADSS1;PAICS;NUDT2
prerank,cilium movement (GO:0003341),0.25392056860186496,0.6914196192688513,0.8517110266159695,1.0,1.0,8/48,17.56%,RSPH6A;SPEF1;GAS8;CAMSAP3;CCDC63;ODAD4;CFAP61;DNAH9
prerank,regulation of mitotic spindle organization (GO:0060236),-0.22885314340134347,-0.6909745569519207,0.9143468950749465,0.984202542941945,1.0,14/35,32.16%,PDCD6IP;PARP3;CHMP4B;TPR;DYNC1H1;NUMA1;GNAI1;TPX2;FSD1;CHMP5;HSPA1B;NUP62;CCSAP;EML3
prerank,nuclear transport (GO:0051169),-0.26917438621161494,-0.6909716241043207,0.8841121495327103,0.9836589261956351,1.0,6/16,32.41%,NUP98;NXT2;PSIP1;NXT1;ANP32A;RBM15B
prerank,DNA geometric change (GO:0032392),-0.2561135981970343,-0.6908843025848164,0.8813559322033898,0.9831975994894416,1.0,5/24,20.32%,ASCC3;ANXA1;RAD50;HMGB2;RECQL
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.2539243021984726,-0.6908698615584562,0.8939096267190569,0.9826663652053171,1.0,6/23,24.53%,REXO4;DNASE1L1;HMGB2;DICER1;DFFB;FOXL2
prerank,protein heterotetramerization (GO:0051290),0.31557915846333223,0.6908465990395537,0.8172484599589322,1.0,1.0,3/13,9.80%,CPSF6;PKD2;GRIN2B
prerank,positive regulation of telomerase activity (GO:0051973),-0.23759503674482452,-0.6907570866000462,0.913135593220339,0.9822285269046229,1.0,10/33,26.85%,KLF4;NAF1;HSP90AB1;MAPK3;MAP3K4;ACD;MAP2K7;WRAP53;CTNNB1;NEK7
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.3054901945814755,0.690692016569221,0.8044943820224719,0.9997850478268335,1.0,4/15,16.08%,RUVBL1;NOP10;CCT7;CCT3
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.32299041141660906,0.6905851732376458,0.796420581655481,0.9979280730672738,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.32299041141660906,0.6905851732376458,0.796420581655481,0.9979280730672738,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.32299041141660906,0.6905851732376458,0.796420581655481,0.9979280730672738,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.2903359789874693,0.6903820757636567,0.7955555555555556,0.9975332584929002,1.0,3/26,6.30%,NR1H3;PTPN22;DDX3X
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.3189344082742972,0.690294948127483,0.8125,0.9969839144409556,1.0,1/13,1.77%,NR1H3
prerank,regulation of protein localization to cell surface (GO:2000008),0.26841607412202584,0.6902919240583931,0.8371647509578544,0.9963290307223068,1.0,1/33,0.83%,NEDD4L
prerank,regulation of amyloid-beta clearance (GO:1900221),0.31452627468320354,0.6900533564930469,0.7822410147991543,0.9959823397100315,1.0,4/16,14.71%,ROCK1;IL4;ABCA7;HMGCR
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3228867347748413,0.6889611454181505,0.7957894736842105,0.9967300004109588,1.0,3/12,8.19%,TK1;TK2;DCK
prerank,fatty acid transport (GO:0015908),0.3001820993422218,0.6885922625081972,0.7952586206896551,0.9965908790310353,1.0,3/17,5.57%,PPARD;SLC27A4;FABP3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.2399005913169878,-0.6884415043746316,0.8666666666666667,0.9839817678260665,1.0,10/29,25.91%,PINX1;PPIA;ANKRD28;HSP90AB1;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,regulation of humoral immune response (GO:0002920),0.25700114908239075,0.6881434166305634,0.8361581920903954,0.9965111529231163,1.0,5/44,9.50%,VTN;CD46;C7;SUSD4;CR2
prerank,regulation of dopamine secretion (GO:0014059),0.2867827297270411,0.6876243631828395,0.827037773359841,0.9965315327163088,1.0,11/25,24.87%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT6;SYT10
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28699507116130274,0.6867492396116532,0.8256029684601113,0.9970107551787043,1.0,8/25,19.21%,SORT1;CHMP2B;MVB12A;DENND10;UBXN6;CHMP3;LEPROTL1;VTA1
prerank,mitotic nuclear membrane organization (GO:0101024),0.2532672461501888,0.6865396021683143,0.8821490467937608,0.9959523590336161,1.0,14/51,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2532672461501888,0.6865396021683143,0.8821490467937608,0.9959523590336161,1.0,14/51,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,mitotic nuclear division (GO:0140014),0.23114160690350025,0.6858543052134142,0.9080645161290323,0.9961672151488068,1.0,1/71,0.31%,EPS8
prerank,negative regulation of signaling (GO:0023057),0.2743533882082877,0.6855988101179724,0.8287401574803149,0.995855126230572,1.0,3/25,6.20%,IL1B;SOCS5;AP1AR
prerank,protein targeting to membrane (GO:0006612),0.2308385227461851,0.6850094815252332,0.9114754098360656,0.9959471725865022,1.0,17/83,18.15%,ZDHHC14;RAB8B;NCF1;ABCD2;ATAD1;SGTB;PIKFYVE;ZDHHC1;ZDHHC2;ZDHHC21;PEX3;ZDHHC23;PEX19;PEX12;ZDHHC9;CHM;NACAD
prerank,synaptic vesicle endocytosis (GO:0048488),0.2677691895856298,0.6849359602141758,0.8352059925093633,0.9953823742895731,1.0,10/33,20.16%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;DNM1;VAMP2;SNAP91;AMPH
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2693115270304683,0.6846446051984089,0.8384615384615385,0.9951120319506742,1.0,10/30,21.36%,ABCD2;SLC27A2;SLC27A4;ACOT2;TECR;ACOX2;ELOVL6;PEX2;ELOVL2;ACSL1
prerank,regulation of histone acetylation (GO:0035065),-0.2355548733857441,-0.6841605279435521,0.9071729957805907,0.9875298523498244,1.0,11/33,24.17%,ARRB1;BRD7;TADA2A;FLCN;HDAC5;MAPK3;NOS1;PARK7;PPARGC1A;CTBP1;BRCA1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.22178925119126963,-0.6840538354695905,0.9373601789709173,0.9870856891547986,1.0,16/39,32.01%,ERCC5;CUL4A;UBB;DDB1;RPA1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;NTHL1;POLD1;GTF2H3;PCNA;RFC5
prerank,carbohydrate catabolic process (GO:0016052),-0.2237092662996384,-0.6837137699413389,0.9110169491525424,0.9868837699586112,1.0,12/38,28.40%,HK2;DERA;NAGA;ENO1;MANBA;MAN2C1;MAN2B2;NEU3;ALDOA;LDHA;HK1;ENO3
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2431422488041128,0.6836216467763638,0.8697916666666666,0.9957978940371938,1.0,9/54,11.61%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300
prerank,pre-miRNA processing (GO:0031054),-0.28634374589434974,-0.6835999821573234,0.8560606060606061,0.9864348681654787,1.0,4/14,20.39%,TUT4;TUT7;AGO1;DICER1
prerank,tRNA transport (GO:0051031),0.26918550295364146,0.6833793737141791,0.8371681415929203,0.9954471015722697,1.0,7/35,14.55%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,chemokine-mediated signaling pathway (GO:0070098),0.25504048349324737,0.6829167061649667,0.8645833333333334,0.9953846164746033,1.0,5/42,6.10%,SH2B3;STK39;ACKR3;CXCL10;CXCL5
prerank,negative regulation of protein secretion (GO:0050709),0.2609974881810202,0.6825473010981121,0.8657487091222031,0.9951971705193707,1.0,4/38,7.20%,NR1H3;IL1B;RHBDF1;IRS1
prerank,recombinational repair (GO:0000725),-0.19522941720445217,-0.6825258051658705,0.9686746987951808,0.9868977662419942,1.0,32/77,35.56%,INO80;RAD51B;SFR1;ERCC5;SAMHD1;BRCA2;NABP1;AP5Z1;RPA1;RAD50;RECQL;RAD52;RAD51C;MCM8;SLX4;RAD51;BRCA1;RPA3;ZSWIM7;RAD54B;HUS1;AP5S1;WRN;HELQ;RMI1;RAD51AP1;ZFYVE26;MORF4L1;HUS1B;RECQL5;RAD51D;NSMCE1
prerank,regulation of Golgi organization (GO:1903358),-0.27063246770879645,-0.6824789151005305,0.8608870967741935,0.9863959970606331,1.0,5/17,17.97%,ARMH3;USP6NL;AKAP9;MAPK3;STX18
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.30627373294374327,0.6815021917576077,0.7914893617021277,0.9958723765169075,1.0,6/13,23.59%,SART3;PRPF6;PRPF31;LSM2;AAR2;SRSF12
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2784107298996331,-0.6814012574668057,0.8747628083491461,0.9868497225054828,1.0,6/15,30.06%,SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.2753095962004237,0.6809783753490902,0.8396946564885496,0.9958965058028079,1.0,5/25,16.33%,CUL3;UGGT2;ZER1;YME1L1;TOR1A
prerank,regulation of centriole replication (GO:0046599),-0.26556867277315543,-0.6807976553750614,0.8905950095969289,0.9868678833150413,1.0,6/18,28.51%,KAT2B;PLK2;ALMS1;PLK4;BRCA1;NUP62
prerank,regulation of type I interferon production (GO:0032479),-0.19104887542674953,-0.6806115442864293,0.9740932642487047,0.9865106653745604,1.0,30/84,33.81%,IRF1;IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;LRRFIP1;RELA;POLR2F;POLR3GL;G3BP1;POLR2E;UBA7;NPLOC4;UBE2L6;POLR3D;RNF216;MYD88;ZBP1;CTNNB1;POLA1;TAX1BP1;POLR1C;ISG15;TRIM21;RNF26;PQBP1;ITCH;POLR3A
prerank,protein K48-linked deubiquitination (GO:0071108),0.28085338266983495,0.6802305424387967,0.7960396039603961,0.9961912901060307,1.0,6/23,17.22%,USP25;OTUD5;OTUB1;USP50;USP33;OTUD7B
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.270103652508985,-0.6799460392127481,0.8533834586466166,0.9866069953276418,1.0,3/16,17.91%,STX7;CEACAM1;CYRIB
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2553349315713129,-0.679466096948163,0.8937381404174574,0.9864619184051387,1.0,2/22,3.38%,PTPRJ;EZR
prerank,cellular response to superoxide (GO:0071451),-0.2993732298304731,-0.6792657600233435,0.855787476280835,0.9861005698119891,1.0,6/10,27.64%,NOS3;PRDX2;ADPRS;MT3;PRDX1;SOD2
prerank,response to endoplasmic reticulum stress (GO:0034976),0.22131177104766242,0.6778464004828282,0.946319018404908,0.9985607645547232,1.0,7/107,6.59%,ATP2A3;MAP3K5;PIK3R1;CHAC1;ITPR1;SCAMP5;ATP2A2
prerank,mitochondrial fusion (GO:0008053),0.29788524725913734,0.6778005407740314,0.8181818181818182,0.9979587480751787,1.0,4/18,15.80%,PLD6;MFF;MFN1;MIEF1
prerank,positive regulation of RNA splicing (GO:0033120),0.26969213955018706,0.6767804209128155,0.8780487804878049,0.9985685409553783,1.0,6/29,19.76%,PIK3R1;TRA2A;DAZAP1;HABP4;RBMX;RBM3
prerank,translational elongation (GO:0006414),-0.18493954209796087,-0.6761613517790487,0.9885386819484241,0.9884416720090696,1.0,33/101,31.99%,MRPL33;EEF1D;EEF1A1;EEF1B2;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;EEFSEC;MRPL46;MRPL39;MRPL17;MRPL12;MRPL1;MRPS26;MRPL35;GTPBP2;MRPL4;RACK1;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49;EEF1A2;MRPL43;MRPL48
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.30953475256293284,0.6761349303441999,0.7748344370860927,0.9987147156394626,1.0,1/11,6.44%,LPO
prerank,glycolipid biosynthetic process (GO:0009247),0.25939098445454667,0.6760532080967965,0.8516377649325626,0.9981552414310547,1.0,6/38,11.03%,PIGU;ST8SIA1;PIGO;B4GALT6;PIGZ;DPM3
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.28341673701974857,-0.6752934149199813,0.8754646840148699,0.9887146196640204,1.0,5/13,25.04%,SDAD1;RAN;RPS15;NUP88;RRS1
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.2779996607136363,-0.674427131208543,0.883495145631068,0.9889631894187438,1.0,12/15,58.60%,KYNU;FAH;HGD;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD;GSTZ1
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3188866653164529,0.6742168265436336,0.7758241758241758,0.9991526786936532,1.0,4/11,18.12%,AGO3;TNRC6C;EIF6;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3188866653164529,0.6742168265436336,0.7758241758241758,0.9991526786936532,1.0,4/11,18.12%,AGO3;TNRC6C;EIF6;NOTCH4
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.3158743720311326,0.6739926521201239,0.8150537634408602,0.9987560443923629,1.0,2/13,8.95%,YAE1;ISCA1
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.23653042045392123,-0.6737110313521142,0.9083503054989817,0.9890788272116824,1.0,7/29,19.87%,COPZ2;TRAPPC10;COPA;TRAPPC3;NAPA;RAB6A;COPB1
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.28529142611959524,0.6734617705901911,0.8365758754863813,0.9987688184081596,1.0,8/22,20.33%,RBX1;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.31484371767385894,0.6728461029757506,0.814498933901919,0.9988246502555082,1.0,4/12,13.28%,RLIM;YTHDC1;RBM15;HNRNPU
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30434267614158933,0.6723379466006498,0.8295218295218295,0.9987896629045987,1.0,2/14,4.39%,PPP3CA;PPP2R2A
prerank,response to UV-B (GO:0010224),-0.27693377079699577,-0.6703599962321191,0.8775894538606404,0.9915728474932375,1.0,4/12,23.81%,MFAP4;RELA;CRIP1;STK11
prerank,intraciliary retrograde transport (GO:0035721),0.3191141140894074,0.670105696677613,0.8004158004158004,1.0,1.0,1/12,2.29%,IFT43
prerank,miRNA metabolic process (GO:0010586),-0.2554746289481251,-0.6698368011944889,0.884990253411306,0.9915198943868021,1.0,5/20,20.39%,TUT4;TUT7;RAN;TENT4B;DICER1
prerank,phasic smooth muscle contraction (GO:0014821),-0.3004516221219473,-0.6686792762645669,0.8890845070422535,0.9919259156746943,1.0,6/10,43.11%,EDN3;EDNRB;GDNF;EDN1;TIFAB;HTR1D
prerank,CENP-A containing chromatin organization (GO:0061641),-0.2340389906389317,-0.6685350512120556,0.9158110882956879,0.9909688118444768,1.0,10/29,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.2340389906389317,-0.6685350512120556,0.9158110882956879,0.9909688118444768,1.0,10/29,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,glucose metabolic process (GO:0006006),0.23359671846584598,0.6683167914491823,0.9078260869565218,1.0,1.0,8/58,13.27%,PER2;PPARD;SLC25A13;TFAP2B;GOT1;ALDOC;GPI;CRY1
prerank,negative regulation of histone modification (GO:0031057),-0.2818405275178264,-0.6682838954610318,0.8654205607476636,0.9906463310496726,1.0,6/14,28.35%,JARID2;CTBP1;BRCA1;AASS;TWIST1;SPHK2
prerank,aromatic amino acid family metabolic process (GO:0009072),0.3135451976284749,0.6677353884903034,0.8207964601769911,1.0,1.0,1/10,3.70%,ATP7A
prerank,positive regulation of defense response to virus by host (GO:0002230),0.27384825040602423,0.6676942580645896,0.8585461689587426,1.0,1.0,5/24,10.05%,PTPN22;IL4;IL12RB1;ZDHHC1;CGAS
prerank,mRNA metabolic process (GO:0016071),0.21948974939312907,0.6671213834652373,0.9523809523809523,1.0,1.0,20/90,17.30%,DHX15;LSM3;PCBP3;NCBP2;AGO3;LSM10;SFPQ;HNRNPR;CPSF6;TCERG1;SSB;YTHDF2;CELF1;RNH1;CNOT10;DIS3L2;KIN;SNRPD3;LSM2;HSF1
prerank,protein autoprocessing (GO:0016540),-0.2590199231945792,-0.6669625048020668,0.878095238095238,0.9912369473364779,1.0,3/17,16.86%,CASP4;AFG3L2;MYRF
prerank,apoptotic nuclear changes (GO:0030262),0.28126938476763147,0.6668915351149556,0.8442307692307692,1.0,1.0,1/24,1.63%,GPER1
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.20852964108980454,-0.6660578612754816,0.9567430025445293,0.9914982624848505,1.0,16/50,24.70%,PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,glycerophospholipid catabolic process (GO:0046475),-0.23832123866071214,-0.6660430268564166,0.92,0.9909642032076368,1.0,4/27,13.20%,PLA2G4A;PLA2G6;ABHD16A;PLA2G15
prerank,microtubule polymerization (GO:0046785),0.2708529543553981,0.665187770319487,0.8533834586466166,1.0,1.0,5/29,10.49%,FGF13;CCDC57;CLASP2;TPPP;TUBG2
prerank,cellular response to misfolded protein (GO:0071218),0.2814561704336691,0.6649991450208782,0.8485436893203884,1.0,1.0,6/20,22.19%,CUL3;UGGT2;DNAJC18;TOR1A;STUB1;POMT2
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.24711149465730087,-0.664927315207183,0.8969465648854962,0.9913769481549394,1.0,7/23,22.72%,BCL2L11;TIMM13;TOMM22;TIMM8B;MAIP1;TIMM9;NDUFA13
prerank,regulation of gene silencing by RNA (GO:0060966),-0.2060481823644763,-0.6647891355943855,0.9582366589327146,0.9904051129578602,1.0,17/50,29.08%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;AGO1;NUP88;NUP214;NUP37;POLR2G;NUP155;NUP62;AGO2
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.2060481823644763,-0.6647891355943855,0.9582366589327146,0.9904051129578602,1.0,17/50,29.08%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;AGO1;NUP88;NUP214;NUP37;POLR2G;NUP155;NUP62;AGO2
prerank,positive regulation of myelination (GO:0031643),0.31650518868130983,0.6638251222903285,0.8356481481481481,1.0,1.0,3/11,8.39%,TPPP;NCMAP;TENM4
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.23736439478077043,-0.6628241013220819,0.8993839835728953,0.9915483456047599,1.0,10/25,31.24%,HSPA5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.23314197327809802,-0.6624657290494299,0.906832298136646,0.9913102302441207,1.0,7/28,20.68%,OCLN;AKAP9;GIT1;MET;TOGARAM1;FES;NUMA1
prerank,regulation of transposition (GO:0010528),-0.2791446618709359,-0.6621428321976108,0.8625235404896422,0.9910436134580337,1.0,7/13,42.84%,SIRT7;SMYD5;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,regulation of synapse maturation (GO:0090128),0.32874954246150745,0.6618750436979902,0.8104575163398693,1.0,1.0,3/10,13.10%,NRXN1;YWHAZ;ANAPC2
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3091980594508963,0.6617576447210857,0.8204545454545454,1.0,1.0,2/10,12.84%,SNCA;SET
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.2319873862444554,0.6616891925435842,0.9143835616438356,1.0,1.0,7/69,12.01%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COX5A;COA6
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.2257548580018064,0.661281652640785,0.9282051282051282,1.0,1.0,13/72,13.63%,RGCC;TNKS1BP1;FOXM1;CNOT2;SOX4;CDKN1A;MYO6;CNOT9;CNOT4;PRMT1;EP300;RPS6KA6;CNOT10
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.27067211099476574,-0.6608894358465088,0.8807692307692307,0.9915185701107314,1.0,1/15,1.42%,STOX2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.2990278437492585,0.6602622691631439,0.8256302521008403,1.0,1.0,3/14,13.82%,ADAM19;PSEN1;ABCA7
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21578757610660018,0.6598839273245839,0.9387144992526159,1.0,1.0,24/105,21.19%,BTRC;CLEC10A;FFAR2;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.30023299563130995,-0.6594759019274882,0.8911819887429644,0.9921543871614317,1.0,5/10,33.73%,NAF1;NHP2;RPUSD4;RPUSD2;RPUSD3
prerank,response to peptide (GO:1901652),-0.2230922437900064,-0.6590491103042752,0.926829268292683,0.9919366222825837,1.0,9/33,24.44%,ANXA1;STAT2;STAT1;STAT3;MMP2;EIF2B2;ERBIN;GNAI1;EIF2B5
prerank,establishment of mitotic spindle localization (GO:0040001),0.2645971846634942,0.658032895691125,0.8788990825688073,1.0,1.0,10/28,18.52%,CLASP2;ITGB1;UBXN2B;NUSAP1;DCTN1;MAD2L1;NDE1;HTT;CENPA;INSC
prerank,cardiocyte differentiation (GO:0035051),-0.2973769371288645,-0.6578860141036781,0.8558225508317929,0.9923425358271831,1.0,3/10,16.16%,AKAP13;GATA6;KDM6B
prerank,nuclear pore complex assembly (GO:0051292),-0.2957722393297563,-0.6574488045131045,0.8731884057971014,0.9921590817888624,1.0,9/10,49.98%,NUP98;TPR;NUP153;NUP107;RTN4;NUP93;AHCTF1;NUP205;TMEM170A
prerank,regulation of cellular response to heat (GO:1900034),-0.1879673702843504,-0.6573998087566865,0.9819121447028424,0.9916714614926149,1.0,26/77,28.91%,CD34;HSPB8;BAG3;FKBP4;CAMK2A;ATM;DNAJB6;HSP90AB1;RPA1;MAPK3;NUP98;TPR;NUP88;NUP214;BAG2;NUP37;YWHAE;RPA3;DNAJC2;NUP155;BAG5;HSPH1;HSPA1B;RPTOR;NUP62;BAG1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3079645407334006,0.6572169510508591,0.8004291845493562,1.0,1.0,5/13,26.80%,ALG12;ALG1;ALG11;DPAGT1;MPDU1
prerank,negative regulation of cilium assembly (GO:1902018),-0.2821289464410478,-0.6567735581353997,0.8837675350701403,0.9916556087122117,1.0,3/12,13.56%,LIMK2;YAP1;TCHP
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24295125698152875,0.656631886312676,0.9204737732656514,1.0,1.0,10/48,11.61%,NOA1;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300
prerank,ureteric bud morphogenesis (GO:0060675),-0.26079391184475337,-0.6566295184491446,0.905587668593449,0.9912364243724315,1.0,2/16,6.22%,BMP4;SIX1
prerank,axonal transport of mitochondrion (GO:0019896),-0.28639537027119966,-0.656166941493958,0.8790786948176583,0.9911008610526664,1.0,3/11,18.05%,HIF1A;SPAST;ACTR10
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.2916626831498014,-0.6559292035619904,0.8706739526411658,0.9907749453466645,1.0,5/11,25.85%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,acetyl-CoA metabolic process (GO:0006084),-0.26318471997045123,-0.6553522391561678,0.8845437616387337,0.9907437985999928,1.0,3/15,18.86%,HMGCS2;ACACA;ACACB
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3098575645670196,0.6544085620082305,0.8367346938775511,1.0,1.0,4/11,24.16%,CCT7;CCT3;TERF1;DKC1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.2613089644323928,-0.654239683094505,0.8994082840236687,0.9910701687724168,1.0,9/16,36.06%,PIGN;PIGL;PIGW;PIGB;PIGC;PIGG;PIGA;DPM2;PIGV
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2781054190076966,-0.6538073026594511,0.8917910447761194,0.9908529594539175,1.0,3/13,19.18%,GFPT2;UAP1;GFPT1
prerank,regulation of leukocyte activation (GO:0002694),0.2996801570945033,0.653763836990863,0.8340336134453782,1.0,1.0,2/14,9.11%,GPER1;LYN
prerank,mitochondrial translational termination (GO:0070126),-0.18244392587815045,-0.6533818564991477,0.9772079772079773,0.9906347712388479,1.0,27/88,29.23%,MRPL33;MRRF;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL46;MRPL39;MTRF1L;MRPL17;MRPL12;MRPL1;MRPS26;MTRF1;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49
prerank,RNA stabilization (GO:0043489),-0.22202265686983236,-0.6531085035298545,0.9522776572668112,0.9902911757772082,1.0,9/33,19.79%,THRAP3;NOCT;NAF1;TENT5A;LARP1;ZCCHC17;ELAVL1;E2F1;TENT5C
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.19065253111202915,-0.6526379668786128,0.9792746113989638,0.9900886947289685,1.0,19/73,24.70%,YAP1;FOXC1;LMO2;GATA2;PSME2;PSMB4;TAL1;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;PSMC2;CBFB;PSMC5;PSMD10
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.2572073712185337,0.6519839865887962,0.8516377649325626,1.0,1.0,14/30,23.20%,GNL3L;CDKN1A;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;DACH1;CERS1;CTC1;EXOSC10
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.27074118941943914,0.651680086409918,0.8648111332007953,1.0,1.0,4/25,12.67%,GPER1;CIDEB;MFF;FAM162A
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.2195724993729094,-0.651632073386995,0.9410526315789474,0.9903278323523131,1.0,14/37,33.30%,ENTPD1;SIDT2;DNASE1L1;ENTPD5;PNPT1;ENTPD2;DFFB;NUDT16;EXOSC7;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.1886339545574302,0.6515158717941031,0.9960681520314548,1.0,1.0,82/264,25.52%,SRPK3;CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;CLNS1A;SYMPK;PPIH;SCNM1;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;PRMT7;DDX23;HNRNPU;LSM8;UPF3B;HNRNPC;HNRNPH2;ELAVL2;COIL;PRPF31;SF3B3;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;CDK13;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;DDX1;SMNDC1;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40;RSRC1;RBM5
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.2719925909345552,-0.6513709224994654,0.9125475285171103,0.9900025348538549,1.0,1/13,5.19%,ADHFE1
prerank,regulation of spindle assembly (GO:0090169),-0.23682519759290802,-0.6512784168099619,0.9268774703557312,0.9895364702724363,1.0,10/25,32.16%,PDCD6IP;CHMP4B;TPR;DYNC1H1;NUMA1;SPAG5;CHMP5;HSPA1B;CCSAP;EML3
prerank,pseudouridine synthesis (GO:0001522),0.2988070848667235,0.6512114026506793,0.8264462809917356,1.0,1.0,5/13,24.16%,TRUB1;NOP10;PUS7;GAR1;DKC1
prerank,mitochondrial RNA metabolic process (GO:0000959),0.29162273721771576,0.6507604534905996,0.8422131147540983,1.0,1.0,3/14,13.05%,SLC25A33;TFAM;FASTKD1
prerank,regulation of protein kinase C signaling (GO:0090036),-0.27204330214990624,-0.6506997368481282,0.8956356736242884,0.989444400875685,1.0,5/14,17.24%,ADGRV1;WNT5A;GPD1L;FLT4;WNT11
prerank,vitamin D metabolic process (GO:0042359),-0.27649530972916864,-0.6498251094055111,0.8920454545454546,0.989591408683992,1.0,8/13,50.27%,CUBN;PIAS4;CYP2R1;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3042111674258643,0.6498203115550699,0.837782340862423,1.0,1.0,2/12,7.20%,ABCD2;IRS1
prerank,vasodilation (GO:0042311),0.2986853692103412,0.6492770440200365,0.8284518828451883,1.0,1.0,1/13,1.63%,GPER1
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.26080882438876085,0.6484984282503513,0.8626692456479691,1.0,1.0,12/28,24.50%,WAS;AUNIP;SETMAR;PRKDC;SHLD3;KMT5B;MRNIP;HSF1;HMGA2;PNKP;NUDT16L1;KDM4D
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.29407722660564234,0.6482579403259389,0.8391752577319588,1.0,1.0,4/13,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,tetrapyrrole metabolic process (GO:0033013),0.2787568097352031,0.648175229609386,0.8375,1.0,1.0,3/18,13.83%,MMADHC;MMAB;LMBRD1
prerank,histone H3-K4 trimethylation (GO:0080182),-0.2828116078767162,-0.6475642041237636,0.8833333333333333,0.9908121691655366,1.0,3/11,15.22%,SETD1B;TET3;BEND3
prerank,ESCRT III complex disassembly (GO:1904903),0.3154490381783467,0.647367673481248,0.83125,1.0,1.0,1/10,6.20%,CHMP2B
prerank,ESCRT complex disassembly (GO:1904896),0.3154490381783467,0.647367673481248,0.83125,1.0,1.0,1/10,6.20%,CHMP2B
prerank,nuclear body organization (GO:0030575),0.28733100323737176,0.6472846015447346,0.8322147651006712,1.0,1.0,3/12,13.00%,ETS1;DYRK3;USP50
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.25460172560693084,-0.6470163714057734,0.8954635108481263,0.9906875293564666,1.0,5/18,29.84%,SIRT7;UBTF;EIF2AK3;LYAR;RASL11A
prerank,negative regulation of histone acetylation (GO:0035067),0.29843498129545676,0.6467395126716832,0.8426966292134831,1.0,1.0,2/11,12.84%,SNCA;SET
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.2881533469481511,-0.6466046264453297,0.8917431192660551,0.9904669837410744,1.0,3/10,15.71%,DNAJB2;DNAJB6;DNAJA4
prerank,glycerolipid catabolic process (GO:0046503),-0.2439214578075199,-0.6462650442604693,0.9400749063670412,0.9901778540724706,1.0,1/19,1.12%,PLA2G4A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.19006288232291646,-0.6460499598690135,0.984375,0.9898154242601424,1.0,25/69,31.02%,STT3B;HSPA5;RNF103;AMFR;RNF185;UBXN4;UBE4B;DNAJB2;EDEM2;UBE2G2;ERLIN2;DNAJC10;HSP90B1;NPLOC4;VCP;SEC61B;FBXO17;DNAJB12;EDEM1;SYVN1;TMUB1;ANKZF1;UBE2J1;FBXO44;AUP1
prerank,acylglycerol catabolic process (GO:0046464),0.2531351365251031,0.6459366998042408,0.9129593810444874,1.0,1.0,3/30,6.95%,FABP3;LIPH;LIPC
prerank,defense response to fungus (GO:0050832),0.27755480133096483,0.6458926575028682,0.8607594936708861,1.0,1.0,3/17,15.54%,CARD9;RARRES2;FAM3A
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.27347346872395895,-0.6457904756386895,0.9037328094302554,0.989473285677545,1.0,5/13,26.83%,UPP2;TDG;NT5C;NEIL1;NTHL1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.2850653017255983,-0.6456047955115506,0.8972477064220183,0.9890784756767907,1.0,3/10,24.85%,LGALS9;CD274;SCRIB
prerank,organophosphate biosynthetic process (GO:0090407),0.24608223071830557,0.6445741491325051,0.8952380952380953,1.0,1.0,8/37,17.82%,FGF2;ITPKB;TPK1;GK;IPMK;LPCAT1;IPPK;PIP5K1A
prerank,intracellular pH reduction (GO:0051452),0.2528750305363294,0.6444125768662023,0.895910780669145,1.0,1.0,6/33,10.28%,GPR89A;GPR89B;DMXL1;ATP6V0E2;RAB38;ATP6V1B2
prerank,spindle assembly (GO:0051225),0.22462795444432423,0.6435984474549298,0.948051948051948,1.0,1.0,9/67,13.80%,STARD9;TNKS;CLASP2;MAPRE2;NEK6;TOGARAM2;MZT1;KIFC2;LSM14A
prerank,maturation of 5.8S rRNA (GO:0000460),-0.2557968856583088,-0.6432081541219103,0.9181286549707602,0.9902268416191854,1.0,1/17,1.20%,NSA2
prerank,tRNA metabolic process (GO:0006399),0.28525119876189664,0.6431980114300279,0.8376753507014028,1.0,1.0,9/17,26.60%,SSB;DARS2;ADAT1;AARS1;POP7;POP5;DTD1;RPP30;FARS2
prerank,positive regulation of histone acetylation (GO:0035066),0.2720764198455219,0.6428374393020334,0.8725490196078431,1.0,1.0,4/23,11.17%,IL1B;RPS6KA4;KAT7;GLYR1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2815396874036332,0.6425606990711057,0.8416666666666667,1.0,1.0,3/16,13.02%,FANCB;CGAS;SHLD3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.22368985714824713,0.6421910062977195,0.9170896785109983,1.0,1.0,11/63,13.63%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300;PRKDC;CNOT10
prerank,production of siRNA involved in RNA interference (GO:0030422),0.31026371612374815,0.6416615776811001,0.8363636363636363,1.0,1.0,2/10,11.89%,TARBP2;TSN
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.21531912945115383,0.6406002793260694,0.9526916802610114,1.0,1.0,16/87,20.21%,SLC25A33;IMMP2L;COX18;UQCRFS1;NDUFB2;SDHAF3;ACAD9;FASTKD3;NDUFAF3;NDUFS6;COX20;OXA1L;NDUFA5;NDUFC2;NDUFAF2;SURF1
prerank,spermatid development (GO:0007286),0.25429156745895304,0.6403272878958615,0.8848263254113345,1.0,1.0,6/32,16.21%,PLD6;RSPH1;YTHDC2;SOX30;CCDC63;ACRBP
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.2786632783020555,0.6394366596344555,0.8781925343811395,1.0,1.0,2/18,3.35%,NRXN1;CACNG7
prerank,nucleotide metabolic process (GO:0009117),0.26620503700040893,0.639059405237121,0.8847736625514403,1.0,1.0,8/23,15.62%,AK8;REXO2;DCK;NMNAT3;DCTD;AK7;AK5;AK4
prerank,potassium ion export across plasma membrane (GO:0097623),0.29387680182663856,0.6385246610211531,0.8695652173913043,1.0,1.0,2/13,7.70%,KCNE4;KCNE5
prerank,negative regulation of double-strand break repair (GO:2000780),0.25728966809068077,0.638325055070653,0.8854961832061069,1.0,1.0,9/30,23.49%,FANCB;AUNIP;CGAS;OTUB1;SHLD3;HSF1;HMGA2;NUDT16L1;FBH1
prerank,hexose biosynthetic process (GO:0019319),0.23144590231214351,0.6380791658977587,0.9150943396226415,1.0,1.0,7/42,15.44%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,peptidyl-proline hydroxylation (GO:0019511),0.305704785471531,0.6379481020834853,0.8400900900900901,1.0,1.0,3/11,10.02%,P4HA1;P3H2;P4HTM
prerank,retrograde axonal transport (GO:0008090),0.2818798608664579,0.6370453648425433,0.8390557939914163,1.0,1.0,7/16,22.35%,TMEM108;DLG2;HAP1;DST;KIF1A;NEFL;SOD1
prerank,cellular response to amino acid starvation (GO:0034198),0.21949910330979228,0.6366201837223454,0.9401574803149606,1.0,1.0,13/71,16.73%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,serine family amino acid catabolic process (GO:0009071),0.30149970261117964,0.6364122204599661,0.8453389830508474,1.0,1.0,3/10,15.53%,GCSH;DAO;DLD
prerank,autophagosome assembly (GO:0000045),-0.19636652448143171,-0.6363408360922375,0.9666666666666667,0.994664928990049,1.0,15/52,28.60%,WIPI2;SMURF1;IRGM;BECN1;ULK2;RAB7A;ATG2A;GABARAPL1;ATG101;EMC6;ATG7;ATG12;STX17;RAB19;ATG14
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.22259445040500597,-0.6359967811973818,0.9441117764471058,0.9943455908442357,1.0,7/28,21.58%,BAG3;TNFRSF1A;CASP8;DAB2IP;BID;DEDD;DEDD2
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2823125652282961,0.6358165705680686,0.8747433264887063,1.0,1.0,2/14,7.48%,NCBP2;CPSF6
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.27176421453247757,0.6354147929816177,0.8757396449704142,1.0,1.0,4/19,11.61%,CDIP1;DDIT4;HIPK1;EP300
prerank,presynapse organization (GO:0099172),0.31041369641562494,0.6348636839969283,0.8473118279569892,1.0,1.0,1/10,2.44%,LRRTM3
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.28877970870976055,-0.6344885981032804,0.8878326996197718,0.994806050058093,1.0,5/10,33.27%,BAG3;SIRT2;JUN;HIF1AN;NCK1
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.28175954139839565,0.6330631261524358,0.8672032193158954,1.0,1.0,2/18,5.44%,NF1;CD300A
prerank,quinone biosynthetic process (GO:1901663),0.2765545946768932,0.6327582918701679,0.8555304740406321,1.0,1.0,4/14,20.48%,COQ2;COQ8A;PDSS1;FDXR
prerank,positive regulation of histone modification (GO:0031058),-0.21195211270561987,-0.6318965553301613,0.9538461538461539,0.9960630834754197,1.0,10/33,24.17%,ARRB1;BRD7;SAP30BP;TADA2A;MAPK3;CDK9;NOS1;PPARGC1A;CTBP1;BRCA1
prerank,negative regulation of ATPase activity (GO:0032780),-0.25317550264465716,-0.6313440121901064,0.9214953271028037,0.9959039186787872,1.0,7/16,38.18%,PXK;IFIT1;PLN;TP53;TNNI3;PPIF;VCPKMT
prerank,mRNA processing (GO:0006397),0.18117658484050247,0.6306783449278633,0.9986928104575163,1.0,1.0,89/287,25.17%,CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;CPSF6;TCERG1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;RNMT;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;RPRD1B;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;DDX23;CELF1;HNRNPU;LSM8;UPF3B;GTF2H5;HNRNPC;CCNH;HNRNPH2;ELAVL2;KIN;GTF2H1;PRPF31;SF3B3;ZC3H11A;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;GTF2H4;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;RNGTT;POLDIP3;SRRM4;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;AKAP8L;SMNDC1;THOC2;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40
prerank,establishment of spindle localization (GO:0051293),0.2832308310964079,0.630468519801063,0.8770491803278688,1.0,1.0,2/14,10.17%,CLASP2;NUSAP1
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2352372051754325,-0.6291879630190256,0.9338677354709419,0.9967603071172475,1.0,6/22,22.86%,PWP1;UBTF;EIF2AK3;LYAR;PIH1D1;SMARCA4
prerank,acyl-CoA metabolic process (GO:0006637),0.24290531146652372,0.629080647672528,0.9174664107485605,1.0,1.0,8/35,15.91%,ACSF2;BAAT;ACOT12;HMGCS1;ACOT2;GLYAT;MLYCD;ACOT7
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.2379842409149297,0.628908886453364,0.9237435008665511,1.0,1.0,9/41,11.61%,NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.25694272982680316,0.6285401165520754,0.8884120171673819,1.0,1.0,9/25,25.07%,SRRM1;PRPF6;DDX23;LSM1;SF3B3;KHSRP;SMNDC1;SRSF4;SF3B1
prerank,megakaryocyte differentiation (GO:0030219),0.29105010825772304,0.6283766706402386,0.8245243128964059,1.0,1.0,2/11,9.43%,SH2B3;MED1
prerank,histone ubiquitination (GO:0016574),0.2704363167314982,0.6280012516857976,0.8857142857142857,1.0,1.0,7/21,21.96%,PHC1;UBE2E1;UBR2;CTR9;UBE2B;HUWE1;UBE2A
prerank,negative regulation of transferase activity (GO:0051348),-0.2189380604613202,-0.6276768195567684,0.9436008676789588,0.9972334875158584,1.0,13/28,31.53%,SMAD7;DTX3L;PINX1;EIF4A2;CDKN1B;PARK7;CDKN1C;INPP5K;TP53;BAG5;ABL1;ZFP36;IRS2
prerank,aerobic electron transport chain (GO:0019646),0.21965179059008627,0.6271028597186585,0.9434931506849316,1.0,1.0,6/68,11.86%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COX5A
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.26635435746524616,-0.624403450625328,0.9349904397705545,0.9988518153040844,1.0,3/13,14.53%,SLC4A10;RAB3GAP1;SHISA7
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.1823800946411593,0.6241738986135422,0.9973154362416108,1.0,1.0,76/241,25.71%,CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;DDX23;HNRNPU;LSM8;UPF3B;HNRNPC;HNRNPH2;ELAVL2;PRPF31;SF3B3;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;SMNDC1;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40;RSRC1;RBM5;ZCRB1
prerank,phospholipid catabolic process (GO:0009395),-0.22381830904123107,-0.6227465941887634,0.9367816091954023,0.9993551419501119,1.0,12/24,41.10%,PLA2G4A;SMPDL3A;ENPP2;GDPD3;PLBD2;PLA2G4F;SMPD1;ANGPTL3;ABHD12;GDE1;PLBD1;PNPLA6
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2928543666648159,0.6226128814683729,0.8590021691973969,1.0,1.0,3/11,9.60%,TPK1;DCK;DCTD
prerank,peptide hormone secretion (GO:0030072),-0.2219466865686846,-0.6215462703267837,0.9532520325203252,0.9995439609904878,1.0,2/26,4.34%,ANXA1;LTBP4
prerank,regulation of centrosome duplication (GO:0010824),-0.21856843474323162,-0.6212841591901005,0.9514767932489452,0.9991702518698866,1.0,8/30,27.68%,PDCD6IP;PLK2;CHMP4B;NAT10;ALMS1;CCNF;CENATAC;CHMP5
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.24935437429834278,-0.6195899606079232,0.9314814814814815,0.9996761919696806,1.0,2/15,9.96%,USP46;NLGN2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.2781816157691865,0.6193591748984593,0.8777292576419214,1.0,1.0,7/15,22.32%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.2781816157691865,0.6193591748984593,0.8777292576419214,1.0,1.0,7/15,22.32%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.2909482341056829,0.6190970753421229,0.8767967145790554,1.0,1.0,2/11,12.28%,AKAP6;RNF207
prerank,regulation of defense response to virus (GO:0050688),-0.25478282599437396,-0.6189172971881277,0.9272727272727272,0.9995660267778211,1.0,7/14,33.55%,PCBP2;PPM1B;ELMOD2;RNF216;RNF26;IFNLR1;ITCH
prerank,snRNA metabolic process (GO:0016073),0.2702405509460662,0.6184093070602565,0.8725099601593626,1.0,1.0,3/17,14.00%,RBM7;INTS1;INTS12
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.1767133278037476,-0.6183986378713748,0.9947780678851175,0.9993519452686721,1.0,23/80,28.90%,CAV1;ANGPT1;LRRK2;SMAD7;FKBP1A;BIRC3;PHF23;FANCI;UBB;SPHK1;SPSB4;ARRDC4;CDK5RAP3;FAM107A;BRCA1;PSMD10;CENPX;BCL10;FANCM;TRIB3;PTTG1IP;RPS2;LAPTM5
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.26239298797000365,0.6180940616803821,0.9006479481641468,1.0,1.0,6/18,24.16%,RUVBL1;NOP10;CCT7;CCT3;EXOSC10;DKC1
prerank,positive regulation of interferon-beta production (GO:0032728),-0.21203000178247214,-0.6180693681390412,0.9524886877828054,0.9990131986761791,1.0,4/33,10.93%,IRF1;OAS2;RNF135;MAVS
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2669535784957334,-0.6180159880938638,0.9094202898550725,0.9985183318681857,1.0,1/12,2.35%,HDAC8
prerank,methylguanosine-cap decapping (GO:0110156),-0.28389551462630636,-0.6176109496528905,0.9146825396825397,0.9982359066195897,1.0,2/10,20.17%,EDC3;PNRC2
prerank,indolalkylamine catabolic process (GO:0046218),-0.2766543329729666,-0.6174037144075001,0.9024390243902439,0.997838634455482,1.0,9/10,57.20%,KYNU;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,regulation of chromosome organization (GO:0033044),0.26054536396189143,0.6172644773138343,0.8803245436105477,1.0,1.0,7/22,18.74%,LIG4;WAPL;SETMAR;RB1;SHCBP1L;PIF1;HNRNPD
prerank,negative regulation of phosphatase activity (GO:0010923),-0.22062224584536555,-0.6171435324446921,0.9533333333333334,0.9974674266665271,1.0,3/25,7.47%,PTPA;FKBP1A;SH3RF2
prerank,response to amino acid starvation (GO:1990928),0.21155533998742124,0.6156914851850038,0.9589905362776026,1.0,1.0,13/72,16.73%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,organophosphate catabolic process (GO:0046434),-0.2697334018977313,-0.6156099042101086,0.908745247148289,0.9978600728115532,1.0,7/11,47.98%,ENPP2;PLBD2;ANGPTL3;ABHD12;PLBD1;PDXP;PON1
prerank,isotype switching (GO:0045190),0.2978846774099953,0.6153449603597,0.8571428571428571,1.0,1.0,1/10,6.89%,LIG4
prerank,RNA splicing (GO:0008380),0.19793900854299507,0.6152798051753544,0.9772727272727273,1.0,1.0,33/95,25.97%,DHX15;NCBP2;SFPQ;SRRM1;RNPS1;TCERG1;SNRNP25;PRPF6;CCAR2;DDX47;SCNM1;DDX23;HNRNPC;LSM1;SF3B3;SNRPD3;KHSRP;USB1;FUS;SNRNP48;PPP2R1A;LUC7L3;LSM6;PTBP1;NOL3;SMNDC1;DHX16;SRSF4;SF3B2;SF3B1;RSRC1;ZCRB1;TARDBP
prerank,maturation of LSU-rRNA (GO:0000470),-0.21868482123838842,-0.6148984118755848,0.9543650793650794,0.9977435994920155,1.0,9/26,31.88%,NSA2;RPL7;RPL10A;MRPL1;FTSJ3;NHP2;MAK16;RPF1;URB1
prerank,negative regulation of cell communication (GO:0010648),0.2546665206065867,0.613798043097125,0.8897795591182365,1.0,1.0,2/21,5.24%,IL1B;SOCS5
prerank,synaptic vesicle membrane organization (GO:0048499),0.26546097982019645,0.613745464763319,0.8829568788501027,1.0,1.0,4/17,11.29%,SNAP25;SYNGR1;STX4;SYP
prerank,negative regulation of centrosome duplication (GO:0010826),-0.27276618758868154,-0.6137014698354383,0.9134615384615384,0.997930284450716,1.0,4/11,27.45%,KAT2B;CCNF;BRCA1;CENATAC
prerank,maturation of SSU-rRNA (GO:0030490),-0.2090482001638871,-0.6133993996626605,0.9624217118997912,0.9975687428599412,1.0,5/34,12.38%,RPS14;RPS19;RPS8;RPS16;UTP6
prerank,histone exchange (GO:0043486),-0.20144469473764598,-0.6129966704443771,0.976545842217484,0.9972759782466234,1.0,12/37,27.17%,RBBP7;CENPC;ANP32E;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;RNF8;CENPX;CENPH
prerank,positive regulation of type I interferon production (GO:0032481),-0.18073458423574035,-0.6127555275348685,0.9947229551451188,0.9969074408920593,1.0,12/73,17.26%,IRF1;STAT1;OAS2;RNF135;MAVS;LRRFIP1;RELA;POLR2F;POLR3GL;G3BP1;TLR4;POLR2E
prerank,protein localization to synapse (GO:0035418),0.2849136037111335,0.6126334575312005,0.8608695652173913,1.0,1.0,2/12,12.65%,NRXN1;NPHS1
prerank,determination of left/right symmetry (GO:0007368),0.24063737557033602,0.6125095461055259,0.9257950530035336,1.0,1.0,3/37,10.34%,NOTCH1;PKD2;CITED2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.21361185404979824,0.6120797163679964,0.9585406301824212,1.0,1.0,16/68,19.25%,CLP1;NCBP2;LSM10;PAPOLA;TBP;POLR1E;SYMPK;POLR1A;GTF2H5;CCNH;GTF2H1;SNRPD3;POLR1B;CPSF7;GTF2H4;MED18
prerank,DNA duplex unwinding (GO:0032508),-0.19246551430660436,-0.6114010135732846,0.974477958236659,0.9971304127041242,1.0,13/50,23.71%,ASCC3;ANXA1;SSBP1;CUL4A;UBB;DDB1;RPA1;RAD50;MCMDC2;RECQL;CETN2;RAD51;ERCC2
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.23567597015368175,-0.6113396653844041,0.9387755102040817,0.9966382449920695,1.0,11/19,48.24%,SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4;NPHP3;OFD1;DNAAF1;ADCY10
prerank,transcription preinitiation complex assembly (GO:0070897),0.2769124985409386,0.6104650846826726,0.874,1.0,1.0,5/12,22.70%,TBP;POLR1E;TAF7L;DR1;TAF7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.22684972687145516,-0.6103238483503859,0.9550102249488752,0.9967163192433617,1.0,4/23,14.03%,CCDC186;KIF1B;CCDC88C;TUBA1B
prerank,nucleus organization (GO:0006997),0.2289336057073717,0.6097939795937458,0.9357638888888888,1.0,1.0,9/47,17.70%,SYNE1;CHMP2B;BIN1;NUP35;NDC1;CHMP3;TOR1A;WDR73;NUP133
prerank,regulation of microtubule polymerization (GO:0031113),0.22840416061248087,0.6093131360739403,0.9236363636363636,1.0,1.0,7/40,13.85%,MAP2;NAV3;SNCA;CAMSAP3;PAK1;TUBB4A;DCTN1
prerank,protein K63-linked deubiquitination (GO:0070536),0.23742458341574565,0.608981117931412,0.9274809160305344,1.0,1.0,5/31,17.22%,USP25;OTUD5;USP50;USP33;OTUD7B
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.2677062404010095,0.6089529504422744,0.88,1.0,1.0,3/16,9.38%,MEIOB;ERCC4;HFM1
prerank,establishment of spindle orientation (GO:0051294),-0.21531488841715918,-0.6084671970533495,0.9700854700854701,0.9972652669883783,1.0,9/28,28.82%,GJA1;NDEL1;FBXW11;ZW10;LLGL2;NUMA1;PAFAH1B1;MISP;NDC80
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.2776137379028037,-0.6075714342204239,0.9236641221374046,0.9972356242458127,1.0,6/10,39.62%,VEGFA;CTNNB1;DISC1;KDM1A;CX3CL1;CX3CR1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.28179442460870097,0.6074822256930652,0.8797327394209354,1.0,1.0,4/11,17.60%,MTOR;IPPK;NOL11;DDX11
prerank,oligodendrocyte differentiation (GO:0048709),-0.22863557501269516,-0.6069801077963727,0.9365671641791045,0.9970092976138399,1.0,7/19,28.49%,SLC8A3;SOX13;MYRF;EIF2B2;EIF2B5;EIF2B4;SOX10
prerank,regulation of phospholipase activity (GO:0010517),-0.274458780218433,-0.6067429756460332,0.9254545454545454,0.9966043653606612,1.0,1/10,3.02%,FGFR2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.2866738102824496,0.6063049828670665,0.8757763975155279,1.0,1.0,3/12,13.96%,ADSL;PPAT;IMPDH2
prerank,lipid droplet organization (GO:0034389),0.2529085287713786,0.6056100035021208,0.9016393442622951,1.0,1.0,3/22,10.56%,CDS2;FAF2;SQLE
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.22953373444676142,-0.6054700071873574,0.932806324110672,0.9967609723575415,1.0,6/20,26.43%,AMPD3;ATIC;LHPP;ADSS1;NT5C2;PAICS
prerank,lipoprotein localization (GO:0044872),-0.2642113373302738,-0.6053318708040064,0.935361216730038,0.996317555360309,1.0,2/11,12.72%,PRKCB;UNC119B
prerank,insulin secretion (GO:0030073),0.262359393932036,0.6051723899346213,0.8917748917748918,1.0,1.0,3/19,8.59%,RIMS2;MAFA;RAB11FIP2
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.24970044792236665,0.605063421161155,0.8992395437262357,1.0,1.0,7/22,19.85%,PSMB11;PSME4;PSMB5;PSMA1;PSMB8;PSMA5;PSMB2
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.18932613626985517,-0.6036689198638924,0.987012987012987,0.9966686742225137,1.0,13/51,22.47%,TNKS2;SMG6;NAF1;PINX1;ATM;MAPK3;XRN1;MAP3K4;SMG5;NAT10;TENT4B;ACD;MAP2K7
prerank,telomere maintenance (GO:0000723),0.22300352310323338,0.603439508358304,0.9483985765124555,1.0,1.0,13/50,17.43%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;XRCC3;NSMCE2;PARP1;PTGES3;SMC6;RPA2;TERF1;APEX1
prerank,chromatin remodeling at centromere (GO:0031055),-0.2081593965490291,-0.6030793531579697,0.9567010309278351,0.9964497448823932,1.0,10/31,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2645002902510912,-0.6012395615807596,0.9165154264972777,0.9969173701030621,1.0,5/11,29.36%,TIMM13;TIMM8B;TIMM9;NDUFA13;TIMM10
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.20023652946166126,0.6011508139022645,0.9908814589665653,1.0,1.0,5/86,6.74%,LIMD1;RBX1;EPAS1;PSMB11;PSMF1
prerank,rRNA modification (GO:0000154),0.24761043104262725,0.6007531551103775,0.9273858921161826,1.0,1.0,9/21,24.16%,FBLL1;NSUN3;NOP10;TFB2M;GAR1;DIMT1;TSR3;THUMPD1;DKC1
prerank,chromosome condensation (GO:0030261),0.22875622685267788,0.6005515345271403,0.9528301886792453,1.0,1.0,13/36,26.86%,GPER1;NUSAP1;RB1;SET;NCAPD3;SMC2;CSNK2A2;AKAP8L;NCAPH;BANF2;BANF1;CSNK2A1;NCAPD2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.20563784781260072,-0.6005008604052278,0.966796875,0.9967723315732104,1.0,9/32,26.85%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,purine-containing compound salvage (GO:0043101),0.2822138806027952,0.6000723903134673,0.8833693304535637,1.0,1.0,2/12,8.19%,ADK;DCK
prerank,kinetochore organization (GO:0051383),-0.24996541112638895,-0.5991261326801434,0.9514925373134329,0.9969761460845527,1.0,8/13,36.29%,CENPC;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2639659394984671,0.5984892700563755,0.8593073593073594,1.0,1.0,5/16,17.80%,RBM24;DND1;DHX36;RC3H1;KHSRP
prerank,telomere maintenance via telomerase (GO:0007004),-0.21045969866110448,-0.5980637783327785,0.9432048681541582,0.9969987060021624,1.0,9/28,25.91%,PINX1;ANKRD28;HSP90AB1;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.1699635172020567,0.5969557622833859,1.0,1.0,1.0,70/336,17.60%,FNIP2;CBX5;RBM24;BCL2L10;FMN2;CIDEB;SPDYA;FANCF;FANCG;NUPR2;FBXO45;CBX3;TAOK3;CASP9;NCOA6;CDKN1A;ERCC4;RAD1;UBA1;SLF2;HTRA2;CBX1;LYN;MSH3;OARD1;CSNK1E;MBD4;TIMELESS;EPHA2;CGAS;ATR;SUSD6;ZDHHC16;BRSK1;AKTIP;MCM7;ETAA1;UBA6;OTUB1;PAK1;APC;PSME4;PRKDC;PARP4;CRY1;PSEN1;TANK;MUTYH;NIPBL;RAD17;ATRIP;KMT5B;BLM;PWWP3A;SUV39H1;TDP1;XRCC3;KIN;GTF2H1;PARP1;XPC;ERCC8;SMC6;MRNIP;CHD1L;FMR1;SUMO1;MASTL;APEX1;DDX11
prerank,divalent inorganic cation homeostasis (GO:0072507),0.2481666428741277,0.59669268119164,0.9205426356589147,1.0,1.0,3/25,6.29%,TFAP2B;ANK3;SNCA
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.24789176113634792,0.5966677431703155,0.9226069246435845,1.0,1.0,6/25,19.13%,HEXIM1;TCERG1;HNRNPU;EAF2;LARP7;CDK13
prerank,body fluid secretion (GO:0007589),-0.2382300607206172,-0.594866568777659,0.9363817097415507,0.9981016045489906,1.0,2/15,6.82%,NPR1;SLC22A4
prerank,protein monoubiquitination (GO:0006513),0.22476881347469976,0.5947446590226633,0.9411764705882353,1.0,1.0,6/36,15.58%,CUL3;RBX1;UBE2E1;KLHL12;CTR9;PEX12
prerank,ubiquinone biosynthetic process (GO:0006744),0.25669731352802394,0.5945020745819369,0.8942528735632184,1.0,1.0,4/15,20.48%,COQ2;COQ8A;PDSS1;FDXR
prerank,lipoprotein transport (GO:0042953),-0.2647620777149863,-0.5941202162191637,0.9307116104868914,0.9979544808255338,1.0,2/10,12.72%,PRKCB;UNC119B
prerank,regulation of protein neddylation (GO:2000434),0.2850773015649303,0.5939894695166258,0.9004424778761062,1.0,1.0,5/10,24.23%,EPAS1;DCUN1D2;DCUN1D4;DCUN1D1;RPL5
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.26218223630843757,-0.5930384606575793,0.9219600725952813,0.9979393976329475,1.0,2/11,13.32%,MFHAS1;CYBA
prerank,fatty acid biosynthetic process (GO:0006633),-0.1775500637316436,-0.5930210702662733,0.9951690821256038,0.9974211917917026,1.0,13/63,23.82%,ELOVL7;HACD4;HACD3;GPX4;ACACA;PTGS2;EPHX2;ELOVL1;ALOX12;HSD17B8;XBP1;LPL;OXSM
prerank,ubiquinone metabolic process (GO:0006743),0.2552682479381306,0.592900297166582,0.8982300884955752,1.0,1.0,4/15,20.48%,COQ2;COQ8A;PDSS1;FDXR
prerank,regulation of mitochondrion organization (GO:0010821),0.21897354030519545,0.5923703763128099,0.9698046181172292,1.0,1.0,5/47,12.39%,PID1;SREBF2;HTRA2;EP300;MFF
prerank,phagosome maturation (GO:0090382),0.22710919495000476,0.5906108936018556,0.9355992844364938,1.0,1.0,6/35,10.28%,MREG;ATP6V0E2;PIKFYVE;CORO1A;RAB38;ATP6V1B2
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.24797626082038182,0.59010889298922,0.9337121212121212,1.0,1.0,1/24,1.19%,NOTCH1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2743533511397645,0.5900381439044681,0.9009009009009009,1.0,1.0,4/11,24.16%,FBLL1;LARP7;EXOSC10;DKC1
prerank,mismatch repair (GO:0006298),-0.2120490384148862,-0.5897470902375814,0.9809322033898306,0.9985068461752776,1.0,9/27,30.97%,TDG;RPA1;ERCC1;MSH6;RPA3;POLD1;ABL1;PCNA;EXO1
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.23603534502263607,-0.5896880412733393,0.9381818181818182,0.9980006435973183,1.0,5/16,26.87%,CEBPG;ULBP1;RAET1E;TUBB4B;LYST
prerank,regulation of viral life cycle (GO:1903900),0.2546934435112692,0.5896587801123914,0.9129554655870445,1.0,1.0,2/21,5.49%,AXL;TRIM62
prerank,negative regulation of protein transport (GO:0051224),0.24507153710712115,0.5882093157195585,0.9319066147859922,1.0,1.0,5/25,14.71%,RHBDF1;NDFIP2;CSK;ERP29;HMGCR
prerank,tyrosine metabolic process (GO:0006570),0.27943297865324956,0.5876945581930176,0.8893805309734514,1.0,1.0,2/11,19.04%,TYR;THAP4
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.2038521207166921,-0.586902627324331,0.9746300211416491,0.9987998974156252,1.0,11/30,30.61%,CAVIN1;POLR2F;POLR2E;UBTF;TTF1;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,cellular response to lectin (GO:1990858),0.1916748550975088,0.5865302046698764,0.9925595238095238,1.0,1.0,23/104,21.19%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.1916748550975088,0.5865302046698764,0.9925595238095238,1.0,1.0,23/104,21.19%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,histone H2A monoubiquitination (GO:0035518),0.2593290825922129,0.5862097581618525,0.9085365853658537,1.0,1.0,5/17,16.09%,RYBP;KDM2B;SKP1;BMI1;TRIM37
prerank,intracellular protein transmembrane transport (GO:0065002),0.21749873289615662,0.5859359184056971,0.9512635379061372,1.0,1.0,20/42,28.05%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;TOMM40;PEX12;PEX2;SEC61A2;TOMM70;DNAJC19;PEX5;PAM16;PEX6;TIMM17A;ZFAND2B;DNLZ;TIMM17B;SEC62;CHCHD4
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2144776894397759,-0.5848975838611988,0.9693251533742331,0.9992418632749365,1.0,2/23,8.50%,LGALS9;PIK3R6
prerank,DNA modification (GO:0006304),-0.21527053922958528,-0.5836739237307675,0.9688149688149689,0.9992807363119922,1.0,7/22,26.83%,PARP3;TDG;EXOSC5;ACD;NEIL3;NEIL1;NTHL1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.23738655683212198,-0.5828521615584845,0.939922480620155,0.9991078003808224,1.0,6/15,31.02%,HSP90B1;NPLOC4;VCP;SEC61B;SYVN1;AUP1
prerank,regulation of immunoglobulin production (GO:0002637),-0.21297719167954507,-0.582733037557969,0.97265625,0.9986407188723697,1.0,4/23,22.38%,RBP4;EPHB2;XBP1;CLCF1
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.22639931686127984,-0.5826583922486264,0.9556840077071291,0.9976283678847662,1.0,5/19,24.60%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.22639931686127984,-0.5826583922486264,0.9556840077071291,0.9976283678847662,1.0,5/19,24.60%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,response to histamine (GO:0034776),0.290122886267308,0.5821364583299226,0.8989010989010989,1.0,1.0,5/10,22.21%,GABRG2;AOC1;GABRB3;GABRB2;DRD2
prerank,stress granule assembly (GO:0034063),0.24668303909852246,0.5820284464619481,0.9163265306122449,1.0,1.0,6/20,17.42%,YTHDF3;DDX3X;YTHDF2;LSM14A;PRRC2C;OGFOD1
prerank,ribosomal large subunit assembly (GO:0000027),0.2424731123393363,0.5811695228484031,0.932806324110672,1.0,1.0,5/24,16.43%,FASTKD2;RSL24D1;BRIX1;RPF2;MRPL20
prerank,mitochondrial fission (GO:0000266),0.2585060149130079,0.5799446540144695,0.9067961165048544,1.0,1.0,5/16,17.53%,MTFP1;MFF;MTFR1;MIEF1;DNM1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.26236158366316176,-0.5783616681783038,0.9139784946236559,0.9989365196794149,1.0,5/10,30.27%,PARP14;PTPN2;PIBF1;SOCS1;INPP5F
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2305225348328644,0.5782960485828371,0.9376181474480151,1.0,1.0,6/29,11.00%,WDR46;RRP36;TBL3;NOP14;TSR2;UTP4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.24870179286534427,-0.5777750925511467,0.9674329501915708,0.9986706025119915,1.0,4/12,25.85%,CCND1;RPS27L;PLK5;TP53
prerank,protein K63-linked ubiquitination (GO:0070534),-0.18087314964016912,-0.5773401745473841,0.9888392857142857,0.998341222555116,1.0,17/41,33.55%,WWP2;UBE2E2;RNF135;TRIM27;RNF115;PELI1;TRAF3IP2;RNF126;RNF8;BFAR;PRKN;PRPF19;NEDD4;UBE2V1;TRIM21;RNF152;ITCH
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.23534627604339975,-0.5768951775619044,0.9552238805970149,0.9979993282299604,1.0,7/15,32.06%,RAB3GAP1;RAB3GAP2;SPCS1;SEC61A1;EDEM1;SRP14;SPCS2
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.2577689950123846,0.5759934645472174,0.9239130434782609,1.0,1.0,3/15,13.00%,DDX3X;CPTP;USP50
prerank,DNA-dependent DNA replication (GO:0006261),-0.15283408018963449,-0.575031619684936,1.0,0.9982729178345123,1.0,51/128,36.85%,BAZ1A;SSBP1;PSME2;PSMB4;UBB;CDK2AP1;PSMB1;PSMD11;PSMD8;RPA1;DBF4;PSME3;SIRT7;PSMD4;PSMA2;MCMDC2;RFC3;TEFM;PSMD3;RECQL;PSMB7;POLE2;RFC1;MCM8;RAD51;CDC45;PSMC2;PSMC5;RPA3;PSMD10;SRPK2;POLA1;POLD1;PSMD7;PRIM2;MCM3;POLE3;WRN;MCM5;MCM10;RFC5;PSMD12;PSMB9;PSMA8;RECQL5;CDC34;TWNK;TOPBP1;PRIMPOL;CDC6;GINS2
prerank,positive regulation of chromatin organization (GO:1905269),-0.24827402154953399,-0.5742797792885246,0.9572953736654805,0.9980657039841377,1.0,4/12,22.33%,H3-3A;TAL1;SIN3A;ACD
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.24446402917260074,-0.5740975393617266,0.9491525423728814,0.9976246998115991,1.0,3/12,18.28%,PRPS2;PRPS1;PRPS1L1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.24712247306292406,0.5732447107320282,0.9350912778904665,1.0,1.0,4/20,19.88%,PSMG3;PTGES3;PSMG2;HOPX
prerank,sensory perception of pain (GO:0019233),-0.2195552163249937,-0.572708812683043,0.9683544303797469,0.9977044169341444,1.0,11/21,38.55%,P2RX4;P2RX7;RETREG1;PTGES;TRPA1;CCR2;CCL2;KCNK4;OPRL1;ALOXE3;PROK2
prerank,microtubule-based transport (GO:0099111),-0.2447028359629317,-0.5722866361762172,0.9509090909090909,0.9973480049993725,1.0,8/13,39.68%,SPEF2;ROPN1L;SPAG17;DYNC1I1;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,7-methylguanosine mRNA capping (GO:0006370),0.22515449635228768,0.571940717302465,0.9295238095238095,1.0,1.0,13/31,24.91%,NCBP2;POLR2C;RNMT;GTF2H5;CCNH;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,7-methylguanosine RNA capping (GO:0009452),0.22515449635228768,0.571940717302465,0.9295238095238095,1.0,1.0,13/31,24.91%,NCBP2;POLR2C;RNMT;GTF2H5;CCNH;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,regulation of chromosome segregation (GO:0051983),-0.23373951865905496,-0.5712913155621439,0.9609053497942387,0.9972623117670837,1.0,11/16,50.84%,PUM1;NUMA1;RMI2;MKI67;CDC6;BUB1;IHO1;KIF2C;AURKB;PUM2;HORMAD1
prerank,regulation of exit from mitosis (GO:0007096),0.2186126348558838,0.5684797859190547,0.9570661896243292,1.0,1.0,6/38,15.10%,RGCC;UBE2E1;CDC14B;ANAPC2;ANAPC7;MAD2L1
prerank,protein sumoylation (GO:0016925),-0.17755128025774436,-0.5681369312878787,0.9882629107981221,0.9979849992565601,1.0,12/49,25.93%,EYA1;STX1A;SAE1;NUP98;TPR;NUP88;PIAS4;NUP214;TRPM4;NUP37;PIAS3;NUP155
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.22821340998711132,0.5679535968731988,0.94921875,1.0,1.0,6/27,15.62%,AK8;RRM1;DCTD;AK7;AK5;AK4
prerank,synaptic vesicle exocytosis (GO:0016079),0.21114841296557846,0.5672826013955132,0.9585798816568047,1.0,1.0,7/40,11.38%,SNAP25;RIMS1;RIMS2;SNCA;SYT1;STX4;SYT2
prerank,centromere complex assembly (GO:0034508),-0.1894582317558262,-0.5654368657382368,0.9803063457330415,0.9985166081110831,1.0,12/36,28.91%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPE;CENPU;CENPX;CENPH;CENPF
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21016419971114508,-0.5650147794894934,0.9598214285714286,0.9981593515461381,1.0,8/23,28.82%,GJA1;NDEL1;FBXW11;ZW10;NUMA1;PAFAH1B1;MISP;NDC80
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18964099115156796,0.5632631593840307,0.9884105960264901,1.0,1.0,21/95,17.06%,FANCB;GINS4;SFPQ;MCM6;MEIOB;REC8;ERCC4;PALB2;AUNIP;MCM7;MCM2;REV3L;NIPBL;SEM1;BLM;XRCC3;NSMCE2;PARP1;RNF138;SMC6;RPA2
prerank,negative regulation of interferon-beta production (GO:0032688),-0.26153621057225407,-0.5626927277591487,0.9560229445506692,0.998477512271914,1.0,4/10,26.07%,PPM1B;SIRPA;REL;PTPRS
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.19863985542126972,-0.5625190951850715,0.9734693877551021,0.9980224354811942,1.0,20/29,49.42%,STX7;CYRIB;TYROBP;RAET1E;ITGAM;PVR;FADD;NOS2;SLAMF6;CD226;IL12A;CRTAM;STAP1;IL23A;KLRD1;CD160;SPI1;LAMP1;KLRK1;IL23R
prerank,microtubule depolymerization (GO:0007019),0.2398818132785195,0.5600439059406409,0.950920245398773,1.0,1.0,1/17,3.36%,NCKAP5
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.21878329313069783,0.5596080321267515,0.9530075187969925,1.0,1.0,7/32,15.97%,CDK15;DHFR;NPAT;RB1;CDK14;CDK5;CCNE1
prerank,purine-containing compound biosynthetic process (GO:0072522),0.23237316857248277,0.5585980700981639,0.9512670565302144,1.0,1.0,4/25,10.64%,ADK;ADSL;DCK;PPAT
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.24596067429399743,0.5582699732017469,0.9407894736842105,1.0,1.0,4/16,13.89%,ACKR3;CCAR2;SNAI2;SFRP2
prerank,phagolysosome assembly (GO:0001845),0.2569886078573444,0.558178161190118,0.9291666666666667,1.0,1.0,2/12,8.41%,PIKFYVE;CORO1A
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2331776138943245,-0.5576087698023219,0.9667318982387475,0.9993074216714388,1.0,5/15,28.98%,LEF1;SMARCA4;TAF11;CTDP1;JUN
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.2094636428515287,-0.5573383779508577,0.9695817490494296,0.9988773493060382,1.0,2/20,12.15%,AKR1B1;STARD3
prerank,receptor recycling (GO:0001881),-0.2502077446415339,-0.5570137214245843,0.9530685920577617,0.998473833165407,1.0,3/10,17.95%,PHETA1;ARFGEF2;REP15
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.19423742667638622,-0.5565961121820543,0.9791231732776617,0.9981026312580443,1.0,10/29,27.39%,THRAP3;NOCT;TENT5A;LARP1;ELAVL1;E2F1;TENT5C;DHX34;EIF4ENIF1;GDNF
prerank,reticulophagy (GO:0061709),-0.23870378871465803,-0.5563158022288053,0.96875,0.9976773287437862,1.0,3/12,16.44%,ULK2;RETREG1;ATG2A
prerank,L-serine metabolic process (GO:0006563),-0.2530810182543466,-0.5559603257722192,0.9496268656716418,0.997283750235971,1.0,3/10,19.56%,CBS;SERINC3;SERINC5
prerank,ERAD pathway (GO:0036503),0.1866976125446027,0.5546242998401102,0.9936708860759493,1.0,1.0,16/83,16.33%,FAM8A1;DERL3;FAF2;FOXRED2;UGGT2;SGTB;UBE2J2;ERLIN1;GET4;RNF121;UBXN6;UBQLN2;DNAJC18;RNF103-CHMP3;TMUB2;TOR1A
prerank,protein localization to kinetochore (GO:0034501),-0.22551247684341275,-0.554564691738866,0.9694072657743786,0.9972432074365057,1.0,3/14,15.45%,ZW10;IK;CENPT
prerank,regulation of cellular response to stress (GO:0080135),0.1772010425522524,0.5543451293239503,1.0,1.0,1.0,26/115,18.00%,ADCY8;CORO2B;NUP43;AJUBA;CASP9;AKT1S1;MTOR;NUP35;CCAR2;NEK6;ATR;DYRK3;DNAJC7;SEC13;NUAK1;NDC1;EP300;RANBP2;RSL1D1;CAMK2G;PTGES3;MAPK1;RPA2;HSF1;NUP133;GSK3B
prerank,RNA modification (GO:0009451),0.19925229199300074,0.5538062612264054,0.9873873873873874,1.0,1.0,12/54,17.95%,NSUN3;TRMT61A;TRUB1;SSB;TRMT1;RBM15;NOP10;PUS7;ELP5;NSUN2;NSUN5;AARS1
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.25501030631564503,0.553650619567587,0.9227642276422764,1.0,1.0,2/14,7.20%,ABCD2;IRS1
prerank,long-term memory (GO:0007616),-0.21017894429400796,-0.5525061626784172,0.9625,0.9974301471867553,1.0,1/19,1.96%,APOE
prerank,negative regulation by host of viral transcription (GO:0043922),-0.24027345331086972,-0.5517147790678151,0.9477477477477477,0.9971761298773599,1.0,8/12,52.82%,HDAC1;INPP5K;JUN;CCL5;CCL4;CCL3;POU2F3;REST
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.21487071046357042,0.5515709523388868,0.9672447013487476,1.0,1.0,7/34,15.15%,GRAMD4;CD300A;CACTIN;LYN;SARM1;LRRC14;NFKBIL1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.15666673067432085,-0.5511716099245146,1.0,0.996859358653333,1.0,21/84,24.70%,CDC16;PSME2;ANAPC4;PSMB4;UBB;PSMB1;PSMD11;PSMD8;PSME3;ANAPC16;PSMD4;FZR1;PSMA2;PSMD3;CDC27;PSMB7;ANAPC5;ECRG4;PSMC2;PSMC5;PSMD10
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.24800652979217663,0.5498717877134727,0.9290322580645162,1.0,1.0,14/14,75.22%,CLP1;TSEN15;DDX1;FAM98B;CPSF4;RTRAF;CSTF2;RTCB;TSEN54;TRPT1;ZBTB8OS;CPSF1;TSEN34;TSEN2
prerank,acyl-CoA biosynthetic process (GO:0071616),0.24619046714475623,0.5497032433239338,0.9397089397089398,1.0,1.0,3/16,15.35%,PPT1;PPT2;MLYCD
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.23457486507127243,-0.5493725477538827,0.9474708171206225,0.9969381522706869,1.0,5/12,30.18%,ACO1;IDH3G;ASS1;SIRT4;IDH3B
prerank,protein methylation (GO:0006479),0.20871367292738943,0.5493018191416906,0.9754385964912281,1.0,1.0,12/40,21.24%,METTL21A;EEF1AKMT1;PRMT1;METTL22;PRMT3;PRMT7;SETD3;FAM98A;SNRPD3;NSD3;ATPSCKMT;NTMT1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.23963318286038732,0.5488324997572162,0.9222689075630253,1.0,1.0,1/16,4.79%,AP1G1
prerank,mitochondrial translation (GO:0032543),0.17622211387397507,0.5477468034480207,0.9954128440366973,1.0,1.0,28/104,21.59%,FASTKD2;NOA1;MRPS27;MTIF2;MRPL55;MRPL58;GATB;GFM2;MRPS30;PTCD3;IARS2;GFM1;GATC;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPS17;MRPL47;MRPL40;MRPL37;MRPL2;MRPL11;TSFM;MRPS15
prerank,histone H2B ubiquitination (GO:0033523),-0.24670052778792767,-0.5473871215227419,0.9489603024574669,0.9970653774997112,1.0,4/10,30.79%,DTX3L;RNF40;RNF8;PAF1
prerank,RNA biosynthetic process (GO:0032774),-0.18832831937170347,-0.5464735011919393,0.9850107066381156,0.9968651781323677,1.0,9/31,27.71%,POLR2A;TBPL1;BRF2;RSF1;TTF1;TAF5;POLA1;NAT14;PRIM2
prerank,B cell activation involved in immune response (GO:0002312),-0.23374218754525333,-0.5461187118108697,0.9602272727272727,0.9964724873841702,1.0,3/13,23.81%,CD180;MSH6;RNF8
prerank,telomere organization (GO:0032200),0.20474132262437209,0.5456494497784619,0.9758812615955473,1.0,1.0,10/43,17.43%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;PARP1;PTGES3;RPA2;TERF1;APEX1
prerank,mitotic metaphase plate congression (GO:0007080),0.19941829669505112,0.5443097991263964,0.9730215827338129,1.0,1.0,4/51,6.20%,RMDN1;CUL3;CHAMP1;CHMP2B
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.232984203365235,0.5424046885308829,0.9494949494949495,1.0,1.0,1/17,2.89%,EMC7
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.22837541064068198,0.5418060582731928,0.9731285988483686,1.0,1.0,8/21,25.65%,NES;TOX;SMARCD3;NAP1L1;FZD9;DRD2;FZD3;DISP3
prerank,tRNA wobble base modification (GO:0002097),-0.22162979713859013,-0.5405899050976339,0.9696969696969697,0.9976665439519645,1.0,6/14,36.28%,ELP3;URM1;KTI12;ADAT2;CTU2;CTU1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.25901784632217156,0.5396472566472478,0.9156118143459916,1.0,1.0,4/10,23.88%,LYN;MAPK1;NBR1;GREM1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.21601727312619556,0.5379873227784893,0.9569288389513109,1.0,1.0,10/29,20.33%,RBX1;GTF2H5;CCNH;GTF2H1;PARP1;XPC;CHD1L;RPA2;GTF2H4;DDB2
prerank,organelle disassembly (GO:1903008),0.20985495267558626,0.5374258828808368,0.9628942486085343,1.0,1.0,6/33,14.05%,PELO;MTIF2;UFM1;DYRK3;GFM2;ATG2B
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.20071882509691175,-0.5372183930653248,0.9835051546391752,0.9981712145530239,1.0,5/22,22.50%,TOM1L1;RNF115;VPS28;RNF126;VPS37D
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2140584920943294,-0.5361132956968129,0.9830148619957537,0.9979806510184379,1.0,6/17,26.83%,ERCC5;TDG;ACD;NEIL3;NEIL1;NTHL1
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.23917007274012664,0.534439433971202,0.9405737704918032,1.0,1.0,3/17,13.54%,ALG12;ALG1;DHDDS
prerank,positive regulation of histone deacetylation (GO:0031065),0.24347818644626523,0.534411809977017,0.9422222222222222,1.0,1.0,5/12,22.92%,PRKD2;NIPBL;PRKD1;AKAP8;AKAP8L
prerank,snRNA transcription (GO:0009301),-0.15746557035029102,-0.5335768370759572,1.0,0.9982278552991637,1.0,16/70,26.26%,POLR2A;NABP1;POLR2F;INTS11;POU2F1;CDK9;RPRD2;POLR2E;POU2F2;TAF5;ICE1;INTS5;POLR2G;CDK7;SNAPC4;TAF11
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.1585743894365953,-0.5326762884761511,1.0,0.9979712811208402,1.0,16/69,26.26%,POLR2A;NABP1;POLR2F;INTS11;POU2F1;CDK9;RPRD2;POLR2E;POU2F2;TAF5;ICE1;INTS5;POLR2G;CDK7;SNAPC4;TAF11
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.23037055072238993,0.5305860942771323,0.9411764705882353,1.0,1.0,1/17,4.79%,AP1G1
prerank,glycolytic process (GO:0006096),0.21330381888759184,0.5305113538436439,0.9595959595959596,1.0,1.0,9/28,24.37%,GCK;ALDOC;GPI;PFKM;PKM;ENO2;PGM1;PFKFB2;PGK1
prerank,negative regulation of DNA recombination (GO:0045910),-0.17019631722600614,-0.5296595365909859,0.9934924078091106,0.9982826541385674,1.0,11/43,24.60%,POLR2A;PARP3;POLR2F;SHLD1;POLR2E;ACD;RMI2;KLHL15;MSH6;PARPBP;POLR2G
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.20414886629687254,-0.5295972372236835,0.9776536312849162,0.9977888960536253,1.0,11/18,52.86%,BID;TMEM14A;ZNF205;HIP1R;BAX;SLC25A5;GSK3A;BOK;MPV17L;TMEM102;MUL1
prerank,positive regulation of telomere capping (GO:1904355),-0.2087193035488515,-0.5295622736531552,0.9806949806949807,0.9972870263560307,1.0,5/17,26.85%,TNKS2;MAPK3;MAP3K4;MAP2K7;NEK7
prerank,meiosis I (GO:0007127),0.2226706241084339,0.5294214447269651,0.9497991967871486,1.0,1.0,4/23,15.65%,MEIOB;BRDT;PTTG1;SLC25A31
prerank,tRNA modification (GO:0006400),0.19036507154189453,0.5291623785089763,0.9918300653594772,1.0,1.0,18/62,24.31%,TRMT61A;TRMT5;TRUB1;SSB;TRMT1;THUMPD2;PUS7;ELP5;MTO1;NSUN2;AARS1;ALKBH1;METTL6;THUMPD1;GTPBP3;TRMT10A;TRMT9B;TRDMT1
prerank,dendritic cell chemotaxis (GO:0002407),-0.21612386946738188,-0.5282851072669468,0.9715370018975332,0.9971107114654075,1.0,8/14,42.44%,TRPM4;CCL19;TRPM2;CCR2;CXCR4;PIK3CG;CCL5;CCR1
prerank,outer dynein arm assembly (GO:0036158),0.2329524048725355,0.5281591994077197,0.9419354838709677,1.0,1.0,15/15,76.73%,CCDC63;ODAD4;DNAH5;CCDC103;LRRC49;DNAAF5;ZMYND10;DNAAF1;ODAD1;DNAAF4;DNAH17;DNAL1;ODAD3;ODAD2;DNAH8
prerank,regulation of T cell activation (GO:0050863),0.20073068805292898,0.527980743617551,0.9801801801801802,1.0,1.0,2/42,3.86%,PTPN22;PAG1
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.24455103242881532,0.5269105910171971,0.9592274678111588,1.0,1.0,3/10,14.23%,VPS9D1;ATP5F1A;ATP5PO
prerank,regulation of interferon-beta production (GO:0032648),-0.16649859920430857,-0.5255566606681977,0.9906759906759907,0.9973398078364552,1.0,11/46,26.07%,IRF1;OAS2;RNF135;MAVS;PPM1B;SIRPA;TLR4;POLR3D;RNF216;REL;PTPRS
prerank,DNA replication checkpoint signaling (GO:0000076),0.23428571428571454,0.5254173845219453,0.9563492063492064,1.0,1.0,16/16,76.59%,TIMELESS;RAD17;TIPIN;DNA2;RAD9A;NAE1;CLSPN;ORC1;RAD9B;CDT1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;CDC45
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2251808702973631,-0.5251109249558491,0.9768339768339769,0.9969479404831889,1.0,1/12,6.61%,PRKCB
prerank,transcription by RNA polymerase III (GO:0006383),-0.1842059040170687,-0.5240647446821916,0.9938398357289527,0.9967009695882532,1.0,7/27,26.25%,IVNS1ABP;POLR3GL;GTF3C2;GTF3C5;GTF3C1;ICE1;SNAPC4
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.19396445482759958,-0.5238453400530926,0.9919191919191919,0.9962456435417384,1.0,9/22,34.32%,MMS19;ISCA2;CIAPIN1;NUBP1;HSPA9;CIAO2B;IBA57;NUBP2;CIAO2A
prerank,DNA catabolic process (GO:0006308),-0.23063974093397493,-0.5229759818711172,0.9682835820895522,0.9959603340532529,1.0,3/11,21.23%,REXO4;DNASE1L1;DFFB
prerank,canonical glycolysis (GO:0061621),0.21199843612570246,0.5215797448070112,0.9574036511156186,1.0,1.0,6/24,18.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,glucose catabolic process to pyruvate (GO:0061718),0.21199843612570246,0.5215797448070112,0.9574036511156186,1.0,1.0,6/24,18.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.182132270713244,-0.5196552123401427,0.980544747081712,0.9962942027693016,1.0,1/27,1.24%,LPAR1
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.22688977876442412,0.5189368411510277,0.9663366336633663,1.0,1.0,2/15,10.41%,CUL3;DYRK3
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.19120190207203852,-0.5187835128546787,0.9779559118236473,0.9959885602590729,1.0,3/21,13.57%,RAB11A;RAD51B;CCND1
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.23932273774274332,0.5163918027446536,0.9313929313929314,1.0,1.0,1/11,6.95%,LIPC
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23540123069195035,0.5144038674565533,0.9590643274853801,1.0,1.0,15/15,76.48%,FANCD2;RAD17;MDC1;MUS81;TIPIN;RAD9A;MRE11;EME2;RAD9B;EME1;NEK11;HUS1B;HUS1;ATF2;CHEK2
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.17207686828427826,-0.5136872351765245,0.9844789356984479,0.9966789562317406,1.0,11/35,32.01%,TDG;RPA1;ADPRS;RFC3;RFC1;RPA3;NEIL1;NTHL1;POLD1;PCNA;RFC5
prerank,negative regulation of lipid catabolic process (GO:0050995),0.22352437275159745,0.5131557412240344,0.9609856262833676,1.0,1.0,1/17,2.62%,IL1B
prerank,"phototransduction, visible light (GO:0007603)",-0.21320879592384712,-0.512357418991557,0.9647495361781077,0.9964780387319705,1.0,3/14,26.05%,ABCA4;RP1;GNAQ
prerank,steroid hormone biosynthetic process (GO:0120178),0.1997545501883237,0.5111109656634907,0.9636015325670498,1.0,1.0,5/29,13.32%,MED1;DHCR7;STAR;SRD5A1;CYP11B1
prerank,microglial cell activation (GO:0001774),-0.19470951494982283,-0.5092839420023807,0.9758364312267658,0.9966709822341632,1.0,1/21,2.11%,APP
prerank,iron-sulfur cluster assembly (GO:0016226),-0.1853737469016316,-0.5092818672039258,0.993801652892562,0.9961630476832822,1.0,11/24,39.43%,MMS19;ISCA2;CIAPIN1;NUBP1;HSPA9;CIAO2B;IBA57;NUBP2;CIAO2A;GLRX3;NFS1
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.20503224050011257,0.5092118547348972,0.9681274900398407,1.0,1.0,6/25,18.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,pyruvate metabolic process (GO:0006090),0.1823599297065088,0.5090308640727917,0.9893617021276596,1.0,1.0,10/52,16.87%,SLC16A3;GCK;ALDOC;PDHX;SRR;GPI;PFKM;PCK2;DLD;PKM
prerank,chromatin disassembly (GO:0031498),0.2288077243951711,0.5086013783857267,0.9643605870020965,1.0,1.0,4/14,19.37%,SET;SMARCD3;NFE2;SMARCD1
prerank,nucleosome disassembly (GO:0006337),0.2288077243951711,0.5086013783857267,0.9643605870020965,1.0,1.0,4/14,19.37%,SET;SMARCD3;NFE2;SMARCD1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.2353568962270075,0.5071744469380746,0.9497907949790795,1.0,1.0,12/12,76.48%,SETMAR;RAD17;NAE1;CLSPN;ORC1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;STK33;CHEK2
prerank,synaptic vesicle transport (GO:0048489),-0.22304201690395759,-0.5071102125362833,0.9658886894075404,0.9961282213555152,1.0,2/11,16.11%,RAB27A;SYNJ1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.20151329614127816,-0.5055769293966881,0.9879759519038076,0.9959416854587325,1.0,6/17,31.02%,HSP90B1;NPLOC4;VCP;SEC61B;SYVN1;AUP1
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.2181894522665988,0.5051959437494947,0.9459459459459459,1.0,1.0,6/17,23.94%,CHAMP1;RB1;CENPA;SPDL1;MTBP;ZWILCH
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.17586838701354698,0.5005673019433412,0.998371335504886,1.0,1.0,17/70,19.85%,TCF15;PSMB11;N4BP2L2;PSMF1;MYB;TCF12;YTHDF2;PSME4;PRKDC;PUS7;KMT2A;PSMB5;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2
prerank,nuclear envelope organization (GO:0006998),0.21045056057940822,0.5005065122011657,0.9624060150375939,1.0,1.0,5/20,22.75%,TOR1B;EMD;TOR1A;LEMD3;SUN2
prerank,phosphate ion transmembrane transport (GO:0035435),-0.21529717586922975,-0.5003077859378353,0.9823529411764705,0.9965068362950215,1.0,4/12,27.90%,SLC20A2;SLC37A1;SLC37A2;SLC25A11
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.1692674050819893,-0.4989256507852765,0.9939516129032258,0.9962804053276233,1.0,9/35,26.85%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.1836154249544614,-0.49838968743624446,0.9876796714579056,0.9958730722658065,1.0,8/24,28.30%,CXCL12;TPT1;SNAI1;TAF9B;BCL2L1;CD44;CDKN2D;CLU
prerank,histone H3-K4 methylation (GO:0051568),0.20015823073516437,0.49834119446694924,0.9783037475345168,1.0,1.0,7/26,19.14%,OGT;KMT2B;SETMAR;CTR9;KMT2A;KMT2D;WDR5
prerank,male meiosis I (GO:0007141),0.22423861852433286,0.4962664466040872,0.9541666666666667,1.0,1.0,16/16,77.60%,BRDT;SLC25A31;FOXJ3;ING2;FOXJ2;ZSCAN21;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;MYBL1;DDX4;TDRD9;SYCP3;HSF2BP
prerank,peptidyl-lysine trimethylation (GO:0018023),0.20402281456559265,0.49514924927246284,0.98,1.0,1.0,9/26,19.72%,OGT;CTR9;SETD3;KMT5B;SUV39H1;KMT2A;KMT2D;SETD5;ATPSCKMT
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.23168706503209735,0.49143375571171954,0.9465811965811965,1.0,1.0,3/10,20.85%,LYN;CD24;LILRB1
prerank,DNA replication (GO:0006260),0.15991076283890338,0.49139413955566097,0.9984076433121019,1.0,1.0,20/105,17.51%,KAT7;MCM6;RBMS1;RAD1;WRNIP1;TIMELESS;ATR;MCM7;MCM2;SET;REV3L;RAD17;ATRIP;BLM;ORC4;KIN;PIF1;NAP1L1;RPA2;RHNO1
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.21539335946120067,0.49087845083388837,0.9513742071881607,1.0,1.0,5/16,23.01%,TRA2A;DAZAP1;RBMX;RBM3;CIRBP
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.21258064981675034,0.49060293088394913,0.973305954825462,1.0,1.0,2/19,8.19%,ADK;DCK
prerank,synaptic vesicle localization (GO:0097479),0.22647937554196518,0.4902884078082042,0.955456570155902,1.0,1.0,4/13,16.33%,KIF5C;SYNDIG1;CDK5;TOR1A
prerank,vesicle transport along microtubule (GO:0047496),0.20592993550452052,0.48998128816527237,0.9787644787644788,1.0,1.0,8/23,19.15%,KIF3A;TRAK1;TRAK2;RAB1A;NDE1;HTT;HAP1;KIF1A
prerank,DNA packaging (GO:0006323),-0.193170631488027,-0.48945001805598803,0.981651376146789,0.9969890565358198,1.0,10/16,49.58%,AIFM1;HAT1;CHAF1A;TP53;NAA10;RBBP4;CHAF1B;NOC2L;M1AP;H1-0
prerank,replication fork processing (GO:0031297),-0.1644083502107042,-0.48934373473517007,0.9954853273137697,0.9965043906391582,1.0,21/38,47.06%,SAMHD1;BRCA2;CDK9;THOC1;RAD51;CENPX;FANCM;WRN;PCNA;FAM111A;ATRX;PRIMPOL;ZRANB3;ALYREF;NUCKS1;EME1;GEN1;TONSL;RTEL1;CENPS;MMS22L
prerank,regulation of DNA recombination (GO:0000018),0.1949762659638895,0.4880696762079609,0.9830827067669173,1.0,1.0,6/32,17.06%,IL4;MSH3;KPNA1;PPP4C;BLM;RPA2
prerank,autophagosome organization (GO:1905037),0.17880062341094247,0.48752170812768325,0.9966887417218543,1.0,1.0,18/50,24.89%,ATG16L1;ATP2A2;TP53INP2;UBXN2B;ATG2B;UBQLN2;VMP1;RAB1A;PIK3C3;ULK3;RAB1B;GABARAP;GABARAPL2;ATG13;ATG9A;TMEM41B;ATG16L2;UBXN2A
prerank,rRNA 3'-end processing (GO:0031125),-0.22265492664483666,-0.4873272387132728,0.9810606060606061,0.996314819920755,1.0,4/10,39.16%,ERI3;EXOSC7;RPS21;ERI1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.23168210915154644,0.4841284328856666,0.9626168224299065,1.0,1.0,3/10,24.16%,CCT7;CCT3;DKC1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.20726494345564056,0.48305604785330875,0.9786407766990292,1.0,1.0,11/22,28.56%,MED13;MED1;MED4;DHX36;MED30;MED16;MED14;PSMC3;SUB1;PSMC4;MED17
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.22686737828313136,0.4830233251202017,0.95,1.0,1.0,6/11,28.68%,UGGT2;TOR1A;POMT2;DERL1;BAG6;UGGT1
prerank,negative regulation of defense response to virus (GO:0050687),0.22711030088549886,0.4821802095317546,0.9722814498933902,1.0,1.0,3/10,16.99%,TARBP2;C1QBP;TRAF3IP1
prerank,protein targeting to mitochondrion (GO:0006626),0.17351656271644822,0.4815537249571427,0.9963898916967509,1.0,1.0,18/52,26.75%,IMMP2L;TIMM22;GRPEL2;TOMM40L;MFF;TIMM23;TOMM40;MIPEP;PMPCB;TOMM70;PITRM1;AGK;DNAJC19;PAM16;TIMM17A;DNLZ;HSP90AA1;TIMM17B
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.20613576955636279,0.48148876588177003,0.9758551307847082,1.0,1.0,1/19,3.23%,UGP2
prerank,modulation by host of symbiont process (GO:0051851),-0.16887297098027787,-0.4804139055814386,0.997907949790795,0.996898523022559,1.0,14/31,41.46%,LEF1;SAP30BP;HDAC1;SMARCA4;INPP5K;TAF11;CTDP1;JUN;AQP1;CCL5;CX3CR1;NUCKS1;SAP30;CCL4
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.2189076101124437,0.48034144019136765,0.9753363228699552,1.0,1.0,4/16,14.32%,MCM6;MCM7;MCM2;BLM
prerank,mitotic chromosome condensation (GO:0007076),0.1913645471451724,0.4797139466955425,0.9879032258064516,1.0,1.0,10/26,26.86%,NUSAP1;RB1;SET;NCAPD3;SMC2;CSNK2A2;AKAP8L;NCAPH;CSNK2A1;NCAPD2
prerank,positive regulation of interferon-alpha production (GO:0032727),0.2121785318199194,0.4787094174699617,0.9714285714285714,1.0,1.0,2/19,7.58%,DDX3X;RIPK2
prerank,mRNA transport (GO:0051028),0.16031053559139752,0.47729684571098246,1.0,1.0,1.0,29/101,25.17%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;KIF5C;UPF3B;EIF4E;RANBP2;ZC3H11A;FMR1;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;ZFP36L1;THOC2;SEH1L;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,nuclear pore organization (GO:0006999),0.2109807224372207,0.4755593310245184,0.9720430107526882,1.0,1.0,3/14,17.70%,NUP35;NDC1;NUP133
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.20838267662818627,0.47527044691487014,0.9740518962075848,1.0,1.0,6/18,22.97%,PCID2;ZC3H11A;NUP133;DDX25;POLDIP3;THOC2
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.23111929014644744,0.4750572150305666,0.9735772357723578,1.0,1.0,3/10,17.24%,BLM;XRCC3;TERF1
prerank,t-circle formation (GO:0090656),0.23111929014644744,0.4750572150305666,0.9735772357723578,1.0,1.0,3/10,17.24%,BLM;XRCC3;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.23111929014644744,0.4750572150305666,0.9735772357723578,1.0,1.0,3/10,17.24%,BLM;XRCC3;TERF1
prerank,tRNA wobble uridine modification (GO:0002098),-0.19221353379970244,-0.4730784651648667,0.9851851851851852,0.9974884513750685,1.0,6/14,36.28%,ELP1;ELP3;URM1;KTI12;CTU2;CTU1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.19957314447808547,0.4706834185084437,0.9897750511247444,1.0,1.0,2/22,7.63%,KAT7;TCERG1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.17902980547505712,0.46945341724947287,1.0,1.0,1.0,6/40,14.32%,MSH3;TIMELESS;ATR;ETAA1;SETMAR;BLM
prerank,RNA 3'-end processing (GO:0031123),0.16332348344481815,0.4672628349747284,0.9983416252072969,1.0,1.0,8/69,11.42%,CLP1;NCBP2;SUPV3L1;SRRM1;PAPOLA;RNPS1;SYMPK;RPRD1B
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.18661061459647077,0.4667229778996563,0.9902534113060428,1.0,1.0,2/29,5.68%,LIMK1;MAGEC2
prerank,mRNA export from nucleus (GO:0006406),0.1546135518484785,0.46315728490767066,1.0,1.0,1.0,21/102,20.86%,NUP43;NCBP2;SRRM1;RNPS1;PCID2;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;POLR2D;HNRNPA2B1;DDX25;POLDIP3;SRSF9
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.19833188232250895,0.4630499915811668,0.9629629629629629,1.0,1.0,6/19,19.23%,MTOR;MAF1;DHX36;CHD8;POLR3F;TENM1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.20420943315947587,0.46297687659633335,0.975051975051975,1.0,1.0,6/19,22.98%,SREBF2;HTRA2;CAMKK2;HTT;CSNK2A2;VDAC1
prerank,negative regulation of viral release from host cell (GO:1902187),0.21369471161226095,0.46266028559969385,0.9714285714285714,1.0,1.0,1/13,3.31%,MID2
prerank,cellular response to UV-A (GO:0071492),-0.20354429619990277,-0.46230593484467497,0.9919354838709677,0.9984133895121443,1.0,2/11,15.44%,PPID;MMP2
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.21111606695852858,0.4616732449487819,0.9707112970711297,1.0,1.0,1/13,3.68%,DERL3
prerank,neuromuscular process (GO:0050905),0.20740730471898086,0.46002036797898904,0.9827956989247312,1.0,1.0,1/16,3.16%,NRXN1
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.17358418841000872,0.4570492871807129,0.9945750452079566,1.0,1.0,4/31,12.82%,LSS;STAR;PRLR;SRD5A1
prerank,aerobic respiration (GO:0009060),0.19147963880385543,0.4570332434668359,0.9844357976653697,1.0,1.0,5/20,20.21%,BLOC1S1;UQCRC2;MTFR1;OXA1L;SURF1
prerank,regulation of histone deacetylation (GO:0031063),-0.19488248860414867,-0.4562489732566124,0.9942418426103646,0.9985904578031327,1.0,3/13,28.35%,SAP30BP;CTBP1;SPHK2
prerank,DNA recombination (GO:0006310),0.1747372115771502,0.4540182300417186,0.9926739926739927,1.0,1.0,8/37,17.51%,SUPV3L1;LIG4;MSH3;TSN;BLM;XRCC3;HDAC10;RHNO1
prerank,phosphate ion transport (GO:0006817),-0.18284105539267298,-0.4524438052621192,0.9860834990059643,0.9984910765361584,1.0,1/16,4.14%,SLC20A2
prerank,aminoglycan metabolic process (GO:0006022),0.21680999309522309,0.4502437147522041,0.9821826280623608,1.0,1.0,10/10,78.33%,B3GALT6;CHST9;B3GAT1;B3GAT2;B4GALT7;XYLT2;GAL3ST3;B3GAT3;XYLT1;CLN6
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.17694850504086723,-0.44643064554249295,0.9961013645224172,0.9985998857974928,1.0,6/16,34.13%,DDX5;SRSF6;PUF60;HNRNPM;PQBP1;CELF4
prerank,protein-DNA complex disassembly (GO:0032986),-0.18048929319795728,-0.44626150400724535,0.9922928709055877,0.9981124004883539,1.0,6/16,36.43%,SMARCC1;RPL23;SMARCA4;SMARCD2;MYC;GRWD1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.19880436270835591,0.44625592102843364,0.9852320675105485,1.0,1.0,1/15,4.81%,CLP1
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.1617954386781586,-0.446155692091667,0.9939879759519038,0.9976174785878739,1.0,11/22,43.08%,ERI3;FTSJ3;EXOSC7;RRS1;ABT1;URB1;RPS21;RPP40;ERI1;KRI1;UTP20
prerank,tRNA 5'-leader removal (GO:0001682),-0.1797365392203443,-0.4429125477364641,0.9981481481481481,0.9974423613905685,1.0,6/13,37.73%,PRORP;RPP38;POP1;RPP25L;RPP21;RPP40
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.17654305463356162,0.4409518966669375,0.991869918699187,1.0,1.0,9/25,26.09%,KAT7;CCAR2;EAF2;SETD5;CCNK;TSFM;CCNT2;WDR43;LDB1
prerank,DNA replication initiation (GO:0006270),0.16890211944894112,0.4398227481981905,0.9962825278810409,1.0,1.0,7/37,17.07%,MCM6;MCM7;MCM2;PRIM1;ORC4;RPA2;POLE4
prerank,protein localization to condensed chromosome (GO:1903083),0.20431168141650852,0.43703886477054527,0.9878048780487805,1.0,1.0,1/12,5.19%,CHAMP1
prerank,RNA export from nucleus (GO:0006405),0.14590845665448032,0.4364022723483789,1.0,1.0,1.0,14/100,14.55%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;HNRNPA1;UPF3B;EIF4E;RANBP2
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.2071547170141656,0.4355856811502194,0.9825708061002179,1.0,1.0,1/10,6.29%,SNCA
prerank,tRNA processing (GO:0008033),0.15301133306887074,0.43414416225789715,1.0,1.0,1.0,18/61,24.31%,CLP1;TRMT61A;TRUB1;SSB;TRMT1;ADAT1;TRMT10C;ELP5;NSUN2;AARS1;POP7;POP5;TSEN15;DDX1;THUMPD1;TRMT10A;TRMT9B;TRDMT1
prerank,mitochondrial translational elongation (GO:0070125),0.1424553636328178,0.4316369850758024,1.0,1.0,1.0,29/88,25.61%,MRPS27;MRPL55;MRPL58;GFM2;MRPS30;PTCD3;GFM1;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPS17;MRPL47;MRPL40;MRPL37;MRPL2;MRPL11;TSFM;MRPS15;MRPL42;DAP3;MRPS11;MRPL32;MRPL14;MRPS16;MRPL41
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.18529541995602872,0.42739080738214663,0.9958333333333333,1.0,1.0,3/20,11.89%,AGO3;TARBP2;TSN
prerank,regulation of catecholamine secretion (GO:0050433),0.1731772037169964,0.42558552492502216,0.9961089494163424,1.0,1.0,11/29,24.87%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT6;SYT10
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.14294426875752825,0.4255707273780559,1.0,1.0,1.0,26/96,25.17%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;THOC2;SEH1L;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,nuclear membrane disassembly (GO:0051081),0.19304693426732422,0.4230250377498076,0.9875,1.0,1.0,5/14,26.40%,NEK6;DCTN1;NEK9;AKAP8L;VRK1
prerank,regulation of interferon-alpha production (GO:0032647),0.17803674843287465,0.41957903660549395,0.9858012170385395,1.0,1.0,2/23,7.58%,DDX3X;RIPK2
prerank,C4-dicarboxylate transport (GO:0015740),0.1899001140882963,0.419446644124641,0.9894291754756871,1.0,1.0,1/14,5.46%,SLC25A13
prerank,pre-replicative complex assembly (GO:0036388),0.1469282061890863,0.41676816074729683,1.0,1.0,1.0,14/64,19.94%,PSMB11;PSMF1;MCM6;MCM7;MCM2;PSME4;ORC4;PSMB5;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;ORC6
prerank,lipid biosynthetic process (GO:0008610),0.14062988456774814,0.4152488162423294,1.0,1.0,1.0,12/77,15.35%,LIPH;LIPC;LSS;STAR;PRLR;SRD5A1;PRKAA1;OLAH;HMGCR;PDSS1;LPCAT1;MLYCD
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.18545960706446382,-0.412612218337805,1.0,0.9990300616584112,1.0,2/10,22.85%,NAF1;PIH1D1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.12700312523951013,-0.41241641174179383,1.0,0.9985371230282973,1.0,2/53,3.96%,CALCRL;ANXA1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.17954319039168434,0.41013733745114,0.9959514170040485,1.0,1.0,5/19,19.22%,CHMP2B;CEP97;HNRNPU;CHMP3;DRG1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.19088776613842376,0.4096387213842197,0.9861660079051383,1.0,1.0,5/13,22.99%,PCID2;MAD2L1;XRCC3;DYNC1LI1;CDK5RAP2
prerank,mRNA 3'-end processing (GO:0031124),0.1387782104541191,0.404620732864335,1.0,1.0,1.0,25/78,26.69%,CLP1;NCBP2;SRRM1;PAPOLA;RNPS1;CPSF6;SYMPK;RPRD1B;UPF3B;ZC3H11A;CPSF7;POLR2D;POLDIP3;SRSF9;PABPC1;THOC2;EIF4A3;TUT1;SRSF4;CASC3;CDC40;LEO1;PAPOLG;TENT2;SRSF3
prerank,regulation of centrosome cycle (GO:0046605),-0.15560646535248657,-0.4031775454755383,1.0,0.998488995614526,1.0,2/21,10.71%,PDCD6IP;CHMP4B
prerank,RNA transport (GO:0050658),0.13264533040342155,0.3809220759636004,1.0,1.0,1.0,20/71,25.17%,RFTN1;NCBP2;SRRM1;RNPS1;KIF5C;HNRNPA1;UPF3B;EIF4E;ZC3H11A;FMR1;HNRNPA2B1;POLDIP3;SRSF9;ZFP36L1;THOC2;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.17235267396826826,0.37985995210178314,0.9870410367170627,1.0,1.0,4/13,19.42%,PTPN1;ABCA7;DDRGK1;PPP1R15A
prerank,androgen metabolic process (GO:0008209),0.159579363695452,0.3709189077917334,0.998003992015968,1.0,1.0,3/18,19.52%,MED1;SRD5A1;HSD17B4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.16885317933588606,0.3449416225153018,1.0,1.0,1.0,10/10,83.13%,APC;KNSTRN;CDC42;RACGAP1;ECT2;NEK2;CCNB1;RCC2;SPAG5;SIRT2
prerank,ncRNA metabolic process (GO:0034660),0.13043967882283114,0.34155232547315945,1.0,1.0,1.0,5/37,17.80%,PLD6;TARBP2;TDRKH;EXD1;KHSRP
prerank,tRNA 5'-end processing (GO:0099116),0.14867445821823125,0.33296922820932623,1.0,1.0,1.0,4/15,21.95%,SSB;TRMT10C;POP7;POP5
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.1427764174044075,0.3223217727718112,1.0,0.9997575274425722,1.0,14/14,85.73%,WDR12;RPF2;DDX18;NOL9;PES1;ZNHIT6;ZNHIT3;BOP1;NIFK;RPL35;RPL7L1;URB1;FTSJ3;RPL7
